Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.7871138738374603,2.5464839253190985,0.0,0.0,0.0,61/87,12.18%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;ZFAND2B;SRP68;RPS6;SEC63;RPL4;RPL22;RPL15;RPL10;RPL32
prerank,cotranslational protein targeting to membrane (GO:0006613),0.7684832573417002,2.5372065668222676,0.0,0.0,0.0,60/91,12.18%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;SRP68;RPS6;SEC63;RPL4;RPL22;RPL15;RPL10;RPL32
prerank,cytoplasmic translation (GO:0002181),0.7571558117233619,2.4894988221693075,0.0,0.0,0.0,61/91,12.67%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPSA;RPL41;RPS28;RPL13;EIF3M;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;RPL22L1;RPS6;RPL4;EIF3I;RPL22;RPL15;RPL10;RPL32;ETF1
prerank,protein targeting to ER (GO:0045047),0.7382043932947684,2.4516899437928568,0.0,0.0,0.0,62/99,12.18%,RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;RPL6;ZFAND2B;SRP68;RPS6;SEC63;SRPRB;RPL4;RPL22;RPL15;RPL10;RPL32
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.7119820736105104,2.3956051343442915,0.0,0.0,0.0,68/110,14.84%,DHX34;RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;EIF3E;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;SMG6;RPL37A;RPS11;RPL28;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;DCP1A;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;PPP2CA;RPL6;RPS6;RPL4;RPL22;RPL15;RPL10;RPL32;ETF1;MAGOHB;RPL19;RPL31;RPL11
prerank,regulation of immune effector process (GO:0002697),0.8002617598399395,2.3092920471160117,0.0,0.0001782808749047671,0.001,15/41,6.82%,C4B;FCGR2B;CFH;CFP;C1QC;IRF4;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,regulation of humoral immune response (GO:0002920),0.787740152435247,2.301294562360966,0.0,0.0001528121784898004,0.001,14/44,6.82%,C4B;FCGR2B;CFH;CFP;C1QC;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,receptor-mediated endocytosis (GO:0006898),0.6495872723847348,2.2278938784310878,0.0,0.0005348426247143013,0.004,30/132,6.71%,MRC1;CD163;DAB2;STAB1;MSR1;AP2A2;FCGR2B;LRP6;APOE;COLEC12;SNX9;FCHO2;LDLR;EPS15;RAB31;CLTC;ITGB1;FCHSD2;CALCRL;ADRB2;FCER1G;LILRB1;CD36;SCARF1;ADM;INSR;PIKFYVE;AP2S1;SYK;LMBRD1
prerank,regulation of complement activation (GO:0030449),0.7722967347202018,2.210700911988878,0.0,0.0008319774162222465,0.006,13/40,6.82%,C4B;CFH;CFP;C1QC;C1QA;C5AR1;C3AR1;C6;C2;CD46;C1QB;CFHR2;CR2
prerank,peptide biosynthetic process (GO:0043043),0.6194683418018718,2.180052236920449,0.0,0.0014975593492000438,0.012,68/153,12.66%,RPS29;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;MRPL13;RPL13;RPS24;RSL24D1;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;DARS1;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;MRRF;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;RPL6;RPS6;RPL4;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;MRPS17
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.6108367156712456,2.172082183700856,0.0,0.0015559058173506947,0.014,98/168,19.82%,DHX34;RPS29;RPS23;RPL17;RPL23;RPS12;RPS16;RPS3;RPS27A;EIF3E;RPL39;RPS18;RPS21;RPL23A;RPS15;RPL37;RPLP1;SAMD4A;RPL26;TUT7;ZFP36L1;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPS8;RPL18A;SMG6;RC3H1;RPL37A;RPS11;RPL28;TENT2;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;DCP1A;RPS14;RPL9;TUT4;RPS9;RPS5;RPS7;RPL34;RPL27;PPP2CA;RPL6;RPS6;RPL4;DCP2;RPL22;RPL15;RPL10;RPL32;ZC3H12A;EXOSC8;DIS3L2;ETF1;MAGOHB;RPL19;POLR2D;RPL31;CNOT9;RPL11;PPP2R2A;TUT1;CNOT11;RPL35;CSDE1;CNOT6L;PYM1;NBDY;RPL7;CNOT4;NBAS;DXO;THRAP3;GSPT1;RPL21;CNOT1;CNOT8;SMG8
prerank,acylglycerol catabolic process (GO:0046464),-0.6683292533358454,-2.125598436667561,0.0,0.017760080856199498,0.018,10/30,17.06%,ABHD12;MGLL;FABP5;LYPLA2;LIPH;LPL;DAGLA;ABHD16A;FABP4;FAAH
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5524320298230992,-2.0673011789704354,0.0,0.031524143519754105,0.064,21/59,13.60%,CADM1;PTPRM;SDK1;ROBO2;CDH2;CDH13;TENM3;CD84;ROBO1;PALLD;CNTN4;BSG;CNTN6;IGSF11;PTPRT;CNTN2;NECTIN2;CELSR2;PECAM1;IGSF21;DSCAML1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4735589798580728,-2.057135350314402,0.0,0.026048118589092593,0.079,45/159,13.60%,CADM1;GRID2;PTPRM;CDH23;PTPRS;ADGRL3;CDH10;SDK1;PTPRD;NLGN1;ROBO2;CDH2;CLDN11;LRRC4C;CDH13;TENM3;LRFN5;FAT4;CDH8;CD84;ACVR1;ROBO1;PALLD;CNTN4;BSG;CNTN6;TENM2;TENM4;IGSF11;PTPRT;CNTN2;UNC5D;NTNG1;NECTIN2;MAG;CELSR2;PECAM1;LRRC4;CDH9;CDH22;IL1RAPL1;ATP2C1;TGFBR2;IGSF21;DSCAML1
prerank,regulation of B cell activation (GO:0050864),0.7920490204849182,2.049260207605928,0.0,0.021928547613286352,0.175,6/25,5.00%,BANK1;FCGR2B;AHR;ZFP36L2;ZFP36L1;THEMIS2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.7368206008110316,2.011546559664015,0.0,0.04492678047600131,0.335,9/34,3.94%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;S100A10
prerank,translation (GO:0006412),0.5516124619751499,2.0040267849037683,0.0,0.04767739968881771,0.374,85/208,15.05%,RPS29;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;EEFSEC;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;MRPL13;RPL13;RPS24;RSL24D1;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;RPS11;RPL28;DARS1;FARS2;RPL30;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;MRRF;RPL5;RPL36;RPL14;RPS14;RPL9;NDUFA7;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;EEF1D;RPL6;RPL22L1;RPS6;RARS2;RPL4;RPL22;EIF4EBP2;RPL15;RPL10;MRPL16;RPL32;WARS2;MRPS17;ETF1;GTPBP1;RPL19;MRPS34;MRPS14;RARS1;RPL31;RPL11;SRBD1
prerank,purine-containing compound catabolic process (GO:0072523),0.8477729639545512,1.9952479601576478,0.0019646365422396855,0.05234326487203962,0.421,4/13,3.66%,GDA;DPYD;XDH;DNPH1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.7213811659024068,1.992389931233907,0.0,0.05161231328493007,0.433,11/32,9.90%,PID1;P2RX7;APP;NUPR1;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;BEND3;IGF1
prerank,purine nucleotide catabolic process (GO:0006195),0.847181933828106,1.990397925396495,0.0019455252918287938,0.04983474809102666,0.442,4/13,3.66%,GDA;HINT1;XDH;DNPH1
prerank,regulation of interleukin-12 production (GO:0032655),0.6700100440367488,1.9710703410730026,0.0,0.06584506979816064,0.551,15/47,10.06%,IL16;LILRA5;FOXP1;TLR8;CMKLR1;IRAK3;LILRB1;TLR4;PIBF1;CCL19;TLR2;CD40;SYK;MAPK14;RIPK2
prerank,cellular potassium ion homeostasis (GO:0030007),-0.7850654678877149,-1.9588382326785658,0.0,0.09479443156996481,0.312,5/13,4.05%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;ATP1B2
prerank,regulation of B cell proliferation (GO:0030888),0.6796807052488002,1.9578069850177113,0.0,0.07696103873520525,0.615,12/44,6.34%,VAV3;CD38;FCGR2B;AHR;LYN;BST1;MEF2C;CD74;IRS2;RC3H1;CD40;BCL2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.7904364089086076,1.936849591074968,0.0,0.10113874033347438,0.713,5/17,4.49%,RBPJ;NOTCH2;JAG1;BMP2;HEY2
prerank,response to molecule of bacterial origin (GO:0002237),0.6168771271462281,1.9362083065815605,0.0,0.0972904203051729,0.717,15/69,5.47%,C4B;FCGR2B;FOXP1;FER;IRAK3;PTPN22;IFNAR1;TLR4;PELI1;RPS6KA3;LBP;TNFRSF11A;GCH1;MAPKAPK2;LY96
prerank,Notch signaling involved in heart development (GO:0061314),0.8712911790922456,1.9358591756306731,0.0,0.09320848287066505,0.72,4/11,4.49%,RBPJ;NOTCH2;JAG1;HEY2
prerank,inflammatory response (GO:0006954),0.5396152035671015,1.9242192610830353,0.0,0.10668947661692237,0.778,35/195,8.22%,HDAC9;FOLR2;PF4;NLRC4;FCGR2B;NRROS;SIGLEC1;ADGRE5;CYBB;HRH1;CCR1;CMKLR1;ALOX15;C5AR1;C3AR1;MFHAS1;CEBPB;CD44;BMP2;CCL8;TLR4;CCL19;ADM;TUSC2;TLR2;IL10RB;MAPKAPK2;CD40;CCRL2;PLA2G2D;TNF;CXCR4;REL;CCR2;CCL24
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6898551019046641,-1.9232540365799276,0.0,0.13018139267594228,0.476,7/18,5.60%,RIMS1;PTK2B;NLGN1;RIMS2;NRXN1;DLG4;SHANK1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6860560526310338,-1.9230121227169483,0.0,0.10907649659182524,0.476,6/20,4.05%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;SLC8A1;ATP1B2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.8001343058814424,1.9208491143184516,0.0034904013961605585,0.10785992931738408,0.798,5/15,1.93%,RBPJ;EGFR;PTPN18;FER;PTPN12
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.6435953013138195,-1.9166774895248677,0.002570694087403599,0.10275475352515422,0.515,16/25,26.00%,ABI3;ARHGAP24;PRKCD;EVL;CEP97;CCP110;EVI5L;CDK10;LIMK2;TBC1D7;PLXNB3;ARHGAP44;CAPZB;ODF2L;TCHP;KANK1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.8245430928860659,1.9159270059367781,0.0,0.11141841558048325,0.814,6/14,3.22%,LILRA5;TLR8;CMKLR1;IRAK3;LILRB1;PIBF1
prerank,lipoxygenase pathway (GO:0019372),0.8246770816290623,1.9131457709892647,0.0,0.11120612420021202,0.829,4/14,3.19%,ALOX5;LTC4S;ALOX15;ALOX5AP
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.7286499478595396,1.9109465594070585,0.0033613445378151263,0.11001910880234182,0.832,7/25,10.93%,RBPJ;HIP1;ARAP1;CBL;RTN4;NUP62;PDE6H
prerank,icosanoid biosynthetic process (GO:0046456),0.8851413632574971,1.9074148844768257,0.001893939393939394,0.11136187507444203,0.845,4/10,4.04%,ALOX5;LTC4S;ALOX5AP;MGST3
prerank,regulation of platelet activation (GO:0010543),0.7550081345720326,1.9046171342316536,0.005385996409335727,0.11261203677605254,0.858,7/21,6.57%,APOE;C1QTNF1;LYN;FCER1G;TLR4;PDGFRA;SYK
prerank,clathrin-dependent endocytosis (GO:0072583),0.7205411316223685,1.8954775832730426,0.0034071550255536627,0.12429742598360362,0.896,10/26,7.72%,ITSN1;AP2A2;SIGLEC1;FCHO2;CLTC;FCHSD2;AP2S1;LMBRD1;ITSN2;CANX
prerank,negative regulation of multicellular organismal process (GO:0051241),0.5294252083420097,1.8953346241213584,0.0,0.12042585550018783,0.896,45/199,10.98%,RBPJ;HDAC9;PAEP;FCGR2B;EGFR;RAB11FIP5;SPRED1;ATP2B1;IL15;GAS6;MEF2C;NR1H4;BMP2;TNNT1;TLR4;NR1D1;GRN;HMGCR;SRGN;ADM;RGCC;IL17RD;MCC;NPR3;HEY2;GRHL2;SPI1;GSK3B;RB1;LNPEP;ROCK1;PLCL2;TNF;ARRDC3;VASN;TRPV3;FOXC2;RPS6KA6;USF3;CORO1C;PPP2CA;SFRP1;DOCK7;PTGER4;SPRED2
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7257822555378964,1.8946866499546542,0.006700167504187605,0.1173645284607445,0.898,8/23,4.25%,MPP1;RIPOR2;BST1;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,neuron cell-cell adhesion (GO:0007158),-0.7423652291101551,-1.889516223480059,0.0,0.1315355988412275,0.636,6/14,6.67%,NCAM2;NRXN3;NLGN1;NRXN1;ASTN2;CNTN4
prerank,peptide cross-linking (GO:0018149),0.7144330959588797,1.8824472388777638,0.003189792663476874,0.1341968767464974,0.935,3/25,4.49%,F13A1;TGM7;KRT10
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.5012580285627743,1.876322588564415,0.0,0.14154452756409655,0.946,104/306,14.46%,EXT1;APOE;RBMS1;RPS29;MEF2A;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RBBP8;RPS16;RPS3;RPS27A;ORC5;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;RPL26;EEFSEC;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;MRPL13;RPL13;FAM111A;RPS24;RSL24D1;RPL24;RPL12;RPL36A;RPS8;RPL18A;RPL37A;THRB;RPS11;RPL28;ORC2;MCM9;POLE2;DARS1;EPC1;RPL30;RPL8;RPL35A;RPS4X;CHEK1;RPS15A;RPL38;RPS17;RPLP0;TOPBP1;MRRF;RPL5;RPL36;TIPIN;RPA1;NR4A2;RPL14;RPS14;RPL9;RPS9;BRIP1;RPS5;RPS7;TOP1MT;RPL34;RPL27;MRPS11;MED20;EEF1D;POLR2B;RPL6;RPS6;RHNO1;B4GALT5;RPL4;POLE3;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;RPA3;MRPS17;GTPBP1;NFKBIB;RPL19;KAT7;KIN;MRPS14;MMS19;POLR2D;RPL31
prerank,negative regulation of ossification (GO:0030279),0.7301145054542022,1.8754702410959476,0.003418803418803419,0.13890627024722854,0.946,5/23,3.76%,RBPJ;CCR1;MEF2C;FGF23;SRGN
prerank,negative regulation of lymphocyte activation (GO:0051250),0.7390462403255343,1.8737806475441494,0.0035149384885764497,0.13831624544694845,0.948,4/21,3.22%,BANK1;FCGR2B;PTPN22;PIBF1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.7434419830483099,1.8707681582880975,0.0017605633802816902,0.1399263947901199,0.951,6/20,1.78%,P2RX7;APP;TXNIP;PSTPIP1;C3AR1;ANO6
prerank,B cell activation (GO:0042113),0.5899448248175726,1.8686394583278474,0.0,0.14001616922783866,0.954,18/68,11.05%,BANK1;HDAC9;ITGA4;PTPRJ;ITGB1;MEF2C;KLF6;CD40;BCL2;CR2;ZAP70;LYL1;CHRNA4;PRKCB;CEBPG;NHEJ1;SLC25A5;CASP8
prerank,positive regulation of immune effector process (GO:0002699),0.690209932280272,1.8670306500881284,0.004754358161648178,0.13960763896388687,0.957,7/27,7.58%,PTPRJ;DDX60;LILRB1;ANKRD17;CD46;LBP;CCR2
prerank,leukotriene metabolic process (GO:0006691),0.7462832896703772,1.8631607357512296,0.0051635111876075735,0.14331108129219702,0.963,8/19,8.38%,ALOX5;LTC4S;ALOX15;ALOX5AP;MGST3;MAPKAPK2;ABCC1;DPEP2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.7960672996829625,1.8598921811046993,0.003816793893129771,0.1462077106779973,0.97,3/13,5.19%,RBPJ;HEY2;SMAD4
prerank,positive regulation of interleukin-1 production (GO:0032732),0.6108795197663917,1.857924771555143,0.0015337423312883436,0.14624125481473896,0.973,16/51,11.05%,NLRC4;P2RX7;APP;IL16;LILRA5;TLR8;CD36;TLR4;CCL19;TMED10;TMEM106A;HSPB1;TNF;RIPK2;TRIM16;CASP8
prerank,modulation by symbiont of host process (GO:0044003),0.8597469365011875,1.8525503059018436,0.0,0.15209431662805759,0.975,4/10,4.23%,MRC1;RPS27A;B2M;TLR2
prerank,nucleotide catabolic process (GO:0009166),0.7619025368477472,1.8504969366647823,0.0038910505836575876,0.1525273921571603,0.977,3/16,3.66%,GDA;XDH;DNPH1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6827953269380094,1.849158815311335,0.013008130081300813,0.15137234818580758,0.978,8/26,7.38%,EGFR;IQGAP1;ZFP36L2;PTPN12;EEF1A1;ZFP36L1;PDE8A;DUSP22
prerank,negative regulation of B cell activation (GO:0050869),0.733986221990851,1.8486302557506755,0.0,0.14915133021380558,0.979,4/21,5.30%,BANK1;FCGR2B;LYN;RC3H1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.686921453086231,-1.839405802531539,0.0,0.22545435975786582,0.848,7/17,5.39%,CACNB2;KCNJ2;SCN1B;SLC8A1;ANK2;CACNA2D1;CACNA1D
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6592927717804419,1.836266287084873,0.007763975155279503,0.1700116768772694,0.986,9/31,9.08%,FCGR2B;VSIG4;LYN;CEBPB;LILRB1;RC3H1;PLA2G2D;CD80;SDC4
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6242488823894767,1.8362070413419136,0.0014970059880239522,0.16651433716105246,0.986,11/40,7.63%,NELL1;P2RX7;ALOX5;ATP2B1;ANO6;MEF2C;CEBPB;OSR1;BMP2;ACVR2A;WNT6
prerank,lipid oxidation (GO:0034440),0.821766169010747,1.833643301076808,0.005244755244755245,0.16863915411910113,0.989,4/12,5.81%,ALOX5;ALOX15;PLA2G7;ADIPOR2
prerank,potassium ion homeostasis (GO:0055075),-0.6258071989564826,-1.8252190212339672,0.0024752475247524753,0.24357950894277608,0.897,6/23,4.45%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;ATP1B2;SLC12A9
prerank,response to muscle stretch (GO:0035994),-0.6986853200827657,-1.8243711139933232,0.0,0.22369629114785816,0.9,3/15,2.58%,CTNNB1;SLC8A1;CDH2
prerank,positive regulation of glycolytic process (GO:0045821),0.7267483697984493,1.823274384480361,0.0017921146953405018,0.18172064707940025,0.992,8/20,9.90%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.7267483697984493,1.823274384480361,0.0017921146953405018,0.18172064707940025,0.992,8/20,9.90%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,dendritic cell migration (GO:0036336),0.7675104933619795,1.8159137556064708,0.003616636528028933,0.19330446709385726,0.993,7/16,10.88%,EPS8;ALOX5;CCR1;CCL19;CXCR4;CCR2;TRPM2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.7044986276271972,-1.8135683302739496,0.002207505518763797,0.23539507168154414,0.921,8/15,23.21%,ABHD12;GGT5;GGT7;ABHD16A;ALDH4A1;SARDH;PRODH;HOGA1
prerank,cellular response to peptide (GO:1901653),0.5882061420595629,1.813026695381103,0.003003003003003003,0.19498545650433455,0.994,23/56,13.91%,FCGR2B;ITGA4;APP;RPL23;PTPN22;ADRB2;CD36;TLR4;SNX6;ZFP36L1;VIM;GSK3B;ABCC1;DDX11;PSEN1;FYN;MDM2;IGF1;RIPK2;CHMP5;NOD2;GJA1;ATP1A3
prerank,retrograde axonal transport (GO:0008090),-0.6805246501702644,-1.811396848732517,0.0044444444444444444,0.22323055476176903,0.923,7/16,11.42%,DST;DLG2;DYNC1H1;KIF1A;KIF5A;TMEM108;KIF1C
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.5608784196133435,-1.8084120577295089,0.0,0.2145164051988096,0.931,10/33,11.45%,CX3CR1;GRID2;NRG3;GRIK2;NLGN1;LRRC4C;FABP5;BDNF;ABR;LRRC4
prerank,positive regulation of ossification (GO:0045778),0.6197792568626068,1.806810438451616,0.007598784194528876,0.20446835452966733,0.995,9/39,2.60%,NELL1;P2RX7;ALOX5;ATP2B1;ZBTB16;ANO6;MEF2C;OSR1;BMP2
prerank,immunoglobulin mediated immune response (GO:0016064),0.8362458323843446,1.8049592647477388,0.001890359168241966,0.20456271733618256,0.995,4/10,2.77%,FCGR2B;TLR8;FCER1G;CD74
prerank,positive regulation of endocytosis (GO:0045807),0.6222197877811448,1.798898892247782,0.001607717041800643,0.21422357272038892,0.997,10/45,3.98%,DAB2;HIP1;APOE;RAB31;ANO6;ANKFY1;CDC42;CBL;CCL19;B2M
prerank,actin nucleation (GO:0045010),0.718434819262358,1.797507046469194,0.010434782608695653,0.2137681522147581,0.997,5/21,8.66%,IQGAP2;ACTR3;ARPC2;ARPC5;TRIM27
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6227701259560532,1.7968554575644304,0.0015432098765432098,0.2117054651412229,0.997,11/42,10.46%,PF4;CCR1;OXSR1;CCL8;THPO;CCL19;WNK1;CCR2;CCL24;SH2B3;RBM15
prerank,barbed-end actin filament capping (GO:0051016),0.7385431216876748,1.796306371898133,0.009884678747940691,0.2058252700775536,0.998,3/18,1.03%,EPS8;ADD3;FLII
prerank,actin filament capping (GO:0051693),0.7385431216876748,1.796306371898133,0.009884678747940691,0.2058252700775536,0.998,3/18,1.03%,EPS8;ADD3;FLII
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.727439971028277,1.7901591471621452,0.008278145695364239,0.2161991711509056,0.999,6/18,6.87%,CMKLR1;C5AR1;C3AR1;LYN;FCER1G;SPG21
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.6505524590339862,1.7891837472002063,0.0064,0.214816952268315,0.999,10/35,6.13%,PDE7B;APOE;ADGRG6;AHR;IRAG1;CD36;RAPGEF2;PDE2A;PDE4D;PDE7A
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.686174248498273,1.7845220224227698,0.0051813471502590676,0.22193422056002007,1.0,8/23,9.90%,P2RX7;APP;ZBTB20;INSR;PFKFB4;PSEN1;SLC4A4;IGF1
prerank,cellular protein metabolic process (GO:0044267),0.47078955442944453,1.7829883300402118,0.0,0.22127442214351983,1.0,118/396,15.75%,APOE;PADI4;IGFBP4;APP;ST8SIA4;CP;RPS29;RPS23;GAS6;MRPL23;RPL17;RPL23;MRPS12;RPS12;DNAJC3;RPS16;RPS3;RPS27A;SHISA5;RPL39;RPS18;RPS21;EEF1A1;RIPK1;RPL23A;SIAH2;FGF23;RPS15;RPL37;RPLP1;RPL26;ST3GAL1;CLN5;RPS10;RPS20;RPS13;PRKN;RPLP2;RPSA;LOX;DUSP12;RPL41;RPS28;MRPL13;RPL13;SERP1;RPS24;RSL24D1;RPL24;RPL12;MANBA;RPL36A;RPS8;RPL18A;NOTUM;RPL37A;RPS11;RPL28;PARL;DARS1;RPL30;RPL8;RPL35A;RPS4X;MSRA;RPS15A;RPL38;RPS17;RPLP0;MRRF;RPL5;RPL36;PSEN1;RPL14;RPS14;RPL9;RPS9;RPS5;RPS7;UBE2D3;RPL34;RPL27;MRPS11;RPL6;IGF1;FBXO11;RPS6;GNMT;PPP4R2;IGFALS;RPL4;RPL22;EIF4EBP2;WFS1;RPL15;RPL10;DENND3;STK38;RPL32;NUCB1;LOXL2;ERO1A;MRPS17;RPL19;SERPIND1;MRPS14;RPN2;RPL31;RPL11;GPC3;SRBD1;MELTF;FN1;ICMT;USP25;NCSTN;ZDHHC2;FBXW2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.6143177734570816,1.7780124035707365,0.0029717682020802376,0.22881390320085063,1.0,10/47,3.95%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;S100A10;ITGB1BP1
prerank,B cell mediated immunity (GO:0019724),0.8318401332063781,1.7772780248713467,0.0038240917782026767,0.2268056875833919,1.0,4/10,2.77%,FCGR2B;TLR8;FCER1G;CD74
prerank,aorta morphogenesis (GO:0035909),0.7238594977932047,1.7771184564431035,0.009074410163339383,0.22373983709690207,1.0,3/17,4.49%,RBPJ;JAG1;HEY2
prerank,regulation of endocytosis (GO:0030100),0.5812782145666971,1.7768988302928697,0.004285714285714286,0.22082708134527534,1.0,9/61,6.24%,DAB2;MCTP1;HIP1;APOE;OPHN1;LILRB1;CCL19;ROCK1;AP2S1
prerank,plasma membrane invagination (GO:0099024),0.654208110770138,1.7767183381524096,0.00505902192242833,0.21807626672046598,1.0,8/29,3.75%,MSR1;FCGR2B;SNX9;DOCK1;CD36;HAVCR1;CDC42;RHOA
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5971531759046593,1.7761895479710985,0.0,0.2160305767310308,1.0,16/45,13.90%,NLRC4;P2RX7;APP;LILRA5;TLR8;CD36;TLR4;CCL19;TMEM106A;HSPB1;TNF;RIPK2;TRIM16;CASP8;NOD2;STAT3
prerank,positive regulation of bone mineralization (GO:0030501),0.627272925128683,1.7750428020408358,0.007861635220125786,0.21548884679686345,1.0,8/35,2.60%,NELL1;P2RX7;ALOX5;ATP2B1;ANO6;MEF2C;OSR1;BMP2
prerank,leukotriene biosynthetic process (GO:0019370),0.7524990709943129,1.7737493573183085,0.010968921389396709,0.21502159187472453,1.0,4/14,4.04%,ALOX5;LTC4S;ALOX5AP;MGST3
prerank,linoleic acid metabolic process (GO:0043651),0.7569967751391719,1.772864188687174,0.008710801393728223,0.2138051708823663,1.0,4/17,7.30%,ALOX5;ALOX15;PNPLA8;ELOVL5
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.7992893142731221,1.7722832980575807,0.005607476635514018,0.21223133556906412,1.0,5/12,10.04%,DAB2;FOXP1;PIAS2;NCOR1;SFRP1
prerank,synaptic vesicle cycle (GO:0099504),-0.5567515555855458,-1.7710854486955145,0.007792207792207792,0.31275502387767307,0.978,19/30,33.57%,RIMS1;NLGN1;SNAP25;PIP5K1C;PCLO;SYNDIG1;CPLX1;VAMP2;SLC17A6;CPLX2;BRSK1;SYT7;WNT7A;DNAJC5;SLC18A2;RAB3A;SNAPIN;SLC17A8;STX1A
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.678462793690336,1.7704028957721945,0.005145797598627788,0.2107702185551753,1.0,9/23,16.01%,DAB2;ZEB2;SMAD4;SDCBP;RNF111;CREBBP;EP300;SNW1;HSP90AB1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.678462793690336,1.7704028957721945,0.005145797598627788,0.2107702185551753,1.0,9/23,16.01%,DAB2;ZEB2;SMAD4;SDCBP;RNF111;CREBBP;EP300;SNW1;HSP90AB1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.8046713502855245,1.76914294182217,0.0038240917782026767,0.210658534056303,1.0,4/10,3.59%,NPL;ST6GAL1;GNPDA1;ST3GAL1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6867543896432898,-1.7685711823951256,0.011312217194570135,0.3018103740500402,0.979,10/13,23.03%,HEXB;CSPG5;CSPG4;HYAL1;IDUA;VCAN;BCAN;BGN;NCAN;DCN
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.7650197331742321,1.767968080000925,0.010714285714285714,0.21050857152216731,1.0,5/15,8.66%,IQGAP2;ACTR3;ARPC2;ARPC5;TRIM27
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5625571961143893,1.7668037253584585,0.0,0.21013222007446183,1.0,8/72,2.55%,ARHGEF3;EPS8;STARD8;NRP1;APOE;RIPOR2;OPHN1;GPR65
prerank,regulation of ossification (GO:0030278),0.6319001626208036,1.764086478194431,0.009523809523809525,0.21337546512977051,1.0,9/36,11.26%,RBPJ;LRP6;ZBTB16;MEF2C;BMP2;NOTUM;DDR2;SFRP1;S1PR1
prerank,cellular response to chemokine (GO:1990869),0.6029316805073911,1.7636212938653832,0.004594180704441042,0.2117316494331949,1.0,12/46,9.36%,PF4;CCR1;RIPOR2;OXSR1;CCL8;CCL19;RHOA;DUSP1;WNK1;CCR2;CCL24;SH2B3
prerank,positive regulation of B cell proliferation (GO:0030890),0.6563974554673065,1.7626704718946058,0.00482315112540193,0.21102802780495739,1.0,8/29,6.34%,VAV3;CD38;BST1;MEF2C;CD74;IRS2;CD40;BCL2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.6517402861400678,-1.761494774744032,0.009433962264150943,0.30630915923751123,0.985,5/17,4.92%,SCN1B;SNTA1;NOS1AP;ANK2;CACNA2D1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8112484354144267,1.7612650287214766,0.007312614259597806,0.21125639287510425,1.0,5/10,3.92%,GAS6;LYN;LILRB1;CCL19;RAPGEF2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6196442765212625,-1.7606299578402547,0.009900990099009901,0.29185732873687836,0.986,6/21,5.39%,SCN1B;SNTA1;NOS1AP;ANK2;CACNA2D1;CACNA1D
prerank,cellular response to zinc ion (GO:0071294),-0.6727036195465927,-1.7583347413518429,0.006741573033707865,0.28327328965638193,0.986,13/15,25.92%,GLRA1;ATP13A2;HVCN1;MT2A;GLRA2;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.6160855394810612,1.7581927753230904,0.012441679626749611,0.21444642381401982,1.0,9/38,5.14%,NEDD9;APP;LILRA5;GAS6;SH3BP5;RAP2B;CASS4;DOK7;GPRC5B
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5632265603979584,1.7577425321115905,0.002797202797202797,0.21280444197456086,1.0,18/66,8.11%,MTSS1;APOE;ALOX5;FBXW7;CASK;NUPR1;XDH;CNMD;TNMD;RGCC;B2M;MCC;CDK6;KLF9;GHRL;PTPRK;SYNJ2BP;CDC73
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7344223829529047,1.7552608486678596,0.012152777777777778,0.2152430609460694,1.0,6/16,9.45%,NRP1;PTPRJ;FER;PDGFRA;PIK3C2A;PDGFC
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5374168296509669,-1.7549764147841278,0.0029069767441860465,0.2785224680273486,0.986,11/37,14.58%,CADM1;GRID2;PTPRD;NLGN1;TENM3;FAT4;TENM2;TENM4;IL1RAPL1;IGSF21;CXADR
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.6229673240288561,1.7548625345155766,0.012558869701726845,0.21349442150664663,1.0,7/33,6.94%,PF4;CCR1;RIPK1;CD74;DCSTAMP;ZFP36L1;TNF
prerank,positive regulation of inflammatory response (GO:0050729),0.5332857704003884,1.7526860828304502,0.0014184397163120568,0.2154929557030712,1.0,20/86,8.54%,APP;IL16;LILRA5;IL15;NUPR1;TSLP;PLA2G7;RIPK1;TLR4;GRN;NFKBIZ;LBP;PDE2A;TLR2;IL17RA;GPRC5B;TNF;ABCC1;CCR2;NINJ1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.620213635061007,-1.7522188325380623,0.006802721088435374,0.27337838746507076,0.987,6/18,10.61%,GRID2;UNC13C;GRIA2;GRIK2;CDH8;NAPA
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6697817844153714,-1.750044482116365,0.01288659793814433,0.26757176362669643,0.989,9/16,18.94%,SIRPA;TREM2;CUEDC2;PDCD4;APOD;ADCY7;ABCD2;CHID1;PYCARD
prerank,sulfur compound catabolic process (GO:0044273),-0.5248293801558156,-1.7493082368580517,0.0,0.25810030548629054,0.989,16/38,24.04%,HEXB;GNS;CSPG5;GGT5;CSPG4;HYAL1;GGT7;IDUA;VCAN;BCAN;BGN;TST;NCAN;FMOD;DCN;PRELP
prerank,regulation of inflammatory response (GO:0050727),0.4889244473413526,1.7478081815122424,0.0,0.22334787629361483,1.0,35/190,7.58%,AOAH;APOE;ALOX5;APP;IL16;LILRA5;FOXP1;IL15;ALOX15;BST1;C1QTNF3;MFHAS1;NR1H4;TSLP;METRNL;PLA2G7;TNFRSF1B;RIPK1;TLR4;NR1D1;GRN;SNX6;NFKBIZ;PDE2A;TLR2;IL17RA;BIRC3;RB1;GHRL;CD200R1;GPRC5B;TNF;ABCC1;KLF4;CCR2
prerank,cellular response to amyloid-beta (GO:1904646),0.6206766412736222,1.7472813517125634,0.009771986970684038,0.22181706455651123,1.0,12/35,9.90%,FCGR2B;ITGA4;APP;ADRB2;CD36;TLR4;SNX6;GSK3B;ABCC1;PSEN1;FYN;IGF1
prerank,synaptic membrane adhesion (GO:0099560),-0.6926044606418641,-1.7462631266450261,0.0,0.25548616315011985,0.991,7/14,16.84%,PTPRS;PTPRD;LRRC4C;LRFN5;NTNG1;LRRC4;GPC6
prerank,positive regulation of defense response (GO:0031349),0.529833750700411,1.7444959917491725,0.0013831258644536654,0.22524515109396578,1.0,21/89,8.54%,APP;IL16;LILRA5;TLR8;IL15;MEF2C;TSLP;PLA2G7;RIPK1;TLR4;GRN;NFKBIZ;PDE2A;TLR2;IL17RA;GPRC5B;RIOK3;TNF;ABCC1;CCR2;NINJ1
prerank,myeloid cell development (GO:0061515),0.6954668333712027,1.744436762551286,0.015463917525773196,0.2229131043700562,1.0,7/18,9.36%,NRROS;APP;FOXP1;THPO;TLR2;ANXA2;SH2B3
prerank,purine ribonucleotide catabolic process (GO:0009154),0.6733511404246322,1.7430956583137318,0.008403361344537815,0.223598723106366,1.0,8/21,14.82%,HINT1;XDH;PDE2A;PDE4D;AMPD3;NT5C2;ACAT1;NUDT18
prerank,T cell activation involved in immune response (GO:0002286),0.766067326404763,1.740622480002894,0.011194029850746268,0.2263636061875932,1.0,4/12,4.01%,FCER1G;LILRB1;CD74;LCP1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.731133979455622,1.7400999762236649,0.007207207207207207,0.22488161896408476,1.0,6/16,11.15%,IGFBP4;BMP2;MYORG;IGF1;ZFAND2B;PHIP
prerank,epithelial cell migration (GO:0010631),0.6236743644191443,1.733945646108994,0.01337295690936107,0.2355201783038789,1.0,12/37,12.75%,ZEB2;PLEKHG5;NRP1;RHOA;PKN2;ROCK1;TNFSF12;STARD13;PXN;KANK2;LOXL2;PLXND1
prerank,embryonic appendage morphogenesis (GO:0035113),0.765443946951248,1.732530000133066,0.01639344262295082,0.23647763390460777,1.0,3/12,9.99%,LRP6;MBNL1;CYP26B1
prerank,smooth muscle cell differentiation (GO:0051145),0.774273435732161,1.7319622206531202,0.007142857142857143,0.2354071609635375,1.0,3/12,4.49%,EDNRB;MEF2C;HEY2
prerank,positive regulation of phagocytosis (GO:0050766),0.5846401199841084,1.7314468108919832,0.001519756838905775,0.23421785001882645,1.0,11/47,3.48%,C4B;FCGR2B;PTPRJ;IL15;DOCK2;GAS6;RAB31;ANO6;FCER1G;C2;CAMK1D
prerank,adrenergic receptor signaling pathway (GO:0071875),0.6791850332704854,1.728810341641554,0.008488964346349746,0.23756639704559834,1.0,8/20,12.97%,ADRB2;DRD1;RAPGEF2;ADCY9;PDE4D;ADRA1D;ADRA1A;LMBRD2
prerank,regulation of interleukin-10 production (GO:0032653),0.5933239954669686,1.7276591150886706,0.006134969325153374,0.23752308008846804,1.0,9/44,6.57%,FCGR2B;LILRA5;IRF4;TSLP;LILRB1;TLR4;PIBF1;CD46;SYK
prerank,response to amyloid-beta (GO:1904645),0.5900546626925585,1.7271490401619196,0.008012820512820512,0.2363689787928556,1.0,12/44,9.90%,FCGR2B;ITGA4;APP;ADRB2;CD36;TLR4;SNX6;GSK3B;ABCC1;PSEN1;FYN;IGF1
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.5842388763540349,-1.7270253317808166,0.01,0.30042952776347065,0.998,17/25,29.16%,FGF13;NCKAP5L;MAPT;STMN3;NCKAP5;TPPP;STMN4;CKAP5;KIF2A;CENPJ;KATNB1;PIN1;KIF14;HDGFL3;MAP7D3;TPPP3;KIF2C
prerank,substrate-dependent cell migration (GO:0006929),0.7385734008649091,1.7269059378152471,0.012797074954296161,0.23464532549116357,1.0,5/14,6.90%,NRP1;OPHN1;ANKS1A;ITGB1BP1;SDCBP
prerank,sterol transport (GO:0015918),0.6892275129368776,1.725174242953193,0.011725293132328308,0.23612273337627337,1.0,3/19,2.76%,MSR1;LDLR;CD36
prerank,cardiac muscle cell development (GO:0055013),0.6698144637739959,1.7222674604932444,0.02027027027027027,0.24002718249321245,1.0,5/20,5.33%,PDLIM5;MYH6;ALPK3;HEY2;PDGFRA
prerank,negative regulation of ATP metabolic process (GO:1903579),0.714671583993042,1.7222113676015207,0.009057971014492754,0.23792423703564308,1.0,3/17,2.06%,PID1;NUPR1;CBFA2T3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5421413436704778,1.720750100730029,0.004310344827586207,0.23859979297301362,1.0,15/76,7.19%,EGFR;APP;SASH1;C1QTNF3;RPS3;PTPN22;RASSF2;TLR4;CCL19;RHOA;TLR2;SPI1;TNF;UACA;PPM1B
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7047726186531978,1.7196869340200824,0.012027491408934709,0.238450670185126,1.0,6/17,8.64%,ADRB2;DRD1;RAPGEF2;ADCY9;ADRA1D;ADRA1A
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5967113202957437,1.7183265747318268,0.00782472613458529,0.23926601895705285,1.0,7/39,3.50%,EGFR;PTPRJ;PTPN18;EPS15;PTPN12;CDC42;CBL
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.552624965397164,1.7167515910400124,0.0071633237822349575,0.24043607083747454,1.0,12/63,6.96%,VAV3;CD38;IL15;BST1;MEF2C;CD74;CD46;CCL19;IRS2;CD40;BCL2;CD80
prerank,cellular response to estradiol stimulus (GO:0071392),0.7010338056827424,1.7166149924570353,0.007017543859649123,0.23853017381852945,1.0,6/18,10.04%,EGFR;ESR1;NCOA3;NRIP1;LCOR;SFRP1
prerank,monocyte chemotaxis (GO:0002548),0.6227747905487584,1.7161451386982574,0.009316770186335404,0.2374796761343054,1.0,7/32,8.25%,FOLR2;CCL8;MSMP;CCL19;TNFRSF11A;CCL24;IL6R
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6799658705195424,1.7157740459713626,0.01559792027729636,0.23633417643570348,1.0,3/20,5.19%,RBPJ;BMP2;SMAD4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.6112977982784258,1.7145885160903767,0.009448818897637795,0.23654118818285652,1.0,9/40,7.63%,DAB2;HIP1;TBC1D5;CBL;CCL19;B2M;INSR;ANXA2;HFE
prerank,macrophage activation (GO:0042116),0.616225602545662,1.7139213498859447,0.009708737864077669,0.23588885152616834,1.0,10/34,6.94%,APP;FOXP1;C1QA;C5AR1;CD93;TLR4;LBP;TMEM106A;SYK;TNF
prerank,positive regulation of B cell activation (GO:0050871),0.5679716741369938,1.7133533081255952,0.007374631268436578,0.23487890507065462,1.0,19/50,17.66%,VAV3;CD38;BST1;MEF2C;CD74;IRS2;PPP2R3C;CD40;BCL2;SYK;NFATC2;KMT5B;NOD2;GPR183;TIRAP;SHLD3;CHRNB2;XBP1;IL6
prerank,heterocycle biosynthetic process (GO:0018130),0.7323732758845459,1.7128862095424349,0.022530329289428077,0.23378565395845124,1.0,4/14,4.55%,ALOX5;MOCS1;HDC;GCH1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.698128805371016,1.7128589832721615,0.019538188277087035,0.23182254986133607,1.0,6/19,4.25%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,rRNA metabolic process (GO:0016072),0.4858614278338545,1.709049825146814,0.0,0.23742518061477044,1.0,56/160,14.84%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RPL28;WDR36;NOP53;RPL30;NOL9;RPL8;RPL35A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;RPL6;HEATR1;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;EXOSC1;RPL31;RPL11
prerank,triglyceride catabolic process (GO:0019433),-0.6049004448117137,-1.7059558277426121,0.0076726342710997444,0.35745578123266136,1.0,4/19,15.17%,FABP5;LIPH;LPL;FABP4
prerank,neurotransmitter secretion (GO:0007269),-0.4949734238563902,-1.7044751705537935,0.00847457627118644,0.3490842559401879,1.0,17/44,22.33%,RIMS1;RIMS2;SNAP25;NRXN1;PIP5K1C;PCLO;DVL1;SYN3;CPLX1;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;CPLX2;BRSK1;GAD1
prerank,ephrin receptor signaling pathway (GO:0048013),0.5337959040357962,1.7009891060663946,0.005479452054794521,0.25228526607773594,1.0,19/82,8.07%,ITSN1;VAV3;AP2A2;LYN;ACTR3;RASA1;CDC42;ANKS1A;CRK;RHOA;ROCK1;ACTB;AP2S1;NGEF;SDCBP;ARPC2;ARPC5;PSEN1;FYN
prerank,positive regulation of phospholipase C activity (GO:0010863),0.6006807665380263,1.7007827113962317,0.009584664536741214,0.2506157614549707,1.0,9/40,5.33%,RASGRP4;EGFR;FGFR1;GNAQ;C5AR1;ESR1;ANG;P2RY6;PDGFRA
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6451360506340272,1.7004775516455137,0.009836065573770493,0.24916651982181992,1.0,11/26,17.18%,DAB2;FOXP1;CLOCK;PIAS2;NCOR1;SFRP1;KANK2;CNOT9;PER1;STRN3;ZBTB7A
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6196161193466113,1.6998165333411344,0.01951219512195122,0.24853223624528947,1.0,7/30,6.57%,LILRA5;IRF4;TSLP;TLR4;PIBF1;CD46;SYK
prerank,negative regulation of hormone secretion (GO:0046888),0.7928840362950649,1.6990543767088648,0.011764705882352941,0.24804620695217774,1.0,2/10,2.94%,RAB11FIP5;FGF23
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49936271135269544,1.6983369659918905,0.001303780964797914,0.24761074153773294,1.0,27/112,8.69%,PF4;APP;LILRA5;PTPRJ;FOXP1;OAS2;GAS6;IRAK3;NR1H4;PTPN22;RIPK1;LILRB1;TLR4;CCL19;LBP;TLR2;NFKBIL1;GHRL;MAPKAPK2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1;TRIM27;CD33
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.7174700734235377,-1.696061719488107,0.014314928425357873,0.36652366866981706,1.0,4/10,9.29%,HK2;PFKL;GFPT1;PFKP
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.698134106269414,1.6959294262788809,0.023131672597864767,0.25096853447308215,1.0,6/17,4.25%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.7153886314133047,1.6947604983211748,0.016791044776119403,0.25135918817872277,1.0,5/15,7.63%,LRP6;BMP2;ANKRD11;EDA;WNT6
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4839090379847669,1.6946320555652046,0.0,0.24958765358933319,1.0,25/151,5.33%,NRP1;EGFR;APOE;APP;NOTCH2;CCR1;FBXW7;GAS6;ALOX15;C5AR1;MFHAS1;PTPN22;CD44;BMP2;CD36;CD74;CCL8;P2RY6;THPO;CCL19;RAPGEF2;TNFRSF11A;PDE8A;RAP1A;PDGFRA
prerank,activation of phospholipase C activity (GO:0007202),0.6300726564756409,1.6932068810780987,0.02027027027027027,0.2505965730463705,1.0,6/29,3.28%,RASGRP4;EGFR;GNAQ;C5AR1;ANG;P2RY6
prerank,regulation of mitochondrial fusion (GO:0010635),0.7650237378324067,1.6930765868123363,0.021442495126705652,0.248965127630471,1.0,2/11,4.00%,PID1;PRKN
prerank,regulation of response to oxidative stress (GO:1902882),0.7819954839657806,1.6930677072891562,0.024242424242424242,0.24707279600924165,1.0,3/11,4.00%,MCTP1;ALOX5;PRKN
prerank,membrane organization (GO:0061024),0.4627479262974395,1.6925811252162095,0.0,0.24631123603319985,1.0,42/227,10.87%,DAB2;ITSN1;TMCC1;AP2A2;HIP1;EGFR;SNX9;FCHO2;MYADM;LDLR;REEP3;EPS15;REPS2;CLTC;ACTR3;RPS27A;ADRB2;SPTBN1;SYNJ1;DCSTAMP;CBL;AGFG1;MYOF;SERP1;SNX3;OCRL;ACTB;GAPVD1;AP2S1;EPN2;ARPC2;ARPC5;VPS4B;FNBP1;PIK3C2A;RABEP1;GLTP;CORO1C;ARRB1;PACSIN2;ATP10B;CHMP5
prerank,negative regulation of cell activation (GO:0050866),0.7194664296552044,1.6912692825049749,0.01838235294117647,0.24745921619864097,1.0,5/14,5.33%,APOE;LDLR;C1QTNF1;NR1D1;PDGFRA
prerank,ribosomal small subunit biogenesis (GO:0042274),0.5975512305626421,1.6910472217648127,0.006309148264984227,0.24609146917451466,1.0,15/39,10.33%,RPS16;RPS15;ERAL1;SNU13;RPSA;RPS28;RPS24;RIOK3;LTV1;RPS17;RPS14;RPS5;RPS7;MRPS11;RPS6
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.5257123920686954,-1.6900356811230859,0.013368983957219251,0.37617688503174274,1.0,14/32,12.44%,ADGRB3;CUX1;SEMA4D;PTPRD;YWHAH;HECW2;SS18L1;NSMF;SDC2;KNDC1;HECW1;CAPRIN1;SS18L2;IL1RAPL1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.7667985647994388,1.6882704026391406,0.011363636363636364,0.2500131753720052,1.0,8/12,14.89%,KLF2;DHRS3;CYP26C1;ASXL1;CYP26B1;TRIM16;CTBP2;SNW1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5424383533737885,1.6874477740555973,0.008379888268156424,0.24993667772862282,1.0,14/67,4.76%,NRP1;NEDD9;MYADM;RREB1;ALOX15;CASS4;DOCK1;CD36;CDC42;CRK;UTRN;S100A10;CDK6;GSK3B
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.49507179848291116,1.684906832808802,0.001282051282051282,0.25340609321317736,1.0,22/121,6.96%,BANK1;NRP1;NEDD9;LILRA5;PTPRJ;CLEC6A;IL15;GAS6;LYN;TSLP;CD44;CASS4;PARP14;CD74;THBS4;PIBF1;DOK7;GPRC5B;PAK2;CD40;TNF;CD80
prerank,embryonic eye morphogenesis (GO:0048048),0.7416000264492575,1.6838569083919062,0.02247191011235955,0.25349990142980444,1.0,2/11,1.94%,LRP6;RARG
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.6097737711796843,1.6815183989425821,0.014539579967689823,0.2568398935228749,1.0,7/32,12.01%,PF4;ANG;RPL39;RPL30;RNASE6;ROMO1;FAM3A
prerank,negative regulation of protein transport (GO:0051224),0.6352240613382019,1.6808943980783093,0.014778325123152709,0.256449397941583,1.0,6/25,6.40%,APOE;HMGCR;NDFIP1;SNX3;RHBDF1;DPH3
prerank,synaptic vesicle exocytosis (GO:0016079),-0.4952548257605541,-1.678001890860795,0.007894736842105263,0.40398263920901784,1.0,15/40,19.42%,RIMS1;UNC13C;RIMS2;SNAP25;PIP5K1C;PCLO;SNAP47;STX3;CPLX1;VAMP2;SYT8;STX2;RIMS3;SYT1;CPLX2
prerank,regulation of bone mineralization (GO:0030500),0.5490051481004495,1.677390061364395,0.010174418604651164,0.2614356268124757,1.0,13/55,6.32%,NELL1;P2RX7;ALOX5;ATP2B1;CCR1;ANO6;MEF2C;OSR1;BMP2;FGF23;SRGN;NOTUM;ACVR2A
prerank,response to interferon-alpha (GO:0035455),0.6927593123088297,1.6768560515849542,0.0216998191681736,0.26065668310372186,1.0,8/16,9.46%,IFITM3;GAS6;IFNAR1;LAMP3;BST2;IFNAR2;RO60;IFITM2
prerank,rRNA processing (GO:0006364),0.4675508930486695,1.6765808971041067,0.0012062726176115801,0.2594772163089466,1.0,58/172,14.84%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RIOK3;RPL28;WDR36;NOP53;RPL30;NOL9;RPL8;RPL35A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;RPL6;HEATR1;RPS6;MRPL1;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;EXOSC1;RPL31;RPL11
prerank,regulation of protein kinase activity (GO:0045859),0.5024639262013062,1.6744881985450875,0.0013458950201884253,0.2619837456725552,1.0,27/106,9.65%,LRP6;GNAQ;SPRED1;DEPTOR;IQGAP1;SNX9;PRKAG2;GAS6;C5AR1;RAP2B;RASSF2;UVRAG;CCL19;RAPGEF2;ITGB1BP1;RAP1A;RB1;CAMKK2;PAK2;SFN;CEP85;HSPB1;TNF;DDR2;TRIM27;SMCR8;CACUL1
prerank,Rho protein signal transduction (GO:0007266),0.5665915890667496,1.6738309755818361,0.006042296072507553,0.2616671434291899,1.0,9/53,7.94%,ARHGEF3;EPS8;PLEKHG5;CDC42;RHOA;ROCK1;CELSR1;ARHGAP29;ARHGDIA
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.6836693625402012,1.673248906947457,0.015463917525773196,0.2611717129204206,1.0,8/21,10.75%,FCGR2B;FOXP1;LYN;PTPN22;ELF2;CBFB;PRKCB;ELF1
prerank,innate immune response (GO:0045087),0.4590452562478159,1.6730499352240114,0.0,0.2597297660398307,1.0,46/217,11.03%,NRROS;APP;CFP;CYBB;COLEC12;TLR8;CLEC6A;IFITM3;LYN;ANG;MFHAS1;FER;ALPK1;RPL39;FCER1G;CD74;TLR4;ANKRD17;SERINC3;B2M;LBP;BCL10;TLR2;FRK;TRIM56;GCH1;TRIM32;CD40;SYK;CR2;ZAP70;BST2;REL;RNASE6;CXCL16;FYN;TRIM68;MFAP4;CLEC4D;TRIM27;IFITM2;RIPK2;STYK1;SP100;NCF2;SLA
prerank,spliceosomal complex assembly (GO:0000245),-0.4768705368797963,-1.672713317077712,0.0,0.411231807696129,1.0,18/46,18.00%,LUC7L3;SETX;SRSF5;DDX39B;SRPK1;PUF60;SRSF10;CELF4;SNRNP200;SRPK2;PRPF19;SF3B1;DDX1;NCBP1;PRPF6;DDX23;RBM5;SRSF9
prerank,B cell differentiation (GO:0030183),0.5667414294872627,1.6717398087080115,0.007692307692307693,0.2605478618692682,1.0,12/46,10.33%,HDAC9;ITGA4;PTPRJ;ITGB1;KLF6;IRF2BP2;CR2;LYL1;CEBPG;FNIP1;NHEJ1;SLC25A5
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.6072787486245566,-1.6704831737611856,0.01650943396226415,0.4058733478168341,1.0,11/19,21.95%,RPTOR;POLR3C;AR;ICE2;ZNF76;MAF1;BRF2;MTOR;PRDX5;POLR3G;ELL
prerank,endothelial tube morphogenesis (GO:0061154),0.7695968752860641,1.6698429242123418,0.01730769230769231,0.26297745215986,1.0,3/10,4.43%,RBPJ;RHOA;CCM2
prerank,clathrin coat assembly (GO:0048268),0.6833509352828538,1.668637938165326,0.022298456260720412,0.2639341384440134,1.0,6/15,8.29%,HIP1;FCHO2;EPS15;CLTC;AP2S1;PIK3C2A
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5078192173001601,1.6682794390722284,0.004048582995951417,0.2628875470615592,1.0,10/86,7.63%,RBPJ;DAB2;ZEB2;BMP2;GDF3;SMAD4;GDF10;ACVR2A;SDCBP;HFE
prerank,placenta development (GO:0001890),0.7210026521277781,1.6680212937824455,0.025878003696857672,0.26168582894738546,1.0,5/12,16.88%,ADAM19;ANG;PLAC1;E2F8;CUL7
prerank,positive regulation of response to external stimulus (GO:0032103),0.48500868746107084,1.6674226873220859,0.002642007926023778,0.26140171105154264,1.0,28/128,8.54%,APP;IL16;LILRA5;TLR8;SASH1;IL15;TSLP;PLA2G7;DDX60;RIPK1;TLR4;GRN;ANKRD17;CCL19;SCARF1;NFKBIZ;PDE2A;TLR2;IL17RA;GPRC5B;PUM2;LY96;RIOK3;TNF;ABCC1;USP15;CCR2;NINJ1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.7620450896344126,1.6664194013044011,0.02697495183044316,0.2617533697368017,1.0,6/12,10.75%,LYN;PTPN22;RC3H1;ELF2;CBFB;ELF1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6363456014191501,1.6654764663942614,0.018363939899833055,0.2621211944761109,1.0,3/24,2.18%,RBPJ;KLF2;CEBPB
prerank,amide transport (GO:0042886),0.6242497436584857,1.6638537503459787,0.02768729641693811,0.2636842709408777,1.0,3/26,4.17%,PLTP;FOLR2;SLC14A1
prerank,adenine nucleotide transport (GO:0051503),0.6940062571725361,1.6635403313335266,0.021052631578947368,0.2626792681940786,1.0,7/17,18.52%,LRRC8D;SLC25A17;SLC25A24;ABCC4;SLC25A5;LRRC8C;SLC25A4
prerank,energy reserve metabolic process (GO:0006112),0.6569753766066999,1.6633133425417588,0.029411764705882353,0.2615515838049064,1.0,6/19,9.41%,PID1;PRKAG2;GBE1;GSK3B;GFPT2;PPP1R3C
prerank,dopaminergic neuron differentiation (GO:0071542),0.656777192678106,1.6631878639751485,0.0162748643761302,0.26018243607799857,1.0,5/19,7.86%,LRP6;PHOX2A;WNT2;MANF;NR4A2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6553881434831741,1.6625182910680947,0.030448717948717948,0.2597596917581183,1.0,6/22,6.94%,APOE;SNX9;TNFRSF1B;ADAM9;ROCK1;TNF
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.6626379481282895,1.6616762216731582,0.011254019292604502,0.26000659969651513,1.0,3/23,1.41%,ALOX5;LTC4S;ALOX15
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5326056641926302,1.6604560777741681,0.005934718100890208,0.2606796540876037,1.0,23/66,13.90%,NLRC4;P2RX7;APP;LILRA5;FOXP1;TLR8;CD36;TLR4;CCL19;GHRL;TMEM106A;HSPB1;TNF;CD33;CARD16;IGF1;RIPK2;TRIM16;CASP8;ZC3H12A;NOD2;FFAR1;STAT3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6388601165730681,1.659852380377124,0.029411764705882353,0.2603928896446474,1.0,7/23,15.43%,NUPR1;C1QTNF3;CBFA2T3;C1QTNF12;NCOR1;EP300;HDAC4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5517801144833289,1.6595617656587462,0.015772870662460567,0.25942476287056854,1.0,22/44,20.34%,GAS6;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;SFN;TNF;KLF4;FNIP1;CARD16;IGBP1;PCID2;YWHAE;LAMTOR5;CAST;USP47;BEX3;HGF;RAF1;CSNK2A1;SNCA
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.7014141134436994,1.6590900974592464,0.023131672597864767,0.25894810859349504,1.0,3/15,2.76%,MSR1;PF4;CD36
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5520833672458363,1.6572371056296138,0.012195121951219513,0.2609774253124,1.0,9/50,6.94%,EGFR;APP;SASH1;RPS3;TLR4;CCL19;RHOA;TLR2;TNF
prerank,cellular response to fluid shear stress (GO:0071498),0.7493094105372309,1.6568364039833017,0.01639344262295082,0.2602281594523104,1.0,8/12,16.14%,MTSS1;KLF2;MEF2C;KLF4;ASS1;SREBF2;PKD2;MAPK7
prerank,endothelial cell development (GO:0001885),0.6377221038180829,1.6565615831887595,0.014446227929373997,0.25917582189280514,1.0,10/25,8.63%,RAP1B;MYADM;CNMD;TNMD;RAPGEF2;PDE2A;RAP1A;PDE4D;COL22A1;MSN
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6305604238043263,1.6564616343700411,0.006611570247933884,0.25784478110043185,1.0,10/26,16.01%,KLF2;CD36;TLR4;INSR;TMEM106A;TNF;KLF4;ASS1;PKD2;HSP90AB1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5395313517250755,1.6551662471783228,0.016591251885369532,0.25906518287926134,1.0,12/55,12.28%,PID1;ALOX5;BST1;XDH;RIPK1;PRKN;PARL;PIKFYVE;FOXM1;MAPK14;ROMO1;ZC3H12A
prerank,second-messenger-mediated signaling (GO:0019932),0.5051724874313499,1.651373935884188,0.009549795361527967,0.2654320731213712,1.0,13/82,7.81%,MCTP1;EDNRB;APOE;HRH1;CCR1;RCAN3;CD36;MCU;CAMKK2;CCRL2;CXCR4;CCR2;MCTP2
prerank,toll-like receptor signaling pathway (GO:0002224),0.5079247865662394,1.651330802065524,0.008379888268156424,0.26396349259736984,1.0,23/84,11.05%,COLEC12;TLR8;IRAK3;NR1H4;RPS27A;S100A1;RIPK1;CD36;TLR4;MAP3K1;RPS6KA3;RFTN1;LBP;BCL10;TLR2;BIRC3;MAPKAPK2;CTSB;LY96;EPG5;UBE2D3;RIPK2;CASP8
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5109550089846061,1.64883577209648,0.010101010101010102,0.2678294003713835,1.0,17/73,7.76%,PF4;APP;LILRA5;PTPRJ;OAS2;RIPK1;TLR4;CCL19;LBP;BCL10;TLR2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7186934646300898,1.648243563350991,0.02018348623853211,0.267507378986415,1.0,2/13,2.01%,RBPJ;MEF2C
prerank,positive regulation of protein binding (GO:0032092),0.5422799432581271,1.6477632971182357,0.0103397341211226,0.2669384258731229,1.0,19/56,14.84%,APOE;APP;TCF7L2;BMP2;RAPGEF2;B2M;PRKN;GSK3B;STK3;NMD3;HFE;PSEN1;PPP2CA;PPP2CB;RIPK2;AMFR;RALB;ADD1;RPL11
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5752717544305634,1.6471074768308458,0.023510971786833857,0.2666980592623665,1.0,5/41,4.49%,RBPJ;JAG1;MEF2C;MYH6;HEY2
prerank,positive regulation of MAPK cascade (GO:0043410),0.45165246404889814,1.6463853588768147,0.0,0.26663566782367204,1.0,43/245,10.21%,NRP1;EGFR;APOE;FGFR1;APP;LILRA5;PTPRJ;NOTCH2;CCR1;IQGAP1;FBXW7;GAS6;ALOX15;C5AR1;MFHAS1;PTPN22;CD44;ADRB2;BMP2;CD36;CD74;CCL8;P2RY6;THPO;CCL19;RAPGEF2;PDE8A;GSDME;RAP1A;INSR;PDGFRA;ROCK1;TMEM106A;CD40;PIK3R6;TNF;CCL24;ADRA1D;ADRA1A;PDGFC;MYDGF;IGF1;ARRB1
prerank,negative regulation of viral life cycle (GO:1903901),0.6826976149872601,1.643892271184516,0.02722323049001815,0.27066041544390357,1.0,7/15,14.92%,IFITM3;SNX3;BST2;IFITM2;LY6E;MID2;PPIA
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.6991182852576119,1.6418886022848274,0.0351493848857645,0.27348684603407825,1.0,2/15,0.49%,PLTP;APOE
prerank,negative regulation of B cell proliferation (GO:0030889),0.7477564842941814,1.6415879057555687,0.026119402985074626,0.27271625434182223,1.0,3/11,5.30%,FCGR2B;LYN;RC3H1
prerank,response to tumor necrosis factor (GO:0034612),0.5023950208723303,1.6413127519103938,0.00554016620498615,0.2716468645855565,1.0,21/91,11.05%,PID1;GBP3;ZFP36L2;RPS3;RIPK1;CCL8;NR1D1;DCSTAMP;ADAM9;CCL19;ZFP36L1;TNFRSF11A;GSDME;GCH1;TRIM32;CD40;CXCL16;CCL24;IGBP1;SFRP1;CASP8
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6510235271111068,1.6392718572757445,0.03231292517006803,0.2746211169206124,1.0,5/19,11.75%,APOE;RAPSN;CHRNA4;ACHE;COLQ
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5571612784585237,1.6370441759049195,0.008982035928143712,0.27795449716299947,1.0,9/48,3.94%,NRP1;NEDD9;MYADM;RREB1;CASS4;DOCK1;CDC42;CRK;S100A10
prerank,purine ribonucleotide transport (GO:0015868),0.6875548132916396,1.6365615766857966,0.029616724738675958,0.2774612385841246,1.0,4/16,6.85%,LRRC8D;SLC25A17;SLC25A24;ABCC4
prerank,regulation of epithelial cell proliferation (GO:0050678),0.500004012594183,1.6363131724104778,0.006775067750677507,0.27642979678206825,1.0,16/85,10.04%,MTSS1;EGFR;TCF7L2;C5AR1;NUPR1;OSR1;NR1D1;GRN;ZFP36L1;B2M;MCC;CDK6;NR4A1;CDC73;IGF1;SFRP1
prerank,positive regulation of transport (GO:0051050),0.49961568641851434,1.6360130808442384,0.011188811188811189,0.275639485590664,1.0,14/85,6.94%,DAB2;FCGR2B;APOE;IL15;DOCK2;GAS6;KMT2A;FCER1G;CAMK1D;CCL19;GSK3B;ACTB;ANXA2;TNF
prerank,signal release from synapse (GO:0099643),-0.47588905147166394,-1.6343809987646616,0.011235955056179775,0.5415748292604107,1.0,16/43,22.33%,RIMS1;SNAP25;NRXN1;PIP5K1C;PCLO;DVL1;SYN3;CPLX1;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;CPLX2;BRSK1;GAD1
prerank,regulation of interleukin-8 production (GO:0032677),0.5159287288418359,1.6333995224816245,0.010101010101010102,0.27990860058978506,1.0,26/69,19.40%,TLR8;PTPN22;RIPK1;CD74;TLR4;LBP;BCL10;TLR2;SYK;TNF;KLF4;CD33;RAB1A;SSC5D;ARRB1;LAMTOR5;NOD2;STAT3;PRKD2;TIRAP;RELA;TLR7;IL6;F2R;MAPKBP1;BCL3
prerank,defense response to bacterium (GO:0042742),0.48445824553398265,1.6325773365333895,0.00390625,0.2802290862745112,1.0,23/105,11.66%,STAB1;NLRC4;CFP;COLEC12;OAS2;ANG;CEBPB;RPL39;FCER1G;TLR4;ANKRD17;LBP;TLR2;GBP7;DROSHA;RPL30;SYK;RNASE6;IL6R;RAB1A;SHC1;ROMO1;CHGA
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.6513063196302469,1.6325497658341628,0.026981450252951095,0.2787860106685403,1.0,3/20,1.61%,DAB2;PID1;CLTC
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5096401684551349,1.6313267157674056,0.011730205278592375,0.2797733620268683,1.0,16/69,7.76%,PF4;APP;LILRA5;PTPRJ;OAS2;RIPK1;TLR4;CCL19;LBP;TLR2;LY96;TMEM106A;SYK;HSPB1;CCR2;PSEN1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6779155969492837,1.6298137162536674,0.03367003367003367,0.2814280286337001,1.0,3/16,2.42%,AHR;PTPN22;TNFRSF1B
prerank,positive regulation of protein metabolic process (GO:0051247),0.48446497731974053,1.6297281698859867,0.0013020833333333333,0.28013496724879683,1.0,32/110,15.31%,WWP1;PAEP;APOE;APP;KLF2;SMURF2;RILP;AXIN1;PRKN;BCL10;GSK3B;TRIM32;TNF;CD80;KLF4;MTPN;PSEN1;RAB7A;TNFSF12;RANBP9;RAB1A;NKD1;ATG7;WFS1;ROCK2;FOXO1;TFR2;NR1H2;NEDD4L;GPC3;PRMT1;RNF41
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.6531393719988021,1.6294235233909031,0.032148900169204735,0.2793707496512857,1.0,3/20,1.61%,DAB2;PID1;CLTC
prerank,negative regulation of inflammatory response (GO:0050728),0.45919660060754636,1.6280500369437039,0.002369668246445498,0.2808805994388786,1.0,39/182,13.33%,CD163;AOAH;APOE;ALOX5;LYN;C1QTNF3;MFHAS1;CYSLTR1;NR1H4;GNG2;METRNL;TNFRSF1B;CALCRL;ADRB2;DRD1;NR1D1;GRN;ADM;RB1;GHRL;CD200R1;ADCY9;ADCYAP1R1;SYK;KLF4;GNB1;FYN;FCGR3A;MAPK14;IGF1;TSHR;PTGER4;PRKACB;HTR6;RAMP2;TNFRSF1A;GLP2R;CREB1;GPR27
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.6207578542408084,1.6271760006745946,0.011589403973509934,0.28111876911521844,1.0,3/25,6.32%,RBPJ;SMAD4;ACVR2A
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6070711626721458,1.626462771018777,0.024518388791593695,0.28112529022100385,1.0,11/27,15.37%,GAS6;LIG4;CD74;WNT2;CDK6;PDGFRA;DDR2;PDGFC;IGF1;MYC;FN1
prerank,regulation of axon guidance (GO:1902667),0.7415376452197937,1.6263966072149356,0.039525691699604744,0.27987744414491317,1.0,3/10,6.20%,NRP1;ZSWIM6;MYCBP2
prerank,positive regulation of neutrophil migration (GO:1902624),0.6662432306753697,1.6262222824012513,0.033391915641476276,0.27885289815407455,1.0,6/18,4.25%,RIPOR2;CD74;THBS4;CAMK1D;CCL19;MCU
prerank,actin cytoskeleton reorganization (GO:0031532),0.5319386481916447,1.6249475174063994,0.015736766809728183,0.2798812641570275,1.0,15/63,11.26%,NRP1;NEDD9;CDC42BPG;FER;CASS4;GPR65;RHOA;MCU;S1PR2;EFS;NRK;GAB1;ANTXR1;PIP5K1A;S1PR1
prerank,regulation of interleukin-6 production (GO:0032675),0.49162178442434407,1.6247215214762507,0.005479452054794521,0.2789685646247324,1.0,23/96,8.25%,APP;IL16;LILRA5;TLR8;GAS6;C1QTNF3;IRAK3;PTPN22;TSLP;CD74;TLR4;LBP;BCL10;TLR2;IL17RA;GHRL;CD200R1;MAPKAPK2;TMEM106A;SYK;TNF;RAB7B;IL6R
prerank,negative regulation of gene expression (GO:0010629),0.435941323328852,1.6245691387045362,0.0011086474501108647,0.27786271762769255,1.0,70/302,13.83%,HDAC9;MSR1;FCGR2B;APOE;APP;ATP2B1;NOTCH2;CCR1;FOXP1;FBXW7;MYADM;ESR1;ZFP36L2;RPS3;DAPK1;MEF2C;PTPN22;BMP2;XDH;PARP14;ERN1;PPHLN1;CD46;SAMD4A;SRGN;RGCC;RPS13;PRKN;JARID2;MRPL13;HEY2;PTBP3;SPI1;RB1;NDFIP1;RACK1;EPC1;SETDB2;TNF;ZNF148;KLF4;YY1;REL;MALSU1;PSEN1;PTBP2;RBM4;NCOR1;TRIM27;SMCR8;H3-3A;ILF3;IGF1;SFRP1;DDX6;PTGER4;EMILIN1;DCP2;HINFP;NANOS3;ROCK2;TRIM71;ZC3H12A;ATP2B4;DIS3L2;ZC3H12D;LSM2;SHMT1;TNRC6C;NDFIP2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5214613333673195,1.6241786305090733,0.011834319526627219,0.27733973053625843,1.0,10/65,5.99%,HIP1;EGFR;PTPRJ;EPS15;ARAP1;FER;PTPN12;CDC42;CBL;RHBDF1
prerank,mitochondrion morphogenesis (GO:0070584),0.7332717592329793,1.6240818917443498,0.03993055555555555,0.2761579534583951,1.0,2/11,2.48%,PID1;MTM1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.637025606181606,1.6238931133876913,0.031088082901554404,0.2751136077537769,1.0,2/21,0.49%,PLTP;APOE
prerank,regulation of Notch signaling pathway (GO:0008593),0.5097499561150984,1.623631651065255,0.006983240223463687,0.2741890283010965,1.0,22/76,15.56%,RBPJ;EGFR;FBXW7;JAG1;CD46;ITGB1BP1;NRARP;EPN2;SYNJ2BP;POGLUT1;ARRB1;MAML1;EGFL7;SREBF2;CREBBP;NIBAN2;NOD2;STAT3;EP300;LFNG;SNW1;TSPAN14
prerank,negative regulation of macrophage activation (GO:0043031),0.6715144699884275,1.6235827202784545,0.021164021164021163,0.2729722518311272,1.0,4/16,3.26%,FCGR2B;LDLR;NR1D1;GRN
prerank,positive regulation of cell cycle (GO:0045787),0.5214787469664406,1.622898353622289,0.0075528700906344415,0.27313146791569465,1.0,21/62,16.20%,EGFR;LRP6;APP;NUPR1;ANKRD17;RGCC;PKN2;TRIM32;CHEK1;RPS15A;CCND3;CCNYL1;MDM2;CCND2;TTL;EIF4EBP1;CCNY;RARA;PKD2;USP22;HCFC1
prerank,response to fatty acid (GO:0070542),0.6674051346079259,1.6227867576351627,0.028933092224231464,0.27205490086549283,1.0,7/17,13.56%,PID1;NR1H4;CD36;KCNK4;FOXO3;FOXO1;FFAR1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.46728306602746383,1.6226407412613466,0.002560819462227913,0.2710295807822567,1.0,26/140,7.94%,ARHGEF3;ITSN1;ARHGAP15;STARD8;VAV3;PLEKHG5;FGD4;ARHGAP9;OPHN1;ARAP1;ARHGAP21;ARHGAP10;ARHGAP18;CDC42;ARHGAP31;RHOA;TRIO;OCRL;ARHGAP29;NGEF;FOXM1;DEPDC1B;ARHGAP12;ARHGAP23;ARHGEF12;ARHGDIA
prerank,heart trabecula morphogenesis (GO:0061384),0.656726354626684,1.6222389300178917,0.027257240204429302,0.27043171227339974,1.0,2/18,0.88%,RBPJ;ADGRG6
prerank,Golgi localization (GO:0051645),0.7338493941392393,1.620424197910887,0.03187250996015936,0.2726531378425076,1.0,3/11,3.32%,ARHGAP21;UVRAG;CDC42
prerank,regulation of histone modification (GO:0031056),-0.6516671016299309,-1.6191181735105178,0.02813852813852814,0.5985408426198879,1.0,7/13,20.20%,CDK9;AKAP8L;FLCN;HPF1;AKAP8;PARK7;PARG
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6721516547531179,1.6173429529334993,0.04482758620689655,0.2775530481158895,1.0,10/16,18.57%,ALOX5;FUT4;RHOA;TNF;ITGB2;MDK;ST3GAL4;RELA;IL6;TRAF6
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.585308511468815,1.6169756731402845,0.015313935681470138,0.27700328163372234,1.0,10/32,11.96%,HDAC9;RHOA;HMOX1;ITGB1BP1;KLF4;PIK3C2A;FOXC2;STARD13;MMRN2;MAP3K3
prerank,superoxide anion generation (GO:0042554),0.7081301917778451,1.6163943085370824,0.025878003696857672,0.2769035222551229,1.0,4/13,15.09%,CYBB;NCF2;CYBA;NOX4
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.731383228876742,1.6155740389191233,0.029850746268656716,0.27744650202040005,1.0,1/13,0.05%,PID1
prerank,regulation of interleukin-13 production (GO:0032656),0.7201230713175746,1.6151153881696723,0.0341726618705036,0.27717228576513636,1.0,3/13,2.14%,LILRA5;IRF4;TSLP
prerank,cholesterol transport (GO:0030301),0.5494158232783078,1.6148884687176541,0.01818181818181818,0.2763386423857974,1.0,4/45,2.76%,MSR1;APOE;LDLR;CD36
prerank,cellular response to cytokine stimulus (GO:0071345),0.4241232632959311,1.6139391694164564,0.0,0.2768669275183895,1.0,70/416,9.60%,F13A1;PID1;PF4;LIFR;ALOX5;IL16;PTPRJ;IRF4;CCR1;PTPN18;GAS6;RIPOR2;ALOX15;PTPN20;GBP3;ZFP36L2;ITGB1;FER;PTPN12;RPS3;DAPK1;IRAK3;IFNAR1;RPS27A;OXSR1;TNFRSF1B;RIPK1;CD36;CCL8;TLR4;NR1D1;DCSTAMP;CBL;CCL19;CRK;ZFP36L1;RHOA;HMOX1;LBP;VIM;PDE2A;TLR2;DUSP1;GSDME;MCL1;GSK3B;IL10RB;GBP7;RC3H1;WNK1;TCF7;CD40;BCL2;SYK;TNF;CD80;CXCR4;CCR2;IL20RB;STAT4;IFNAR2;FYN;CCL24;IL6R;RO60;UBE2K;SH2B3;NDN;IFITM2;STAT6
prerank,hemidesmosome assembly (GO:0031581),-0.6655954162500943,-1.6107755548276206,0.020833333333333332,0.6230743795236389,1.0,4/11,17.75%,DST;ITGA6;LAMA3;ITGB4
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5481437139795973,1.610632705550379,0.02848575712143928,0.2820843037671263,1.0,11/46,10.08%,RBPJ;IL15;TLR4;NR1D1;NPR3;RB1;LNPEP;PLCL2;ARRDC3;FOXC2;DOCK7
prerank,negative regulation of protein localization to membrane (GO:1905476),0.6203711098356957,1.6096402136927928,0.029315960912052116,0.28288312641707314,1.0,4/24,3.95%,DAB2;PID1;CLTC;ITGB1BP1
prerank,negative regulation of T cell activation (GO:0050868),0.5723855060030856,1.608492655439877,0.02857142857142857,0.2839312507544401,1.0,9/35,9.08%,FCGR2B;VSIG4;RIPOR2;PTPN22;CEBPB;LILRB1;PLA2G2D;CD80;SDC4
prerank,calcium-mediated signaling (GO:0019722),0.4803555962229866,1.607606237609593,0.00909090909090909,0.28450736593586157,1.0,14/93,7.81%,MCTP1;EDNRB;EGFR;P2RX7;PTPRJ;CCR1;PPP3CA;RCAN3;MCU;CAMKK2;CCRL2;CXCR4;CCR2;MCTP2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.6147796622895361,1.60752553847115,0.01335559265442404,0.28335626481724846,1.0,9/25,16.01%,KLF2;CD36;TLR4;INSR;TNF;KLF4;ASS1;PKD2;HSP90AB1
prerank,regulation of protein binding (GO:0043393),0.4774379493044014,1.607516007132648,0.00788436268068331,0.2821199337756383,1.0,28/114,11.25%,DAB2;APP;TCF7L2;BMP2;NES;CRK;RAPGEF2;ITGB1BP1;B2M;PRKN;BTBD1;GSK3B;RACK1;CFHR2;ROCK1;DISC1;ACTB;STK3;NMD3;DDX11;HFE;PSEN1;CARD16;PPP2CA;RIPK2;MARK2;PPP1CA;AMFR
prerank,B cell receptor signaling pathway (GO:0050853),0.5880123825545122,1.6071379554883483,0.029259896729776247,0.28168853650619613,1.0,8/32,9.25%,VAV3;CD38;MEF2C;RFTN1;BCL2;SYK;PRKCB;NFATC2
prerank,regulation of cellular respiration (GO:0043457),0.6553159662924382,1.606653245771694,0.034926470588235295,0.28136508556430406,1.0,4/17,6.27%,CBFA2T3;IFNAR1;IL10RB;NOP53
prerank,endocrine system development (GO:0035270),-0.550792402222815,-1.6059389524981427,0.021377672209026127,0.6324068791545038,1.0,6/21,19.27%,TGFBR1;SALL1;NF1;PAX8;WNT4;DKK3
prerank,mesenchymal cell differentiation (GO:0048762),0.5359083077289267,1.6044415514420696,0.019756838905775075,0.2843619223646212,1.0,10/51,5.43%,RBPJ;LRP6;FGFR1;S100A4;MEF2C;FBXL17;BMP2;HEY2;GSK3B;ROCK1
prerank,mRNA splice site selection (GO:0006376),-0.5046908543703039,-1.6042259739256146,0.014005602240896359,0.6240508411120261,1.0,15/30,30.05%,LUC7L3;SETX;SRSF5;PUF60;SRSF10;CELF4;SRSF12;SFSWAP;SRSF9;CELF6;CELF5;SRSF6;ISY1;PSIP1;SNRPC
prerank,positive regulation of proteolysis (GO:0045862),0.5284842560109286,1.6035225691558979,0.029940119760479042,0.2850945769825785,1.0,11/55,6.94%,NLRC4;APOE;CTSC;SNX9;TNFRSF1B;RCN3;ADAM9;CLN6;RHBDD1;TRIM32;TNF
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6801565564432314,1.6034710365595228,0.032432432432432434,0.28397107147822287,1.0,5/15,6.94%,APOE;SNX9;TNFRSF1B;ADAM9;TNF
prerank,negative regulation of protein metabolic process (GO:0051248),0.5320656317445642,1.6024914220134565,0.020989505247376312,0.28470370534357103,1.0,10/48,5.43%,EDNRB;EGFR;APOE;LDLR;IRAK3;RILP;HMGCR;SF3B3;SNX3;ROCK1
prerank,regulation of immune response (GO:0050776),0.46460599569931404,1.5998917879661188,0.0037593984962406013,0.2885742223977994,1.0,26/135,9.29%,FCGR2B;ITGA4;COLEC12;IRF4;FOXP1;IL15;AHR;LYN;ITGB1;PTPN22;CD300LG;CLEC2D;LILRB1;DENND1B;CD300LD;B2M;KIR3DL2;BIRC3;CD200R1;CD40;SYK;ZMPSTE24;FCGR3B;FCGR3A;CD33;RAET1E
prerank,cAMP-mediated signaling (GO:0019933),0.6297990208488966,1.5989532343957522,0.04020100502512563,0.28937291353184713,1.0,7/24,6.13%,PDE7B;ADGRG6;AHR;RAPGEF2;PDE2A;PDE4D;PDE7A
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5783589581590705,1.5973756780824813,0.03387096774193549,0.29150988962647206,1.0,11/31,16.73%,IL16;TLR4;CCL19;TLR2;CD40;SYK;MAPK14;RIPK2;MDK;SCIMP;TIRAP
prerank,negative regulation of protein catabolic process (GO:0042177),0.5564081401500864,1.5971001728415473,0.023291925465838508,0.29087210436385463,1.0,9/40,5.43%,NELL1;EGFR;IRAK3;RILP;HMGCR;RIC1;SF3B3;SNX3;ROCK1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5247269239150351,1.5951358814295513,0.0334855403348554,0.2939950250642323,1.0,22/50,20.34%,GAS6;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;PAK2;SFN;TNF;KLF4;FNIP1;CARD16;IGBP1;YWHAE;LAMTOR5;USP47;BEX3;HGF;RAF1;PLAUR;CSNK2A1;SNCA
prerank,membrane depolarization during action potential (GO:0086010),-0.5219960828050224,-1.5943983097787424,0.017587939698492462,0.6574034140086897,1.0,8/26,14.30%,KCNJ2;YWHAH;SCN1B;SLC8A1;CACNA1D;SCN8A;CACNA1C;SCN1A
prerank,negative regulation of glycolytic process (GO:0045820),0.732392760974539,1.5938608815776623,0.039473684210526314,0.2941589301529947,1.0,4/10,15.43%,NUPR1;CBFA2T3;NCOR1;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.732392760974539,1.5938608815776623,0.039473684210526314,0.2941589301529947,1.0,4/10,15.43%,NUPR1;CBFA2T3;NCOR1;HDAC4
prerank,positive regulation of lipid storage (GO:0010884),0.6318211357444422,1.5927452260666655,0.0288135593220339,0.2950938000913183,1.0,6/21,12.28%,MSR1;EHD1;OSBPL11;VSTM2A;SREBF2;ZC3H12A
prerank,gene expression (GO:0010467),0.4237322137788908,1.5921353818050457,0.0,0.2950764803748048,1.0,104/348,15.09%,DHX8;RBMS1;RPS29;MEF2A;RPS23;MRPL23;RPL17;RPL23;MRPS12;RPS12;RPS16;RPS3;RPS27A;RPL39;RPS18;RPS21;EEF1A1;RPL23A;RPS15;RPL37;RPLP1;AGFG1;RPL26;RPS10;RPS20;RPS13;RPLP2;RPSA;RPL41;RPS28;MRPL13;RPL13;RPS24;RSL24D1;RPL24;RPL12;RPL36A;RPS8;RPL18A;SMG6;DROSHA;RPL37A;THRB;RPS11;RPL28;RNASEL;ATXN1;DARS1;EPC1;RPL30;NOL9;HNRNPF;RPL8;RPL35A;RPS4X;RPS15A;RPL38;RPS17;RPLP0;CPSF3;MRRF;SRSF4;RPL5;RPL36;NR4A2;RNGTT;RPL14;NUP133;RBM4;RPS14;RPL9;RPS9;RPS5;RPS7;RPL34;RPL27;MRPS11;MED20;APOBEC1;POLR2B;RPL6;RPS6;NUP62;THOC6;RPL4;RPL22;EIF4EBP2;RPL15;RPL10;RPL32;NUP98;MRPS17;MRPL44;MAGOHB;NFKBIB;RPL19;MRPS14;MMS19;POLR2D;RPL31;RPL11;NOVA1;SRBD1;NOX4
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4884973506378492,1.590191619304245,0.00938337801608579,0.29791179898773845,1.0,19/86,10.06%,BANK1;NRP1;EGFR;APP;PTPRJ;CLEC6A;IL15;RAP2B;BST1;CD44;CD74;THBS4;PAK2;CD80;FYN;IL6R;IGF1;SFRP1;RIPK2
prerank,keratan sulfate catabolic process (GO:0042340),-0.6776296801606916,-1.589901302686728,0.030107526881720432,0.6647507187137747,1.0,2/11,2.47%,HEXB;GNS
prerank,ribosome biogenesis (GO:0042254),0.4451426780630601,1.5891327126321542,0.0036319612590799033,0.29875732007900097,1.0,62/187,16.16%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;RPS15;RPL37;RPLP1;RPL26;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;RPL37A;RPL28;WDR36;LTV1;NOP53;RPL30;NOL9;RPL8;RPL35A;RPL38;RPS17;RPLP0;RPL5;MALSU1;RPL36;RPL14;RPS14;RPL9;RPS9;RPS7;RPL34;RPL27;MTREX;RPL6;HEATR1;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;RPL19;EXOSC1;RPL31;RPL11;XPO1;NOP58;MPHOSPH6;LSG1
prerank,neuron fate commitment (GO:0048663),-0.6064239078168866,-1.589061147389563,0.024608501118568233,0.6524831705556992,1.0,2/14,2.63%,TGFBR1;MYT1L
prerank,regulation of macrophage differentiation (GO:0045649),0.6651146448554957,1.5886182605356443,0.045774647887323945,0.29855710945208896,1.0,3/15,2.67%,PF4;C1QC;RIPK1
prerank,ribosomal small subunit assembly (GO:0000028),0.6536294772802166,1.5875830558618835,0.041666666666666664,0.2995823017905884,1.0,7/16,9.26%,RPS15;ERAL1;RPSA;RPS28;RPS14;RPS5;MRPS11
prerank,alcohol catabolic process (GO:0046164),0.7251881613338964,1.5872811419739252,0.03802281368821293,0.2989814111712347,1.0,3/10,6.24%,APOE;SCARF1;CYP27A1
prerank,regulation of biosynthetic process (GO:0009889),0.7142055544445005,1.5860673871584126,0.0390625,0.30026283254573005,1.0,2/11,6.05%,ALOX5;PIKFYVE
prerank,regulation of keratinocyte proliferation (GO:0010837),0.6217992398965188,1.5860547088115076,0.04470198675496689,0.29906834180975783,1.0,5/22,5.25%,NOTCH2;CASK;ZFP36L1;KLF9;PTPRK
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6618072721756991,1.585815298154698,0.04609929078014184,0.2984595074286276,1.0,2/16,2.01%,RBPJ;MEF2C
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.7040748435661524,1.5845250326148375,0.032432432432432434,0.29981379712815387,1.0,6/13,13.67%,FCGR2B;ALOX5;NUPR1;MANF;WFS1;NR1H2
prerank,cellular response to organic cyclic compound (GO:0071407),0.46080158089692247,1.5841836295302862,0.012531328320802004,0.2993142573039697,1.0,36/141,12.28%,EGFR;P2RX7;RAP1B;HRH1;CTNNA1;AHR;DIAPH1;ESR1;NCOA3;MEF2C;NR1H4;GNG2;DRD1;P2RY6;ZFP36L1;RAPGEF2;PDE2A;AOC1;NR3C1;RAP1A;ACTB;RIOK3;TNF;EPG5;NRIP1;GNB1;MSN;HCN3;LCOR;SFRP1;SPIDR;TRPM2;JUP;KCNQ1;ROCK2;ZC3H12A
prerank,defense response to protozoan (GO:0042832),0.7121424796254767,1.5837227627176085,0.03260869565217391,0.2990797169992396,1.0,5/12,6.14%,PF4;IRF4;GBP7;BATF2;CD40
prerank,glycosphingolipid metabolic process (GO:0006687),-0.47421094120910684,-1.5834378607479163,0.025,0.6657864457555762,1.0,11/42,9.69%,HEXB;LARGE1;CERK;ST3GAL5;ST6GALNAC3;SMPD4;ESYT1;NEU1;ASAH1;ESYT2;GBA2
prerank,glycolipid metabolic process (GO:0006664),-0.45978503419002403,-1.5831158707301034,0.0160857908847185,0.6515412519817185,1.0,12/47,9.69%,HEXB;CERK;ST3GAL6;ST6GALNAC3;SMPD4;ESYT1;NEU1;ASAH1;ST6GALNAC4;ESYT2;SCCPDH;GBA2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.6773472173249098,1.5827630971538718,0.03423423423423423,0.29993803926209184,1.0,1/15,0.03%,DAB2
prerank,cardiac muscle cell action potential (GO:0086001),-0.5029524365183852,-1.5824811671116965,0.01832460732984293,0.6400444022978964,1.0,8/30,5.39%,FGF12;KCNJ2;ATP1B1;SCN1B;SLC8A1;ANK2;CACNA2D1;CACNA1D
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.681471772322236,1.581990378938947,0.04797047970479705,0.30034809203896684,1.0,5/14,7.06%,DDX60;ANKRD17;TLR2;PUM2;USP15
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.534179111858373,1.5812716811039629,0.025954198473282442,0.3006745711980833,1.0,8/45,7.63%,DAB2;BMP2;GDF3;SMAD4;GDF10;ACVR2A;SDCBP;HFE
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5003362116069944,1.581239775658847,0.0310192023633678,0.2995413493547568,1.0,16/68,8.25%,APP;IL16;LILRA5;TLR8;TSLP;CD74;TLR4;LBP;BCL10;TLR2;IL17RA;TMEM106A;SYK;TNF;RAB7B;IL6R
prerank,positive regulation of cell differentiation (GO:0045597),0.42989114645677573,1.5809780679352865,0.0011441647597254005,0.2989120071315056,1.0,34/237,6.90%,DAB2;MSR1;PF4;NELL1;FGFR1;TCF4;CTNNA1;CMKLR1;MEF2A;ZBTB16;RIPOR2;WDFY2;MEF2C;RIN2;CEBPB;KITLG;BMP2;CD36;ALX1;CDC42;GDF3;ZFP36L1;RHOA;RPS6KA3;RGCC;RAPGEF2;RAP1A;GPRC5B;SMAD4;MEDAG;TRIM32;BLOC1S5;ACVR2A;SDCBP
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4861239429967717,1.5809518844461197,0.01793103448275862,0.29779034514170954,1.0,10/80,5.36%,EPS8;NRP1;P2RX7;RIPOR2;ARAP1;ACTR3;WASF2;CDC42;CCL19;DOCK11
prerank,negative regulation of protein secretion (GO:0050709),0.5579463192257283,1.5799071659669486,0.018404907975460124,0.29877099834429555,1.0,9/38,11.90%,APOE;RAB11FIP5;HMGCR;PRKN;RHBDF1;DPH3;SFRP1;CHGA;KCNB1
prerank,negative regulation of immune system process (GO:0002683),0.655407381476422,1.5797093007332497,0.04085257548845471,0.2980275779047551,1.0,3/16,3.80%,FCGR2B;LYN;HMOX1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.43340778728943696,1.5794632849465804,0.001160092807424594,0.2973435889290048,1.0,42/214,11.24%,NRP1;EGFR;APOE;APP;SPRED1;NOTCH2;CCR1;FBXW7;GAS6;ALOX15;C5AR1;LYN;MFHAS1;PTPN22;CD44;BMP2;CD36;CD74;CCL8;TLR4;P2RY6;THPO;CCL19;RAPGEF2;ITGB1BP1;PDE8A;RAP1A;SMAD4;PDGFRA;SYK;TNF;SYNJ2BP;CCL24;ADRA1A;RANBP9;CNKSR3;RPS6KA6;PDGFC;ARRB1;SPRED2;EMILIN1;SHC1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.671376424227718,1.5786902393234081,0.04512635379061372,0.29772220413423395,1.0,3/13,3.41%,NRROS;BMP2;CD46
prerank,regulation of cartilage development (GO:0061035),0.6296273778256615,1.5783418032700784,0.039655172413793106,0.2973397120538127,1.0,3/18,2.60%,TRPS1;ZBTB16;BMP2
prerank,"phototransduction, visible light (GO:0007603)",0.6858745627926679,1.5783159808012892,0.05090909090909091,0.29623748980168146,1.0,4/14,8.00%,GNAQ;RP1;PDE6A;GNB1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6188273113881317,1.578046831703069,0.03281519861830743,0.2956805257146789,1.0,3/22,2.10%,FCGR2B;PTPRJ;PTPN22
prerank,polarized epithelial cell differentiation (GO:0030859),0.686752591876726,1.5779955334168942,0.05631067961165048,0.2946415604846558,1.0,6/13,11.56%,OPHN1;CDC42;RAB10;RHOA;MSN;MYO9A
prerank,positive regulation of T cell migration (GO:2000406),0.6193190422424502,1.5769523390830211,0.035523978685612786,0.29581439177028573,1.0,5/20,7.58%,APP;OXSR1;RHOA;WNK1;CCR2
prerank,negative regulation of protein processing (GO:0010955),-0.639432742706786,-1.574556516321838,0.03164556962025317,0.6675974030025262,1.0,5/12,18.67%,SERPINE2;TMEM59;PRNP;GAS1;SERPINE1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5087687586332548,1.5741843810724798,0.016200294550810016,0.3000748620765501,1.0,13/56,5.47%,TLR8;RPS27A;ALPK1;S100A1;CD36;TLR4;RPS6KA3;LBP;BCL10;TLR2;MAPKAPK2;CTSB;LY96
prerank,positive regulation of heart rate (GO:0010460),0.6488960279902322,1.573961368525995,0.04584040747028863,0.2994998509046219,1.0,7/17,14.25%,ADM;PDE4D;ADRA1D;ADRA1A;KCNQ1;SCN3B;ATP2A2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5202141644719439,1.5733949355360242,0.0282574568288854,0.2994599821226857,1.0,19/49,18.04%,TLR8;RIPK1;CD74;TLR4;LBP;BCL10;TLR2;SYK;TNF;RAB1A;LAMTOR5;NOD2;STAT3;PRKD2;TIRAP;RELA;TLR7;IL6;F2R
prerank,response to reactive oxygen species (GO:0000302),0.5142050543081266,1.571373599772859,0.027906976744186046,0.3025658411097528,1.0,15/54,12.85%,EGFR;APOE;FER;RPS3;ADAM9;HMOX1;CAMKK2;PTPRK;PDGFRA;STK24;FYN;TXNRD2;PXN;ROMO1;AGAP3
prerank,cardiac muscle cell contraction (GO:0086003),-0.5717597767080554,-1.571163583585557,0.03178484107579462,0.6711929224021261,1.0,9/19,22.63%,FGF12;KCNJ2;SCN1B;CACNA2D1;CACNA1D;CACNA1C;SCN1A;CAMK2D;SCN2B
prerank,regulation of glycolytic process (GO:0006110),0.4999499963148575,1.5708373322727505,0.014144271570014143,0.30251491213284903,1.0,21/68,17.18%,P2RX7;APP;PRKAG2;NUPR1;ZBTB20;CBFA2T3;PGAM1;INSR;PFKFB4;PSEN1;SLC4A4;NUP133;NCOR1;IGF1;NUP62;NUP98;EP300;HDAC4;ARNT;NUP153;ZBTB7A
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.6079415227645509,1.568923964396763,0.03488372093023256,0.30503397192100734,1.0,3/20,4.49%,RBPJ;BMP2;HEY2
prerank,protein localization to synapse (GO:0035418),-0.6485801173431599,-1.567576501470316,0.022727272727272728,0.6756552499641113,1.0,5/12,5.60%,NLGN1;NRXN1;DLG4;PCLO;SHANK1
prerank,detection of visible light (GO:0009584),0.6586083369059388,1.5674996536262515,0.03597122302158273,0.3068423599316812,1.0,5/16,18.29%,GNAQ;RP1;GNA11;REEP6;ABCA4
prerank,negative regulation of myotube differentiation (GO:0010832),-0.6393941006009993,-1.567460209512904,0.030634573304157548,0.6617330552207779,1.0,7/12,19.51%,TMEM119;BHLHE41;BDNF;HDAC5;NOTCH1;HDAC3;HDAC1
prerank,negative regulation of defense response (GO:0031348),0.4980872900124805,1.567300748822901,0.022889842632331903,0.3061768317787562,1.0,13/77,7.22%,AOAH;APOE;ALOX5;C1QTNF3;MFHAS1;IRAK3;NR1H4;METRNL;NR1D1;RB1;GHRL;PPM1B;KLF4
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4783686438881937,1.5657595303963658,0.012129380053908356,0.30826845383441875,1.0,20/86,12.12%,EPS8;STARD8;DENND1A;RASGRP4;NOTCH2;OPHN1;LYN;STK19;SYNGAP1;IRS2;FOXM1;ARHGDIA;DENND4C;IGF1;STARD13;NUP62;SHC1;KANK2;DENND3;ARHGAP17
prerank,actin filament polymerization (GO:0030041),0.5776397472773341,1.5652729505023208,0.04477611940298507,0.30810435971632794,1.0,5/29,1.76%,PSTPIP2;DIAPH1;GAS7;PSTPIP1;ANG
prerank,negative regulation of metabolic process (GO:0009892),0.5163855389551294,1.5638453220120565,0.03343023255813953,0.31013120891042306,1.0,11/54,10.08%,RBPJ;IL15;TLR4;NR1D1;NPR3;RB1;LNPEP;PLCL2;ARRDC3;FOXC2;DOCK7
prerank,autonomic nervous system development (GO:0048483),0.646674478491713,1.5635973367957199,0.044142614601018676,0.30958313023896106,1.0,3/17,2.92%,NRP1;EDNRB;PHOX2A
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6311735400884172,1.5634788870083152,0.043859649122807015,0.3086811502334921,1.0,6/19,7.31%,APP;KLF2;TMEM106A;TNF;KLF4;MTPN
prerank,positive chemotaxis (GO:0050918),0.6423861779352287,1.5634553408802798,0.04355400696864112,0.30762844214481283,1.0,2/17,0.78%,NRP1;PTPRJ
prerank,myoblast fusion (GO:0007520),-0.6408927244150453,-1.5630725064269992,0.0392156862745098,0.6692405468468925,1.0,3/12,1.66%,CD9;ADGRB3;JAM2
prerank,neuron migration (GO:0001764),0.5247409767203718,1.5627256694935288,0.020833333333333332,0.30809609396667326,1.0,14/48,10.58%,NRP1;FGFR1;NAV1;MEF2C;SH3RF1;RAPGEF2;LRP12;USP9X;DISC1;CELSR1;NR4A2;TUBGCP2;CCK;MARK2
prerank,early endosome to Golgi transport (GO:0034498),0.6962034552189754,1.5618065597110418,0.05303030303030303,0.3089334747949404,1.0,2/11,1.46%,SNX2;SNX8
prerank,protein localization to mitochondrion (GO:0070585),-0.6578677618292004,-1.5616152195320019,0.017167381974248927,0.6642995141478049,1.0,2/11,8.84%,HK2;MTCH2
prerank,lipid catabolic process (GO:0016042),-0.5662575433769402,-1.5608726786579827,0.03132530120481928,0.6548497013297878,1.0,5/18,9.77%,LIPH;LPL;PPT1;ACADL;SIRT2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.6090854961129548,1.5595756210426164,0.038917089678511,0.31234809283315196,1.0,6/22,4.74%,SASH1;RELL1;MFHAS1;BMP2;XDH;SPI1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5969540500251812,1.558951191355996,0.045531197301854974,0.31250306490109037,1.0,6/24,7.58%,CCR1;LYN;ANO6;PLA2G7;DUSP1;CCR2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5864079587726991,1.5588101593498187,0.044326241134751775,0.3116927222930091,1.0,8/25,9.20%,NRP1;EGFR;APP;ANG;BCL10;SDCBP;PSEN1;KCTD20
prerank,regulation of fatty acid metabolic process (GO:0019217),0.6414884079715236,1.5583369199682224,0.0392156862745098,0.31155990370199405,1.0,4/17,8.14%,PRKAG2;UGT1A8;ADIPOR2;NCOR1
prerank,positive regulation of binding (GO:0051099),0.4841003037592686,1.5583056295141526,0.01652892561983471,0.31056403736469934,1.0,26/84,15.28%,APOE;APP;TCF7L2;BMP2;CLN5;RAPGEF2;B2M;PRKN;GSK3B;STK3;NMD3;DPH3;DDX11;HFE;CEBPG;PSEN1;GMNN;KDM4D;IGF1;RIPK2;AMFR;RARA;RALB;ADD1;RPL11;STMN1
prerank,cellular response to fatty acid (GO:0071398),0.7035019138665457,1.5581465629403182,0.035849056603773584,0.3097651943040439,1.0,2/12,2.03%,PID1;NR1H4
prerank,regulation of glucose import (GO:0046324),0.5693884828394707,1.5577479334603435,0.029556650246305417,0.30949188464978183,1.0,5/30,4.97%,PID1;PRKAG2;C1QTNF12;IRS2;INSR
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.5920077660694917,-1.5572800017297581,0.027649769585253458,0.6601004169993913,1.0,12/16,37.17%,DCPS;WBP4;SNRNP200;SRSF12;SFSWAP;DDX23;SART1;PSIP1;SNRPC;RBM22;SRSF1;NCBP2
prerank,regulation of protein transport (GO:0051223),0.5712837372968383,1.5571369920667784,0.03577235772357724,0.309720146372618,1.0,10/27,13.83%,LCP1;NDFIP1;SNX3;RHBDF1;GAPVD1;STXBP5;TNF;DNAJC1;DISP1;NDFIP2
prerank,purine nucleotide metabolic process (GO:0006163),0.5809121126294077,1.557092033154305,0.05423728813559322,0.30873698297387403,1.0,3/24,3.66%,GDA;XDH;DNPH1
prerank,response to cytokine (GO:0034097),0.4481255922493574,1.5553082004608543,0.005025125628140704,0.3113261942099865,1.0,29/141,9.46%,PID1;LIFR;APP;IFITM3;PTPN18;PTPN20;PTPN12;IRAK3;RIPK1;CD74;LAMP3;ADAM9;RHOA;TNFRSF11A;TRIM56;GCH1;MCL1;MAPKAPK2;TRIM32;CD40;BCL2;BST2;CXCR4;REL;IFNAR2;CXCL16;IL6R;IGBP1;IFITM2
prerank,transition metal ion homeostasis (GO:0055076),0.5721504072606184,1.5551724041182213,0.049069373942470386,0.310501786786193,1.0,12/28,17.84%,CP;HMOX1;B2M;PRKN;FTL;FBXL5;HFE;HMOX2;TFR2;ABCB7;NEO1;PICALM
prerank,positive regulation of nervous system process (GO:0031646),-0.5677360246974142,-1.555131620104392,0.03537735849056604,0.6578743797156051,1.0,8/18,12.20%,RIMS1;RIMS2;PARD3;ITGAX;CST7;TENM4;TPPP;RNF10
prerank,intraciliary retrograde transport (GO:0035721),-0.6429468965724435,-1.5546892533587149,0.024390243902439025,0.6476397786939012,1.0,6/12,18.45%,IFT140;DYNLT2B;WDR19;DYNC2H1;IFT43;DYNC2I1
prerank,cGMP-mediated signaling (GO:0019934),0.6834029492968123,1.5530445324624345,0.031192660550458717,0.31360396903043336,1.0,4/13,4.20%,APOE;IRAG1;CD36;PDE2A
prerank,ncRNA processing (GO:0034470),0.43010974777771294,1.5518329142076626,0.002347417840375587,0.3149131544006593,1.0,63/200,14.84%,RPL17;RPL23;RPS16;NOL6;RPL39;RPL23A;PRKRA;RPS15;RPL37;RPLP1;RPL26;TUT7;RPLP2;SNU13;RPL41;RPS28;RPL13;RPS24;RPL24;RPL12;RPL36A;RPL18A;DROSHA;RPL37A;RPL28;WDR36;FARS2;NOP53;RPL30;NOL9;RPL8;RPL35A;RPL38;RPS17;RPLP0;RPL5;RPL36;RPL14;RPS14;RPL9;TUT4;RPS9;RPS7;RPL34;RPL27;MTREX;RPL6;HEATR1;RPS6;RPL4;RPL22;RPL15;RPL10;DDX10;RPL32;EXOSC8;ESF1;MRPL44;RPP30;RPL19;EXOSC1;RPL31;RPL11
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4958705125705184,1.5513964461379963,0.031029619181946404,0.31476666931236846,1.0,23/62,18.45%,PF4;ZBTB16;KMT2A;LYN;MEF2C;CDK6;SPI1;CBFB;PRKCB;CDC73;ASH2L;KMT2C;H3-3A;RBM15;CREBBP;KMT2E;TNRC6C;EP300;PRMT1;PRKCQ;FES;MAFB;CNOT4
prerank,establishment of apical/basal cell polarity (GO:0035089),0.6627485778972382,1.5512915050326106,0.04744525547445255,0.3139020274860381,1.0,5/14,11.56%,OPHN1;CDC42;RHOA;MSN;MYO9A
prerank,negative regulation of cilium assembly (GO:1902018),-0.6220239037489625,-1.5493544079352344,0.0389908256880734,0.6616452344899877,1.0,9/12,25.96%,CEP97;CCP110;EVI5L;MAP4;CDK10;LIMK2;TBC1D7;ODF2L;TCHP
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6580151002288276,1.548173868762474,0.05458089668615984,0.31947932782934263,1.0,4/14,6.14%,ITGA4;ANO6;RGCC;CD40
prerank,cellular response to oxygen-containing compound (GO:1901701),0.41491668337719584,1.547243940487195,0.0,0.32037432175168334,1.0,67/291,13.56%,PID1;PF4;EGFR;P2RX7;RAP1B;AHR;ESR1;LYN;NCOA3;FER;RPS3;DAPK1;MEF2C;NR1H4;GNG2;TNFRSF1B;LILRB1;DRD1;WNT2;TLR4;NR1D1;P2RY6;ADAM9;ZFP36L1;RHOA;RAPGEF2;LBP;BCL10;VIM;PDE2A;TLR2;NFKBIL1;AOC1;RAP1A;CAMKK2;PTPRK;PDGFRA;MTR;LY96;ACTB;CD80;WNT6;NRIP1;GNB1;CDC73;MAPK14;HCN3;CARD16;LCOR;SFRP1;TSHR;CD68;PXN;CHMP5;KCNK4;ROMO1;KCNQ1;ROCK2;LAMTOR5;ZC3H12A;ATP2B4;NOD2;AGAP3;FOXO1;CREB1;NFKBIB;SHMT1
prerank,negative regulation of catabolic process (GO:0009895),0.5075378288965676,1.5464700225063177,0.028315946348733235,0.321080874417952,1.0,10/47,8.14%,EGFR;NUPR1;IRAK3;CBFA2T3;RILP;HMGCR;SF3B3;SNX3;TNF;NCOR1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.49293309830864485,1.5459737228996069,0.028368794326241134,0.3210339370585122,1.0,18/67,11.99%,VAV3;NRP1;CYBB;ABI1;WASF2;DOCK1;CDC42;CRK;RHOA;PAK2;MAPKAPK2;ROCK1;HSPB1;FYN;MAPK14;PXN;NCF2;ROCK2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5848259181242934,-1.5445655252211716,0.04090909090909091,0.6733976839548805,1.0,9/16,21.19%,ARHGAP24;PIK3CB;RASGRF1;CADM4;STMN3;AUTS2;ARF6;SH3BP1;ARHGAP44
prerank,keratinocyte differentiation (GO:0030216),0.5694738133777183,1.5443280023046162,0.051070840197693576,0.32361710255387655,1.0,6/29,5.23%,TXNIP;JAG1;EXPH5;ADAM9;KRT10;CLIC4
prerank,sensory perception of smell (GO:0007608),-0.6370790062974774,-1.5421288241673605,0.05714285714285714,0.6736303525466167,1.0,4/11,21.46%,ADCY3;SLC24A4;BBS4;MKKS
prerank,myofibril assembly (GO:0030239),0.5304341918226461,1.5408228772136936,0.041158536585365856,0.3300899915562906,1.0,7/42,5.33%,FLII;TMOD1;MYH6;MYOM2;TNNT1;TMOD3;PDGFRA
prerank,actin filament organization (GO:0007015),0.4383866603432729,1.540141728240565,0.011221945137157107,0.33045860547199263,1.0,35/151,14.38%,EPS8;HIP1;NEDD9;MYO5A;FLII;ABI1;TMOD1;NRAP;CASS4;CDC42;RHOA;LCP1;MCU;TMOD3;GHRL;EFS;MYO7A;ARHGAP12;DSTN;RHOBTB1;PLS1;CORO1C;RFLNB;MYO1E;MYO1C;GAS2L1;ARHGAP17;SVIL;NEB;CORO7;RND3;TPM3;WASL;RHOC;CGNL1
prerank,acute inflammatory response (GO:0002526),0.590266052208336,1.5399304669416871,0.04215851602023609,0.3298677074940237,1.0,4/23,8.25%,ANO6;CEBPB;LBP;IL6R
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.4789732409755004,1.5383792513074317,0.022377622377622378,0.3320688802349127,1.0,17/80,9.18%,SNX2;TBC1D5;SNX8;CLTC;ANKFY1;EVI5;SNX6;CLN5;RIC1;SNX3;TBC1D14;PIKFYVE;RAB7A;RAB7B;TRIM27;DENND5A;TRAPPC10
prerank,cellular response to nitrogen compound (GO:1901699),0.6126254180902827,1.5375082092263137,0.056218057921635436,0.3328399063369117,1.0,9/20,12.32%,NR1H4;AOC1;RIOK3;EPG5;DDX11;ATRX;SPIDR;ROCK2;ATP2B4
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.43950419650909645,1.5373813235566993,0.008883248730964468,0.3320379669195397,1.0,57/158,18.91%,PLEKHG5;CLEC6A;S100A4;SHISA5;ALPK1;RIPK1;CD74;ANKRD17;CCL19;PELI1;RHOA;HMOX1;PRKN;BCL10;BIRC3;NDFIP1;GPRC5B;TRIM32;TMEM106A;CD40;TNF;BST2;MIER1;REL;PRKCB;TRIM68;TRIM27;TFG;CARD16;EEF1D;RIPK2;NUP62;WLS;CASP8;MAP3K3;LAMTOR5;VAPA;TERF2IP;NOD2;TNFRSF1A;UBE2N;GJA1;NDFIP2;MID2;RHOC;TRIM25;PPM1A;BRD4;TIRAP;TAB3;RELA;F2R;ECM1;TRAF6;IRAK4;PLK2;DDX21
prerank,regulation of epidermal cell differentiation (GO:0045604),0.620484188601479,1.5364910505323828,0.04145936981757877,0.3329291148724828,1.0,6/21,6.03%,SGPP1;GDF3;ZFP36L1;ROCK1;CBFB;SFN
prerank,negative regulation of transport (GO:0051051),0.5104052861293509,1.5364694815390851,0.024844720496894408,0.33191398613338,1.0,16/51,13.83%,MCTP1;FCGR2B;LILRB1;PRKN;TLR2;NDFIP1;RACK1;SNX3;BST2;RAB7A;CRYAB;PIP4P2;SNX33;RUBCN;NR1H2;NDFIP2
prerank,Notch signaling pathway (GO:0007219),0.5008089514739705,1.535392171262352,0.04129793510324484,0.3332828683437434,1.0,19/59,15.71%,RBPJ;NOTCH2;JAG1;BMP2;NRARP;HEY2;GMDS;DTX2;PSEN1;MAML1;CREBBP;MIB1;PLXND1;EP300;MDK;WWC1;SNW1;MYC;NCSTN
prerank,RNA transport (GO:0050658),-0.4062529895673246,-1.5350426184492372,0.003436426116838488,0.6963353807276744,1.0,30/71,21.55%,THOC1;RBFOX1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;FLOT1;KIF5C;SRSF2;FMR1;RNPS1;U2AF1;CKAP5;UPF3B;CASC3;TGFBR2;SIDT2;NCBP1;HNRNPA1;ATXN2;SRSF11;THOC3;SIDT1;SRSF9;TST;POLDIP3;ALYREF;U2AF2
prerank,negative regulation of immune response (GO:0050777),0.43993980553519757,1.5348237742945172,0.0036719706242350062,0.3334253636000281,1.0,33/154,13.33%,CD163;FCGR2B;ALOX15;LYN;CYSLTR1;FER;IRAK3;GNG2;CALCRL;ADRB2;LILRB1;DRD1;ADM;SPI1;RC3H1;ADCY9;ADCYAP1R1;SYK;PPM1B;CCR2;GNB1;FYN;FCGR3A;TRIM27;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,protein hydroxylation (GO:0018126),-0.5814478728272914,-1.5340719965933234,0.029612756264236904,0.689366724682102,1.0,7/15,19.16%,ASPH;P3H2;OGFOD1;PLOD3;P3H3;VIPAS39;P3H4
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.5606247882657673,1.5330114325557493,0.053156146179401995,0.3363337274645703,1.0,4/31,4.55%,ALOX5;MOCS1;HDC;GCH1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5173224457567792,1.5327911301126662,0.03538461538461538,0.33565219416175784,1.0,6/43,3.50%,EGFR;PTPRJ;EPS15;SNX6;CDC42;CBL
prerank,negative regulation of RNA metabolic process (GO:0051253),0.6234200925318435,1.5322922211060543,0.06701030927835051,0.33563248353329367,1.0,7/18,12.28%,ESR1;RPS13;PTBP3;TNF;PTBP2;NCOR1;ZC3H12A
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6250290752234687,1.5313243559828629,0.05098684210526316,0.3366248542558983,1.0,5/18,11.96%,HDAC9;HMOX1;PIK3C2A;FOXC2;MAP3K3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.4631806373077729,1.5313162879504068,0.019525801952580194,0.3355832812890948,1.0,16/93,7.38%,FCGR2B;APP;MAP3K5;SASH1;RELL1;MFHAS1;RASSF2;SH3RF1;BMP2;XDH;RIPK1;AXIN1;CCL19;SPI1;SDCBP;DUSP22
prerank,regulation of protein kinase B signaling (GO:0051896),0.4277999535654047,1.5297930425079285,0.0023923444976076554,0.33786194195280395,1.0,34/193,9.91%,BANK1;HIP1;EGFR;FGFR1;PTPRJ;TCF7L2;GAS6;ESR1;ITGB1;MFHAS1;CASS4;RCN3;KITLG;XDH;FGF23;MYORG;THPO;CCL19;ITGB1BP1;FRS2;ICOS;IRS2;INSR;RACK1;PDGFRA;NOP53;TNF;CD80;GAB1;FYN;TSPYL5;SH2B3;MYDGF;RTN4
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5999185753417868,1.5287501222491653,0.06440677966101695,0.33901622068683107,1.0,2/19,2.01%,RBPJ;MEF2C
prerank,regulation of microtubule polymerization (GO:0031113),-0.46304260428306965,-1.528513299396674,0.01971830985915493,0.7054364319746358,1.0,12/40,13.13%,NAV3;MAP2;PAK1;TBCD;CAMSAP1;MAPT;MAPRE3;GBA2;TOGARAM1;NUMA1;MAPRE1;EML2
prerank,regulation of monocyte differentiation (GO:0045655),0.6432255414845196,1.527384191845136,0.06514084507042253,0.34095462845345104,1.0,5/14,4.56%,FOXP1;CD74;DCSTAMP;ZFP36L1;CDK6
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.43005477188832736,1.5270578788432794,0.0125,0.3405677268196403,1.0,20/161,5.73%,DAB2;LRP6;APOE;IGFBP4;TCF7L2;TLE4;PSMA7;TNN;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;MCC;UBAC2;ZNRF3;GSK3B;NOTUM;CTNND1;STK3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4773419921255877,1.5259071714316184,0.02564102564102564,0.34184607983608656,1.0,11/70,4.87%,NRP1;ITGA4;ATRNL1;PEAK1;OPHN1;FER;MEF2C;RHOA;GRHL2;SPI1;RB1
prerank,regulation of developmental growth (GO:0048638),0.565121253327557,1.5258604997485943,0.048154093097913325,0.3408575301331403,1.0,7/29,13.88%,APOE;APP;GSK3B;INSR;IGF1;LATS2;MFSD2A
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5811100005213355,1.5257397479934887,0.05752961082910321,0.3400738046232951,1.0,12/25,19.39%,OPHN1;RPL23;LAMP3;RPL5;HFE;RPS7;RPL11;PRKCG;HSP90AB1;EFNA1;CSNK2A2;CSNK2A1
prerank,neutrophil activation involved in immune response (GO:0002283),0.40172408638510476,1.5245537040179766,0.001076426264800861,0.34158285481985035,1.0,90/428,11.67%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;IQGAP1;CTSC;ARHGAP9;CLEC12A;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;ANO6;BST1;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;FCER1G;LILRB3;CD36;GRN;ATP8B4;RAB10;ARL8A;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;FTL;PGAM1;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;CNN2;SYK;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;CD53;RAB7A;OSTF1;FCGR3B;CLEC4D;CD33;VCL;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;LAMP2;AMPD3;ENPP4;CD68;ATG7;TRPM2;FTH1;JUP;STK10;SNAP23;CDK13;NPC2
prerank,platelet degranulation (GO:0002576),0.4542858809032066,1.5229838338970898,0.01683937823834197,0.343833043897872,1.0,18/118,10.64%,F13A1;PF4;APP;PHACTR2;GAS6;SELENOP;LYN;CD36;SRGN;MANF;APOOL;FAM3C;ABCC4;VCL;PROS1;IGF1;LAMP2;CALM1
prerank,amyloid fibril formation (GO:1990000),0.5120994007094433,1.5228941548744797,0.04552352048558422,0.342962090922627,1.0,10/51,5.03%,TGFBI;APP;ITM2B;RPS27A;RIPK1;SIAH2;CD36;B2M;PRKN;USP9X
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.7008761536388792,1.5223782483928934,0.07047619047619047,0.3430810986997627,1.0,5/10,11.56%,OPHN1;CDC42;RHOA;MSN;MYO9A
prerank,odontogenesis (GO:0042476),0.5378745197699101,1.5214566474574047,0.046849757673667204,0.34411904923538805,1.0,7/35,7.63%,LRP6;OSR1;BMP2;ANKRD11;EDA;TUFT1;WNT6
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.5578282690102673,-1.5213061557288068,0.03640776699029126,0.7304721256154852,1.0,12/19,28.74%,CUX1;PTPRD;SS18L1;CAPRIN1;SS18L2;IL1RAPL1;CDKL5;DBN1;FBXW8;CDKL3;CUX2;CAMK2B
prerank,acute-phase response (GO:0006953),0.6712723761515678,1.5212801878733466,0.0625,0.34340147829604734,1.0,6/12,23.64%,CEBPB;LBP;IL6R;IL6;IL22;PLSCR1
prerank,neutrophil degranulation (GO:0043312),0.4001738145867423,1.5207850230841324,0.0010706638115631692,0.34342082859382644,1.0,89/425,11.67%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;IQGAP1;CTSC;ARHGAP9;CLEC12A;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;ANO6;BST1;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;FCER1G;LILRB3;CD36;GRN;ATP8B4;RAB10;ARL8A;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;FTL;PGAM1;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;CNN2;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;CD53;RAB7A;OSTF1;FCGR3B;CLEC4D;CD33;VCL;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;LAMP2;AMPD3;ENPP4;CD68;ATG7;TRPM2;FTH1;JUP;STK10;SNAP23;CDK13;NPC2
prerank,blood vessel morphogenesis (GO:0048514),0.5049546452164131,1.520778427888479,0.03143712574850299,0.34239299846438376,1.0,8/54,6.57%,RBPJ;NRP1;RASA1;ADM;LOX;CCM2;HEY2;SYK
prerank,response to prostaglandin E (GO:0034695),0.7026779247316306,1.5207373239011737,0.06826568265682657,0.34146157450133524,1.0,5/10,10.80%,GNG2;CCL19;GNB1;SFRP1;PTGER4
prerank,negative regulation of type I interferon production (GO:0032480),-0.4496977963280616,-1.5205929083365504,0.0273972602739726,0.7221656484543808,1.0,15/40,15.34%,SIRPA;PTPRS;HAVCR2;CYLD;OTUD5;IRF3;MAVS;UBA7;RNF216;NLRC5;IKBKE;UFD1;NPLOC4;ITCH;PCBP2
prerank,regulation of chromatin organization (GO:1902275),-0.5972281913685261,-1.5198352942994489,0.0365296803652968,0.7145997694825497,1.0,7/14,24.63%,CDK9;HNRNPU;SSRP1;HPF1;TLK2;PARG;MKI67
prerank,regulation of hydrolase activity (GO:0051336),0.48162102840201254,1.518401648685867,0.028208744710860368,0.34551476010147125,1.0,13/71,7.32%,ARHGAP15;VAV3;FGD4;FGD6;ARHGAP9;CRK;PLXNC1;ITGB1BP1;OCRL;PLXNA4;NGEF;PPP1R17;ARHGAP12
prerank,regulation of protein metabolic process (GO:0051246),0.5194742798988548,1.5181376093009722,0.03877221324717286,0.34508238305593564,1.0,16/44,16.14%,APOE;APP;KLF2;LDLR;SPOP;PARL;KLF4;MTPN;SPOPL;MDM2;WFS1;ROCK2;NEDD4L;ZDHHC2;HSP90AB1;MAPK7
prerank,negative regulation of protein binding (GO:0032091),0.48249099998429273,1.5178167863122007,0.03443328550932568,0.3447004837203478,1.0,14/71,7.63%,DAB2;ITGA4;ADRB2;NES;ITGB1BP1;B2M;GSK3B;RACK1;CFHR2;ROCK1;DISC1;ACTB;DDX11;HFE
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6079224848546207,1.516770595376938,0.054945054945054944,0.34585534655409256,1.0,5/20,14.00%,C1QTNF3;C1QTNF12;UGT1A8;NCOR1;EP300
prerank,dendritic cell chemotaxis (GO:0002407),0.6485297055385137,1.516515594830953,0.06306306306306306,0.3454226337798761,1.0,7/14,16.81%,CCR1;CCL19;CXCR4;CCR2;TRPM2;GPR183;CCL5
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5564074469286561,1.5154365276761548,0.052545155993431854,0.3466603042955925,1.0,3/27,2.76%,MSR1;PF4;CD36
prerank,positive regulation of immune response (GO:0050778),0.48460509325204615,1.5151947584718979,0.026905829596412557,0.34610786417131306,1.0,8/64,5.78%,FCGR2B;TLR8;IL15;LILRB1;CD74;GRN;CD46;RIOK3
prerank,epithelial cell differentiation (GO:0030855),0.46403076461760295,1.515156892159918,0.020188425302826378,0.3451968683898698,1.0,7/88,5.37%,DAB2;MAF;JAG1;RAB10;DNPH1;GRHL2;CTSB
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.48261942324524065,-1.5148696474904877,0.03626943005181347,0.728670745985785,1.0,13/27,23.03%,CHST11;XYLT1;CSPG5;CHPF2;CSPG4;VCAN;PXYLP1;BCAN;BGN;NCAN;UGDH;B3GAT1;DCN
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6037317235476566,1.5148536108505983,0.059130434782608696,0.3447993946083393,1.0,4/18,6.57%,DOCK2;FCER1G;LBP;SYK
prerank,cardiac conduction system development (GO:0003161),0.5844519682592527,1.514734951499655,0.04982817869415808,0.344016406138604,1.0,8/24,20.10%,NOTCH2;HEY2;SMAD4;MAML1;GJA1;BMPR1A;SMAD1;SMAD5
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.48385967097994553,-1.5146608591333033,0.030726256983240222,0.7185340212649587,1.0,22/32,32.43%,PRKCD;CALM2;MAGI2;PPP1R16B;NSMF;CAMTA1;PPP1R7;ANKLE2;PPP2R5A;CDCA2;MTOR;PTPA;SPPL3;CALM3;TGFB1;PIN1;PDGFRB;SMPD1;PTBP1;CDH5;SYMPK;PPP1R15A
prerank,histone deubiquitination (GO:0016578),0.6148745276514149,1.5146604158757,0.0664451827242525,0.3431756108815535,1.0,11/18,21.80%,USP3;ATXN7;BRCC3;USP15;USP21;USP16;ENY2;USP22;USP7;UIMC1;ATXN7L3
prerank,negative regulation of reproductive process (GO:2000242),0.6270693556264394,1.5145860713261972,0.06340579710144928,0.3423707994704577,1.0,6/17,14.86%,PAEP;DUSP1;IGF1;GJA1;NPPC;ARHGDIB
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5382575453364181,1.5143188791167044,0.04146730462519936,0.34193341645647873,1.0,11/33,12.32%,APOE;MEF2C;RHOA;RGCC;ITGB1BP1;TNF;KLF4;STARD13;JUP;MMRN2;ATP2B4
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6896757199730075,1.514282231104163,0.0695970695970696,0.3410100926812808,1.0,1/10,0.05%,PID1
prerank,regulation of dendrite development (GO:0050773),-0.45995407124880433,-1.5140026207319373,0.02894736842105263,0.7109087134723485,1.0,10/37,8.98%,CSMD3;ADGRB3;SEMA4D;HECW2;NSMF;SDC2;KNDC1;BCL11A;HECW1;ALK
prerank,establishment of epithelial cell polarity (GO:0090162),0.5945393644684884,1.5136487568715649,0.06920415224913495,0.3414207198860659,1.0,11/19,20.49%,OPHN1;CDC42;RHOA;MSN;CLASP1;CYTH1;MYO9A;SIPA1L3;GOLPH3;EZR;CYTH3
prerank,ceramide transport (GO:0035627),0.6725005528979618,1.5128603763313482,0.05458089668615984,0.34202878469660764,1.0,2/12,1.59%,PLTP;SGPP1
prerank,cardiac atrium morphogenesis (GO:0003209),0.6325788877514393,1.512688840590446,0.05807622504537205,0.3413767146020296,1.0,4/16,4.49%,NOTCH2;BMP2;MYH6;HEY2
prerank,thyroid hormone generation (GO:0006590),0.694463143380881,1.5123792688477675,0.07915057915057915,0.34105538868424584,1.0,2/10,3.44%,CPQ;TPO
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.6906964350745319,1.51222567589102,0.06563706563706563,0.3403458090340083,1.0,1/11,0.03%,DAB2
prerank,regulation of T cell proliferation (GO:0042129),0.4864407245793982,1.5113620474158804,0.043227665706051875,0.34123263344627375,1.0,10/61,9.08%,VSIG4;IL15;CEBPB;TNFRSF1B;LILRB1;CD46;CCL19;PLA2G2D;CD80;SDC4
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.47806618639757537,1.5109957350876888,0.02442528735632184,0.3409902032512799,1.0,17/71,8.23%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;FCER1G;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,response to chemokine (GO:1990868),0.6550938914290108,1.5106253966679668,0.06205673758865248,0.34081864204252005,1.0,7/13,12.28%,RIPOR2;OXSR1;RHOA;DUSP1;WNK1;SH2B3;ZC3H12A
prerank,regulation of vasculogenesis (GO:2001212),0.6683617458885656,1.5105513147313572,0.061567164179104475,0.340018289017667,1.0,5/14,4.84%,RIN2;XDH;RAPGEF2;HEY2;RAP1A
prerank,intestinal lipid absorption (GO:0098856),0.6925663048388928,1.5098567245269878,0.08752327746741155,0.3405565341860613,1.0,2/11,2.76%,LDLR;CD36
prerank,glycolytic process (GO:0006096),-0.4933246580642712,-1.509718262855552,0.026829268292682926,0.7224585618594607,1.0,13/28,21.84%,HK2;PFKL;PGM1;ALDOA;PKM;PGK1;ENO1;ENO3;TPI1;GAPDHS;GAPDH;PFKFB2;LDHA
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6492089347015035,-1.5091250400384626,0.04852320675105485,0.7144986558782526,1.0,4/10,4.92%,CACNB2;PDE4B;NOS1AP;CACNA2D1
prerank,chloride transmembrane transport (GO:1902476),-0.4210372848858245,-1.508417189668057,0.022222222222222223,0.7079220464813047,1.0,23/48,25.14%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC12A9;GABRB1;ANO3;GLRB;SLC1A1;GABRA2;SLC12A6;GLRA1;GABRG2;SLC6A1;GLRA3;CFTR;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,negative regulation of secretion by cell (GO:1903531),0.5247913923756284,1.508079136650438,0.04051863857374392,0.3431861897158387,1.0,8/38,6.40%,APOE;TNFRSF1B;LILRB1;FGF23;HMGCR;STXBP6;RHBDF1;DPH3
prerank,cellular response to cAMP (GO:0071320),0.5513953660383196,1.5078080192079042,0.05709876543209876,0.3428311344942431,1.0,8/30,11.86%,RAP1B;AHR;ZFP36L1;RAPGEF2;PDE2A;RAP1A;HCN3;KCNQ1
prerank,regulation of cellular component size (GO:0032535),0.5584225656643386,1.5077024034307558,0.04120443740095087,0.3420847468423371,1.0,13/30,17.92%,EPS8;VAV3;RARG;MTPN;MSN;PPP1CA;LAMTOR5;NEB;RAB3B;PTEN;LARS1;PICALM;RAB22A
prerank,regulation of establishment of cell polarity (GO:2000114),0.631051962507818,1.5074905858058663,0.07755775577557755,0.34159804170919406,1.0,7/16,12.68%,RAP1B;KIF20B;RIPOR2;RACK1;ROCK1;ROCK2;BCAS3
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5774315728005346,-1.506982642367552,0.051470588235294115,0.704676251653046,1.0,4/15,4.05%,SLC12A2;ATP1B1;SLC8A1;ATP1B2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.4743990866940841,1.5055063199203198,0.024079320113314446,0.344770519423866,1.0,17/73,8.23%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;FCER1G;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,neutrophil mediated immunity (GO:0002446),0.39619579390075915,1.5050633409304073,0.001075268817204301,0.3447016392309248,1.0,89/432,11.67%,IQGAP2;HGSNAT;AP2A2;ALOX5;ADGRE5;CFP;CYBB;STOM;RAP1B;PTPRJ;IQGAP1;CTSC;ARHGAP9;CLEC12A;DIAPH1;DOCK2;RAB31;C5AR1;RAP2B;CD93;GMFG;C3AR1;DNAJC3;ANO6;BST1;NRAS;CD44;TNFRSF1B;GYG1;EEF1A1;KCNAB2;FCER1G;LILRB3;CD36;GRN;ATP8B4;RAB10;ARL8A;RHOA;S100A11;B2M;TLR2;AOC1;FRK;LAMP1;FTL;PGAM1;RAP1A;MANBA;TXNDC5;CTSB;ROCK1;PRCP;ATP6V0A1;DNASE1L1;ANXA2;CNN2;SDCBP;YPEL5;BST2;ARPC5;PSEN1;HMOX2;CD53;RAB7A;OSTF1;FCGR3B;CLEC4D;CD33;VCL;RAB14;MGST1;MAPK14;IMPDH2;CMTM6;LRG1;ARMC8;LAMP2;AMPD3;ENPP4;CD68;ATG7;TRPM2;FTH1;JUP;STK10;SNAP23;CDK13;NPC2
prerank,actin crosslink formation (GO:0051764),0.6842610795490377,1.504793478725906,0.07063197026022305,0.3443620337416708,1.0,2/12,4.01%,EPS8;LCP1
prerank,ceramide catabolic process (GO:0046514),-0.5836585846519482,-1.5043245831167997,0.043478260869565216,0.7074220778185464,1.0,5/14,13.09%,HEXB;NEU1;ASAH1;ASAH2;ACER2
prerank,negative regulation of T cell proliferation (GO:0042130),0.553697466808692,1.5042127277383142,0.06611570247933884,0.34467668467096535,1.0,7/28,9.08%,VSIG4;CEBPB;LILRB1;RC3H1;PLA2G2D;CD80;SDC4
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.3793257306474481,-1.5037782538885,0.0038314176245210726,0.7003725406939854,1.0,39/95,28.95%,CSNK1E;SDCCAG8;CEP135;TMEM67;SCLT1;ODF2;DYNC1H1;CEP97;RAB3IP;CEP162;CEP192;AHI1;CEP250;HAUS8;MKS1;CEP63;CCP110;HAUS7;CKAP5;MAPRE1;HAUS3;TCTN1;CENPJ;B9D2;DCTN2;CEP89;IQCB1;CNTRL;HAUS2;DCTN1;PLK4;CDK1;HAUS6;YWHAG;TTBK2;TUBA4A;CEP152;TCTN2;B9D1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.5314487716236304,1.5034463152958073,0.0515625,0.3453090517381478,1.0,15/41,14.55%,GAS6;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;LBP;NFKBIL1;GHRL;TRIM27;CD33;IGF1;ZC3H12A;RARA;ARG2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4572194077931207,-1.503076096084453,0.019886363636363636,0.694332827751016,1.0,8/38,8.23%,CACNB2;BIN1;KCNJ2;SCN1B;ANK2;CACNA2D1;CACNA1D;CTNNA3
prerank,triglyceride homeostasis (GO:0070328),0.573155336190989,1.5030709359129006,0.05555555555555555,0.34517223227668375,1.0,4/26,4.93%,APOE;C1QTNF3;NR1H4;PNPLA8
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.4085045930760205,1.5029465507349076,0.005820721769499418,0.34447945574786837,1.0,52/248,14.85%,DAB2;ZEB2;EGFR;LRP6;APOE;IGFBP4;GNAQ;TCF7L2;TLE4;SMURF2;PSMA7;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;NRARP;MCC;UBAC2;ZNRF3;GSK3B;GPRC5B;NOTUM;CTNND1;FRAT1;STK3;WNK1;PPM1B;PSMB2;TBL1XR1;PSEN1;CDK14;LIMD1;TBL1X;CUL3;NKD1;SFRP1;WLS;PPP1CA;JUP;AMFR;PSMA6;LRRK1;PLEKHA4;LATS2;CCNY;MDK;PSMA3;PSMD1;PSMD5;NPHP3;GPC3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.38401603018045105,-1.5022704202054513,0.007352941176470588,0.6886653818575493,1.0,34/84,20.25%,DDX5;SON;DDX17;RBM25;NCL;RBFOX1;SRRM4;FXR2;SRSF3;TIA1;HNRNPU;SRPK1;PUF60;SRSF10;FMR1;CELF4;KHDRBS3;RNPS1;SRPK2;CIRBP;NOVA2;C1QBP;QKI;SRSF12;NCBP1;RBMXL1;SFSWAP;HNRNPA1;RBM5;RBM39;SRSF9;MBNL3;FXR1;CELF6
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5347679316323976,1.50160969124152,0.0589171974522293,0.34626699820158235,1.0,9/35,7.79%,APOE;ALOX5;MEF2C;XDH;CNMD;TNMD;RGCC;GHRL;SYNJ2BP
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4201858040137446,1.5010473514916687,0.013563501849568433,0.34652294217058766,1.0,39/182,12.32%,MSR1;APOE;APP;NOTCH2;CCR1;FOXP1;FBXW7;MYADM;LDLR;ESR1;MEF2C;PTPN22;BMP2;XDH;PARP14;CD46;PRKN;HEY2;SPI1;RB1;NDFIP1;RACK1;SETDB2;SDCBP;TNF;ZNF148;KLF4;YY1;REL;PSEN1;SMCR8;APOBEC1;IGF1;SFRP1;EMILIN1;HINFP;ROCK2;ZC3H12A;ATP2B4
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.469618134222956,1.5010048718093023,0.02109704641350211,0.3456875801207483,1.0,18/75,12.32%,STAB1;PF4;ALOX5;SPRED1;THBS4;CNMD;TNMD;RGCC;GHRL;ROCK1;KLF4;CCR2;SYNJ2BP;AMOT;EMILIN1;ROCK2;NIBAN2;ATP2B4
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5628050054854776,1.5007796154063109,0.046822742474916385,0.34529209191663235,1.0,7/27,5.47%,IRAK3;RPS27A;CD36;TLR4;MAP3K1;TLR2;LY96
prerank,regulation of cholesterol efflux (GO:0010874),0.5439015550245181,1.500143121052958,0.054098360655737705,0.34573549990604313,1.0,2/30,0.49%,PLTP;APOE
prerank,negative regulation of viral entry into host cell (GO:0046597),0.6594548281533037,1.5001142280224324,0.07303370786516854,0.34486308306913455,1.0,5/12,13.84%,IFITM3;SNX3;IFITM2;LY6E;MID2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3905741095732317,1.4993660830735567,0.0,0.3453596092740742,1.0,95/532,11.96%,F13A1;PF4;TNFRSF25;LIFR;ALOX5;IL16;RAP1B;PTPRJ;IRF4;CCR1;IFITM3;IL15;OAS2;ALOX15;SERPINB2;PSMA7;ITGB1;FER;IRAK3;IFNAR1;RPS27A;TSLP;CD44;TNFRSF1B;RIPK1;FCER1G;CD36;CCL8;PLVAP;CDC42;CBL;CCL19;CRK;PITPNA;PELI1;HMOX1;IL17RB;IL17RC;B2M;LCP1;LBP;VIM;TNFRSF11A;MCL1;IL17RA;SPI1;BIRC3;IRS2;IL10RB;SMAD4;PAK2;ADIPOR2;RNASEL;ANXA2;CD40;EDARADD;BCL2;HNRNPF;CNN2;SYK;MAP3K8;TNF;CD80;RPLP0;BST2;EDA;PSMB2;CCR2;IL20RB;STAT4;CANX;IFNAR2;IRF2;FYN;CCL24;IL6R;TRIM68;TNFSF12;MSN;SH2B3;NDN;IFITM2;STAT6;IL1RL1;RIPK2;SP100;PLP2;SLA;SHC1;S1PR1;IL15RA;PSMA6;FOXO3;JAK1;MAP3K3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5020974684074103,1.499100221521524,0.04833836858006042,0.3450205590916992,1.0,17/49,18.93%,PF4;KMT2A;MEF2C;THPO;CBFB;RAB7B;ASH2L;KMT2C;H3-3A;RBM15;KMT2E;TNRC6C;EP300;PRMT1;PRKCQ;CNOT4;PITHD1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4006041933652121,-1.4984054278344896,0.0036231884057971015,0.6972511743706861,1.0,30/63,25.14%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC25A3;SLC37A2;SLC12A9;GABRB1;ANO3;GLRB;SLC1A1;SLC25A14;GABRA2;SLC12A6;GLRA1;SLC37A4;GABRG2;SLC6A1;GLRA3;CFTR;SLC25A10;SLC20A2;SLC37A3;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.6065665101086958,1.4975957451305941,0.075,0.3471896759441948,1.0,8/18,21.18%,AOAH;MANBA;ADAMTS9;NGLY1;SAMHD1;NEU4;DERA;FBXO6
prerank,granulocyte differentiation (GO:0030851),0.611768915724083,1.4974852911870375,0.05574324324324324,0.3464588516358858,1.0,6/18,14.00%,CBFA2T3;SPI1;LBR;DEK;RARA;EP300
prerank,regulation of adaptive immune response (GO:0002819),0.6042161027828321,1.4974098288817654,0.07557117750439367,0.34568661644034343,1.0,3/18,1.41%,FCGR2B;AHR;ALOX15
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4337391540563407,1.4970771643477618,0.026717557251908396,0.34554220422768966,1.0,38/138,17.68%,RBPJ;HDAC9;NOTCH2;ESR1;RARG;NR1H4;NR2C1;NR1D1;NR3C1;THRB;NR4A1;TBL1XR1;NR4A2;NCOR1;GTF2A2;ESRRB;TBL1X;ESR2;NR2F1;POLR2B;MED26;MAML1;CREBBP;GTF2E2;GTF2A1;NR1H2;RARA;POLR2D;MED27;SNW1;NR2C2;GTF2H3;GTF2B;MED17;NR5A2;TAF12;GTF2H1;NR6A1
prerank,glycerolipid catabolic process (GO:0046503),-0.5370678727929865,-1.4966385656888979,0.04714640198511166,0.6970239733363095,1.0,4/19,4.99%,ABHD12;MGLL;SMPD4;LYPLA2
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.49923944932693265,-1.4963567840470051,0.04929577464788732,0.6801419016722218,1.0,9/24,13.07%,HK2;PFKL;ALDOA;PKM;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,canonical glycolysis (GO:0061621),-0.49923944932693265,-1.4963567840470051,0.04929577464788732,0.6801419016722218,1.0,9/24,13.07%,HK2;PFKL;ALDOA;PKM;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.39133899584398757,1.4958719464412598,0.0,0.34725079653753416,1.0,136/572,16.62%,RBPJ;DAB2;HDAC9;ZEB2;TRPS1;EDNRB;KLF2;TCF7L2;FOXP1;MEF2A;ZBTB16;RREB1;TFEC;ESR1;RPL23;SMURF2;RARG;MEF2C;NR1H4;RPS27A;CEBPB;MITF;OSR1;NCOA5;BMP2;NR2C1;ALX1;NR1D1;PRKN;LARP7;PDE2A;FRK;NR3C1;NKAP;IRF2BP2;HEY2;SPI1;SAP130;RB1;NFIC;USP9X;ARID5A;SMAD4;TRIM33;THRB;IRX2;CBFB;PHF21A;ORC2;ATXN1;NOP53;EPC1;DMAP1;FOXM1;BAG3;SDCBP;ZNF568;TNF;ZNF148;KLF4;YY1;BRMS1L;DUSP22;MIER1;THAP11;GATAD2A;TBL1XR1;PSEN1;NR4A2;NRIP1;IRF2;KLF10;CDC73;RPS14;NCOR1;ZBTB5;FNIP1;ATRX;FOXC2;BACH1;TRIM27;MDM2;HIVEP1;TBL1X;ESR2;LRRFIP1;UBE2D3;BEND3;IGBP1;LCOR;NR2F1;PURA;ZNF205;SPEN;SP100;MIER3;HSBP1;ETS2;SREBF2;CREBBP;KANK2;WFS1;FOXO3;RPL10;LOXL2;NFIX;PEG3;CTBP2;WWOX;NR1H2;RARA;STAT3;EP300;BCOR;NEDD4L;WWC1;SNW1;GATAD2B;MYC;HDAC4;NR2C2;ZHX1;SFPQ;RUNX3;HEXIM2;E2F8;KDM1A;HCFC1;ZGPAT;PPM1A;LIN37;PER1;ZNF177;TBX2;NFATC3;GLIS2
prerank,positive regulation of cell death (GO:0010942),0.4853092547308118,1.4949257442664174,0.03609022556390978,0.3482485266505891,1.0,11/59,10.06%,FCGR2B;MAP3K5;C1QA;RARG;RIPK1;CD36;GSK3B;TNF;HTATIP2;FYN;RIPK2
prerank,synaptic vesicle endocytosis (GO:0048488),0.5377506256255032,1.4942820499367322,0.04983388704318937,0.3487145910905584,1.0,6/33,7.72%,ITSN1;FCHO2;OPHN1;SYNJ1;ITSN2;CANX
prerank,regulation of MAPK cascade (GO:0043408),0.42694682699384817,1.4941999401537067,0.015931372549019607,0.3479856484015827,1.0,27/157,9.90%,EGFR;P2RX7;FGFR1;LILRA5;SPRED1;PTPRJ;IQGAP1;LYN;ADRB2;BMP2;CD74;THPO;DUSP1;GSDME;INSR;PAK2;ROCK1;STK3;TMEM106A;VRK2;SYK;NRK;ADRA1D;ADRA1A;LBH;MYDGF;IGF1
prerank,negative regulation of angiogenesis (GO:0016525),0.46247463642839565,1.4912595258158252,0.015471167369901548,0.3532746961784775,1.0,22/84,12.32%,STAB1;PF4;ALOX5;KLF2;SPRED1;THBS4;CNMD;TNMD;RGCC;GHRL;ROCK1;TNF;EPN2;KLF4;CCR2;SYNJ2BP;AMOT;ADAMTS9;EMILIN1;ROCK2;NIBAN2;ATP2B4
prerank,positive regulation of phosphorylation (GO:0042327),0.408252407228872,1.4902387826675763,0.005787037037037037,0.3545853789677328,1.0,42/240,10.21%,DAB2;NRP1;EGFR;P2RX7;FGFR1;APP;GAS6;WDFY2;ZBTB20;LYN;ANG;KRAS;BMP2;RIPK1;CD74;FGF23;AXIN1;THPO;NIBAN1;BCL10;PDE8A;INSR;CAMKK2;RACK1;PFKFB4;PDGFRA;CD40;ACVR2A;SDCBP;TNF;FAM20A;CCND3;PSEN1;SLC4A4;FNIP1;DDR2;KCTD20;CCND2;MYDGF;EPHB4;IGF1;ARRB1
prerank,amino acid import (GO:0043090),-0.517716265951727,-1.4896447162705853,0.04987531172069826,0.7033105865727155,1.0,6/21,21.94%,SLC1A3;SLC36A1;SLC1A1;SLC7A8;SLC6A1;SLC22A4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.41673686749102756,1.4889088329134117,0.009445100354191263,0.3563797739942169,1.0,32/190,9.36%,BANK1;P2RX7;SPRED1;DEPTOR;PTPRJ;MYADM;ESR1;LYN;C1QTNF3;NR1H4;XDH;RIPK1;NR1D1;PDE2A;DUSP1;NPRL3;MCL1;SPI1;RACK1;BCL2L2;PDE4D;RIOK3;NOP53;BCL2;UACA;PPM1B;ARHGAP12;FNIP1;LIMD1;MDM2;MAPK14;SH2B3
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.6260844190228491,-1.4883880091071637,0.05150214592274678,0.7006913925645898,1.0,6/11,20.22%,LRP5;STAT1;FGFR2;TGFBR2;PDGFA;WNT5A
prerank,positive regulation of cellular respiration (GO:1901857),0.6780021793223117,1.4879487699331344,0.07385229540918163,0.3575208732760762,1.0,3/11,5.07%,NUPR1;IFNAR1;IL10RB
prerank,negative regulation of receptor binding (GO:1900121),0.6755434813841674,1.487768176291887,0.08379888268156424,0.35697161202709876,1.0,3/10,14.25%,B2M;HFE;ATP2A2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.650399084451748,1.4870146954160532,0.0872865275142315,0.3576433510043292,1.0,3/13,6.29%,APOE;BMP2;ERLIN1
prerank,cell part morphogenesis (GO:0032990),0.6531774480718633,1.486917310959377,0.06143344709897611,0.3569621960823972,1.0,2/13,2.48%,PID1;MTM1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6892528330315478,1.486567535080233,0.08349146110056926,0.3568590365881478,1.0,3/10,5.58%,ZEB2;RAPGEF2;ATP7A
prerank,Rap protein signal transduction (GO:0032486),0.6856838858027479,1.4852037673303513,0.08,0.35885484208318175,1.0,4/10,4.84%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,regulation of B cell apoptotic process (GO:0002902),0.6553552283469759,1.485159068498931,0.09814814814814815,0.3580369900263034,1.0,4/12,8.33%,FOXP1;LYN;IRS2;FNIP1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.4406279598785259,1.4848907010587487,0.020434227330779056,0.357589806022183,1.0,24/116,13.33%,CD163;FCGR2B;LYN;CYSLTR1;GNG2;CALCRL;ADRB2;DRD1;ADM;ADCY9;ADCYAP1R1;SYK;GNB1;FYN;FCGR3A;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6611847529302625,1.4842082174724496,0.07231040564373897,0.3581008328055475,1.0,4/12,12.28%,ESR1;TNF;NCOR1;ZC3H12A
prerank,regulation of mRNA processing (GO:0050684),-0.4713852283089573,-1.4841897949877094,0.028645833333333332,0.7132337471344367,1.0,16/32,19.82%,SON;PABPN1;SAFB;SRSF3;SAFB2;TIA1;SRPK1;SRSF10;KHDRBS3;SRPK2;QKI;NCBP1;CDK11B;RBM39;DHX9;AHCYL1
prerank,response to axon injury (GO:0048678),-0.535955311178262,-1.4841613744426199,0.05066079295154185,0.7045709113989069,1.0,4/18,6.59%,RTN4RL1;TREM2;APOD;P2RY12
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5022415290277868,-1.48396581972171,0.05924170616113744,0.696899075206711,1.0,6/25,5.92%,CACNB2;CAPN3;PLCG1;ANK2;TRPC1;AKAP6
prerank,positive regulation of cholesterol transport (GO:0032376),0.5549396392800887,1.483237253351783,0.06105610561056106,0.359230560482351,1.0,2/27,0.49%,PLTP;APOE
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6249666816048698,1.4831373907395309,0.08450704225352113,0.35758932852066866,1.0,6/14,7.95%,BLVRB;UGT1A4;UGT1A1;HMOX1;ABCC1;HMOX2
prerank,heme catabolic process (GO:0042167),0.6249666816048698,1.4831373907395309,0.08450704225352113,0.35758932852066866,1.0,6/14,7.95%,BLVRB;UGT1A4;UGT1A1;HMOX1;ABCC1;HMOX2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3950519100045877,1.4829214083799893,0.0033222591362126247,0.3571461893693724,1.0,59/348,12.33%,RBPJ;PID1;PF4;P2RX7;APP;KLF2;TBC1D5;GAS6;ADAM19;RPL23;C1QTNF1;RPS3;MEF2C;PTPN22;KRAS;MITF;OSR1;BMP2;LILRB1;CD36;CD74;FGF23;DRD1;LAMP3;TLR4;PPHLN1;CD46;RGCC;PRKN;PDE2A;TLR2;HEY2;GSK3B;INSR;ROCK1;ANXA2;SETDB2;TNF;KLF4;MTPN;RPL5;HFE;WNT6;PSEN1;VSTM2A;MSN;RPS7;MAPK14;IGF1;ARRB1;MED26;SP1;EMILIN1;HINFP;WFS1;ROCK2;LAMTOR5;ZC3H12A;SLC38A2
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6396452067194928,-1.4817720703177353,0.039761431411530816,0.6988591816914501,1.0,4/10,32.08%,ACTN2;PLEK;WDR1;CARMIL2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6174592870959718,-1.481159885420736,0.06772009029345373,0.6933937282374887,1.0,4/11,4.92%,CACNB2;BIN1;NOS1AP;CACNA2D1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.5058406487055872,1.4806798601275382,0.05572289156626506,0.36093052264907555,1.0,14/47,13.07%,CMKLR1;ZBTB16;RREB1;WDFY2;METRNL;CEBPB;BMP2;GDF3;ZFP36L1;MEDAG;VSTM2A;SFRP1;ZC3H12A;CREB1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.359327904538066,-1.4799885796556183,0.0038022813688212928,0.6907835684550723,1.0,30/107,12.47%,CX3CR1;GRID2;NRG3;SLC12A2;DGKI;RIMS1;SNCAIP;DLGAP2;GRM7;GRIK2;NLGN1;RIMS2;CDH2;LRRC4C;DLG4;DLGAP1;GRM3;CLN3;USP46;BDNF;KCTD13;FMR1;DGKZ;SYN3;CPLX1;ABR;TMEM108;LRRC4;NPTX1;LGI1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5934178503762494,1.4798831407422781,0.08488964346349745,0.3617776880249525,1.0,6/21,5.43%,CCR1;GAS6;FGF23;SRGN;HEY2;ROCK1
prerank,positive regulation of cilium assembly (GO:0045724),-0.5428693308527682,-1.479410659785635,0.04738154613466334,0.6854358647652528,1.0,9/18,23.42%,CEP135;CROCC;CCP110;WRAP73;ENTR1;KCTD17;BBS4;HAP1;TAPT1
prerank,blood vessel diameter maintenance (GO:0097746),0.5370032189047756,1.4793181064882326,0.05238095238095238,0.3621177269259693,1.0,6/34,11.99%,EDNRB;KLF2;ITGB1BP1;ROCK1;GCLM;ROCK2
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5352562577878717,1.4792112424814905,0.058823529411764705,0.36147398513197226,1.0,4/32,5.81%,APOE;PRKAG2;ZBTB20;ADIPOR2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6009703005259062,-1.4790643322378985,0.06521739130434782,0.6790270914020273,1.0,8/12,26.37%,RIMS1;UNC13C;RIMS2;SYT8;RIMS3;SYT1;SYT7;SYT5
prerank,positive regulation of cell population proliferation (GO:0008284),0.38716612664414185,1.4789405980488588,0.002157497303128371,0.3611538062062149,1.0,99/423,17.35%,RBPJ;PID1;FOLR2;EGFR;LIFR;FGFR1;CHP2;TCF7L2;FOXP1;IL15;KIF20B;GAS6;C5AR1;RPL23;LYN;GRK5;BST1;FER;LIG4;MEF2C;TSLP;KRAS;OSR1;KITLG;BMP2;CD74;FGF23;WNT2;GRN;NES;THPO;HMOX1;ITGB1BP1;TNFRSF11A;CDK6;IRS2;INSR;S1PR2;PDGFRA;ACER3;BCL2;RPS4X;FOXM1;RPS15A;SDCBP;TNF;BST2;TIPIN;IL6R;RPS9;DDR2;ADRA1D;ASH2L;TSPYL5;MDM2;PDGFC;CCND2;CACUL1;CUL3;IGF1;SFRP1;TSHR;SLC25A5;RPS6;PHIP;SHC1;ROMO1;CDK13;MAP3K3;NAMPT;NOD2;GLP2R;RBPMS2;GJA1;CRLF2;RNF187;RARA;DERL2;MDK;HMGN5;PRMT1;IL13RA1;BMPR1A;MYC;FN1;HDAC4;KDM1A;PTEN;TBX2;PRDX3;CCL5;IGF1R;EAPP;RELA;CNOT6L;GDF9;NACC1;XBP1;GAREM1
prerank,regulation of inclusion body assembly (GO:0090083),-0.625064872606526,-1.4786326437802257,0.060041407867494824,0.6731373373150566,1.0,6/11,20.51%,SNCAIP;SACS;DNAJB2;DNAJB1;BAG5;DNAJA4
prerank,mesenchymal to epithelial transition (GO:0060231),-0.6352626325686995,-1.4770282011884555,0.06277056277056277,0.672927468126696,1.0,3/10,11.80%,SALL1;BASP1;PAX8
prerank,phasic smooth muscle contraction (GO:0014821),0.6800172411067986,1.4763853275041101,0.08208955223880597,0.3658297141064354,1.0,4/10,19.58%,EDNRB;HTR1D;GDNF;TIFAB
prerank,negative regulation of kinase activity (GO:0033673),0.48169743352648964,1.4758738290755495,0.04817518248175182,0.3659798980976067,1.0,14/62,8.90%,LRP6;GNAQ;SPRED1;DEPTOR;PRKAG2;ITGB1BP1;IRS2;RB1;PAK2;SFN;CEP85;HSPB1;TRIM27;SMCR8
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.44131737348797356,1.4755997778261705,0.027166882276843468,0.3655984437881223,1.0,20/110,11.26%,PF4;ADGRE5;GNAQ;ADGRG6;ADGRE1;GNG2;CALCRL;ADRB2;GPR65;DRD1;ADM;RAPGEF2;S1PR2;ADCY9;GNB1;ADRA1D;ADRA1A;TSHR;PTGER4;S1PR1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.45959745933964546,1.4752288273168697,0.03967168262653899,0.36559377354551836,1.0,13/76,8.64%,HRH1;CMKLR1;C5AR1;ESR1;C3AR1;GPR65;DRD1;P2RY6;ANO1;P2RY10;HOMER1;ADRA1D;ADRA1A
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.38994081590633123,1.475173647425362,0.0021810250817884407,0.3648228235043878,1.0,74/390,11.24%,ITSN1;VAV3;MTSS1;AP2A2;NRP1;NEDD9;RASGRP4;EGFR;FGFR1;CYBB;SPRED1;PTPRJ;LYN;FER;ACTR3;ABI1;WASF2;RASA1;CASS4;DOCK1;ADRB2;ATP6V1B1;FGF23;CDC42;ANKS1A;CBL;CRK;RHOA;RAPGEF2;FRS2;FRK;GSK3B;IRS2;INSR;PAK2;MAPKAPK2;PDGFRA;ROCK1;EFS;ATP6V0A1;ACTB;KIF16B;AP2S1;HNRNPF;SYK;NGEF;SDCBP;ZAP70;ARPC2;ARPC5;GAB1;PSEN1;FYN;AP3S1;PIK3C2A;ATP6V1A;FOXC2;DDR2;SULF2;RAB14;MAPK14;PDGFC;ZNF106;POLR2B;EPHB4;IGF1;NUS1;STYK1;PXN;NCF2;SPRED2;SLA;PHIP;SHC1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.5741616778359026,-1.4748961583524973,0.06140350877192982,0.6749916063630355,1.0,10/13,35.55%,GRIK2;SYNGR1;SLC4A10;CLN3;SHISA7;SHISA9;SHISA8;SYP;RAB3A;SHISA6
prerank,synapse assembly (GO:0007416),-0.3964056900661276,-1.4746615391984847,0.02112676056338028,0.6686182528049874,1.0,17/67,13.85%,GRID2;DNM3;ADGRL3;SDK1;GABRB3;NLGN1;CDH2;NRXN1;FARP1;FGF13;DVL1;BDNF;SHANK2;GABRA2;LRRC4;SPOCK2;GABRG2
prerank,positive regulation of protein catabolic process (GO:0045732),0.4559919808666587,1.4745521219816873,0.036061026352288486,0.36528185874938834,1.0,23/84,15.60%,WWP1;APOE;SNX9;SMURF2;TNFRSF1B;RILP;ADAM9;AXIN1;PRKN;GSK3B;TRIM32;TNF;RAB7A;TNFSF12;MSN;NKD1;ATG7;SNX33;FOXO1;NEDD4L;GPC3;RNF41;VGLL4
prerank,endocytic recycling (GO:0032456),0.4826353020304419,1.4742520343570245,0.05319148936170213,0.3650775895568101,1.0,11/50,9.73%,DENND1A;EHD4;EPS15;DENND1B;SNX27;EHD1;SNX3;EIPR1;RAB7A;RAB14;CMTM6
prerank,gluconeogenesis (GO:0006094),-0.4499892769977992,-1.4740398883788375,0.051630434782608696,0.6641594584968648,1.0,16/39,21.17%,PGM1;ALDOA;MDH1;CRTC2;PGK1;ENO1;PCK2;ENO3;SLC37A4;TPI1;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4705339651817741,-1.4739001351877685,0.049723756906077346,0.6576386069300452,1.0,10/30,11.07%,F11R;TJP1;MBP;SLC12A2;JAM2;TJP2;LAMA2;WNK3;PECAM1;SLC1A1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.5289537865636125,1.4738371415671205,0.06612903225806452,0.3651858707727672,1.0,12/36,14.11%,EGFR;APOE;S100A1;CYGB;NPR3;GCH1;NOSTRIN;TNF;NUS1;CALM1;ATP2B4;WASL
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5158007848871268,1.4735854931029773,0.05357142857142857,0.3648092907197775,1.0,7/36,7.63%,NRP1;FBXW7;NCOA3;ITGB1;ADRB2;CCR2;HFE
prerank,regulation of sensory perception of pain (GO:0051930),-0.6054639057069984,-1.4731780298403365,0.07538802660753881,0.6538921684597961,1.0,4/11,10.63%,MGLL;CCL3;ZFHX2;TMEM100
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.5820914112057303,1.472967973482195,0.07366482504604052,0.36528976133748065,1.0,4/20,6.14%,ITGA4;ANO6;RGCC;CD40
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6749229538207567,1.4728053334601514,0.0847145488029466,0.3647523598358819,1.0,2/11,4.08%,CLEC6A;NFKBIZ
prerank,regulation of T cell migration (GO:2000404),0.5995450571160233,1.4727152640669736,0.06690777576853527,0.36410183085057857,1.0,4/18,5.09%,APP;RIPOR2;RHOA;CD200R1
prerank,actin filament bundle assembly (GO:0051017),0.5414149811150324,1.4726819886500815,0.056782334384858045,0.3632851192070219,1.0,3/33,4.01%,EPS8;NEDD9;LCP1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6409250082965476,1.4722771904279282,0.09174311926605505,0.36329633118452526,1.0,6/13,12.09%,CNMD;TNMD;EPN2;EMILIN1;MMRN2;NIBAN2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4993646155333238,1.4720213099354382,0.04387291981845688,0.3629807122888023,1.0,11/48,11.96%,HDAC9;FGFR1;HMOX1;CD40;HSPB1;PIK3C2A;FOXC2;MAPK14;NUS1;SP1;MAP3K3
prerank,carbohydrate derivative transport (GO:1901264),0.5775713308416837,1.471977942420026,0.07875457875457875,0.36223108163150586,1.0,7/18,13.88%,PLTP;LBP;SLC29A1;VLDLR;SLC10A7;NPC2;MFSD2A
prerank,regulation of cell development (GO:0060284),0.5286619703921926,1.4718373454454348,0.06998444790046657,0.361622216448755,1.0,5/36,4.61%,HDAC9;NOTCH2;GRN;HEY2;CLOCK
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.458462409594822,1.4712319062618304,0.03305785123966942,0.36205043494404304,1.0,16/76,10.12%,DAB2;FBXW7;CBFA2T3;ARIH1;PIAS1;PRICKLE1;AXIN1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;MDM2;RNF19B;COP1;RNF14
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.508612593834544,1.4707763418225803,0.06729264475743349,0.3620770773012689,1.0,12/39,15.56%,RBPJ;JAG1;ITGB1BP1;EPN2;POGLUT1;MAML1;CREBBP;NOD2;STAT3;EP300;SNW1;TSPAN14
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6014412262213586,1.4704876711247177,0.0812720848056537,0.36179076150839196,1.0,4/18,3.18%,FBXW7;LILRB1;LILRB3;TLR4
prerank,protein localization to cell junction (GO:1902414),-0.5109610596085894,-1.4700326152709953,0.05897435897435897,0.6606937026725751,1.0,7/22,5.60%,TJP1;NLGN1;DLG4;PCLO;FERMT2;TJP2;SHANK1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.6745072503722257,1.4698680986149755,0.08187134502923976,0.36218535783064787,1.0,3/10,5.98%,NELL1;RIC1;ANXA2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.46500441946770754,1.4692712222754882,0.037142857142857144,0.36250779363734387,1.0,16/70,8.23%,VAV3;FCGR2B;LYN;ACTR3;ABI1;WASF2;DOCK1;CDC42;CRK;WIPF1;ACTB;SYK;ARPC2;ARPC5;FYN;FCGR3A
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5364983984639383,1.4690379553437019,0.06379585326953748,0.36214231696170546,1.0,9/30,10.12%,DAB2;FOXP1;NCOA2;PIAS2;NCOR1;TRIM68;H3-3A;SFRP1;RNF14
prerank,female gamete generation (GO:0007292),0.5481467474031426,1.4689473984746475,0.04833333333333333,0.3614811356334251,1.0,10/29,17.61%,DIAPH2;USP9X;MCM9;NANOS3;HORMAD1;PIWIL2;MDK;MCM8;GDF9;DMC1
prerank,positive regulation of nervous system development (GO:0051962),-0.42966887759144984,-1.4688244275699698,0.03932584269662921,0.6586492486279609,1.0,11/42,9.33%,CX3CR1;NUMB;GRID2;PTPRD;NLGN1;NRXN1;TGM2;EPHB1;BDNF;NUMBL;SYNDIG1
prerank,regulation of multicellular organism growth (GO:0040014),0.6282721545634502,1.468670426392811,0.0840630472854641,0.36123196070039615,1.0,4/15,13.88%,APP;GHRL;IGF1;MFSD2A
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.5141615253888219,-1.4685980683958963,0.05203619909502263,0.6529118384866742,1.0,12/20,31.97%,HSPA4;BBS12;PTGES3;PSMG2;NDUFAF1;HOPX;TMEM35A;CCT2;MKKS;PSMG1;BBS10;HSPA1A
prerank,regulation of protein phosphorylation (GO:0001932),0.3972964608311859,1.4676377346917469,0.004489337822671156,0.3625735467539972,1.0,41/256,9.59%,DAB2;PID1;EGFR;LRP6;APP;MYADM;GAS6;WDFY2;LYN;BST1;FER;CEBPB;KRAS;BMP2;XDH;RIPK1;CD74;FGF23;AXIN1;THPO;NIBAN1;PRKN;PDE8A;INSR;CAMKK2;RACK1;CD40;NOP53;ACVR2A;HSPB1;TNF;FAM20A;CCND3;MOB1B;FYN;FNIP1;KDM4D;CORO1C;CCND2;MYDGF;PPP2CA
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.383321109135196,1.4672070411409794,0.0,0.3626257814246244,1.0,105/509,13.10%,PLEKHG5;HIP1;EGFR;FGFR1;APP;LILRA5;PTPRJ;TCF7L2;IQGAP1;SASH1;CLEC6A;GAS6;ESR1;NUPR1;RPL23;S100A4;LYN;ITGB1;MFHAS1;RPS3;SHISA5;DDX60;ALPK1;CASS4;KITLG;ADRB2;BMP2;RIPK1;CD74;FGF23;MYORG;TLR4;RPS15;RPL37;ANKRD17;THPO;CBL;CCL19;PELI1;RHOA;HMOX1;RAPGEF2;RPS20;ITGB1BP1;PRKN;FRS2;BCL10;TLR2;ICOS;GSDME;BIRC3;IRS2;NDFIP1;INSR;RACK1;GPRC5B;PDGFRA;PUM2;ROCK1;TRIM32;TMEM106A;CD40;BCL2;MIOS;TNF;CD80;USP15;BST2;MIER1;REL;GAB1;PRKCB;FYN;TRIM68;FNIP1;ADRA1D;ADRA1A;TSPYL5;TRIM27;SMCR8;TFG;CARD16;PDGFC;MYDGF;EEF1D;IGF1;RTN4;RIPK2;NUP62;WLS;F10;CASP8;SHC1;MAP3K3;ROCK2;STRN;DHX33;LAMTOR5;VAPA;TERF2IP;HTR6;NOD2;TNFRSF1A;UBE2N;GJA1
prerank,neuron remodeling (GO:0016322),0.6852571513433618,1.4669642504130809,0.08128544423440454,0.3622741661762744,1.0,4/10,3.55%,APP;C1QA;ANKS1A;SCARF1
prerank,regulation of cell size (GO:0008361),0.581654154079464,1.466835873800498,0.06622516556291391,0.3617438354713158,1.0,6/23,8.63%,VAV3;DEPTOR;RARG;RHOA;MTPN;MSN
prerank,"phagocytosis, engulfment (GO:0006911)",0.5097111758553908,1.4663594938691074,0.06220095693779904,0.36189127992707903,1.0,8/36,7.97%,MSR1;FCGR2B;DOCK1;CD36;HAVCR1;CDC42;ARHGAP12;RHOBTB1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6442287737504884,1.4657360115306692,0.08695652173913043,0.3624069034598601,1.0,2/12,6.96%,PAEP;CD80
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4473806030006287,1.4654923210811162,0.03824362606232295,0.36206392286622807,1.0,20/80,12.10%,MAP3K5;GAS6;DAPK1;CD44;SH3RF1;SIAH2;LAMP3;RPS6KA3;BCL10;SFN;SYK;TNF;UACA;KLF4;FNIP1;CARD16;CYCS;IGBP1;YWHAE;LAMTOR5
prerank,glutamate receptor signaling pathway (GO:0007215),-0.43747206489038687,-1.4654864659693287,0.04113110539845758,0.6597145136818676,1.0,14/37,10.87%,GRID2;PTK2B;GRM7;GRIA2;GRIK2;DAGLB;GRM3;GRIA4;CLN3;GRIN3A;FMR1;DAGLA;PLCB1;GRIN2A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4440170613110983,1.4641279969545873,0.03783783783783784,0.3640430191093137,1.0,19/95,11.64%,DAB2;ZEB2;SPRED1;SMURF2;RPS27A;SNX6;IL17RD;SMAD4;TRIM33;SNX25;HTRA3;SDCBP;VASN;RNF111;DAND5;SPRED2;EMILIN1;CREBBP;PMEPA1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6291499621637607,1.4639783952108842,0.08468468468468468,0.3635317993571809,1.0,4/14,10.51%,NRP1;GAB1;NUS1;MYO1C
prerank,regulation of chemokine production (GO:0032642),0.5152529142309166,1.4629201372585028,0.06655574043261231,0.3649381081826224,1.0,9/36,8.25%,APP;FOXP1;TSLP;CD74;TLR4;HMOX1;TLR2;TNF;IL6R
prerank,inositol phosphate-mediated signaling (GO:0048016),0.584130729870251,1.4627323513393844,0.07614213197969544,0.36450254205131516,1.0,2/19,1.02%,HRH1;PPP3CA
prerank,superoxide metabolic process (GO:0006801),0.5341960693740323,1.4618141843552095,0.06497622820919176,0.36555341243908485,1.0,7/29,17.04%,NRROS;CYBB;ATP7A;NCF2;CYBA;NOX4;PRDX2
prerank,actin filament bundle organization (GO:0061572),0.537390601619278,1.4616780395803346,0.05958132045088567,0.36503614162344633,1.0,5/33,9.64%,EPS8;NEDD9;LCP1;PLS1;RFLNB
prerank,respiratory system development (GO:0060541),-0.4611218370486746,-1.4605972331232862,0.046798029556650245,0.6744794343343035,1.0,16/32,29.16%,CHD7;BASP1;FGF2;FGFR2;LOXL3;BAG6;CCDC39;SPEF2;PROX1;PDPN;CCDC40;FGF1;WNT7B;FGF7;SMCHD1;BMP4
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.42001944670034597,1.46020407517647,0.02258469259723965,0.36725699254422745,1.0,28/150,9.91%,HIP1;EGFR;FGFR1;PTPRJ;TCF7L2;GAS6;ESR1;ITGB1;MFHAS1;CASS4;KITLG;FGF23;MYORG;THPO;CCL19;ITGB1BP1;FRS2;ICOS;IRS2;INSR;PDGFRA;TNF;CD80;GAB1;FYN;TSPYL5;MYDGF;RTN4
prerank,positive regulation of neuron death (GO:1901216),0.4906364979771384,1.4601712713015815,0.051036682615629984,0.3664780211758588,1.0,9/46,8.07%,FCGR2B;MAP3K5;C1QA;NUPR1;TLR4;GRN;GSK3B;TNF;FYN
prerank,striated muscle cell development (GO:0055002),0.6174092924375636,1.4598632293015363,0.08743169398907104,0.3663491695262161,1.0,4/14,4.86%,FLII;TMOD1;MYH6;TMOD3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5522425095950466,1.4598349941811288,0.0784,0.365575726780616,1.0,10/27,12.28%,GAS6;C1QTNF3;IRAK3;PTPN22;TLR4;GHRL;CD200R1;TNF;ARRB1;ZC3H12A
prerank,cyclooxygenase pathway (GO:0019371),-0.6398508940159235,-1.4588802730657675,0.058695652173913045,0.6751494737484238,1.0,5/10,24.97%,HPGDS;PTGS1;PTGES3;PTGIS;PTGDS
prerank,regulation of muscle cell differentiation (GO:0051147),0.5380557466307504,1.4587707061075963,0.07476635514018691,0.3668852893308653,1.0,7/31,9.18%,HDAC9;CTNNA1;MEF2A;MEF2C;CDC42;RBM4;MAPK14
prerank,response to glucocorticoid (GO:0051384),0.5479939382100868,1.4587407249052713,0.07742998352553541,0.36614275504213956,1.0,7/26,11.10%,ZFP36L2;ADAM9;ZFP36L1;NR3C1;TNF;PDCD7;SLIT3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.5257196732967424,1.4585963360986873,0.061611374407582936,0.3656632068575677,1.0,13/34,17.43%,NRP1;ERN1;ITGB1BP1;MAPKAPK2;NR4A1;HSPB1;GAB1;MAPK14;NUS1;RAMP2;PRKD2;RELA;SPRY2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6040095324685363,1.4583262002611204,0.07894736842105263,0.36542112075313504,1.0,8/18,13.27%,CTNNA1;MDFIC;MFHAS1;GSK3B;POLR1A;RAB23;UFM1;LATS2
prerank,cell-matrix adhesion (GO:0007160),0.444432810594296,1.4582725420767482,0.03804347826086957,0.36474606740161475,1.0,18/95,11.35%,LYVE1;ITGA4;SIGLEC1;PEAK1;ITGB1;TNN;CD44;ADAM9;ITGB1BP1;ITGBL1;PTPRK;VCL;RCC2;ADAMTS9;PIP5K1A;THSD1;EMILIN1;PPFIA1
prerank,positive regulation of transmembrane transport (GO:0034764),0.6306742549646277,1.4571441322932563,0.08976660682226212,0.3662133715106839,1.0,2/13,1.78%,P2RX7;ANO6
prerank,RNA polyadenylation (GO:0043631),0.5367927992094664,1.456402394455836,0.06779661016949153,0.3662046246204625,1.0,10/26,16.42%,APP;TENT2;CPSF3;CDC73;GRSF1;SCAF8;PAPOLA;WDR33;TUT1;CPSF2
prerank,mRNA polyadenylation (GO:0006378),0.5367927992094664,1.456402394455836,0.06779661016949153,0.3662046246204625,1.0,10/26,16.42%,APP;TENT2;CPSF3;CDC73;GRSF1;SCAF8;PAPOLA;WDR33;TUT1;CPSF2
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6568352374660473,1.4558930044755882,0.09764918625678119,0.36642714732239623,1.0,4/11,8.63%,DAB2;PRKN;EIPR1;MSN
prerank,neuromuscular process controlling balance (GO:0050885),-0.5916821412291183,-1.4557663287625433,0.08565310492505353,0.6817409255394598,1.0,5/12,6.62%,CDH23;NRXN1;CLN3;SHANK1;PCDH15
prerank,neuron maturation (GO:0042551),0.6004187443336515,1.4547488076588768,0.0824561403508772,0.3680796326487764,1.0,6/18,4.20%,APP;C1QA;ANKS1A;SCARF1;CLN5;B4GALT6
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.6333242498146061,-1.4545443560966234,0.06976744186046512,0.6801066257285806,1.0,4/10,16.22%,DIP2B;DIP2A;FLCN;PARK7
prerank,negative regulation of apoptotic process (GO:0043066),0.37894468608714305,1.4538135108819719,0.003236245954692557,0.3691092904231818,1.0,78/444,12.28%,DAB2;CD38;EGFR;APOE;TNFAIP8;NOTCH2;TPT1;GAS6;NUPR1;GRK5;DNAJC3;ITGB1;LIG4;MEF2C;NR1H4;RPS27A;TSLP;BABAM2;RASA1;CD44;OSR1;SH3RF1;RIPK1;ARHGAP10;SIAH2;CD74;LAMP3;GRN;SNX6;CBL;RPS6KA3;PRKN;MCL1;GSK3B;BIRC3;RB1;GHRL;RHBDD1;GLO1;PAK2;BCL2L2;TXNDC5;SFN;BCL2;HIGD1A;BAG3;HSPB1;TNF;KLF4;HTATIP2;PSEN1;NR4A2;BIRC6;ARHGDIA;FNIP1;MAPK8IP2;TRIM27;CARD16;IGBP1;CCND2;MYDGF;IGF1;SFRP1;RIPK2;NUP62;THOC6;PCID2;PHIP;DFFA;SHC1;CRYAB;WFS1;YWHAE;RPL10;NIBAN2;LAMTOR5;UFM1;ZC3H12A
prerank,embryonic organ development (GO:0048568),0.46808500668314207,1.4535435521446134,0.04,0.36884989535318846,1.0,7/61,4.68%,RBPJ;KMT2A;KITLG;NES;TPO;HEY2;PBX3
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5583255928679204,1.4509745829023655,0.09212730318257957,0.37334811767801834,1.0,5/23,6.94%,MAP3K5;SASH1;RPS3;TNFRSF11A;TNF
prerank,negative regulation of response to stimulus (GO:0048585),0.4756309796438966,1.4507953719698188,0.06386066763425254,0.37290157956167547,1.0,11/60,11.96%,MCTP1;FCGR2B;ALOX5;CASK;LYN;CDK6;KLF4;SH2B3;VPS13C;WFS1;MAP3K3
prerank,regulation of osteoblast proliferation (GO:0033688),0.59254843011798,1.450734201734536,0.09172661870503597,0.37221566142427426,1.0,5/17,4.47%,NELL1;TNN;BMP2;RHOA;NPR3
prerank,positive regulation of filopodium assembly (GO:0051491),0.5644406406885089,1.4504373980587513,0.07692307692307693,0.3720073565171927,1.0,5/24,5.36%,NRP1;RIPOR2;ARAP1;CDC42;DOCK11
prerank,positive regulation of protein maturation (GO:1903319),0.6667402908188433,1.4503983517858556,0.10727969348659004,0.3712593329523311,1.0,2/11,4.92%,NLRC4;RHBDD1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5695351989155234,1.4498346468781278,0.08766233766233766,0.3715680813834148,1.0,8/24,11.99%,SGPP1;NCOA3;ZFP36L1;GRHL2;ROCK1;CBFB;TRIM16;ROCK2
prerank,actin polymerization or depolymerization (GO:0008154),0.4888305860146882,1.4494135943403283,0.0547945205479452,0.37162245804181177,1.0,8/50,4.90%,PSTPIP2;FLII;DIAPH1;GAS7;PSTPIP1;ANG;ABI1;GHRL
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5504091386446591,1.448805868162935,0.08375209380234507,0.3720783071580054,1.0,5/26,6.94%,PF4;FGFR1;MCL1;BCL2;TNF
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6436667261833249,1.4487629833374722,0.09461966604823747,0.3713754780104006,1.0,3/11,7.86%,LRP6;WNT2;NR4A2
prerank,regulation of fat cell differentiation (GO:0045598),0.4558634702140625,1.4486082981093464,0.0625,0.37091336023936794,1.0,19/74,13.07%,ALOX5;CMKLR1;ZBTB16;ZFP36L2;WDFY2;CEBPB;BMP2;NR1D1;GDF3;ZFP36L1;TRIO;MEDAG;TNF;ASXL1;SFRP1;TRIB2;ZC3H12A;FOXO1;CREB1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5897012394926494,1.448244469588734,0.09584086799276673,0.37082954161907694,1.0,7/17,14.70%,EGFR;RGCC;CCND3;CCNYL1;CCND2;CCNY;PKD2
prerank,response to insulin (GO:0032868),0.4479003633099168,1.4477806260911383,0.049575070821529746,0.3710942963613457,1.0,11/80,4.97%,HDAC9;MYO5A;TBC1D4;RAB31;FER;RAB8B;RAB10;ZFP36L1;SLC2A4;IRS2;INSR
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.40862156827108126,1.4467623460377792,0.029150823827629912,0.37242534103513675,1.0,45/166,17.73%,ZEB2;EGFR;KLF2;LDLR;EIF3E;CD36;TLR4;NR1D1;CCL19;SAMD4A;NIBAN1;RPL26;RGCC;VIM;IRS2;INSR;ATP7A;NMD3;RPS4X;TNF;KLF4;ELOVL5;RPL5;LARP4B;ZNF205;IGF1;SP1;ASS1;ARPP19;LARP4;PIWIL2;NR1H2;KAT7;MFSD2A;PRKD2;PKD2;PRMT1;MYC;HSP90AB1;ARNT;CCL5;ABCB10;IL6;HGF;PYM1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.49629384465158505,1.4463669769944696,0.06116207951070336,0.372356982069635,1.0,8/40,6.90%,DAB2;TCF7L2;JAG1;BMP2;ALX1;RGCC;SMAD4;SDCBP
prerank,toxin transport (GO:1901998),0.66296816697905,1.4458955799969004,0.09803921568627451,0.372530891686839,1.0,3/10,9.31%,ANTXR2;ANTXRL;ANTXR1
prerank,mitochondrial protein processing (GO:0034982),0.6535199332838173,1.445545865912119,0.07677902621722846,0.372471625354833,1.0,1/11,0.60%,IMMP2L
prerank,regulation of ATP biosynthetic process (GO:2001169),0.6125706264247082,1.4451360257646098,0.08617594254937164,0.37258150623624003,1.0,1/16,0.05%,PID1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4266885267663181,1.4448730083689947,0.02610966057441253,0.3723426035558314,1.0,21/113,10.83%,NRP1;EGFR;TCF7L2;NOTCH2;RREB1;C5AR1;ANG;NRAS;OSR1;BMP2;THBS4;GRN;NRARP;NR4A1;CCL24;TNFSF12;MYDGF;IGF1;RTN4;SFRP1;EGFL7
prerank,adherens junction organization (GO:0034332),-0.4097570675640548,-1.4446771981775313,0.030985915492957747,0.716808933314075,1.0,16/48,12.08%,CADM1;TJP1;CTNNB1;CDH10;SMAD7;TBCD;CDH2;CDH13;PIP5K1C;FERMT2;CDH8;CADM2;NECTIN2;AFDN;CDH9;CDH22
prerank,regulation of microtubule depolymerization (GO:0031114),-0.48575417026258794,-1.4446369937485557,0.06823529411764706,0.7101043867335726,1.0,5/25,4.14%,NAV3;CLASP2;CAMSAP1;MAP1B;FGF13
prerank,response to lipopolysaccharide (GO:0032496),0.4176883526050811,1.4446355680135472,0.023047375160051217,0.37203294170850254,1.0,29/138,10.87%,PF4;FOXP1;FER;IRAK3;MEF2C;PTPN22;IFNAR1;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;PELI1;RHOA;RPS6KA3;LBP;BCL10;VIM;TNFRSF11A;NFKBIL1;GCH1;MAPKAPK2;LY96;CD80;CDC73;MAPK14;CARD16;CD68;CHMP5
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3835735145173274,1.4438960636050797,0.0011098779134295228,0.37289943902361034,1.0,57/348,10.21%,DAB2;BANK1;NRP1;EGFR;APP;PTPRJ;IQGAP1;SNX9;CLEC6A;IL15;PRKAG2;GAS6;WDFY2;LYN;RASSF2;KRAS;CD44;BMP2;RIPK1;CD74;FGF23;THBS4;GDF3;AXIN1;THPO;CCL19;NIBAN1;RAPGEF2;PDE8A;RAP1A;INSR;CAMKK2;RACK1;SMAD4;PAK2;S1PR2;GDF10;CD40;ACVR2A;SDCBP;TNF;FAM20A;CD80;CCND3;HFE;IL6R;FNIP1;DDR2;UBE2K;PDGFC;CCND2;MYDGF;CACUL1;IGF1;RIPK2;DOCK7;ARRB1
prerank,regulation of myelination (GO:0031641),-0.4802098241395756,-1.443602999322212,0.06097560975609756,0.7080775093739538,1.0,9/25,12.20%,JAM2;PARD3;ITGAX;CST7;TENM4;NSUN5;SIRT2;TPPP;RNF10
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5780334928966461,1.4430054834319914,0.0873440285204991,0.37382038064321693,1.0,5/20,12.17%,MCUB;MCU;PARL;SLC8B1;MICU3
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6470793811253028,1.4430002420844577,0.09774436090225563,0.3730638732929067,1.0,2/11,3.09%,C1QTNF3;C1QTNF12
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5067055454562619,1.4426539311325728,0.06782334384858044,0.373091092631266,1.0,15/43,14.55%,GAS6;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;LBP;NFKBIL1;GHRL;TRIM27;CD33;IGF1;ZC3H12A;RARA;ARG2
prerank,sodium ion homeostasis (GO:0055078),-0.501209952203413,-1.4425156193639885,0.06958762886597938,0.7063569516755533,1.0,4/21,4.05%,SLC12A2;ATP1B1;SLC8A1;ATP1B2
prerank,brain development (GO:0007420),-0.3431747202191724,-1.442479963694586,0.0,0.6999214669015407,1.0,57/136,21.54%,CX3CR1;ADGRL3;CTNNA2;ROBO2;EPHA7;ZFHX3;CNTNAP2;CDH2;PBX2;BPTF;PITPNM1;AFF2;AATK;NDRG4;APOD;NF1;CIC;CNTN4;SYNJ2;BAG6;PPT1;RAB18;UTP3;ZFHX2;SPEF2;MEIS3;SHROOM2;GRIN2A;NKX2-2;SMARCA1;PROX1;EML1;CTNS;MEIS1;TGFBR2;DSCAML1;EEF1AKMT4-ECE2;ZIC1;POU6F1;SHROOM4;CDK5RAP3;SMG9;TBC1D23;DNAJC30;ADGRL2;EGR2;PBX1;PTPN11;PLXNB2;BBS4;PAFAH1B3;ROGDI;HAP1;NNAT;CDK5RAP1;MKKS;PBX4
prerank,positive regulation of interleukin-4 production (GO:0032753),0.5958633927834596,1.441781395459569,0.09306569343065693,0.374261119987839,1.0,4/17,6.57%,IRF4;CEBPB;FCER1G;SYK
prerank,negative regulation of programmed cell death (GO:0043069),0.3794661291615615,1.4415863019495454,0.0088008800880088,0.37393361543379494,1.0,58/355,12.13%,DAB2;CD38;EGFR;TNFAIP8;NOTCH2;TPT1;GAS6;NUPR1;GRK5;DNAJC3;NR1H4;RPS27A;TSLP;BABAM2;RASA1;CD44;OSR1;SH3RF1;RIPK1;ARHGAP10;SIAH2;CD74;CBL;RPS6KA3;MCL1;GSK3B;BIRC3;GHRL;RHBDD1;GLO1;PAK2;BCL2L2;TXNDC5;BCL2;HIGD1A;BAG3;HSPB1;HTATIP2;PSEN1;BIRC6;ARHGDIA;RAB7A;CCND2;MYDGF;IGF1;SFRP1;RIPK2;NUP62;THOC6;PCID2;PHIP;SHC1;KANK2;CRYAB;WFS1;RPL10;NIBAN2;UFM1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.504937359858586,-1.440918212663174,0.07875894988066826,0.6999034086677175,1.0,8/20,16.91%,GRK2;GRK3;YWHAB;APLP1;RGS2;MRAP2;GPRASP1;PLEK
prerank,regulation of cell junction assembly (GO:1901888),0.5453219898413797,1.4408309201859797,0.08031496062992126,0.3747080907626509,1.0,7/27,5.69%,PDLIM5;RAP1B;MEF2C;RAPGEF2;RAP1A;ROCK1;CBFB
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.375553369737196,1.440578557248119,0.002109704641350211,0.37447805876388135,1.0,142/497,19.76%,RBPJ;HDAC9;WWP1;CD38;TCF7L2;MDFIC;FOXP1;AHR;ZBTB16;GAS6;SMURF2;RPS3;DAPK1;CBFA2T3;TSHZ3;BMP2;PRICKLE1;ALX1;NR1D1;SNX6;SAMD4A;S100A11;YWHAQ;JARID2;NR3C1;NKAP;MRPL13;HEY2;CLOCK;SPI1;GSK3B;RB1;RACK1;ARID5A;SMAD4;PTPRK;TRIM33;ATXN1;EPC1;SETDB2;DMAP1;FOXM1;ZNF568;TNF;ZNF148;KLF4;MALSU1;GATAD2A;GMNN;KLF10;RBM4;BTAF1;NCOR1;MIDEAS;LIMD1;MDM2;LBH;ILF3;GCFC2;SFRP1;SPEN;RBM15;RCOR2;DDX6;ZMYND15;PHC3;SHC1;CRYAB;FOXK2;HINFP;NANOS3;NIBAN2;TRIM71;KDM5C;FOXK1;LOXL2;SP3;FOXO1;CTBP2;PSPC1;SHMT1;NR1H2;RARA;KAT7;MBD1;BCOR;TERF1;KAT6A;CNOT9;EHMT1;NAB1;SNW1;HDAC4;PEX14;ZHX1;VGLL4;SFPQ;HEXIM2;USP47;KDM1A;CREB3L1;ATR;ZGPAT;PER1;TBX2;RCOR1;GLIS2;FOXP2;RELA;LHX1;NACC1;ZBTB7A;NR2F2;SYNCRIP;PA2G4;MECOM;ARID4A;GZF1;RFX3;ZBTB14;TRAF6;SUMO1;ID3;THRA;RNF139;BRMS1;EIF2AK2;EIF2AK1;INPP5K;ENPP1;SFMBT1;CIART;BCL3;TLE1;CTCF;SET;EIF2AK3;MECP2;CREBZF;CNOT1;CNOT8;ERN2
prerank,lipid droplet formation (GO:0140042),-0.6176065705811336,-1.4404342207659486,0.05835010060362173,0.6956737726938474,1.0,6/10,29.30%,AUP1;CDS1;SQLE;CDS2;BSCL2;ZFYVE1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.6319460148677185,1.4402027513618834,0.08818011257035648,0.3745681181749157,1.0,6/14,9.90%,LDLR;TNFRSF1B;NR1D1;GRN;CD200R1;IGF1
prerank,lymphocyte proliferation (GO:0046651),0.5643775579471109,1.4401519871522974,0.08571428571428572,0.37386707530953034,1.0,5/22,8.63%,MEF2C;CD40;BCL2;CR2;MSN
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.6735157862801945,1.4400397821895001,0.10076045627376426,0.3733201520505823,1.0,3/10,1.78%,RAB31;ALOX15;ANO6
prerank,regulation of cilium assembly (GO:1902017),-0.39524170345463383,-1.439829058405541,0.02,0.6919650412136346,1.0,32/62,23.52%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;CEP97;IFT140;TBC1D10A;IFT88;CROCC;TBC1D22A;IFT20;DYNLT2B;TBC1D22B;TBC1D9B;CCP110;EVI5L;TBC1D24;ENTR1;TBC1D20;CDK10;CDKL5;LIMK2;TBC1D7;TBC1D1;KCTD17;BBS4;TBC1D2;TBC1D10B;ODF2L;TAPT1;TBC1D15
prerank,phospholipid metabolic process (GO:0006644),-0.3765588346112095,-1.4397197213274346,0.02702702702702703,0.6861551238537723,1.0,21/71,22.15%,ABHD12;LPCAT1;PLCB2;ENPP2;PCYT2;PLPP3;LPL;GNPAT;PLPPR1;GPX4;PIP4K2B;ANGPTL3;SMPD2;LGALS13;PLA2G3;ABCA2;ACP6;PLPP2;AGPAT3;GDE1;TNFAIP8L3
prerank,regulation of apoptotic process (GO:0042981),0.36937523898451863,1.4390133466070394,0.0,0.3747201491050492,1.0,115/676,13.49%,DAB2;ARHGEF3;ITSN1;VAV3;CD38;TNFRSF25;PLEKHG5;HIP1;NLRC4;FGD4;EGFR;TNFAIP8;MAP3K5;STK17B;NOTCH2;IFT57;TPT1;GAS6;NUPR1;GRK5;DNAJC3;ANO6;ITGB1;RARG;RPS3;DAPK1;MEF2C;NR1H4;RPS27A;TSLP;BABAM2;RASA1;RASSF2;STEAP3;CD44;OSR1;SH3RF1;RYBP;BMP2;RIPK1;ARHGAP10;LILRB1;SIAH2;CD74;CBL;RPS6KA3;PRKN;BCL10;MCL1;TRIO;GSK3B;BIRC3;GHRL;RHBDD1;GLO1;RACK1;PAK2;BCL2L2;TXNDC5;CTSB;STK3;NOP53;BCL2;HIGD1A;NGEF;TRIM24;BAG3;HSPB1;TNF;HTATIP2;PSEN1;ARHGEF12;BIRC6;ARHGDIA;ATF6;MAP3K20;CCND2;MYDGF;IGF1;RTN4;SFRP1;RIPK2;FBXO11;RPS6;NUP62;ATG7;THOC6;PCID2;CASP8;CTNNBL1;PHIP;CHM;DFFA;SHC1;CREBBP;CRYAB;WFS1;FOXO3;RPL10;NIBAN2;UFM1;DIABLO;MAP3K11;ITGB3BP;FBXO10;PPP1R13B;ARHGEF9;FAM162A;GLS2;FOXO1;NET1;SOS2;LATS2;TMBIM4;DDX42
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6710102995312441,1.438918018098103,0.10545454545454545,0.37414097175218464,1.0,3/10,5.69%,IRF4;SH3RF1;CBFB
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.48317599860890487,1.4384206609128862,0.055299539170506916,0.3743528013545113,1.0,6/46,3.75%,NRP1;ITGA4;ATRNL1;PEAK1;FER;RHOA
prerank,neuromuscular junction development (GO:0007528),-0.4884323471617653,-1.438265010715024,0.06067961165048544,0.6864350536996355,1.0,5/24,6.33%,CACNB2;CACNB4;UNC13C;DVL1;DNAJA3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.569856979221453,1.4369867585521348,0.09878682842287695,0.3765552976830005,1.0,6/20,6.94%,LYN;PTPN22;TLR4;LBP;BCL10;TNF
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4616016010114128,-1.4356462083287278,0.032520325203252036,0.6913150765489937,1.0,7/30,5.39%,FGF12;KCNJ2;SCN1B;SNTA1;ANK2;CACNA2D1;CACNA1D
prerank,regulation of BMP signaling pathway (GO:0030510),0.45784696795103663,1.4355658139049998,0.05270655270655271,0.3787032942490252,1.0,9/73,6.39%,RBPJ;SMURF2;CRIM1;BMP2;GDF3;SMAD4;TRIM33;ACVR2A;HTRA3
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5338144782022647,1.4348969568072132,0.0989010989010989,0.37933983827206313,1.0,5/28,4.00%,CTSC;FBXW7;NUPR1;AXIN1;PRKN
prerank,prostanoid metabolic process (GO:0006692),-0.5588732734184332,-1.4346356806936216,0.0718954248366013,0.689410507095586,1.0,3/13,7.82%,HPGDS;PTGS1;PTGR2
prerank,dendrite morphogenesis (GO:0048813),-0.4358502939086055,-1.4341882405339328,0.053763440860215055,0.6854696250807327,1.0,13/35,10.64%,MAP2;CTNNA2;DOCK10;DLG4;FARP1;DIP2A;SHANK1;DVL1;EPHB1;SDC2;MAP6;CELSR2;MINK1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.550539710926197,1.4334416411153375,0.07601351351351351,0.3817976777748417,1.0,8/26,10.36%,APOE;S100A1;FGF23;NPR3;GCH1;ATP7A;TNF;NUS1
prerank,sterol homeostasis (GO:0055092),0.45843112595022595,1.4326484030047177,0.054441260744985676,0.3827359701937381,1.0,5/65,4.03%,HDAC9;APOE;LDLR;NR1D1;EHD1
prerank,microvillus organization (GO:0032528),0.6161401233629877,1.43247819415886,0.11298482293423272,0.3823253091604601,1.0,4/13,4.84%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6344469545277021,1.4320615824256824,0.09737827715355805,0.3824618798047352,1.0,4/12,18.20%,CLEC6A;CCR2;PRKCQ;ZBTB1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.6280123340764222,1.4318972854730234,0.10091743119266056,0.382053413986799,1.0,3/13,7.58%,EDNRB;GNAI3;CCR2
prerank,regulation of neuron projection development (GO:0010975),-0.3320873423810178,-1.4318112021528493,0.01015228426395939,0.6900710037505376,1.0,55/163,21.19%,CSMD3;ABI3;RTN4RL1;MYLIP;TANC2;PTPRS;PTK2B;CTNNA2;SETX;ITGA6;SCN1B;MAGI2;PAK1;ULK4;CDH2;LRRC4C;TENM3;PRAG1;PPFIA2;FBXO7;ATP1B2;KIF1A;NDRG4;SCARB2;NTRK3;TWF2;BDNF;KNDC1;SERPINI1;NTNG1;MAG;EFNB2;SPOCK1;IL1RAPL1;RAPGEF1;NDNF;EPHA3;MINAR1;CDKL5;BRSK2;GPC2;SRCIN1;FUT9;NCS1;ZDHHC15;PAK3;DBN1;FKBP4;PLXNB2;PLA2G3;PLXNB3;WNT5A;BAG5;TWF1;ARHGAP44
prerank,positive regulation of phospholipid transport (GO:2001140),0.6699056927060462,1.4318013537593317,0.09714285714285714,0.3815011048382123,1.0,1/10,0.49%,APOE
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5384816858452445,1.4316621005059926,0.1037567084078712,0.38107483633386513,1.0,6/25,12.21%,CNRIP1;SNX6;CBL;TNF;HFE;CBLB
prerank,negative regulation of response to external stimulus (GO:0032102),0.4370244630530075,1.4312539510877187,0.04252400548696845,0.38116593111113234,1.0,17/105,7.22%,AOAH;APOE;ALOX5;CASK;C1QTNF3;MFHAS1;IRAK3;NR1H4;METRNL;DRD1;NR1D1;CRK;NFKBIL1;RB1;GHRL;PPM1B;KLF4
prerank,endoplasmic reticulum organization (GO:0007029),0.4509988522682791,1.4311373804745708,0.05063291139240506,0.38062718687570496,1.0,8/72,4.62%,TMCC1;APP;REEP3;ATL1;VCPIP1;RAB10;HMOX1;SERP1
prerank,androgen receptor signaling pathway (GO:0030521),-0.5940544079499415,-1.43093741455046,0.07855626326963906,0.6881272353962936,1.0,4/11,9.27%,DDX5;DDX17;KDM3A;AR
prerank,ovarian follicle development (GO:0001541),0.620394922021088,1.430673734605294,0.10357142857142858,0.3808312951016296,1.0,2/13,2.18%,ANG;CEBPB
prerank,AMP metabolic process (GO:0046033),0.6169726113791923,1.4299508596420956,0.1088929219600726,0.3816552242416745,1.0,6/13,19.35%,XDH;ADSS2;AMPD3;ADSS1;AK3;AK4
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.6516173901049851,1.429199169222533,0.11632653061224489,0.38244418670776387,1.0,4/10,9.59%,PARP14;PIBF1;SH2B3;PPP2CA
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.47573983398081615,-1.429135546952537,0.0705596107055961,0.6897910048136024,1.0,9/25,13.07%,HK2;PFKL;ALDOA;PKM;PGK1;ENO1;PFKP;ENO3;TPI1
prerank,cranial nerve development (GO:0021545),-0.5895016165937084,-1.4289844497611952,0.07809110629067245,0.6846287303499491,1.0,3/11,10.79%,SALL1;CHD7;TMEM126A
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.6051362497453774,-1.4287730528985698,0.06680161943319839,0.6798854953100769,1.0,3/11,5.92%,TREM2;NOS1AP;AKAP6
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.37601888532052574,1.4286089035349323,0.00544069640914037,0.38301694377913037,1.0,118/417,19.76%,RBPJ;HDAC9;WWP1;CD38;TCF7L2;MDFIC;FOXP1;AHR;ZBTB16;GAS6;SMURF2;CBFA2T3;TSHZ3;BMP2;PRICKLE1;ALX1;NR1D1;SNX6;YWHAQ;JARID2;NR3C1;NKAP;HEY2;CLOCK;SPI1;RB1;ARID5A;SMAD4;PTPRK;TRIM33;ATXN1;EPC1;SETDB2;DMAP1;FOXM1;ZNF568;TNF;ZNF148;KLF4;GATAD2A;GMNN;KLF10;BTAF1;NCOR1;MIDEAS;LIMD1;MDM2;LBH;ILF3;GCFC2;SFRP1;SPEN;RBM15;RCOR2;ZMYND15;PHC3;SHC1;CRYAB;FOXK2;HINFP;NIBAN2;KDM5C;FOXK1;LOXL2;SP3;FOXO1;CTBP2;PSPC1;NR1H2;RARA;KAT7;MBD1;BCOR;KAT6A;EHMT1;NAB1;SNW1;HDAC4;PEX14;ZHX1;VGLL4;SFPQ;HEXIM2;USP47;KDM1A;CREB3L1;ZGPAT;PER1;TBX2;RCOR1;GLIS2;FOXP2;RELA;LHX1;NACC1;ZBTB7A;NR2F2;PA2G4;MECOM;ARID4A;GZF1;RFX3;ZBTB14;TRAF6;SUMO1;ID3;THRA;BRMS1;INPP5K;SFMBT1;CIART;BCL3;TLE1;CTCF;SET;MECP2;CREBZF;ERN2
prerank,cholesterol homeostasis (GO:0042632),0.45886666920897784,1.4285959499170702,0.05660377358490566,0.3822924529321085,1.0,5/64,4.03%,HDAC9;APOE;LDLR;NR1D1;EHD1
prerank,positive regulation of programmed cell death (GO:0043068),0.38496777498804907,1.4282861015580948,0.012429378531073447,0.3822075762545776,1.0,46/272,13.27%,ARHGEF3;ITSN1;VAV3;PLEKHG5;NLRC4;FGD4;TNFAIP8;MAP3K5;STK17B;ANO6;ITGB1;RARG;DAPK1;RPS27A;RASSF2;RYBP;BMP2;RIPK1;LILRB1;BCL10;TRIO;RACK1;STK3;SYK;NGEF;TNF;HTATIP2;PSEN1;ARHGEF12;ATF6;MAP3K20;SFRP1;RPS6;ATG7;CASP8;CTNNBL1;FOXO3;DIABLO;MAP3K11;ITGB3BP;ARHGEF9;FAM162A;FOXO1;NET1;SOS2;LATS2
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6033078154777569,-1.4281301978238852,0.07592190889370933,0.6768939246655803,1.0,5/10,24.80%,SLC1A3;SLC1A1;SLC25A22;SLC1A2;SLC25A13
prerank,epithelial to mesenchymal transition (GO:0001837),0.48174256214432093,1.427734100484174,0.0755287009063444,0.3825446142603607,1.0,7/47,5.43%,RBPJ;FGFR1;S100A4;BMP2;HEY2;GSK3B;ROCK1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5301975139498731,-1.426459994378024,0.08277404921700224,0.6778382335305059,1.0,8/16,19.30%,DDX5;DDX17;PUF60;CELF4;PQBP1;SRSF9;DHX9;RBM17
prerank,integrin-mediated signaling pathway (GO:0007229),0.4516905693485911,1.425960318333329,0.057665260196905765,0.3855786194099833,1.0,12/73,6.57%,DAB2;NRP1;NEDD9;ITGB1;DOCK1;CDC42;ADAM9;ITGB1BP1;ITGBL1;CCM2;PTPRA;SYK
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3952069537424695,1.4256581722722577,0.024691358024691357,0.3855191601978745,1.0,37/186,15.72%,DAB2;LRP6;APOE;IGFBP4;TCF7L2;TLE4;PSMA7;BMP2;PRICKLE1;SIAH2;AXIN1;PRKN;MCC;UBAC2;ZNRF3;GSK3B;RACK1;NOTUM;CTNND1;STK3;PSMB2;LIMD1;CUL3;NKD1;SFRP1;AMFR;PSMA6;LATS2;WWOX;MDK;PSMA3;PSMD1;PSMD5;NPHP3;NLK;VGLL4;TMEM131L
prerank,positive regulation of calcium ion transport (GO:0051928),0.5082126472037082,1.425230065646624,0.08333333333333333,0.38564134140511175,1.0,5/36,2.75%,P2RX7;LILRA5;ATP2B1;CCR1;STIM2
prerank,positive regulation of JNK cascade (GO:0046330),0.45005161791989706,1.424876406704166,0.055232558139534885,0.3856048836213548,1.0,11/70,7.38%,FCGR2B;APP;MAP3K5;MFHAS1;RASSF2;SH3RF1;RIPK1;AXIN1;CCL19;SDCBP;DUSP22
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.6241896879727431,-1.4248465104393955,0.07127882599580712,0.6791787018483608,1.0,5/10,20.51%,SORL1;SACS;DNAJB2;DNAJB1;DNAJA4
prerank,protein deneddylation (GO:0000338),-0.6223319183715438,-1.4248379052667883,0.10208333333333333,0.6737587448362166,1.0,6/10,21.39%,COPS7A;COPS8;COPS4;COPS6;GPS1;TOR1A
prerank,pyruvate metabolic process (GO:0006090),-0.40466989875485554,-1.4241907480193003,0.05278592375366569,0.671167663620464,1.0,15/52,13.07%,HK2;PFKL;PGM1;SLC16A3;ALDOA;PKM;BSG;PGK1;ENO1;SLC16A1;VDAC1;PCK2;ENO3;PDHX;TPI1
prerank,transport along microtubule (GO:0010970),0.6136102158088916,1.4241768938806063,0.11214953271028037,0.3862809985679308,1.0,6/13,13.19%,APP;ARHGAP21;CDC42;BAG3;DYNC1I2;BORCS5
prerank,response to interferon-gamma (GO:0034341),0.4460844265106213,1.424121513441104,0.06195965417867435,0.38564226275330243,1.0,16/67,10.54%,IFITM3;GBP3;DAPK1;CD74;CCL8;TLR4;CCL19;TLR2;GCH1;GBP7;CD40;BST2;CXCL16;CCL24;IFITM2;SP100
prerank,regulation of biomineral tissue development (GO:0070167),0.5409029130140625,1.4239415524875212,0.0967741935483871,0.38523979754760007,1.0,8/26,11.99%,GAS6;CEBPB;HEY2;NOTUM;ROCK1;DDR2;S1PR1;ROCK2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5968032783654205,1.4236265672977857,0.08256880733944955,0.38519200629568856,1.0,6/15,9.18%,RIPOR2;DCSTAMP;ADAM9;EHD1;CD53;MAPK14
prerank,regulation of aerobic respiration (GO:1903715),0.6039375078747684,1.423588770480126,0.10163339382940109,0.38454051139140955,1.0,4/15,9.82%,CBFA2T3;ATP7A;NOP53;COX7A2L
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5915871126076236,-1.4225751672496967,0.08227848101265822,0.6721626791980837,1.0,7/11,18.91%,SAFB;SAFB2;SRPK1;SRPK2;NCBP1;CDK11B;DHX9
prerank,homeostasis of number of cells (GO:0048872),-0.5773955448173134,-1.4216471370058794,0.09312638580931264,0.6707786758967661,1.0,5/12,23.87%,CX3CR1;OCIAD1;LPCAT3;NOTCH1;NAPEPLD
prerank,regulation of metal ion transport (GO:0010959),0.5831957767714845,1.42079788519084,0.10296684118673648,0.38951354105731684,1.0,4/16,8.81%,IL16;BCL2;STIM1;PLN
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.48723839335478486,1.4207278084734585,0.081203007518797,0.38892811225433704,1.0,7/41,5.14%,NEDD9;LILRA5;FBXW7;GAS6;CASS4;DOK7;GPRC5B
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3942512360068052,1.4207158921904657,0.019138755980861243,0.3882076297078597,1.0,68/208,19.45%,PLEKHG5;CLEC6A;ESR1;S100A4;NR1H4;SHISA5;ALPK1;RIPK1;CD74;NR1D1;ANKRD17;CCL19;PELI1;RHOA;HMOX1;PRKN;BCL10;BIRC3;NDFIP1;GPRC5B;RIOK3;TRIM32;TMEM106A;CD40;HSPB1;TNF;BST2;PPM1B;MIER1;REL;PRKCB;TRIM68;TRIM27;TFG;CARD16;EEF1D;RIPK2;NUP62;WLS;CASP8;MAP3K3;LAMTOR5;ZC3H12A;VAPA;TERF2IP;NOD2;TNFRSF1A;UBE2N;GJA1;NDFIP2;MID2;RHOC;TRIM25;PPM1A;PER1;BRD4;TIRAP;TAB3;RELA;F2R;ECM1;TRAF6;NLRX1;IRAK4;PLK2;DDX21;MAPKBP1;TLE1
prerank,regulation of macrophage migration (GO:1905521),-0.6223729446666874,-1.4198479021453208,0.08463251670378619,0.6728295631865827,1.0,6/10,13.11%,CX3CR1;PTK2B;CSF1;P2RY12;MTUS1;CD200
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4807471704990126,1.419781272669942,0.08373590982286634,0.38949223860360715,1.0,6/39,6.94%,ITGA4;GAS6;ANO6;RGCC;CD40;TNF
prerank,negative regulation of cyclase activity (GO:0031280),0.6175540875119102,1.4194152174506116,0.09340659340659341,0.3894940379880304,1.0,3/14,7.58%,EDNRB;GNAI3;CCR2
prerank,lymphocyte differentiation (GO:0030098),0.4484137852617583,1.4188066666935086,0.06480117820324006,0.3900276168988005,1.0,17/68,15.43%,HDAC9;ITGA4;PTPRJ;ITGB1;PTPN22;KLF6;CR2;ZAP70;LYL1;CEBPG;NHEJ1;SLC25A5;LY6D;KAT7;LFNG;NFAM1;HDAC4
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.516781137221492,1.4186208179554618,0.07605177993527508,0.3896379361597365,1.0,6/29,7.58%,CCR1;GAS6;ANO6;PLA2G7;TNF;CCR2
prerank,lymphocyte migration (GO:0072676),0.5077557114436625,1.4184906226293306,0.07886435331230283,0.3891989902029162,1.0,10/32,17.31%,CCL8;MSMP;CCL19;ZAP70;CCL24;MSN;S1PR1;CKLF;CCL5;CCL25
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.558671388806105,-1.4183906756155278,0.08547008547008547,0.6735338570906912,1.0,9/13,27.51%,SRSF10;DDX20;CD2BP2;PRPF19;SRSF12;PRPF6;SART3;PRPF31;AAR2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.48177568643092006,-1.4180709128473004,0.06666666666666667,0.6697189874866244,1.0,7/23,11.42%,CCDC88B;KIF1A;KIF5A;MYO10;KIF5C;MAP6;KIF1C
prerank,myeloid cell differentiation (GO:0030099),0.47373602694465433,1.4180367190633663,0.076103500761035,0.3893411197636153,1.0,13/47,16.74%,RASGRP4;ZBTB16;LYN;MFHAS1;SPI1;RPS14;NCOA6;SLC25A5;KMT2E;TET2;KAT6A;TIRAP;PRDX3
prerank,glycogen biosynthetic process (GO:0005978),0.6220229328804372,1.4175276505976113,0.10902255639097744,0.38890930085546255,1.0,5/12,9.41%,GBE1;GYG1;NR1D1;PGM2L1;PPP1R3C
prerank,glucan biosynthetic process (GO:0009250),0.6220229328804372,1.4175276505976113,0.10902255639097744,0.38890930085546255,1.0,5/12,9.41%,GBE1;GYG1;NR1D1;PGM2L1;PPP1R3C
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6537223295755652,1.416959115520021,0.13148148148148148,0.389325141328756,1.0,2/10,2.14%,IRF4;TSLP
prerank,positive regulation of organelle organization (GO:0010638),0.5041635062604518,1.4161868872242331,0.0817391304347826,0.39029838935542277,1.0,8/32,8.90%,P2RX7;LIG4;ADRB2;UVRAG;SYNJ1;GSK3B;ANXA2;SMCR8
prerank,limb morphogenesis (GO:0035108),0.5621014434153179,1.416050443300919,0.10304054054054054,0.3898370556205587,1.0,2/20,1.18%,LRP6;MBNL1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4174024655881027,1.4157041010047917,0.04298356510745891,0.3898381755838936,1.0,24/117,13.33%,CD163;LYN;CYSLTR1;GNG2;CALCRL;ADRB2;DRD1;ADM;ADCY9;ADCYAP1R1;SYK;PLA2G2D;GNB1;FYN;FCGR3A;MAPK14;TSHR;PTGER4;PRKACB;HTR6;RAMP2;GLP2R;CREB1;GPR27
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.49784222387417787,-1.4154378847731028,0.08436724565756824,0.6759812149396665,1.0,8/20,21.06%,CALM2;ATP1B1;SLC8A1;ANK2;CACNA1C;SLC9A1;CAMK2D;CALM3
prerank,fat cell differentiation (GO:0045444),0.4584339219354191,1.4152021138296298,0.06423357664233577,0.39012120840749553,1.0,9/57,7.86%,PID1;TCF7L2;C1QTNF3;METRNL;NR4A1;TRIM32;OSBPL11;KLF4;NR4A2
prerank,myeloid leukocyte differentiation (GO:0002573),0.4579475049746735,1.4151915581212482,0.06598240469208211,0.3894113314650279,1.0,16/65,14.00%,FOXP1;IL15;CBFA2T3;CDC42;DCSTAMP;CCL19;TNFRSF11A;SPI1;GLO1;BATF2;MAPK14;CASP8;SNX10;DEK;RARA;EP300
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4624453233121501,1.4151719136152068,0.06188466947960619,0.3887180421401225,1.0,9/62,5.60%,ARHGEF3;RASGRP4;NOTCH2;LYN;MAPRE2;STK19;GPR65;IRS2;P2RY10
prerank,glycoprotein biosynthetic process (GO:0009101),-0.36232725979699365,-1.4151096881822054,0.021739130434782608,0.6723199699574702,1.0,27/79,18.40%,LARGE1;CHST11;ST3GAL5;XYLT1;GCNT2;ST3GAL6;BMPR1B;COG3;B3GALNT2;B3GALT1;CANT1;B3GALT5;ALG1;GAL3ST4;B3GALT2;ST8SIA1;SERP2;ST3GAL3;B3GNT2;ST8SIA3;B4GALT7;ALG3;MGAT1;FUT9;CHST10;GOLGA2;ST3GAL2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5911357620190841,1.4149301751032166,0.10583941605839416,0.3885084896349412,1.0,7/17,14.89%,RBPJ;MAML1;CREBBP;PLXND1;EP300;WWC1;SNW1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6327162075702368,1.4147456195621506,0.11069418386491557,0.3881469025115861,1.0,5/11,9.09%,ALOX5;KLF2;EPN2;SYNJ2BP;ADAMTS9
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5210787162309473,1.4147229342548329,0.08813559322033898,0.38746971082219067,1.0,4/26,3.50%,APP;FBXW7;SNX6;CBL
prerank,regulation of amyloid fibril formation (GO:1905906),0.6014541069769969,1.414345668777611,0.09760589318600368,0.3875780084898238,1.0,3/15,1.24%,APOE;APP;LDLR
prerank,positive regulation of ion transport (GO:0043270),0.471293183201966,1.4143036997160265,0.0734632683658171,0.3869221275839069,1.0,20/48,18.96%,P2RX7;LILRA5;ATP2B1;CCR1;ANO6;STIM2;DRD1;CNKSR3;WFS1;SCN3B;FFAR1;SNX4;RAB3B;CCL5;CHRNB2;F2R;GDNF;CAMK2A;VAMP8;P2RX4
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5697248876222248,-1.4139949850000064,0.0924170616113744,0.6714378839183631,1.0,3/13,8.72%,BIN1;PTK2B;ACTN2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.605872981732658,-1.413833169638739,0.1038135593220339,0.667089843025547,1.0,2/10,8.39%,DNMT3A;PCGF5
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.40301528998038033,1.4136829018416577,0.022304832713754646,0.38741911582620014,1.0,45/149,17.66%,NLRC4;APP;FER;RPS3;IRAK3;RPS27A;RIPK1;CD36;TLR4;BCL10;TNFRSF11A;TLR2;CLOCK;TRIM32;CD40;TNF;MTPN;EDA;PRKCB;RAB7B;TRIM68;TRIM27;CARD16;RIPK2;PSMA6;DHX33;LAMTOR5;TERF2IP;NOD2;UBE2N;NFKBIB;MID2;STAT3;EP300;PRKD2;PPIA;TRIM25;TIRAP;PRDX3;TAB3;PRKCQ;RELA;ZBTB7A;FLOT2;IL6
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6634393078457728,1.4136489992020234,0.08957952468007313,0.38679543332693195,1.0,3/11,4.00%,MEF2C;BMP2;FRS2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3636575551600794,1.412471681551209,0.0,0.3885626761736328,1.0,181/807,16.62%,RBPJ;DAB2;HDAC9;WWP1;CD38;ZEB2;TRPS1;EDNRB;KLF2;TCF7L2;MDFIC;FOXP1;MEF2A;AHR;ZBTB16;RREB1;GAS6;TFEC;ESR1;RPL23;SMURF2;RARG;MEF2C;NR1H4;CBFA2T3;RPS27A;CEBPB;MITF;OSR1;NCOA5;TSHZ3;BMP2;PRICKLE1;NR2C1;ALX1;NR1D1;SNX6;YWHAQ;PRKN;JARID2;LARP7;PDE2A;FRK;NR3C1;NKAP;IRF2BP2;HEY2;CLOCK;SPI1;SAP130;RB1;NFIC;USP9X;ARID5A;SMAD4;PTPRK;TRIM33;THRB;IRX2;CBFB;PHF21A;ORC2;ATXN1;NOP53;EPC1;SETDB2;DMAP1;FOXM1;SDCBP;ZNF568;TNF;ZNF148;KLF4;YY1;BRMS1L;DUSP22;MIER1;THAP11;GATAD2A;TBL1XR1;PSEN1;NR4A2;GMNN;NRIP1;IRF2;KLF10;BTAF1;CDC73;RPS14;NCOR1;ZBTB5;FNIP1;FOXC2;MIDEAS;LIMD1;BACH1;TRIM27;MDM2;HIVEP1;TBL1X;LBH;ESR2;LRRFIP1;UBE2D3;BEND3;IGBP1;LCOR;NR2F1;PURA;ILF3;ZNF205;GCFC2;SFRP1;SPEN;RBM15;RCOR2;SP100;MIER3;HSBP1;ZMYND15;ETS2;PHC3;SHC1;SREBF2;CREBBP;KANK2;CRYAB;FOXK2;HINFP;WFS1;FOXO3;RPL10;NIBAN2;KDM5C;FOXK1;LOXL2;SP3;NFIX;FOXO1;CREB1;PEG3;CTBP2;PSPC1;WWOX;NR1H2;RARA;KAT7;STAT3;MBD1;EP300;BCOR;NEDD4L;KAT6A;EHMT1;WWC1;NAB1;SNW1;GATAD2B;MYC;HDAC4;KDM2A;PEX14;NR2C2;ZHX1;VGLL4;SFPQ;RUNX3;HEXIM2;USP47;E2F8;KDM1A;CREB3L1;HCFC1;ZGPAT;PPM1A;LIN37;PER1;ZNF177;TBX2;RCOR1;GLIS2
prerank,cellular response to growth factor stimulus (GO:0071363),0.4018366144137873,1.4120367421671733,0.03225806451612903,0.38879336468792136,1.0,28/151,8.05%,NRP1;EGFR;IQGAP1;ZFP36L2;PTPN12;MEF2C;CD44;EEF1A1;BMP2;WNT2;ERN1;ZFP36L1;RAPGEF2;ITGB1BP1;EHD1;PDE2A;PDE8A;NR3C1;RAP1A;RACK1;SMAD4;MAPKAPK2;NR4A1;ACVR2A;HSPB1;KLF4;DUSP22;VSTM2A
prerank,microvillus assembly (GO:0030033),0.595214804868684,1.4105875647550445,0.12040133779264214,0.3911684468797137,1.0,4/14,4.84%,RAP1B;RAP2B;RAPGEF2;RAP1A
prerank,positive regulation of neuron differentiation (GO:0045666),0.49491194027997104,1.4105204366186457,0.08962264150943396,0.3905756586289561,1.0,7/40,5.88%,FGFR1;TCF4;MEF2C;BMP2;RHOA;GPRC5B;TRIM32
prerank,icosanoid metabolic process (GO:0006690),0.4987546561518202,1.4104887464513005,0.07418856259659969,0.3899460614009908,1.0,8/40,8.38%,ALOX5;LTC4S;ALOX15;ALOX5AP;PNPLA8;MAPKAPK2;ABCC1;DPEP2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.6535420458373213,1.4100161322592837,0.11632270168855535,0.3901764466993054,1.0,4/10,12.67%,RPS27A;TUT7;TUT4;DIS3L2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5635708907472742,-1.409798630923316,0.09555555555555556,0.6778891306656857,1.0,7/14,29.41%,PKM;CPEB2;FMR1;UNK;DHX9;CPEB1;CNBP
prerank,response to lipid (GO:0033993),0.4218303525435617,1.4087856333510864,0.043941411451398134,0.39208526570026814,1.0,26/105,14.37%,FOXP1;ESR1;FER;RARG;IRAK3;PTPN22;IFNAR1;CD36;TLR4;PELI1;RPS6KA3;LBP;TNFRSF11A;GCH1;MAPKAPK2;LY96;OVCA2;VPS4B;ASXL1;TRIM16;FOXO3;FOXO1;FFAR1;RARA;STAT3;RBP4
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6544869117893853,1.4087099536808854,0.12815533980582525,0.39152805531803003,1.0,2/10,3.03%,LRP6;WNT2
prerank,cellular response to lipid (GO:0071396),0.3927000349089181,1.407197914919782,0.018427518427518427,0.39388016021726696,1.0,42/191,13.92%,PID1;PF4;EGFR;AHR;ESR1;LYN;NCOA3;MEF2C;NR1H4;TNFRSF1B;LILRB1;WNT2;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;NFKBIL1;NR3C1;LY96;CD80;WNT6;NRIP1;CDC73;MSN;MGST1;MAPK14;CARD16;LCOR;SFRP1;CD68;CHMP5;KCNK4;ROCK2;ZC3H12A;NOD2;CREB1;NFKBIB;ATP1A3;ATP1A1
prerank,dopamine metabolic process (GO:0042417),0.5797573110974084,1.4069065264209613,0.11272727272727273,0.3937465062991476,1.0,6/18,5.58%,DRD1;PRKN;DAO;GCH1;MOXD1;ATP7A
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5284390055190223,1.4066758262285297,0.09983361064891846,0.39354009430599757,1.0,7/28,14.35%,EGFR;FBXW7;NRARP;ARRB1;EGFL7;NIBAN2;LFNG
prerank,positive regulation of cytokine production (GO:0001819),0.3757669618105635,1.4058252403505656,0.010262257696693273,0.3946484446318152,1.0,64/292,14.81%,PAEP;APP;IL16;LILRA5;IRF4;FOXP1;TLR8;CLEC6A;IL15;C1QTNF3;RPS3;NR1H4;PTPN22;TSLP;CEBPB;SPTBN1;RIPK1;FCER1G;LILRB1;CD74;TLR4;PIBF1;CD46;CCL19;HMOX1;RGCC;RFTN1;LBP;BCL10;TLR2;IL17RA;PDE4D;TMED10;TMEM106A;CD40;SYK;TNF;CD80;CCR2;CEBPG;RAB7B;IL6R;TRIM27;SULF2;LRRFIP1;MAPK14;RAB1A;STAT6;RIPK2;PTGER4;CREBBP;ROCK2;DHX33;LAMTOR5;POLR3D;NOD2;CRLF2;RARA;STAT3;EP300;MDK;CYBA;PRKD2;NFAM1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.6398816012886082,1.4057351095982498,0.125,0.3941722928733754,1.0,5/11,11.05%,NUPR1;RIPK1;PELI1;BIRC3;CASP8
prerank,negative regulation of protein depolymerization (GO:1901880),-0.4784254878576071,-1.405358968670425,0.07857142857142857,0.6917290315830052,1.0,6/24,8.77%,NAV3;CLASP2;CAMSAP1;FGF13;PLEKHH2;ARHGEF2
prerank,maintenance of protein localization in organelle (GO:0072595),-0.5091255844309923,-1.4053351076765344,0.0853932584269663,0.6867447323774951,1.0,8/19,23.42%,HK2;SKP1;HNRNPU;SUPT7L;ARL2BP;BBS4;TAF8;TAPT1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5676668416815805,1.4053106522864607,0.12,0.39438221627185843,1.0,4/19,3.48%,CMKLR1;MPP1;BST1;CAMK1D
prerank,catecholamine biosynthetic process (GO:0042423),0.6347227088374349,1.4046511702578366,0.1371841155234657,0.39501428742226763,1.0,3/11,4.60%,DAO;GCH1;MOXD1
prerank,activin receptor signaling pathway (GO:0032924),-0.5379277314986728,-1.4044869011443224,0.08444444444444445,0.6852045108302707,1.0,4/15,15.94%,TGFBR1;ACVR1;ACVR1C;ACVR1B
prerank,organophosphate catabolic process (GO:0046434),-0.5960095790692089,-1.4041360297048986,0.0911214953271028,0.681744341182904,1.0,2/11,2.40%,ABHD12;ENPP2
prerank,negative regulation of cell development (GO:0010721),0.5345099819082706,1.4037543172537086,0.08803986710963455,0.3961789438004253,1.0,7/25,9.90%,FBXW7;LILRB1;B2M;GSK3B;TNF;RFLNB;IGF1
prerank,L-amino acid transport (GO:0015807),-0.45466001544919454,-1.402459945427381,0.07772020725388601,0.6838645991400017,1.0,7/28,12.85%,SLC1A3;SLC36A1;SLC36A4;SLC1A1;SLC25A22;SLC7A8;CTNS
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5946323342275937,1.401581654679064,0.11487758945386065,0.39991737048958337,1.0,6/14,16.33%,ADK;ADSS2;LHPP;IMPDH2;ADSS1;GMPS
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.3939334652539097,-1.4011881816538116,0.03680981595092025,0.6844369883720541,1.0,9/54,5.92%,KCNMA1;BIN1;DPP10;KCNJ2;DPP6;KCNIP4;NOS1AP;CACNA1D;AKAP6
prerank,Ras protein signal transduction (GO:0007265),0.40432313541864995,1.400786858928625,0.0389937106918239,0.4009378263730182,1.0,16/137,5.94%,ARHGEF3;EPS8;PLEKHG5;RAP1B;RREB1;RAP2B;NRAS;KRAS;RHOA;RAPGEF2;GRAP;RAP1A;RB1;ROCK1;CELSR1;ARHGAP29
prerank,regulation of p38MAPK cascade (GO:1900744),0.49280699540661504,1.3997688718656311,0.0911854103343465,0.40237645137475925,1.0,8/35,4.74%,SASH1;RELL1;MFHAS1;PTPN22;BMP2;XDH;DUSP1;SPI1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5363913581339969,-1.399553798832034,0.09929078014184398,0.6864646463896941,1.0,3/15,5.51%,CX3CR1;CTNNB1;NF1
prerank,keratan sulfate metabolic process (GO:0042339),-0.44049142710311173,-1.3995313990922245,0.06284153005464481,0.6817759710497002,1.0,5/31,2.98%,HEXB;ST3GAL6;GNS;CHST1;B4GALT4
prerank,cellular response to organonitrogen compound (GO:0071417),0.424932144954429,1.399000006329418,0.05221932114882506,0.4031784053870265,1.0,22/99,12.10%,P2RX7;RAP1B;HRH1;CTNNA1;AHR;DIAPH1;MEF2C;NR1H4;P2RY6;ZFP36L1;RAPGEF2;PDE2A;AOC1;RAP1A;ACTB;HCN3;SFRP1;TSHR;TRPM2;JUP;KCNQ1;LAMTOR5
prerank,regulation of protein export from nucleus (GO:0046825),0.540547883001117,1.3986956665463623,0.09385665529010238,0.4030876939563627,1.0,9/23,16.29%,TCF7L2;GAS6;GSK3B;BAG3;SP100;YWHAE;UHMK1;PTPN14;ANP32B
prerank,regulation of protein catabolic process (GO:0042176),0.41603503791790025,1.398533993172481,0.056375838926174496,0.402723267086996,1.0,26/99,15.73%,WWP1;EGFR;SMURF2;IRAK3;EEF1A1;RILP;AXIN1;HMGCR;PRKN;GSK3B;SF3B3;SNX3;TRIM32;TNF;RAB7A;TNFSF12;MDM2;NKD1;ATG7;FOXO1;NEDD4L;GPC3;WDR91;RNF41;PRKCG;ZDHHC2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.500647680134966,1.398487973443073,0.09162717219589257,0.4021110984201236,1.0,4/33,3.50%,HIP1;FBXW7;ARAP1;CBL
prerank,regulation of protein kinase A signaling (GO:0010738),-0.4896543667299481,-1.3982864173133889,0.09263657957244656,0.6820796052991867,1.0,8/20,18.08%,PRKAR1A;PRKAR1B;AKAP6;AKAP7;IAPP;MIF;ADGRV1;PJA2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.3053942977238773,-1.3981271153983246,0.0,0.6780737629238842,1.0,74/264,18.00%,DDX5;SNRNP70;SRRM2;FUS;DDX17;ZCCHC8;HNRNPA3;ELAVL2;HNRNPUL1;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;HNRNPU;DHX35;SNRNP48;SRPK1;PUF60;GEMIN2;PPIL3;SRSF2;PNN;DCPS;SNRPA1;SRSF10;CCAR1;PPIE;PRPF4;CELF4;WBP4;SNRNP200;SYF2;DNAJC8;CSTF2;DDX41;RNPS1;CWC25;DDX20;XAB2;USP49;SRPK2;SNRPN;RAVER2;CD2BP2;PRPF19;SRRT;U2AF1;PQBP1;UPF3B;CASC3;NOVA2;SF3B1;DDX1;SRSF12;POLR2C;NCBP1;TGS1;STRAP;PRPF6;PCBP1;DDX23;PCBP2;HNRNPA1;RBM5;HNRNPH1;SNIP1;ZMAT5;CLP1;SNRPB2;SART1;SRSF11;SRSF9
prerank,cardiac myofibril assembly (GO:0055003),0.5814434806249167,1.3981176604674084,0.12,0.40225061825079744,1.0,3/15,5.33%,MEF2A;NRAP;PDGFRA
prerank,regulated exocytosis (GO:0045055),0.3966782962052176,1.3979990481621827,0.028117359413202935,0.4017617480762507,1.0,17/173,6.85%,F13A1;PF4;RAB11FIP5;APP;PHACTR2;GAS6;RAB31;SELENOP;LYN;CD36;RAB10;SRGN;MANF;TMED10;APOOL;FAM3C;ABCC4
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5065082767402538,1.3976896905413543,0.10410094637223975,0.40168745420911345,1.0,3/31,5.19%,RBPJ;MYH6;SMAD4
prerank,negative regulation of complement activation (GO:0045916),0.6552751899440663,1.3974611816455753,0.11670020120724346,0.40145793216690034,1.0,3/10,6.82%,VSIG4;CD46;CR2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5869305912232403,1.3972296807504043,0.10912343470483005,0.40122173233288083,1.0,5/17,10.21%,PTPN22;KLF4;CD33;SSC5D;ARRB1
prerank,retinoic acid metabolic process (GO:0042573),0.6062491528562565,1.397008132937554,0.11829944547134935,0.40100875871642006,1.0,5/14,9.99%,UGT1A7;UGT1A8;UGT1A1;CYP26C1;CYP26B1
prerank,response to UV-A (GO:0070141),0.6085368928968287,1.3969027626027433,0.13089005235602094,0.4005151291323098,1.0,1/14,0.45%,EGFR
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.4726619178417293,-1.3967931515650005,0.06553398058252427,0.6787756929972136,1.0,11/23,24.74%,PREB;AUP1;SURF4;UFD1;NPLOC4;SYVN1;SEC13;SELENOS;TMEM129;FAF2;SEC61B
prerank,neural crest cell differentiation (GO:0014033),0.5678662326043458,1.3964758981796186,0.11775362318840579,0.4007357199128942,1.0,4/18,6.88%,LRP6;MEF2C;FBXL17;CYP26C1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.4790854865333274,-1.3964038495216675,0.0741687979539642,0.6757952399537054,1.0,10/21,23.03%,CHST11;CSPG5;CHPF2;CSPG4;VCAN;BCAN;BGN;NCAN;UGDH;DCN
prerank,lipid transport (GO:0006869),0.42468875224307984,1.3960769541516085,0.05827814569536424,0.4009369738287989,1.0,15/97,9.15%,PLTP;APOE;SLC10A6;LDLR;NR1H4;NCOA2;CD36;ABCA9;PITPNA;SLC25A17;LBP;ABCC4;ABCA6;SLC10A3;GLTP
prerank,establishment of spindle localization (GO:0051293),-0.5468341978941011,-1.3957820377439527,0.10851063829787234,0.6737730674820682,1.0,7/14,22.45%,CLASP2;DYNC1H1;LLGL1;MAP4;LLGL2;NUSAP1;ESPL1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.5560524892109576,1.3957671569102816,0.10800744878957169,0.40088354943100596,1.0,8/20,16.01%,EGFR;RGCC;CCND3;CCNYL1;CCND2;CCNY;PKD2;HSP90AB1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3952869126771178,1.3953823073634322,0.03527980535279805,0.4010079738787853,1.0,43/166,17.68%,RBPJ;HDAC9;NOTCH2;ESR1;RARG;NR1H4;NR2C1;NR1D1;NR3C1;THRB;NR4A1;TBL1XR1;POLR1A;NR4A2;NCOR1;GTF2A2;NCOA6;ESRRB;TBL1X;ESR2;POLR1B;NR2F1;POLR2B;MED26;MAML1;CREBBP;GTF2E2;POLR1G;GTF2A1;NR1H2;RARA;POLR2D;MED27;SNW1;NR2C2;GTF2H3;GTF2B;MED17;NR5A2;CRCP;TAF12;GTF2H1;NR6A1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5914491621720613,1.3952853547473896,0.11387900355871886,0.40052415083786413,1.0,4/16,6.94%,APOE;HMGCR;ROCK1;TNF
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5506138354017316,1.394576207836759,0.0852994555353902,0.40135697129508857,1.0,4/20,6.34%,MCL1;GSK3B;BCL2L2;BCL2
prerank,collagen fibril organization (GO:0030199),-0.35881988970075923,-1.393582438870495,0.015748031496062992,0.6779225494606351,1.0,39/88,25.78%,DST;TGFBR1;COL27A1;COL11A1;ITGA6;TLL1;NF1;P3H2;ADAMTS3;LOXL3;PLOD3;COL23A1;LAMA3;COL25A1;COL1A2;COL19A1;COL11A2;COL8A1;COL26A1;ITGB4;COL6A2;COL16A1;COLGALT2;COL6A3;COL4A2;P3H4;COL4A6;TGFB2;ADAMTS2;COL9A3;COL9A1;COL3A1;COL6A1;COL20A1;COL13A1;COL5A3;P4HA1;P4HA3;COL4A4
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5334836634689847,1.3933412006764674,0.10309278350515463,0.4031074801925881,1.0,6/22,16.68%,TNFRSF1B;LILRB1;TNF;CCR2;NOD2;SCIMP
prerank,response to cAMP (GO:0051591),0.4838991528682838,1.3932298754773491,0.0943952802359882,0.4026611405761462,1.0,6/37,4.84%,RAP1B;AHR;ZFP36L1;RAPGEF2;PDE2A;RAP1A
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3924775831615227,1.3928026247063967,0.03618817852834741,0.402841997099135,1.0,24/175,8.46%,PID1;TNFRSF25;GBP3;ZFP36L2;PSMA7;RPS3;TNFRSF1B;RIPK1;CCL8;NR1D1;PLVAP;DCSTAMP;CCL19;ZFP36L1;TNFRSF11A;GSDME;BIRC3;CD40;EDARADD;TNF;EDA;PSMB2;CCL24;TNFSF12
prerank,embryonic limb morphogenesis (GO:0030326),0.4883180107640292,1.3927644360007905,0.10076335877862595,0.4022529400642368,1.0,8/34,11.28%,LRP6;MBNL1;RARG;OSR1;INTU;MAP3K20;CYP26B1;CREBBP
prerank,regulation of type I interferon production (GO:0032479),-0.36488755818770446,-1.392200044484603,0.039711191335740074,0.6791632520219248,1.0,34/84,23.07%,IRF8;CTNNB1;XRCC5;CYLD;DTX4;OTUD5;IRF3;MAVS;UBA7;POLR3E;POLR3C;DDX41;RNF216;NLRC5;CGAS;IRF7;NLRP4;IKBKE;UFD1;PQBP1;XRCC6;NPLOC4;ITCH;PCBP2;DHX9;POLR3G;TRIM21;GAPDH;POLR1C;G3BP1;POLR2L;PIN1;POLR3A;ILRUN
prerank,protein insertion into membrane (GO:0051205),0.5055299161562986,1.3917644825932196,0.09195402298850575,0.40366264269847674,1.0,5/32,8.14%,EGFR;APP;HMOX1;SERP1;TRAM2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6359871064463155,1.391029843427526,0.1367837338262477,0.40441404034199324,1.0,3/10,13.29%,PRKRA;DROSHA;MRPL44
prerank,vitamin transport (GO:0051180),0.5135206282633498,1.3906649551686656,0.1076923076923077,0.4044831630394725,1.0,7/29,17.24%,FOLR2;TCN2;AFM;SLC2A2;SLC23A1;SLC5A6;SLC35F3
prerank,thymus development (GO:0048538),-0.5596478799762854,-1.39038547465569,0.1019522776572668,0.6819106541988782,1.0,1/13,0.14%,TGFBR1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5983778127127974,-1.3902687068606514,0.1069182389937107,0.6779092968393674,1.0,5/10,18.80%,LRP5;STAT1;FGFR2;TGFBR2;PDGFA
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4352466540547827,1.3881824606013378,0.06205923836389281,0.4090909361654031,1.0,15/75,10.83%,NRP1;ITGA4;FGFR1;ANG;NRAS;BMP2;THBS4;HMOX1;NRARP;NR4A1;CCL24;TNFSF12;MYDGF;SP1;EGFL7
prerank,relaxation of muscle (GO:0090075),-0.5506852134682249,-1.3877471104926957,0.11214953271028037,0.6842100169590817,1.0,4/13,8.43%,KCNJ2;ATP1B1;SLC8A1;RGS2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.40609629188542506,1.386405014466691,0.03980099502487562,0.41237728443464267,1.0,32/132,12.87%,APOE;P2RX7;APP;SNX9;ZBTB20;DAPK1;TNFRSF1B;ADAM9;TRIM65;GSK3B;IRS2;INSR;PFKFB4;RC3H1;ROCK1;TNF;PSEN1;SLC4A4;ATF6;TRIM68;PIK3C2A;MSN;TRIM27;GRSF1;TPCN1;IGF1;ZC3H18;SNX33;FOXO3;ZC3H12A;GTPBP1;FOXO1
prerank,calcium import into the mitochondrion (GO:0036444),0.6323490615141872,1.3863691542507912,0.13988657844990549,0.4117508609186129,1.0,3/10,12.17%,MCUB;MCU;MICU3
prerank,mesonephros development (GO:0001823),0.635997511771948,1.3856568742091089,0.12612612612612611,0.4126052930638612,1.0,2/11,2.38%,ZBTB16;OSR1
prerank,receptor catabolic process (GO:0032801),0.5372815259647535,1.3852950953803798,0.1054421768707483,0.41269071269213603,1.0,10/24,13.96%,AP2A2;CLTC;UVRAG;ZNRF3;KIF16B;SNX25;AP2S1;VLDLR;AP2B1;CLTA
prerank,mRNA processing (GO:0006397),-0.29845486519504594,-1.384472713213781,0.0,0.692706582251981,1.0,92/287,22.46%,DDX5;GTF2H2;SNRNP70;SON;SRRM2;FUS;CPSF6;ZCCHC8;HNRNPA3;ELAVL2;HNRNPUL1;THOC1;AKAP8L;SRRM4;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;RPRD1A;HNRNPU;DHX35;SNRNP48;CCNH;PUF60;GEMIN2;PPIL3;SRSF2;PNN;SNRPA1;SRSF10;CCAR1;PPIE;PRPF4;WBP4;SNRNP200;SYF2;DNAJC8;ERCC2;TCERG1;CSTF2;DDX41;RNPS1;CWC25;XAB2;USP49;SNRPN;RAVER2;CD2BP2;PRPF19;SRRT;U2AF1;PQBP1;UPF3B;CASC3;NOVA2;SF3B1;SRSF12;POLR2C;NCBP1;PRPF6;PCBP1;DDX23;PCBP2;HNRNPA1;RBM5;HNRNPH1;SNIP1;ZMAT5;CLP1;SNRPB2;SART1;SRSF11;THOC3;SRSF9;DHX9;RBM17;POLDIP3;PRMT9;RBM14;GTF2H4;ALYREF;U2AF2;ESS2;METTL3;TFIP11;SART3;ALKBH5;POLR2L;IK;UBL5
prerank,negative regulation of phosphorylation (GO:0042326),0.4317808823827953,1.384369973048036,0.05955678670360111,0.4139591722603243,1.0,24/85,16.74%,PID1;LRP6;MYADM;NUPR1;LYN;CBFA2T3;XDH;NIBAN1;PRKN;IRS2;ROCK1;NCOR1;CORO1C;ZC3H12A;CDKN2C;TERF2IP;IBTK;PPIA;HDAC4;NPRL2;PTPN13;PPP1R15B;PTEN;PRDX3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4442615821120198,-1.3834969650735947,0.09399477806788512,0.6923968038831299,1.0,11/32,16.44%,NAV3;MAP2;CLASP2;TBCD;CAMSAP1;FGF13;ARHGEF2;MAPRE1;EML2;CLIP3;APC2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5615200850774084,1.3834596907380825,0.10638297872340426,0.41512791762420936,1.0,6/18,7.06%,DDX60;ANKRD17;BIRC3;PUM2;NOP53;USP15
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5851353764772464,1.3832780293578038,0.12110091743119267,0.4147933772927141,1.0,5/15,11.84%,TCF7L2;GAS6;GSK3B;BAG3;YWHAE
prerank,aortic valve development (GO:0003176),0.5025853554236559,1.3831343851424154,0.11182108626198083,0.4144348327450629,1.0,10/34,12.88%,JAG1;TNFRSF1B;BMP2;HEY2;RB1;ROCK1;SLIT3;EMILIN1;ROCK2;TNFRSF1A
prerank,regulation of establishment of protein localization (GO:0070201),-0.5268203714041599,-1.3830766722741694,0.11409395973154363,0.6896205242460618,1.0,3/14,2.04%,CTSD;CEP135;TREM2
prerank,carboxylic acid catabolic process (GO:0046395),0.6046463039523204,1.382920170713606,0.13221601489757914,0.41421187192069886,1.0,2/12,2.52%,NPL;GNPDA1
prerank,T cell differentiation in thymus (GO:0033077),0.595793908969447,1.3828941541958593,0.1294820717131474,0.41356571798184344,1.0,3/14,3.70%,ZFP36L2;LIG4;ZFP36L1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4520026099307028,1.38285103771839,0.08100147275405008,0.41296636611162474,1.0,9/56,7.63%,DAB2;BMP2;GDF3;SMAD4;GDF10;SNX25;ACVR2A;SDCBP;HFE
prerank,protein deacylation (GO:0035601),-0.47876008992997043,-1.382652487360012,0.08737864077669903,0.687077573913277,1.0,13/23,21.31%,ABHD17C;LYPLA2;SIRT7;PPT1;HDAC7;SIRT2;ABHD17A;HDAC5;ABHD10;SIRT5;HDAC3;HDAC1;HDAC6
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3966128905055842,1.3825890999521027,0.04094292803970223,0.41284323920822014,1.0,34/150,12.59%,PID1;LRP6;GNAQ;SPRED1;DEPTOR;MYADM;PRKAG2;LYN;DNAJC3;RASSF2;XDH;NIBAN1;ITGB1BP1;PRKN;RB1;RACK1;PAK2;PDE4D;SFN;CEP85;SNX25;HSPB1;TRIM27;SMCR8;CNKSR3;CORO1C;SFRP1;CALM1;SPRED2;EMILIN1;PMEPA1;TRIB2;ZC3H12A;TERF2IP
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5962716253736217,1.382171566514735,0.11690647482014388,0.4130480130364323,1.0,4/14,3.37%,SPRED1;OSR1;XDH;GDF3
prerank,regulation of signal transduction (GO:0009966),0.38528638094355505,1.3820897647937647,0.03975903614457831,0.4125413522343656,1.0,37/190,11.28%,RASGRP4;LIFR;IGFBP4;APP;MDFIC;ALOX15;CDC42SE2;ESR1;GRK5;BST1;FBXL17;CD36;DHRS3;AXIN1;CD46;CRK;ITGB1BP1;INTU;SNX3;CBFB;RGS8;CD80;SYNJ2BP;FYN;HOMER1;MAPK8IP2;ZDHHC3;PPP2CA;ZFAND2B;NUP62;SP100;PXN;ELF1;WDR11;AMFR;SREBF2;CREBBP
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4270627369286811,1.3820753205608973,0.04979253112033195,0.4118873610187867,1.0,18/88,9.58%,NRP1;APOE;ALOX5;ANG;NRAS;BMP2;XDH;THBS4;CNMD;TNMD;RGCC;NRARP;GHRL;NR4A1;SYNJ2BP;CCL24;TNFSF12;MYDGF
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4737220286685442,1.3817323200580458,0.09692307692307692,0.4118943481065498,1.0,12/47,15.31%,PID1;XDH;RIPK1;CD36;TLR4;SYK;MAPK14;ROMO1;ZC3H12A;ITGB2;CYBA;RNF41
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4879011352069634,1.3815186913317676,0.09131736526946108,0.41168560697182405,1.0,9/42,5.43%,NRP1;PTPRJ;RIN2;CD36;UTRN;S100A10;CDK6;GSK3B;ROCK1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6501704302956763,1.3812530876430862,0.15384615384615385,0.41166289625534813,1.0,6/10,23.64%,IRAK3;KLF4;SH2B3;MAPK7;PTPRC;TLE5
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4858524832618393,1.3812233306274195,0.09794628751974724,0.41104990689451376,1.0,4/40,6.34%,PID1;RTL10;TUSC2;BCL2
prerank,macrophage chemotaxis (GO:0048246),0.6396995317335993,1.3812157244371819,0.12355212355212356,0.4103843940731356,1.0,1/10,0.44%,EDNRB
prerank,regulation of phagocytosis (GO:0050764),0.4491820660254759,1.3801878165757084,0.07142857142857142,0.4118885407319505,1.0,11/53,6.94%,FCGR2B;IL15;DOCK2;GAS6;FCER1G;CAMK1D;TLR2;RACK1;SNX3;SYK;TNF
prerank,regulation of plasminogen activation (GO:0010755),-0.5595422632482498,-1.379731098134051,0.11521739130434783,0.6943348572961208,1.0,3/12,7.71%,PLGRKT;SERPINE2;ENO1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5547621623224839,1.3794404346452873,0.11363636363636363,0.4128564203024139,1.0,7/19,16.73%,NR1H4;TLR4;LBP;LY96;ITGB2;SCIMP;TIRAP
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4841770706291598,1.3787759385536302,0.09335443037974683,0.41357428124880136,1.0,9/38,7.06%,TLR8;SASH1;DDX60;GRN;ANKRD17;PUM2;LY96;RIOK3;USP15
prerank,ATP transport (GO:0015867),0.6373176195948643,1.3783241690236971,0.14015151515151514,0.4138790510914168,1.0,5/10,22.82%,SLC25A17;SLC25A24;SLC25A5;SLC25A4;CD47
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3527587026892592,1.3782400536831956,0.0010131712259371835,0.4133679113888962,1.0,183/834,16.92%,RBPJ;DAB2;PID1;ZEB2;PF4;ETV1;EGFR;LRP6;APP;KLF2;CHP2;TCF7L2;TCF4;IRF4;PPP3CA;MEF2A;AHR;RREB1;TFEC;KMT2A;ESR1;NCOA3;JAG1;RARG;TCF12;MEF2C;NR1H4;ACTR3;RPS27A;NCOA2;CEBPB;MITF;OSR1;BMP2;RIPK1;KLF6;LILRB1;HOXD8;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;TLR4;NR1D1;CDK12;RPS6KA3;RGCC;ITGB1BP1;PRKN;LARP7;TLR2;NR3C1;HEY2;CLOCK;GRHL2;SPI1;NCOA7;NFIC;SMAD4;THRB;NR4A1;RNASEL;FOSL2;CD40;EPC1;ACVR2A;FOXM1;TNF;KLF4;YY1;REL;HTATIP2;MED16;SATB2;TBL1XR1;CEBPG;E2F5;FIZ1;NR4A2;NRIP1;IRF2;KLF10;CDC73;ATF6;ATRX;TET3;NCOA6;FOXC2;ESRRB;KMT2C;HIVEP1;TBL1X;FOXJ3;MED6;ASXL1;MLXIP;MYDGF;STAT6;NR2F1;USP16;IGF1;RIPK2;ARRB1;RNF111;ZNF296;CREBRF;MAML1;SP1;TFDP1;ELF1;JUP;PHIP;MLLT10;SREBF2;CREBBP;EAF2;BCL11B;MYBL2;FOXK2;CDK13;HINFP;NFIA;CRTC3;FOXO3;DCAF6;ZC3H12A;NAMPT;BCAS3;NOD2;PLXND1;SP3;NFIX;FOXO1;TNFRSF1A;CREB1;PEG3;CTBP2;WWOX;TFR2;NR1H2;RARA;KAT7;TET2;STAT3;EP300;KLF5;WASL;JUND;CRLF3;KAT6A;USF1;PRKD2;PKD2;WWC1;RTRAF;SNW1;BMPR1A;MYC;MTF1;SMARCD1;HDAC4;NR2C2;SFPQ;SENP1;ELK1;E2F8;KDM1A;HOXB3;MAPK7;HCFC1;PPARGC1B;ACTR2;PER1;NFATC3;ARNT;BRD4;GLIS2;MED17;NR5A2;EAPP;RELA
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5609113233113817,1.377094204426541,0.1366906474820144,0.4151354376479525,1.0,3/18,2.01%,ITGA4;FGFR1;MEF2C
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.5629053875283863,1.3764642611090587,0.1320754716981132,0.4157649148827875,1.0,3/18,8.63%,DAB2;SNX3;MSN
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6165677537317026,1.375838940455754,0.12121212121212122,0.41645138942932847,1.0,2/12,1.61%,PF4;CLTC
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.4667479251552541,-1.3755295108753711,0.09046454767726161,0.7065943112467447,1.0,8/24,11.23%,PEX5L;PDE3B;PRKAR1A;UBE2B;GNAI1;PRKAR1B;CGAS;PDE3A
prerank,cellular zinc ion homeostasis (GO:0006882),-0.46546911547302267,-1.3750298982462068,0.0831353919239905,0.7041261556703667,1.0,14/26,25.96%,SLC30A9;ATP13A2;SLC39A13;SLC39A14;MT2A;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;SLC39A6
prerank,positive regulation of gene expression (GO:0010628),0.3609132192150847,1.3745617596065105,0.014099783080260303,0.41857459948305364,1.0,79/442,14.00%,RBPJ;PID1;PF4;EGFR;P2RX7;APP;CLEC6A;IL15;GAS6;ADAM19;RPL23;C1QTNF1;C1QTNF3;RPS3;MEF2C;PTPN22;KRAS;EIF3E;MITF;OSR1;BMP2;RIPK1;LILRB1;CD36;CD74;FGF23;DRD1;LAMP3;ERN1;TLR4;CD46;SAMD4A;NIBAN1;RPL26;RGCC;PRKN;VIM;PDE2A;TLR2;HEY2;GSK3B;ROCK1;ACTB;RPS4X;TNF;KLF4;RPL5;HFE;WNT6;PSEN1;POLR1A;LARP4B;VSTM2A;MSN;RPS7;MAPK14;POLR1B;DYRK1A;IGF1;MYO1C;MED26;SP1;PTGER4;EMILIN1;HINFP;ROCK2;LAMTOR5;DEK;ZC3H12A;SLC38A2;POLR1G;RAMP2;GJA1;LARP4;TFR2;PIWIL2;TNRC6C;STAT3;EP300
prerank,synaptic vesicle localization (GO:0097479),-0.5590070662479018,-1.3739080273528346,0.10344827586206896,0.703867303870776,1.0,6/13,9.33%,NLGN1;RAB27A;KIF5A;SPG11;KIF5C;SYNDIG1
prerank,lipoprotein biosynthetic process (GO:0042158),0.6224827751815546,1.3735319079384156,0.14102564102564102,0.4201543647998366,1.0,7/11,20.04%,APOE;WIPI1;ATG7;ATG10;WIPI2;UGCG;PIK3C3
prerank,regulation of macrophage activation (GO:0043030),0.5047998126802891,1.373519558692528,0.08970099667774087,0.4194928825505546,1.0,5/30,4.14%,FCGR2B;MFHAS1;CD74;TLR4;LBP
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4227148673121448,1.373228007463774,0.07407407407407407,0.4193977068191141,1.0,6/78,2.56%,DAB2;PID1;EGFR;CLTC;ITGB1;SPTBN1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5886858176996966,-1.3728600023571411,0.10947368421052632,0.7038363895363356,1.0,2/10,0.88%,CX3CR1;CTNNB1
prerank,telomere organization (GO:0032200),-0.3988748451559017,-1.3721002312532171,0.056818181818181816,0.7023621669646207,1.0,14/43,13.41%,DNA2;XRCC5;CTC1;ATM;PARP1;STN1;PTGES3;DOT1L;BLM;LTO1;HUS1;TERF2;PARP3;XRCC6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6153559400637159,1.3720568889524507,0.12885662431941924,0.4212045002774192,1.0,4/12,6.34%,CD44;CD74;RPL26;BCL2
prerank,T cell differentiation (GO:0030217),0.4740620433023894,1.371659392956374,0.09359605911330049,0.42129949091522634,1.0,9/40,9.39%,ZFP36L2;LIG4;PTPN22;FCER1G;ZFP36L1;SPI1;TCF7;ZAP70;NHEJ1
prerank,endoderm development (GO:0007492),0.5951046571013779,1.3714105036872124,0.1285444234404537,0.4211692508163548,1.0,3/13,7.52%,DUSP1;KIF16B;DUSP2
prerank,embryonic hemopoiesis (GO:0035162),0.6119047974327071,1.3709760743869148,0.13721804511278196,0.42146113099241483,1.0,4/12,9.36%,KMT2A;KITLG;TPO;SH2B3
prerank,response to histamine (GO:0034776),0.6517900407560707,1.3709499631259718,0.14444444444444443,0.4208312920892031,1.0,3/10,4.28%,HRH1;DIAPH1;AOC1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4655411842161655,1.3697535378058525,0.09878419452887538,0.42269996728698445,1.0,12/46,8.63%,RAP1B;SERPINB2;CDC42;PITPNA;LCP1;PAK2;ANXA2;HNRNPF;CNN2;RPLP0;STAT4;MSN
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.484212271471892,1.3688242236200283,0.09574468085106383,0.4240133378584316,1.0,5/38,6.27%,BANK1;PTPRJ;XDH;RACK1;NOP53
prerank,T-helper cell differentiation (GO:0042093),0.6016144567035071,1.3687787454332412,0.12867647058823528,0.4234216200867175,1.0,6/14,17.97%,FOXP1;ATP7A;PTGER4;GPR183;IL6;BATF
prerank,vasculogenesis (GO:0001570),0.48726964060900546,1.3687691746763582,0.09433962264150944,0.4227637592713887,1.0,5/32,4.49%,SPRED1;RASA1;ADM;CCM2;HEY2
prerank,stem cell differentiation (GO:0048863),0.4755674996703418,1.3683860097978766,0.1043613707165109,0.4229009123181452,1.0,5/39,4.03%,LRP6;MEF2C;OSR1;FBXL17;JARID2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6133011925870566,1.3678068053177712,0.15263157894736842,0.42346991232609155,1.0,8/12,20.32%,APOE;ROCK1;TMED10;RANBP9;ROCK2;FLOT2;PICALM;FKBP1A
prerank,endothelial cell migration (GO:0043542),0.48730408057879915,1.3673239115027647,0.10542635658914729,0.4237900008681638,1.0,9/37,12.75%,PLEKHG5;NRP1;RHOA;NR4A1;TNFSF12;STARD13;PXN;LOXL2;PLXND1
prerank,positive regulation of ruffle assembly (GO:1900029),0.5907383123964824,1.36705299773631,0.13133208255159476,0.4236781622132559,1.0,1/13,0.09%,EPS8
prerank,regulation of protein dephosphorylation (GO:0035304),-0.4141068973992315,-1.3666519737814307,0.10382513661202186,0.7200738148605323,1.0,18/37,22.46%,PRKCD;CALM2;PPP1R16B;NSMF;YWHAB;CAMTA1;PPP1R7;TSC1;ANKLE2;PPP6R1;PPP1R16A;PPP2R5A;CDCA2;PTPA;SPPL3;CALM3;TGFB1;PIN1
prerank,regulation of cellular component movement (GO:0051270),0.46616883431757133,1.366638567563197,0.10256410256410256,0.42389905490132473,1.0,11/49,6.20%,EGFR;ZSWIM6;DIAPH1;LYN;ARAP1;ARHGAP18;RHOA;CDK6;PKN2;ROCK1;MYCBP2
prerank,cellular response to alkaloid (GO:0071312),-0.5031465734574422,-1.3664415946816846,0.10208816705336426,0.716560062278129,1.0,5/17,10.59%,SLC8A1;TGM2;CASP7;BLM;CASP6
prerank,regulation of JUN kinase activity (GO:0043506),0.4962358904218477,1.3659197481814542,0.10662358642972536,0.42478801571324704,1.0,6/33,6.94%,MAP3K5;SASH1;RPS3;PTPN22;TNFRSF11A;TNF
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3028819670522287,-1.3657194953089626,0.014814814814814815,0.7149502429009225,1.0,47/224,12.63%,CACNB2;PLP1;SLC1A3;KCND2;MBP;DLG2;GRM7;CACNB4;UNC13C;GRIA2;GRIK2;GABRB3;NLGN1;SNAP25;NRXN1;DLG4;DLGAP1;GRM3;HTR2C;PRKAR1A;PTCHD1;GRIA4;KCNQ3;PRKAR1B;KIF5A;HCRTR2;GABRB1;SPG11;RPS6KA1;APBA1;DTNA;GLRB;HRH2;CACNA1E;CHRM3;CAMK4;KCNA1;HTR7;CPLX1;MINK1;GRIN2A;SLC1A1;GABRA2;RPS6KA2;SLC12A6;NPTX1;GLRA1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4058876678898083,1.3656906701877425,0.062087186261558784,0.42456076653028635,1.0,23/108,11.02%,APP;GNAQ;MDFIC;ESR1;BMP2;AXIN1;PRKN;TLR2;RACK1;SNX3;NOTUM;DISC1;CBFB;DEPDC1B;PSEN1;CDC73;CDK14;SULF2;PPP2CA;NKD1;SFRP1;WLS;PPP1CA
prerank,positive regulation of biosynthetic process (GO:0009891),0.47879259599816226,1.3652755930397797,0.10983606557377049,0.42480945992810165,1.0,13/40,18.04%,APOE;ZBTB20;CD36;TLR4;RGCC;VIM;MTPN;CREB1;CYBA;CREB3L1;CCL5;SLC5A3;F2R
prerank,nitric oxide mediated signal transduction (GO:0007263),0.5784092583993615,1.3645259836855108,0.1267361111111111,0.425766585102896,1.0,2/16,2.76%,APOE;CD36
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4191898874750922,1.3635960679849464,0.0647887323943662,0.42703710035874254,1.0,16/85,10.12%,DAB2;FBXW7;NUPR1;CBFA2T3;ARIH1;PIAS1;PRICKLE1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;MDM2;RNF19B;COP1;RNF14
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4443918007910702,1.3629565113649975,0.08175182481751825,0.42769693315200447,1.0,13/54,12.32%,APOE;FGFR1;MEF2C;RGCC;PRCP;CD40;HSPB1;TNF;MAPK14;NUS1;SP1;JUP;ATP2B4
prerank,chloride transport (GO:0006821),-0.34881636470090727,-1.362954256586543,0.03690036900369004,0.7217186390569597,1.0,30/74,25.14%,SLC1A3;SLC12A2;GABRB3;ANO4;SLC4A10;SLC12A9;TTYH1;PACC1;GABRB1;ANO3;GLRB;SLC1A1;GABRA2;CLCN2;SLC12A6;GLRA1;GABRG2;CLCN4;SLC6A1;GLRA3;CFTR;FXYD1;ANO8;SLC12A4;GLRA2;ANO5;SLC12A5;GABRA4;GABRR2;SLC12A1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.39307427928657107,1.3627427689936014,0.04197530864197531,0.4274986252299099,1.0,17/152,5.83%,PF4;ADGRE5;GNAQ;ADGRG6;ADGRE1;GRK5;WASF2;GNAI3;CALCRL;ADRB2;GPR65;DRD1;ADM;PDE2A;S1PR2;ADCY9;ADCYAP1R1
prerank,axon extension (GO:0048675),0.5253622847119542,1.3621228563518366,0.14166666666666666,0.4281256924079889,1.0,8/23,16.01%,NRP1;USP9X;ALCAM;ULK2;SLIT3;SLIT1;SLC9A6;HSP90AB1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5837243883496559,1.3612453035377612,0.13123844731977818,0.429333063945234,1.0,2/13,5.19%,DAB2;SMAD4
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.5398797719632636,-1.3602082229887307,0.11611374407582939,0.7280998862439786,1.0,10/13,32.49%,YWHAB;MDFI;GET4;DBN1;GOPC;FLNA;SUFU;LATS1;PKD1;NFKBIE
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.5602887382104067,1.3598111646490636,0.13458262350936967,0.4316894212278657,1.0,7/18,12.68%,RAP1B;KIF20B;RIPOR2;RACK1;ROCK1;ROCK2;BCAS3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.42529184653195357,-1.3597088311333911,0.09944751381215469,0.7258671153011736,1.0,14/35,27.93%,CTNNB1;XRCC5;HNRNPA2B1;ATM;MAPK3;MAP2K7;MAP3K4;CCT7;HNRNPA1;CCT2;ACD;CCT8;FBXO4;AURKB
prerank,lymphocyte chemotaxis (GO:0048247),0.49407661470417963,1.3595390453213732,0.10423452768729642,0.43158400039620354,1.0,12/34,17.31%,GAS6;CCL8;MSMP;CCL19;HSD3B7;CXCL16;CCL24;CKLF;CYP7B1;GPR183;CCL5;CCL25
prerank,manganese ion transport (GO:0006828),-0.5410432670600868,-1.3588161823141554,0.1393258426966292,0.7249665005500634,1.0,7/14,15.85%,TRPC4;TRPC1;TRPC3;SLC11A2;TRPC5;ATP2C1;SLC39A14
prerank,presynapse assembly (GO:0099054),-0.5125718716864811,-1.3584552949498212,0.11670480549199085,0.7223419552679805,1.0,5/16,12.44%,PTPRD;NLGN1;PCLO;DVL1;IL1RAPL1
prerank,bile acid and bile salt transport (GO:0015721),0.5292890423893487,1.3584538062426994,0.12312811980033278,0.43324901977089186,1.0,5/24,8.56%,SLC10A6;NR1H4;NCOA2;ABCC4;SLC10A3
prerank,negative regulation of establishment of protein localization (GO:1904950),0.6317974823898508,1.358317884795453,0.11434108527131782,0.4328521867668499,1.0,4/10,14.27%,NDFIP1;SNX3;NDFIP2;TERF1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4316066129694312,1.3580732282557562,0.1069364161849711,0.4326942863892366,1.0,15/63,11.15%,FGFR1;DEPTOR;TCF7L2;SH3RF1;RIPK1;SIAH2;BCL10;PAK2;TNF;BIRC6;TNFSF12;IGF1;SP100;CASP8;PHIP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4164461521632424,1.358016936982456,0.07443820224719101,0.43213635871600553,1.0,24/95,13.39%,PF4;FCGR2B;MEF2C;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;TLR2;NFKBIL1;LY96;CD80;CDC73;MAPK14;CARD16;CD68;CHMP5;ZC3H12A;NOD2;NFKBIB
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5962380516111816,1.357355815280815,0.16633663366336635,0.4328193369630302,1.0,9/12,19.49%,B4GALT6;MYCBP2;B4GALT5;HSP90AB1;EPHB6;PTEN;CHRNB2;ARHGAP35;SPTBN4
prerank,pinocytosis (GO:0006907),0.6278601177895046,1.357343244787571,0.16506717850287908,0.43218734674494347,1.0,4/10,12.26%,DOCK2;MAPKAPK2;SNX33;SNX5
prerank,regulation of viral entry into host cell (GO:0046596),0.49157029309804845,1.356787668580001,0.12080536912751678,0.43266635531374315,1.0,9/30,15.82%,IFITM3;CD74;SNX3;TRIM68;TRIM27;IFITM2;LY6E;MID2;TRIM25
prerank,glucose homeostasis (GO:0042593),0.41835632997162625,1.3567602982721914,0.075,0.43205291611338953,1.0,19/83,14.48%,ALOX5;TCF7L2;FOXA3;NR1D1;LRRC8D;SLC2A4;MCU;INSR;ADIPOR2;RPS6;FOXK2;WFS1;SLC8B1;KCNB1;FOXK1;FOXO1;STAT3;RBP4;USF1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.4307755755080093,-1.3564418768115578,0.10026385224274406,0.7262685622919044,1.0,13/32,27.93%,CTNNB1;XRCC5;ATM;MAPK3;MAP2K7;MAP3K4;CCT7;HNRNPA1;CCT2;ACD;CCT8;FBXO4;AURKB
prerank,exit from mitosis (GO:0010458),0.5973390109549727,1.3559099612065717,0.15584415584415584,0.4332094411837286,1.0,1/12,0.09%,EPS8
prerank,regulation of lamellipodium organization (GO:1902743),0.5912392804130971,1.3548766037088749,0.1564748201438849,0.4348409353043608,1.0,3/14,3.32%,FER;CD44;CDC42
prerank,regulation of neuron projection arborization (GO:0150011),-0.5057255540587733,-1.3547376171296346,0.1159090909090909,0.7287741386943203,1.0,9/15,23.84%,DLG4;DVL1;MACF1;NTNG1;DVL2;GRIP1;MOV10;WNT5A;FZD4
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.5214323759454069,1.3542116957939938,0.13893653516295026,0.43558855238584154,1.0,7/23,16.20%,SH3BP5;SNX6;CBL;DUSP22;CBLB;SH3BP5L;ZGPAT
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3817863104807463,-1.3541889715425377,0.05555555555555555,0.7267343430812666,1.0,20/54,21.69%,IVNS1ABP;SENP2;CTNNB1;CAPN3;SMAD7;HDAC8;SIRT7;ARRB2;UBXN1;ADGRB1;N4BP1;MINAR1;PARK7;SQSTM1;GNL3L;TRIM21;PRR7;BAG5;U2AF2;COPS9
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6015374183737505,1.3539963019338759,0.15613382899628253,0.4354009717776944,1.0,2/11,6.06%,PF4;TMEM106A
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5365194810543901,1.35389464337604,0.13859649122807016,0.43494735284175084,1.0,7/22,8.54%,LYN;MFHAS1;PTPN22;NR1D1;LBP;RAB7B;NINJ1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4109485665259861,-1.3528685079432723,0.10112359550561797,0.7280770518543063,1.0,13/35,15.09%,DDX5;DDX17;SRC;SAFB;KDM3A;TRIP4;PGR;WBP2;AR;EGLN2;CALCOCO1;PADI2;NCOA4
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5229490090377691,1.3527199043341975,0.1248,0.4366539594287389,1.0,5/24,5.43%,NRP1;PTPRJ;MAPRE2;S100A10;ROCK1
prerank,zymogen activation (GO:0031638),-0.4035725382377611,-1.351976132561645,0.07219251336898395,0.7273610841791407,1.0,8/39,7.37%,ASPH;KLK2;LGMN;VSIR;TBC1D10A;PLAU;CYFIP2;PGK1
prerank,response to amino acid (GO:0043200),-0.43352709069209483,-1.3519245717535866,0.10054347826086957,0.723442344458506,1.0,14/31,27.36%,RPTOR;IPO5;NSMF;RRAGD;GLRB;GLRA1;GLRA3;RRAGB;MTOR;SESN2;GLRA2;CPEB1;RRAGA;SH3BP4
prerank,positive regulation of lyase activity (GO:0051349),-0.5190991042470094,-1.3515964702605603,0.11963882618510158,0.720675146181383,1.0,6/14,16.22%,CACNA1D;NF1;ISCU;FXN;CACNA1C;PARK7
prerank,cellular response to calcium ion (GO:0071277),0.43568118964788943,1.350835808627979,0.09130434782608696,0.4400312347047198,1.0,11/67,6.45%,CHP2;IQGAP1;MEF2A;ALOX15;MEF2C;ALOX5AP;CPNE2;CLIC4;CPNE7;SLC25A24;CPNE8
prerank,regulation of mitochondrion organization (GO:0010821),0.45418874488222616,1.3507534323789014,0.1104199066874028,0.43955001365136137,1.0,6/47,5.82%,PID1;FBXW7;PRKN;PDE2A;GSK3B;PARL
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.5100145362722341,1.3506390365395815,0.1291390728476821,0.4391332641491125,1.0,9/27,13.46%,RNASE4;ERN1;NYNRIN;CPSF3;RNASE6;LACTB2;ZC3H12A;ZC3H12D;RPP30
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.39955647702303154,1.350630926123359,0.06910039113428944,0.4384854419818361,1.0,13/108,7.05%,HIP1;NLRC4;MAP3K5;IFT57;RPS3;DAPK1;XDH;RIPK1;BCL10;RACK1;SYK;TNF;UACA
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4179540567823667,1.3505870774241435,0.08309859154929577,0.4379072319001177,1.0,14/78,10.12%,DAB2;CBFA2T3;ARIH1;PIAS1;PRICKLE1;PRKN;GSK3B;RACK1;ANKIB1;NOP53;MDM2;RNF19B;COP1;RNF14
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4450624404920385,1.3499890080538723,0.09419152276295134,0.4385452154777709,1.0,10/47,15.04%,EDNRB;APOE;APP;KLF4;MTPN;NANOS3;FOXO3;RPL10;NR1H2;WDR91
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5761429533900639,1.3498317580363912,0.1440972222222222,0.4382176027839338,1.0,2/14,6.96%,PAEP;CD80
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5316861569173957,1.3493485983025109,0.13298791018998274,0.43861425286802774,1.0,2/21,5.19%,DAB2;SMAD4
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5300581718969868,-1.3490309593431147,0.12727272727272726,0.7264468380158428,1.0,3/13,9.36%,LARGE1;CHST1;CHST2
prerank,Golgi to endosome transport (GO:0006895),0.5431609718856583,1.3490125994473898,0.14285714285714285,0.4386942543079516,1.0,8/16,15.02%,EPS15;KIF16B;WIPI1;RAB14;VPS13C;VPS13A;CORO7;MON2
prerank,neuron apoptotic process (GO:0051402),0.5395876310431343,1.3487674664532836,0.14492753623188406,0.43856295760765956,1.0,5/19,12.69%,APP;LIG4;BCL2;DIABLO;FAM162A
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6256848927955236,1.3485625090349094,0.1362763915547025,0.43829155686475696,1.0,2/10,1.93%,PTPRJ;PTPN12
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4326883840881136,1.348300081049949,0.07960893854748603,0.43813733916908837,1.0,9/66,6.94%,EGFR;FGFR1;MAP3K5;SASH1;RPS3;TNFRSF11A;CD40;PIK3R6;TNF
prerank,organophosphate ester transport (GO:0015748),0.5237747159985877,1.3482192652037057,0.12169312169312169,0.4376779560976773,1.0,7/24,15.58%,PLTP;LDLR;PITPNA;EPG5;NPC2;OSBPL8;OSBPL5
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.47348620835094074,-1.3481862684955648,0.11617312072892938,0.7257065039190718,1.0,5/21,8.77%,NAV3;CLASP2;CAMSAP1;FGF13;ARHGEF2
prerank,regulation of cell morphogenesis (GO:0022604),-0.4288779804847255,-1.3477156739549203,0.07957559681697612,0.7234828960056119,1.0,13/30,18.77%,EFNA5;FMNL2;SPARC;CAMSAP1;FERMT2;MACF1;ZMYM6;NTNG1;BCL9L;ZMYM3;STRIP1;PDPN;MOV10
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5506623733175154,1.3474558784337307,0.12950819672131147,0.438701285386757,1.0,4/19,5.43%,NRP1;PTPRJ;S100A10;ROCK1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4058674487774233,1.3474191496883088,0.07908847184986595,0.4381376821276054,1.0,19/100,10.12%,DAB2;CBFA2T3;ARIH1;PIAS1;RYBP;PRICKLE1;WAC;PRKN;GSK3B;RACK1;ANKIB1;NOP53;SDCBP;HFE;MDM2;RNF19B;COP1;UBQLN4;RNF14
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3881948786120735,1.3472297023544277,0.0670886075949367,0.437857828766108,1.0,26/138,11.24%,MTSS1;NEDD9;RASGRP4;EGFR;LIFR;FGFR1;LYN;FER;ABI1;CASS4;FRS2;FRK;TRIO;INSR;PDGFRA;GUCY2D;EFS;ACVR2A;SYK;ZAP70;FYN;DDR2;EPHB4;STYK1;SLA;SHC1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.49549024231621475,-1.3471359354978274,0.12249443207126949,0.7217618793669998,1.0,6/16,21.06%,CALM2;SLC8A1;ANK2;CACNA1C;CAMK2D;CALM3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5590249254300277,1.3470507933836604,0.13837638376383765,0.43758987999554105,1.0,4/17,7.58%,CCR1;ANO6;PLA2G7;CCR2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5800429935431975,1.3467803732807917,0.14922480620155038,0.43755972839625246,1.0,7/14,15.67%,PPP3CA;DUSP1;PPP2CA;PPP2CB;PPP1CA;PPP2R2A;PPP1R15B
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4358279367266892,-1.3466447407688602,0.09399477806788512,0.7196229483536571,1.0,7/28,13.12%,NAV3;PAK1;MAPT;TOGARAM1;NUMA1;CKAP5;MAPRE1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.5790053047400544,-1.3461297894548105,0.12916666666666668,0.7177340937100904,1.0,4/10,9.17%,THOC1;DDX39B;ETAA1;CCAR2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5820342683564174,1.3459901900746103,0.1532567049808429,0.43858515162744516,1.0,4/11,11.05%,COLEC12;RIPK1;RFTN1;CASP8
prerank,microtubule polymerization (GO:0046785),-0.43260080301564324,-1.3459531944352676,0.09651474530831099,0.7145792532601132,1.0,15/29,26.85%,CLASP2;FGF13;MAPT;CCDC57;TUBGCP5;TPPP;CKAP5;TUBGCP3;CENPJ;GOLGA2;TUBGCP6;PIN1;HDGFL3;MAP7D3;TPPP3
prerank,pulmonary valve development (GO:0003177),0.5533432762820131,1.3457328288130121,0.13427561837455831,0.43850636155110767,1.0,4/18,4.49%,NOTCH2;JAG1;TNFRSF1B;HEY2
prerank,regulation of cytokine production (GO:0001817),0.3923464648035405,1.345356974132544,0.07450980392156863,0.4386008405300494,1.0,17/126,7.58%,HDAC9;FCGR2B;ALOX5;ATP2B1;FOXP1;CLEC6A;IL15;LYN;C1QTNF3;TNFRSF1B;SRGN;RGCC;TRIM56;MAPKAPK2;TRIM32;TNF;CCR2
prerank,regulation of myoblast fusion (GO:1901739),0.6035715672708141,1.3450772951509968,0.17272727272727273,0.438552103186442,1.0,4/11,9.18%,RIPOR2;EHD1;CD53;MAPK14
prerank,regulation of fibroblast proliferation (GO:0048145),0.4601190978292254,1.3449724413011637,0.11746031746031746,0.43813492220804207,1.0,13/45,10.93%,GAS6;LIG4;CD74;WNT2;CDK6;PDGFRA;TRIM32;CDC73;DDR2;PDGFC;IGF1;SFRP1;FTH1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6225543934768059,1.3447562577917067,0.1436265709156194,0.43731985840674625,1.0,6/10,13.96%,AP2A2;CLTC;AP2S1;VLDLR;AP2B1;CLTA
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6225543934768059,1.3447562577917067,0.1436265709156194,0.43731985840674625,1.0,6/10,13.96%,AP2A2;CLTC;AP2S1;VLDLR;AP2B1;CLTA
prerank,negative regulation of MAPK cascade (GO:0043409),0.41797237819754474,1.344322983181432,0.08641975308641975,0.43764180960381466,1.0,26/87,16.22%,APOE;P2RX7;SPRED1;PTPRJ;LYN;IRAK3;TLR4;ITGB1BP1;DUSP1;SMAD4;FOXM1;SYNJ2BP;RANBP9;CNKSR3;SH2B3;RPS6KA6;IGBP1;SPRED2;EMILIN1;STK38;FOXO1;PPIA;MYC;RGS14;DUSP7;PTEN
prerank,phagosome acidification (GO:0090383),-0.4437828313647748,-1.3439675290126105,0.09898477157360407,0.7184621096472446,1.0,10/26,12.34%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C
prerank,regulation of intracellular signal transduction (GO:1902531),0.3559339699452305,1.3439476441557388,0.017167381974248927,0.43777258659851503,1.0,54/420,7.94%,ARHGEF3;ITSN1;ARHGAP15;STARD8;VAV3;PLEKHG5;FGD4;EGFR;MOB3B;SPRED1;CLEC6A;CMKLR1;SGMS1;ARHGAP9;PRKAG2;OPHN1;RBBP8;LYN;BST1;ARAP1;PTPN22;RASSF2;RCN3;ARHGAP21;ARHGAP10;PRKAG3;ARHGAP18;CDC42;CRK;ARHGAP31;RHOA;PDE2A;PHF20;TRIO;BIRC3;PAK2;OCRL;STK3;ARHGAP29;VRK2;NOP53;CHEK1;NGEF;DEPDC1B;HSPB1;TNF;NRK;TOPBP1;ARHGAP12;ARHGAP23;RPL5;ARHGEF12;RPA1;ARHGDIA
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3904262738172404,1.3428426252403207,0.07692307692307693,0.43945067885368505,1.0,19/140,8.64%,P2RX7;CCR1;CMKLR1;C5AR1;ESR1;C3AR1;C1QTNF1;CYSLTR1;GPR65;CD36;DRD1;GHRL;PDGFRA;P2RY10;CCRL2;CXCR4;CCR2;ADRA1D;ADRA1A
prerank,negative regulation of lyase activity (GO:0051350),0.5659268837136445,1.3426011359249663,0.14338235294117646,0.4392923678990627,1.0,3/16,7.58%,EDNRB;GNAI3;CCR2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4534910877690188,-1.3421643139459487,0.10396039603960396,0.7216148788740459,1.0,9/25,17.15%,ATP1B1;ATP1B2;ANK2;CTSS;ACTN2;WNK3;GLRX;STAC;CFTR
prerank,receptor metabolic process (GO:0043112),0.45211643879319946,1.342089989322648,0.10229007633587786,0.4396996332183172,1.0,12/53,6.57%,RAB31;CLTC;ITGB1;CALCRL;FCER1G;LILRB1;CD36;UVRAG;ADM;KIF16B;SNX25;SYK
prerank,regulation of GTPase activity (GO:0043087),0.3772026666554597,1.3414933442482468,0.06211936662606577,0.440383216115846,1.0,30/177,7.32%,ARHGAP15;VAV3;FGD4;FGD6;SNX9;ARHGAP9;ARAP1;ITGB1;MAPRE2;EVI5;USP6NL;CCL8;CCL19;CRK;PLXNC1;RAPGEF2;S100A10;ITGB1BP1;RIC1;GSK3B;RAP1A;RACK1;DOCK11;OCRL;RGS8;WNK1;CD40;PLXNA4;NGEF;ARHGAP12
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5612660318788394,1.3409825604842727,0.13970588235294118,0.4408295206867348,1.0,3/16,9.82%,NUPR1;ATP7A;COX7A2L
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5278356222453493,1.3409425874260246,0.15425531914893617,0.44028677687102435,1.0,11/20,21.17%,ADSS2;LHPP;IMPDH2;AMPD3;NT5C2;ADSS1;GMPS;AK3;AK4;HPRT1;PAICS
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.545927314312429,1.3409009066946884,0.15017064846416384,0.43975023008760794,1.0,4/18,4.89%,ZFP36L2;ZFP36L1;NR3C1;KLF9
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.5577732079408843,1.3404887809152621,0.1443850267379679,0.4400182641522018,1.0,6/16,10.36%,APOE;S100A1;NPR3;GCH1;TNF;NUS1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.47813306374195635,1.3402924842174782,0.125,0.4398022446391701,1.0,7/34,7.52%,PTPRJ;PTPN18;PTPN12;PTPN22;DUSP1;DUSP22;DUSP2
prerank,cardiac cell development (GO:0055006),0.6108764758796548,1.3398222501816894,0.17234848484848486,0.4401585741948359,1.0,3/11,2.92%,JAG1;MYH6;ALPK3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5972820766365654,1.339562601166786,0.15667311411992263,0.44016396989687034,1.0,5/12,7.22%,FOXP1;CD74;TLR4;TNF;KLF4
prerank,positive regulation of apoptotic process (GO:0043065),0.36062566135167046,1.339447795196051,0.02378255945639864,0.43979082255017576,1.0,48/293,13.27%,ARHGEF3;ITSN1;VAV3;PLEKHG5;NLRC4;FGD4;TNFAIP8;MAP3K5;STK17B;NUPR1;ANO6;ITGB1;RARG;RPS3;DAPK1;RPS27A;RASSF2;RYBP;BMP2;RIPK1;LILRB1;GRN;BCL10;TRIO;RACK1;STK3;NGEF;TNF;PSEN1;ARHGEF12;ATF6;MAP3K20;SFRP1;RPS6;ATG7;CASP8;CTNNBL1;FOXO3;DIABLO;ZC3H12A;MAP3K11;ITGB3BP;ARHGEF9;FAM162A;FOXO1;NET1;SOS2;LATS2
prerank,myoblast differentiation (GO:0045445),0.5700866150657394,1.339227996354495,0.15425531914893617,0.4396421678230948,1.0,7/14,11.67%,TCF7L2;MBNL1;JAG1;PLEKHM3;RB1;IGF1;HINFP
prerank,membrane lipid metabolic process (GO:0006643),-0.4619862069069222,-1.3380125869704005,0.10638297872340426,0.733836149441492,1.0,10/22,22.63%,CERK;ST3GAL6;B4GALT4;ST6GALNAC4;TECR;CERKL;SERINC1;SPTLC1;ARV1;AGK
prerank,ribosome assembly (GO:0042255),0.45560452570083426,1.3378612923240338,0.11093990755007704,0.4418059860843561,1.0,15/47,11.89%,RPL23A;RPS15;ERAL1;RPSA;RPS28;RSL24D1;RPL24;NOP53;RPLP0;RPL5;RPS14;RPS5;MRPS11;RPL6;RPL10
prerank,negative regulation of cytokine production (GO:0001818),0.37876227696019193,1.3376098507487535,0.055819477434679333,0.4417143925136913,1.0,19/163,5.09%,HDAC9;FCGR2B;VSIG4;LILRA5;ATP2B1;TLR8;CMKLR1;GAS6;C1QTNF3;IRAK3;NR1H4;PTPN22;LILRB1;TLR4;PIBF1;SRGN;RGCC;GHRL;CD200R1
prerank,regulation of calcium ion transport (GO:0051924),0.4323184983745588,1.3371739454581868,0.10919540229885058,0.442032953528835,1.0,20/54,19.24%,IL16;LILRA5;ATP2B1;CCR1;LILRB1;STIM2;BCL2;STIM1;HOMER1;CD33;PLN;WFS1;SLC8B1;FFAR1;PKD2;CCL5;F2R;CAMK2A;P2RX4;INPP5K
prerank,lipid droplet organization (GO:0034389),-0.4633589158757757,-1.3371628605809853,0.10688836104513064,0.7333832753769935,1.0,7/22,23.35%,AUP1;RAB18;CDS1;SQLE;CDS2;BSCL2;FAF2
prerank,regulation of angiogenesis (GO:0045765),0.3712135608165688,1.3370547512774733,0.05078597339782346,0.4416521935603116,1.0,41/192,12.83%,STAB1;PF4;ALOX5;SPRED1;SASH1;ITGB1;THBS4;GRN;CNMD;TNMD;HMOX1;RGCC;GHRL;ROCK1;CD40;PIK3R6;HSPB1;STIM1;KLF4;HTATIP2;GAB1;CCR2;PRKCB;SYNJ2BP;ADAM12;AMOT;TNFSF12;NINJ1;MYDGF;SFRP1;SP100;SP1;JUP;EMILIN1;CEMIP2;ROCK2;NIBAN2;ZC3H12A;ATP2B4;PLXND1;RAMP2
prerank,positive regulation of chemokine production (GO:0032722),0.4496695585384949,1.336860240190298,0.12479740680713128,0.441386473241851,1.0,10/44,8.25%,APP;TSLP;CD74;TLR4;HMOX1;TLR2;IL17RA;SYK;TNF;IL6R
prerank,carbohydrate catabolic process (GO:0016052),-0.40502177106891407,-1.3363327042407085,0.09399477806788512,0.7328697365310722,1.0,14/38,21.84%,HK2;PFKL;PGM1;ALDOA;PKM;NEU1;PGK1;ENO1;ENO3;TPI1;GAPDHS;GAPDH;PFKFB2;LDHA
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.40898006397255016,1.3349079434305473,0.07957559681697612,0.4448327835059992,1.0,31/88,21.17%,NELL1;EDNRB;APOE;RPS3;DAPK1;SAMD4A;RIC1;MRPL13;RACK1;MALSU1;RBM4;DNAJC1;ILF3;DDX6;NANOS3;TRIM71;SHMT1;CNOT9;CLN8;SYNCRIP;TM4SF20;RNF139;EIF2AK2;EIF2AK3;CNOT1;CNOT8;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7
prerank,regulation of steroid metabolic process (GO:0019218),0.5187245391835982,1.334733282035955,0.13368055555555555,0.4445360384229514,1.0,4/23,3.64%,APOE;NR1H4;UGT1A8;UGT1A1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5519559764721342,1.334284158903259,0.14545454545454545,0.44475455002303216,1.0,2/17,2.10%,PTPRJ;PTPN22
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5945066363376167,1.3339114531304943,0.17594254937163376,0.4450162591499961,1.0,2/11,2.67%,PF4;RIPK1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4283954817798282,-1.3338289745874006,0.12128712871287128,0.738819363617899,1.0,13/28,20.19%,MAP2;CLASP2;CAMSAP1;MAP1B;MAPT;MAPRE3;GBA2;STMN3;STMN4;MAPRE1;SKA2;FKBP4;PRUNE1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.43480900009230067,-1.3330574602602001,0.08673469387755102,0.7379221095329764,1.0,6/26,13.12%,NAV3;PAK1;MAPT;TOGARAM1;NUMA1;MAPRE1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5832285454815882,1.3322795934839275,0.1556350626118068,0.4478284821535887,1.0,7/13,15.73%,ARID1B;SPI1;CHEK1;ELOF1;SERTAD2;SMARCD1;ARID1A
prerank,regulation of defense response (GO:0031347),0.4203468799049954,1.331773362535358,0.08299319727891157,0.44824633067675584,1.0,11/76,7.58%,FCGR2B;APOE;ALOX5;FOXP1;ALOX15;BST1;PTPN22;GRN;BIRC3;ZMPSTE24;CCR2
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5194041974672226,1.3316541342811894,0.1362126245847176,0.44782801744116196,1.0,2/22,1.70%,APOE;ZBTB20
prerank,ventricular septum development (GO:0003281),-0.4031179088984599,-1.331615482285768,0.10227272727272728,0.7393300809689451,1.0,10/37,13.46%,TGFBR1;SALL1;SMAD7;ROBO2;ACVR1;ROBO1;TGFBR3;MDM4;PROX1;TGFBR2
prerank,retina homeostasis (GO:0001895),0.5165938820376947,1.3307731354315293,0.12914485165794065,0.4490875207292105,1.0,5/23,6.92%,SLC28A2;B2M;POTEF;ACTB;HSPB1
prerank,organic acid transport (GO:0015849),0.40825083923672134,1.3299958720608043,0.09198423127463863,0.4502009663661065,1.0,21/94,17.60%,FOLR2;SLC10A6;NR1H4;SLC16A10;NCOA2;LRRC8D;SLC43A2;SLC25A17;ABCC4;SLC10A3;SLC38A1;SLC38A2;MFSD2A;SLC23A1;SLC23A2;SLC26A7;SLC25A30;SLC7A7;SLC6A6;SLC5A6;SLC36A2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5763860480879571,1.3299332002500268,0.15083798882681565,0.4496932818060043,1.0,2/13,0.59%,ITGA4;FGFR1
prerank,phospholipid translocation (GO:0045332),0.4932218320665991,1.3295439574735863,0.1583198707592892,0.4498991434666688,1.0,9/28,13.88%,P2RX7;ATP11C;ANO6;PLSCR5;ATP8B4;ABCC1;ATP10B;PLSCR4;MFSD2A
prerank,B cell homeostasis (GO:0001782),0.6080697742305265,1.3295147847273088,0.18216318785578747,0.4493350335815554,1.0,4/10,6.03%,LYN;MEF2C;DOCK11;PPP2R3C
prerank,regulation of response to biotic stimulus (GO:0002831),0.4993261226028637,1.3293099404883413,0.13700787401574804,0.4491559129975205,1.0,6/28,6.67%,FCGR2B;FOXP1;PTPN22;CD36;BIRC3;ZMPSTE24
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.583328834906731,1.3291367053652443,0.1636029411764706,0.4488744943061842,1.0,3/12,5.36%,FCGR2B;NOTCH2;DOCK11
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.4173217151321158,1.32871541246339,0.09887005649717515,0.4491324203960381,1.0,26/72,18.84%,LIFR;GAS6;IRAK3;TSLP;PIAS1;RIPK1;CD74;BIRC3;RACK1;CBFB;RNASEL;VRK2;SYK;TNF;IFNAR2;ELF1;CASP8;JAK1;TNFRSF1A;SPPL2B;HSP90AB1;SPPL2A;MADD;IFNGR1;PTPN6;SUMO1
prerank,cellular response to glucagon stimulus (GO:0071377),-0.48399242565474765,-1.3284772032532919,0.1357142857142857,0.7478916523439267,1.0,5/17,10.15%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,acyl-CoA metabolic process (GO:0006637),-0.41219310738877735,-1.3282685165530606,0.0906801007556675,0.7448532372421206,1.0,12/35,26.23%,ACOT9;ACACA;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1;SUCLG2
prerank,negative regulation of mRNA processing (GO:0050686),-0.49826406197836304,-1.3277310950801442,0.14893617021276595,0.743118934212933,1.0,8/15,24.71%,SRSF10;RNPS1;C1QBP;SRSF12;SFSWAP;SRSF9;U2AF2;SRSF6
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.43860505499349306,1.327505651601696,0.1025260029717682,0.45118432416523935,1.0,11/49,13.90%,IL15;LYN;TSLP;PARP14;PIBF1;CD40;TNF;IL6R;IGF1;TNFRSF1A;STAT3
prerank,protein autophosphorylation (GO:0046777),0.3751318111885173,1.3271787591979893,0.06487148102815178,0.45124101055993,1.0,32/157,12.36%,EGFR;FGFR1;STK17B;PEAK1;LYN;GRK5;FER;DAPK1;OXSR1;RIPK1;ERN1;CDK12;GSK3B;INSR;CAMKK2;PAK2;MAPKAPK2;PDGFRA;STK24;PIKFYVE;VRK2;HTATIP2;ULK2;VRK1;DDR2;DYRK1A;EPHB4;MARK2;STK10;MAP3K3;MKNK1;MAP3K11
prerank,negative regulation of autophagosome assembly (GO:1902902),0.5811531853597123,1.3271675395003062,0.16974169741697417,0.45063528327140173,1.0,4/13,8.90%,NUPR1;MTM1;FEZ2;SMCR8
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.43424695486981524,1.3270256782437109,0.10638297872340426,0.45031973589741797,1.0,15/59,12.88%,TLR8;RPS27A;RIPK1;TLR4;BCL10;TLR2;NFKBIL1;BIRC3;ROCK1;LY96;TNF;REL;RIPK2;ROCK2;TNFRSF1A
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.40271730777416037,1.32684418402788,0.09366391184573003,0.45005086164150093,1.0,17/87,12.18%,FGFR1;SPRED1;ZFP36L2;CD44;FGF23;CBL;ZFP36L1;ITGB1BP1;FRS2;NR4A1;KIF16B;HNRNPF;RAB14;POLR2B;SFRP1;SPRED2;TRIM71
prerank,T cell activation (GO:0042110),0.4171037036438766,1.3267929986967983,0.0912981455064194,0.4495481360667599,1.0,11/69,11.05%,IRF4;PPP3CA;PTPN22;CD44;CD74;CCL19;LCP1;ZAP70;MSN;NHEJ1;CASP8
prerank,histone H4 deacetylation (GO:0070933),0.6129210450469096,1.3267046683593007,0.17702448210922786,0.4491307789635987,1.0,1/10,0.10%,HDAC9
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4986768432398033,-1.325276172367254,0.12962962962962962,0.7489480188676148,1.0,8/15,24.74%,AUP1;UFD1;NPLOC4;SYVN1;SELENOS;TMEM129;FAF2;SEC61B
prerank,folic acid-containing compound metabolic process (GO:0006760),0.5446659576917141,1.325073020131208,0.1506849315068493,0.4522002431398084,1.0,2/19,6.61%,FOLR2;MTHFD2L
prerank,regulation of insulin secretion (GO:0050796),0.4013065381577279,1.3249469819121535,0.0896551724137931,0.4518567957071192,1.0,25/101,14.90%,ALOX5;TCF7L2;NR1H4;NR1D1;PRKN;MCU;CLOCK;IRS2;RAP1A;GHRL;TNF;EIPR1;KCNG2;SFRP1;HADH;CHGA;DOC2B;SLC8B1;SLC2A2;KCNB1;GLUD1;FFAR1;TRH;RBP4;ITPR3
prerank,heme biosynthetic process (GO:0006783),-0.46379669858499833,-1.3240725828067381,0.09975669099756691,0.7499194141530237,1.0,12/22,25.61%,FECH;CPOX;FXN;ABCG2;COX15;FLVCR1;HMBS;ALAS2;UROD;PGRMC1;PPOX;ALAS1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.35979938205486045,-1.323766045019815,0.0706713780918728,0.7474852121160748,1.0,20/67,9.51%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;FXR2;PPP1R16B;IFT140;MYO10;ATP8B1;TBC1D10A;IFT88;TWF2;RDX;TBC1D22A;IFT20;FMR1;DYNLT2B;TBC1D22B;TBC1D9B
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.4933475670464027,1.3234732828485132,0.12898089171974522,0.45437558850934234,1.0,3/29,0.63%,MCTP1;APOE;APP
prerank,mesonephric tubule development (GO:0072164),-0.5098451158053363,-1.3230509665007089,0.12731481481481483,0.7463274377998573,1.0,4/15,4.91%,SALL1;NPNT;ROBO2;FGFR2
prerank,hexose biosynthetic process (GO:0019319),-0.3983542924740648,-1.3228208603045057,0.11235955056179775,0.7434581907072048,1.0,17/42,21.17%,PGM1;ALDOA;MDH1;CRTC2;PGK1;ENO1;AKR1B1;PCK2;ENO3;SLC37A4;TPI1;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.41097208546479264,1.3222843916415712,0.09620596205962059,0.45630721289460896,1.0,20/79,13.05%,CASK;SMURF2;CRIM1;BMP2;GDF3;CNMD;TNMD;SMAD4;TRIM33;ACVR2A;HTRA3;EPN2;SULF2;UBE2D3;DAND5;EMILIN1;MMRN2;NIBAN2;ATP2B4;RBPMS2
prerank,cell-cell junction assembly (GO:0007043),-0.35351752538169007,-1.322088702053674,0.059800664451827246,0.742608767008504,1.0,13/63,5.53%,CD9;TJP1;CTNNB1;EPB41L3;CDH10;SMAD7;TBCD;CDH2;CLDN11;PIP5K1C;TLN2;CDH8;FLCN
prerank,negative regulation by host of viral process (GO:0044793),0.6090673576375689,1.321638529447392,0.18,0.45706436154381014,1.0,4/10,12.58%,CCL8;PRKN;ZC3H12A;VAPA
prerank,neuron projection morphogenesis (GO:0048812),-0.3151744231406049,-1.320876294557127,0.02857142857142857,0.7436749522263674,1.0,41/137,14.27%,MAP4K4;MAP2;CTNNB1;EPB41L3;NCKAP1;CTNNA2;NLGN1;DOCK10;IMPACT;PAK1;CNTNAP2;PARD3;DLG4;SGK1;MAP1B;NYAP2;FARP1;NEFH;DIP2A;FGFR2;NCKAP1L;ANKRD27;SHANK1;DVL1;MYO16;CNTN4;EPHB1;BDNF;SDC2;NTNG1;MAP6;LLGL1;S100B;CELSR2;MINK1;AFG3L2;CTNND2;DSCAML1;APBB1;SLITRK5;ADGRB1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.48753141678999995,1.3200744861851612,0.14091680814940577,0.4597922216539814,1.0,9/32,11.89%,APP;NR1H4;PGAM1;ROCK1;TMED10;MTPN;NANOS3;FOXO3;RPL10
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3375341192694164,1.3200144106943459,0.001006036217303823,0.4593108796393686,1.0,229/1082,16.62%,RBPJ;DAB2;PID1;CD38;ZEB2;PF4;ETV1;EGFR;LRP6;APOE;APP;MAP3K5;KLF2;CHP2;TCF7L2;TCF4;IRF4;MDFIC;PPP3CA;FLI1;MEF2A;AHR;ZBTB16;RREB1;TFEC;KMT2A;ESR1;NCOA3;JAG1;RARG;TCF12;MEF2C;NR1H4;ACTR3;RPS27A;NCOA2;CEBPB;MITF;OSR1;RYBP;BMP2;RIPK1;KLF6;LILRB1;CD74;PHF8;HOXD8;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;TLR4;NR1D1;AXIN1;WAC;RPS6KA3;RGCC;ITGB1BP1;PRKN;BCL10;TLR2;NR3C1;TRIM56;HEY2;RASL11A;CLOCK;GRHL2;ARID1B;SPI1;NCOA7;NFIC;CAMKK2;SMAD4;ELF2;THRB;NR4A1;RNASEL;FOSL2;CD40;EPC1;ACVR2A;CHEK1;FOXM1;TNF;CD80;LYL1;KLF4;YY1;REL;HTATIP2;MED16;SATB2;TBL1XR1;CEBPG;E2F5;PSEN1;FIZ1;NR4A2;NRIP1;IRF2;KLF10;ATF6;ATRX;TET3;NCOA6;FOXC2;ESRRB;KMT2C;SCAF8;HIVEP1;TBL1X;LBH;ESR2;FOXJ3;NFATC2;DYRK1A;MED6;ASXL1;MLXIP;MYDGF;STAT6;NR2F1;USP21;USP16;ILF3;IGF1;HEATR1;SFRP1;RIPK2;RNF14;ARRB1;RNF111;NUP62;ZNF296;CREBRF;SP100;TRIM16;MAML1;SP1;TFDP1;PCID2;ELF1;ELOF1;SERTAD2;JUP;PHIP;ETS2;MLLT10;SHC1;SREBF2;CREBBP;EAF2;ANKRD49;BCL11B;MYBL2;FOXK2;HINFP;NFIA;CRTC3;FOXO3;DCAF6;DHX33;NIBAN2;SNX5;ZC3H12A;FOXK1;NAMPT;BCAS3;NOD2;SP3;NFIX;FOXO1;TNFRSF1A;KMT2E;CREB1;SFR1;PEG3;CTBP2;WWOX;TFR2;XPC;RNF187;NR1H2;RARA;KAT7;TET2;STAT3;EP300;KLF5;WASL;JUND;MMS19;CRLF3;KAT6A;USF1;HMGN5;PRKD2;PKD2;RTRAF;SNW1;ENY2;BMPR1A;MYC;MTF1;NSD3;USP22;SMARCD1;HDAC4;NR2C2;SFPQ;SENP1;ARID1A;RUNX3;ELK1;E2F8;KDM1A;HOXB3;MAPK7;HCFC1;PPARGC1B;ACTR2;PPM1A;PER1;NFATC3;ARNT;BRD4;GLIS2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4142768645006817,1.3197656800454611,0.0884450784593438,0.45921121410177246,1.0,15/74,14.95%,RBPJ;PSMA7;RPS27A;HIGD1A;PSMB2;LIMD1;BACH1;CREBBP;PSMA6;HIF3A;EP300;PSMA3;PSMD1;PSMD5;ELOC
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.28752579694317254,-1.3195998277037895,0.008064516129032258,0.7450440978395572,1.0,80/241,23.79%,DDX5;SNRNP70;SRRM2;FUS;ZCCHC8;HNRNPA3;ELAVL2;HNRNPUL1;SRRM1;SRSF5;PABPN1;HNRNPA2B1;DDX39B;SRSF3;HNRNPU;DHX35;SNRNP48;PUF60;PPIL3;SRSF2;PNN;SNRPA1;SRSF10;CCAR1;PPIE;PRPF4;WBP4;SNRNP200;SYF2;DNAJC8;CSTF2;DDX41;RNPS1;CWC25;XAB2;USP49;SNRPN;RAVER2;CD2BP2;PRPF19;SRRT;U2AF1;PQBP1;UPF3B;CASC3;NOVA2;SF3B1;SRSF12;POLR2C;NCBP1;PRPF6;PCBP1;DDX23;PCBP2;HNRNPA1;RBM5;HNRNPH1;SNIP1;ZMAT5;CLP1;SNRPB2;SART1;SRSF11;SRSF9;DHX9;RBM17;RBM14;ALYREF;U2AF2;ESS2;METTL3;TFIP11;SART3;POLR2L;IK;UBL5;PRPF31;TRA2A;ZCRB1;HNRNPA0
prerank,negative regulation of wound healing (GO:0061045),0.49914371617259723,1.3189582853768058,0.13278688524590163,0.4603124868796235,1.0,6/28,9.33%,APOE;ALOX5;CASK;CRK;TNF;CLASP1
prerank,cellular response to glucose stimulus (GO:0071333),0.48294866949115567,1.3189447285581628,0.15248796147672553,0.45971903659240587,1.0,5/30,5.11%,RAB11FIP5;GAS6;ZBTB20;ERN1;RACK1
prerank,RNA processing (GO:0006396),-0.2992423767191682,-1.3184242359553184,0.016666666666666666,0.7458627517818454,1.0,50/176,16.94%,IVNS1ABP;SON;LUC7L3;FUS;CPSF6;DDX17;ZCCHC8;HNRNPUL1;THOC1;SETX;ADAR;AKAP8L;SRRM4;SRRM1;ADARB2;SRSF5;PABPN1;HNRNPA2B1;DDX39B;RP9;TARDBP;DDX47;HNRNPU;ELAVL4;SNRNP48;SRPK1;GEMIN2;SRSF2;SNRPA1;PRPF4;WBP4;CCAR2;TCERG1;RNPS1;DDX20;SRPK2;SNRPN;U2AF1;ADARB1;LIN28B;SF3B1;NCBP1;PRPF6;DDX23;RBM5;HNRNPH1;ZMAT5;RBM39;CLP1;PABPC4
prerank,regulation of interleukin-1 production (GO:0032652),0.5721455594583479,1.3183494060935288,0.16226415094339622,0.46038411320692446,1.0,4/15,5.79%,FOXP1;GAS6;TLR4;TMED10
prerank,electron transport chain (GO:0022900),0.5514138492232966,1.317520555087054,0.15601503759398497,0.4615257019882213,1.0,6/15,17.74%,ENOX2;ETFDH;ETFA;SDHA;UQCRFS1;ETFB
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5777655546043146,1.3162099912501135,0.1534090909090909,0.4635066326336656,1.0,6/13,17.54%,RPS15;LTV1;NMD3;XPO1;LSG1;RRS1
prerank,cellular glucan metabolic process (GO:0006073),0.6014084071982044,1.3161826124108682,0.18029739776951673,0.4629511028290552,1.0,4/11,9.41%,PRKAG2;GBE1;GSK3B;PPP1R3C
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.34664933820319516,1.316168975586395,0.013669821240799159,0.46235809604451866,1.0,125/476,19.45%,CD38;EGFR;LRP6;APOE;MAP3K5;KLF2;TCF4;IRF4;MDFIC;FLI1;AHR;ZBTB16;RREB1;KMT2A;ESR1;MEF2C;NR1H4;CEBPB;MITF;RYBP;BMP2;KLF6;CD74;PHF8;ALX1;NR1D1;AXIN1;WAC;BCL10;TRIM56;HEY2;CLOCK;ARID1B;CAMKK2;SMAD4;ELF2;EPC1;FOXM1;TNF;CD80;LYL1;KLF4;MED16;TBL1XR1;PSEN1;NCOA6;FOXC2;ESRRB;TBL1X;LBH;ESR2;NFATC2;DYRK1A;USP21;USP16;ILF3;IGF1;SFRP1;RNF14;RNF111;NUP62;SP100;TRIM16;SP1;PCID2;ELF1;PHIP;ETS2;SHC1;CREBBP;ANKRD49;FOXK2;HINFP;FOXO3;NIBAN2;SNX5;FOXK1;SP3;FOXO1;KMT2E;CREB1;SFR1;XPC;RNF187;NR1H2;RARA;STAT3;EP300;MMS19;CRLF3;KAT6A;HMGN5;ENY2;MYC;NSD3;USP22;HDAC4;ARID1A;RUNX3;ELK1;HCFC1;PPM1A;BRD4;GLIS2;MED17;NR5A2;RELA;LHX1;NR2F2;GTF2H1;MECOM;IL6;PICALM;F2R;MAFB;RFX3;PHF5A;RAI1;DVL3;PITHD1;THRAP3;INPP5K;RNF6;BCL3;CTCF
prerank,folic acid metabolic process (GO:0046655),0.5435455220748902,1.3156334253933033,0.1692573402417962,0.46292287036996954,1.0,2/18,6.61%,FOLR2;MTHFD2L
prerank,negative regulation of cartilage development (GO:0061037),-0.5241780380648986,-1.315546966227152,0.16400911161731208,0.7531696813776777,1.0,7/13,35.99%,TGFBR1;PTPN11;GREM1;EFEMP1;PTHLH;WNT9A;SNAI2
prerank,primary neural tube formation (GO:0014020),0.4744345901992239,1.3150531202611258,0.14556962025316456,0.46359266106124397,1.0,5/30,5.59%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3627836838881795,-1.3149269511488355,0.08588957055214724,0.7518434229124452,1.0,18/57,13.29%,DLG2;DLGAP2;PTK2B;GRIA2;NLGN1;DLG4;DLGAP1;DLG3;GRIA4;SHANK1;GSG1L;ACTN2;CACNG7;MINK1;GRIN2A;NPTX1;CACNG8;SHISA7
prerank,cobalamin metabolic process (GO:0009235),0.5410008304652236,1.3149163145690879,0.16808149405772496,0.46326429118902845,1.0,5/17,12.22%,TCN2;MTR;LMBRD1;ABCC1;MMAB
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4804782527536555,-1.3142157017122393,0.1592356687898089,0.7509909959546838,1.0,6/16,36.06%,CLDN11;CLDN12;CLDN18;CLDN1;CLDN5;CLDN14
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6062057734141997,1.3137630779822846,0.17773788150807898,0.4651235553767112,1.0,2/10,7.32%,LRP6;ARHGAP12
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.42261392339545933,1.3128633303243609,0.11482558139534883,0.4663813348564345,1.0,14/67,9.25%,EGFR;FGFR1;IL15;LYN;FER;ABI1;PIBF1;INSR;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.35541865175123577,1.3115405305137482,0.03733031674208145,0.4685565066473,1.0,58/260,16.41%,MTSS1;NRP1;FGD4;EMP1;P2RX7;RAP1B;EHD4;FGD6;EMP3;RAP2B;OPHN1;ANO6;ITGB1;ACTR3;RILP;PIBF1;RAB8B;RAPGEF2;EHD1;INTU;RAP1A;PMP22;S1PR2;OCRL;DISC1;ABCC4;SDCBP;EXOC4;TEKT5;VCL;FHDC1;RAB1A;RAB23;PIP5K1A;RFX2;PCNT;PDE6D;WDR11;S1PR1;SNX10;CEP19;STK36;PARVB;EXOC2;NTN1;SPEF1;RAB11A;PCM1;IFT80;PARVA;NPHP3;TXNDC15;FXYD5;FGD3;EXOC8;ATP6V0D1;FAM161A;ACTR2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.5118495475921749,1.3115398929943212,0.1443661971830986,0.46793152426575196,1.0,7/22,10.98%,SPRED1;RPL23;RPS15;RPL37;RPS20;RPS7;SPRED2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.616743115258683,1.3114725748157168,0.1569767441860465,0.4674267472786842,1.0,1/10,0.49%,APOE
prerank,regulation of phosphatase activity (GO:0010921),0.5053462955127151,1.3114373540849575,0.16206896551724137,0.46687910270660554,1.0,4/24,7.06%,CHP2;BMP2;PPP1R26;PPP1R17
prerank,cytosolic transport (GO:0016482),0.3883530634081641,1.3112090081098808,0.08533333333333333,0.46673885571805734,1.0,25/108,15.04%,SNX2;TBC1D5;EPS15;CLTC;ANKFY1;EVI5;RILP;SNX6;CLN5;RIC1;LAMP1;KIF16B;PIKFYVE;RAB7A;TRIM27;DENND5A;RAB14;SNX16;VPS13C;VPS13A;SNX5;CORO7;VPS26A;MON2;WDR91
prerank,endothelial cell proliferation (GO:0001935),0.5635885408924138,1.3111939544003033,0.16292134831460675,0.4661423740605071,1.0,4/17,4.22%,ERN1;HMOX1;ITGB1BP1;NRARP
prerank,glycogen metabolic process (GO:0005977),0.48583908756298233,1.3108028582724012,0.1669421487603306,0.4663770864919096,1.0,8/27,10.64%,PRKAG2;GBE1;GYG1;NR1D1;PGM2L1;GSK3B;PPP1R3C;CALM1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.48718032510334686,-1.3107294364502378,0.15401785714285715,0.7609557323405783,1.0,5/15,14.64%,GRM7;DAGLB;GRM3;DAGLA;GRM5
prerank,positive regulation of cell migration (GO:0030335),0.35302408691523673,1.310477412706969,0.06018518518518518,0.4664863324421284,1.0,38/253,10.73%,DAB2;NRP1;NEDD9;EGFR;SEMA4A;CCR1;PPP3CA;MYADM;RREB1;KIF20B;SMURF2;ITGB1;FER;CASS4;DOCK1;BMP2;SYNE2;DRD1;GRN;ADAM9;S100A11;RAPGEF2;INSR;RACK1;PDGFRA;TRIM32;SDCBP;GAB1;CCR2;CXCL16;CCL24;DDR2;CLASP1;PDGFC;IGF1;RTN4;MYO1C;F10
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.47765126250691703,1.3103780631498536,0.1504,0.4660724891884537,1.0,5/30,4.79%,RASGRP4;NOTCH2;LYN;STK19;IRS2
prerank,mRNA destabilization (GO:0061157),0.4674753684828361,1.310223806370237,0.13671274961597543,0.46578000960238325,1.0,12/38,14.37%,ZFP36L2;TUT7;ZFP36L1;RC3H1;ROCK1;TUT4;ROCK2;TRIM71;ZC3H12A;DIS3L2;ZC3H12D;POLR2D
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.49020290579354847,-1.309930822893674,0.13302752293577982,0.7605839198481035,1.0,4/17,8.98%,SORL1;PDE3B;APOC1;ALK
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.5817356192275099,1.3093906041248409,0.1750503018108652,0.4670158189381151,1.0,7/12,16.89%,ADRB2;UVRAG;INSR;TNF;SMCR8;BNIP3;IGF1R
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5173022112709352,1.3092768711569773,0.17657342657342656,0.46666782999148365,1.0,3/22,4.11%,IL15;NR1H4;RFTN1
prerank,activation of protein kinase A activity (GO:0034199),-0.48895804570094625,-1.3091970701517128,0.14081145584725538,0.7599126160471104,1.0,5/16,10.15%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.3726814671220743,-1.30840200391944,0.07301587301587302,0.7596078733559457,1.0,18/50,21.55%,IVNS1ABP;SENP2;SMAD7;HDAC8;SIRT7;ARRB2;UBXN1;ADGRB1;LIMK1;N4BP1;MINAR1;PARK7;SQSTM1;GNL3L;PRR7;BAG5;TAF1;U2AF2
prerank,endosome organization (GO:0007032),0.4511045260696033,1.3080576191912026,0.14761904761904762,0.468743404841507,1.0,8/41,11.69%,TMCC1;RILP;SNX3;PI4K2B;WASHC4;CORO1C;SNX10;SNX33
prerank,tetrapyrrole metabolic process (GO:0033013),0.527493025699551,1.3075588340038509,0.17281879194630873,0.4691766177247073,1.0,5/18,12.22%,TCN2;MTR;LMBRD1;ABCC1;MMAB
prerank,chemical synaptic transmission (GO:0007268),-0.2856952152375128,-1.3074864525581298,0.02,0.7595019366525483,1.0,58/284,13.18%,CACNB2;PLP1;GRID2;SLC1A3;KCND2;MBP;DLG2;RIMS1;DLGAP2;GRM7;CACNB4;UNC13C;GRIA2;GRIK2;GABRB3;NLGN1;SNAP25;NRXN1;DLG4;DLGAP1;GRM3;HTR2C;PRKAR1A;PTCHD1;GRIA4;CDH8;KCNQ3;PRKAR1B;KIF5A;HCRTR2;GABRB1;DVL1;SPG11;RPS6KA1;APBA1;DTNA;GLRB;HRH2;CACNA1E;CHRM3;CAMK4;SYN3;KCNA1;HTR7;CPLX1;NAPA;MINK1;GRIN2A;SLC1A1;GABRA2;RPS6KA2;SLC12A6;TBC1D24;PTPRN2;NPTX1;GLRA1;LIN7A;VAMP2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.526308056966766,1.3074613480579143,0.1711229946524064,0.4687456345909357,1.0,8/18,17.66%,BMP2;RGCC;RB1;DDR2;CLASP1;EMILIN1;MELTF;IL6
prerank,skeletal system development (GO:0001501),0.3765366501365996,1.306904872960861,0.06870229007633588,0.4693952944008363,1.0,26/148,11.16%,TRPS1;EXT1;FGFR1;CMKLR1;ZBTB16;CD44;BMP2;GDF3;CNMD;RPS6KA3;NPR3;RPL13;ANKRD11;GHRL;NOTUM;ATP7A;GDF10;VKORC1;COL9A2;PAPSS2;SULF2;RFLNB;IGF1;PTGER4;SLC10A7;ETS2
prerank,negative regulation of immune effector process (GO:0002698),0.5737543534887628,1.3062482616805255,0.17407407407407408,0.4701974654267491,1.0,4/13,5.30%,FER;LILRB1;GRN;RC3H1
prerank,ERBB2 signaling pathway (GO:0038128),0.47330324207924135,1.3060447726585003,0.14903846153846154,0.4700146581972291,1.0,8/31,17.65%,EGFR;PTPN18;PTPN12;GAB1;SHC1;NRG2;CUL5;SOS1
prerank,acylglycerol metabolic process (GO:0006639),-0.40096862714351267,-1.3056652172960679,0.09063444108761329,0.7628286691865837,1.0,10/37,9.24%,ABHD12;DGKI;MGLL;DGKB;LYPLA2;LPL;GK;APOC1;DGKZ;LMF1
prerank,synapse organization (GO:0050808),-0.31468289957722045,-1.3053943039622597,0.052132701421800945,0.7603503639675194,1.0,23/125,8.30%,APBB2;CX3CR1;CACNB2;PTPRS;DNM3;ADGRL3;CACNB4;SDK1;PTPRD;UNC13C;NLGN1;CDH2;NRXN1;LRRC4C;PPFIA2;LRFN5;FARP1;PPFIA4;DVL1;BDNF;MAPT;CNTN2;NTNG1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4750388057387981,1.3041849882342502,0.12828947368421054,0.47342731030200974,1.0,5/33,5.30%,PTPRJ;RPS3;PTPN22;BCL10;RC3H1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4965048191528804,1.3040726239589098,0.1703204047217538,0.4730717926996475,1.0,5/24,15.18%,PID1;GFPT2;CYCS;COX10;MYC
prerank,ventricular septum morphogenesis (GO:0060412),-0.42029928168874975,-1.3039783003152545,0.13064133016627077,0.7623268039733964,1.0,11/27,20.57%,TGFBR1;SMAD7;ROBO2;ACVR1;ROBO1;TGFBR3;PROX1;TGFBR2;NOTCH1;TGFB2;SOX11
prerank,lipoprotein localization (GO:0044872),0.5879390173925365,1.3036406724576755,0.18504672897196262,0.4733936002357177,1.0,8/11,27.87%,CD36;PRKCB;ZDHHC3;MIA3;UNC119;VMP1;PPARG;ZDHHC17
prerank,neuron projection organization (GO:0106027),0.5531910575504133,1.3033993115199705,0.1575984990619137,0.47328975983409527,1.0,5/15,9.06%,APP;GSK3B;INSR;PSEN1;PLS1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.4312388538485235,1.3030612450774428,0.12272727272727273,0.47344074398572217,1.0,7/53,5.99%,APOE;FBXW7;OPHN1;NUPR1;LAMP3;PRKN;RHBDF1
prerank,miRNA metabolic process (GO:0010586),0.5199009851349411,1.3023631068113268,0.15245009074410162,0.47438318089562315,1.0,7/20,12.67%,PRKRA;TUT7;SND1;DROSHA;TUT4;TRIM71;DIS3L2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4050814851447684,1.3020622686232417,0.11052631578947368,0.47448795840996527,1.0,22/87,14.86%,EPS8;IQGAP2;NOTCH2;IQGAP1;BST1;ARHGAP18;CRK;RHOA;PDGFRA;ROCK1;CELSR1;BST2;ARHGDIA;RHOBTB1;TRPM2;ROCK2;ARHGAP17;NEB;RND3;RHOC;MDK;ARHGDIB
prerank,regulation of phosphorylation (GO:0042325),0.38621315211556995,1.3016281654841255,0.08139534883720931,0.47480861849410305,1.0,25/120,12.78%,NRP1;EGFR;APP;PRKAG2;LYN;ANG;FER;BCL10;PGAM1;ROCK1;NOP53;SDCBP;HSPB1;PSEN1;NUP133;FNIP1;KCTD20;KDM4D;CORO1C;PPP2CA;NUP62;PHIP;CDKN2C;NUP98;DSCAM
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5613469599802918,1.301601532919317,0.17025089605734767,0.4742317399471954,1.0,4/14,5.14%,LILRB1;CD74;BCL10;GPRC5B
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.5033006298959011,1.3015701219436568,0.15358931552587646,0.4736770823768193,1.0,6/24,9.18%,CTNNA1;MEF2A;MEF2C;CDC42;RBM4;MAPK14
prerank,relaxation of cardiac muscle (GO:0055119),-0.512055889359784,-1.3006979086884907,0.1496437054631829,0.7719415051962583,1.0,4/13,8.43%,KCNJ2;ATP1B1;SLC8A1;RGS2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4875279499203305,-1.3005548530420383,0.16706443914081145,0.769019647899519,1.0,8/16,15.09%,DDX5;DDX17;SAFB;TRIP4;AR;EGLN2;PADI2;NCOA4
prerank,B cell proliferation (GO:0042100),0.5386281558345621,1.3002975470926963,0.18214285714285713,0.47583740611678804,1.0,4/17,6.82%,MEF2C;CD40;BCL2;CR2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.31767782704446984,-1.3001177606863108,0.00904977375565611,0.7673287536863782,1.0,26/118,7.43%,ABI3;TANC2;ADGRB3;SEMA4D;CTNNB1;EFNA5;FMNL2;CLASP2;PAK1;CDH2;HECW2;LRRC4C;SPARC;CAMSAP1;PPFIA2;ETS1;FERMT2;FGF2;KIF1A;NSMF;FGFR2;NF1;MAPT;SDC2;KNDC1;ZMYM6
prerank,neuron projection development (GO:0031175),-0.2984885343149534,-1.2997615193405374,0.01675977653631285,0.7650921741390359,1.0,52/168,16.15%,PLP1;MAP4K4;PTPRM;MAP2;EPB41L3;NCKAP1;GRM7;GPM6B;NLGN1;ATXN10;WHRN;DOCK10;PAK1;CNTNAP2;DLG4;SGK1;CAMSAP1;NYAP2;NEFH;DIP2A;MICALL1;NCKAP1L;ZFYVE27;ANKRD27;SHANK1;IFT88;MYO16;CNTN4;EPHB1;BDNF;RASGRF1;MAPT;ERCC6;STX3;STMN3;ADCYAP1;MINK1;TMEM108;STMN4;TBC1D24;LGI1;PPP1R9A;PQBP1;CTNND2;OMG;RAB35;MAP4;EPHB2;ADGRV1;TBC1D23;DCLK1;ULK1
prerank,regulation of transport (GO:0051049),0.4568348935981887,1.2995203261526547,0.152276295133438,0.4768342552987672,1.0,8/36,17.26%,NRP1;PRKN;ACTB;GAPVD1;RAB11A;WWC1;REEP6;FES
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5172006637484667,1.2993957857157479,0.17796610169491525,0.4758738192351968,1.0,4/21,6.94%,PF4;MCL1;BCL2;TNF
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5172006637484667,1.2993957857157479,0.17796610169491525,0.4758738192351968,1.0,4/21,6.94%,PF4;MCL1;BCL2;TNF
prerank,positive regulation of lipid transport (GO:0032370),0.5735384064071274,1.299084421573681,0.17748091603053434,0.4759220542807559,1.0,1/12,0.49%,APOE
prerank,cellular glucose homeostasis (GO:0001678),0.4489086063006402,1.2985749813031984,0.15445859872611464,0.47641998200800917,1.0,11/41,12.87%,GAS6;ZBTB20;FOXA3;ERN1;NR1D1;LRRC8D;RACK1;FOXK2;KCNB1;FOXK1;FOXO1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.5272897973686099,1.2982361493474115,0.18864774624373956,0.4765372456257282,1.0,5/20,8.11%,PF4;ZBTB16;ZFP36L1;CDK6;CDC73
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4823157978406287,-1.2977581552228563,0.155902004454343,0.7697347622847767,1.0,6/17,15.04%,SYNGR1;SNAP25;SNAP47;AP3D1;STX3;STX2
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4195055343917606,-1.2967894696980014,0.13414634146341464,0.7700635058628932,1.0,12/27,27.26%,RIMS1;RIMS2;SYT6;VAMP2;SYT8;RIMS3;SYT1;VAMP7;SYT13;SYT7;SYT5;SYT17
prerank,regulation of tube diameter (GO:0035296),0.5799164115715036,1.296483544412355,0.17750439367311072,0.4791807399087854,1.0,5/13,15.66%,ITGB1BP1;ROCK1;GCLM;ROCK2;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),0.5799164115715036,1.296483544412355,0.17750439367311072,0.4791807399087854,1.0,5/13,15.66%,ITGB1BP1;ROCK1;GCLM;ROCK2;SCPEP1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.49853608891376366,-1.296358313718778,0.1596244131455399,0.768191192406089,1.0,8/14,24.71%,SRSF10;RNPS1;C1QBP;SRSF12;SFSWAP;SRSF9;U2AF2;SRSF6
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5032019039678919,1.2962519206781626,0.1652754590984975,0.4790252477320001,1.0,5/24,6.34%,TPT1;CD44;CD74;TRIM32;BCL2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5563706461917248,1.296229753995648,0.1824953445065177,0.4784531788648052,1.0,3/13,6.52%,NRP1;PLXNC1;PLXNA4
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3970615284576364,1.2959004044302627,0.10644257703081232,0.4785262820850328,1.0,26/88,16.25%,APP;MYO5A;EPS15;CLTC;EXOC6B;RAB10;FTL;TXNDC5;STXBP6;KIF16B;AP4S1;EXOC4;RABEP1;RAB14;ARRB1;FTH1;SNAP23;VPS13C;VPS13A;EXOC2;CORO7;CLTA;MON2;OSBPL5;RABIF;EXOC8
prerank,tube closure (GO:0060606),0.4686502862927695,1.295639780038102,0.16113744075829384,0.47849726001917714,1.0,5/31,5.59%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,atrial septum morphogenesis (GO:0060413),0.5891639215171933,1.2955684668790208,0.16819012797074953,0.47804478141310563,1.0,2/10,4.49%,NOTCH2;HEY2
prerank,protein depolymerization (GO:0051261),-0.4211326610434025,-1.295255593560584,0.14841849148418493,0.7690273582884883,1.0,13/27,24.01%,NCKAP5L;TWF2;MICAL3;STMN3;NCKAP5;STMN4;CKAP5;KIF2A;MICAL2;TWF1;KATNB1;WDR1;KIF14
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6015925289006879,1.2949509464068478,0.17519685039370078,0.47884480526892875,1.0,3/10,7.58%,OXSR1;WNK1;CCR2
prerank,negative regulation of signal transduction (GO:0009968),0.3529313178603747,1.2948084779135471,0.07428571428571429,0.47852843544374996,1.0,68/249,20.73%,PID1;EGFR;PTPRJ;FBXW7;PTPN18;LYN;HERC4;PTPN12;IRAK3;BMP2;TMEM25;XDH;SIAH2;CNMD;TNMD;NRARP;NFKBIL1;RB1;RACK1;NOTUM;BCL2;CYP26C1;TNF;EPN2;PRKCB;NR4A2;MAPK8IP2;SULF2;CARD16;ASXL1;NKD1;CYP26B1;SFRP1;ARRB1;EGFL7;EMILIN1;KANK2;MMRN2;NIBAN2;NTN1;WWOX;GPC3;NLK;RGS14;VGLL4;PALM;CREB3L1;PTEN;GLIS2;CCL5;PRKCQ;LGR4;ZBTB7A;SPRY2;PIP4K2A;INPP5K;TRIB1;ENPP1;CSNK2A2;CSNK2A1;TLE1;CNOT1;TMBIM6;GRB14;SNCA;NFATC1;SIAH1;PHACTR4
prerank,regulation of response to stress (GO:0080134),-0.5534872656251478,-1.294697388827113,0.1517094017094017,0.7676143747127504,1.0,2/10,1.41%,EIF4G1;ADCY8
prerank,positive regulation of catabolic process (GO:0009896),0.41712319208967835,1.2946137824617796,0.14180206794682423,0.4783251081158568,1.0,16/65,15.31%,WWP1;SMURF2;RILP;AXIN1;PRKN;GSK3B;TRIM32;TNF;RAB7A;TNFSF12;NKD1;ATG7;FOXO1;NEDD4L;GPC3;RNF41
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3525964693852459,1.294026762213203,0.0572737686139748,0.47899073819962834,1.0,64/234,17.33%,NLRC4;LRP6;APP;ESR1;FER;RPS3;IRAK3;RPS27A;RIPK1;CD36;WNT2;TLR4;CAMK1D;RGCC;BCL10;TNFRSF11A;TLR2;CLOCK;STK3;TRIM32;CD40;TNF;MTPN;EDA;PRKCB;CEBPG;RAB7B;TRIM68;DDR2;TRIM27;ESR2;CARD16;RIPK2;TFDP1;JUP;PSMA6;CRTC3;BUD31;STK36;DHX33;LAMTOR5;TERF2IP;NOD2;UBE2N;NFKBIB;MID2;STAT3;EP300;PRKD2;NFAM1;PPIA;HDAC4;TRIM25;KDM1A;PTEN;PPARGC1B;TIRAP;PRDX3;TAB3;PRKCQ;RELA;ZBTB7A;TAF12;FLOT2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4489303270396542,1.2938546763691412,0.1620795107033639,0.478783293969026,1.0,11/39,17.03%,MYADM;JAG1;BMP2;RGCC;WNK1;KLF4;ASS1;FXYD5;MAPK7;MIA3;PODXL
prerank,fatty acid transport (GO:0015908),0.5405002382889017,1.2936308840898199,0.1971326164874552,0.4786652881703173,1.0,3/17,3.98%,APOE;CD36;SLC25A17
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.41702024707327806,1.293475290172783,0.10863095238095238,0.4783941904133225,1.0,11/57,9.90%,IL15;LYN;TSLP;PARP14;PIBF1;CD40;TNF;IL6R;SH2B3;PPP2CA;IGF1
prerank,modified amino acid transport (GO:0072337),0.5627819360458202,1.293385685028203,0.2014260249554367,0.47798132828330575,1.0,1/15,0.22%,FOLR2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.49271299708749483,1.2932702346443534,0.14974182444061962,0.4776205034980046,1.0,2/24,0.82%,NRP1;SEMA4A
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4631788973378832,1.2930501510097796,0.15650741350906094,0.4775018654225628,1.0,8/34,8.16%,LYN;MFHAS1;IRAK3;TLR4;NR1D1;NFKBIL1;LY96;RAB7B
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.46330358671361044,1.2918926734047786,0.16833333333333333,0.47940106582902303,1.0,8/33,16.14%,TCF7L2;GAS6;NUPR1;WFS1;CAST;RAMP2;MDK;MAPK7
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5440682759884833,1.2917434528260452,0.18959731543624161,0.47911603453875645,1.0,1/17,0.10%,HDAC9
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5327667966059952,1.29169936205365,0.1836007130124777,0.4786033551647548,1.0,2/17,2.38%,CEBPB;OSR1
prerank,regulation of RNA metabolic process (GO:0051252),0.4195643573917199,1.2915947141237327,0.1514705882352941,0.47823466791099867,1.0,12/59,8.72%,AHNAK;OAS2;MBNL1;RASA1;MITF;TNFRSF1B;PTBP3;RC3H1;MBNL2;HNRNPF;PTBP2;GRSF1
prerank,intracellular pH reduction (GO:0051452),-0.4008804531559462,-1.2913810943028379,0.11458333333333333,0.7771489186515774,1.0,13/33,17.25%,TCIRG1;ATP6V1C1;DMXL2;ATP6V0A2;ATP6V1D;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C;RAB20;TMEM9
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3899137265155053,1.290792124608162,0.12264150943396226,0.47936019552538317,1.0,15/98,12.28%,PID1;APOE;TBC1D5;IFNAR1;XDH;RIPK1;INSR;IL10RB;ANXA2;KLF4;MAPK14;RAB1A;ARRB1;ROMO1;ZC3H12A
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4175623585099332,-1.2904384808860216,0.15263157894736842,0.7775042622053344,1.0,17/29,28.56%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;DGKZ;FLT3;ATG14;EEF1A2;TGFB1;TNFAIP8L3;TEK;CD81;PDGFRB;IRS1;PRKD1
prerank,antibacterial humoral response (GO:0019731),0.5280777190137534,1.2903615375506443,0.16917293233082706,0.4797325471000829,1.0,3/16,7.85%,ANG;RPL39;RNASE6
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5434752379681584,1.290343807761968,0.20212765957446807,0.4791631820788264,1.0,2/14,6.94%,CCR1;TNF
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5525219372504518,1.2901688590451623,0.1926605504587156,0.4789283452556456,1.0,4/13,9.25%,CD44;CD74;MDM2;DYRK1A
prerank,cartilage development (GO:0051216),0.4343963716210378,1.2891770002093759,0.13967310549777118,0.4805590806996179,1.0,8/49,8.81%,ZBTB16;MEF2C;CD44;OSR1;BMP2;GHRL;ATP7A;SULF2
prerank,pyroptosis (GO:0070269),0.5520282940200091,1.289143001048542,0.19160583941605838,0.4800437614350957,1.0,3/15,11.05%,NLRC4;GSDME;CASP8
prerank,sodium-independent organic anion transport (GO:0043252),-0.5504738053600386,-1.2887863925077208,0.16846652267818574,0.7804581847656246,1.0,3/10,15.26%,SLCO2B1;SLCO4C1;SLCO4A1
prerank,membrane repolarization (GO:0086009),-0.498025298470093,-1.2881563787609371,0.1697674418604651,0.7795124397106845,1.0,3/15,4.05%,KCNJ2;ATP1B1;ATP1B2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.4891259866560908,-1.2880050291062488,0.1728110599078341,0.7766869447130305,1.0,9/15,29.08%,COL11A1;WHRN;KCNA1;PIEZO2;SCN1A;ADGRV1;MKKS;HPN;TMC1
prerank,mesoderm development (GO:0007498),-0.46753487013877404,-1.287550875034829,0.14105793450881612,0.775043009052524,1.0,6/18,19.31%,JAK2;IKZF1;BTK;TBX6;IKZF3;GDF11
prerank,histone H3-K4 trimethylation (GO:0080182),0.590556109267926,1.2873265418712487,0.1860036832412523,0.48349376604735467,1.0,5/11,13.84%,KMT2A;TET3;WDR82;BEND3;TET2
prerank,regulation of macrophage cytokine production (GO:0010935),0.5676387689111182,1.2865986853728688,0.17293233082706766,0.4844802584523147,1.0,4/13,5.14%,IRAK3;LILRB1;CD74;GPRC5B
prerank,regulation of platelet aggregation (GO:0090330),-0.4689507058262071,-1.2863418849579162,0.16745283018867924,0.7763719828593156,1.0,4/17,0.79%,F11R;CD9;PRKCD;SERPINE2
prerank,smooth muscle tissue development (GO:0048745),-0.5525307249120933,-1.2863337335395204,0.19027484143763213,0.7730818372009963,1.0,8/10,36.70%,NF1;PROX1;SMO;ENG;BMP4;MYLK;SHH;EFEMP2
prerank,positive regulation of protein kinase activity (GO:0045860),0.36274518924823823,1.285879960795112,0.07672634271099744,0.4854788267548501,1.0,29/148,10.64%,NEDD9;LILRA5;IQGAP1;SNX9;PRKAG2;GAS6;RASSF2;CASS4;ADRB2;AXIN1;CCL19;RHOA;RAPGEF2;DOK7;RAP1A;INSR;GPRC5B;INCENP;PAK2;STK3;TNF;NRK;IL6R;DDR2;PPP2CA;CACUL1;PARP16;MARK2;CALM1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5412128328748935,1.2845203207857336,0.20397111913357402,0.4877659349685125,1.0,3/15,7.58%,NKAP;SYK;CCR2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.44006529042870585,1.2840830044169234,0.1575037147102526,0.4881119838730274,1.0,8/44,3.95%,NRP1;GPR65;CDC42;ARHGEF10L;RHOA;RGCC;S100A10;ITGB1BP1
prerank,myelin assembly (GO:0032288),-0.5514546486428806,-1.2840272596468927,0.18619246861924685,0.7788212893241381,1.0,6/10,22.69%,CD9;EPB41L3;TENM4;TPPP;ABCA2;GPC1
prerank,positive regulation of synapse assembly (GO:0051965),-0.42045396902751264,-1.2838671939608597,0.14795918367346939,0.7761079759347026,1.0,12/27,19.02%,GRID2;SEMA4D;PTPRD;NLGN1;NRXN1;EPHB1;BDNF;SYNDIG1;IL1RAPL1;EPHB2;IL1RAP;VSTM5
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.34112678449821565,-1.283468338258867,0.08247422680412371,0.7743169489563282,1.0,35/69,28.82%,TMEM67;MAN1B1;UBE4A;AUP1;USP19;RNF103;BAG6;DNAJB2;EDEM1;UFD1;FBXO44;UBXN4;UBE2J1;NPLOC4;ECPAS;TRIM13;DNAJB14;RNF5;STUB1;SYVN1;FAM8A1;SELENOS;RNF103-CHMP3;TMEM129;FOXRED2;FAF2;UBQLN1;YOD1;SEC61B;SGTA;DNAJC18;UBQLN2;UBE2G2;FBXO2;STT3B
prerank,macrophage migration (GO:1905517),0.56013083807688,1.2834272153767659,0.18691588785046728,0.48895917241817216,1.0,5/13,18.96%,EDNRB;CCR2;CKLF;CCL5;P2RX4
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.44232218111831006,1.2829638482410262,0.1568627450980392,0.48934753293400235,1.0,9/44,11.94%,PRKAG2;OSBPL9;ALOX15;HMGCR;HSD3B7;CYP27A1;PMVK;OSBPL1A;LBR
prerank,response to estrogen (GO:0043627),0.4720358267381779,1.282892969665055,0.16720257234726688,0.48888417476366725,1.0,11/31,15.82%,ESR1;GHRL;ARID5A;TRIM24;ASH2L;SFRP1;BCAS3;SFR1;RARA;EP300;TRIM25
prerank,pulmonary valve morphogenesis (GO:0003184),0.5263964420088899,1.2826889573998153,0.2007042253521127,0.4887178491303108,1.0,3/17,4.49%,NOTCH2;JAG1;HEY2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3976660618293873,1.281540059005752,0.12428571428571429,0.49064945478222355,1.0,8/76,3.43%,NRP1;P2RX7;SNX9;ALOX15;FER;FCHSD2;CDC42;NES
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.5384253685830458,1.2813940530227794,0.21453900709219859,0.4903781990347563,1.0,6/16,12.86%,ZFP36L2;ZFP36L1;RC3H1;TRIM71;ZC3H12A;ZC3H12D
prerank,engulfment of apoptotic cell (GO:0043652),-0.48263852871440993,-1.2813322615851221,0.15418502202643172,0.77933033286204,1.0,8/15,27.76%,XKR6;RHOBTB2;XKR4;RHOH;ADGRB1;RHOG;XKR8;MEGF10
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3864507982697646,1.2810405743529498,0.10583446404341927,0.49060200819098226,1.0,25/101,13.39%,PF4;LYN;MEF2C;PTPN22;TNFRSF1B;LILRB1;TLR4;NR1D1;ADAM9;RHOA;LBP;BCL10;VIM;NFKBIL1;LY96;TNF;CD80;CDC73;MAPK14;CARD16;CD68;CHMP5;ZC3H12A;NOD2;NFKBIB
prerank,positive regulation of synaptic transmission (GO:0050806),-0.34120682639314226,-1.280997304983205,0.09025270758122744,0.7774139594953207,1.0,26/72,17.62%,RIMS1;PTK2B;ADCY8;SLC24A2;GRIK2;NLGN1;RIMS2;NRXN1;DLG4;LGMN;FLOT1;KCTD13;FMR1;SHANK2;CACNG7;GRIN2A;LGI1;CACNG8;VAMP2;SHISA7;EPHB2;ADCY1;RIMS3;SQSTM1;CACNG4;SYT1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.48185852886357494,1.2803657323460986,0.16749585406301823,0.4914806335008624,1.0,6/25,7.58%,IRF4;RPS3;SPTBN1;PDE4D;CD80;CCR2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.4332169241150755,-1.2790080797174106,0.14962593516209477,0.7817928144929625,1.0,6/23,7.76%,PTK2B;NOS1AP;ANK2;UBASH3B;CACNA2D1;PRNP
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5906031446859349,1.2788708551853998,0.1973929236499069,0.49422061164111,1.0,6/11,18.32%,LYN;SYK;JAK1;CCL5;PRKCQ;PLAUR
prerank,cellular response to insulin stimulus (GO:0032869),0.37353033520825596,1.2787491213608952,0.09350649350649351,0.49390734290293575,1.0,23/124,11.24%,HDAC9;MYO5A;TBC1D4;RAB31;FER;ATP6V1B1;RAB8B;RAB10;ZFP36L1;SLC2A4;GSK3B;IRS2;INSR;ATP6V0A1;GAB1;AP3S1;PIK3C2A;ATP6V1A;FOXC2;DENND4C;ZNF106;PHIP;SHC1
prerank,protein catabolic process (GO:0030163),0.4108172729814479,1.277651522947679,0.15384615384615385,0.4957640627439746,1.0,14/59,11.98%,APOE;RIPK1;SIAH2;NR1D1;CLN5;CLN6;PRKN;MANBA;TRIM24;ADAMTS9;LAMP2;CLPX;NGLY1;DENND3
prerank,cellular response to osmotic stress (GO:0071470),0.4901668590153525,1.2775692428953715,0.16803953871499178,0.495347252129035,1.0,4/21,3.70%,OXSR1;RCSD1;LRRC8D;ZFP36L1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.5936487821248082,1.2773382866319085,0.19439252336448598,0.49523966513466927,1.0,3/11,3.92%,LYN;MEF2C;RAPGEF2
prerank,regulation of gene expression (GO:0010468),0.3259259694204545,1.275865087623965,0.015166835187057633,0.4978175457966546,1.0,165/903,15.75%,RBPJ;PID1;MSR1;AHNAK;PF4;NELL1;APOE;P2RX7;APP;NOTCH2;CCR1;FOXP1;FBXW7;AHR;MBNL1;MYADM;RREB1;CRIP1;GAS6;FOXN2;ADAM19;NFXL1;ESR1;RPL23;C1QTNF1;LYN;HINT1;RPS3;MEF2C;PTPN22;NCOA2;CEBPB;KRAS;MITF;OSR1;RYBP;BMP2;XDH;PARP14;LILRB1;CD36;CD74;FGF23;DRD1;LAMP3;TLR4;CD46;ZFP36L1;RGCC;PRKN;NFKBIZ;PDE2A;TLR2;NR3C1;NKAP;HEY2;PTBP3;CDK6;CLOCK;SPI1;GSK3B;RB1;NDFIP1;INSR;RACK1;RC3H1;PUM2;ROCK1;TGFBRAP1;MBNL2;TCF7;ATXN1;SETDB2;HNRNPF;KDM6A;TNF;ZNF148;LYL1;KLF4;YY1;REL;RPL5;HFE;WNT6;PSEN1;PTBP2;IRF2;VSTM2A;TRIM68;RO60;TDRD7;ATRX;ZNF628;LIMD1;ESRRB;BACH1;MSN;TRIM27;GRSF1;LIN54;SMCR8;RPS7;HMG20A;ESR2;MAPK14;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;IGF1;TESMIN;SFRP1;RNF14;JMJD1C;MED26;SP1;ATXN1L;CASP8;EMILIN1;CREBBP;MYBL2;FOXK2;HINFP;NFIA;ROCK2;AFF1;LAMTOR5;TRIM71;ZC3H12A;ATP2B4;SLC38A2;TERF2IP;SP3;RAMP2;GJA1;LARP4;PEG3;PSPC1;ZNF326;RNF187;TNRC6C;KAT7;NDFIP2;STAT3;EP300;MLF2;HMGN5;ATXN7L3B;WWC1;NAB1;RPL11;NOVA1;BMPR1A;MYC;MYT1;NSD3;FN1;NLK;HDAC4;NR2C2;SFPQ;UBAP2;RUNX3
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5667088362987116,1.2756479438288246,0.21530249110320285,0.49767752174864666,1.0,6/12,22.93%,MYO7A;NKD1;DSCAM;STAT3;SDK2;PROM1
prerank,organonitrogen compound catabolic process (GO:1901565),0.41841408372351496,1.2756198593470243,0.13676470588235295,0.49712105827063935,1.0,12/57,10.29%,NPL;CPQ;PLA2G7;GNPDA1;CLN5;CLN6;PNPLA8;LNPEP;SGPL1;TRIM24;ENPEP;CLPX
prerank,histone H3 deacetylation (GO:0070932),0.5311219585190596,1.27537927721317,0.19073083778966132,0.4970376282001584,1.0,1/15,0.10%,HDAC9
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.47665039581553337,1.2749066584766178,0.1680129240710824,0.49743968332724126,1.0,7/29,13.88%,APOE;LDLR;ZBTB20;ELOVL5;CREB1;NR1H2;MFSD2A
prerank,negative regulation of cellular protein localization (GO:1903828),0.4563248382275387,1.2743596603841951,0.16585365853658537,0.4980181957309671,1.0,10/34,14.32%,CTNNA1;RIPOR2;MFHAS1;SPI1;GSK3B;LEPROTL1;SNX33;ROCK2;LATS2;NEDD4L
prerank,regulation of cation channel activity (GO:2001257),-0.3190960344524039,-1.2743233027957164,0.08178438661710037,0.7967616274112498,1.0,25/89,13.29%,CACNB2;FGF14;FGF12;DLG2;PTK2B;CACNB4;CALM2;GRIA2;NLGN1;DLG4;DLG3;GRIA4;FGF13;ANK2;CTSS;SHANK1;JPH1;GSG1L;ACTN2;CACNG7;MINK1;GRIN2A;CACNG8;VAMP2;SHISA7
prerank,embryonic heart tube development (GO:0035050),-0.49693923712618865,-1.2739195399268664,0.16993464052287582,0.7949883828236886,1.0,2/14,4.57%,NDRG4;ACVR1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.36812012142932227,-1.2733710416205202,0.11676646706586827,0.7938462587665701,1.0,17/44,23.61%,NDRG4;ACVR1;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;MICAL2;NOTCH1;SRF;ENG;BBS4;MKKS;CCDC40;STIL
prerank,myeloid dendritic cell activation (GO:0001773),0.5590454391437752,1.2729781028029428,0.1956124314442413,0.5005690361101603,1.0,3/12,5.19%,DOCK2;DCSTAMP;BATF2
prerank,microtubule depolymerization (GO:0007019),-0.4689526854765663,-1.2726470554943312,0.16666666666666666,0.7933932417056527,1.0,12/17,34.75%,NCKAP5L;STMN3;NCKAP5;STMN4;CKAP5;KIF2A;KATNB1;KIF14;KIF2C;KIF18B;KIF19;KIF24
prerank,proteasome assembly (GO:0043248),-0.5417791518964066,-1.2725965214007646,0.1812366737739872,0.7903636310700207,1.0,5/11,15.01%,PSMD13;POMP;PSMD9;PSMG2;PSMD4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4492534718030035,1.272405253549045,0.1664167916041979,0.5011526697421896,1.0,14/40,19.39%,FBXW7;RPL23;AXIN1;RPL5;HFE;RPS7;UBQLN4;RPL11;XPO1;PTEN;GLMN;RNF139;CSNK2A2;CSNK2A1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3991147721633928,1.2723627131722488,0.14972527472527472,0.5006319126352704,1.0,17/68,20.22%,FOLR2;TPK1;TCN2;MTR;MTHFD2L;LMBRD1;ABCC1;AOX1;MMAB;SHMT1;SLC23A1;SLC23A2;SLC5A6;BTD;ENPP1;CYB5A;MTHFD1L
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.4864999724759944,-1.2722173875726552,0.15765765765765766,0.7885657125467436,1.0,5/15,15.65%,HECW2;CENPE;NEK6;TACC3;RIOK2
prerank,positive regulation of leukocyte activation (GO:0002696),0.5080922544819043,1.271711328195988,0.19855595667870035,0.5013676181406755,1.0,5/18,8.45%,TSLP;HAVCR1;TLR4;LBP;CLEC4D
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5279897871994292,1.2715664155204744,0.1967509025270758,0.5011251743729933,1.0,2/17,3.32%,NRP1;CDC42
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.5331961239190429,-1.2715318574860162,0.18828451882845187,0.7879952948179003,1.0,3/11,8.69%,TREM2;CDH13;CCL3
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5326728945021644,1.2714695200325536,0.19720767888307156,0.5007428970851417,1.0,2/16,4.09%,AOAH;PGM2L1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.4424213910573554,-1.271394991994755,0.14832535885167464,0.78206659276733,1.0,6/21,9.13%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.4424213910573554,-1.271394991994755,0.14832535885167464,0.78206659276733,1.0,6/21,9.13%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.38407688004057206,-1.2712381351379272,0.1293800539083558,0.7795284646165973,1.0,8/35,12.45%,CDH23;CDH10;NLGN1;CDH13;CDH8;CDH9;CDH22;ATP2C1
prerank,cellular response to hormone stimulus (GO:0032870),0.4068463004748301,1.2710240136203899,0.13966480446927373,0.5010895290130226,1.0,20/69,13.92%,NCOA3;MEF2C;NCOA2;ZFP36L1;NR3C1;KLF9;ARID5A;CTSB;THRB;TRIM24;SFRP1;SLIT3;GAS2L1;BCAS3;RAMP2;SFR1;RARA;STAT3;ATP1A3;ATP1A1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5449165544690745,1.2709390481769907,0.22678571428571428,0.500673821603982,1.0,4/15,9.91%,REEP3;ATL1;RAB10;RTN4
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.41982769182102575,-1.2707403946168916,0.15815085158150852,0.7783746157008266,1.0,13/25,25.03%,LDB1;THOC1;DDX39B;CCNT2;ERCC6;HTATSF1;CCAR2;HMGN1;EAF1;ALYREF;ELL;CCNK;CCNT1
prerank,positive regulation of macrophage migration (GO:1905523),-0.447251284521915,-1.2705360820440355,0.15714285714285714,0.7760589275805196,1.0,7/19,10.34%,CSF1;TREM2;MAPK3;P2RY12;AKIRIN1;CCL3;CSF1R
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.39938881792859254,-1.2705138022167424,0.14958448753462603,0.7730392336961834,1.0,14/30,20.12%,HEXB;CHST11;CSPG5;CHPF2;CSPG4;HYAL1;DSEL;NDNF;IDUA;VCAN;BCAN;BGN;NCAN;UGDH
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5413731976820807,1.270010567739653,0.1872791519434629,0.5021339138054952,1.0,3/15,4.37%,ZFP36L2;ZFP36L1;NR3C1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.43614675253176505,-1.2694121275075654,0.15012106537530268,0.7739148277446063,1.0,10/20,16.91%,NCKAP1;FMNL2;RHOQ;NCKAP1L;FHOD1;LLGL1;STRIP1;LLGL2;ARF6;PLEK
prerank,cellular protein catabolic process (GO:0044257),0.42051052600370287,1.2691923022825282,0.1416184971098266,0.5032703945257032,1.0,17/59,13.96%,AP2A2;CTSC;CLTC;RIPK1;SIAH2;PRKN;CTSB;AP2S1;RAB7A;MDM2;CLPX;VLDLR;CASP8;PSMA6;DENND3;AP2B1;CLTA
prerank,regulation of cholesterol storage (GO:0010885),0.5375739783975625,1.2691185554761069,0.19348659003831417,0.5028282014128973,1.0,2/15,4.03%,MSR1;EHD1
prerank,mitotic DNA replication (GO:1902969),-0.5623265916103609,-1.268369831844541,0.1986754966887417,0.7748954018767814,1.0,6/10,26.87%,LIG1;MCM3;GINS3;MCM6;MCM2;MCMDC2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.476485107512203,-1.2683648051024603,0.17782909930715934,0.7718774905919974,1.0,6/16,17.73%,GPR137B;GPR137C;RRAGD;FLCN;SEH1L;RRAGB
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5530594209577538,1.2679501210175612,0.19807692307692307,0.5047989175606223,1.0,4/13,16.20%,SNX6;CBL;CBLB;ZGPAT
prerank,positive regulation of myelination (GO:0031643),-0.5353395612741966,-1.267620548294522,0.19264069264069264,0.7716061378860236,1.0,7/11,17.72%,PARD3;ITGAX;CST7;TENM4;TPPP;RNF10;EGR2
prerank,response to sterol (GO:0036314),-0.5421670942970588,-1.2672527503979356,0.18333333333333332,0.7699133261908444,1.0,5/11,21.93%,TGFBR1;CCL3;TGFBR2;ABCA2;TGFB1
prerank,regulation of interleukin-4 production (GO:0032673),0.5097362302473744,1.2671115373481008,0.225,0.5060687244545237,1.0,4/21,6.57%,IRF4;CEBPB;FCER1G;SYK
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5542049932946128,1.2668932191417135,0.21292775665399238,0.5059598585763608,1.0,3/13,2.77%,GAS6;TSLP;CD74
prerank,negative regulation of DNA replication (GO:0008156),0.5482474942833641,1.2667234299722232,0.21863799283154123,0.5057287474355793,1.0,4/13,16.18%,S100A11;GMNN;TERF1;ATR
prerank,negative regulation of axon extension (GO:0030517),-0.4050926497540277,-1.2666303623513295,0.14177215189873418,0.7691250829858907,1.0,7/30,9.71%,MAP2;SEMA4D;PTPRS;SEMA4C;DIP2B;SEMA4G;MAG
prerank,organic hydroxy compound transport (GO:0015850),0.458266111589008,1.2665777605082071,0.16300940438871472,0.5054817828915417,1.0,8/36,14.37%,SLC10A6;NR1H4;NCOA2;GHRL;ABCC4;SLC10A3;NPC2;RBP4
prerank,negative regulation of protein modification process (GO:0031400),0.38927541590660236,1.266533649916096,0.14931506849315068,0.5049871928291892,1.0,9/79,4.76%,PID1;LRP6;MYADM;LYN;MFHAS1;XDH;NIBAN1;PRKN;GSK3B
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4161348922165667,-1.2664100658144373,0.18863049095607234,0.7670229205914698,1.0,7/26,5.60%,RIMS1;PTK2B;NLGN1;RIMS2;NRXN1;DLG4;SHANK1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5837035353334072,1.2655056004304193,0.21189591078066913,0.5060252286762282,1.0,4/10,20.43%,PPP3CA;NFATC2;NFATC3;NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),0.5837035353334072,1.2655056004304193,0.21189591078066913,0.5060252286762282,1.0,4/10,20.43%,PPP3CA;NFATC2;NFATC3;NFATC1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.544697380859889,1.2654520855127318,0.2033271719038817,0.5055355087783718,1.0,6/14,14.80%,RHOA;ITGB1BP1;KLF4;STARD13;MMRN2;TBXA2R
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5684900189949411,1.2653369027657673,0.2184557438794727,0.5051974203807817,1.0,1/11,0.34%,NRP1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5441603697052328,1.2652492409629104,0.19855595667870035,0.504807516288015,1.0,5/15,8.74%,CD44;CD74;PRKN;BCL2;MDM2
prerank,regulation of T cell chemotaxis (GO:0010819),0.5742152236737283,1.265245678130422,0.188715953307393,0.5042233536096047,1.0,3/11,7.58%,OXSR1;WNK1;CCR2
prerank,response to interleukin-6 (GO:0070741),0.5832639497348958,1.2651801762653503,0.20415879017013233,0.503788012408752,1.0,1/10,0.05%,PID1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.41165908904464776,-1.2647416294522413,0.1340782122905028,0.7702649529338661,1.0,6/28,18.94%,SIRPA;CCDC88B;NCKAP1L;XRCC6;THY1;PYCARD
prerank,regulation of focal adhesion assembly (GO:0051893),0.42371489578954313,1.264704223407038,0.17066290550070523,0.5042785842210011,1.0,16/54,12.68%,NRP1;PTPRJ;PEAK1;RHOA;S100A10;ITGB1BP1;ROCK1;PTPRA;DUSP22;VCL;RCC2;CLASP1;CORO1C;SFRP1;ROCK2;BCAS3
prerank,DNA replication initiation (GO:0006270),0.44342931215321063,1.2641258633524395,0.17896389324960754,0.504951280261737,1.0,13/37,16.82%,ORC5;ORC2;POLE2;PRIM2;TOPBP1;RPA1;GMNN;PURA;POLE3;RPA3;POLE4;MCM8;PRIM1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.37812573002394095,1.2635663831679278,0.1362397820163488,0.5056161837316595,1.0,13/102,5.86%,HDAC9;MYO5A;TBC1D4;RAB31;FER;RAB8B;RAB10;ZFP36L1;SLC2A4;IRS2;INSR;ADCY9;NR4A1
prerank,regulation of small molecule metabolic process (GO:0062012),0.4717577568409446,1.263493080770542,0.16193656093489148,0.5051887107240369,1.0,6/28,12.35%,APOE;NR1H4;PRKN;FMO5;FOXK2;FOXK1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.46167105094211036,1.2633833400468584,0.1669449081803005,0.504825591832252,1.0,4/28,6.34%,MAP3K5;CEBPB;ERN1;BCL2
prerank,negative regulation of viral transcription (GO:0032897),0.5437935564369922,1.262856212562379,0.2147117296222664,0.5053679564493034,1.0,5/13,13.84%,IFITM3;LARP7;TRIM32;TRIM27;MID2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4177007977121985,1.2624068587361912,0.16187594553706505,0.5057751985447183,1.0,7/53,12.60%,HRH1;CCR1;CALCRL;DRD1;TSHR;HTR1D;HTR6
prerank,proteoglycan metabolic process (GO:0006029),-0.4144564845901996,-1.2623313997715269,0.17402597402597403,0.7762107982174454,1.0,10/26,17.94%,CHST11;XYLT1;BMPR1B;HS3ST4;SULF1;CANT1;GAL3ST4;HPSE;B4GALT7;CHST10
prerank,regulation of response to external stimulus (GO:0032101),0.37805916781996163,1.261743283625503,0.1286624203821656,0.5067770055947446,1.0,29/121,16.92%,FCGR2B;ALOX5;FOXP1;ALOX15;BST1;PTPN22;CD36;GRN;BIRC3;PDE6A;PDGFRA;GUCY2D;STK24;ZMPSTE24;CXCR4;CCR2;PPEF1;CALM1;CASP8;PSMA6;USP14;NOD2;SAMHD1;SEMA7A;GRK4;ERAP1;BRD4;TIRAP;RELA
prerank,nuclear export (GO:0051168),-0.32179920451187377,-1.2613211771623964,0.10181818181818182,0.7768035670826753,1.0,37/80,32.48%,THOC1;SRRM1;SRSF5;NXF1;DDX39B;SRSF3;SRSF2;RANBP17;RANBP3L;RNPS1;U2AF1;UPF3B;CASC3;NCBP1;HNRNPA1;SRSF11;EGR2;THOC3;SRSF9;POLDIP3;ALYREF;U2AF2;SMURF1;TGFB1;RITA1;CSE1L;SRSF6;EIF4E;RANBP3;NUP214;CHP1;MALT1;NEMF;THOC7;U2AF1L4;STRADB;PKD1
prerank,positive regulation of tissue remodeling (GO:0034105),0.6007823099058178,1.2606505745859888,0.2075134168157424,0.5086334811577813,1.0,3/10,11.99%,IL15;ROCK1;ROCK2
prerank,type I interferon signaling pathway (GO:0060337),0.43769782282997116,1.2603555266846482,0.1674074074074074,0.5081313379206113,1.0,11/41,11.81%,IRF4;IFITM3;OAS2;IFNAR1;RNASEL;BST2;IFNAR2;IRF2;IFITM2;SP100;JAK1
prerank,cellular response to type I interferon (GO:0071357),0.43769782282997116,1.2603555266846482,0.1674074074074074,0.5081313379206113,1.0,11/41,11.81%,IRF4;IFITM3;OAS2;IFNAR1;RNASEL;BST2;IFNAR2;IRF2;IFITM2;SP100;JAK1
prerank,regulation of programmed cell death (GO:0043067),0.3584474289796579,1.2602452043658454,0.1211750305997552,0.5077850102713816,1.0,29/161,12.84%,TNFRSF25;HIP1;NLRC4;IFT57;TPT1;RARG;RPS3;DAPK1;STEAP3;RIPK1;PRKN;BIRC3;CTSB;ACER3;NOP53;TRIM24;TNF;HTATIP2;RTN4;FBXO11;NUP62;CHM;DFFA;CREBBP;KANK2;WFS1;FBXO10;PPP1R13B;GLS2
prerank,body fluid secretion (GO:0007589),-0.4734141698420933,-1.2601176717883562,0.18018018018018017,0.7782190563005971,1.0,11/15,49.38%,ERBB4;SLC22A4;GUCA1B;NPR1;APLN;VEGFA;VIP;PRLR;OXTR;CSN3;SLC22A2
prerank,regulation of cell killing (GO:0031341),0.5215124125680036,1.2586303377287,0.20572450805008943,0.5106731542050601,1.0,1/16,0.45%,CFH
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5205256292791858,-1.2582272123523022,0.18101545253863136,0.7824122893558432,1.0,5/13,24.65%,SORL1;GCC2;BRSK2;CD81;TM9SF4
prerank,dendritic cell differentiation (GO:0097028),0.4930327886736494,1.2575359182746793,0.18088737201365188,0.5125034163270964,1.0,6/22,5.19%,GAS6;LYN;LILRB1;DCSTAMP;CCL19;BATF2
prerank,positive regulation of vasculogenesis (GO:2001214),0.5889601592422264,1.257291214915815,0.2333965844402277,0.5124492368404998,1.0,3/10,4.84%,RIN2;RAPGEF2;RAP1A
prerank,transcription by RNA polymerase II (GO:0006366),0.3373210540719815,1.2569581249326645,0.07519640852974187,0.5125669200762577,1.0,74/305,17.68%,RBPJ;HDAC9;MAF;NOTCH2;RREB1;C5AR1;ESR1;RARG;NR1H4;NR2C1;NR1D1;CDK12;NR3C1;NFIC;THRB;CBFB;NR4A1;TRIM24;NELFA;CPSF3;MED16;TBL1XR1;NR4A2;RNGTT;IWS1;CDC73;NCOR1;GTF2A2;SNRPG;ESRRB;SCAF8;MED18;TBL1X;ESR2;MED20;RPRD2;NR2F1;POLR2B;MED26;MAML1;SP1;TFDP1;PCID2;ELOF1;CREBBP;GTF2E2;EAF2;CDK13;DEK;ELP4;NFIX;GTF2A1;KLF13;NR1H2;RARA;MBD1;POLR2D;MED27;SNW1;PAPOLA;ELOC;WDR33;NR2C2;GTF2H3;CPSF2;GTF2B;MED17;NR5A2;LHX1;TAF12;XBP1;GTF2H1;INTS1;NR6A1
prerank,histone H3 acetylation (GO:0043966),-0.3694528522423588,-1.2568570841132467,0.15217391304347827,0.7845532473019388,1.0,9/40,11.07%,PHF14;LDB1;ING4;TADA1;WDR5;NAA60;SUPT7L;MBIP;BRCA2
prerank,response to glucagon (GO:0033762),-0.44403736684613676,-1.2563396748120748,0.18048780487804877,0.7835233566151485,1.0,5/19,10.15%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.4983838509659169,-1.2563158501009486,0.17972350230414746,0.7806719586543062,1.0,6/13,20.72%,CACNB2;ANK2;CACNA1C;KCNN2;GJC1;KCNJ3
prerank,positive regulation of protein secretion (GO:0050714),0.3935422743258024,1.255964360497689,0.14447592067988668,0.5141595926291297,1.0,21/69,14.92%,TCF7L2;ANG;C1QTNF3;EXPH5;TLR4;ADAM9;TLR2;MCU;IRS2;GHRL;TMED10;GOLPH3L;CD33;IGF1;WLS;ACHE;DOC2B;GLUD1;TRH;RBP4;PPIA
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4915961761954154,1.2559574126354536,0.18229166666666666,0.5135945633695301,1.0,4/22,7.58%,EDNRB;GNAI3;STIM1;CCR2
prerank,regulation of histone deacetylation (GO:0031063),-0.5041740113935073,-1.2550844856874415,0.19696969696969696,0.7822255313821179,1.0,5/13,23.54%,AKAP8L;SAP30BP;AKAP8;CAMK2D;CTBP1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4903541340051953,1.2548584758822043,0.20394736842105263,0.515489267932925,1.0,10/24,19.75%,ALOX5;PRKN;RACK1;WFS1;NR1H2;USP25;CREB3L1;XBP1;TXNDC12;TMBIM6
prerank,phospholipid transport (GO:0015914),0.4220341327058469,1.2547532988484038,0.1811263318112633,0.5151438091392075,1.0,6/52,3.71%,PLTP;APOE;LDLR;ATP11C;ATP8B4;PITPNA
prerank,negative regulation of interleukin-10 production (GO:0032693),0.525700780689359,1.2547373782553501,0.20790378006872853,0.514590567836864,1.0,2/16,2.74%,FCGR2B;LILRB1
prerank,ncRNA 3'-end processing (GO:0043628),-0.4806948953618807,-1.253962357311001,0.18599562363238512,0.7835298720038406,1.0,5/14,25.27%,INTS6L;PTCD1;TRNT1;TOE1;INTS7
prerank,positive regulation of neurogenesis (GO:0050769),-0.33473570089873983,-1.2538569134938722,0.08445945945945946,0.7809535109973011,1.0,17/68,12.44%,CX3CR1;NUMB;CUX1;CTNNB1;PTPRD;ROBO2;PLXNA2;TGM2;SS18L1;ROBO1;NUMBL;MAP6;TIAM1;CAPRIN1;TIAM2;SS18L2;IL1RAPL1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.42862999443714,-1.2538141621506682,0.15594059405940594,0.7782061111993599,1.0,7/21,21.06%,CALM2;SLC8A1;ANK2;AKAP6;CACNA1C;CAMK2D;CALM3
prerank,epithelial cell-cell adhesion (GO:0090136),0.5734138737878309,1.2537758155856855,0.23486238532110093,0.5162315633586392,1.0,4/11,11.09%,SERPINB8;THBS4;VCL;JUP
prerank,female gonad development (GO:0008585),0.5006509290544536,1.253611459816226,0.19185059422750425,0.5160300373753743,1.0,2/19,2.18%,ANG;CEBPB
prerank,lamellipodium organization (GO:0097581),0.46264345891234415,1.2532916119001725,0.18566775244299674,0.5161802637660315,1.0,13/29,24.55%,SNX2;ITGB1;VCL;S1PR1;PARVB;SPEF1;GOLPH3;ARFIP2;ARHGEF6;KIT;PTPRO;CCDC88A;SNX1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5583379856571541,1.2528752566973163,0.21317157712305027,0.5164515662885408,1.0,3/12,6.70%,DSE;UST;CHST12
prerank,carbohydrate homeostasis (GO:0033500),0.3992259748156857,1.2526210496330574,0.16807909604519775,0.5164081396901349,1.0,13/67,14.48%,ALOX5;TCF7L2;SLC2A4;MCU;INSR;ADIPOR2;RPS6;WFS1;SLC8B1;KCNB1;STAT3;RBP4;USF1
prerank,establishment of endothelial barrier (GO:0061028),0.46961049387658255,1.2525663487339744,0.19809825673534073,0.5159517166966461,1.0,9/29,9.53%,RAP1B;MYADM;RAP2B;RAPGEF2;PDE2A;RAP1A;PDE4D;MSN;RAB1A
prerank,ERBB signaling pathway (GO:0038127),0.3989073802541012,1.2523302908764142,0.13682678311499272,0.5158895929701834,1.0,9/64,8.29%,EGFR;IQGAP1;PTPN18;REPS2;PTPN12;CBL;KIF16B;GAB1;PIK3C2A
prerank,activation of GTPase activity (GO:0090630),-0.3203190897996261,-1.2522203892144226,0.0796812749003984,0.7811987036168558,1.0,22/89,11.25%,ARHGAP45;SIPA1L2;ARHGAP24;TBC1D16;TBC1D8;ARHGAP25;GARNL3;SGSM3;GMIP;SGSM2;TBC1D10A;NTRK3;ARHGAP22;RASGRF1;TBC1D22A;TBC1D22B;TIAM1;TBC1D9B;TIAM2;ABR;EVI5L;TSC1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5155592675979065,1.2521627640479043,0.20035460992907803,0.5157019065109664,1.0,5/17,9.25%,CD44;CD74;PRKN;MDM2;DYRK1A
prerank,regulation of smooth muscle contraction (GO:0006940),0.5041378939457879,1.2515148886954746,0.20341880341880342,0.5165746704150866,1.0,2/20,2.53%,ATP2B1;ADRB2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5089208508840533,1.2515144581628617,0.21291448516579406,0.51599228634472,1.0,2/18,1.00%,APOE;CTSC
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5437905549004415,1.2511449145176778,0.2158671586715867,0.516264071108516,1.0,6/12,21.17%,ADSS2;LHPP;IMPDH2;ADSS1;GMPS;PAICS
prerank,B cell activation involved in immune response (GO:0002312),0.5523671060974542,1.2509175296449089,0.21102661596958175,0.5162139778845447,1.0,2/13,2.01%,FCGR2B;LIG4
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4829576439964332,1.250856903069888,0.2167235494880546,0.5157841988713919,1.0,4/26,4.56%,C1QC;LILRB3;TLR4;CDK6
prerank,inner ear morphogenesis (GO:0042472),-0.4375951559008287,-1.2504745709693046,0.17,0.7847873970720769,1.0,7/22,16.10%,CHD7;FGFR2;MYO6;PAX8;ZIC1;EPHB2;MYO3B
prerank,positive regulation of axonogenesis (GO:0050772),-0.3686663872794853,-1.2503527354552209,0.1346153846153846,0.7823996204195989,1.0,19/43,22.66%,SEMA4D;ROBO2;PLXNA2;ROBO1;ZFYVE27;MACF1;TWF2;BDNF;MAPT;MAP6;TIAM1;TIAM2;LIMK1;CDKL5;DBN1;PLXNB2;PLXNB3;PLXNB1;CHODL
prerank,protein localization to condensed chromosome (GO:1903083),-0.5128929299598813,-1.2497883350505758,0.21739130434782608,0.7815888674252376,1.0,7/12,29.81%,KNL1;SPDL1;ZW10;IK;CDK1;AURKB;TTK
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4571638553045297,1.2497549002997714,0.196513470681458,0.517730061812668,1.0,7/30,9.25%,TPT1;RPS3;CD44;CD74;TRIM32;MDM2;DYRK1A
prerank,chromatin assembly or disassembly (GO:0006333),-0.5306574137581057,-1.2495700810230768,0.1926977687626775,0.7795420707550217,1.0,8/11,38.23%,HDAC8;TP53;HIRIP3;CHAF1A;MTA2;NOC2L;SUV39H2;M1AP
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5236652822727244,-1.2495682283124925,0.20084566596194503,0.7767310452434253,1.0,6/11,25.54%,P3H2;OGFOD1;EGLN2;P4HTM;P4HA1;P4HA3
prerank,receptor internalization (GO:0031623),0.4321155419835733,1.2493237787828921,0.183206106870229,0.5181701650474786,1.0,10/44,6.71%,RAB31;CLTC;ITGB1;CALCRL;FCER1G;LILRB1;CD36;ADM;SYK;LMBRD1
prerank,negative regulation of calcium ion transport (GO:0051926),0.5379493431083291,1.2488269523060063,0.22727272727272727,0.518673966823162,1.0,8/15,23.06%,LILRB1;TRIM27;CD33;PLN;SLC30A1;INPP5K;TMBIM6;PACSIN3
prerank,histone H3-K4 methylation (GO:0051568),0.466476234671374,1.2487409637998939,0.20234113712374582,0.5182780580553644,1.0,7/26,9.43%,KMT2A;KDM6A;TET3;ASH2L;KMT2C;WDR82;BEND3
prerank,protein neddylation (GO:0045116),-0.5009936399074124,-1.2486913609186092,0.1888412017167382,0.7772686609679123,1.0,7/13,33.61%,UBA3;RBX1;RNF7;DCUN1D2;DCUN1D5;DCUN1D3;DCUN1D4
prerank,intracellular cholesterol transport (GO:0032367),0.545860297504698,1.2484356349921926,0.21062271062271062,0.5183216647111152,1.0,2/15,1.24%,LRP6;LDLR
prerank,ganglioside metabolic process (GO:0001573),-0.43540097850253817,-1.247647413617836,0.16435185185185186,0.7782193709510341,1.0,5/20,7.53%,HEXB;ST3GAL5;ST6GALNAC3;NEU1;ST6GALNAC4
prerank,regulation of leukocyte activation (GO:0002694),0.5451368805498242,1.2474945670237731,0.2459016393442623,0.5198527050805675,1.0,4/14,8.69%,LYN;MFHAS1;CD74;CD33
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.42604360232668725,-1.247155839295835,0.18329466357308585,0.7772572528995308,1.0,7/21,11.84%,PTK2B;CSF1;MAPK3;AKIRIN1;CSF1R;MTUS1;MIF
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.5530211462024403,1.2468800505907438,0.21428571428571427,0.520658860660005,1.0,4/12,15.70%,DPYD;DPYSL2;CRMP1;DPYSL5
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5366920126964714,1.2461358309530923,0.22994652406417113,0.5216740607583623,1.0,7/14,20.58%,CMPK1;NMNAT3;NMNAT2;AK8;AK3;AK4;ME1
prerank,covalent chromatin modification (GO:0016569),-0.49633000347593265,-1.2460428129116001,0.19376391982182628,0.7783434439147828,1.0,8/14,33.91%,SIRT7;PARK7;HDAC1;AURKB;MBD2;HLCS;HELLS;SIRT1
prerank,cell-cell junction organization (GO:0045216),-0.324363330279221,-1.2460080094090977,0.1048951048951049,0.7757282125036286,1.0,25/79,19.58%,CADM1;TJP1;CDH10;SDK1;CDH2;CDH13;TLN2;CDH8;TJP2;FLCN;CADM2;NECTIN2;CSF1R;AFDN;PKP4;TLN1;CDH9;CDH22;CTNND2;CXADR;MARVELD2;CDH4;ARVCF;TGFB2;GJC1
prerank,regulation of chromatin binding (GO:0035561),0.5961675306019796,1.2451158148750816,0.24157303370786518,0.5233021606050599,1.0,4/10,9.43%,DDX11;GMNN;BTAF1;KDM4D
prerank,import into cell (GO:0098657),-0.36953777184961384,-1.2448439053699736,0.15151515151515152,0.7770600182812388,1.0,13/41,23.77%,SLC1A3;TREM2;IL10RA;SLC36A1;SNAP25;SLC11A2;SLC7A8;SLC12A6;SLC39A14;LRSAM1;SLC12A4;SLC22A4;SLC27A1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5078001778402966,1.2447910387617733,0.22262118491921004,0.5234065008587435,1.0,6/17,16.81%,NRP1;S100A11;IGF1;DOCK7;MDK;CCL5
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4163930736582468,1.2447466287536648,0.19407407407407407,0.5229217483663406,1.0,12/51,11.99%,NRP1;GPR65;CDC42;ARHGEF10L;RHOA;RGCC;S100A10;ITGB1BP1;SFRP1;SYNPO;PXN;ROCK2
prerank,positive regulation of histone modification (GO:0031058),-0.3882014815222428,-1.244102667338578,0.16290726817042606,0.7771973974962428,1.0,8/33,11.96%,CDK9;AKAP8L;MAPK3;FMR1;SAP30BP;BRCA1;PAF1;AKAP8
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5038890468060033,-1.2439479844172692,0.20212765957446807,0.7750904340121128,1.0,5/12,21.99%,PLEKHH2;PLEK;LIMA1;SH3BP1;WDR1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.512854359535425,1.2435590128570317,0.2014388489208633,0.5249948793581426,1.0,5/16,15.70%,DPYD;DPYSL2;CRMP1;TET2;DPYSL5
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.44609801628281853,-1.2430860993216268,0.20149253731343283,0.7756280626651447,1.0,5/19,18.04%,PRKCD;DAGLB;ABCD2;MTLN;ANGPTL3
prerank,positive regulation of chromatin organization (GO:1905269),0.5376458208665452,1.242940735968556,0.20488721804511278,0.5257579999326092,1.0,6/12,14.27%,MIER1;ATRX;H3-3A;TERF2IP;UBE2N;TERF1
prerank,cardiac muscle cell differentiation (GO:0055007),0.49286764601155575,1.2427715760260027,0.21227197346600332,0.5255420427889597,1.0,4/21,2.92%,MEF2C;BMP2;MYH6;ALPK3
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4942784563546926,1.2427616112012012,0.18518518518518517,0.5249897006930452,1.0,7/22,11.99%,MEF2A;SMAD4;ROCK1;GLRX3;MTPN;IGF1;ROCK2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.521655248349354,1.2426332631845451,0.21783876500857632,0.524687698853004,1.0,2/15,1.24%,FBXW7;LDLR
prerank,circulatory system development (GO:0072359),0.3640807160513144,1.2425086069601634,0.13838120104438642,0.524420564571853,1.0,23/118,14.70%,HDAC9;PDLIM5;FBXW7;MEF2A;CRIP1;MEF2C;OSR1;BMP2;ALPK3;HEY2;PDLIM1;KDM6A;CACYBP;NCOA6;FOXC2;CASP8;WDR11;RAMP2;POPDC3;BCOR;RBP4;SMYD4;PKD2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.4071167854998036,1.2422354912754388,0.17296511627906977,0.524419083869649,1.0,7/51,8.25%,CCR1;CMKLR1;GAS6;ANO6;PLA2G7;CCR2;IL6R
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.512198305048197,1.2411327353432362,0.2198581560283688,0.5262804356330665,1.0,5/18,8.14%,EGFR;ESR1;RIPK1;TNF;NCOR1
prerank,central nervous system development (GO:0007417),-0.2693669403019841,-1.2408039669141526,0.023255813953488372,0.7813352644968253,1.0,86/250,20.70%,CX3CR1;MBP;CHD7;NCKAP1;ADGRL3;MOG;ROBO2;EPHA7;ZFHX3;CNTNAP2;CDH2;PBX2;ELP3;BPTF;PITPNM1;AFF2;AATK;NDRG4;APOD;NF1;CIC;JRKL;CNTN4;SYNJ2;CNTN6;LOXL3;AHI1;RNF103;SERPINI1;BAG6;PPT1;MAL;RAB18;S100B;UTP3;GBA2;ZFHX2;ADAM22;MEIS3;SHROOM2;TBX6;GRIN2A;SPOCK1;TPPP;NKX2-2;SOX10;SMARCA1;PAX8;ALDH5A1;NPTX1;PROX1;EML1;CTNS;MEIS1;ANKLE2;TGFBR2;DSCAML1;EEF1AKMT4-ECE2;ZIC1;POU6F1;SHROOM4;MARCKS;CDK5RAP3;SMG9;TBC1D23;DCLK1;DNAJC30;ADGRL2;VCAN;SMO;VIT;BCAN;SH3GL2;EGR2;TPP1;PBX1;ZIC4;PTPN11;NCAN;PLXNB2;PAFAH1B3;ROGDI;HAP1;NNAT;SOX11;CDK5RAP1
prerank,peptidyl-arginine modification (GO:0018195),0.5261727928595568,1.2406436616413037,0.2188612099644128,0.5267588604721909,1.0,1/15,0.54%,PADI4
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4045797798033433,-1.2404771072762604,0.18716577540106952,0.7798155502609595,1.0,7/29,9.40%,DPP10;FGF12;DPP6;SNTA1;KCNIP4;CACNA1D;WNK3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4605905586226795,-1.2401066458971566,0.19708029197080293,0.7784261875342331,1.0,6/17,19.59%,ATP1B1;SLC8A1;ATP1B2;CACNA1C;GJC1;GJD3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.42495850171227184,-1.2395605841066943,0.17590361445783131,0.7776373886203198,1.0,5/22,9.42%,MVB12B;PTPN23;SNF8;TOM1L1;VPS37A
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.5319738892461802,-1.239355556301806,0.2149122807017544,0.7756547478129479,1.0,4/10,6.57%,CD9;PRKCD;SERPINE2;RDX
prerank,glial cell development (GO:0021782),0.4741350542908302,1.239270543969177,0.1969439728353141,0.5292981090745628,1.0,4/25,4.56%,NRROS;APP;TLR2;CDK6
prerank,lung epithelium development (GO:0060428),0.5787872617443404,1.2391638807753718,0.23540489642184556,0.5289851596532854,1.0,2/10,4.62%,RCN3;GRHL2
prerank,neutrophil chemotaxis (GO:0030593),0.41284625478150755,1.2385610807445313,0.20574886535552195,0.5297624984913852,1.0,12/53,17.31%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24;CKLF;ITGB2;PPIA;CCL5;CCL25
prerank,negative regulation of protein kinase activity (GO:0006469),0.37854930815672155,1.2385225731562823,0.1711229946524064,0.5292507690012052,1.0,15/88,9.55%,LRP6;GNAQ;SPRED1;DEPTOR;PRKAG2;SH3BP5;ITGB1BP1;RB1;PAK2;SFN;CEP85;HSPB1;TRIM27;SMCR8;CORO1C
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5068091248427116,1.238239321476613,0.22401433691756273,0.5292977972410338,1.0,6/16,16.33%,ADSS2;LHPP;IMPDH2;AMPD3;ADSS1;GMPS
prerank,secretion (GO:0046903),-0.47727451198538584,-1.2379370273321353,0.2074235807860262,0.7781044191830334,1.0,7/14,33.65%,RIMS1;TPD52;SLC22A4;PRKCI;GUCA1B;NPR1;FBLN5
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5608023216405883,1.237873107332312,0.21361058601134217,0.5295163862616333,1.0,5/11,16.96%,LYN;MFHAS1;CYBA;TIRAP;ACOD1
prerank,microglial cell activation (GO:0001774),0.4841275071870042,1.2378396652110129,0.21080139372822299,0.5290054327970268,1.0,5/21,6.94%,APP;C1QA;C5AR1;GRN;TNF
prerank,regulation of JNK cascade (GO:0046328),0.3700915520907227,1.2378276157209394,0.1401098901098901,0.5284594702520248,1.0,15/101,8.50%,FCGR2B;EGFR;APP;MAP3K5;MFHAS1;RASSF2;SH3RF1;RIPK1;AXIN1;CCL19;PRKN;SDCBP;DUSP22;NCOR1;MAPK8IP2
prerank,cellular response to oxidative stress (GO:0034599),0.3617171636080795,1.2377507034629147,0.13753213367609254,0.5280532078917584,1.0,31/118,17.04%,EGFR;CYBB;FER;RPS3;DAPK1;HMOX1;CAMKK2;PTPRK;PDGFRA;SLC25A24;VRK2;MSRA;RAD52;CYCS;TXNRD2;PXN;NCF2;ROMO1;FOXO3;RBM11;ZC3H12A;ERO1A;AGAP3;FOXO1;CYBA;PKD2;PPIA;NOX4;ARNT;PRDX3;PRDX2
prerank,inhibitory synapse assembly (GO:1904862),-0.5129391983884328,-1.2373835333715864,0.20910973084886128,0.777433901192786,1.0,7/11,28.03%,GABRB3;FGF13;GABRA2;GABRG2;WNT5A;PLXNB1;CBLN4
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.314689102223917,1.2373411985543046,0.005,0.5284280013218039,1.0,361/1667,18.02%,RBPJ;DAB2;PID1;HDAC9;ZEB2;MAF;TRPS1;PF4;ETV1;EDNRB;EGFR;LRP6;APOE;APP;KLF2;CHP2;TCF7L2;TCF4;IRF4;FOXP1;PPP3CA;FLI1;MEF2A;AHR;ZBTB16;RREB1;TFEC;KMT2A;HIVEP2;ESR1;RPL23;SMURF2;ZBTB20;RBBP8;NCOA3;JAG1;RARG;TCF12;MEF2C;NR1H4;ACTR3;RPS27A;NCOA2;CEBPB;MITF;PIAS1;OSR1;NCOA5;TSHZ3;BMP2;RIPK1;KLF6;ARID4B;LILRB1;TBX15;PHF8;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;WNT2;ALX1;HOXA10;TLR4;NR1D1;CRK;CDK12;RPS6KA3;RGCC;BAZ2B;ITGB1BP1;PRKN;TOX4;LARP7;PDE2A;PHF20;TLR2;FRK;NR3C1;NKAP;IRF2BP2;HEY2;CTDSP1;CLOCK;GRHL2;PBX3;DMRTA2;ARID1B;SPI1;SAP130;NCOA7;RB1;KLF9;KDM7A;NFIC;USP9X;ARID5A;BATF2;SMAD4;ZFP2;ELF2;TRIM33;THRB;IRX2;CBFB;PHF21A;NR4A1;RNASEL;FOSL2;ORC2;TCF7;ZBTB25;CD40;ATXN1;PIAS2;NOP53;EPC1;ACVR2A;MED13L;DMAP1;FOXM1;ZNF235;SDCBP;ZNF568;TNF;KLF3;ZNF148;TSHZ1;LYL1;KLF4;EPC2;ZSCAN25;YY1;BRMS1L;DUSP22;MIER1;REL;HTATIP2;THAP11;GATAD2A;MED16;SATB2;TBL1XR1;STAT4;PRKCB;CEBPG;E2F5;PSEN1;FIZ1;NR4A2;LHX5;NRIP1;IRF2;KLF10;IRX5;CDC73;RPS14;NCOR1;ZBTB5;ATF6;FNIP1;ATRX;TET3;NCOA6;FOXC2;MIDEAS;ARID3A;ESRRB;BRIP1;BACH1;TRIM27;MDM2;KMT2C;LCORL;OLIG2;HIVEP1;MED18;TBL1X;ESR2;LRRFIP1;UBE2D3;MAPK14;FOXJ3;ATF7;NFATC2;MED20;MAMLD1;MED6;BEND3;IGBP1;ASXL1;MLXIP;MYDGF;LCOR;STAT6;NR2F1;USP16;PURA;ZNF205;IGF1;RIPK2;RFX2;RNF14;JMJD1C;ARRB1;RNF111;ZNF296;SPEN;CREBRF;RCOR2;SP100;MED26;MIER3;MAML1;SP1;TFDP1;ELF1;HSBP1;JUP;PHIP;ETS2;MLLT10;SREBF2;CREBBP;EAF2;KANK2;BCL11B;MYBL2;FOXK2;MED15;CDK13;HINFP;WFS1;NFIA;CRTC3;FOXO3;BUD31;RPL10;DCAF6;DEK;ZC3H12A;ATP2B4;FOXK1;LOXL2;TADA2B;NAMPT;BCAS3;ZBTB8B;NOD2;ELP4;ZFP3;CHD2;SP3;NFIX;FOXO1;TNFRSF1A;CREB1;CCNQ;PEG3;KLF13;CTBP2;ZBTB7C;WWOX;TFR2;NR1H2;ZBTB10;RARA;TNRC6C;KAT7;HIF3A;TET2;STAT3;EP300;KLF5;PROX2;BCOR;WASL;JUND;NEDD4L;CRLF3;KAT6A;MED27;USF1;PRKD2;PKD2;WWC1;RTRAF;SNW1;ELOC;GATAD2B;ENY2;BMPR1A;MYC;MTF1;MYT1;SMARCD1;HDAC4;KDM2A;NR2C2;ZHX1;SFPQ;SENP1;ARID1A;RUNX3;ELK1;HEXIM2;GTF2H3;E2F8;KDM1A;ZFP62;HOXB3;POU5F2;CREB3L1;MAPK7;HCFC1;ZGPAT;PTEN;ZNF569;PPARGC1B;ACTR2;PPM1A;LIN37;PER1;ZNF177;TBX2;NFATC3;ARNT;RCOR1;BRD4;GLIS2;MED17;FOXP2;NR5A2;RELA;LHX1;NACC1;CARF;ZBTB7A;NR2F2;ZNF22;XBP1;MEF2B;GTF2H1;MECOM;ARID4A;ZFP28;IL6;HGF;NR6A1;SP8;GMEB1;ZNF32;ZBTB41;EFNA1;GZF1;SS18;BATF;HSF5;ZBTB12;ZBTB40
prerank,estrogen metabolic process (GO:0008210),0.5257311093155309,1.2372856727603916,0.24179620034542315,0.5279750363539633,1.0,4/15,9.82%,UGT1A7;UGT1A1;SULT1A1;HSD17B7
prerank,response to calcium ion (GO:0051592),0.36917882191528195,1.2365446898047932,0.14597544338335608,0.5291055384253377,1.0,16/102,8.32%,CHP2;IQGAP1;PPP3CA;MEF2A;ALOX15;MEF2C;ALOX5AP;ADAM9;KCNMB1;CPNE2;CLIC4;CPNE7;SLC25A24;CPNE8;STIM1;HOMER1
prerank,negative regulation of binding (GO:0051100),0.38470569550762257,1.2357677954968758,0.1643835616438356,0.5302382265604769,1.0,15/81,11.02%,DAB2;NES;ITGB1BP1;GSK3B;RACK1;CFHR2;ROCK1;DISC1;ACTB;DDX11;BTAF1;PLN;CARD16;SP100;PPP1CA
prerank,cytosolic calcium ion transport (GO:0060401),0.4677471685402046,1.2353589553116573,0.22056384742951907,0.5305800910688511,1.0,8/28,14.90%,MCUB;ATP2B1;MCU;ADRA1A;MICU3;SLC35G1;ATP2A2;ITPR3
prerank,regulation of neuroinflammatory response (GO:0150077),0.5000334479487794,1.2353001712830942,0.21228070175438596,0.5301267582849285,1.0,6/19,9.90%,NUPR1;TNFRSF1B;NR1D1;CD200R1;TNF;IGF1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5378707631992732,1.2349954440230149,0.2236842105263158,0.5302034714079241,1.0,5/15,11.99%,MEF2A;ROCK1;MTPN;IGF1;ROCK2
prerank,regulation of potassium ion transport (GO:0043266),-0.39284185324153476,-1.2346964310062145,0.17473118279569894,0.7841830803490657,1.0,7/31,8.72%,DPP10;PTK2B;DPP6;KCNIP4;ANK2;CACNA1D;ACTN2
prerank,neuron projection extension (GO:1990138),0.4463688629338989,1.2345702908494627,0.2009966777408638,0.5305985013621995,1.0,6/32,8.15%,NRP1;IQGAP1;TNN;USP9X;ALCAM;ULK2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5588393019131621,1.2344047927167143,0.2346368715083799,0.5303748445130241,1.0,3/11,9.91%,ATL1;VCPIP1;RTN4
prerank,cytoplasmic microtubule organization (GO:0031122),-0.34584754035930926,-1.2341166044088714,0.14814814814814814,0.7835145637116024,1.0,20/54,20.58%,DST;CCDC88B;DYNC1H1;CAMSAP1;FIGN;CLIP2;CRIPT;MAPT;TUBGCP5;PLK3;STMN3;TPPP;NUMA1;TUBGCP3;CLIP3;LIMK2;WDR73;FSD1;TUBGCP6;CLIP4
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4310165710840901,1.234008015875867,0.21147540983606558,0.5306341213917378,1.0,10/39,14.37%,TCF7L2;MCU;IRS2;GHRL;HFE;DOC2B;GLUD1;TFR2;TRH;RBP4
prerank,protein complex oligomerization (GO:0051259),0.38303524977825704,1.2333382373120643,0.17997293640054127,0.5316289681692438,1.0,12/85,9.43%,HGSNAT;NLRC4;EHD4;ATL1;LRRC8D;EHD1;BCL10;MCU;MPP2;HOMER1;NINJ1;BEND3
prerank,acylglycerol homeostasis (GO:0055090),0.49065621670668036,1.2330570996925752,0.2204585537918871,0.5316783785521891,1.0,2/20,4.93%,APOE;PNPLA8
prerank,skeletal muscle organ development (GO:0060538),-0.4053953762018593,-1.233027805678335,0.2047872340425532,0.7848665732567176,1.0,5/26,12.36%,LARGE1;BASP1;IGSF8;CFLAR;ZBTB18
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.4019819203528271,-1.2328870361034856,0.19298245614035087,0.7801592296779755,1.0,10/29,25.43%,ACOT9;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.4019819203528271,-1.2328870361034856,0.19298245614035087,0.7801592296779755,1.0,10/29,25.43%,ACOT9;ACSF2;OXSM;ACSL6;ACOT7;ACBD6;THEM4;ACOT11;ACOT8;ACOT1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5293669191426236,1.232788740712403,0.22163120567375885,0.5317322738280873,1.0,3/15,6.70%,DSE;UST;CHST12
prerank,positive regulation of heart contraction (GO:0045823),0.49253764425185376,1.2327731224219933,0.2443280977312391,0.531197898660782,1.0,6/19,14.25%,ADM;ADRA1A;CHGA;KCNQ1;SCN3B;ATP2A2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5477315913788953,1.2327645446621958,0.22846441947565543,0.5306463433932024,1.0,2/12,1.24%,APOE;LDLR
prerank,positive regulation of protein modification process (GO:0031401),0.3433109189900477,1.2327065266635249,0.12004662004662005,0.5302115168108927,1.0,35/203,13.06%,DAB2;EGFR;APP;GAS6;WDFY2;LYN;KRAS;BMP2;RIPK1;CD74;FGF23;AXIN1;THPO;NIBAN1;PDE8A;INSR;CAMKK2;RACK1;CD40;ACVR2A;TNF;FAM20A;CCND3;FNIP1;DYRK1A;CCND2;MYDGF;ARRB1;CALM1;ATG7;ROCK2;TERF2IP;BRAT1;UBE2N;ATG10
prerank,positive regulation of developmental growth (GO:0048639),-0.3592695057597784,-1.2325085306974966,0.12341772151898735,0.7788092446762144,1.0,15/49,21.81%,SEMA4D;RIMS1;RIMS2;ZFYVE27;MACF1;TWF2;BDNF;MAPT;PLCB1;LIMK1;CDKL5;SYT1;DBN1;CPNE5;SMURF1
prerank,cell chemotaxis (GO:0060326),0.4007462867420486,1.2323158862324561,0.15666178623718888,0.5304621721918015,1.0,9/60,7.58%,PLEKHG5;NRP1;CCR1;PDGFRA;NR4A1;CCRL2;ABCC1;CXCR4;CCR2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.383516225231845,1.2316997341551414,0.18585298196948682,0.531268254900042,1.0,11/73,12.69%,HIP1;NLRC4;IFT57;XDH;RIPK1;RACK1;TNF;CYCS;CASP8;DIABLO;FAM162A
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5786313479103169,1.2312314857111677,0.25650557620817843,0.5311585330245759,1.0,3/10,7.22%,MYADM;WNK1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5786313479103169,1.2312314857111677,0.25650557620817843,0.5311585330245759,1.0,3/10,7.22%,MYADM;WNK1;KLF4
prerank,cellular response to interleukin-12 (GO:0071349),0.4158140051170436,1.231024953934244,0.19849624060150375,0.5310850707849255,1.0,12/48,8.63%,RAP1B;SERPINB2;CDC42;PITPNA;LCP1;PAK2;ANXA2;HNRNPF;CNN2;RPLP0;STAT4;MSN
prerank,regulation of wound healing (GO:0061041),0.43278102233186866,1.2310174662960025,0.18263473053892215,0.5305377383810536,1.0,4/42,3.52%,ALOX5;CASK;ITGB1;CRK
prerank,response to ethanol (GO:0045471),-0.47553816692208756,-1.230960731287678,0.1978021978021978,0.7817425190338572,1.0,4/14,12.63%,GRIN3A;ADCY7;GRIN2A;GLRA1
prerank,protein autoubiquitination (GO:0051865),0.3974256251297901,1.2307014067647064,0.18248175182481752,0.530684251695822,1.0,23/61,18.57%,SH3RF1;PRKN;RNF141;TRIM68;MDM2;RNF19B;UBE2D3;UHRF2;CUL3;AMFR;RNF185;TRIM71;RNF115;RNF187;BFAR;KLHL24;RNF122;ASB4;RNF41;RNF146;UBE2A;CNOT4;TRAF6
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5634585640731431,1.2305752481148269,0.24091778202676864,0.5303755828137182,1.0,3/11,7.63%,AHR;LILRB1;HFE
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5498633196914433,1.230329869306512,0.2427007299270073,0.5303327229211595,1.0,6/12,17.66%,ESR1;TNF;NCOR1;ZC3H12A;STAT3;IL6
prerank,regulation of phosphate metabolic process (GO:0019220),0.5179378748326509,1.2300317511863468,0.23679417122040072,0.5304280506690404,1.0,4/16,9.45%,PGAM1;SMG6;PSEN1;IGBP1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.37747732816871243,1.229686373853118,0.15895953757225434,0.5306192902464199,1.0,14/70,12.88%,P2RX7;TNFRSF1B;RIPK1;MCL1;GSK3B;BCL2L2;BCL2;BAG3;TNF;IL6R;TNFSF12;CASP8;DIABLO;TNFRSF1A
prerank,positive regulation of cell communication (GO:0010647),-0.39249466440474334,-1.2296230707359357,0.16625916870415647,0.7838892565149355,1.0,10/28,20.57%,RIMS1;GRIK2;PTPN23;RIMS2;DLG4;KCTD13;LGI1;RIMS3;SYT1;SOX11
prerank,regulation of autophagosome maturation (GO:1901096),0.5375267989137381,1.2294151595534328,0.25274725274725274,0.5306802275187951,1.0,5/13,13.46%,ADRB2;UVRAG;SMCR8;UBQLN4;RUBCN
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.4135007387418611,-1.2293006525310408,0.18588235294117647,0.7823874295196056,1.0,12/23,28.33%,INTS3;WEE1;PLK3;BUB1B;BUB1;PABIR1;CDK5RAP3;ZFYVE19;ZW10;ZWINT;AURKB;CHMP4C
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5696308995062479,1.2289039880157049,0.25660377358490566,0.5312499265769799,1.0,2/10,2.74%,FCGR2B;LILRB1
prerank,lipoprotein transport (GO:0042953),0.5613152333815585,1.2288680840741064,0.23371647509578544,0.5307859363974482,1.0,7/10,27.87%,CD36;PRKCB;MIA3;UNC119;VMP1;PPARG;ZDHHC17
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.46114503300876813,1.2284822994228115,0.19400630914826497,0.5310840885431511,1.0,6/30,13.18%,ARHGEF3;GPR65;P2RY10;ARRB1;GPR17;NET1
prerank,negative regulation of JNK cascade (GO:0046329),-0.3951997430266814,-1.228394277965253,0.17783505154639176,0.7829059801723229,1.0,5/31,3.65%,SIRPA;CYLD;DUSP10;PDCD4;GPS2
prerank,positive regulation of interferon-beta production (GO:0032728),0.4453021304264136,1.2281572203672113,0.2247191011235955,0.5312072695869057,1.0,6/33,5.78%,TLR8;OAS2;TLR4;TLR2;TRIM56;RIOK3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.466160021830056,1.228093854326478,0.2150170648464164,0.5308043381739165,1.0,8/26,17.95%,ALOX5;CD36;TLR4;PIKFYVE;CYBA;ABCB7;TRAP1;SLC5A3
prerank,lymphocyte mediated immunity (GO:0002449),0.546526813241035,1.2280412658678093,0.2395644283121597,0.5303719464892498,1.0,2/12,3.41%,JAG1;CD46
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3930583654830496,-1.2276289410138848,0.17539267015706805,0.7831114863189768,1.0,8/29,19.95%,RAB6B;TRAPPC3;COG3;VTI1B;NAPA;COG2;COPA;GOSR2
prerank,negative regulation of bone mineralization (GO:0030502),0.5356389661142609,1.2273390806993811,0.22363636363636363,0.5313588594417911,1.0,7/13,19.31%,CCR1;FGF23;SRGN;RFLNB;BCOR;ECM1;ENPP1
prerank,peptidyl-tyrosine modification (GO:0018212),0.4037714134868767,1.2271135695009634,0.1894273127753304,0.5313378653996813,1.0,12/56,9.25%,EGFR;FGFR1;LYN;FER;ABI1;INSR;PDGFRA;SYK;ZAP70;FYN;DDR2;DYRK1A
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4182465851076374,1.226730785079863,0.19005847953216373,0.5316917526825116,1.0,11/46,11.22%,SPRED1;LYN;TLR4;ITGB1BP1;SMAD4;SYNJ2BP;RANBP9;CNKSR3;RPS6KA6;SPRED2;EMILIN1
prerank,negative regulation of receptor internalization (GO:0002091),-0.49699203612615983,-1.2264831858657974,0.23255813953488372,0.7845559390556102,1.0,6/12,19.61%,RIN3;DLG4;ANKRD13B;ANKRD13D;ATXN2;ANKRD13A
prerank,oligodendrocyte differentiation (GO:0048709),-0.43015115801795495,-1.2260577079971342,0.19015659955257272,0.7835619986899389,1.0,15/19,45.64%,EIF2B3;NSUN5;TPPP;SOX10;SOX13;SOX8;EIF2B5;SLC8A3;EIF2B2;SHH;PRDM8;SOX6;HES5;MYRF;PTPRZ1
prerank,iron ion homeostasis (GO:0055072),0.3935854646750672,1.2259056838927223,0.1861152141802068,0.5329189796628211,1.0,21/58,18.51%,CP;HMOX1;B2M;FTL;NDFIP1;SMAD4;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;FTH1;TFR2;ABCB7;MYC;ATP6V0D1;NEO1;PICALM;SCARA5
prerank,myotube differentiation (GO:0014902),-0.45733865624573466,-1.2258099203001565,0.17995444191343962,0.7818745433482784,1.0,3/17,1.66%,ADGRB3;SORT1;JAM2
prerank,regulation of vacuole organization (GO:0044088),0.4918552774876351,1.2255029280108214,0.24444444444444444,0.5332459129119184,1.0,6/20,6.05%,MTM1;MTMR3;NPRL3;TBC1D14;ANXA2;PIKFYVE
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3971324189004837,-1.2252161014115508,0.1918158567774936,0.7812705698722304,1.0,8/27,9.74%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;AGAP2;FLT3
prerank,membrane raft organization (GO:0031579),0.5277749930172235,1.224450291615908,0.24584103512014788,0.5350735161080779,1.0,4/15,5.98%,MYADM;S100A10;RFTN1;ANXA2
prerank,RNA export from nucleus (GO:0006405),-0.3020163507562311,-1.2241984238144283,0.09401709401709402,0.7824809992891351,1.0,37/100,26.62%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;U2AF1;MCM3AP;UPF3B;CASC3;NCBP1;SEH1L;HNRNPA1;NXT1;SRSF11;THOC3;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,positive regulation of signal transduction (GO:0009967),0.3351191108941926,1.2238659245121701,0.11216056670602124,0.5358432261247044,1.0,54/238,15.19%,RBPJ;NRP1;KLF2;SASH1;CLEC6A;GAS6;JAG1;RPS3;TSLP;BMP2;CD74;MYORG;C1QTNF12;ERN1;P2RY6;SLC2A4;ITGB1BP1;TLR2;GHRL;LY96;DISC1;TTC23;DEPDC1B;CD80;EPN2;PRKCB;CDC73;HOMER1;SULF2;GKAP1;ASXL1;POGLUT1;IGF1;SFRP1;MYO1C;WLS;TRIM16;MAML1;PDE6H;PHIP;CREBBP;STK36;SNX5;NOD2;CTBP2;CRLF2;STAT3;EP300;PRKD2;PKD2;SNW1;NECAB2;DSTYK;TXNDC15
prerank,Rac protein signal transduction (GO:0016601),0.48887906819679294,1.2236436344794857,0.2038664323374341,0.5357765122525642,1.0,1/18,0.09%,EPS8
prerank,response to estradiol (GO:0032355),0.43940925387295743,1.2230062776458888,0.20565149136577707,0.5366395180231128,1.0,6/31,10.04%,EGFR;ESR1;NCOA3;NRIP1;LCOR;SFRP1
prerank,cellular response to copper ion (GO:0071280),-0.45917434967002796,-1.2224877554437734,0.20675105485232068,0.7860926885162637,1.0,11/16,25.92%,PRNP;HSF1;MT2A;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F
prerank,epithelial cell morphogenesis (GO:0003382),0.5063107395247263,1.222485736246299,0.23476702508960573,0.5372430295159786,1.0,4/17,7.67%,CNMD;TNMD;GRHL2;COL22A1
prerank,cellular response to mechanical stimulus (GO:0071260),0.4101043420785097,1.2223333885391305,0.2,0.5370385864452341,1.0,12/46,12.88%,TLR8;TLR4;MAP3K1;BCL10;PDE2A;CD40;CNN2;CHEK1;PTGER4;CASP8;KCNK4;TNFRSF1A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3445380748283363,1.2220365026125584,0.13383838383838384,0.5371405081568562,1.0,34/163,14.81%,VAV3;CD38;PTPRJ;PSMA7;MEF2C;PTPN22;DENND1B;NFKBIZ;RFTN1;BCL10;THEMIS2;PAK2;RC3H1;PDE4D;WNK1;BCL2;SYK;SPG21;ZAP70;PSMB2;PRKCB;FYN;NFATC2;RIPK2;EIF2B1;PSMA6;ZC3H12A;UBE2N;FYB1;PSMA3;PSMD1;PSMD5;PRKD2;NFAM1
prerank,sarcomere organization (GO:0045214),0.4571026600811552,1.2219561243475454,0.20270270270270271,0.5367649576263179,1.0,3/27,3.13%,MYH6;MYOM2;TNNT1
prerank,actin-myosin filament sliding (GO:0033275),0.4316595211477921,1.2214945857077069,0.21141975308641975,0.5367035234333486,1.0,7/38,15.26%,TMOD1;MYH6;TNNT1;VIM;NEB;TPM3;MYBPC3
prerank,muscle filament sliding (GO:0030049),0.4316595211477921,1.2214945857077069,0.21141975308641975,0.5367035234333486,1.0,7/38,15.26%,TMOD1;MYH6;TNNT1;VIM;NEB;TPM3;MYBPC3
prerank,positive regulation of interferon-gamma production (GO:0032729),0.41228198162259255,1.2211834292844204,0.19728915662650603,0.5368649811404655,1.0,8/48,8.66%,TLR8;PTPN22;LILRB1;TLR4;PDE4D;CCR2;CEBPG;TRIM27
prerank,cellular response to amino acid stimulus (GO:0071230),-0.38676076797675685,-1.2207964108299936,0.17553191489361702,0.7895840706182802,1.0,16/33,27.36%,RPTOR;IPO5;UBR1;NSMF;RRAGD;SESN3;CASTOR2;GLRA1;RRAGB;MTOR;SESN2;GLRA2;CASTOR1;CPEB1;RRAGA;SH3BP4
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.44826758951807183,1.2203749203692418,0.22039473684210525,0.5380549887674823,1.0,14/29,23.65%,TCF7L2;TLE4;TCF7;CDC73;ASH2L;CREBBP;EP300;MYC;BCL9;TLE1;AXIN2;KAT5;TCF7L1;RBBP5
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.537759320088433,1.2203183496739765,0.2459016393442623,0.5376264502810428,1.0,3/13,8.05%,RREB1;METRNL;VSTM2A
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3104508094592011,-1.2198942531111083,0.10101010101010101,0.7902723670984078,1.0,24/80,20.45%,RAB6B;PLPP3;ARF5;STX18;COG3;KIF5A;BICD2;ATP9A;CENPE;COG4;SURF4;NAPA;ERGIC3;KIF1C;KIF3A;KIF11;KIF15;KIF3B;USE1;KIF2A;TMED7;COPA;DNAJC28;ZW10
prerank,fatty acid metabolic process (GO:0006631),0.36092426100727903,1.2195621354822832,0.16601815823605706,0.5387868139467624,1.0,10/115,5.81%,AOAH;ALOX5;LTC4S;ALOX15;CD36;ALOX5AP;UGT1A8;PNPLA8;SGPL1;ADIPOR2
prerank,response to copper ion (GO:0046688),-0.4332263091378654,-1.2192247995511518,0.19290465631929046,0.7900285424444806,1.0,13/20,25.92%,IL1A;PRNP;HSF1;MT2A;ATP7B;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.45122890862697745,-1.2187980676189836,0.2175824175824176,0.788923719116193,1.0,9/16,33.44%,ACACA;DIP2A;ACSS1;PPT1;SCD;SLC25A1;GCDH;CBR4;PPCS
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3563395221040797,1.2186031870051863,0.14938271604938272,0.5403042858850734,1.0,27/142,14.90%,ATP2B1;CCR1;CMKLR1;C5AR1;ESR1;C3AR1;C1QTNF1;CYSLTR1;CD36;GHRL;PDGFRA;CCRL2;CXCR4;CCR2;ADRA1D;ADRA1A;PLN;PTGER4;TRPC7;YWHAE;SLC8B1;ATP2B4;FFAR1;SLC35G1;CD52;TBXA2R;ITPR3
prerank,response to alcohol (GO:0097305),-0.3944074767500705,-1.2185038959570642,0.19799498746867167,0.7874594326802586,1.0,7/27,13.46%,TGFBR1;GRIN3A;TGFBR3;CCL3;GRIN2A;GLRA1;TGFBR2
prerank,positive regulation of cell projection organization (GO:0031346),-0.29568256142604166,-1.2184323713549972,0.08403361344537816,0.7851950937397124,1.0,31/115,13.33%,CUX1;PTK2B;PTPRD;SETX;ITGA6;ROBO2;SCN1B;MAGI2;DLG4;TENM3;PLXNA2;ATP1B2;SS18L1;NDRG4;SCARB2;ROBO1;DVL1;NTRK3;TWF2;BDNF;SERPINI1;MAP6;TIAM1;CAPRIN1;TIAM2;SS18L2;DVL2;IL1RAPL1;RAPGEF1;NDNF;EPHA3
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.30207088230840384,-1.2183815085785996,0.11297071129707113,0.7828918166321871,1.0,36/96,26.62%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;U2AF1;MCM3AP;UPF3B;CASC3;NCBP1;SEH1L;NXT1;SRSF11;THOC3;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,negative regulation of centrosome duplication (GO:0010826),-0.5111354884528404,-1.2182235081890942,0.22573839662447256,0.7809464988060476,1.0,3/11,8.88%,TMEM67;CENATAC;BRCA1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.474455026387099,-1.2182110245735749,0.22954545454545455,0.7785317952001156,1.0,7/14,23.30%,CSTF2;DDX1;FAM98B;CLP1;RTCB;TSEN54;TSEN15
prerank,cell junction assembly (GO:0034329),-0.3006469176830887,-1.2177834872028772,0.08076923076923077,0.7776195902634273,1.0,23/100,13.82%,TJP1;FBLIM1;DNM3;ADGRL3;CDH10;SDK1;NLGN1;ITGA6;CDH2;NRXN1;TLN2;FARP1;FERMT2;CDH8;FLCN;BDNF;SHANK2;PKP4;TLN1;CDH9;CDH22;CTNND2;SPOCK2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4564405932749647,1.217636946881616,0.21160409556313994,0.541939448206917,1.0,2/24,1.22%,TRPS1;ZBTB16
prerank,regulation of cellular component biogenesis (GO:0044087),0.42515875774297707,1.2175804404835349,0.20909090909090908,0.5415295289145755,1.0,7/39,5.43%,APOE;RAP1B;CD36;CCL19;RAPGEF2;RAP1A;ROCK1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.45212991569951044,1.216940052972219,0.22979397781299524,0.5424411163477937,1.0,8/29,9.60%,IL15;FER;IFNAR1;PIAS1;CCR2;STAT4;IFNAR2;STAT6
prerank,cell cycle G2/M phase transition (GO:0044839),-0.2835872179869394,-1.2167586818748006,0.09954751131221719,0.7786190962157404,1.0,42/130,25.32%,CSNK1E;SDCCAG8;CEP135;AKAP8L;ODF2;OPTN;DYNC1H1;SKP1;CEP192;CCNH;CEP250;FBXL7;CCDC57;HAUS8;WEE1;CEP63;PLK3;CCP110;PLCB1;AKAP8;HAUS7;CKAP5;MAPRE1;HAUS3;CHEK2;BRSK2;CENPJ;FBXL6;FBXL3;TAF2;DCTN2;LCMT1;BRSK1;CNTRL;MASTL;HAUS2;DCTN1;PLK4;CDK1;HAUS6;CCNA2;YWHAG
prerank,defense response to Gram-positive bacterium (GO:0050830),0.4229017834683162,1.216494398922351,0.20125786163522014,0.5428220168308168,1.0,9/40,11.66%,ANG;RPL39;LBP;TLR2;GBP7;DROSHA;RNASE6;ROMO1;CHGA
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5556967353372199,1.215639310943608,0.25137614678899084,0.5440694803013971,1.0,6/11,15.73%,ARID1B;CHEK1;ELOF1;SERTAD2;SMARCD1;ARID1A
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4247151394995772,1.2152573794262016,0.21335504885993486,0.5443179163210886,1.0,8/36,9.00%,GAS6;TSLP;RIPK1;PARP14;CD74;PRKN;CXCR4;UBE2K
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.35844504812813394,-1.2147272772126974,0.16566265060240964,0.7834898278583834,1.0,20/46,32.19%,HK2;FBXO7;TIMM44;GDAP1;TOMM40;TIMM8B;GRPEL1;AIP;TOMM20;TOMM40L;TIMM21;BCAP31;TOMM34;FIS1;TOMM5;AKT1;TIMM17B;TIMM13;DNLZ;CHCHD4
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.39847811993959553,1.2145263823971473,0.19225037257824143,0.5453713838122486,1.0,14/57,10.33%,RPS16;RPS15;RPL26;RPS28;RPS24;LTV1;RPL35A;RPL38;RPS17;RPL5;MALSU1;RPL14;RPS7;RPS6
prerank,granulocyte chemotaxis (GO:0071621),0.403932785150973,1.2144614261082767,0.20933734939759036,0.5449506596400946,1.0,7/55,8.22%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.44709318390171293,1.214346150547592,0.23164763458401305,0.5446484359315683,1.0,8/29,11.05%,RPS27A;RIPK1;TLR4;BIRC3;LY96;CD40;UBE2D3;CASP8
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.42447529384912724,1.2136580908904824,0.23162939297124602,0.5456798529941176,1.0,12/36,16.01%,OPHN1;RYBP;LAMP3;WAC;NOP53;SDCBP;HFE;EIF3H;RPL11;PRKCG;USP25;HSP90AB1
prerank,neurotransmitter uptake (GO:0001504),-0.499977218574745,-1.2136496341967185,0.22440087145969498,0.7850258154677666,1.0,2/12,2.74%,SLC1A3;SNAP25
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.36975520285725516,-1.2133577781958382,0.16964285714285715,0.7836635677798027,1.0,13/37,13.33%,EFNA5;CYLD;CLASP2;MAPT;BICD2;MAP6;MAPRE3;STMN3;PHLDB1;TPPP;STMN4;MAPRE1;EPHA3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.33654638550994503,-1.2132322906065454,0.14730878186968838,0.7817195220060817,1.0,17/51,23.12%,CTNNB1;XRCC5;CTC1;SRC;HNRNPU;ATM;MAPK3;MAP2K7;STN1;TERF2;MAP3K4;CCT7;HNRNPA1;GNL3L;CCT2;ACD;CCT8
prerank,innate immune response in mucosa (GO:0002227),0.5374271521991186,1.2121097012047468,0.2782101167315175,0.5484115386201629,1.0,1/10,2.50%,RPL39
prerank,ruffle organization (GO:0031529),-0.4544480338124135,-1.2118348925656366,0.23130841121495327,0.7840993979848628,1.0,8/16,24.45%,PLEKHA1;CSF1R;AIF1;ARF6;PLEK;LIMA1;CORO1B;TPM1
prerank,reverse cholesterol transport (GO:0043691),0.523897342371124,1.2115865156291956,0.25089605734767023,0.5490602077452854,1.0,1/13,0.49%,APOE
prerank,calcium ion homeostasis (GO:0055074),0.3648966380054089,1.211526125799077,0.16960651289009498,0.5486259422538453,1.0,16/95,12.32%,ATP2B1;CCR1;TPT1;STIM2;CCL8;ATP6V1B1;CCL19;CD40;FAM20A;STIM1;CCR2;TMEM165;SLC10A7;WFS1;SLC8B1;ATP2B4
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.46213089432938587,-1.2111905726564312,0.2348993288590604,0.783876743062251,1.0,3/15,4.57%,SMAD7;MAGI2;ACVR1
prerank,positive regulation of cellular process (GO:0048522),0.31305991968586605,1.2109242143917056,0.07620041753653445,0.5493153469238956,1.0,76/565,10.33%,FOLR2;FCGR2B;EGFR;LRP6;P2RX7;LIFR;FGFR1;LILRA5;PTPRJ;COLEC12;CHP2;PPP3CA;IL15;KIF20B;DOCK2;GAS6;NUPR1;RPL23;LYN;GRK5;BST1;FER;TSLP;KRAS;TNFRSF1B;KITLG;FCER1G;CD36;FGF23;WNT2;TLR4;GRN;ANKRD17;CDC42;THPO;CAMK1D;DNPH1;ZFP36L1;RPS6KA3;ITGB1BP1;LBP;TNFRSF11A;TLR2;IRS2;INSR;S1PR2;PDGFRA;ACER3;TRIM32;BCL2;RPS4X;CHEK1;FOXM1;RPS15A;SDCBP;TNF;MTPN;TIPIN;CXCL16;IL6R;RPS9;ADRA1D;ASH2L;TSPYL5;MDM2;PDGFC;CCND2;CACUL1;CUL3;H3-3A;IGF1;SFRP1;RIPK2;TSHR;SLC25A5;RPS6
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.42560250912055664,-1.2106928960366645,0.20654911838790932,0.7830625406532666,1.0,9/23,29.86%,HSPA4;BCL2L11;SAMM50;BMF;TIMM8B;TIMM29;AGK;PMAIP1;TIMM13
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5429227618885106,1.2106670223294527,0.2519230769230769,0.5493450881921315,1.0,2/11,4.49%,JAG1;HEY2
prerank,dermatan sulfate metabolic process (GO:0030205),0.5348894546612655,1.2104997491814649,0.25087719298245614,0.5491606159498279,1.0,3/13,6.70%,DSE;UST;CHST12
prerank,regulation of autophagosome assembly (GO:2000785),0.43704817102473964,1.210402368196306,0.21900161030595813,0.5488014769742692,1.0,8/33,8.90%,NUPR1;MTM1;MTMR3;NPRL3;FEZ2;TBC1D14;PIKFYVE;SMCR8
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5174316710211457,-1.2099325899606466,0.23160173160173161,0.7833221315748925,1.0,5/11,20.73%,SRC;MAPK3;ATP9A;MAP2K2;CHMP3
prerank,sterol metabolic process (GO:0016125),0.39906954240500336,1.209436170798093,0.19497784342688332,0.5503039481379293,1.0,13/60,16.03%,APOE;PRKAG2;HMGCR;CLN6;CYP27A1;CYP26C1;PMVK;OSBPL1A;CYP26B1;LBR;CLN8;OSBPL5;CYP7B1
prerank,heart looping (GO:0001947),-0.36107402584053727,-1.2092388260670832,0.17101449275362318,0.7833864028815923,1.0,16/40,23.61%,NDRG4;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;MICAL2;NOTCH1;SRF;ENG;BBS4;MKKS;CCDC40;STIL
prerank,regulation of cell-cell adhesion (GO:0022407),-0.369764900451322,-1.209161856251701,0.15633423180592992,0.7812664934225497,1.0,11/39,12.60%,EFNA5;SMAD7;EPHA7;SRC;TENM3;FERMT3;CELSR2;AFDN;MINK1;PTPRG;ADAM8
prerank,telomere maintenance (GO:0000723),-0.33966630607820236,-1.2088948578380898,0.14106583072100312,0.7798307069564693,1.0,13/50,13.41%,DNA2;XRCC5;CTC1;ATM;PARP1;STN1;PTGES3;BLM;LTO1;HUS1;TERF2;PARP3;XRCC6
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3699408155498096,-1.2088620502121519,0.1855072463768116,0.7776195402631997,1.0,7/34,8.43%,PDE4B;CALM2;SMAD7;ATP1B1;SLC8A1;ANK2;RGS2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.34025343067267527,-1.208116546386651,0.13694267515923567,0.7779819371226623,1.0,19/52,20.25%,DDX5;DDX17;RBM25;RBFOX1;SRRM4;FXR2;HNRNPU;PUF60;FMR1;CELF4;KHDRBS3;RNPS1;NOVA2;SRSF12;HNRNPA1;RBM5;MBNL3;FXR1;CELF6
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5068105625361806,1.2081133350188147,0.26527050610820246,0.5526088889981577,1.0,3/16,5.88%,TPT1;RPS3;TRIM32
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5403613360744688,1.2071271596859896,0.2509578544061303,0.5530702763766752,1.0,4/12,9.68%,RB1;CDC27;NSMCE2;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5403613360744688,1.2071271596859896,0.2509578544061303,0.5530702763766752,1.0,4/12,9.68%,RB1;CDC27;NSMCE2;CUL3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5403613360744688,1.2071271596859896,0.2509578544061303,0.5530702763766752,1.0,4/12,9.68%,RB1;CDC27;NSMCE2;CUL3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4556427199282008,1.2066440912011966,0.21833333333333332,0.5536050758262668,1.0,11/23,21.96%,MTM1;SYNJ1;MTMR3;OCRL;PIP4P2;PTEN;MTMR1;PIP4P1;INPP5K;MTMR6;MTMR12
prerank,negative regulation of cellular metabolic process (GO:0031324),0.4246613069090846,1.2062415647705744,0.22591362126245848,0.5539338778018966,1.0,6/37,8.14%,EDNRB;APOE;UGT1A8;PRKN;SDCBP;NCOR1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.5262125700775738,1.2058371897772635,0.23540489642184556,0.554272739144804,1.0,7/13,14.16%,LDLR;ITGB1;FCER1G;CD36;SYK;SREBF2;ITGB2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.3125013566293238,-1.205779427469921,0.1259259259259259,0.783717908325706,1.0,34/83,31.86%,CSNK1E;SDCCAG8;CEP135;ODF2;DYNC1H1;TP53;CEP192;CEP250;HAUS8;CEP63;CCP110;HAUS7;CKAP5;MAPRE1;HAUS3;CENPJ;DCTN2;HMMR;CNTRL;HAUS2;DCTN1;KIF14;PLK4;CDK1;HAUS6;YWHAG;TUBA4A;CEP152;DYRK3;NEK10;TUBA1A;CENPF;TUBG1;AURKA
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.38002939174592365,1.2053275036724778,0.2020497803806735,0.5548636205039069,1.0,14/74,11.15%,PF4;TCF7L2;SH3RF1;RIPK1;SIAH2;HMOX1;MCL1;GSK3B;BCL2;TNF;BIRC6;IGF1;CASP8;PHIP
prerank,regulation of transferase activity (GO:0051338),-0.43683340648713226,-1.205046820091458,0.22695035460992907,0.7839807120808062,1.0,9/17,27.88%,LDB1;ATM;NLRC5;LDB2;PARP4;BAG5;SLAMF8;EMP2;JMJD8
prerank,protein localization to Golgi apparatus (GO:0034067),-0.39386427336184615,-1.204619352213527,0.17754569190600522,0.7830403839337358,1.0,6/27,8.03%,SORL1;ARL5C;OPTN;GCC2;BICD2;IFT20
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3928132206279742,1.2045506228029275,0.1917024320457797,0.5560534135252211,1.0,18/64,11.99%,PEAK1;CASK;BST1;JAG1;RASA1;CD36;RHOA;UTRN;CDK6;GSK3B;ROCK1;PTPRA;VCL;CLASP1;CORO1C;SFRP1;JUP;ROCK2
prerank,organelle fission (GO:0048285),0.47520825180821735,1.2045458697091136,0.24319727891156462,0.5555096703925723,1.0,2/24,4.00%,TMCC1;PRKN
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4194655713089445,-1.204318122912932,0.22541966426858512,0.7818271333835773,1.0,10/22,23.17%,CALM2;ATP1B1;ANK2;AKAP6;STAC2;SLC9A1;STAC;HAP1;CALM3;STAC3
prerank,response to iron ion (GO:0010039),0.5264103956867311,1.203902616402492,0.22346368715083798,0.5563590979700234,1.0,5/12,13.49%,B2M;BCL2;HFE;ACO1;TFR2
prerank,sphingolipid metabolic process (GO:0006665),-0.3006468099546276,-1.203439519789426,0.10276679841897234,0.78248611109177,1.0,35/108,21.20%,HEXB;CERK;ENPP2;ST6GALNAC3;SPNS2;SMPD4;PPM1L;PLPP3;ESYT1;NSMAF;NEU1;ASAH1;PPT1;ASAH2;CERS4;SAMD8;ESYT2;GBA2;DEGS1;TECR;CERS5;ACER2;CERS1;CERKL;PSAP;SERINC1;SGMS2;SPTLC1;SMPD2;CERS2;ABCA2;ARV1;PLPP2;KDSR;ARSA
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.48807454716325815,-1.201919624100793,0.25738396624472576,0.7855962824612126,1.0,9/12,38.25%,CDC7;MCM3;MCM6;MCM2;MCM7;MCMDC2;GINS4;CDC45;MCM5
prerank,regulation of regulated secretory pathway (GO:1903305),-0.3727362509168151,-1.201821936007172,0.18575063613231552,0.7836596616036613,1.0,14/34,27.26%,RIMS1;RIMS2;RAB27A;VPS18;SYT6;SYT8;RIMS3;SYT1;RAB15;SYT13;RIMS4;SYT7;SYT5;SYT17
prerank,dendritic spine organization (GO:0097061),-0.399233471887358,-1.2017646976304666,0.215,0.7815915583465795,1.0,8/26,7.76%,TREM2;DOCK10;DLG4;LGMN;DIP2A;SHANK1;EPHB1;PRNP
prerank,response to laminar fluid shear stress (GO:0034616),0.5631495473173055,1.2016674525719546,0.26653696498054474,0.560784891605977,1.0,5/10,16.14%,KLF2;KLF4;ASS1;SREBF2;MAPK7
prerank,establishment of protein localization to membrane (GO:0090150),0.3851751656675197,1.2015184238317613,0.21333333333333335,0.5605310520539158,1.0,18/66,15.73%,EGFR;RAB10;RFTN1;PIKFYVE;ZDHHC14;SDCBP;ZDHHC3;VPS37C;SEC63;MYO1C;CHM;RAB11A;ZDHHC24;RABGEF1;SYNE3;ZDHHC20;ICMT;ZDHHC2
prerank,positive regulation of reproductive process (GO:2000243),-0.38619148581769003,-1.200629403370885,0.20526315789473684,0.783071996573441,1.0,8/31,15.94%,LHFPL2;SIRT2;TACR3;PLCB1;PDE3A;GLRA1;C1QBP;ACVR1B
prerank,filopodium assembly (GO:0046847),0.49679784920578157,1.200452075056314,0.24329159212880144,0.5623777067070556,1.0,3/16,5.22%,FGD4;FGD6;S1PR2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5223196344923411,1.2003278228534544,0.26003824091778205,0.5620472938063796,1.0,2/13,4.22%,NRP1;NRARP
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5312046015292669,1.1998437632041734,0.2569832402234637,0.5626427564549129,1.0,4/11,10.31%,PARP14;PARP8;PARP11;PARP16
prerank,dendritic spine morphogenesis (GO:0060997),-0.4563184005270371,-1.1993971350191557,0.2182628062360802,0.784838108010845,1.0,8/15,18.30%,DOCK10;DLG4;DIP2A;SHANK1;EPHB1;CTNND2;EPHB2;PAK3
prerank,osteoclast differentiation (GO:0030316),0.4781812137759953,1.1992361561990634,0.24834437086092714,0.5634768678545117,1.0,7/22,11.55%,FOXP1;DCSTAMP;TNFRSF11A;GLO1;ANXA2;MAPK14;SNX10
prerank,MAPK cascade (GO:0000165),0.31979163649668674,1.198698589316496,0.11851015801354402,0.5641259210073805,1.0,49/295,11.96%,RASGRP4;EGFR;FGFR1;MAP3K5;SPRED1;MEF2A;RGL1;ZFP36L2;PSMA7;MEF2C;RASAL2;RPS27A;RASA1;SYNGAP1;NRAS;KRAS;KITLG;SPTBN1;FGF23;PLVAP;ZFP36L1;RAPGEF2;IL17RD;FRS2;CCM2;IRS2;CAMKK2;MAPKAPK2;PDGFRA;GFRA3;PTPRA;MAP3K8;TNF;NRK;PSMB2;FYN;RANBP9;RASA2;MAP3K20;CUL3;IGF1;CALM1;PTGER4;PDE6D;SHC1;PSMA6;JAK1;YWHAE;MAP3K3
prerank,cellular response to reactive oxygen species (GO:0034614),0.38754870932825175,1.198231406519878,0.2,0.5645862292142546,1.0,19/59,17.66%,EGFR;MAP3K5;FER;RPS3;OSER1;RIPK1;CAMKK2;PTPRK;PDGFRA;PXN;TRPM2;ROMO1;AGAP3;NET1;PKD2;MAPK7;PRDX3;RELA;IL6
prerank,mRNA transport (GO:0051028),-0.2945393445830138,-1.198090227457259,0.12608695652173912,0.7868693910705847,1.0,38/101,26.62%,THOC1;SRRM1;SRSF5;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;KIF5C;SRSF2;FMR1;UPF1;RNPS1;NUP85;U2AF1;MCM3AP;UPF3B;CASC3;NCBP1;SEH1L;NXT1;SRSF11;THOC3;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3881194419749604,-1.1976761122448678,0.1890547263681592,0.7859631389426863,1.0,7/26,18.40%,LARGE1;GK;SCCPDH;GAL3ST4;TPI1;ALG8;ST3GAL2
prerank,negative regulation of proteolysis (GO:0045861),-0.37165924447580556,-1.1972940917951527,0.2,0.7849520693231884,1.0,8/34,13.47%,SERPINE2;TMEM59;CLN3;CST7;BAG6;PRNP;GAS1;CST3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.37315460440756365,1.1972202140123358,0.1966053748231966,0.5663724174274293,1.0,14/74,10.98%,DAB2;SPRED1;BMP2;ALX1;RGCC;IL17RD;SMAD4;SDCBP;VASN;CLASP1;USF3;PPP2CA;SFRP1;SPRED2
prerank,vasoconstriction (GO:0042310),0.5488377258347035,1.1971497408233671,0.2698706099815157,0.5659861090909459,1.0,2/11,8.29%,EDNRB;PIK3C2A
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5309734378877481,1.1968069596673403,0.24517374517374518,0.5662330821770497,1.0,2/12,3.75%,APP;RHOA
prerank,negative regulation of developmental growth (GO:0048640),-0.38873393251099453,-1.1967096607503842,0.20424403183023873,0.7847939867193567,1.0,5/30,4.14%,MAP2;PTPRS;DUSP10;DIP2B;FGF13
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5495081872826484,1.1966797956166615,0.27171903881700554,0.5659594943419103,1.0,3/11,6.34%,CD44;CD74;BCL2
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3404838955525868,-1.196512632079893,0.15680473372781065,0.7831915770922919,1.0,12/49,15.85%,F11R;MAP2;GMIP;RASA4;CPEB2;RDX;CST7;ARFGEF1;TERF2;CST3;HRAS;SLC39A14
prerank,protein polymerization (GO:0051258),0.39577469054647607,1.19612034080723,0.21758569299552907,0.5666844672032035,1.0,6/56,4.00%,PSTPIP2;DIAPH1;GAS7;PSTPIP1;ANG;PRKN
prerank,negative chemotaxis (GO:0050919),-0.36619025583503273,-1.1961084381203497,0.203125,0.7823087273259154,1.0,7/33,5.58%,SEMA4D;UNC5C;EPHA7;SEMA4C;ITGB3;ROBO1;SEMA4G
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4752178607509219,1.1951616069516828,0.2609427609427609,0.5682860813561316,1.0,7/21,16.92%,FOXP1;RPS3;BCL10;PRKCB;PRKD2;NFAM1;RELA
prerank,regulation of lipid catabolic process (GO:0050994),-0.42718210133107903,-1.1950474385636618,0.22511848341232227,0.7836041145176772,1.0,6/19,22.62%,PDE3B;APOC1;ALK;TYSND1;ANGPTL3;BSCL2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5272558112839362,1.1950424236655417,0.25471698113207547,0.5680196963197353,1.0,4/12,8.44%,GRN;CLN5;CLN6;TMEM165
prerank,positive regulation of hydrolase activity (GO:0051345),0.34694160366259985,1.194997938370685,0.17825537294563842,0.5675625942447112,1.0,22/137,6.14%,CHP2;SNX9;ARAP1;ITGB1;MAPRE2;EVI5;RPS3;RCN3;USP6NL;BMP2;CCL8;CCL19;RHOA;RAPGEF2;S100A10;RIC1;GSK3B;RAP1A;RACK1;DOCK11;RGS8;CD40
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4578864799262412,1.1946070543836327,0.24744027303754265,0.5678286105757291,1.0,3/24,5.99%,APOE;CTSC;RHBDF1
prerank,muscle cell migration (GO:0014812),0.5666145731417674,1.1945461046113877,0.29464285714285715,0.5674051021601426,1.0,3/10,5.43%,THBS4;ITGB1BP1;ROCK1
prerank,positive regulation of cell motility (GO:2000147),0.32965770689748825,1.194462296299063,0.1471291866028708,0.5670431890053769,1.0,20/205,5.88%,DAB2;NEDD9;EGFR;SEMA4A;CCR1;PPP3CA;MYADM;ITGB1;FER;CASS4;BMP2;SYNE2;DRD1;GRN;ADAM9;CCL19;INSR;RACK1;PDGFRA;TRIM32
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.43608476044623534,1.1943308694223225,0.2296416938110749,0.5667709500898586,1.0,8/30,11.05%,RPS27A;RIPK1;TLR4;BIRC3;LY96;CD40;UBE2D3;CASP8
prerank,negative regulation of endocytosis (GO:0045806),0.461475059249849,1.1940837548579704,0.24040066777963273,0.5667637892251092,1.0,5/24,13.67%,MCTP1;LILRB1;SNX33;RUBCN;NR1H2
prerank,regulation of urine volume (GO:0035809),0.5533090770596937,1.1934226506477035,0.27289719626168224,0.5676988846266819,1.0,2/10,4.47%,ADM;NPR3
prerank,regulation of T cell cytokine production (GO:0002724),0.5123572494633167,1.1933296243216551,0.26824817518248173,0.5673798410135061,1.0,4/15,7.63%,TNFRSF1B;B2M;CCR2;HFE
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4664159624977355,-1.192896990740468,0.24672489082969432,0.7887822047197499,1.0,3/13,5.66%,IRAK2;UNC93B1;PIK3R4
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.515121374732384,-1.192483850980739,0.2542016806722689,0.7879513946664022,1.0,4/10,9.17%,VSIR;NCKAP1L;PRNP;DDIT3
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.36675106656284123,-1.1923282367907564,0.1994750656167979,0.7862272404683672,1.0,13/32,23.26%,GTF2H2;CCNH;MAPK3;UBTF;ERCC2;TAF1C;TAF1D;RRN3;GTF2H4;TAF1;POLR1C;POLR2L;TBP
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3472254159714784,-1.1913663684373184,0.2011173184357542,0.7872818715767735,1.0,9/44,9.40%,KCNMA1;KCNJ2;ATP1B1;NOS1AP;ATP1B2;ANK2;AKAP6;ACTN2;WNK3
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5402793856040757,1.1911393535247785,0.27927927927927926,0.5718249591857744,1.0,7/11,22.41%,SMAD4;GLRX3;ATP2B4;FOXO1;LMNA;P2RX4;MLIP
prerank,negative regulation of intracellular protein transport (GO:0090317),0.46542048810975034,1.1908269340611275,0.25333333333333335,0.5719514329583542,1.0,5/22,12.13%,MDFIC;ITGB1BP1;RAB23;SP100;UFM1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.49836610245200835,-1.1900462863409753,0.2374727668845316,0.7896750558224208,1.0,7/11,21.93%,TGFBR1;SMAD7;ACVR1;TGFBR3;TGFBR2;TGFB2;TGFB1
prerank,regulation of microglial cell activation (GO:1903978),0.5084346987345485,1.1891102741259074,0.2735674676524954,0.5753585143611899,1.0,3/15,3.26%,LDLR;NR1D1;GRN
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4948200536962949,1.188357191882569,0.259765625,0.5766133659121051,1.0,4/16,9.59%,PARP14;PIBF1;SH2B3;PPP2CA
prerank,regulation of striated muscle contraction (GO:0006942),-0.3812862909801265,-1.1878612083822762,0.23097112860892388,0.7950944433504841,1.0,13/27,34.47%,CALM2;SMAD7;ANK2;GRK2;TNNI1;CALM3;SLC8A3;HCN4;RNF207;DMD;ASB3;MYL2;TNNT3
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4803531546277391,1.1877040386922226,0.23429541595925296,0.5774846405798726,1.0,5/20,13.29%,PRKRA;PUM2;DROSHA;TRIM71;MRPL44
prerank,regulation of neutrophil migration (GO:1902622),0.5562716352123935,1.1872962091974986,0.267578125,0.5778479143251797,1.0,2/10,1.79%,MPP1;BST1
prerank,negative regulation of cell junction assembly (GO:1901889),0.45939828860735915,1.1870548356441621,0.24666666666666667,0.577815571183352,1.0,10/25,12.68%,ITGB1BP1;TLR2;ROCK1;TNF;DUSP22;RCC2;CORO1C;SLIT1;ROCK2;BCAS3
prerank,neural tube closure (GO:0001843),0.42622263002746175,1.1867549381863036,0.2527646129541864,0.5779955708899432,1.0,5/34,5.59%,LRP6;PRICKLE1;BCL10;GRHL2;CELSR1
prerank,natural killer cell mediated immunity (GO:0002228),-0.4569643049654888,-1.1861530441602905,0.22911694510739858,0.7988439720870572,1.0,2/15,0.68%,LYST;PLEKHM2
prerank,calcium ion transmembrane transport (GO:0070588),0.3615055446435735,1.1849996932421059,0.1991701244813278,0.5813356561261198,1.0,19/86,14.70%,P2RX7;MCUB;ATP2B1;GAS6;ANO6;MCU;PARL;TRPV3;TMEM165;GRIN2D;TRPM2;TRPC7;SLC8B1;MICU3;ATP2B4;MCOLN2;SLC35G1;ATP2A2;PKD2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4766211937043465,-1.1848720012731195,0.2505399568034557,0.8009944879077919,1.0,5/13,24.65%,SORL1;EDEM1;BCAP31;CD81;TM9SF4
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4935088966855236,-1.1848372679314978,0.24776785714285715,0.7988854370803038,1.0,3/12,11.72%,BIN1;CTNNA3;CACNA1C
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4798999349681754,1.1845641837715482,0.27389705882352944,0.5816969056639106,1.0,3/18,7.67%,PRKAG2;C1QTNF12;PRKCB
prerank,regulation of hormone secretion (GO:0046883),0.49122591188454845,1.1843788733277254,0.274582560296846,0.5815401679342891,1.0,2/15,3.30%,FGF23;SNX6
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.4745716640773815,-1.1842062121255121,0.24336283185840707,0.7988592602298267,1.0,4/13,14.98%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5009800271708807,1.1840438605196766,0.27798507462686567,0.581744764161041,1.0,6/14,19.35%,SMPDL3A;CMPK1;AK8;ENPP1;AK3;AK4
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5324816733498923,1.1834483738259856,0.299625468164794,0.5824374351621433,1.0,3/12,8.59%,ZFP36L2;JAG1;ESRRB
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.33584252395357456,-1.1827880977842602,0.18731117824773413,0.8017916061123047,1.0,9/48,8.55%,CAPN3;PTK2B;CALM2;PLCG1;ANK2;UBASH3B;TRPC1;AKAP6;JPH1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4734872291330055,1.1824377986036152,0.2764505119453925,0.584177867402096,1.0,4/20,11.44%,APOE;NR1H4;SREBF2;FMO5
prerank,transcription by RNA polymerase I (GO:0006360),-0.3614191905102175,-1.1822703427537555,0.2005420054200542,0.8013955162765193,1.0,13/34,23.26%,GTF2H2;CCNH;MAPK3;UBTF;ERCC2;TAF1C;TAF1D;RRN3;GTF2H4;TAF1;POLR1C;POLR2L;TBP
prerank,N-glycan processing (GO:0006491),0.48130589405796176,1.1814820572071134,0.2639138240574506,0.5857904988923747,1.0,2/18,0.67%,MAN2A1;ST8SIA4
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.41447971741021944,1.181436055912584,0.23222748815165878,0.5853202598660119,1.0,13/38,19.45%,ESR1;NR1H4;RIPK1;NR1D1;RIOK3;PPM1B;CASP8;ZC3H12A;PPM1A;PER1;NLRX1;MAPKBP1;TLE1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.30065632023883826,1.181387579792876,0.023046092184368736,0.5848591359644553,1.0,383/1645,19.47%,RBPJ;HDAC9;WWP1;CD38;ZEB2;MAF;TRPS1;ETV1;EGFR;LRP6;APOE;MAP3K5;KLF2;TCF7L2;TCF4;IRF4;MDFIC;FOXP1;FLI1;MEF2A;AHR;ZBTB16;RREB1;GAS6;FOXN2;TFEC;KMT2A;HIVEP2;NFXL1;ESR1;SMURF2;ZBTB20;RBBP8;HINT1;TCF12;MEF2C;NR1H4;CBFA2T3;NCOA2;CEBPB;MITF;PIAS1;OSR1;RYBP;TSHZ3;BMP2;PRICKLE1;KLF6;ARID4B;TBX15;CD74;PHF8;HOXD8;NR2C1;PHOX2A;FOXA3;RAX;ALX1;HOXA10;NR1D1;SNX6;AXIN1;WAC;CRK;RPS6KA3;YWHAQ;BAZ2B;TOX4;JARID2;BCL10;PHF20;NR3C1;NKAP;TRIM56;IRF2BP2;HEY2;CTDSP1;CLOCK;GRHL2;PBX3;DMRTA2;ARID1B;SPI1;NCOA7;RB1;KLF9;KDM7A;TCEA2;NFIC;INSR;CAMKK2;ARID5A;BATF2;SMAD4;PTPRK;ZFP2;ELF2;TRIM33;TGFBRAP1;IRX2;CBFB;NR4A1;FOSL2;TCF7;ZBTB25;ATXN1;PIAS2;EPC1;SETDB2;MED13L;DMAP1;FOXM1;ZNF235;ZNF568;TNF;CD80;KLF3;ZNF148;TSHZ1;LYL1;KLF4;EPC2;ZSCAN25;YY1;REL;HTATIP2;THAP11;GATAD2A;MED16;SATB2;TBL1XR1;STAT4;PRKCB;CEBPG;E2F5;PSEN1;NR4A2;LHX5;GMNN;IRF2;KLF10;IRX5;BTAF1;NCOR1;ZBTB5;ATF6;CDK14;ATRX;ZNF628;NCOA6;FOXC2;MIDEAS;LIMD1;ARID3A;ESRRB;BRIP1;BACH1;MDM2;LCORL;OLIG2;HIVEP1;LIN54;MED18;TBL1X;HMG20A;LBH;ESR2;LRRFIP1;MAPK14;FOXJ3;ATF7;NFATC2;DYRK1A;MED20;MAMLD1;MED6;MLXIP;PPP2CA;LCOR;STAT6;NR2F1;USP21;USP16;PURA;ILF3;ZNF205;RPL6;GCFC2;IGF1;TESMIN;SFRP1;RFX2;RNF14;JMJD1C;ARRB1;RNF111;NUP62;ZNF296;SPEN;RBM15;CREBRF;RCOR2;SP100;MED26;TRIM16;SP1;TFDP1;PCID2;ELF1;ATXN1L;ZMYND15;PHIP;ETS2;PHC3;SHC1;SREBF2;CREBBP;ANKRD49;CRYAB;BCL11B;MYBL2;FOXK2;HINFP;NFIA;FOXO3;CDK17;NIBAN2;DEK;SNX5;KDM5C;ATP2B4;FOXK1;LOXL2;TADA2B;TERF2IP;ZBTB8B;ELP4;ZFP3;CHD2;SP3;NFIX;FOXO1;KMT2E;CREB1;SFR1;CCNQ;PEG3;KLF13;CTBP2;ZBTB7C;PSPC1;ZNF326;XPC;RNF187;NR1H2;ZBTB10;RARA;KAT7;HIF3A;STAT3;MBD1;EP300;KLF5;MLF2;PROX2;BCOR;JUND;MMS19;CRLF3;KAT6A;MED27;USF1;HMGN5;EHMT1;WWC1;NAB1;SNW1;ELOC;ENY2;MYC;MTF1;MYT1;NSD3;USP22;NLK;RGS14;SMARCD1;HDAC4;KDM2A;PEX14;NR2C2;ZHX1;VGLL4;SFPQ;ARID1A;RUNX3;ELK1;HEXIM2;USP47;E2F8;KDM1A;ZFP62;HOXB3;POU5F2;CREB3L1;HCFC1;ZGPAT;ZNF569;PPARGC1B;PPM1A;PER1;ZNF177;TBX2;NFATC3;ARNT;RCOR1;BRD4;GLIS2;MED17;FOXP2;GPBP1;NR5A2;PRKCQ;RELA;LHX1;NACC1;CARF;ZBTB7A;NR2F2;ZNF22;MEF2B;GTF2H1;PA2G4;MECOM;ARID4A;ZFP28;IL6;NR6A1;SP8;GMEB1;ZNF32;PICALM;ZBTB41;GZF1;BATF;HSF5;ZBTB12;ZBTB40;F2R;ZBTB1;MAFB;ZBTB8A;ATF2;RFX3;SRCAP;PERM1;PHF5A;ZBTB14;TRAF6;PLAG1;PHF20L1;RAI1;DVL3;SUMO1;ID3;THRA;KDM4C;PITHD1;TOX2;BRMS1;WDR77;THRAP3;SMAD1;UXT;INPP5K;ZNF3;RNF6;SFMBT1;CIART;BCL3;TLE1;CTCF;SET
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.45647200978266256,-1.1809750540513635,0.2570806100217865,0.8035802298828265,1.0,8/14,19.35%,SEC31A;SEC24A;TBC1D20;SCAP;SEC23B;SEC31B;SEC24B;SEC13
prerank,cellular response to hexose stimulus (GO:0071331),0.4578781425633522,1.180725607167589,0.24745762711864408,0.585878815574623,1.0,4/23,5.11%,GAS6;ZBTB20;ERN1;RACK1
prerank,dephosphorylation (GO:0016311),0.33468870120937944,1.1805472331604476,0.18781725888324874,0.5857233716504843,1.0,26/147,11.02%,PTPRJ;PPP3CA;PTPN18;SGPP1;PTPN12;PTPN22;MTM1;DUSP28;MTMR3;DUSP12;DUSP1;CTDSP1;SSH2;PTPRK;PTPRA;PPM1B;HDHD2;DUSP2;PPP4R1;CTDSP2;LHPP;PPP2CA;PPP2CB;PPEF1;PPP4R2;PPP1CA
prerank,response to organonitrogen compound (GO:0010243),0.4225489414576912,1.1803389146264047,0.25462962962962965,0.585672634696001,1.0,12/38,19.01%,IRAK3;NR1H4;RCN3;PRKN;RHBDD1;TRPM2;RNF185;MEAK7;KAT7;IL6;RRAGC;RNF139
prerank,negative regulation of blood coagulation (GO:0030195),0.41661729446703927,1.1800807397051576,0.25040916530278234,0.5856956250951197,1.0,4/38,5.33%,APOE;SERPINB2;C1QTNF1;PDGFRA
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5437241030459024,1.1798324538128182,0.2977867203219316,0.5857349182480043,1.0,3/10,8.54%,PTPN22;LBP;NINJ1
prerank,nuclear body organization (GO:0030575),-0.4914457953783131,-1.179761779878884,0.27824267782426776,0.8056799858220188,1.0,5/12,11.34%,AFF2;ETS1;USP50;HABP4;SRPK2
prerank,neuropeptide signaling pathway (GO:0007218),-0.3272646327946751,-1.1795175667447697,0.16013071895424835,0.8043715309092649,1.0,13/58,18.46%,SORL1;SORT1;SORCS1;HCRTR2;GLRB;ADCYAP1;SORCS3;GPR84;GLRA1;PENK;GLRA3;CPE;GPR149
prerank,regulation of MAP kinase activity (GO:0043405),0.36584132610799286,1.179281762654603,0.21589403973509932,0.5864141103179554,1.0,13/92,9.45%,EGFR;APOE;FGFR1;PTPRJ;LYN;IRAK3;CDK12;DUSP1;CD40;PIK3R6;TNF;SH2B3;PDGFC
prerank,lipid modification (GO:0030258),0.4176134679888478,1.1786547472958622,0.24153846153846154,0.5872724977215664,1.0,4/37,2.21%,ALOX5;ALOX15;SGPP1;PLA2G7
prerank,regulation of macromolecule metabolic process (GO:0060255),0.33428844999157253,1.178109942961518,0.1908763505402161,0.5879356880087975,1.0,35/170,17.03%,NELL1;APOE;APP;FOXP1;AHR;LDLR;CRIP1;RASA1;ZFP36L1;MTMR3;NFKBIZ;NKAP;CDK6;KIF16B;KDM6A;PSEN1;TRIM68;RO60;TRIM27;HMG20A;IGF1;HINFP;ROCK2;AFF1;ZC3H12A;PEG3;RNF187;ATXN7L3B;NOVA1;MYC;UBAP2;MKLN1;MTMR1;CAVIN4;LHX1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3505493389689935,1.178100325465556,0.22593582887700533,0.5874078331607704,1.0,20/105,14.43%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMA3;PSMD1;PSMD5
prerank,positive regulation of protein polymerization (GO:0032273),-0.3168251542024904,-1.1780762567977365,0.17894736842105263,0.8069682297370896,1.0,13/65,13.12%,NAV3;BIN1;NCKAP1;EVL;PTK2B;PRKCE;PAK1;NCKAP1L;MAPT;TPPP;TOGARAM1;NUMA1;MAPRE1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.34868970583188047,1.1777955472203445,0.2242503259452412,0.5875215728154392,1.0,19/112,7.38%,NRROS;ZFP36L2;ITGB1;MEF2C;RPS27A;WNT2;ADAM9;CBL;ZFP36L1;RHOA;PDE2A;NR3C1;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;USP15;DUSP22
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4185111869427629,1.1776448409201592,0.24024960998439937,0.5873110417446785,1.0,4/35,6.21%,ALOX5;LTC4S;ALOX5AP;PAM
prerank,membrane protein proteolysis (GO:0033619),0.4175432971953242,1.1775656669666987,0.24462809917355371,0.5869314249295984,1.0,15/37,22.04%,ADAM19;ADAM9;RHBDD1;PARL;PSEN1;SPPL2B;NCSTN;ERAP1;SPPL2A;PRKCQ;RELA;TRAF6;MBTPS2;ADAM17;NFKB1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4900909898566768,-1.177252946303905,0.2691511387163561,0.8076010680642455,1.0,5/12,24.35%,ABCG1;ITGB3;ITGAV;ABCA1;ABCA5
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.5141561751716253,-1.177102098262634,0.2851153039832285,0.8059515066483247,1.0,8/10,44.50%,RUVBL1;ZNHIT6;TAF9;ZNHIT3;PIH1D2;SHQ1;RUVBL2;PIH1D1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5323891354444963,1.176715558424738,0.2780952380952381,0.5882995113547034,1.0,5/12,16.59%,FUT4;WNK1;ASS1;MDK;MIA3
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5156532839021869,1.1766699270642933,0.3019538188277087,0.587853835091524,1.0,5/13,16.84%,MDFIC;RAB23;SP100;UFM1;NUP153
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5031850993286303,1.176539551810204,0.29831144465290804,0.5875587782885542,1.0,6/15,17.66%,TLR4;IL17RA;TNF;NOD2;STAT3;IL6
prerank,regulation of cellular protein catabolic process (GO:1903362),0.48119328868942496,1.1765029789808539,0.26895306859205775,0.5870893685228763,1.0,6/18,16.72%,NELL1;RIC1;MSN;WDR91;VGLL4;AMER1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4733639808079111,1.1760783323458073,0.2768670309653916,0.5874289172265794,1.0,3/18,5.19%,LILRB1;CD46;SMAD4
prerank,protein mannosylation (GO:0035268),-0.4040645505091842,-1.1760504415054587,0.22305764411027568,0.8072724752639155,1.0,9/22,24.11%,LARGE1;DPY19L4;TMTC4;DPY19L1;TMTC2;DPY19L3;TMTC1;FKTN;DPM2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4880433723351656,1.1758181357053923,0.2594594594594595,0.5869003041245237,1.0,4/15,8.27%,AP3B1;AP3M1;BLOC1S5;AP3S1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4880433723351656,1.1758181357053923,0.2594594594594595,0.5869003041245237,1.0,4/15,8.27%,AP3B1;AP3M1;BLOC1S5;AP3S1
prerank,response to leucine (GO:0043201),-0.5111052952365293,-1.1754836781152338,0.2525879917184265,0.8048777933939217,1.0,4/10,5.87%,RPTOR;UBR1;RRAGD;SESN3
prerank,cellular response to leucine (GO:0071233),-0.5111052952365293,-1.1754836781152338,0.2525879917184265,0.8048777933939217,1.0,4/10,5.87%,RPTOR;UBR1;RRAGD;SESN3
prerank,positive regulation of kinase activity (GO:0033674),0.34987534674653686,1.175462995930104,0.20917678812415655,0.5871756157732108,1.0,17/107,9.86%,EGFR;FGFR1;IQGAP1;SNX9;PRKAG2;GAS6;RASSF2;CD74;CCL19;RAPGEF2;RAP1A;INSR;PDGFRA;TNF;DDR2;CACUL1;EPHB4
prerank,hyaluronan metabolic process (GO:0030212),0.44925581540434806,1.1753274030966478,0.25041736227045075,0.5869382083106501,1.0,2/23,2.35%,LYVE1;CD44
prerank,cellular response to lectin (GO:1990858),0.35055843405636555,1.1753128234127241,0.22459893048128343,0.5858711309088742,1.0,20/104,14.43%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMA3;PSMD1;PSMD5
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.35055843405636555,1.1753128234127241,0.22459893048128343,0.5858711309088742,1.0,20/104,14.43%,CLEC10A;CLEC6A;PSMA7;LYN;NRAS;KRAS;FCER1G;BCL10;PAK2;SYK;PSMB2;FYN;CLEC4D;CREBBP;PSMA6;PRKACB;EP300;PSMA3;PSMD1;PSMD5
prerank,hyaluronan catabolic process (GO:0030214),0.4725073432046336,1.1751319446431299,0.2547008547008547,0.585722916057901,1.0,2/18,2.35%,LYVE1;CD44
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3451244394524132,-1.1751003335797854,0.21306818181818182,0.8040436176684752,1.0,7/41,5.03%,TJP1;GCNT2;PTPN23;SMAD7;PLPP3;FLOT1;PIEZO1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.39691267436032,1.1741090283103672,0.23981191222570533,0.5875369040774374,1.0,7/45,8.29%,EGFR;IQGAP1;REPS2;CBL;KIF16B;GAB1;PIK3C2A
prerank,regulation of microtubule nucleation (GO:0010968),-0.5052348782855104,-1.1740809118930522,0.2717842323651452,0.8053959234050426,1.0,9/10,41.79%,PAK1;CKAP5;EML2;DCTN1;HSPA1A;HSPA1B;RANGRF;ARHGEF7;GIT1
prerank,transepithelial transport (GO:0070633),-0.4499763680008887,-1.1740802628169333,0.257847533632287,0.80325056895341,1.0,6/15,18.89%,SLC1A3;SLC12A2;SLC1A1;ABCG2;CXADR;SLC1A2
prerank,icosanoid secretion (GO:0032309),0.5201988221365146,1.173658066403013,0.26838235294117646,0.5880063822420823,1.0,2/12,6.85%,PNPLA8;ABCC4
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.351486110439414,-1.1735978951390311,0.24585635359116023,0.8027769101161355,1.0,7/41,8.72%,KCNMA1;KCNJ2;NOS1AP;ANK2;CTSS;AKAP6;ACTN2
prerank,cellular macromolecule catabolic process (GO:0044265),0.3927220507307784,1.1729881612821405,0.25217391304347825,0.5890013192326117,1.0,11/49,11.98%,RIPK1;SIAH2;PRKN;SND1;MANBA;DNASE1L1;RNASE6;ADAMTS9;MTREX;NGLY1;DENND3
prerank,glycolipid biosynthetic process (GO:0009247),-0.3589975939501658,-1.1729716101172607,0.23295454545454544,0.8027250338711548,1.0,12/38,24.11%,LARGE1;ST3GAL5;PGAP2;SCCPDH;ST8SIA1;ST8SIA3;PIGL;ST3GAL2;PIGH;PGAP3;PIGB;DPM2
prerank,regulation of tissue remodeling (GO:0034103),0.47862835715477425,1.1727016814120146,0.27827648114901254,0.5890876633304185,1.0,4/18,14.31%,IL15;THBS4;DDR2;MDK
prerank,regulation of interleukin-17 production (GO:0032660),0.432618785382216,1.1726271523054737,0.2687813021702838,0.5887034243837095,1.0,4/31,4.11%,IL15;NR1H4;TLR4;RFTN1
prerank,protein modification process (GO:0036211),0.3689597103550755,1.1726123948758025,0.22531293463143254,0.588180204600222,1.0,19/76,15.75%,PADI4;ST8SIA4;ST3GAL1;LOX;DUSP12;SERP1;MANBA;MSRA;UBE2D3;FBXO11;GNMT;PPP4R2;STK38;LOXL2;ERO1A;RPN2;ICMT;USP25;FBXW2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4367296165146148,1.1715876929234277,0.24958677685950414,0.589925932050674,1.0,5/27,9.28%,MAP3K5;RPS27A;CCM2;MAP3K8;MAP3K20
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3924483400463452,1.1714676493219178,0.25152439024390244,0.5896435761054192,1.0,10/45,13.22%,APP;RC3H1;PUM2;MTPN;TDRD7;NANOS3;FOXO3;RPL10;TRIM71;LARP4
prerank,positive regulation of GTPase activity (GO:0043547),-0.2670874570375292,-1.171227810095486,0.12418300653594772,0.8065590370952155,1.0,41/188,11.61%,ARHGAP45;SIPA1L2;F11R;ARHGAP24;TBC1D16;MAP4K4;SEMA4D;TBC1D8;ASAP3;ARHGAP25;GARNL3;DOCK9;ITGA6;DOCK10;ARHGAP27;SGSM3;GMIP;TGM2;SGSM2;FERMT2;NF1;FLCN;TBC1D10A;NTRK3;RGS6;ARHGAP22;RASGRF1;TBC1D22A;CCL3;TBC1D22B;TIAM1;TBC1D9B;ADCYAP1;MMUT;TIAM2;AFDN;ABR;PKP4;EVI5L;TSC1;RAPGEF3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.37510853047556075,1.1711156552651902,0.2175732217573222,0.5898672339449086,1.0,13/65,11.64%,NRROS;SPRED1;SMURF2;RPS27A;SNX6;IL17RD;SNX25;HTRA3;VASN;DAND5;SPRED2;EMILIN1;PMEPA1
prerank,neutrophil migration (GO:1990266),0.3860797956737946,1.1710140472029977,0.25892857142857145,0.5896023576086096,1.0,7/58,8.22%,PF4;FCER1G;CCL8;CCL19;PIKFYVE;SYK;CCL24
prerank,cellular response to interleukin-6 (GO:0071354),0.441261228048152,1.170578711250571,0.27759197324414714,0.5899855449076866,1.0,5/26,5.19%,PID1;FER;CBL;SPI1;SMAD4
prerank,phosphate ion homeostasis (GO:0055062),0.5441454631711854,1.1704638027135024,0.2826086956521739,0.5896833433415467,1.0,3/10,19.31%,FGF23;XPR1;ENPP1
prerank,positive regulation of calcium ion import (GO:0090280),-0.48127148244461015,-1.170235174873337,0.26526315789473687,0.8077767435227549,1.0,9/12,49.33%,CCL3;PDGFRB;CXCL12;STC1;RAMP3;ATP2A1;CCL2;PDGFB;CALCR
prerank,regulation of protein secretion (GO:0050708),0.3415236439735485,1.170173632760505,0.21391752577319587,0.5898069984715487,1.0,25/119,12.44%,APOE;ALOX5;ANG;EXPH5;ADAM9;HMGCR;CLOCK;RAP1A;TMED10;RHBDF1;DPH3;STXBP5;TNF;EIPR1;KCNG2;GOLPH3L;CD33;DNAJC1;IGF1;HADH;ACHE;SLC8B1;SLC2A2;KCNB1;DISP1
prerank,phosphate ion transport (GO:0006817),-0.4382694689389151,-1.169795825215739,0.25396825396825395,0.807165295828592,1.0,7/16,20.91%,SLC25A3;SLC37A2;SLC25A14;SLC37A4;SLC25A10;SLC20A2;SLC37A3
prerank,sulfation (GO:0051923),0.5343159103635374,1.169786580352899,0.28544423440453687,0.5901701133423857,1.0,3/11,13.73%,UST;SULT1A1;SULT6B1
prerank,regulation of interferon-beta production (GO:0032648),0.3998284094026837,1.169668898484855,0.25308641975308643,0.5898725378421676,1.0,10/46,7.46%,TLR8;OAS2;LILRB1;TLR4;TLR2;TRIM56;RIOK3;PPM1B;YY1;REL
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3742194265135004,-1.1696007779119668,0.23901098901098902,0.8056876995449809,1.0,10/33,14.01%,PIK3CB;NYAP2;PLEKHA1;NF1;MYO16;PIK3C2B;SIRT2;PIK3R5;C1QBP;TYRO3
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.4655369984000366,1.1692096435231722,0.26287744227353466,0.5903110445753832,1.0,4/21,5.66%,LRP6;AXIN1;GSK3B;FRAT1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.42506205388428775,1.168205713867698,0.2755267423014587,0.5920011523084224,1.0,9/31,12.57%,YWHAQ;GSK3B;SFN;BCL2;ZNF205;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.42297976028314194,1.168183198555659,0.26484751203852325,0.5914994315371271,1.0,5/35,5.33%,IQGAP2;NRP1;NOTCH2;CDC42;PDGFRA
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3983886536959452,-1.1677850408717783,0.25,0.8096853406992133,1.0,10/23,18.76%,CUL4A;COPS7A;PARP1;COPS8;DDB2;RBX1;COPS4;COPS6;GPS1;UBB
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.48437181214615316,1.1676190735592034,0.2522851919561243,0.592213245944485,1.0,3/18,8.00%,GNAQ;RGS8;GNB1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.44301930828488056,1.1670911204577576,0.2808798646362098,0.592843992668125,1.0,7/25,10.24%,MEF2C;GSK3B;MPP2;CHRNA4;MAPK8IP2;INSYN2A;GRIN2D
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5103425491104938,1.1663975305862524,0.29775280898876405,0.5938898409254002,1.0,2/13,4.55%,GAS6;LAMP1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.4803093315047622,-1.1660887706789755,0.2717842323651452,0.813390836278205,1.0,5/12,16.02%,MAP2;TBCD;MAPRE1;EML2;CLIP3
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.4852348422700705,-1.1657818651955807,0.284796573875803,0.8122993856498963,1.0,4/11,20.28%,HTRA2;ST18;PARK7;PRR7
prerank,response to interleukin-1 (GO:0070555),0.37155302336397034,1.1652665182904227,0.24963289280469897,0.5958146839317316,1.0,28/73,23.64%,APP;GBP3;IRAK3;CCL8;NR1D1;CCL19;TNFRSF11A;RC3H1;CD40;CCL24;IGBP1;SFRP1;ZC3H12A;HDAC4;CCL5;RELA;ACOD1;CCL25;TRAF6;HAS2;SNCA;CCL14;NFKB1;CD47;IL1R1;TANK;MAPK11;TLE5
prerank,cellular response to metal ion (GO:0071248),0.34358075901240415,1.1650676229144281,0.2297650130548303,0.5956840428498456,1.0,16/123,7.63%,EGFR;CHP2;IQGAP1;MEF2A;ALOX15;MEF2C;ALOX5AP;B2M;PRKN;AOC1;CPNE2;CLIC4;CPNE7;SLC25A24;CPNE8;HFE
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.4135455987352568,-1.1650500333346154,0.25542168674698795,0.8126759284356087,1.0,8/19,23.12%,CEP135;TREM2;PTP4A3;CCT7;CENPJ;CCT2;WRAP53;CCT8
prerank,cell projection assembly (GO:0030031),-0.4095634628317339,-1.164547139531458,0.2641975308641975,0.8121625161796213,1.0,8/22,19.28%,NCKAP1;NEFH;RHOQ;NCKAP1L;RHOH;PARVG;PDGFA;RHOG
prerank,cellular response to ATP (GO:0071318),0.4921016798088354,1.1641095305382045,0.30127041742286753,0.5973377587088997,1.0,1/14,0.51%,P2RX7
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.42379769631835273,-1.1640610908196731,0.26785714285714285,0.8116930597305656,1.0,5/17,14.42%,CPSF6;CDK9;CTR9;HSF1;NCBP1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.3099739538711424,-1.164019863598072,0.1757188498402556,0.8097360988511718,1.0,22/72,19.24%,GTF2H2;CUL4A;CCNH;COPS7A;COPS8;RBX1;ERCC6;COPS4;PPIE;ERCC2;LIG1;XAB2;XRCC1;HMGN1;UVSSA;PRPF19;RFC2;POLR2C;COPS6;GPS1;UBB;RFC1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.5269893314039118,1.163961668884567,0.2859778597785978,0.5970941882859978,1.0,2/11,2.60%,NR1H4;BMP2
prerank,RNA splicing (GO:0008380),-0.29262782570563267,-1.1639209869762355,0.16260162601626016,0.8079672568332125,1.0,27/95,16.21%,IVNS1ABP;LUC7L3;FUS;SRRM1;DDX39B;RP9;TARDBP;DDX47;SNRNP48;SRPK1;GEMIN2;SRSF2;SNRPA1;SRSF10;PRPF4;WBP4;CCAR2;TCERG1;RNPS1;SRPK2;SNRPN;U2AF1;SF3B1;NCBP1;PRPF6;DDX23;ZMAT5
prerank,positive regulation of actin nucleation (GO:0051127),0.5279353474081282,1.163889658661752,0.2988929889298893,0.5967247000459434,1.0,2/11,2.42%,WASF2;FCHSD2
prerank,oligosaccharide metabolic process (GO:0009311),-0.33654153750849936,-1.1637170576752602,0.2222222222222222,0.8065421950160966,1.0,16/46,18.40%,ST3GAL6;ST6GALNAC3;MAN1B1;B3GALT1;NEU1;ST6GALNAC4;B3GALT5;GAL3ST4;B3GALT2;ST8SIA1;ST6GAL2;ST3GAL3;ST8SIA3;IDUA;FUT9;ST3GAL2
prerank,positive regulation of metabolic process (GO:0009893),0.34658329666649984,1.1636065759797396,0.2170439414114514,0.5968462010890032,1.0,19/103,10.91%,IRF4;CMKLR1;CEBPB;ADRB2;CD36;CAMK1D;GHRL;INSR;ADIPOR2;SYK;TNF;CXCR4;CCR2;BEND3;PDGFC;STAT6;TSHR;HADH;ACHE
prerank,regulation of vasoconstriction (GO:0019229),0.43593993789296603,1.1632511516869828,0.27796610169491526,0.5971513016062918,1.0,4/27,8.64%,ATP2B1;ADM;ADRA1D;ADRA1A
prerank,water transport (GO:0006833),-0.4884091988426924,-1.163115739573164,0.2781316348195329,0.8064348530361561,1.0,5/12,47.18%,PDPN;CFTR;AQP4;AQP1;SLC5A1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5428611288509898,1.162732511276541,0.2971014492753623,0.5977645394183614,1.0,2/10,4.33%,RIPK1;PDE8A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.340256705443032,1.1619466367062858,0.2158176943699732,0.59897201219989,1.0,33/122,17.73%,EGFR;EIF3E;TLR4;CCL19;SAMD4A;NIBAN1;RPL26;RGCC;VIM;TLR2;IRS2;INSR;TMEM106A;NMD3;RPS4X;KLF4;MTPN;RPL5;LARP4B;IGF1;NAMPT;NOD2;LARP4;PIWIL2;KAT7;PRKD2;PRMT1;MYC;ABCB10;XBP1;IL6;HGF;PYM1
prerank,protein targeting to lysosome (GO:0006622),-0.406446489385178,-1.1615475910734432,0.24257425742574257,0.8096558085634804,1.0,4/20,5.14%,SORL1;GNPTAB;SCARB2;GCC2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.436343002864236,1.1612550345399815,0.2685810810810811,0.6000280931958893,1.0,3/28,4.76%,APOE;APP;GSK3B
prerank,monoacylglycerol metabolic process (GO:0046462),-0.4643121486916747,-1.1605772107526555,0.2878787878787879,0.8109894631785874,1.0,5/13,17.06%,ABHD12;MGLL;ABHD16A;AWAT2;FAAH
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4627003788063975,1.160258293990692,0.28066914498141265,0.6017271791765242,1.0,8/21,16.89%,ADAM19;ADAM9;PSEN1;SPPL2B;NCSTN;ERAP1;SPPL2A;PRKCQ
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.42959627999107525,-1.1600633969811642,0.25415676959619954,0.8106372540344976,1.0,6/16,20.81%,LYST;PLEKHM2;VAMP2;CORO1A;VAMP7;ULBP1
prerank,regulation of telomerase activity (GO:0051972),-0.33576265284388496,-1.1599094227215285,0.21652421652421652,0.8091447875854475,1.0,11/45,14.57%,CTNNB1;XRCC5;SRC;TP53;ATM;MAPK3;MAP2K7;PTGES3;MAP3K4;CERS1;PARP4
prerank,regulation of dendritic spine development (GO:0060998),-0.4164535979902497,-1.1597213933187653,0.25934579439252337,0.8077024651003152,1.0,8/19,8.11%,TANC2;PTPRS;NLGN1;PPFIA2;KIF1A;GRIN3A;SHANK1;FMR1
prerank,canonical Wnt signaling pathway (GO:0060070),0.36784227763666133,1.159239492130951,0.2374821173104435,0.6035224523486791,1.0,12/68,11.02%,LRP6;TCF7L2;RARG;WNT2;AXIN1;GSK3B;FRAT1;TCF7;WNT6;NR4A2;SFRP1;PPP1CA
prerank,lipid homeostasis (GO:0055088),0.3833049758764188,1.1590476669865546,0.23880597014925373,0.6034493192892444,1.0,6/57,4.93%,APOE;FBXW7;ZBTB20;RCN3;IRS2;PNPLA8
prerank,ganglion development (GO:0061548),0.5230259604945289,1.158983998688765,0.3013182674199623,0.6030411316022584,1.0,1/11,0.34%,NRP1
prerank,negative regulation of phagocytosis (GO:0050765),0.4676900879413026,1.158800788555763,0.2746858168761221,0.6029045034070734,1.0,4/17,5.18%,FCGR2B;TLR2;RACK1;SNX3
prerank,aggrephagy (GO:0035973),0.43048321080761653,1.1586657498975306,0.26666666666666666,0.6026885996597008,1.0,7/27,13.05%,WDFY3;RPS27A;PRKN;VIM;PCNT;DYNC1I2;UBE2N
prerank,ureteric bud development (GO:0001657),-0.4211470000594567,-1.1585282249190854,0.25900900900900903,0.80969863845055,1.0,4/17,4.91%,SALL1;NPNT;ROBO2;FGFR2
prerank,positive regulation of type 2 immune response (GO:0002830),0.4946364095159737,1.1584687905987368,0.2962962962962963,0.6026077666162823,1.0,5/14,17.66%,CD74;DENND1B;NOD2;RARA;IL6
prerank,myotube cell development (GO:0014904),0.5438606964186552,1.1583859005983104,0.30711610486891383,0.6022628046977443,1.0,2/10,9.90%,MYORG;IGF1
prerank,sensory perception of pain (GO:0019233),0.45340446594459116,1.1582452689489877,0.2823920265780731,0.6020325921311679,1.0,4/21,11.13%,P2RX7;CHRNA4;CCR2;KCNK4
prerank,amino sugar metabolic process (GO:0006040),0.5318955310903959,1.157971787869772,0.2978723404255319,0.6021390651038276,1.0,4/10,14.21%,ST6GAL1;ST3GAL1;GFPT2;EXTL2
prerank,glucose metabolic process (GO:0006006),-0.3276101595817455,-1.1576788943843435,0.2,0.8106138211293045,1.0,20/58,21.17%,LRP5;PGM1;ALDOA;MDH1;APOD;CRTC2;GAA;PGK1;ENO1;PCK2;ENO3;SLC37A4;TPI1;HECTD4;SLC39A14;SLC25A10;GAPDHS;ATF4;GAPDH;SLC25A1
prerank,negative regulation of GTPase activity (GO:0034260),-0.40142292270028057,-1.1575020180086244,0.2471131639722864,0.8092654587734481,1.0,9/22,20.54%,F11R;GMIP;RASA4;CPEB2;RDX;ARFGEF1;HRAS;PLXNB3;GPSM1
prerank,negative regulation of axonogenesis (GO:0050771),-0.3849897727897351,-1.1574211695450851,0.2694300518134715,0.8075086963393575,1.0,10/27,16.42%,MAP2;PTPRS;DIP2B;FGF13;GDI1;LINGO1;MAG;OMG;ULK1;THY1
prerank,negative regulation of viral genome replication (GO:0045071),0.40034102794513443,1.1572790063367688,0.2561174551386623,0.6031518751732997,1.0,8/40,9.78%,IFITM3;OAS2;FAM111A;RNASEL;TNF;BST2;IFITM2;ILF3
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4521174758077964,-1.15689104716206,0.2717149220489978,0.8072266775491781,1.0,6/15,20.02%,CPEB2;ZFAND1;ATF3;HSF1;HNRNPA1;GSTO2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.409023907281947,1.156534965455103,0.2647058823529412,0.6043615558841093,1.0,9/33,11.81%,ALOX5;KLF2;S100A1;EPN2;KLF4;SYNJ2BP;ADAMTS9;CEMIP2;JAK1
prerank,ameboidal-type cell migration (GO:0001667),0.38254847810436327,1.1565276017804529,0.2646616541353383,0.6038334685808266,1.0,7/51,9.55%,ITGA4;SEMA4A;PKN2;PDLIM1;SGPL1;AMOT;CORO1C
prerank,negative regulation of chemotaxis (GO:0050922),-0.36640510097023327,-1.1564274257053506,0.23393316195372751,0.8068378225388062,1.0,13/31,27.82%,SEMA4D;ROBO2;SEMA4C;ROBO1;SEMA4G;AIF1;NOTCH1;CORO1B;SEMA4F;SEMA3B;SEMA3F;SEMA3A;SEMA3D
prerank,regulation of actin filament-based process (GO:0032970),0.36913656700376263,1.1561073567187592,0.2523364485981308,0.6042498886754255,1.0,11/70,7.97%,IQGAP2;IQGAP1;BST1;ARHGAP18;CRK;RHOA;ROCK1;CELSR1;CNN2;BST2;RHOBTB1
prerank,cellular response to interleukin-4 (GO:0071353),0.542876105840917,1.1559031166895988,0.29277566539923955,0.6041172499279711,1.0,4/10,17.28%,DCSTAMP;TCF7;STAT6;XBP1
prerank,axonal transport (GO:0098930),-0.3498231592127224,-1.1556713286395017,0.24731182795698925,0.8073058491131268,1.0,9/36,14.09%,DST;DYNC1H1;KIF1A;AP3B2;MAPT;AP3D1;TMEM108;KIF3A;KIF3B
prerank,response to glucose (GO:0009749),0.394099566483103,1.155404333552084,0.2545454545454545,0.604740260671573,1.0,6/46,5.11%,TCF7L2;GAS6;ZBTB20;ERN1;IRS2;RACK1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5155359594975091,1.1548259814751236,0.31721470019342357,0.6054975439454102,1.0,3/12,14.37%,TLR4;NOD2;RBP4
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.47497038276557446,-1.1548000131665934,0.2920168067226891,0.8082683134610276,1.0,4/12,15.04%,SNAP25;SNAP47;STX3;STX2
prerank,response to purine-containing compound (GO:0014074),0.46779015358590104,1.1543780560064054,0.28596187175043325,0.6059992387370536,1.0,2/17,3.28%,P2RX7;P2RY6
prerank,hemopoiesis (GO:0030097),0.3522165048130778,1.1537577919879705,0.23076923076923078,0.6068220902081098,1.0,23/87,17.64%,RASGRP4;NOTCH2;ZBTB16;KMT2A;ZFP36L2;JAG1;KITLG;TPO;LYL1;NCOA6;ASH2L;SH2B3;SFRP1;CDK13;TET2;KAT6A;RUNX3;MKNK2;CD164;TIRAP;PRDX3;MECOM;ARMC6
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.36174109825062883,1.1535076682358212,0.24492753623188407,0.6068677789620852,1.0,15/70,14.48%,CYBB;PSMA7;FCER1G;CD36;B2M;LNPEP;MFSD6;PSMB2;NCF2;SNAP23;PSMA6;PSMA3;PSMD1;PSMD5;CYBA
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.4723044215900998,-1.1534176704358867,0.2575107296137339,0.8108682842271231,1.0,3/11,5.05%,CD274;TWSG1;VSIR
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.45464366362971037,1.1533200382051858,0.296229802513465,0.6067631707914916,1.0,5/21,14.40%,MCUB;MCU;SLC8B1;MICU3;PDZD8
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.42964044774776905,-1.153296295141738,0.29082774049217003,0.8092538320676763,1.0,6/15,26.39%,CNOT7;NLRC5;STAT2;MUL1;METTL3;TTLL12
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4025185590336313,1.1531974835651189,0.2765625,0.6064962415520312,1.0,9/36,12.32%,APOE;MEF2C;RGCC;TNF;SYNJ2BP;ADAMTS9;SP100;JUP;ATP2B4
prerank,regulation of embryonic development (GO:0045995),0.4212070650534737,1.1531688032655578,0.2783171521035599,0.6060263577593126,1.0,16/34,22.46%,INSR;RAB14;CLASP1;RPS6KA6;POGLUT1;B4GALT5;CCSAP;NIBAN2;EHMT1;NPHP3;NR2C2;LHX1;TRIP12;RACGAP1;NIPBL;WDPCP
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.44196063562843413,1.1531585075746367,0.27848101265822783,0.6055096010898,1.0,6/26,9.91%,MFHAS1;PTPN22;LBP;TLR2;NINJ1;RTN4
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.4412283943028502,1.1527778504409365,0.27454242928452577,0.6058193871469756,1.0,4/27,5.60%,C3AR1;GPR65;DRD1;P2RY10
prerank,regulation of astrocyte differentiation (GO:0048710),-0.4738987381843318,-1.1525707275454364,0.30217391304347824,0.8097222318714511,1.0,2/12,0.79%,BIN1;SERPINE2
prerank,negative regulation of translation (GO:0017148),0.3599684014471484,1.1519193653803208,0.266754270696452,0.607199259266701,1.0,34/87,23.11%,RPS3;DAPK1;EIF3E;SAMD4A;MRPL13;RACK1;ROCK1;MALSU1;RBM4;ILF3;DDX6;EIF4EBP2;NANOS3;ROCK2;EIF4EBP1;TRIM71;SHMT1;CNOT9;SYNCRIP;EIF2AK4;RNF139;EIF2AK2;EIF2AK3;CNOT1;CNOT8;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7;METTL16;EPRS1;CPEB3;PCIF1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.49869681864204757,1.1518853878728976,0.2768959435626102,0.6061958604235197,1.0,5/13,13.90%,IL15;SHC1;IL15RA;JAK1;STAT3
prerank,cellular response to interleukin-15 (GO:0071350),0.49869681864204757,1.1518853878728976,0.2768959435626102,0.6061958604235197,1.0,5/13,13.90%,IL15;SHC1;IL15RA;JAK1;STAT3
prerank,ureteric bud morphogenesis (GO:0060675),-0.42492984537135436,-1.151846859335349,0.30045871559633025,0.8102753948176399,1.0,3/16,4.13%,SALL1;NPNT;FGF2
prerank,regulation of cellular metabolic process (GO:0031323),0.39072138225335123,1.1518288798932568,0.25673534072900156,0.6057714966308979,1.0,5/45,6.63%,PID1;PRKN;PARL;KIF16B;FOXM1
prerank,nuclear membrane organization (GO:0071763),-0.410108607052532,-1.1517955247215728,0.28444444444444444,0.8084788299003323,1.0,7/19,23.95%,AKAP8L;TARDBP;CHMP4B;NSFL1C;EMD;TOR1A;DCTN1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.47458105642770887,-1.1516677536236395,0.3,0.8069227761108669,1.0,4/12,14.98%,B3GALT1;B3GALT5;B3GALT2;B3GNT2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38932312296181504,1.1515924016899157,0.2595419847328244,0.605758865261158,1.0,7/49,6.34%,SGMS1;NUPR1;GSDME;MCL1;RACK1;BCL2L2;BCL2
prerank,regulation of proteolysis (GO:0030162),-0.3356387875097816,-1.1515402621772501,0.20485175202156333,0.8053289218899657,1.0,8/48,7.60%,ASPH;SERPINE2;CAPN3;GSAP;CLN3;TBC1D10A;CYFIP2;BAG6
prerank,amino acid import across plasma membrane (GO:0089718),-0.3885812037214673,-1.151525375197598,0.265625,0.8034410558788908,1.0,4/24,11.34%,SLC1A3;SLC36A1;SLC1A1;SLC7A8
prerank,megakaryocyte differentiation (GO:0030219),0.5131959963546493,1.1507698036516822,0.31053604436229204,0.6070226714875797,1.0,2/11,9.36%,THPO;SH2B3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.5002364561283713,1.150760657772388,0.27099236641221375,0.6065058516505557,1.0,7/13,18.57%,RHOA;TNF;ITGB2;MDK;RELA;IL6;TRAF6
prerank,sodium ion transport (GO:0006814),-0.2949554390859535,-1.1506526190379265,0.18253968253968253,0.8043575021866418,1.0,11/85,7.42%,SLC12A2;SLC24A3;SLC24A2;ATP1B1;SCN1B;SLC8A1;SGK1;FGF13;SLC38A7;NALCN;SLC24A4
prerank,phosphorylation (GO:0016310),0.29991804985815673,1.1497631306564362,0.17293233082706766,0.6082230328251035,1.0,72/385,12.36%,POMK;FGFR1;APP;MAP3K5;STK17B;SGK3;PEAK1;CDC42BPG;PRKAG2;GAS6;GMFG;LYN;GRK5;STK19;FER;DAPK1;IRAK3;OXSR1;BMP2;PRKAG3;ERN1;MAP3K1;CDK12;IP6K3;FRK;CDK6;GSK3B;INSR;CAMKK2;GNPTG;PKN2;PAK2;MAPKAPK2;ROCK1;STK24;STK3;RNASEL;WNK1;VRK2;ACVR2A;SYK;CHEK1;FAM20A;ZAP70;NRK;PPP4R1;PRKCB;BIRC6;FYN;CDK14;CDK20;VRK1;LIMD1;DYRK1A;FGGY;MAP3K20;MAST1;ILF3;DGKH;MARK2;MAML1;STK10;CDK13;JAK1;STK36;CDK17;ROCK2;STK38;PRKACB;MKNK1;TRIB2;MAP3K11
prerank,response to muramyl dipeptide (GO:0032495),0.5062770976917725,1.149735997521335,0.2895238095238095,0.6077429512754925,1.0,5/12,12.73%,PTPN22;VIM;RIPK2;CHMP5;NOD2
prerank,positive regulation of embryonic development (GO:0040019),0.46843878977013087,1.1494021014468143,0.2897822445561139,0.6080215691367834,1.0,6/19,17.03%,OSR1;RACK1;B4GALT5;NIBAN2;NR2C2;LHX1
prerank,regulation of innate immune response (GO:0045088),0.3819832810784773,1.149317072152249,0.2608695652173913,0.6076567510840556,1.0,16/57,16.96%,FCGR2B;TLR8;IRAK3;PTPN22;BIRC3;RIOK3;RNASEL;IFNAR2;CASP8;POLR3D;SAMHD1;ERAP1;HSP90AB1;TIRAP;CCL5;ACOD1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4277403183760597,1.1492126156166116,0.29360967184801384,0.6073793586742313,1.0,7/26,15.38%,APP;PKN2;MDM2;CUL3;TTL;EIF4EBP1;USP22
prerank,histone lysine demethylation (GO:0070076),0.4365631306551907,1.1485650430646945,0.2995008319467554,0.6083380122087425,1.0,9/25,18.88%,PHF8;KDM7A;KDM6A;KDM4D;JMJD1C;KDM5C;KDM2A;KDM1A;KDM4C
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.3493651910677541,-1.1480461935608126,0.24338624338624337,0.8110608519315219,1.0,13/37,18.45%,IFT81;IFT140;DYNLRB1;IFT88;IFT20;WDR19;DYNC2H1;KIF3A;SSX2IP;IFT52;KIF3B;IFT43;DYNC2I1
prerank,long-term memory (GO:0007616),0.46831065618129064,1.1471989320827258,0.30927835051546393,0.6108119347835357,1.0,3/19,3.91%,APOE;LDLR;SLC2A4
prerank,centromere complex assembly (GO:0034508),-0.35259331636793817,-1.1470265050439608,0.24193548387096775,0.8125108605584598,1.0,15/36,30.17%,CENPC;CENPE;NASP;KNL1;MIS18BP1;RUVBL1;DLGAP5;CENPX;CENPV;CENPP;CENPN;CENPH;CENPI;MIS18A;CENPF
prerank,zinc ion homeostasis (GO:0055069),-0.3814206690337626,-1.146775159871359,0.2426470588235294,0.8114179633678201,1.0,15/28,25.96%,SLC30A9;ATP13A2;SLC39A13;SLC39A14;MT2A;TMC8;MT1B;MT1G;MT1E;MT1A;MT1X;MT1H;MT1M;MT1F;SLC39A6
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.41991591521859895,-1.1466357035885468,0.2702078521939954,0.8098980181524587,1.0,5/18,10.68%,NAV3;HAVCR2;PRNP;HDAC7;CD34
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.4607218929235914,-1.1464908752793697,0.3103448275862069,0.80842570922237,1.0,6/13,10.70%,JAK2;MGAT5;IL7R;PTPRT;DOT1L;JAK3
prerank,axon guidance (GO:0007411),-0.2574841381518709,-1.146243785861422,0.10126582278481013,0.8073482674944159,1.0,35/201,7.97%,PTPRM;NCAM1;NRXN3;SEMA4D;UNC5C;PIK3CB;EVL;EFNA5;ROBO2;EPHA7;SCN1B;SRC;NRXN1;SEMA4C;GRB10;PLXNA2;PLCG1;ROBO1;LYPLA2;KIF5A;SEMA4G;PALLD;MAPK3;KIF5C;CNTN4;EPHB1;BDNF;BSG;EPHA10;CNTN6;RHOH;CNTN2;SHC3;UNC5D;LAMA2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5309724912593862,1.1459668027098167,0.32971014492753625,0.6130227867437796,1.0,1/10,0.26%,DSE
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.4973406355814366,-1.1459089838684382,0.31333333333333335,0.8065740720843002,1.0,8/10,36.47%,SETD4;SETD3;SETD2;SETD6;SMYD2;METTL18;EEF1AKMT2;SETD7
prerank,pre-miRNA processing (GO:0031054),0.505084062330151,1.1458562594803754,0.3175182481751825,0.6127219146711624,1.0,5/14,13.29%,PRKRA;TUT7;DROSHA;TUT4;MRPL44
prerank,protein localization to cilium (GO:0061512),-0.36464207609682875,-1.1457668813158595,0.25935828877005346,0.8051074943860441,1.0,10/32,20.64%,BBS9;ATP6V1D;IFT140;IFT20;WDR19;INVS;TCTN1;TULP3;BBS4;ARL3
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.45603980935439276,1.1457484221557126,0.28647686832740216,0.6124328406381752,1.0,11/20,22.04%,ADAM9;RHBDD1;PSEN1;SPPL2B;NCSTN;SPPL2A;RELA;TRAF6;MBTPS2;ADAM17;NFKB1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.44213793005498897,1.1456881985859466,0.29541595925297115,0.6120241687421519,1.0,9/24,19.31%,GSK3B;IRS2;INSR;PPP1R3C;IGF1;PPP1R3D;PPP1R3B;INPP5K;ENPP1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3394837313093807,1.1451931524786656,0.23567708333333334,0.612610898593224,1.0,24/124,14.43%,AP2A2;TCF7L2;PPP3CA;CLTC;SMURF2;PSMA7;GNG2;PRICKLE1;CDC42;RHOA;PDE6A;CELSR1;AP2S1;PSMB2;GNB1;SFRP1;CALM1;PLCB3;PSMA6;TNRC6C;AP2B1;PSMA3;PSMD1;PSMD5
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4677134768876847,1.1450960603892424,0.2976827094474153,0.6122692905663308,1.0,5/17,9.32%,SASH1;CD36;NFKBIL1;LY96;CARD16
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.44537569930830645,1.1446170315447668,0.2847222222222222,0.6128575868865385,1.0,7/23,10.64%,APP;PRKAG2;AXIN1;S1PR2;UBE2K;RIPK2;CALM1
prerank,skeletal system morphogenesis (GO:0048705),0.38801828458674736,1.1444644012533274,0.2708978328173375,0.6126640966893395,1.0,7/42,9.99%,LRP6;FGFR1;ALX1;ANKRD11;PDGFRA;RFLNB;CYP26B1
prerank,base conversion or substitution editing (GO:0016553),-0.4765994552792686,-1.144156744807745,0.29227557411273486,0.8085613493782093,1.0,5/11,27.50%,ADAR;ADARB2;ADARB1;METTL3;NUDT16
prerank,aortic valve morphogenesis (GO:0003180),0.4201481309503693,1.1439389513494047,0.27751196172248804,0.6133248242199765,1.0,7/30,11.99%,JAG1;HEY2;RB1;ROCK1;SLIT3;EMILIN1;ROCK2
prerank,positive regulation of DNA repair (GO:0045739),0.38058333124316207,1.1439341086127455,0.2787136294027565,0.6128036378801174,1.0,8/46,7.70%,EGFR;RPS3;BABAM2;FAM168A;FOXM1;BRCC3;DDX11;CEBPG
prerank,negative regulation of viral process (GO:0048525),0.37176910763715154,1.1436428628483994,0.2870229007633588,0.612902602698323,1.0,14/57,14.92%,IFITM3;OAS2;LARP7;FAM111A;RNASEL;TRIM32;TNF;BST2;TRIM27;IFITM2;ILF3;BANF1;MID2;PPIA
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4149819912834693,1.1435985723252013,0.29383116883116883,0.6124628253529345,1.0,6/32,9.55%,RREB1;ACTR3;WASF2;CDC42;ARPC2;CORO1C
prerank,regulation of exocytosis (GO:0017157),-0.3294985586939629,-1.143479847701192,0.2553191489361702,0.8088856116860449,1.0,20/46,21.01%,CADPS;CLASP2;RIMS2;RAB27A;RAB3C;LGI3;CPLX1;IL1RAPL1;VAMP2;RAB12;CFTR;SYT1;RAB15;CPLANE2;RAB8A;CPLX2;HAP1;CHMP6;CHMP3;RAB9A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.46589208085338185,-1.1433579609881155,0.28,0.8073611284977152,1.0,8/13,41.97%,UPP2;DUT;NT5M;UNG;NEIL2;NEIL1;DCTPP1;MBD4
prerank,negative regulation of platelet activation (GO:0010544),0.4779718425057523,1.1430533117750006,0.2867383512544803,0.6132061461985512,1.0,5/16,9.36%,APOE;C1QTNF1;PDGFRA;ADAMTS18;SH2B3
prerank,negative regulation of anoikis (GO:2000811),0.4955443759570811,1.1430237361082891,0.3204225352112676,0.6127343140944328,1.0,3/14,6.34%,ITGB1;MCL1;BCL2
prerank,coenzyme A metabolic process (GO:0015936),0.49513743604354404,1.1426011501039999,0.31194295900178254,0.6131629155139069,1.0,1/14,0.18%,SLC25A16
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.4409364262722233,1.1425504134778623,0.2827476038338658,0.6127402244930029,1.0,5/23,19.23%,ENDOG;DNASE1L1;DFFA;FBH1;KPNB1
prerank,generation of neurons (GO:0048699),0.3203488098268025,1.1423027835950834,0.2079806529625151,0.6127515216711668,1.0,26/190,10.58%,NRP1;FGFR1;NAV1;OPHN1;MEF2C;SH3RF1;WNT2;RAPGEF2;LRP12;HEY2;CDK6;USP9X;DISC1;CELSR1;IRX2;MTPN;WNT6;NR4A2;LHX5;IRX5;TUBGCP2;OLIG2;ACSL3;CCK;DOCK7;MARK2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2739275524760236,-1.142183589281222,0.17488789237668162,0.8093143480893479,1.0,60/125,31.86%,CLASP2;DYNC1H1;CENPC;RANBP2;CENPE;WDR62;KNL1;NEK6;NUP85;TACC3;KIF11;CKAP5;EML1;MAPRE1;BUB1B;KIF3B;BUB1;SEH1L;DLGAP5;MAP4;SPDL1;NDC80;NUSAP1;KIF2A;INTS13;SKA2;BCCIP;NSL1;PTPA;CDCA8;B9D2;RCC1;SEC13;SETD2;DCTN2;ZW10;CENPP;CENPN;CENPH;ESPL1;ZWINT;STIL;BIRC5;MAD2L1;CEP126;CENPI;SPC25;AURKB;PMF1;DYNLL2;KIF2C;TTK;CENPF;SGO1;NUDC;PPP1CC;CLIP1;NUF2;TUBG1;AURKA
prerank,negative regulation of leukocyte migration (GO:0002686),0.5186470235219096,1.141846582589698,0.312625250501002,0.6132512950469842,1.0,3/10,11.22%,HMOX1;CD200R1;EMILIN1
prerank,cellular response to leucine starvation (GO:1990253),-0.49358814280532226,-1.1418442014726797,0.3159041394335512,0.8085235119454172,1.0,7/10,19.45%,GCN1;IMPACT;RRAGD;SESN3;RRAGB;MTOR;SESN2
prerank,cellular response to alcohol (GO:0097306),0.3915550084678114,1.1415476416538213,0.2872340425531915,0.6133843799203984,1.0,11/42,11.88%,LRP6;CTNNA1;AHR;GNG2;KLF9;GNB1;SFRP1;SPIDR;PTGER4;JUP;GRAMD1B
prerank,regulation of stress fiber assembly (GO:0051492),0.3615411615780012,1.1415377813777994,0.26337448559670784,0.6128722772604227,1.0,22/74,15.28%,NRP1;ARAP1;WASF2;GPR65;CDC42;ARHGEF10L;RHOA;RGCC;S100A10;ITGB1BP1;PAK2;ROCK1;CLASP1;SFRP1;PXN;PTGER4;PPFIA1;ROCK2;ARHGAP28;RHOC;CGNL1;STMN1
prerank,synaptic vesicle transport (GO:0048489),-0.484802096332227,-1.141471680754409,0.2953020134228188,0.8078008486296248,1.0,4/11,6.42%,RAB27A;KIF5A;SPG11;KIF5C
prerank,ribosomal large subunit assembly (GO:0000027),0.4433076582785456,1.141347094799346,0.28619528619528617,0.6127826470974733,1.0,11/24,17.69%,RPL23A;RSL24D1;RPL24;NOP53;RPLP0;RPL5;RPL6;RPL10;RPL11;RRS1;DDX28
prerank,regulation of mast cell degranulation (GO:0043304),0.4834902333189917,1.1412179203922224,0.28191489361702127,0.6125546114707171,1.0,6/14,19.43%,LYN;FER;SYK;UNC13D;FES;STXBP2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.34091942392212093,-1.140717628608531,0.22459893048128343,0.8083098295193815,1.0,7/40,8.11%,PRKCD;CDK9;FXR2;ETAA1;MAPT;SIRT7;FMR1
prerank,cell projection organization (GO:0030030),-0.3742463933235733,-1.1406730198062338,0.2631578947368421,0.8066016022795668,1.0,8/30,7.38%,NCKAP1;ATP1B2;CSPG5;NEFH;RHOQ;NCKAP1L;P2RY12;RHOH
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3970022895111309,1.1395520827030476,0.2949101796407186,0.61571507508633,1.0,6/44,4.27%,APOE;PTPRJ;LYN;IRAK3;PTPN22;DUSP1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.48823988962178433,1.1393600545037708,0.30303030303030304,0.6150975802153589,1.0,10/15,27.00%,ZFP36L2;ZFP36L1;NANOS3;TNRC6C;CNOT1;CPEB3;TOB1;NANOS1;AGO2;ZFP36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.48823988962178433,1.1393600545037708,0.30303030303030304,0.6150975802153589,1.0,10/15,27.00%,ZFP36L2;ZFP36L1;NANOS3;TNRC6C;CNOT1;CPEB3;TOB1;NANOS1;AGO2;ZFP36
prerank,gland development (GO:0048732),-0.3184279972531464,-1.1392499217240604,0.25609756097560976,0.8093599266279062,1.0,13/59,21.10%,TGFBR1;SALL1;FGFR2;NF1;TGFBR3;PAX8;PROX1;CDK5RAP3;WNT4;PHF2;NOTCH4;DKK3;ARID5B
prerank,regulation of organelle organization (GO:0033043),0.35146625177886764,1.1385068090702017,0.2652482269503546,0.6164323608090573,1.0,10/80,5.82%,ZEB2;MYO5A;DIAPH1;USP6NL;MTM1;PRKN;PDE2A;PAK2;CLIC4;PARL
prerank,vesicle transport along microtubule (GO:0047496),-0.3935938990753675,-1.1384387787055035,0.2678132678132678,0.810193461184078,1.0,11/23,26.78%,DYNC1H1;KIF1A;CLN3;KIF5A;KIF1C;KIF3A;KIF3B;BICDL1;HAP1;KIFAP3;KIF5B
prerank,anterior/posterior pattern specification (GO:0009952),-0.3208116280744117,-1.1377552580596495,0.24919093851132687,0.8105339123344603,1.0,10/53,17.47%,TGFBR1;BASP1;LRP5;HOXC4;BHLHE41;DDIT3;CELSR2;HOXA3;HOXC5;HOXB9
prerank,neuron development (GO:0048666),0.32922413694607905,1.1377297418643917,0.2372670807453416,0.6176885056014746,1.0,21/141,6.22%,ETV1;APOE;APP;OPHN1;LYN;RP1;MEF2C;CLN5;RAPGEF2;EHD1;LRP12;B4GALT6;PBX3;GSK3B;RB1;ROCK1;FRY;ATP7A;MANF;WNK1;BLOC1S5
prerank,long-chain fatty acid transport (GO:0015909),0.41869279875136883,1.136607895934973,0.2819672131147541,0.6197658923989633,1.0,3/30,2.76%,APOE;PRKAG2;CD36
prerank,secondary palate development (GO:0062009),-0.43532497989908436,-1.1364546808161091,0.31648351648351647,0.8129072020718323,1.0,7/14,27.92%,CHD7;TGFBR3;TGFBR2;TGFB2;WNT5A;LEF1;WNT7A
prerank,response to exogenous dsRNA (GO:0043330),0.4656194280681173,1.1363227977054964,0.3055555555555556,0.6198793883972031,1.0,3/18,4.11%,COLEC12;IRAK3;RFTN1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4060744373260413,1.1361752753634227,0.2884310618066561,0.6196743528572369,1.0,14/37,20.07%,RPL23;RYBP;WAC;NOP53;SDCBP;RPL5;HFE;RPS7;EIF3H;RPL11;HSP90AB1;CSNK2A2;CSNK2A1;USP7
prerank,nucleotide-excision repair (GO:0006289),-0.27997196823158427,-1.1361212210885396,0.1918819188191882,0.8121554025635099,1.0,30/101,19.24%,GTF2H2;CUL4A;TP53;CCNH;COPS7A;PARP1;COPS8;DDB2;RBX1;ERCC6;SLC30A9;COPS4;PPIE;ERCC2;HUS1;LIG1;XAB2;XRCC1;BRCA2;HMGN1;UVSSA;PRPF19;RFC2;POLR2C;COPS6;GPS1;POLE;POLL;UBB;RFC1
prerank,regulation of mast cell activation (GO:0033003),0.5178790513921192,1.1360637392374244,0.31702544031311153,0.61938350725526,1.0,3/10,2.86%,LYN;TSLP;HAVCR1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4872219104577044,1.1355276407610664,0.3125,0.6200465349716558,1.0,4/14,13.72%,CCL19;NFKBIZ;CD80;RARA
prerank,aerobic respiration (GO:0009060),-0.40692737860442985,-1.1351334297715447,0.2847222222222222,0.8135586831934364,1.0,12/20,40.23%,SDHB;NDUFS7;SLC25A14;UQCRC1;UQCRB;UQCR10;MTFR1;MTFR2;ATP5F1D;OXA1L;SURF1;SDHC
prerank,negative regulation of interleukin-1 production (GO:0032692),0.44929651417171856,1.1349504891393463,0.30824372759856633,0.6208383644416752,1.0,7/23,13.56%,GAS6;GHRL;CD33;CARD16;IGF1;ZC3H12A;FFAR1
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3301310329530074,-1.134412534485846,0.2719298245614035,0.813994201278716,1.0,16/43,23.61%,NDRG4;AHI1;BBS7;CCDC39;TBX6;VANGL2;TGFBR2;SMO;MICAL2;NOTCH1;SRF;ENG;BBS4;MKKS;CCDC40;STIL
prerank,regulation of osteoclast differentiation (GO:0045670),0.41302911485033283,1.134099111799875,0.28687196110210694,0.6222240242009578,1.0,5/33,6.94%,CCR1;CEBPB;LILRB3;TLR4;TNF
prerank,somite development (GO:0061053),-0.4670215021864963,-1.1340067725642862,0.3014256619144603,0.8135498823327265,1.0,6/11,36.77%,LOXL3;SMO;SOX11;MEOX2;SHH;SFRP2
prerank,monocarboxylic acid transport (GO:0015718),0.3874624665702613,1.1339481587297662,0.2818991097922849,0.6220352180048303,1.0,7/51,8.56%,SLC10A6;SLC16A7;NR1H4;NCOA2;CD36;ABCC4;SLC10A3
prerank,pharyngeal system development (GO:0060037),-0.4391640922587794,-1.1338200660798068,0.2997711670480549,0.8123331229610262,1.0,1/15,0.14%,TGFBR1
prerank,protein stabilization (GO:0050821),0.3217886007313783,1.1333027107884592,0.2393681652490887,0.6229912607124365,1.0,40/168,17.33%,HIP1;GNAQ;FBXW7;RPL23;RASSF2;PRKRA;GRN;PRKN;AFM;LAMP1;USP9X;CTNND1;STK3;NOP53;BAG3;SUGT1;RPL5;CCT6A;RPS7;TBL1X;IGF1;RTN4;LAMP2;CRYAB;WFS1;CREB1;TSPAN1;EP300;PARVA;RPL11;NLK;MCM8;HSP90AB1;HCFC1;PTEN;COG7;SEC16A;CCT3;MFSD1;FLOT2
prerank,epidermal cell differentiation (GO:0009913),0.39314025171760786,1.132702961212363,0.27503974562798095,0.6238143564794348,1.0,5/41,5.23%,TXNIP;JAG1;ADAM9;KRT10;CLIC4
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3419610032156731,-1.1325397034444573,0.2375366568914956,0.8146719002951911,1.0,9/39,9.40%,FGF14;FGF12;PRKCE;YWHAH;SCN1B;HECW2;FGF13;HECW1;WNK3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.34544621507296214,-1.1324973983156557,0.26795580110497236,0.8129515556644807,1.0,8/35,9.75%,ARHGAP24;RASAL3;LZTR1;SCAI;FLCN;STAMBP;KCTD13;STMN3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3035995383069712,-1.1321716480041,0.19387755102040816,0.8121330579368748,1.0,18/69,14.01%,PLCL1;PLCB2;PIK3CB;PLCB4;NYAP2;PLEKHA1;PI4KA;NF1;MYO16;INPP5F;PIK3C2B;SIRT2;CSF1R;PLCB1;PLCH1;PIK3R5;C1QBP;TYRO3
prerank,protein localization to cell-cell junction (GO:0150105),-0.43543283759340473,-1.131391055098403,0.3282937365010799,0.8128471576573089,1.0,3/15,5.48%,F11R;TJP1;TJP2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.35953596538977745,1.1313300506962674,0.276797829036635,0.6263863612520706,1.0,14/71,11.51%,CTSC;RPS27A;FBXL17;NR1D1;PRKN;RHBDD1;USP9X;CTSB;VPS4B;MDM2;CLPX;CASP8;NGLY1;PSMA6
prerank,vasodilation (GO:0042311),0.49723865050141774,1.130884044920718,0.32228360957642727,0.6268346457947361,1.0,2/13,2.53%,KLF2;ADRB2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.35359037318642395,1.130837311829677,0.26880222841225626,0.6264153226743142,1.0,16/77,11.15%,TCF7L2;SH3RF1;RIPK1;SIAH2;PRKN;MCL1;RB1;BCL2L2;BCL2;TNF;NR4A2;BIRC6;MAPK8IP2;IGF1;SLC25A5;PHIP
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.45676819750571235,1.130750057653525,0.29947460595446584,0.6260576032564857,1.0,6/18,17.66%,LYN;CAMK1D;IL6R;SLC8B1;MDK;IL6
prerank,defense response to symbiont (GO:0140546),0.34200477621646425,1.1307255240122422,0.26549865229110514,0.6255833524648537,1.0,16/92,10.67%,TLR8;IFITM3;OAS2;LILRB1;SERINC3;TLR2;TRIM56;RNASEL;CD40;BCL2;BST2;IFNAR2;RNASE6;IRF2;IFITM2;ATG7
prerank,cellular iron ion homeostasis (GO:0006879),0.36780026339184857,1.130321628617477,0.2983508245877061,0.6259192015409687,1.0,17/55,16.26%,CP;HMOX1;FTL;NDFIP1;SMAD4;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;FTH1;TFR2;ABCB7;MYC;ATP6V0D1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.4802266837792652,-1.1302885535614966,0.32599118942731276,0.8147146436830711,1.0,5/10,24.51%,FMR1;CBARP;GPR35;CALM3;CRHR1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4313891904048508,1.1298892155599016,0.31158238172920066,0.6263505717512252,1.0,4/24,7.30%,ACTR3;WASF2;CDC42;ARPC2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4167560451520128,-1.1297729157363863,0.30869565217391304,0.8145997086225609,1.0,8/17,25.31%,EMC9;BAG6;EMC10;EMC1;GET4;EMC6;MMGT1;SGTA
prerank,regulation of T cell mediated immunity (GO:0002709),0.500609919503175,1.129710383607078,0.3370577281191806,0.6262006286801066,1.0,2/10,7.58%,TNFRSF1B;CCR2
prerank,metal ion export (GO:0070839),0.4130345089405385,1.1292566093568144,0.30385852090032156,0.62670704913858,1.0,10/31,17.48%,FXYD2;ATP7A;SLC4A4;KCNQ1;ATP2B4;ATP1A3;ATP1A4;ATP1A1;KCNK5;KCNE3
prerank,rRNA methylation (GO:0031167),-0.3966584933580817,-1.1290944372837481,0.27638190954773867,0.8149981374027773,1.0,12/22,35.25%,NSUN5;TFB2M;FTSJ3;MRM3;MRM2;FDXACB1;MTERF4;EMG1;TFB1M;NOP2;FBL;METTL15
prerank,coenzyme A biosynthetic process (GO:0015937),0.518611647814704,1.1290133750487423,0.33081285444234404,0.6256810182461575,1.0,1/11,0.18%,SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.518611647814704,1.1290133750487423,0.33081285444234404,0.6256810182461575,1.0,1/11,0.18%,SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.518611647814704,1.1290133750487423,0.33081285444234404,0.6256810182461575,1.0,1/11,0.18%,SLC25A16
prerank,protein phosphorylation (GO:0006468),0.29253202469488193,1.1289348806072736,0.19491525423728814,0.6253302402450125,1.0,84/479,12.36%,EGFR;FGFR1;APP;MAP3K5;STK17B;SGK3;PEAK1;CDC42BPG;PRKAG2;GAS6;GMFG;LYN;GRK5;STK19;FER;DAPK1;IRAK3;ABI1;OXSR1;BMP2;RIPK1;PRKAG3;ERN1;TLR4;MAP3K1;CAMK1D;CDK12;RPS6KA3;TLR2;IP6K3;FRK;CDK6;GSK3B;INSR;CAMKK2;INCENP;PKN2;PAK2;MAPKAPK2;PDGFRA;ROCK1;STK24;STK3;RNASEL;WNK1;VRK2;ACVR2A;SYK;CHEK1;FAM20A;USP15;ZAP70;NRK;HTATIP2;PPP4R1;PRKCB;BIRC6;FYN;ULK2;CDK14;CDK20;VRK1;DDR2;MAPK14;DYRK1A;MAP3K20;MAST1;RPS6KA6;ILF3;EPHB4;MARK2;MAML1;STK10;CDK13;JAK1;STK36;MAP3K3;CDK17;ROCK2;STK38;PRKACB;MKNK1;TRIB2;MAP3K11
prerank,cardiac muscle tissue development (GO:0048738),0.38056459146654736,1.1284298670358912,0.2982998454404946,0.625887528463056,1.0,10/50,16.56%,NOTCH2;BMP2;HEY2;SMAD4;ADAMTS9;MAML1;GJA1;RBP4;BMPR1A;TBX2
prerank,myelination (GO:0042552),-0.32811193034389197,-1.128284096930726,0.24786324786324787,0.8157133459796058,1.0,16/46,13.03%,PLP1;MBP;EPB41L3;PARD3;CMTM8;NF1;MAL;SIRT2;DEGS1;ABCD2;NFASC;TPPP;SOX10;SCN8A;BCAS1;PLLP
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4470936120176501,1.128161143004341,0.3178036605657238,0.6259558571006059,1.0,5/22,7.22%,MYADM;CD44;WNK1;TNF;KLF4
prerank,smoothened signaling pathway (GO:0007224),-0.35528644768334017,-1.1279108754110136,0.28329297820823246,0.8151142076092123,1.0,14/32,28.95%,PTCHD1;DYRK2;SMO;GPC2;HIPK1;ULK3;GLI3;DISP2;TMEM231;TMEM17;STIL;TTBK2;TCTN2;B9D1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.41471305110115064,-1.1277955485419648,0.28738317757009346,0.8137110081480089,1.0,3/16,4.13%,SALL1;NPNT;FGF2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.40950348480503385,1.1275785678698156,0.3024390243902439,0.6267329959309855,1.0,5/35,7.63%,HIP1;CBL;CCL19;B2M;HFE
prerank,cellular calcium ion homeostasis (GO:0006874),0.3307409390927007,1.1274749432579834,0.25617685305591675,0.6264499301382662,1.0,25/133,14.40%,MCUB;ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;MCU;CD40;BCL2;STIM1;CCR2;PSEN1;TMEM165;PLN;TRPC7;SLC10A7;WFS1;YWHAE;SLC8B1;MICU3;ATP2B4;SLC35G1;ATP2A2;PDZD8
prerank,phosphatidic acid metabolic process (GO:0046473),-0.31443294143059053,-1.1271143185241623,0.23728813559322035,0.8141177554261488,1.0,16/48,27.01%,LPCAT1;DGKB;PLA2G6;LIPH;GNPAT;DGKZ;DDHD1;PLA2G3;ACP6;AGPAT3;GPD1L;SLC27A1;ABHD8;DGKG;AGPAT2;DGKA
prerank,regulation of cytoskeleton organization (GO:0051493),0.33929212007618775,1.1270358583453297,0.28258064516129033,0.6268966297142469,1.0,23/108,14.35%,IQGAP2;P2RX7;IQGAP1;DIAPH1;BST1;ARHGAP18;CRK;RHOA;GSK3B;PAK2;CLIC4;ROCK1;CELSR1;BST2;RHOBTB1;CLASP1;MARK2;ROCK2;ARHGAP17;RND3;SPEF1;RHOC;KATNBL1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.40546755680821794,1.1263742683030062,0.3027375201288245,0.6279465212144837,1.0,7/32,9.55%,CASK;JAG1;RASA1;ITGB1BP1;DUSP22;RCC2;CORO1C
prerank,oligodendrocyte development (GO:0014003),-0.4314469419138701,-1.1261481063232872,0.3062645011600928,0.8154284590622742,1.0,5/15,11.32%,PLP1;EIF2B3;NSUN5;TPPP;SOX10
prerank,cortical cytoskeleton organization (GO:0030865),-0.3323689123336242,-1.1260409460774503,0.2571428571428571,0.8139551380605345,1.0,14/41,16.91%,EPB41L3;NCKAP1;FMNL2;NLGN1;RHOBTB2;RHOQ;NCKAP1L;FHOD1;RHOH;LLGL1;STRIP1;LLGL2;ARF6;PLEK
prerank,sympathetic nervous system development (GO:0048485),0.47412832075532146,1.1259516886277054,0.31478260869565217,0.6283580419602407,1.0,1/15,0.34%,NRP1
prerank,positive regulation of vasoconstriction (GO:0045907),0.49773748099495424,1.1259358160761117,0.3308550185873606,0.6278649266438826,1.0,5/13,23.68%,ADRA1D;ADRA1A;TBXA2R;F2R;CAV1
prerank,vitamin D metabolic process (GO:0042359),0.49883600239795334,1.125607945198027,0.3132075471698113,0.6280941147096771,1.0,2/13,3.63%,FGF23;UGT1A4
prerank,regulation of cell population proliferation (GO:0042127),0.289477812939458,1.1253666337103794,0.1671794871794872,0.6281225771299837,1.0,120/691,15.44%,FOLR2;PF4;EGFR;LIFR;FGFR1;APP;PTPRJ;CHP2;TCF7L2;SGK3;IL15;KIF20B;NUPR1;RPL23;LYN;GRK5;BST1;FER;JAG1;RARG;BNIPL;CBFA2T3;ABI1;TSLP;KRAS;PIAS1;KITLG;BMP2;FGF23;PRKRA;WNT2;THPO;ZFP36L1;RHOA;S100A11;RGCC;RAPGEF2;ITGB1BP1;TNFRSF11A;FRK;NPR3;GSDME;CDK6;IRS2;GHRL;INSR;S1PR2;PTPRK;PDGFRA;ACER3;BCL2;RPS4X;FOXM1;RPS15A;SDCBP;KLF4;DUSP22;PDS5B;STAT4;TIPIN;BIRC6;KLF10;CDC73;IL6R;RPS9;CGREF1;ADRA1D;ADRA1A;ASH2L;TSPYL5;CD33;MDM2;THAP12;SH2B3;PDGFC;CCND2;STAT6;CACUL1;CUL3;IGF1;SFRP1;TSHR;SLC25A5;RPS6;NUP62;FTH1;JUP;PHIP;SHC1;KANK2;ROMO1;CDK13;STRN;NIBAN2;TRIM71;CDKN2C;NAMPT;DIS3L2;GLP2R;CTBP2;MEAK7;CRLF2;ZBTB7C;RNF187;RARA;STAT3;DERL2;JUND;HMGN5;PKD2;PRMT1;IL13RA1;NOX4;BMPR1A;MYC;MELTF;RNF41;FN1;HDAC4;PINX1
prerank,regulation of phospholipase C activity (GO:1900274),0.4916255609729424,1.1251924613592637,0.3170289855072464,0.6279883497923648,1.0,3/15,5.33%,FGFR1;ESR1;PDGFRA
prerank,extracellular matrix assembly (GO:0085029),0.4386198307478613,1.1246607207151533,0.3254237288135593,0.6286668787416035,1.0,8/23,14.14%,GAS6;ATP7A;MFAP4;PXDN;EMILIN1;RAMP2;NTN4;TNXB
prerank,regulation of cholesterol esterification (GO:0010872),0.5235524881661063,1.124572835821899,0.3352059925093633,0.6283441781474661,1.0,1/10,0.49%,APOE
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2963419972966938,-1.1245009630897114,0.22727272727272727,0.8171876850065933,1.0,19/72,13.19%,NAV3;PRKCD;MAP2;TREM2;CLASP2;TBCD;CAMSAP1;FGF13;SHANK1;TWF2;PLEKHH2;IAPP;ARHGEF2;PFDN2;ARFGEF1;VBP1;MAPRE1;EML2;CORO1A
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4592468838620264,-1.123904230887838,0.32553191489361705,0.8172401179945282,1.0,6/12,11.50%,HNRNPU;NELFB;RNF168;RECQL5;TCERG1;NELFCD
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.41255161212344377,1.1238955768265009,0.2967409948542024,0.6293083119000902,1.0,9/28,15.86%,SPI1;BCL2;BAG3;TNF;ZDHHC3;CASP8;DIABLO;TNFRSF1A;GABARAP
prerank,positive regulation of endothelial cell migration (GO:0010595),0.35043421246656953,1.1238318657187742,0.27823691460055094,0.628924158921123,1.0,16/84,12.68%,NRP1;FGFR1;FOXP1;SASH1;RIN2;GRN;ITGB1BP1;CD40;HSPB1;FOXC2;MAPK14;NUS1;SP1;ROCK2;ZC3H12A;BCAS3
prerank,regulation of mononuclear cell migration (GO:0071675),0.44189305482476327,1.1236928210432031,0.3240418118466899,0.6286999410216942,1.0,7/23,16.81%,CMKLR1;LYN;TNF;MSN;STK10;MDK;CCL5
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4388686358518571,-1.1236693640588717,0.30598669623059865,0.8162595752102614,1.0,3/14,4.92%,SLC24A2;SLC8A1;CACNA2D1
prerank,histone deacetylation (GO:0016575),0.3884348174339268,1.1235732067454383,0.29510703363914376,0.6284476420813823,1.0,13/43,16.60%,HDAC9;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;RCOR2;MIER3;SMARCAD1;HDAC4;SFPQ;PER1;RCOR1
prerank,protein maturation (GO:0051604),-0.28009823206685724,-1.123311197776963,0.2033195020746888,0.8155370579449699,1.0,27/95,20.19%,SORL1;NFU1;CLN3;CTSS;APH1A;ADAMTS3;NAA40;F3;NAA60;MMP16;LMF1;DNAJB11;AFG3L2;AEBP1;ISCA1;EEF1AKMT4-ECE2;TSPAN33;NAA35;TYSND1;ADAM10;CPM;CPE;FURIN;STUB1;CIAO1;BOLA2;NNAT
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.37493684289816026,-1.1232902317747908,0.29120879120879123,0.8138089681804572,1.0,4/24,2.42%,JAK2;OCIAD1;PTK2B;IL10RA
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4072810320907577,-1.1228934489710722,0.3055555555555556,0.8133553528479818,1.0,4/19,4.69%,DLG2;PARD3;DLG3;MTCL1
prerank,cellular response to interferon-gamma (GO:0071346),0.3456075363406212,1.1226262862225473,0.2707482993197279,0.6300845918438658,1.0,14/88,8.27%,IRF4;OAS2;GBP3;DAPK1;CD44;CCL8;TLR4;CCL19;B2M;TLR2;GBP7;IRF2;CCL24;TRIM68
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.4403952084928758,-1.1221986048504216,0.3515981735159817,0.8138576441087978,1.0,8/14,35.99%,TGFBR1;PTPN11;GREM1;EFEMP1;PTHLH;RFLNA;WNT9A;SNAI2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.36587299760336006,1.1221580098066053,0.2972972972972973,0.6305976525029855,1.0,11/57,11.05%,NLRC4;MAP3K5;DAPK1;BCL10;SYK;TNF;UACA;FYN;CYCS;RIPK2;CASP8
prerank,ether lipid metabolic process (GO:0046485),0.47716847725189915,1.1219724224729533,0.32169117647058826,0.6304951924331068,1.0,8/14,17.11%,AGMO;PLA2G7;PEX7;AGPS;PAFAH1B1;PLAAT3;FAR1;PEDS1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.42160555153454865,1.1207317733108642,0.30642504118616143,0.6327821908160857,1.0,1/27,0.05%,PID1
prerank,maturation of SSU-rRNA (GO:0030490),0.3988130418761101,1.1206518659232585,0.3068362480127186,0.6324310372008726,1.0,8/34,9.97%,RPS16;SNU13;RPS28;RPS8;RIOK3;RPS14;MRPS11;HEATR1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4189473134627748,1.1206507659745844,0.315702479338843,0.6319097041432199,1.0,7/26,13.84%,KMT2A;VCPKMT;TET3;WDR82;BEND3;KMT5B;TET2
prerank,positive regulation of bone resorption (GO:0045780),0.5154449039111407,1.1205855705989622,0.33568904593639576,0.63152272243993,1.0,3/11,6.57%,DCSTAMP;TNFRSF11A;SYK
prerank,mitochondrion localization (GO:0051646),0.4441850237217346,1.1188790063902792,0.30887372013651876,0.634813588512675,1.0,5/19,13.59%,MEF2A;MTM1;MARK2;BRAT1;TRAK2
prerank,cellular protein modification process (GO:0006464),0.2831702373264367,1.1188267844111432,0.12880324543610547,0.6344080804556705,1.0,191/983,16.43%,F13A1;APOE;MAN2A1;PADI4;IGFBP4;FGFR1;APP;ST8SIA4;MAP3K5;CP;PTPRJ;STK17B;SGK3;PPP3CA;FBXW7;PEAK1;PTPN18;ZBTB16;CDC42BPG;PRKAG2;GAS6;GMFG;PSMA7;UST;LYN;GRK5;DNAJC3;PGAP1;STK19;FER;PTPN12;DAPK1;IRAK3;PTPN22;SHISA5;OXSR1;MTM1;BMP2;FUT4;PARP14;ASB14;FGF23;TGM7;PRKAG3;ERN1;MAP3K1;PARP8;ST3GAL1;CDK12;MTMR3;BTBD1;LOX;DUSP12;DUSP1;IP6K3;FRK;KRT10;CDK6;CTDSP1;SERP1;GSK3B;SSH2;MANBA;RHBDD1;INSR;CAMKK2;PKN2;PAK2;PTPRK;MAPKAPK2;NOTUM;ROCK1;KLHL13;STK24;STK3;RNASEL;FBXL5;KLHL5;WNK1;VRK2;ACVR2A;PTPRA;SYK;CHEK1;MSRA;FAM20A;ZAP70;WIPI1;PPM1B;NRK;PSMB2;PIGU;DUSP2;PPP4R1;CTDSP2;UBXN7;PRKCB;BIRC6;FYN;FCGR3A;CDK14;CDK20;VRK1;UBE2D3;ALG5;DYRK1A;MAP3K20;COP1;MAST1;LHPP;RAB1A;PPP2CA;PPP2CB;CUL3;ILF3;FBXO11;PARP16;GNMT;NUS1;PPEF1;PPP4R2;MARK2;MAML1;ATG7;B4GALT5;PPP1CA;CHM;STK10;NGLY1;PSMA6;CDK13;PTP4A2;WFS1;JAK1;STK36;DCAF6;CDK17;ROCK2;ENGASE;STK38;PRKACB;MKNK1;TRIB2;NUCB1;MAP3K11;LOXL2;ERO1A;FBXO10;ATG10;CREB1;LATS2;CDKL4;RARA;RAB11A;ASB12;HIF3A;SERPIND1;SUMF2;TGM4;PSMA3;PSMD1;RPN2;PSMD5;PRKD2;GPC3;ELOC;BMPR1A;MELTF;ST3GAL4;ASB4;FN1;NLK;PTPN13;PPP2R2A;PRKCG;WIPI2;PTPN14;ICMT;USP25;GMFB;FBXW2;RUNX3;GRK4;DUSP7;ATG5;PTEN;COG7;MKNK2;PRRT1;HSP90B1;PPM1A
prerank,homologous chromosome segregation (GO:0045143),-0.39276118775738195,-1.1186642294393574,0.2942528735632184,0.8235782854469791,1.0,5/20,16.00%,CENPC;SIRT7;ZCWPW1;FANCD2;IHO1
prerank,intestinal absorption (GO:0050892),-0.4395770436750703,-1.1185232565213696,0.328159645232816,0.8222492738834674,1.0,3/13,7.13%,F11R;TJP2;SLC2A5
prerank,positive regulation of neuron migration (GO:2001224),0.5022103016888274,1.1185116047527097,0.34014869888475835,0.6346108363335139,1.0,2/11,3.92%,KIF20B;RAPGEF2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.30178595399123614,1.1183678904722183,0.24211711711711711,0.6344079408715775,1.0,41/308,11.19%,DAB2;APOE;IRF4;CLEC6A;CMKLR1;IL15;ZBTB16;RREB1;GAS6;SMURF2;NCOA3;C1QTNF3;CEBPB;ADRB2;BMP2;CD36;ALX1;RGCC;LBP;GHRL;SMAD4;ROCK1;ADIPOR2;SYK;SDCBP;TNF;CXCR4;CCR2;ESRRB;ADRA1D;ADRA1A;PDGFC;STAT6;RTN4;TSHR;TRIM16;PTGER4;HADH;B4GALT5;ACHE;KMT5B
prerank,neural crest cell migration (GO:0001755),0.3916746794966681,1.1180750334543221,0.3103448275862069,0.6345302467659891,1.0,2/36,0.82%,NRP1;SEMA4A
prerank,heart development (GO:0007507),0.31556116231521203,1.117133683979998,0.2685643564356436,0.6360994174823754,1.0,28/150,15.37%,HDAC9;PDLIM5;MEF2A;CRIP1;MEF2C;OSR1;BMP2;MYH6;ALPK3;INSR;PDLIM1;KDM6A;CACYBP;NCOA6;FOXC2;EPHB4;DAND5;CASP8;WDR11;RAMP2;POPDC3;BCOR;RBP4;SMYD4;PKD2;GPC3;MYBPC3;FN1
prerank,regulation of immunoglobulin production (GO:0002637),0.4364362709014273,1.117011580972926,0.32698961937716264,0.6358413039594466,1.0,5/23,17.66%,FCGR2B;RBP4;GPI;XBP1;IL6
prerank,receptor clustering (GO:0043113),-0.367899271623478,-1.116827926889458,0.2925531914893617,0.8259535564085915,1.0,8/27,6.33%,DLG2;NLGN1;MAGI2;NRXN1;DLG4;DLG3;DVL1;DNAJA3
prerank,sodium ion export across plasma membrane (GO:0036376),0.49669801216372533,1.1164082938037236,0.3279569892473118,0.6366629600576948,1.0,5/13,13.92%,FXYD2;SLC4A4;ATP1A3;ATP1A4;ATP1A1
prerank,mRNA export from nucleus (GO:0006406),-0.2754545139064629,-1.115940731289411,0.2245762711864407,0.8271757658774914,1.0,37/102,26.62%,THOC1;SRRM1;SRSF5;PABPN1;HNRNPA2B1;NXF1;DDX39B;SRSF3;NUP210;RANBP2;SRSF2;UPF1;RNPS1;NUP85;U2AF1;MCM3AP;UPF3B;CASC3;NCBP1;SEH1L;NXT1;SRSF11;THOC3;SRSF9;AAAS;SEC13;POLDIP3;GLE1;ALYREF;U2AF2;ALKBH5;SLBP;SRSF6;NDC1;EIF4E;NUP93;NUP50
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3198909400643376,1.1157217061720879,0.2675,0.6375999769647844,1.0,34/152,17.21%,ZEB2;EGFR;SMURF2;PSMA7;BMP2;AXIN1;NRARP;TLR2;GPRC5B;DISC1;FRAT1;WNK1;DEPDC1B;PPM1B;PSMB2;TBL1XR1;CDC73;SULF2;TBL1X;SFRP1;WLS;JUP;PSMA6;LRRK1;PLEKHA4;PSMA3;PSMD1;PSMD5;GPC3;USP47;PPM1A;AMER1;LGR4;RNF146
prerank,ion transport (GO:0006811),-0.27663641360282365,-1.1154381550873556,0.22169811320754718,0.8269868492506733,1.0,31/111,18.89%,SLC1A3;SLC12A2;SLC24A3;SLC24A2;SLC8A1;SLC36A1;SLC9A8;TRPM3;PIEZO1;GABRB1;GLRB;LASP1;SLC24A4;SLC25A26;VDAC1;SLC4A2;SLC1A1;SLC25A22;SLC12A6;PIEZO2;SLC17A5;GLRA1;CTNS;TMEM63C;SLC9A1;KCNN2;SLC25A10;SLC24A5;SLC20A2;SLC17A6;SLC1A2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.4515576447628289,1.1153491602268792,0.3299492385786802,0.6379488844737738,1.0,3/20,8.00%,GNAQ;RGS8;GNB1
prerank,axonemal dynein complex assembly (GO:0070286),-0.3668614682326158,-1.1148206477806695,0.29743589743589743,0.8271642830665931,1.0,10/28,24.84%,TTC12;CCDC39;DNAI4;DNAH8;DNAH5;ODAD1;ODAD2;CCDC40;DNAI3;SPAG1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4533162599104251,-1.1147957726858881,0.29550827423167847,0.8254560935322218,1.0,9/13,27.21%,NFU1;LTO1;YAE1;ISCA1;CIAO1;BOLA2;GLRX5;CIAO2B;CISD3
prerank,apoptotic process (GO:0006915),0.30412376483427556,1.114725291278387,0.26626506024096386,0.6388728004953405,1.0,23/203,9.91%,PAEP;TNFRSF25;HIP1;APP;NOTCH2;AHR;ZBTB16;IFT57;BNIPL;DAPK1;LIG4;RIPK1;PRUNE2;TLR2;STK3;BCL2;CHEK1;CXCR4;TNFSF12;ADRA1A;MDM2;PPP2CA;RTN4
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4154808393012993,1.114225216481227,0.3161290322580645,0.6394573168947119,1.0,1/28,0.05%,PID1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4498178180707323,1.1137801777781242,0.31382978723404253,0.6399018095921553,1.0,4/18,10.91%,APOE;ADAM19;PSEN1;ACHE
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.33511026517192516,1.113767752533704,0.2705718270571827,0.6394069796235193,1.0,22/93,18.10%,EGFR;APP;GAS6;RASSF2;CD44;AXIN1;RACK1;PDE4D;TNF;FNIP1;CNKSR3;RIPK2;DOCK7;ATP2B4;TERF2IP;CNOT9;PRKD2;HSP90AB1;PTEN;SPRY2;IL6;RAF1
prerank,regulation of nervous system development (GO:0051960),-0.3394152169319041,-1.1137346366771723,0.26519337016574585,0.8271109758829517,1.0,6/37,9.77%,CX3CR1;CTNNB1;BHLHE41;TENM4;NSUN5;SIRT2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.31602911495175684,-1.113536978870279,0.23661971830985915,0.8259445397153513,1.0,16/52,17.14%,EPB41L2;DPP10;PRKCE;TREM2;GNAI1;STX3;WNK3;PDPK1;STAC2;NUMA1;EPHA3;EPHB2;CLIP3;ARF6;SQSTM1;STAC
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4679111135750914,1.112900381053563,0.3505338078291815,0.6408462499015546,1.0,4/15,7.63%,IRAK3;LILRB1;TNF;HFE
prerank,mesenchyme development (GO:0060485),-0.42147613935139316,-1.1126467436802814,0.3422818791946309,0.827116945096878,1.0,3/15,9.67%,TGFBR1;FGFR2;CRELD1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4486538399077081,1.112348425211782,0.3244206773618538,0.6415860446046717,1.0,2/18,3.17%,FCGR2B;ERN1
prerank,negative regulation of macroautophagy (GO:0016242),0.417642289685038,1.112093358165081,0.3275039745627981,0.6416568429830386,1.0,6/26,13.46%,NUPR1;MTM1;FEZ2;SMCR8;UBQLN4;RUBCN
prerank,positive regulation of signaling (GO:0023056),-0.3382927217111484,-1.110421678738789,0.2597402597402597,0.8325937265779195,1.0,7/37,8.45%,RIMS1;GRIK2;PTPN23;RIMS2;DLG4;KCTD13;INPP5F
prerank,skeletal muscle contraction (GO:0003009),0.4443224230119469,1.1101144586371148,0.3299319727891156,0.6455750828516086,1.0,2/19,3.13%,RCSD1;TNNT1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.4334370876187951,-1.1093625550416386,0.31521739130434784,0.8342401214435904,1.0,5/14,20.74%,FUS;PARP1;ERCC6;RAD51AP1;WRAP53
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.2597285629010915,-1.1093269287567566,0.22685185185185186,0.8326027714767027,1.0,51/129,32.09%,CSNK1E;SDCCAG8;CEP135;ODF2;OPTN;DYNC1H1;SKP1;CEP192;CCNH;CEP250;FBXL7;CCDC57;HAUS8;WEE1;CEP63;PLK3;CCP110;PLCB1;HAUS7;CKAP5;MAPRE1;HAUS3;CHEK2;BRSK2;CENPJ;FBXL6;FBXL3;TAF2;DCTN2;LCMT1;BRSK1;CNTRL;MASTL;HAUS2;DCTN1;PLK4;CDK1;HAUS6;CCNA2;YWHAG;FBXL12;TUBA4A;CEP152;BTRC;CCNB2;TUBA1A;LATS1;FBXL22;TUBG1;AURKA;CDK7
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.47298264679443175,-1.1085556854953824,0.35469107551487417,0.8334200146446235,1.0,2/11,8.72%,BIN1;ACTN2
prerank,regulation of protein sumoylation (GO:0033233),-0.40377917758969506,-1.1084996369879612,0.31880733944954126,0.8318363790620068,1.0,9/17,23.93%,CTNNB1;CAPN3;PARK7;MUL1;GNL3L;SAE1;UBA2;PIAS4;PIAS3
prerank,histone modification (GO:0016570),0.33329504850289093,1.1080831136339064,0.28534031413612565,0.6498098538412534,1.0,27/109,16.64%,HDAC9;PADI4;USP3;ATXN7;PHF20;INCENP;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;USP21;USP16;RCOR2;MIER3;CREBBP;UBE2N;EP300;KAT6A;EHMT1;PRMT1;ENY2;NSD3;USP22;HDAC4;RCOR1;UBE2U
prerank,epithelial tube morphogenesis (GO:0060562),0.4032426924266601,1.108063923083314,0.3328,0.6493163396592501,1.0,3/32,4.43%,MTSS1;MEF2C;CCM2
prerank,protein localization to chromatin (GO:0071168),0.4599268055948923,1.1076172656988728,0.34210526315789475,0.6498081548159685,1.0,3/18,6.07%,ESR1;PPHLN1;MCM9
prerank,cellular response to inorganic substance (GO:0071241),0.4351052004891109,1.1071682673926961,0.35528596187175043,0.6502236337332279,1.0,6/21,12.87%,AOC1;MTR;DDX11;ATRX;SPIDR;FOXO1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3840697694435833,-1.1066155903186117,0.3251833740831296,0.8361288699293667,1.0,4/21,6.22%,RASAL3;ARHGAP25;LZTR1;STAMBP
prerank,response to light stimulus (GO:0009416),-0.30350975533372426,-1.1066017377406607,0.26299694189602446,0.8344284220545046,1.0,12/55,12.18%,GTF2H2;MAPK10;UBE2B;MAP2K7;DDB2;PRIMPOL;ERCC6;FECH;ERCC2;CCAR2;UVSSA;CIRBP
prerank,regulation of chemotaxis (GO:0050920),0.4029373771618329,1.1063276702809404,0.3178036605657238,0.6516040183477941,1.0,5/30,7.44%,ZSWIM6;CCL19;PDGFRA;MYCBP2;CXCR4
prerank,regulation of TORC1 signaling (GO:1903432),-0.34064192072756655,-1.1063006412412197,0.27146814404432135,0.8337033418140295,1.0,8/33,8.53%,GPR137B;GPR137C;STK11;RRAGD;ATM;FLCN;SESN3;CASTOR2
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3839506163554757,-1.1062310600901455,0.31630170316301703,0.8321696250909877,1.0,9/22,16.22%,MAP2;CAMSAP1;MAP1B;MAPT;AKAP13;MAPRE3;GBA2;AEBP1;PARK7
prerank,heart contraction (GO:0060047),-0.32753289235459765,-1.1059408574946328,0.2818181818181818,0.8313426969821417,1.0,6/41,7.31%,ATP1B1;SCN1B;SLC8A1;SGCD;GRK2;GAA
prerank,axon development (GO:0061564),-0.2901331635272624,-1.105349647999656,0.2645161290322581,0.8315128962702971,1.0,20/78,16.80%,RTN4RL1;PLP1;GRM7;CTNNA2;PARD3;MAP1B;NEFH;FGFR2;CNTN4;MAPT;NTNG1;LLGL1;S100B;AFG3L2;DSCAML1;APBB1;SLITRK5;ADGRB1;EPHB2;BRSK2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5259638201528412,1.1053241807380443,0.37777777777777777,0.6533436395748262,1.0,3/10,10.61%,ATP7A;THAP4;KYAT1
prerank,atrial septum development (GO:0003283),0.484595780526091,1.1052994841302575,0.3410714285714286,0.6528639864733222,1.0,4/13,14.72%,NOTCH2;HEY2;DAND5;NPHP3
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4219390891506416,1.105122579128648,0.3473684210526316,0.6527234969953859,1.0,7/25,14.55%,ITGA4;ITGB1;CD200R1;NINJ1;JUP;ITGB2;PARVA
prerank,I-kappaB phosphorylation (GO:0007252),0.5083112298020078,1.1049669351886595,0.3504761904761905,0.6525365386213191,1.0,2/10,4.23%,TLR4;TLR2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.41809022092455994,1.1046265463047527,0.32737030411449014,0.6527819037863982,1.0,5/24,6.94%,FBXW7;NUPR1;GRN;MCL1;TNF
prerank,renal water homeostasis (GO:0003091),-0.3803404960628145,-1.104225975872201,0.3182957393483709,0.8334491444382595,1.0,7/23,16.43%,ADCY3;ADCY8;PRKAR1A;PRKAR1B;ADCY7;MYO5B;ADCY1
prerank,mRNA catabolic process (GO:0006402),0.3827598352431353,1.104159199390297,0.3236196319018405,0.6533255904736501,1.0,10/44,13.34%,DHX34;ZFP36L2;ERN1;TUT7;RC3H1;TUT4;DCP2;DIS3L2;ZC3H12D;LSM2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.3141569588642939,-1.1033259544957648,0.28450704225352114,0.8345982612082972,1.0,19/49,24.31%,LDLRAD4;SORL1;TREM2;IMPACT;SRC;ANKRD27;IAPP;HSF1;PYDC1;ULK1;PARK7;LCMT1;HDAC6;HMGB1;TFIP11;TMC8;DACT1;KIF14;PRKCZ
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.36517715594378675,-1.1027903881139245,0.319693094629156,0.8345929946666056,1.0,4/24,2.11%,F11R;TJP1;TMEFF2;CLASP2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5202396948706037,1.1026562519639989,0.36397748592870544,0.6562484499268689,1.0,2/10,8.00%,PDE6A;GNB1
prerank,activation of protein kinase B activity (GO:0032148),0.40656398781612146,1.1022078925441574,0.3162251655629139,0.6567574367039722,1.0,7/29,14.92%,GAS6;ANG;ITGB1BP1;INSR;IGF1;OSBPL8;PPIA
prerank,actomyosin structure organization (GO:0031032),0.3483300836347783,1.1015281689760934,0.31170662905500707,0.6578125041250633,1.0,12/75,5.51%,FLII;EPB41L1;CDC42BPG;ITGB1;TMOD1;MYH6;MYOM2;TNNT1;RHOA;TMOD3;ROCK1;PDLIM1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3577066855804855,-1.1009115643826162,0.29219143576826195,0.8390682175357034,1.0,5/27,8.45%,ABHD12;ENPP2;SMPD4;PLA2G6;INPP5F
prerank,positive regulation of cellular component organization (GO:0051130),0.32257115529299474,1.1005508264989352,0.304,0.6595543278331221,1.0,10/107,6.94%,DAB2;APOE;RPS3;CCL19;GSK3B;RB1;INSR;RACK1;SYK;TNF
prerank,regulation of DNA replication (GO:0006275),0.37344414857843544,1.1001208929325998,0.32608695652173914,0.6599889198926283,1.0,11/49,14.27%,EGFR;ORC5;ANKRD17;S100A11;ESCO2;GMNN;ESCO1;PPP2CA;RBBP6;KAT7;TERF1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.4560200846580457,1.100095805208647,0.34146341463414637,0.6595129369615611,1.0,3/17,3.41%,JAG1;TLR4;CD46
prerank,response to hydrogen peroxide (GO:0042542),0.3752347144655139,1.100032768361496,0.3198757763975155,0.6591149826326695,1.0,15/45,18.05%,MAP3K5;RPS3;OSER1;RIPK1;ADAM9;HMOX1;STK24;FYN;TRPM2;NET1;MAPK7;PRDX3;RELA;IL6;APTX
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3795442143744103,-1.0998065956414498,0.3194103194103194,0.8407747038223418,1.0,6/22,9.13%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,regulation of membrane repolarization (GO:0060306),-0.4444698655447219,-1.0995514313060706,0.36077481840193704,0.8398778855620156,1.0,3/13,5.92%,KCNJ2;CACNA2D1;AKAP6
prerank,limb development (GO:0060173),-0.3552613917277186,-1.0993287415990312,0.3128205128205128,0.8388130040434519,1.0,5/28,11.11%,SALL1;CHD7;BMPR1B;IQCE;RSPO2
prerank,steroid biosynthetic process (GO:0006694),0.36439807287787757,1.0986058263795306,0.3244047619047619,0.6618632445975329,1.0,8/56,11.94%,PRKAG2;OSBPL9;HMGCR;HSD3B7;CYP27A1;PMVK;OSBPL1A;LBR
prerank,regulation of monooxygenase activity (GO:0032768),0.4289656002172429,1.09830004688959,0.36724137931034484,0.6620571715135343,1.0,8/23,20.34%,EGFR;CYGB;NOSTRIN;CALM1;WASL;LYPLA1;GDNF;SNCA
prerank,response to acidic pH (GO:0010447),0.4803105693011651,1.0980471467783406,0.35372848948374763,0.6620743626287233,1.0,2/13,2.55%,RAB11FIP5;GPR65
prerank,defense response to virus (GO:0051607),0.32750066253818877,1.0976636713019936,0.30933333333333335,0.662403018582762,1.0,16/100,10.67%,TLR8;IFITM3;OAS2;LILRB1;SERINC3;TLR2;TRIM56;RNASEL;CD40;BCL2;BST2;IFNAR2;RNASE6;IRF2;IFITM2;ATG7
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3424607407185315,1.0971990575792432,0.31875881523272215,0.6629568860427486,1.0,19/79,14.77%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;MFSD6;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;AP2B1;CAPZA1;CLTA;CAPZA2
prerank,mitochondrion distribution (GO:0048311),0.4937399874134472,1.0971092956028425,0.36142322097378277,0.6626298561051062,1.0,4/12,13.59%,MEF2A;MTM1;ARMC1;TRAK2
prerank,cellular component assembly (GO:0022607),0.29922769252178544,1.0968323790419388,0.2825836216839677,0.6627071479414903,1.0,31/253,9.91%,EPS8;NEDD9;SNX9;GAS6;KMT2A;OPHN1;REPS2;RP1;VCPIP1;MITF;SPTBN1;CD74;SKAP2;CDC42;RHOA;LCP1;GRHL2;WIPF1;ST13;ACTB;REC8;CD40;DARS1;HFE;STX7;TUBGCP2;RANBP9;MDM2;PLS1;CFAP206;RTN4
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.32182896202346906,1.09671997295352,0.3016905071521456,0.6624320198482997,1.0,28/129,17.21%,ZEB2;EGFR;SMURF2;PSMA7;AXIN1;NRARP;GPRC5B;FRAT1;WNK1;PPM1B;PSMB2;TBL1XR1;TBL1X;SFRP1;WLS;JUP;PSMA6;LRRK1;PLEKHA4;PSMA3;PSMD1;PSMD5;GPC3;USP47;PPM1A;AMER1;LGR4;RNF146
prerank,kinetochore organization (GO:0051383),-0.43381877949748393,-1.0962985191178942,0.33940774487471526,0.8467966437063554,1.0,8/13,31.65%,CENPC;CENPE;DLGAP5;NDC80;CENPH;CDT1;CENPF;NUF2
prerank,histone H3-K9 demethylation (GO:0033169),0.5034912768059936,1.0962253141528557,0.38361266294227186,0.663012226066952,1.0,6/11,18.88%,PHF8;KDM7A;KDM4D;JMJD1C;KDM1A;KDM4C
prerank,negative regulation of signaling (GO:0023057),-0.36633073018452156,-1.0962237887946953,0.2987951807228916,0.845312520579719,1.0,6/25,20.17%,OPTN;ACVR1;UBASH3B;GLRA1;AP1AR;IGFBP3
prerank,pore complex assembly (GO:0046931),0.44053398830751667,1.0961357208237004,0.3345008756567426,0.6626878968858585,1.0,2/19,1.78%,P2RX7;ANO6
prerank,negative regulation of cell adhesion (GO:0007162),0.3457861202073655,1.096059235593755,0.31734837799717913,0.6623240875549153,1.0,10/72,7.94%,TGFBI;RIPOR2;JAG1;RASA1;PLXNC1;RHOA;ITGB1BP1;DUSP1;PLXNA4;ARHGDIA
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4060327532316988,-1.0957113235664366,0.34186046511627904,0.8452981305916473,1.0,5/16,20.46%,CADM1;NECTIN2;SLAMF6;RASGRP1;KLRD1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.449683252785274,1.0956993821084513,0.3720508166969147,0.6625824304783396,1.0,3/17,2.42%,GMFG;WASF2;FCHSD2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.367709558054309,1.0955385930215569,0.31871345029239767,0.6624206453643813,1.0,10/51,10.69%,SMURF2;CRIM1;BMP2;GDF3;SMAD4;TRIM33;ACVR2A;HTRA3;UBE2D3;DAND5
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5020090030502621,1.0951933051319969,0.3352165725047081,0.6626980275870757,1.0,3/10,6.61%,KMT2A;SMAD4;CHEK1
prerank,protein polyglutamylation (GO:0018095),-0.45417558263684255,-1.0950155178361527,0.37339055793991416,0.8456752460183165,1.0,3/11,12.43%,TTLL11;TTLL7;TTLL1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.3559008801769534,-1.0949430892816174,0.3082901554404145,0.8442296031925154,1.0,8/27,19.32%,AK2;DCTD;TYMS;GLRX;DUT;DTYMK;NUDT13;GUK1
prerank,negative regulation of peptidase activity (GO:0010466),0.3767182111594046,1.0944062255826805,0.3292867981790592,0.6639742476046804,1.0,2/47,1.51%,SERPINB8;SERPINB2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.36381806039344156,1.094134027872402,0.3219584569732938,0.6640550086118008,1.0,14/54,11.89%,RPL23A;RPL26;SNU13;RSL24D1;RPL24;NOP53;RPL35A;RPLP0;RPL5;MALSU1;RPL14;RPL6;MRPL1;RPL10
prerank,lipid phosphorylation (GO:0046834),-0.4747234213164895,-1.0939550586392295,0.35368421052631577,0.8457841432786517,1.0,3/10,8.78%,DGKI;DGKB;DGKZ
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.33892567923607564,-1.0935187082718785,0.3137254901960784,0.8454392891879818,1.0,16/34,28.56%,FGR;PTK2B;FGF2;FLT1;PIK3R4;P2RY12;FLT3;ATG14;TGFB1;TNFAIP8L3;TEK;PIK3R2;PDGFRB;PIK3R3;IRS1;PRKD1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.34613810761028746,-1.0933789480671483,0.30637254901960786,0.8441269361683782,1.0,5/31,4.24%,ABI3;TANC2;NLGN1;PPFIA2;KIF1A
prerank,negative regulation of cellular process (GO:0048523),0.2847008642081043,1.092979656718229,0.2638743455497382,0.6661691447272856,1.0,104/521,16.59%,TGFBI;FCGR2B;ALOX5;APP;PTPRJ;TXNIP;CASK;RIPOR2;NUPR1;LYN;RARG;BNIPL;CBFA2T3;ABI1;RASA1;TNFRSF1B;BMP2;LILRB1;PRKRA;DCSTAMP;PLXNC1;S100A11;RGCC;RAPGEF2;ITGB1BP1;PRKN;TLR2;DUSP1;PDE8A;FRK;GSDME;CDK6;RB1;RACK1;SNX3;SMAD4;PTPRK;NR4A1;BCL2;PLXNA4;FOXM1;BST2;KLF4;VPS4B;PDS5B;MALSU1;GMNN;ARHGDIA;KLF10;CDC73;SPOCD1;CGREF1;ADRA1A;CD33;ESR2;THAP12;SH2B3;PPP2CA;RTN4;SFRP1;PARP16;NUP62;SP100;FTH1;SERTAD2;SLIT3;EMILIN1;ST7L;KANK2;CRYAB;VPS13C;PIP4P2;WFS1;STRN;NIBAN2;CDKN2C;PPP1R13B;DIS3L2;PLXND1;DSCAM;GJA1;CTBP2;ZBTB7C;PIWIL2;SPEF1;NR1H2;MDK;CRLF3;CCN5;PKD2;ARHGDIB;NOX4;TMEM109;MYC;RNF41;PINX1;PTPN14;VGLL4;RUNX3;ATG5;PTEN;ANP32B;CD164;MIA3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.38442922298804705,-1.09276721407541,0.33101851851851855,0.8444362323378879,1.0,6/21,5.88%,EXTL3;XYLT1;HS3ST5;HS3ST4;HS6ST1;SULF1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5124403256136655,1.0924833759834505,0.36432637571157495,0.6667981169630389,1.0,3/10,6.14%,LYN;LILRB1;CD40
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.3959569611843391,-1.0923188008229514,0.3480278422273782,0.8441624238576951,1.0,5/17,20.46%,CADM1;NECTIN2;SLAMF6;RASGRP1;KLRD1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.43534702286897536,-1.09220034604412,0.35384615384615387,0.8428355474332421,1.0,6/13,11.50%,HNRNPU;NELFB;RNF168;RECQL5;TCERG1;NELFCD
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32688539059556504,1.092172590329556,0.3157894736842105,0.667013441494292,1.0,21/101,13.75%,EGFR;FGFR1;ADRB2;RHOA;RGCC;RAPGEF2;INCENP;CD40;PIK3R6;TNF;CCND3;CCNYL1;PDGFC;CCND2;PPP2CA;PARP16;CALM1;ATP2B4;NOD2;CCNY;RALB
prerank,regulation of protein modification process (GO:0031399),0.3590613882967325,1.0921585757292693,0.35098335854765506,0.666517837159959,1.0,12/50,11.15%,SPRED1;LYN;FER;NOP53;HSPB1;FNIP1;KDM4D;CORO1C;PPP2CA;ATG7;SPRED2;PHIP
prerank,calcium ion import into cytosol (GO:1902656),-0.423184115699448,-1.0916561276547971,0.3429844097995546,0.8428121262216696,1.0,3/15,4.92%,SLC24A2;SLC8A1;CACNA2D1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.49605066444347273,1.0910924393125503,0.3937007874015748,0.668466321476388,1.0,5/12,17.95%,CD36;TLR4;ZNF205;CYBA;SLC5A3
prerank,positive regulation of growth (GO:0045927),0.35051068328075274,1.0908785328986805,0.3319209039548023,0.6684275844400652,1.0,17/64,14.11%,EGFR;CDC42;DNPH1;RPS6KA3;RFTN1;INSR;TRIM32;BCL2;SDCBP;MTPN;CXCL16;H3-3A;SFRP1;WFS1;BRAT1;MFSD2A;DERL2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.36372686828370515,-1.0908643692100428,0.33604336043360433,0.8437746791226017,1.0,15/27,22.46%,PRKCD;CALM2;SRC;PPP1R16B;NSMF;CAMTA1;PPP1R7;ANKLE2;PPP2R5A;CDCA2;PTPA;SPPL3;CALM3;TGFB1;PIN1
prerank,regulation of cell adhesion (GO:0030155),0.3204182599422101,1.0905177655392697,0.31794871794871793,0.668707538103787,1.0,30/129,17.26%,TGFBI;PTPRJ;PPP3CA;MYADM;RIPOR2;LYN;RASA1;PLXNC1;ITGB1BP1;DUSP1;ROCK1;PLXNA4;TNF;CXCR4;ARHGDIA;PPP2CA;CYTH1;ROCK2;RSU1;PLXND1;DSCAM;MDK;PRKD2;ARHGDIB;ZDHHC2;CD164;MIA3;CCL5;PODXL;FES
prerank,positive regulation of protein acetylation (GO:1901985),-0.4443808491274549,-1.090403868530321,0.3432203389830508,0.8435399043783938,1.0,3/12,11.61%,DIP2B;DIP2A;RAPGEF3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4858516467488301,1.0901044136197224,0.36416184971098264,0.6686281841086117,1.0,3/12,9.90%,CHP2;TNF;IGF1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4858516467488301,1.0901044136197224,0.36416184971098264,0.6686281841086117,1.0,3/12,9.90%,CHP2;TNF;IGF1
prerank,regulation of ion transmembrane transport (GO:0034765),0.3983738832341527,1.0900805265423479,0.34841628959276016,0.6681521489243408,1.0,7/33,14.32%,P2RX7;ANO6;KCNJ14;WNK1;YWHAE;KCNQ1;NEDD4L
prerank,regulation of hemopoiesis (GO:1903706),0.5022611860905515,1.0896672902337212,0.36177474402730375,0.6685843715089245,1.0,4/10,18.21%,CBFB;PRKCB;CREBBP;MAFB
prerank,protein deacetylation (GO:0006476),0.37937438601412105,1.0896222075066972,0.34065934065934067,0.6681737693287152,1.0,8/41,10.56%,HDAC9;BRMS1L;MIER1;TBL1XR1;MIDEAS;TBL1X;RCOR2;MIER3
prerank,morphogenesis of an epithelium (GO:0002009),0.41052993637903096,1.0891630105536263,0.3415032679738562,0.6687336591898391,1.0,4/25,8.74%,LRP6;ACTB;ARHGAP12;VCL
prerank,regulation of endothelial cell migration (GO:0010594),0.337481283397986,1.0891424148580044,0.3388203017832647,0.6682615485521234,1.0,15/85,12.68%,NRP1;APOE;FOXP1;SASH1;RIN2;GRN;ITGB1BP1;PRCP;SYNJ2BP;FOXC2;ADAMTS9;SP100;ROCK2;ZC3H12A;BCAS3
prerank,regulation of intracellular transport (GO:0032386),-0.325911277172178,-1.0889288404545931,0.30512820512820515,0.8465868961665802,1.0,14/38,20.06%,MAP2;DYNC1H1;NEFH;INPP5F;ATP9A;DYNLT2B;GRIPAP1;NUMA1;ATP13A2;GAS1;DNAJC30;AAAS;PLA2G3;HAP1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.37756074962790337,-1.0889071280210003,0.33651551312649164,0.8449659185837464,1.0,9/22,17.54%,MAGI2;NTRK3;BDNF;MAPT;TMEM108;WASF1;RAPGEF1;RAB35;SH3GL2
prerank,regulation of T cell activation (GO:0050863),-0.32280119585125555,-1.0887402987897137,0.3323442136498516,0.8438280484496686,1.0,3/42,1.25%,SIRPA;PAG1;CCDC88B
prerank,cellular response to radiation (GO:0071478),0.37709691947976176,1.088616077492021,0.3373860182370821,0.668941952745449,1.0,10/40,13.18%,LIG4;CLOCK;RRH;GPR52;MAPK14;KDM4D;EEF1D;SPIDR;RHNO1;NET1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.37388010178582765,-1.0884198440556503,0.3266832917705736,0.8432232675082718,1.0,12/24,25.61%,FECH;CPOX;FXN;ABCG2;COX15;FLVCR1;HMBS;ALAS2;UROD;PGRMC1;PPOX;ALAS1
prerank,cellular protein-containing complex assembly (GO:0034622),0.31009061493497747,1.0879087170034583,0.31435643564356436,0.6700096598709718,1.0,25/160,11.71%,HIP1;IMMP2L;TCF4;SNX9;FCHO2;EPS15;CLTC;ADRB2;UVRAG;AXIN1;SMAD4;STXBP6;TBCA;AP2S1;HIGD1A;RPL38;PIK3C2A;MAPK8IP2;COX7A2L;RTN4;CENPT;PXN;EIF4B;RAB5IF;TBCE
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3375779146711554,1.0871810145196097,0.3148936170212766,0.6711375869294164,1.0,12/86,10.39%,APOE;APP;SNX9;ALOX15;FER;RPS3;FCHSD2;RB1;PSEN1;CCL24;CLASP1;SYNPO
prerank,plasma membrane organization (GO:0007009),0.3514597751690411,1.0871368291943255,0.3323442136498516,0.6707202292145706,1.0,11/61,11.79%,P2RX7;SNX9;ANO6;SPTBN1;PLSCR5;MYOF;SERP1;CXCR4;PACSIN2;SNX33;PLSCR4
prerank,regulation of membrane depolarization (GO:0003254),-0.3951763846760155,-1.0870690487830061,0.3378684807256236,0.845819454716883,1.0,11/18,41.23%,SMAD7;SCN1B;CAMK2D;SCN2B;GPD1L;HCN4;FHL1;PTPN3;SCN10A;RANGRF;GJA5
prerank,regulation of hippo signaling (GO:0035330),0.4491073042161072,1.0868923213242667,0.351493848857645,0.6707561143729647,1.0,8/17,20.00%,MOB3B;LIMD1;MAPK14;WWC1;VGLL4;MARK3;DLG5;WWC2
prerank,renal system development (GO:0072001),-0.29942234696355735,-1.0857886728447017,0.2835820895522388,0.8482053161640368,1.0,8/52,12.70%,TGFBR1;SALL1;STAT1;IFT88;SULF1;BAG6;PAX8;PROX1
prerank,receptor recycling (GO:0001881),-0.48286913553555844,-1.0857398805047769,0.37551020408163266,0.8466952156903036,1.0,5/10,32.39%,SORL1;EHD3;PHETA1;NSG1;REP15
prerank,snRNA processing (GO:0016180),-0.3972135803394149,-1.0857019925508855,0.3230088495575221,0.8451281310736696,1.0,6/16,25.27%,INTS6L;INTS3;TOE1;INTS9;INTS11;INTS7
prerank,carboxylic acid metabolic process (GO:0019752),0.38880144853295096,1.0856043172664618,0.3421487603305785,0.6731749553051894,1.0,7/33,14.45%,ST6GAL1;ST3GAL1;DAO;GNMT;GLUD1;SLC23A1;SLC23A2
prerank,regulation of ERAD pathway (GO:1904292),-0.45903157151837276,-1.0853549739727872,0.36645962732919257,0.8445389490524743,1.0,4/11,11.56%,TMEM259;USP19;BAG6;UBXN1
prerank,regulation of cell migration (GO:0030334),0.285600067700683,1.085297704003145,0.2671009771986971,0.6733831223971166,1.0,48/382,10.04%,DAB2;MCTP1;NEDD9;EGFR;PTPRJ;SEMA4A;SGK3;CCR1;PPP3CA;SASH1;MYADM;RAP2B;ITGB1;FER;JAG1;MITF;CASS4;BMP2;SYNE2;CD74;FGF23;DRD1;GRN;ADAM9;PLXNC1;RHOA;INSR;RACK1;CLIC4;PTPRK;PDGFRA;ROCK1;STK24;TRIM32;PLXNA4;SDCBP;BST2;DUSP22;CXCL16;CCL24;AMOT;VCL;RCC2;PDGFC;CORO1C;NKD1;IGF1;SFRP1
prerank,regulation of filopodium assembly (GO:0051489),0.3829860623795491,1.0851055104427672,0.3507692307692308,0.6732835556952564,1.0,5/38,5.36%,NRP1;RIPOR2;ARAP1;CDC42;DOCK11
prerank,phosphate ion transmembrane transport (GO:0035435),-0.43832191516984986,-1.084706352121553,0.34989200863930886,0.8449271408117027,1.0,7/12,20.91%,SLC25A3;SLC37A2;SLC25A14;SLC37A4;SLC25A10;SLC20A2;SLC37A3
prerank,vasculature development (GO:0001944),0.451762787627387,1.0840988498553927,0.3503521126760563,0.675038820019957,1.0,2/16,5.33%,FBXW7;PDGFRA
prerank,cellular response to amino acid starvation (GO:0034198),-0.2912624080817862,-1.083996107063734,0.31333333333333335,0.8454476220577761,1.0,25/71,20.33%,TCIRG1;RPTOR;ATP6V1C1;GCN1;IMPACT;ATP6V1D;RRAGD;FLCN;SESN3;ATP6V1H;MAPK3;DAP;ATP6V1G1;CASTOR2;ATP6V0B;ATP6V0D2;ATP6V0C;SEH1L;MLST8;RRAGB;MTOR;SEC13;SESN2;ATF4;MAPK8
prerank,microtubule nucleation (GO:0007020),-0.3854580594078643,-1.0839149639241787,0.34352941176470586,0.8440565146053616,1.0,8/20,19.77%,CLASP2;CCDC57;TUBGCP5;TPPP;TUBGCP3;CENPJ;GOLGA2;TUBGCP6
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.40515906424232073,-1.0838219365571908,0.3619047619047619,0.8427089126185351,1.0,3/15,6.81%,SORT1;ZFYVE27;BDNF
prerank,negative regulation of response to wounding (GO:1903035),0.44352901810021844,1.0830114861200306,0.3460207612456747,0.6770359015566969,1.0,3/19,3.52%,ALOX5;CASK;CRK
prerank,regulation of cell projection organization (GO:0031344),-0.4351384947872291,-1.0826938869983582,0.3739130434782609,0.844676701585011,1.0,4/13,8.30%,SEMA4D;TREM2;MACF1;NTNG1
prerank,positive regulation of viral genome replication (GO:0045070),-0.3547371348708529,-1.0826255292785245,0.30445544554455445,0.8432279476960147,1.0,9/29,18.99%,ADAR;CNOT7;SRPK1;PPIE;SRPK2;ADARB1;TOP2A;TARBP2;TMEM39A
prerank,protein export from nucleus (GO:0006611),-0.36252200681554214,-1.0826109861561377,0.3341645885286783,0.841633366582233,1.0,12/27,36.03%,RANBP17;RANBP3L;EGR2;SMURF1;TGFB1;CSE1L;RANBP3;NUP214;CHP1;STRADB;PKD1;RAN
prerank,positive regulation of insulin secretion (GO:0032024),0.3819285396877639,1.0821692481699348,0.34105960264900664,0.6784140002395908,1.0,9/36,14.37%,TCF7L2;MCU;IRS2;GHRL;ANO1;DOC2B;GLUD1;TRH;RBP4
prerank,protein localization to plasma membrane (GO:0072659),0.3174346816716963,1.082001628572838,0.3055555555555556,0.6782551932250388,1.0,34/129,17.33%,LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;RAPGEF2;S100A10;ITGB1BP1;EHD1;RAP1A;ROCK1;TNF;ZDHHC3;DENND4C;PIP5K1A;JUP;KCNB1;ROCK2;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;TMED2;TSPAN14;ZDHHC2;RAB3B;SEC16A;SLMAP;FLOT2
prerank,mammary gland epithelium development (GO:0061180),-0.428319055863963,-1.0819741501541016,0.3797752808988764,0.8419240187084157,1.0,11/14,34.35%,JAK2;CSF1R;ERBB4;ID2;WNT4;WNT7B;AKT1;EPHA2;LATS1;SCRIB;WNT3
prerank,fatty acid transmembrane transport (GO:1902001),0.43369000740663877,1.0805540955072908,0.3720508166969147,0.6810741583508897,1.0,2/19,2.76%,PRKAG2;CD36
prerank,fatty acid biosynthetic process (GO:0006633),0.3451897608047035,1.0786996234339212,0.3347517730496454,0.6847901079231569,1.0,5/63,7.30%,ALOX5;LTC4S;ALOX15;HACD4;ELOVL5
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.24676733947067891,-1.0786013803031216,0.2542372881355932,0.8509633027462776,1.0,31/198,11.24%,HK2;INPP4B;CERK;INPP5D;PLCB2;PIK3CB;PLD4;PTPRD;PFKL;EPHA7;PAK1;GFPT1;DUSP10;PLCB4;PLPP3;PI4KA;PLCG1;ALDOA;LPL;GK;MAPK3;PGK1;PLPPR1;DUSP15;ALK;GPX4;PFKP;XYLB;MINPP1;PLCB1;PLCH1
prerank,cellular response to sterol (GO:0036315),0.46803828759633537,1.0782981885488496,0.36988847583643125,0.6851860165218695,1.0,1/13,0.46%,LRP6
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.35477343340702633,-1.078042329797746,0.3399503722084367,0.8511801063757622,1.0,10/27,30.55%,SLC1A3;SLC36A4;SLC1A1;SLC25A22;SLC7A8;SLC1A2;SLC25A13;SLC1A4;SLC25A29;SLC7A3
prerank,artery development (GO:0060840),-0.36742467250457944,-1.0780406517651475,0.32041343669250644,0.8495466369559735,1.0,5/23,5.51%,TGFBR1;SMAD7;ROBO2;ROBO1;NF1
prerank,positive regulation of chromosome organization (GO:2001252),0.455367077355569,1.0778663219343652,0.38727272727272727,0.6856583097266189,1.0,3/15,8.37%,LIG4;DDX11;ATRX
prerank,histone H3-K36 demethylation (GO:0070544),0.5001196825574634,1.07768818520754,0.3817829457364341,0.6855209873629313,1.0,4/10,18.88%,PHF8;KDM7A;KDM2A;KDM4C
prerank,protein localization to cell periphery (GO:1990778),0.31514820144296624,1.0774710516222694,0.31539424280350437,0.6854888618086755,1.0,35/133,17.33%,LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;RAPGEF2;S100A10;ITGB1BP1;EHD1;RAP1A;ROCK1;TNF;RABEP1;ZDHHC3;DENND4C;PIP5K1A;JUP;KCNB1;ROCK2;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;TMED2;TSPAN14;ZDHHC2;RAB3B;SEC16A;SLMAP;FLOT2
prerank,regulation of secretion by cell (GO:1903530),0.3538173513285242,1.0773763368950386,0.3343108504398827,0.6851784199007912,1.0,9/54,8.73%,MCTP1;MEF2C;RAB8B;RAB10;RIC1;RHBDF1;STXBP5;MCTP2;DNAJC1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.3603199335292682,1.0770285824666714,0.34735202492211836,0.685452822159891,1.0,10/46,12.28%,CHP2;TCF7L2;GAS6;GSK3B;DMAP1;BAG3;PSEN1;JUP;YWHAE;ZC3H12A
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.46082299035637014,-1.0768067164356683,0.37782340862423,0.8519265349900924,1.0,3/10,7.76%,CD274;PRKAR1A;PRNP
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.33520471593555023,1.0764032602937064,0.36428571428571427,0.6864608181487312,1.0,11/72,12.18%,FGFR1;SPRED1;FGF23;CBL;FRS2;KIF16B;HNRNPF;RAB14;POLR2B;SPRED2;TRIM71
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4803294833716905,1.076003115051118,0.3672014260249554,0.6868533045052121,1.0,3/11,13.88%,LDLR;NR1H2;MFSD2A
prerank,retinal metabolic process (GO:0042574),-0.4408632358104707,-1.075882412988449,0.3642241379310345,0.8532136775235633,1.0,2/12,5.36%,BCO2;RDH10
prerank,regulation of establishment of planar polarity (GO:0090175),0.3320213065690987,1.075638153631847,0.345679012345679,0.6872130713101609,1.0,17/88,14.72%,AP2A2;CLTC;SMURF2;PSMA7;PRICKLE1;CDC42;RHOA;CELSR1;AP2S1;PSMB2;PSMA6;SPEF1;AP2B1;PSMA3;PSMD1;PSMD5;NPHP3
prerank,potassium ion import across plasma membrane (GO:1990573),-0.31007624686443963,-1.075391289173307,0.3006134969325153,0.853169834507318,1.0,16/41,25.14%,SLC12A2;KCNJ2;ATP1B1;ATP1B2;SLC12A9;SLC12A6;KCNK9;ABCC9;KCNJ3;KCNJ10;KCNJ13;SLC12A4;SLC12A5;KCNJ9;KCNH2;SLC12A1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3571590021504427,-1.0753713622251784,0.3426395939086294,0.8516060450399887,1.0,8/25,21.06%,NOS1AP;FGF13;ANK2;CTNNA3;CACNA1C;CXADR;CAMK2D;CALM3
prerank,base-excision repair (GO:0006284),-0.30368823945855883,-1.0752563567740812,0.33229813664596275,0.8503171512331195,1.0,16/48,23.22%,DNA2;PARP1;ERCC6;LIG1;XRCC1;POLG;RFC2;NEIL3;POLE;HUWE1;POLL;RFC1;ADPRS;PARG;APEX2;POLD4
prerank,regulation of receptor internalization (GO:0002090),-0.33274618467346667,-1.0752421279905917,0.33045977011494254,0.8487360313351459,1.0,9/35,10.48%,RIN3;MAGI2;DLG4;FLOT1;AHI1;FMR1;ARRB2;ANKRD13B;ANKRD13D
prerank,apoptotic DNA fragmentation (GO:0006309),0.4437836966735905,1.0749529613872932,0.3815126050420168,0.6883046076061722,1.0,2/16,11.20%,ENDOG;DFFA
prerank,protein dephosphorylation (GO:0006470),0.30647598048099767,1.0748644923723412,0.32639791937581275,0.6879646560302787,1.0,24/135,11.02%,PTPRJ;PPP3CA;PTPN18;PTPN12;PTPN22;MTM1;MTMR3;DUSP12;DUSP1;CTDSP1;SSH2;PTPRK;PTPRA;PPM1B;DUSP22;DUSP2;PPP4R1;CTDSP2;LHPP;PPP2CA;PPP2CB;PPEF1;PPP4R2;PPP1CA
prerank,negative regulation of translational initiation (GO:0045947),0.4774606448108091,1.0739802626031931,0.3783783783783784,0.6894548649410434,1.0,6/13,19.13%,EIF3E;RBM4;EIF4EBP2;EIF4EBP1;EIF2AK4;EIF2AK1
prerank,response to interleukin-4 (GO:0070670),0.4991188733561105,1.0735734856775319,0.3803088803088803,0.6899092226262885,1.0,2/10,6.00%,DCSTAMP;TCF7
prerank,regulation of neurotransmitter transport (GO:0051588),0.44490662058529373,1.0727291342979859,0.3664259927797834,0.6912758893354936,1.0,3/16,7.81%,MCTP1;MEF2C;MCTP2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3272230545697145,1.0725436559411152,0.32320441988950277,0.691162574559535,1.0,10/92,3.95%,NRP1;FOXP1;SASH1;RREB1;MAPRE2;RIN2;DOCK1;GRN;ADAM9;ITGB1BP1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3416186369704691,-1.0724811852146239,0.3558897243107769,0.8557292241458718,1.0,7/29,9.13%,GTF2H2;CUL4A;CCNH;PARP1;DDB2;RBX1;ERCC2
prerank,actin filament depolymerization (GO:0030042),-0.44808748714283625,-1.072450732098962,0.3702928870292887,0.854224570840584,1.0,5/11,21.99%,TWF2;MICAL3;MICAL2;TWF1;WDR1
prerank,anion transport (GO:0006820),-0.33862853097982426,-1.0722145755035524,0.3371757925072046,0.8533819570198883,1.0,5/33,12.35%,SLCO2B1;VDAC1;SLC4A2;ABCG2;SLC17A5
prerank,mucosal immune response (GO:0002385),0.43989032848615545,1.072124828834716,0.3902439024390244,0.6915769044468107,1.0,1/15,2.50%,RPL39
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.36610459622800323,1.072057984066815,0.34328358208955223,0.6912130938239629,1.0,12/48,14.67%,SLC25A16;GUCY2D;ADCY9;ADSS2;PAPSS2;IMPDH2;SLC35B3;AMPD3;PANK1;NPPC;ADSS1;ACAT1
prerank,positive regulation of T cell proliferation (GO:0042102),0.34878694000505417,1.0720273206887965,0.3709677419354839,0.6907476142141632,1.0,8/55,9.90%,IL15;RPS3;CD46;CCL19;SYK;CD80;CCR2;IGF1
prerank,response to amino acid starvation (GO:1990928),-0.2871598691893605,-1.071618060010142,0.3220338983050847,0.8536248825186202,1.0,25/72,20.33%,TCIRG1;RPTOR;ATP6V1C1;GCN1;IMPACT;ATP6V1D;RRAGD;FLCN;SESN3;ATP6V1H;MAPK3;DAP;ATP6V1G1;CASTOR2;ATP6V0B;ATP6V0D2;ATP6V0C;SEH1L;MLST8;RRAGB;MTOR;SEC13;SESN2;ATF4;MAPK8
prerank,positive regulation of phosphatase activity (GO:0010922),0.4308593756322455,1.0715610762224081,0.3607705779334501,0.6912904255682788,1.0,3/21,2.60%,CHP2;MEF2C;BMP2
prerank,cellular lipid catabolic process (GO:0044242),0.3968983626387511,1.0715504193929994,0.36,0.6907929354374854,1.0,1/27,0.11%,AOAH
prerank,response to growth factor (GO:0070848),-0.31911718790685867,-1.0707173421015816,0.3236994219653179,0.8549087508943262,1.0,10/41,16.56%,TGFBR1;CTNNB1;BMPR1B;ACVR1;TWF2;HTRA2;TGFBR2;ACVR1C;ACVR1B;TBC1D7
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.41410255163914345,1.0706327739560308,0.3407534246575342,0.692334399336695,1.0,7/23,16.92%,C1QTNF3;SPI1;UACA;PPM1B;ZC3H12A;PPM1A;RELA
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3899359806791522,1.0704892120393057,0.3696763202725724,0.6921197840443505,1.0,10/29,17.88%,SPRED1;IL17RD;VASN;USF3;PPP2CA;SFRP1;SPRED2;PTEN;SPRY2;EFNA1
prerank,detection of mechanical stimulus (GO:0050982),-0.3834507734569041,-1.070267985302447,0.3484042553191489,0.8547422823568274,1.0,4/19,11.78%,CTNNB1;CDH2;PIEZO1;PIEZO2
prerank,negative regulation of hemostasis (GO:1900047),0.47162122488786895,1.0701297678538741,0.3787878787878788,0.6924016406084315,1.0,1/12,0.49%,APOE
prerank,regulation of interleukin-2 production (GO:0032663),0.3684807372455931,1.0696832209526796,0.3671274961597542,0.6929012383701675,1.0,8/43,8.66%,VSIG4;IRF4;RPS3;SPTBN1;PDE4D;CD80;CCR2;TRIM27
prerank,chromatin remodeling at centromere (GO:0031055),-0.3413358755155787,-1.0695404076568862,0.3350383631713555,0.8553828061153794,1.0,12/31,28.14%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPV;CENPP;CENPN;CENPH;CENPI;MIS18A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.35452267396933207,1.069271871654237,0.3411420204978038,0.6933008355266153,1.0,23/52,23.07%,SAMD4A;TUT7;RC3H1;DCP1A;TUT4;DDX6;DCP2;EXOSC8;LSM4;LSM2;POLR2D;EXOSC1;CNOT9;HBS1L;CNOT11;CNOT6L;CNOT4;CNOT1;CNOT8;PATL1;PAN3;EXOSC3;CNOT2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.28210473426883703,1.068989197435733,0.3050483351235231,0.6934177731269351,1.0,87/366,18.59%,APP;AHR;RREB1;FOXN2;NFXL1;ESR1;HINT1;MEF2C;NCOA2;CEBPB;MITF;ORC5;RYBP;BMP2;ANKRD17;NR3C1;CLOCK;SPI1;RB1;INSR;TGFBRAP1;TCF7;ATXN1;ESCO2;LYL1;MTPN;GMNN;ESCO1;IRF2;ATRX;ZNF628;LIMD1;ESRRB;BACH1;LIN54;HMG20A;ESR2;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;TESMIN;RNF14;JMJD1C;SP1;ATXN1L;CREBBP;MYBL2;FOXK2;HINFP;NFIA;NANOS3;FOXO3;RPL10;TERF2IP;SP3;RBBP6;PSPC1;KAT7;STAT3;EP300;MLF2;HMGN5;WWC1;NAB1;MYT1;NSD3;NLK;NR2C2;SFPQ;RUNX3;HCFC1;PPARGC1B;GPBP1;NR5A2;PRKCQ;RELA;ZNF22;GZF1;METAP1;MAFB;ATF2;RFX3;PERM1;PLAG1
prerank,positive regulation of TOR signaling (GO:0032008),-0.3199812138438659,-1.0687768539810982,0.35,0.8561323471461246,1.0,7/40,5.53%,RPTOR;GPR137B;TREM2;GPR137C;RRAGD;NCKAP1L;FLCN
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.35021926174870843,1.0686647088554933,0.3382352941176471,0.6936807315850351,1.0,15/56,14.89%,EGFR;ANKRD17;RGCC;RB1;CDC27;NSMCE2;CCND3;VPS4B;RCC2;CCND2;CUL3;TFDP1;KMT2E;RAB11A;RAD51B
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4509613027071139,1.068663990456371,0.4027072758037225,0.6931552300324283,1.0,7/17,14.24%,S1PR2;ROCK1;TNF;VCL;ROCK2;TNFRSF1A;ADD1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.416879296184752,1.0685337884254085,0.3788927335640138,0.6929313996175346,1.0,5/21,15.18%,ZFP36L2;ZFP36L1;IGF1;PTGER4;MYC
prerank,axonogenesis (GO:0007409),-0.23641089522912676,-1.0679926584847304,0.21428571428571427,0.8570234905500717,1.0,53/237,13.77%,NCAM1;NRXN3;SEMA4D;UNC5C;PIK3CB;EVL;EFNA5;CTNNA2;ROBO2;EPHA7;SCN1B;SRC;PARD3;NRXN1;SEMA4C;MAP1B;GRB10;PLCG1;NEFH;FGFR2;ROBO1;LYPLA2;KIF5A;SEMA4G;SPG11;PALLD;MAPK3;KIF5C;CNTN4;EPHB1;BDNF;BSG;EPHA10;CNTN6;CNTN2;SHC3;UNC5D;LAMA2;NTNG1;LLGL1;S100B;EFNB2;ENAH;LAMA3;AFG3L2;LGI1;AUTS2;GFRA1;EPHA3;SPTB;DSCAML1;APBB1;SLITRK5
prerank,histone H2A monoubiquitination (GO:0035518),-0.39024301064282757,-1.0676665087374073,0.37530864197530867,0.8564003765401182,1.0,10/17,26.89%,SKP1;DDB2;RNF168;PCGF5;PCGF6;PCGF2;RING1;BMI1;PCGF1;KDM2B
prerank,cellular response to estrogen stimulus (GO:0071391),0.47215681946602556,1.0672880829936968,0.4,0.6952508419098656,1.0,6/14,13.72%,ARID5A;TRIM24;SFRP1;BCAS3;SFR1;RARA
prerank,eye photoreceptor cell development (GO:0042462),0.4477703266448142,1.0670898112587572,0.40370370370370373,0.6951998611373482,1.0,2/15,7.04%,RP1;MYO7A
prerank,establishment of protein localization to extracellular region (GO:0035592),0.377242935074106,1.0670888486932961,0.36645962732919257,0.6946772279148522,1.0,10/39,16.72%,STEAP3;RCN3;RAB8B;RAB10;AFM;CANX;PDIA4;RAB3B;MIA3;GOLPH3
prerank,cellular response to ionizing radiation (GO:0071479),0.3552695863595481,1.0666886300036154,0.3755725190839695,0.6950803431366431,1.0,16/47,16.18%,LIG4;RPL26;CLOCK;TSPYL5;MDM2;MAPK14;MAP3K20;KDM4D;EEF1D;SPIDR;RHNO1;CRYAB;NET1;TMEM109;KDM1A;ATR
prerank,phospholipid catabolic process (GO:0009395),-0.3565346067932216,-1.0666287573767808,0.34025974025974026,0.858150901311188,1.0,3/24,3.39%,ABHD12;ENPP2;SMPD4
prerank,presynaptic endocytosis (GO:0140238),0.4003660896025349,1.0664589829416684,0.3664383561643836,0.6950966639629125,1.0,4/24,7.72%,FCHO2;OPHN1;SYNJ1;CANX
prerank,negative regulation of vascular permeability (GO:0043116),0.4758507949271049,1.0664298436722315,0.3770491803278688,0.6946382620961126,1.0,2/12,4.20%,PTPRJ;PDE2A
prerank,cellular response to DNA damage stimulus (GO:0006974),0.28289936763554435,1.0659078327563785,0.3296582138919515,0.6953768889085256,1.0,81/336,18.36%,VAV3;RNF169;FOXP1;CRIP1;SUSD6;RBBP8;LYN;USP3;RPS3;BABAM2;VCPIP1;TNFRSF1B;UVRAG;WAC;MCL1;FAM111A;BCL2L2;MAPKAPK2;SFN;MCM9;POLE2;NOP53;BCL2;WDR76;CHEK1;TOPBP1;YY1;CHRNA4;PDS5B;DDX11;PSEN1;RPA1;RAD54L;NCOA6;SHPRH;BACH1;ASH2L;MAPK14;NFATC2;RAD52;MTREX;USP16;UBQLN4;SPIDR;ZRANB3;POLE3;KMT5B;XPA;HINFP;POLH;CBX1;ZC3H12A;FOXO1;BRAT1;RBBP6;MUTYH;XPC;USP45;KIN;MMS19;USP28;RAD51B;PWWP3A;MYC;SAMHD1;FBH1;USP47;GTF2H3;MCM8;FANCL;ATR;UBE2U;RFC3;GTF2H1;ASF1A;BATF;ZBTB40;APTX;UBE2A;ZBTB1;ATF2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4177682844287172,1.065836497308222,0.3826530612244898,0.6950140857140849,1.0,4/23,3.18%,GAS6;NR1H4;LILRB1;TLR4
prerank,positive regulation of locomotion (GO:0040017),-0.34528045874541935,-1.065805103262913,0.3480392156862745,0.8593106184973193,1.0,7/27,13.82%,TREM2;CCDC25;P2RY12;STX3;CSF1R;AIF1;SPOCK2
prerank,Fc receptor signaling pathway (GO:0038093),0.31234260192597724,1.065583511976829,0.3541114058355438,0.6950642376808612,1.0,22/110,16.92%,VAV3;PPP3CA;PSMA7;LYN;FER;FCER1G;MAP3K1;BCL10;PAK2;SYK;PSMB2;NFATC2;CALM1;SHC1;PSMA6;PSMA3;PSMD1;PSMD5;NFATC3;TAB3;PRKCQ;RELA
prerank,intermediate filament organization (GO:0045109),0.44635521834264064,1.0655536979937086,0.36597938144329895,0.6946136789410325,1.0,2/17,4.18%,MTM1;VIM
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3573025383966069,-1.0652183282110275,0.3442622950819672,0.8596702885831733,1.0,8/24,22.86%,IL1A;SULF1;BRCA1;HPSE;ATF4;CCBE1;TGFB1;HIF1A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.33104792507346775,1.0651549498183752,0.36615811373092927,0.6944668279872236,1.0,18/78,14.77%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;AP2B1;CAPZA1;CLTA;CAPZA2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.33104792507346775,1.0651549498183752,0.36615811373092927,0.6944668279872236,1.0,18/78,14.77%,AP2A2;FCGR2B;CLTC;RILP;FCER1G;CD74;PIKFYVE;AP2S1;CANX;RAB7A;KIF4A;OSBPL1A;DYNC1I2;SEC24D;AP2B1;CAPZA1;CLTA;CAPZA2
prerank,histone mRNA catabolic process (GO:0071044),0.45061748893015974,1.064056115548129,0.3897707231040564,0.6964863604956357,1.0,5/15,16.36%,TUT7;TENT2;TUT4;DCP2;TUT1
prerank,excitatory postsynaptic potential (GO:0060079),0.4201474924758349,1.0639946838761782,0.4098939929328622,0.6960914569653758,1.0,5/19,10.24%,MEF2C;GSK3B;MPP2;MAPK8IP2;GRIN2D
prerank,RNA 3'-end processing (GO:0031123),-0.28099748054826845,-1.063824036426232,0.3108108108108108,0.8624509042521522,1.0,22/69,21.55%,THOC1;SRRM1;SRSF5;PABPN1;DDX39B;SRSF3;RPRD1A;SRSF2;CSTF2;RNPS1;U2AF1;LIN28B;UPF3B;CASC3;NCBP1;CLP1;SRSF11;THOC3;SRSF9;POLDIP3;ALYREF;U2AF2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.41127792153289205,1.0638156326788581,0.38974358974358975,0.695947326752119,1.0,6/24,12.59%,KMT2A;RPS3;ZRANB3;DFFA;NIBAN2;TERF2IP
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3286766988955562,1.0637502187932932,0.36126373626373626,0.6955694438554116,1.0,10/85,7.47%,AP2A2;CLTC;SMURF2;PSMA7;PRICKLE1;CDC42;RHOA;CELSR1;AP2S1;PSMB2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3132049808172172,1.0637078664128312,0.35723771580345287,0.6951665054480842,1.0,22/109,16.92%,VAV3;PPP3CA;PSMA7;LYN;FER;FCER1G;MAP3K1;BCL10;PAK2;SYK;PSMB2;NFATC2;CALM1;SHC1;PSMA6;PSMA3;PSMD1;PSMD5;NFATC3;TAB3;PRKCQ;RELA
prerank,regulation of viral transcription (GO:0046782),0.3638122254233681,1.06369191744481,0.36245954692556637,0.6946833633508708,1.0,9/39,14.37%,MDFIC;IFITM3;LARP7;TRIM32;NELFA;TRIM27;POLR2B;MID2;POLR2D
prerank,negative regulation of insulin secretion (GO:0046676),0.4417057562359377,1.0627035598589283,0.3955479452054795,0.6963618995147933,1.0,4/17,11.90%,PRKN;SFRP1;CHGA;KCNB1
prerank,regulation of ruffle assembly (GO:1900027),-0.3612567538493669,-1.0625953952185174,0.3708133971291866,0.8648223771970259,1.0,6/23,6.59%,ABI3;ARHGAP24;EVL;NLGN1;RDX;P2RY12
prerank,intracellular lipid transport (GO:0032365),0.4163230761702607,1.062534657455128,0.3803786574870912,0.6962213010039373,1.0,2/21,1.59%,PRKAG2;SGPP1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4514435402376713,1.0624805456558246,0.3877917414721723,0.6958158858469704,1.0,3/16,8.05%,RREB1;METRNL;VSTM2A
prerank,regulation of neurogenesis (GO:0050767),-0.2992522883177607,-1.0623809257082408,0.31788079470198677,0.8639509296134927,1.0,7/55,8.34%,CX3CR1;NUMB;SORL1;CTNNB1;TGM2;BHLHE41;NUMBL
prerank,regulation of receptor binding (GO:1900120),0.4908527573194754,1.062155155499767,0.3898305084745763,0.6959822122775536,1.0,3/10,14.25%,B2M;HFE;ATP2A2
prerank,polyol biosynthetic process (GO:0046173),0.44683705237192417,1.062043161334259,0.3823008849557522,0.6957385902200092,1.0,3/16,6.24%,IP6K3;ACER3;CYP27A1
prerank,fibrinolysis (GO:0042730),0.46773756344673834,1.0617384578569378,0.37732342007434944,0.6959318071504037,1.0,1/13,1.51%,SERPINB2
prerank,extracellular matrix organization (GO:0030198),-0.22731494798705976,-1.0614599739347217,0.24107142857142858,0.865318237871006,1.0,80/276,22.30%,DST;TGFBR1;ITGB5;F11R;COL27A1;KLK2;NPNT;GPM6B;ADAMTSL1;JAM2;COL11A1;ITGA6;GFOD2;SPARC;SPP1;ADAMTS16;TLL1;ITGB3;FGF2;FLOT1;ITGAX;CTSS;NF1;P3H2;ADAMTS3;BSG;LOXL3;ADAMTS4;APLP1;ITGA5;LAMA2;PLOD3;MMP16;COL23A1;ADAMTS20;PECAM1;LAMA3;SCUBE1;ADAM8;NDNF;ADAMTS1;MATN4;SPOCK2;COL25A1;COL1A2;COL19A1;COL11A2;ADAM10;TNR;COL8A1;VCAN;VIT;BCAN;COL26A1;ITGB4;FURIN;COL6A2;COL16A1;BGN;COLGALT2;FLRT2;SERPINE1;COL6A3;COL4A2;ITGAV;PDGFA;P3H4;NCAN;COL4A6;TGFB2;ADAMTS2;COL9A3;CTSK;COL9A1;ITGAD;COL3A1;TGFB1;COL6A1;COL20A1;ITGA10
prerank,regulation of epithelial cell migration (GO:0010632),-0.3060159541999296,-1.0614066984860302,0.3565217391304348,0.8638891830224162,1.0,9/51,5.79%,EVL;PRKCE;PTPN23;CLASP2;ENPP2;SRC;DUSP10;PLCG1;MACF1
prerank,protein-containing complex disassembly (GO:0032984),0.3531706998379226,1.0608718486555648,0.37367624810892586,0.6973623560220188,1.0,17/54,18.82%,LRP6;RPL23;UVRAG;AXIN1;GSK3B;FRAT1;EPG5;LAMP2;PPP1CA;MYC;VPS16;WIPI2;GABARAP;AMER1;PYM1;VAMP8;DVL3
prerank,regulation of actin filament polymerization (GO:0030833),0.33726120712039354,1.0606635780230116,0.36812411847672777,0.6973305976700697,1.0,10/69,8.22%,SNX9;MYADM;ALOX15;FER;RASA1;FCHSD2;ARHGAP18;SSH2;MTPN;CCL24
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3830022238184852,1.0605815820422055,0.384251968503937,0.6969913321302862,1.0,6/31,8.53%,CRIM1;TNN;FGF23;CDK6;GDF10;LIMD1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.40606724297006347,-1.0602966920684733,0.36613272311212813,0.8658039417397254,1.0,8/15,26.37%,NLGN1;CLN3;USP46;SYN3;CNTNAP4;HAP1;BAIAP3;STXBP1
prerank,response to nitric oxide (GO:0071731),0.45759189933349204,1.059915240972522,0.39233576642335766,0.6980057579016429,1.0,3/13,12.87%,CCL19;MTR;FOXO1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.45728375160250884,-1.0595407656775773,0.39651416122004357,0.8666561653998581,1.0,5/10,32.46%,IMPACT;ERRFI1;ENG;CHP1;MVP
prerank,regulation of spindle assembly (GO:0090169),-0.3491892823764272,-1.0593761398937378,0.3702770780856423,0.8655717944305448,1.0,5/25,6.31%,EML3;DYNC1H1;CEP97;HNRNPU;CHMP4B
prerank,regulation of myotube differentiation (GO:0010830),0.40761734963630847,1.0592964947906207,0.375,0.6988972677273724,1.0,1/24,0.10%,HDAC9
prerank,regulation of DNA repair (GO:0006282),0.3604187069567697,1.059273648717601,0.3987441130298273,0.6984323097169828,1.0,10/44,13.82%,EGFR;RPS3;BABAM2;BRCC3;CEBPG;RAD52;POLH;DEK;UBE2N;KAT7
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.33944273507862543,-1.058596559376735,0.35294117647058826,0.8664504994278298,1.0,17/29,37.65%,ACACA;PPT1;TECR;ACSL4;ACSL6;SCD;SLC25A1;ACSBG1;ELOVL1;GCDH;ACSF3;ELOVL7;CBR4;HACD2;ELOVL6;ELOVL2;HSD17B8
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.40546112601864986,1.0581274310886166,0.38617200674536256,0.7004671422197181,1.0,9/24,16.59%,CNMD;TNMD;EPN2;PRKCB;EMILIN1;MMRN2;NIBAN2;PRKD2;ARNT
prerank,skin development (GO:0043588),0.3434352163240965,1.0570756100778906,0.3617021276595745,0.7023976154501125,1.0,7/65,6.03%,TXNIP;JAG1;ADAM9;KRT10;CLIC4;ATP7A;SFN
prerank,positive regulation of cytokinesis (GO:0032467),0.37828907806746503,1.0569933602158508,0.3704974271012007,0.7020774697899097,1.0,6/32,12.60%,KIF20B;CDC42;RHOA;PKN2;CUL3;SVIL
prerank,cilium assembly (GO:0060271),-0.2300451055919237,-1.0569908753058663,0.25,0.8698978183013867,1.0,100/297,27.79%,CSNK1E;ASAP1;CFAP74;SDCCAG8;BBS9;CEP135;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;ODF2;DYNC1H1;LRGUK;CCDC66;IFT81;ATP6V1D;CEP97;IFT140;RAB3IP;DZIP1;DYNLRB1;CEP162;IFT88;CEP192;TTC8;AHI1;CEP250;CCDC57;HAUS8;IFT20;BBS7;MKS1;CEP63;DYNLT2B;WDR19;CCDC39;CCP110;SPAG16;DYNC2H1;VANGL2;KIF3A;SSX2IP;TOGARAM1;HAUS7;CKAP5;MAPRE1;HAUS3;TCTN1;IFT52;KIF3B;WDR90;CDC14A;RPGRIP1;CFAP298;CFAP410;NUDCD3;CENPJ;CPLANE2;NOTCH1;IFT43;DYNC2I1;EHD3;B9D2;RAB8A;TMEM138;DNAH5;PLA2G3;BBS4;DCTN2;ARL3;CEP89;IQCB1;HDAC6;TMEM231;MKKS;CCDC40;CNTRL;FLNA;GALNT11;TMEM17;PTPDC1;HAUS2;DCTN1;PLK4;CDK1;HAUS6;KIFAP3;YWHAG;CEP126;EXOC3;TTC39C;UNC119B;CFAP70;CFAP46;IFT172;TTBK2;TUBA4A;CFAP43;CEP152
prerank,positive regulation of intracellular protein transport (GO:0090316),0.30274878878442957,1.0569770347946006,0.36855670103092786,0.7015988862554907,1.0,26/144,12.68%,CHP2;TCF7L2;FBXW7;KIF20B;GAS6;YWHAQ;ITGB1BP1;GSK3B;SFN;BCL2;DMAP1;BAG3;PSEN1;FYN;UBE2D3;PCNT;MYO1C;TFDP1;CASP8;JUP;SREBF2;YWHAE;KCNB1;ZC3H12A;PPP1R13B;BCAS3
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.3803653068475971,-1.0568308837932385,0.37817258883248733,0.8688247700380846,1.0,2/19,0.53%,F11R;TJP1
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4137580494400324,1.056519743190654,0.3857374392220421,0.7021077429305287,1.0,5/24,8.63%,ITGA4;ITGB1;ROCK1;SYK;MSN
prerank,cGMP metabolic process (GO:0046068),0.46818013867078045,1.0562489358249632,0.40966010733452596,0.7022234990282119,1.0,3/12,13.93%,PDE2A;GUCY2D;NPPC
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.42674983652538206,1.0561396686123603,0.3963515754560531,0.701950179653798,1.0,8/21,11.99%,PEAK1;RHOA;ROCK1;PTPRA;VCL;CLASP1;CORO1C;ROCK2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.31775005799329425,1.0560055544198652,0.3807588075880759,0.7017245594346637,1.0,23/107,16.39%,MAP3K5;ALOX15;CEBPB;RCN3;THBS4;ERN1;NIBAN1;PRKN;GSK3B;RHBDD1;BCL2;ATF6;WFS1;RNF185;UFM1;PDIA4;ERO1A;ATG10;ATP2A2;PPP1R15B;CREB3L1;HSP90B1;SEC16A
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.3688371686360579,1.0559600048278635,0.36335403726708076,0.7013133762711796,1.0,4/39,4.22%,NRP1;LRP6;BMP2;NRARP
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.46607161981712736,1.0558106897331296,0.3794466403162055,0.7011247638263608,1.0,6/12,19.49%,MYCBP2;PAFAH1B1;SZT2;EPHB6;CHRNB2;SPTBN4
prerank,ketone body metabolic process (GO:1902224),-0.44456237293297185,-1.0557221323936556,0.3811563169164882,0.8707451765768495,1.0,5/10,33.84%,ACSS3;HMGCLL1;OXCT1;AACS;BDH1
prerank,protein polyubiquitination (GO:0000209),0.2808892340639034,1.0556835492203684,0.34807256235827666,0.7009230576871665,1.0,56/297,14.43%,WWP1;SASH1;FBXW7;SMURF2;PSMA7;ARIH1;RPS27A;FBXL17;UBE2E3;SIAH2;PELI1;RMND5A;PRKN;TRIM56;LNPEP;RC3H1;SPOP;UBE2Q2;CBFB;TRIM32;FBXL5;ANKIB1;BCL2;CDC27;PSMB2;TRIM68;SHPRH;TRIM27;MDM2;RNF19B;TPP2;UBE2K;UBE2D3;CUL3;MKRN1;FBXO11;RNF14;ZNRF2;AMFR;PSMA6;UBE3B;TRIM71;FBXO10;MKRN3;UBE2R2;RNF115;UBE2N;RBBP6;RNF187;RNF19A;BFAR;ANKRD39;NEDD4L;PSMA3;PSMD1;PSMD5
prerank,chromatin remodeling (GO:0006338),0.3172624895403815,1.0554128477843268,0.3654618473895582,0.7010713980933608,1.0,27/100,18.88%,PADI4;ESR1;HNRNPC;BAZ2B;JARID2;ARID1B;RB1;ACTB;KDM6A;SATB2;ATRX;KDM4D;POLE3;KDM5C;TADA2B;SMARCAD1;GATAD2B;MYC;SMARCD1;HDAC4;ARID1A;HCFC1;ZBTB7A;NPM3;ZBTB1;SRCAP;KDM4C
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.32027525362464604,-1.0553213285037988,0.37960339943342775,0.8703871365186486,1.0,9/39,15.12%,PIK3CB;EFR3B;PI4KA;SOCS2;TTC7B;SOCS7;PIK3C2B;PIP4K2B;PIP4K2C
prerank,epiboly involved in wound healing (GO:0090505),0.4405890086165247,1.0552650517709252,0.39019963702359345,0.7008731688403699,1.0,3/16,4.01%,CD44;RHOA;LCP1
prerank,regulation of protein import into nucleus (GO:0042306),0.371843654107878,1.0551005974395458,0.3782467532467532,0.7007505714600505,1.0,9/36,12.28%,CHP2;MDFIC;DMAP1;BAG3;PSEN1;RAB23;JUP;UFM1;ZC3H12A
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.43430433521312933,-1.0550241692672442,0.4139433551198257,0.8697124441632327,1.0,5/12,19.21%,ATP1B1;ATP1B2;WNK3;GLRX;FXYD1
prerank,wound healing (GO:0042060),-0.2823440755143749,-1.0545601888788858,0.323943661971831,0.8696060095908902,1.0,9/62,7.38%,DST;TGFBR1;PAK1;AHNAK2;ITGB3;FGF2;NF1;MACF1;DCBLD2
prerank,regulation of cellular component organization (GO:0051128),0.302703360722818,1.0543928894256072,0.3490445859872611,0.7018617424757072,1.0,13/135,6.94%,HIP1;APOE;RAP1B;SGK3;OPHN1;IRAK3;CD36;IL17RB;RAPGEF2;RAP1A;ROCK1;AP2S1;TNF
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.31953455176186646,1.0543151630878504,0.36723910171730517,0.701523096141199,1.0,19/104,11.64%,SPRED1;SMURF2;CRIM1;RPS27A;BMP2;SNX6;GDF3;IL17RD;SMAD4;TRIM33;SNX25;ACVR2A;HTRA3;VASN;UBE2D3;DAND5;SPRED2;EMILIN1;PMEPA1
prerank,positive regulation of developmental process (GO:0051094),0.2956903941374815,1.0542021428916688,0.3786407766990291,0.7012585550088252,1.0,43/164,20.42%,APOE;FGFR1;ZBTB16;RREB1;SMURF2;NCOA3;CEBPB;BMP2;RPS6KA3;PRKN;MCU;KRT10;INSR;TNF;PSEN1;ESRRB;CLASP1;CORO1C;RTN4;VLDLR;B4GALT5;KMT5B;NIBAN2;GJA1;MDK;BMPR1A;NR2C2;HSP90AB1;SLC6A6;BNIP3;LHX1;SHLD3;XBP1;PA2G4;LMNA;MFF;GDNF;DVL3;CCN2;DLG5;HMCES;SHLD2;DNM1L
prerank,regulation of acrosome reaction (GO:0060046),-0.4536185599273329,-1.0540850257022674,0.4247967479674797,0.8695127586248309,1.0,2/10,12.63%,PLCB1;GLRA1
prerank,T cell proliferation (GO:0042098),-0.4254647093881146,-1.054007243448036,0.38222222222222224,0.8681980389702509,1.0,1/13,0.11%,CADM1
prerank,receptor signaling pathway via STAT (GO:0097696),0.4021885597608461,1.0537945478661197,0.38486312399355876,0.7016587482283381,1.0,9/25,14.70%,IFNAR1;PIAS1;THPO;CCR2;STAT4;IFNAR2;STAT6;STAT3;PKD2
prerank,glycerol metabolic process (GO:0006071),-0.4636325973696538,-1.053730498223192,0.41163793103448276,0.8674763227826476,1.0,5/10,31.69%,GK;TPI1;ANGPTL3;GOT1;COQ2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.45360510938782844,-1.053722940697357,0.4161490683229814,0.8659423939829591,1.0,3/10,15.95%,WHRN;IFT88;ADGRV1
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3710687442331351,-1.0536955672129182,0.3743961352657005,0.8644965583278603,1.0,7/20,22.06%,SKP1;HNRNPU;SUPT7L;ARL2BP;PARK7;BBS4;TAF8
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3698466771849477,1.053466725040405,0.386046511627907,0.7019019696376723,1.0,12/38,16.01%,KLF2;CD36;TLR4;INSR;TNF;KLF4;ASS1;ROCK2;ZC3H12A;ATP2B4;PKD2;HSP90AB1
prerank,cellular response to organic substance (GO:0071310),0.31255314593042405,1.0533905557347236,0.3918741808650065,0.7015330288898689,1.0,13/116,7.44%,PID1;PTPN18;PTPN20;NCOA3;PTPN12;NR1H4;NCOA2;RHOA;RACK1;ACVR2A;TNF;KLF4;CXCR4
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.48150048452819694,1.0530902679104908,0.42994241842610365,0.7017135236251634,1.0,2/11,2.67%,EGFR;RIPK1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.373417795509419,-1.0527625724802172,0.35,0.8659117708020666,1.0,12/20,36.74%,TGFBR1;DNAJB2;ITCH;EPAS1;HIF1A;UBQLN1;DCUN1D2;DCUN1D5;HSPA1A;DCUN1D3;HSPA1B;EGR1
prerank,response to nutrient levels (GO:0031667),-0.39873298206867597,-1.0525396171885126,0.3544600938967136,0.865094804821403,1.0,5/17,19.69%,RPTOR;EIF4G1;ULK1;MTOR;ATF4
prerank,acylglycerol biosynthetic process (GO:0046463),0.4068590619380994,1.0521854830842348,0.385,0.7031928257644169,1.0,3/23,4.40%,ANG;AGMO;MOGAT2
prerank,central nervous system neuron development (GO:0021954),0.44126776320826555,1.05206881739112,0.40574506283662476,0.7029383600149973,1.0,7/15,17.80%,RAPGEF2;B4GALT6;ATP7A;B4GALT5;HSP90AB1;PTEN;ARHGAP35
prerank,regulation of cellular senescence (GO:2000772),-0.3414869011408448,-1.0520501952378405,0.3783783783783784,0.8651213478847541,1.0,8/28,13.84%,ABI3;NUAK1;ZKSCAN3;NEK6;CGAS;AKT3;TERF2;YPEL3
prerank,regulation of cell differentiation (GO:0045595),-0.2464328762947977,-1.0518019590136372,0.3146067415730337,0.8643733561858556,1.0,26/148,10.03%,TGFBR1;DDX5;BIN1;CDK9;DDX17;OCIAD1;CSF1;YWHAH;NLGN1;SMAD7;CLASP2;ZFHX3;BMPR1B;BIRC2;GPS2;FGFR2;NF1;RPS6KA1;TRIP4;BDNF;SIK1;ALK;TIAM1;AR;ZFHX2;PHLDB1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.48140894139698054,1.0516493208111883,0.4020618556701031,0.7033776515878578,1.0,2/10,4.87%,C5AR1;RB1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4440907394086032,1.0516240316252137,0.39824561403508774,0.7029287919471123,1.0,3/16,7.55%,RB1;REC8;PDS5B
prerank,positive regulation of telomerase activity (GO:0051973),-0.3238732775507884,-1.0515732976065104,0.3702770780856423,0.8635382718503574,1.0,12/33,27.95%,CTNNB1;XRCC5;MAPK3;MAP2K7;PTGES3;MAP3K4;CCT2;WRAP53;ACD;NVL;AURKB;GREM1
prerank,cell-substrate junction assembly (GO:0007044),-0.3287005108274958,-1.051507270577811,0.36528497409326427,0.8622456388142001,1.0,9/33,17.75%,DST;ITGA6;SRC;FERMT2;ACTN2;LAMA3;TRIP6;THY1;ITGB4
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.4481248795080828,-1.0513938492028376,0.3839835728952772,0.8611034821774309,1.0,3/10,12.26%,DLGAP2;DLGAP1;NPTX1
prerank,protein K48-linked ubiquitination (GO:0070936),0.34522857100841664,1.0513653603750017,0.36959761549925485,0.7030134829355598,1.0,20/54,19.89%,UBE2E3;PELI1;PRKN;UBE2Q2;TRIM32;UBE2K;UBE2D3;CUL3;AMFR;UBE2R2;RNF115;RNF187;BFAR;NEDD4L;RNF146;FBXO38;UBE2A;SKP2;RNF6;KBTBD7
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.45163819353411033,1.0502540837943886,0.41560798548094374,0.7049490105496705,1.0,1/15,0.59%,FGFR1
prerank,protein import into peroxisome membrane (GO:0045046),0.4186169860728572,1.0501534877660403,0.38945578231292516,0.7046708887265246,1.0,4/22,6.62%,RAB8B;SLC25A17;PXMP2;PEX26
prerank,mononuclear cell differentiation (GO:1903131),-0.35339448076768065,-1.0501520991970048,0.3915094339622642,0.8634907460232698,1.0,7/24,10.34%,IRF8;PDE1B;TREM2;IKZF1;AXL;FLT3;CSF1R
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.39162852739764414,1.049912587125999,0.39661016949152544,0.7047098843383668,1.0,7/27,10.19%,ALOX15;CEPT1;PNPLA8;PLA2G2D;CHKB;ETNPPL;PLAAT1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.24303296645531125,-1.0495040274505418,0.3076923076923077,0.8639966659061192,1.0,38/172,15.12%,LPCAT2;INPP4B;INPP5D;LPIN2;SLC44A2;LPCAT1;PIK3CB;DGKB;PITPNM1;PIP5K1C;PCYT2;SELENOI;PLEKHA1;FGF2;PCYT1B;PI4KA;CLN3;LIPH;PIK3R4;PITPNM3;PTDSS1;SYNJ2;GNPAT;INPP5F;PTDSS2;DGKZ;PIK3C2B;DDHD1;LPCAT3;PIK3R5;MTMR4;ETNK1;CHPT1;MBOAT7;CDS1;PIP4K2B;STARD7;PIP4K2C
prerank,regulation of microtubule-based movement (GO:0060632),-0.44048235115788004,-1.0493352459433125,0.3995943204868154,0.863050973143035,1.0,6/11,21.31%,MAP2;NEFH;DYNLT2B;CFAP298;HAP1;HDAC6
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3476646496594814,1.0491847654936752,0.368575624082232,0.7058169572506001,1.0,14/54,17.75%,GAS6;RIPK1;PRKN;BIRC3;RACK1;SYK;TNF;UBE2K;CARD16;CASP8;TNFRSF1A;SPPL2B;SPPL2A;MADD
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5070594219921838,1.048190933999322,0.432,0.7075223796101039,1.0,4/10,16.59%,CD36;TLR4;CD68;MIA3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.3790559375722007,-1.0481269011304903,0.41134751773049644,0.8653022973506292,1.0,4/20,8.88%,DIP2B;DIP2A;MAPK3;BRCA1
prerank,sterol biosynthetic process (GO:0016126),0.38110886313308673,1.0480099426413454,0.3996865203761755,0.7073810739293408,1.0,13/33,24.87%,PRKAG2;HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,positive regulation of cartilage development (GO:0061036),0.425254007471114,1.0479543303068246,0.4137291280148423,0.7070015768987495,1.0,4/17,14.31%,ZBTB16;BMP2;LOXL2;MDK
prerank,regulation of endocytic recycling (GO:2001135),-0.44419882997542637,-1.0477302630575163,0.4088983050847458,0.8650201343184011,1.0,4/11,8.72%,SORL1;INPP5F;ATP9A;ACTN2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.40549134296458733,-1.0476212250017751,0.4009433962264151,0.8637810933694782,1.0,2/15,4.91%,TGFBR1;FGFR2
prerank,positive regulation of response to wounding (GO:1903036),0.4131838532589639,1.0475643118106985,0.4179357021996616,0.7073171893027558,1.0,3/24,3.55%,ITGB1;GRN;SCARF1
prerank,monocyte differentiation (GO:0030224),-0.45160754902689704,-1.0474132288093068,0.41596638655462187,0.862967907885725,1.0,4/10,29.16%,PDE1B;CSF1R;MT1G;BMP4
prerank,cardiac muscle contraction (GO:0060048),-0.32045853359523657,-1.047102045766747,0.3835227272727273,0.8624716060111318,1.0,5/34,7.31%,ATP1B1;SCN1B;SLC8A1;GRK2;GAA
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.3528320075170188,-1.0467187145164918,0.41823056300268097,0.862088223953637,1.0,5/25,10.63%,TP53;BCL2L11;MLLT11;BMF;TNFSF10
prerank,response to organic cyclic compound (GO:0014070),-0.29548734591282716,-1.0466776205978061,0.3724340175953079,0.8607241269462205,1.0,10/52,11.07%,CTNNB1;SPP1;PAQR8;SOCS2;GGT5;IL18;KYNU;CCL3;GGT7;SLC1A1
prerank,COPII-coated vesicle budding (GO:0090114),-0.27930115743380424,-1.0464419501081066,0.35555555555555557,0.8599911319135672,1.0,24/68,20.89%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;SCAP;TRAPPC9;SEC23B;SEC31B;TRAPPC6A;GOLGA2;SEC24B;TRAPPC2;SEC13;BET1;GOSR2;TRAPPC2L
prerank,negative regulation of transferase activity (GO:0051348),-0.337077761293931,-1.046142962466657,0.3687002652519894,0.8593927983649052,1.0,9/28,16.22%,SMAD7;SRC;TP53;HNRNPU;EIF4A2;MAPT;CERS1;LIMK1;PARK7
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3253684757488388,1.0460736862911912,0.37390029325513197,0.710134203388548,1.0,17/73,18.10%,EGFR;APP;GAS6;CD44;AXIN1;TNF;FNIP1;RIPK2;DOCK7;ATP2B4;TERF2IP;CNOT9;PRKD2;HSP90AB1;SPRY2;IL6;RAF1
prerank,regulation of axon extension (GO:0030516),-0.32052912518291354,-1.046003671283785,0.39295392953929537,0.8583210890197429,1.0,9/37,9.71%,MAP2;PTPRS;DIP2B;ZFYVE27;MACF1;TWF2;OLFM1;MAPT;MAG
prerank,camera-type eye morphogenesis (GO:0048593),0.49096318744652334,1.0442101373144288,0.4324853228962818,0.7138700910085612,1.0,1/10,0.46%,LRP6
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.38370746936520417,-1.0441053244980965,0.38826185101580135,0.8624769886620942,1.0,6/17,9.77%,EIF4G1;CALM2;SMAD7;PARD3;CADM4;SIRT2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.42209638001499783,1.043989332194424,0.4055459272097054,0.7138505151349138,1.0,2/16,8.48%,LILRB1;STX7
prerank,negative regulation of neuron projection development (GO:0010977),-0.2905506426946394,-1.043905262687472,0.35294117647058826,0.861606938122589,1.0,11/56,10.90%,RTN4RL1;MYLIP;PTPRS;NLGN1;PRAG1;BCL11A;GDI1;LINGO1;MAG;EFNB2;SPOCK1
prerank,phospholipid dephosphorylation (GO:0046839),0.3630224128231269,1.0438629065823612,0.3790951638065523,0.7136289072615525,1.0,5/37,5.45%,SGPP1;MTM1;SYNJ1;MTMR3;OCRL
prerank,organelle assembly (GO:0070925),-0.21944961000900245,-1.0438086551832066,0.2236842105263158,0.8604011542558936,1.0,117/385,23.07%,ASAP1;CAPN3;BBS9;BIN2;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;SNF8;DYNC1H1;IRGM;CCDC66;IFT81;TMOD2;ATP6V1D;CENPC;HPS4;IFT140;RAB3IP;ATG2A;DZIP1;CEP162;ATXN2L;IFT88;AUP1;TTC8;CHMP4B;CHMP4A;MAPT;AHI1;ATG16L1;CEP250;CCDC57;HAUS8;IFT20;BBS7;TUBGCP5;OGFOD1;MKS1;CEP63;CENPE;DYNLT2B;WDR19;VPS37A;MAPRE3;SPAG16;DYNC2H1;RAB38;CD34;NEK6;WDR45;KIF3A;NSFL1C;SSX2IP;CIRBP;HAUS7;TUBGCP3;FARP2;MAPRE1;HAUS3;CORO1A;TCTN1;IFT52;MAP1LC3A;CDS1;KIF3B;GABARAPL1;WDR90;ATG9A;SQLE;DLGAP5;CDC14A;ULK1;CDS2;ATXN2;CFAP298;CFAP410;NUDCD3;CENPJ;TRAPPC6A;CPLANE2;NOTCH1;GOLGA2;IFT43;HDAC3;DYNC2I1;EMC6;EHD3;ATG14;B9D2;RCC1;RAB8A;TMEM138;DNAH5;PLA2G3;BBS4;TUBGCP6;CHMP6;ARL3;CEP89;CHMP3;RBM14;WDR45B;IQCB1;HDAC6;TMEM231;MKKS;PRRC2C;G3BP1;FLNA;GALNT11;TMEM17;BSCL2;PTPDC1;EDC3;HAUS2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4126496770980607,-1.0437008392712055,0.4157303370786517,0.8592543407378679,1.0,4/14,8.72%,ATP1B1;ATP1B2;ANK2;ACTN2
prerank,prostaglandin metabolic process (GO:0006693),-0.34135596163923654,-1.043539835995672,0.4030612244897959,0.8582908801378006,1.0,6/26,11.84%,HPGDS;DAGLB;PTGS1;PTGES3;PTGR2;MIF
prerank,inositol lipid-mediated signaling (GO:0048017),-0.2994573606041885,-1.0432832886505716,0.3843843843843844,0.8575720683650955,1.0,11/50,11.24%,PLCL1;ADAP2;PLCB2;PIK3CB;PLCB4;PI4KA;INPP5F;PIK3C2B;CSF1R;PLCB1;PLCH1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.34115357767204213,-1.043217959800856,0.3958333333333333,0.8548075168893238,1.0,11/29,28.14%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPP;CENPN;CENPH;CENPI;MIS18A
prerank,CENP-A containing chromatin organization (GO:0061641),-0.34115357767204213,-1.043217959800856,0.3958333333333333,0.8548075168893238,1.0,11/29,28.14%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPP;CENPN;CENPH;CENPI;MIS18A
prerank,myelin maintenance (GO:0043217),-0.4541550838645245,-1.0423860655453283,0.4148936170212766,0.8559558560880862,1.0,3/10,10.39%,EPB41L3;DEGS1;ABCD2
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.39535316387397756,-1.0422864169387687,0.3891509433962264,0.8547905809031773,1.0,3/15,9.36%,LARGE1;CHST1;CHST2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.34242640525251683,1.0422518609794067,0.38904899135446686,0.7168085704411273,1.0,10/55,8.46%,NUPR1;RPS3;RIPK1;BCL10;GSDME;RACK1;PAK2;BCL2;TNF;TNFSF12
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.37083128331390863,1.0420073045545921,0.38996763754045305,0.7168285073476509,1.0,9/37,10.98%,APP;SPRED1;PRKAG2;AXIN1;S1PR2;UBE2K;RIPK2;CALM1;SPRED2
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.33041635693619326,1.0416563361081448,0.37681159420289856,0.717080052445732,1.0,8/69,6.34%,APOE;LIG4;MEF2C;RASA1;GRN;SNX6;PRKN;BCL2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.39118010605785425,1.041655024915137,0.39932885906040266,0.7165668454028149,1.0,6/27,10.98%,SPRED1;CD44;CD74;MDM2;DYRK1A;SPRED2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.40271050215938925,1.0415138455755542,0.40034364261168387,0.7163694410656104,1.0,5/21,15.58%,PLA2G2D;PLAAT3;OSBPL8;OSBPL10;OSBPL5
prerank,gliogenesis (GO:0042063),-0.4028725113264586,-1.0415101550595478,0.40503432494279173,0.8556791905600937,1.0,2/15,2.58%,CD9;CDH2
prerank,metal ion homeostasis (GO:0055065),-0.3079204358197524,-1.0415005470473886,0.40633245382585753,0.8542643968179308,1.0,8/40,12.80%,SLC12A2;SLC8A1;SLC12A9;KCNA1;TMTC2;SLC7A8;SLC12A6;COX11
prerank,small GTPase mediated signal transduction (GO:0007264),0.31239991016141294,1.0408986075816549,0.40053404539385845,0.7172182004889199,1.0,22/103,14.78%,RGL1;RREB1;RIN2;NRAS;KRAS;SIAH2;ARHGAP18;ARHGAP31;RAPGEF2;GRAP;RB1;NUCB2;GNB1;MAPK14;IGF1;SHC1;RASSF1;NUCB1;NTN1;RALB;RALGDS;USP28
prerank,cAMP biosynthetic process (GO:0006171),-0.44398219075586,-1.04084477501707,0.4004282655246253,0.8547608914641054,1.0,4/10,16.43%,ADCY3;ADCY8;ADCY7;ADCY1
prerank,positive regulation of secretion by cell (GO:1903532),-0.2785050055565523,-1.0407466106104521,0.3680297397769517,0.8536369386236528,1.0,9/70,4.87%,FRMD4A;SLC12A2;CADPS;ABCG1;TREM2;CLASP2;RAB27A;IL1A;GRK2
prerank,dendrite self-avoidance (GO:0070593),-0.38827345293267923,-1.0406215174636655,0.3918269230769231,0.8525601238689281,1.0,6/16,13.60%,PALLD;CNTN4;BSG;CNTN6;CNTN2;DSCAML1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.31863119990308425,1.0401037513521667,0.384297520661157,0.7184755068307002,1.0,15/90,10.91%,IRF4;CMKLR1;CEBPB;ADRB2;CD36;GHRL;ADIPOR2;SYK;CXCR4;CCR2;PDGFC;STAT6;TSHR;HADH;ACHE
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.36652531029798807,1.0400557578971372,0.4081967213114754,0.7180609213546031,1.0,4/35,7.94%,NRP1;SEMA4A;PLXNA4;ARHGDIA
prerank,axoneme assembly (GO:0035082),-0.32810049745781805,-1.03997306260574,0.39690721649484534,0.8531883145567459,1.0,7/31,12.66%,CFAP74;LRGUK;TTC12;CCDC39;SPAG16;TOGARAM1;DNAI4
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.4579483325145697,1.039333259955734,0.3992467043314501,0.7191847939491043,1.0,2/12,1.94%,IQGAP1;JAG1
prerank,ceramide metabolic process (GO:0006672),-0.29697191022021346,-1.0391948200021635,0.41904761904761906,0.854005109499772,1.0,20/49,21.05%,CERK;ST6GALNAC3;SMPD4;PLPP3;NSMAF;ASAH1;ASAH2;CERS4;SAMD8;DEGS1;CERS5;ACER2;CERS1;SGMS2;SPTLC1;SMPD2;TLCD3B;CERS2;ABCA2;PLPP2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4575838143643173,1.0389013276576298,0.42778793418647165,0.7196546797306476,1.0,3/11,15.85%,ITM2B;NECAB2;ITM2C
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.44976609748020235,-1.0387851750153225,0.425,0.8538091936639806,1.0,5/10,23.39%,EMC9;EMC10;EMC1;EMC6;MMGT1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.32932022172921893,-1.0386421214018455,0.37467700258397935,0.8527571131107481,1.0,7/32,3.79%,DLG2;PTK2B;GRIA2;NLGN1;DLG4;DLG3;GRIA4
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4423542884062655,1.038082346768191,0.42526690391459077,0.720996933965721,1.0,5/16,11.99%,MEF2A;ROCK1;MTPN;IGF1;ROCK2
prerank,Golgi to plasma membrane transport (GO:0006893),0.3516139251594539,1.0380204098122652,0.39313572542901715,0.7205993175214368,1.0,8/47,8.59%,RAB31;EXOC6B;SPTBN1;RAB10;STXBP6;EXOC4;RABEP1;GOLPH3L
prerank,positive regulation of protein processing (GO:0010954),0.4300000545807036,1.03774331820445,0.431740614334471,0.7207149539594775,1.0,2/19,4.92%,NLRC4;RHBDD1
prerank,chromatin disassembly (GO:0031498),-0.4171676159591995,-1.0376944005745872,0.4068965517241379,0.8529234430987667,1.0,3/14,4.52%,SMARCB1;SMARCC2;SMARCE1
prerank,nucleosome disassembly (GO:0006337),-0.4171676159591995,-1.0376944005745872,0.4068965517241379,0.8529234430987667,1.0,3/14,4.52%,SMARCB1;SMARCC2;SMARCE1
prerank,modulation by host of symbiont process (GO:0051851),-0.3320581034801843,-1.037668917216442,0.4074074074074074,0.8516017872314234,1.0,17/31,37.59%,CX3CR1;TARDBP;SMARCB1;SAP30BP;CCL3;JUN;HDAC1;NAPEPLD;LEF1;CCNT1;HPN;CARD9;TFAP4;SMARCA4;HMGA2;CCL4;LRRC19
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.2757641954381122,-1.037607678576098,0.40129449838187703,0.8503553265564217,1.0,26/69,30.13%,CDK9;RPAP2;INTS3;RPRD1A;CCNT2;POU2F2;ICE2;SRRT;POLR2C;NCBP1;INTS13;ELL2;ELL;TAF8;POLR2L;TAF9;INTS9;TBP;CCNK;INTS11;CCNT1;INTS7;POLR2I;TAF13;ICE1;SNAPC1
prerank,negative regulation of innate immune response (GO:0045824),0.36989775758316895,1.0375301091257876,0.4076335877862595,0.7206731411225301,1.0,4/34,7.06%,VSIG4;IRAK3;GRN;USP15
prerank,regulation of Golgi organization (GO:1903358),0.4241903740922832,1.037484704738908,0.42201834862385323,0.7202537173206806,1.0,2/17,2.47%,MYO5A;USP6NL
prerank,positive regulation of cell junction assembly (GO:1901890),-0.28076701789305186,-1.0373269880195706,0.3633440514469453,0.8497712717329721,1.0,16/56,16.57%,GRID2;MAP4K4;PTPRD;NLGN1;CNTNAP2;NRXN1;FERMT2;FLOT1;EPHB1;BDNF;SYNDIG1;TSC1;IL1RAPL1;EPHB2;THY1;IL1RAP
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.37216856459030956,-1.0372610331953542,0.4096109839816934,0.8485746050216955,1.0,9/17,39.73%,NOS1AP;AKAP6;VAMP2;KCNAB1;RNF207;KCNG1;ANK3;KCNS1;KCNE4
prerank,negative regulation of lipid storage (GO:0010888),-0.3828213616557911,-1.0371962872266742,0.39351851851851855,0.8473701520312122,1.0,3/19,4.03%,ABCG1;TREM2;ITGB3
prerank,RNA stabilization (GO:0043489),-0.32666472041862793,-1.0368455274302344,0.3883248730964467,0.8470225096989737,1.0,6/33,13.88%,TENT5C;FUS;HNRNPU;TRDMT1;CIRBP;TAF15
prerank,regulation of B cell differentiation (GO:0045577),0.4298857937972273,1.0367563823780377,0.4254937163375224,0.721339160122342,1.0,5/17,10.04%,ZFP36L2;ZFP36L1;PPP2R3C;SYK;SFRP1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.3443147294613222,1.0362449657734853,0.39514978601997147,0.7219933540876209,1.0,3/55,2.35%,LYVE1;HGSNAT;CD44
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3686154024192554,-1.0360488049908727,0.3976190476190476,0.8480146021012257,1.0,4/20,8.68%,PTDSS1;GSS;GATM;PTDSS2
prerank,mitochondrial genome maintenance (GO:0000002),0.4620316005161813,1.0359050005863144,0.4226415094339623,0.7222187427161673,1.0,5/11,19.55%,MEF2A;MGME1;LONP1;SLC25A4;SLC25A36
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.35012136200821653,-1.0356470904634794,0.38875305623471884,0.8478101756091022,1.0,10/24,23.56%,CTC1;SRC;HNRNPU;PARP1;STN1;TERF2;HNRNPA1;GNL3L;ACD;SLX4
prerank,negative regulation of developmental process (GO:0051093),0.33189919547161845,1.0355392952898592,0.3924050632911392,0.7225434755768744,1.0,17/69,16.90%,GAS6;BMP2;PRKN;HEY2;CDK6;SPI1;RC3H1;ROCK1;FOXM1;RPS6KA6;SFRP1;ROCK2;LOXL2;ANP32B;TBX2;BNIP3;ARPIN
prerank,histone mRNA metabolic process (GO:0008334),0.38162494732783003,1.0350907428377008,0.40614886731391586,0.723020559019965,1.0,8/27,16.42%,TUT7;TENT2;CPSF3;TUT4;SNRPG;DCP2;TUT1;CPSF2
prerank,bone development (GO:0060348),0.3593690211881385,1.0350234915818184,0.39365079365079364,0.7226605134669569,1.0,9/39,13.10%,LRP6;RPL13;NOTUM;VKORC1;SULF2;CYP26B1;PTGER4;SLC10A7;GJA1
prerank,negative regulation of cell projection organization (GO:0031345),-0.30371168001467347,-1.0349315471188754,0.4084967320261438,0.8485469173609799,1.0,9/48,10.90%,RTN4RL1;MYLIP;PTPRS;YWHAH;PRAG1;PRNP;MAG;EFNB2;SPOCK1
prerank,protein transport (GO:0015031),0.27602550649872115,1.034516902564763,0.3841059602649007,0.7232970237254155,1.0,50/332,11.15%,APOE;SNX9;TXNIP;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;STEAP3;RCN3;CALCRL;USP6NL;SPTBN1;RILP;CD36;CD74;ATP6V1B1;SNX6;RAB8B;RAB10;SNX27;EHD1;AP3B1;AFM;RIC1;TBC1D14;ATP6V0A1;TMED10;TBC1D2B;RABGAP1L;HFE;PRKCB;CANX;SGSM1;ARRDC3;RAB7A;ATP6V1A;STX7;GOLPH3L;RAB14;RAB1A;CMTM6;RAB23;LAMP2;ARL4A;VLDLR;WLS;SLC10A7;WDR11
prerank,carbohydrate biosynthetic process (GO:0016051),-0.3627738348419034,-1.0343985655679713,0.417607223476298,0.8487266049754569,1.0,7/21,18.40%,ST3GAL6;B3GALT1;B3GALT5;B3GALT2;ST3GAL3;FUT9;ST3GAL2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3317632535667319,1.0337648824782928,0.40416047548291234,0.7243923681970914,1.0,8/61,8.37%,EGFR;RPS3;BABAM2;RGCC;USP9X;BRCC3;CEBPG;ATRX
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3379925138799142,-1.0333100610390955,0.41494845360824745,0.8504942288314434,1.0,16/30,30.90%,DDX5;TP53;STK11;MYO6;MDM4;ACER2;FHIT;PYCARD;SESN2;USP10;GREM1;PDK2;PMAIP1;RRP8;E2F7;MYBBP1A
prerank,organic substance transport (GO:0071702),0.3049736157371838,1.0333067825859685,0.3969849246231156,0.7249516965172504,1.0,27/121,18.80%,PLTP;TXNIP;RCN3;CALCRL;RILP;SLC22A18;ABCA9;TCN2;ABCA6;ARRDC3;RAB7A;CMTM6;DISP1;RAMP2;GM2A;SLC6A2;MFSD2A;SLC23A1;SNX4;CLN8;HSP90B1;MIA3;SLC35F3;SLCO2A1;CHKA;ABCA4;TOM1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.38945146237079215,-1.032845799180774,0.41855203619909503,0.8504336364693234,1.0,5/15,11.81%,TJP1;FGF2;PKM;ITGA5;PDPK1
prerank,negative regulation of neuron death (GO:1901215),0.3142984199457649,1.032532014551216,0.3917963224893918,0.7261238622279171,1.0,12/93,6.34%,APOE;LIG4;MEF2C;RASA1;TNFRSF1B;GRN;SNX6;PRKN;KIR3DL2;GSK3B;CD200R1;BCL2
prerank,Golgi inheritance (GO:0048313),0.46551712459317784,1.0323306464506987,0.43873517786561267,0.7260732773096032,1.0,2/11,8.51%,VCPIP1;VRK1
prerank,photoreceptor cell development (GO:0042461),0.4321519019760911,1.032236163313814,0.40150093808630394,0.725769337802377,1.0,3/14,13.88%,RP1;MYO7A;MFSD2A
prerank,neuronal action potential (GO:0019228),-0.36311503281336266,-1.0321161723716343,0.41363636363636364,0.8513018072004586,1.0,9/22,40.30%,KCNA1;KCNA2;SCN8A;SCN1A;CACNA1H;MYH14;CACNA1G;ANK3;SCN10A
prerank,Wnt signaling pathway (GO:0016055),0.31248036121173983,1.0320606240244015,0.4117647058823529,0.725628359572636,1.0,14/92,10.55%,LRP6;TCF7L2;RARG;RPS27A;WNT2;AXIN1;GSK3B;SNX3;FRAT1;TCF7;WNT6;NR4A2;SFRP1;WLS
prerank,GTP metabolic process (GO:0046039),0.44213004499028596,1.030877350968837,0.4166666666666667,0.7278105198305027,1.0,7/15,19.35%,GNAI3;IMPDH2;RAB23;GTPBP1;EFL1;AK3;AK4
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.37913175839054364,-1.0308277028172077,0.410958904109589,0.8538014245552303,1.0,6/16,15.51%,LARGE1;ST3GAL5;ST6GALNAC3;ST6GALNAC4;ST8SIA1;ST8SIA3
prerank,regulation of gluconeogenesis (GO:0006111),0.383576308211089,1.0307936990919049,0.42105263157894735,0.7274984488649182,1.0,5/27,14.00%,C1QTNF3;C1QTNF12;GNMT;ARPP19;EP300
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.37963931729339895,-1.0305923153478018,0.42168674698795183,0.853130752335265,1.0,4/17,10.63%,FGF2;BTG1;AHI1;TMEM100
prerank,ganglioside biosynthetic process (GO:0001574),0.437706400602649,1.0304648905821971,0.4375,0.7277473089869619,1.0,3/15,4.20%,ST8SIA4;ST3GAL1;B4GALT6
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3710417402567122,1.0304498256576955,0.42225859247135844,0.7272728950607702,1.0,9/34,11.15%,RGCC;RB1;INSR;CDC27;NSMCE2;CUL3;IGF1;NUP62;PHIP
prerank,melanosome organization (GO:0032438),-0.3453975167005422,-1.0303413567353572,0.41968911917098445,0.8524579329274937,1.0,6/26,10.65%,LYST;HPS4;AP3D1;AP1M1;SHROOM2;RAB38
prerank,protein-containing complex assembly (GO:0065003),0.27928393472443547,1.0302905461915721,0.39815880322209435,0.7271260812938068,1.0,35/259,9.68%,HGSNAT;P2RX7;TCF7L2;CTSC;SNX9;TLE4;KMT2A;REPS2;ANO6;MITF;RIPK1;CD74;SKAP2;AXIN1;ITGB1BP1;MCU;GSK3B;WIPF1;ST13;TMED10;TCF7;CD40;DARS1;TNF;HFE;CDC73;ASH2L;TUBGCP2;RANBP9;TRAPPC4;MDM2;TFG;TRAPPC10;RAB1A;CUL3
prerank,cell differentiation in spinal cord (GO:0021515),-0.4408413153261599,-1.029981351470694,0.40524193548387094,0.8521931569214857,1.0,2/10,11.69%,MDGA2;SOX13
prerank,negative regulation of leukocyte activation (GO:0002695),0.4271902722197862,1.0296186919976054,0.43853211009174314,0.7280867978783168,1.0,2/15,3.26%,FCGR2B;GRN
prerank,regulation of protein kinase C signaling (GO:0090036),0.44632392133982995,1.0295161330257332,0.4218455743879473,0.7278064717594319,1.0,3/14,8.64%,MYADM;CD40;ADRA1A
prerank,positive regulation of ERAD pathway (GO:1904294),-0.41714759408421775,-1.0293398595779053,0.4144736842105263,0.8527755717459422,1.0,7/13,27.02%,TMEM259;BAG6;BCAP31;RNFT1;UBQLN1;SGTA;UBQLN2
prerank,proteoglycan biosynthetic process (GO:0030166),-0.32672634751213875,-1.0290344306485608,0.3897849462365591,0.8523318157849137,1.0,14/31,24.47%,CHST11;EXTL3;XYLT1;BMPR1B;CANT1;GAL3ST4;HS3ST3B1;B4GALT7;PXYLP1;CHST10;UGDH;B3GALT6;B3GAT1;GLCE
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.28228554733744865,-1.0287590083386182,0.3848684210526316,0.8504347509955682,1.0,22/56,31.25%,NUBPL;TMEM126A;NDUFAF6;NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;TIMM21;ECSIT;NDUFAB1;NDUFS1;NDUFAF8;ACAD9;NDUFA6;DMAC2;NDUFAF3;NDUFV2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.28228554733744865,-1.0287590083386182,0.3848684210526316,0.8504347509955682,1.0,22/56,31.25%,NUBPL;TMEM126A;NDUFAF6;NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;TIMM21;ECSIT;NDUFAB1;NDUFS1;NDUFAF8;ACAD9;NDUFA6;DMAC2;NDUFAF3;NDUFV2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.31117542329066095,-1.0287518813263619,0.384180790960452,0.8490903351011783,1.0,9/37,10.39%,SIRPA;PLD4;TREM2;CUEDC2;PDCD4;APOD;APPL1;ADCY7;ABCD2
prerank,cholesterol efflux (GO:0033344),0.414507451013524,1.0284788416261705,0.42245989304812837,0.7295230849762604,1.0,1/20,0.49%,APOE
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4081215381968887,1.0284429141824065,0.42280701754385963,0.7290813906844557,1.0,6/20,11.05%,NUPR1;RIPK1;PELI1;BIRC3;SDCBP;CASP8
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.44397245711583394,-1.028427452959355,0.421505376344086,0.8472953190141059,1.0,1/10,7.69%,CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.44397245711583394,-1.028427452959355,0.421505376344086,0.8472953190141059,1.0,1/10,7.69%,CEP250
prerank,piRNA metabolic process (GO:0034587),0.41328245290151416,1.0278845090301658,0.427536231884058,0.729869140702755,1.0,4/19,23.02%,MOV10L1;PIWIL2;TEX15;TDRKH
prerank,retinoid metabolic process (GO:0001523),0.3252125780935732,1.027226340201788,0.40611961057023643,0.7308853256343,1.0,14/71,18.29%,APOE;DHRS3;UGT1A7;UGT1A8;UGT1A1;SDC3;SDC4;CYP26B1;RBP4;GPC3;SCPEP1;RDH5;RBP1;ABCA4
prerank,regulation of axonogenesis (GO:0050770),-0.28832469387124054,-1.027223832304051,0.4027777777777778,0.8495286036431042,1.0,21/51,22.66%,ROBO2;PAK1;CDH2;LRRC4C;PLXNA2;ROBO1;GDI1;MAP6;LINGO1;TIAM1;MAG;TIAM2;OMG;THY1;BRSK2;PAK3;PLXNB2;PLXNB3;BRSK1;PLXNB1;CHODL
prerank,spindle assembly (GO:0051225),-0.27564862769575355,-1.0271368014327407,0.3954248366013072,0.8484084248435934,1.0,30/67,23.07%,CLASP2;CEP192;HAUS8;TUBGCP5;CEP63;MAPRE3;NEK6;WRAP73;KIF11;TOGARAM1;HAUS7;NUMA1;TUBGCP3;MAPRE1;HAUS3;CHEK2;KIF3B;KIFC2;KIF2A;GOLGA2;HDAC3;BCCIP;AAAS;RCC1;TUBGCP6;KIFC1;TOGARAM2;FLNA;MAP9;HAUS2
prerank,cellular component disassembly (GO:0022411),-0.297896024028791,-1.0268839516099728,0.3896551724137931,0.8478229220786162,1.0,24/53,36.07%,KLK2;TLL1;FLOT1;CTSS;BSG;ADAMTS4;MMP16;SCUBE1;ADAM8;ADAM10;FURIN;CTSK;A2M;DYRK3;MMP15;CAPNS1;MMP14;HTRA1;TLL2;KIF9;MMP8;ADAMTS15;TIMP1;CAPN1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.2322244998818674,-1.026277055149963,0.4098360655737705,0.8482899002202281,1.0,58/185,25.63%,CSNK1E;ANAPC15;SDCCAG8;CEP135;ODF2;HECW2;DYNC1H1;SKP1;PSMD13;CEP192;PSMD12;APPL1;CEP250;HAUS8;CEP63;CENPE;ERCC2;PSMD9;SIRT2;CCP110;NEK6;ANAPC11;UBE2S;PSME3;HAUS7;CKAP5;MAPRE1;HAUS3;BUB1B;PSMA4;PSMD8;PSMF1;PSMD4;CDC14A;UBE2E1;RIOK2;NEK11;ID2;UBE2D1;PSMB8;CENPJ;PSME1;UBB;ANAPC5;DCTN2;HMMR;ZW10;CNTRL;HAUS2;DCTN1;KIF14;PLK4;PSMC2;CDK1;HAUS6;MAD2L1;YWHAG;PSMB10
prerank,steroid catabolic process (GO:0006706),-0.43981250201190936,-1.026226634845657,0.44420600858369097,0.8470979742242529,1.0,2/10,3.23%,YWHAH;SPP1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3710736583434727,1.0260426149446047,0.42356687898089174,0.7329877620914637,1.0,8/36,8.50%,DEPTOR;SGMS1;RPS3;RB1;BCL2;TNF;NR4A2;MAPK8IP2
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.36780805975266,1.0259164129114704,0.4264705882352941,0.7327725989032152,1.0,8/34,10.28%,MEF2C;GSK3B;MPP2;CHRNA4;MAPK8IP2;INSYN2A;GRIN2D;GABRA3
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3845282603617992,-1.0256991162006692,0.42857142857142855,0.8473912483885718,1.0,9/16,49.71%,SOX5;TGFB2;FOXC1;PTN;SOX6;DHX36;SP7;TCF15;RBM24
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.435785771393831,-1.0254309000194983,0.4475374732334047,0.8468856559275313,1.0,4/11,10.36%,F11R;TJP1;TJP2;AFDN
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3901750735616295,1.0251667856101068,0.41442953020134227,0.7339463065785543,1.0,5/27,11.84%,AHNAK;PDE4D;PLN;CALM1;YWHAE
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3909100178113616,1.0248988857928814,0.411864406779661,0.7340479394236253,1.0,8/24,18.42%,FCER1G;B2M;MFSD6;HFE;CANX;SEC24D;ERAP1;TAPBP
prerank,cell cycle checkpoint signaling (GO:0000075),-0.4228896675433801,-1.024793305606137,0.4406047516198704,0.8474958837052097,1.0,5/12,22.72%,WEE1;BUB1B;BUB1;ZW10;ZWINT
prerank,phosphatidylcholine catabolic process (GO:0034638),0.476498057366577,1.0246483888859927,0.43529411764705883,0.7341299949925433,1.0,2/10,4.93%,PLA2G7;PNPLA8
prerank,organelle organization (GO:0006996),0.2700918287243515,1.0241788155647953,0.42872687704026113,0.7346444413773002,1.0,81/388,16.88%,TMCC1;FGD4;NEDD9;APOE;FGD6;DIAPH1;EPS15;RAB31;ATL1;LIG4;ATXN7;USP6NL;ARHGAP21;ARHGAP10;CDC42;ATP8B4;PRKN;TTC29;ATP7A;TMED10;PI4K2B;DPYSL2;PIKFYVE;PEX7;CNN2;CYP26C1;VPS4B;NIPSNAP2;GEM;RAB7A;CCL24;STX7;LIMD1;GOLPH3L;RANBP9;RAB14;RAB30;CLASP1;MAST1;CYCS;KIF4A;RAB1A;CENPT;POLG2;MTX1;PACSIN2;CHMP5;PHIP;VPS13C;FAM161B;CHGA;VAPA;BCAS3;PYROXD2;DIAPH3;LARP4;WASL;MDK;PDZD8;SPTBN5;CEP78;PLAAT3;TMED2;PKD2;SIPA1L3;PPIA;SYNE3;MYC;REEP6;PEX14;FGD3;VPS51;HCFC1;COG7;FAM161A;SEC16A;RAB32;MIA3;GOLPH3;PRDX3;CUL7
prerank,muscle tissue morphogenesis (GO:0060415),0.423497558274612,1.0241027102465268,0.44680851063829785,0.7343079454090431,1.0,2/16,4.49%,BMP2;HEY2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.41195143459740746,1.0240728604382716,0.4346978557504873,0.7338600269892677,1.0,7/19,21.48%,RGCC;VIM;EMILIN1;CREB3L1;IL6;F2R;CIITA
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.46799234998736766,1.0240028220871735,0.43021032504780116,0.7334880207973888,1.0,2/11,8.07%,PRKN;FYN
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4553408573727332,1.0239431644481134,0.42988929889298894,0.7331120632830082,1.0,3/12,5.71%,RAB10;CELSR1;ACTB
prerank,positive regulation of innate immune response (GO:0045089),0.37170922156940894,1.0238045513976775,0.40842787682333875,0.732925703519764,1.0,6/30,12.63%,TLR8;LBP;SPI1;RIOK3;UBE2K;POLR3D
prerank,negative regulation of cell cycle (GO:0045786),0.32467081138902526,1.023801326291054,0.39917127071823205,0.7324249458837928,1.0,17/73,17.23%,NUPR1;BMP2;LILRB1;HECA;DUSP1;CDK6;RB1;PTPRK;NR4A1;GMNN;PPP1R13B;LATS2;NPPC;RUNX3;HEXIM2;PTEN;NR2F2
prerank,regulation of translation (GO:0006417),0.2881929967364578,1.0234476698878534,0.4141791044776119,0.7326741842496951,1.0,54/173,21.17%,APP;RPS3;DAPK1;EIF3E;SAMD4A;NIBAN1;RPL26;RPS6KA3;VIM;MRPL13;RACK1;RPS4X;HSPB1;MTPN;RPL5;MALSU1;LARP4B;RBM4;EIF1;ILF3;DDX6;EIF4B;NANOS3;FOXO3;RPL10;TRIM71;ETF1;LARP4;PIWIL2;SHMT1;CNOT9;EIF3H;EIF5;CSDE1;TRAP1;SYNCRIP;IL6;PYM1;METAP1;NSUN3;EIF2AK4;RNF139;EIF2AK2;GSPT1;BCL3;EIF2AK3;CNOT1;CNOT8;GIGYF2;ENC1;DAPK3;IGF2BP3;MTRF1;PUS7
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.36503002190889694,-1.0232994500881658,0.4250559284116331,0.850644744762467,1.0,7/20,18.40%,ST3GAL6;B3GALT1;B3GALT5;B3GALT2;ST3GAL3;FUT9;ST3GAL2
prerank,positive regulation of cell growth (GO:0030307),-0.26079543150907486,-1.0231480790406033,0.4,0.849705016711243,1.0,24/96,16.15%,TGFBR1;RPTOR;SEMA4D;RIMS1;EIF4G1;RIMS2;HDGFL2;ZFYVE27;MACF1;RPS6KA1;AKAP6;TWF2;BDNF;MAPT;EXOSC9;HYAL1;DDX49;FXN;LGI1;LIMK1;NCBP1;PABIR1;ADAM10;CDKL5
prerank,actin filament-based transport (GO:0099515),0.40364652055463573,1.02313360173889,0.4223385689354276,0.7328903916241344,1.0,6/21,14.11%,MYO5A;SYNE2;MYO7A;MYO1E;MYO1C;WASL
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.31738429895287235,-1.0223607076058792,0.4297297297297297,0.850693888696321,1.0,12/33,21.76%,CTC1;STN1;ANKRD28;PTGES3;TNKS1BP1;TERF2;GAR1;DCLRE1B;RFC1;WRAP53;RAD51;ACD
prerank,regulation of neuron death (GO:1901214),0.31401623440157544,1.0223059115071793,0.4199438202247191,0.7342776822108218,1.0,9/82,5.09%,FCGR2B;MAP3K5;C1QA;MEF2C;TNFRSF1B;PRKN;KIR3DL2;GSK3B;CD200R1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.27027237186790787,-1.0222516019817955,0.40875912408759124,0.8496886230886048,1.0,18/76,15.62%,IRAK2;HAVCR2;CYLD;OTULIN;COMMD7;CCDC22;DAP;ARRB2;DDIT3;PRMT2;PARP10;NLRC5;MTURN;CD200;ADORA3;PYDC1;ITCH;CDK5RAP3
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3655197989191227,1.0220526454809797,0.41347626339969373,0.734335956505969,1.0,6/37,8.96%,NUPR1;RPS3;GSDME;RACK1;BCL2;RPS7
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3941838162055479,1.0218842025496107,0.4280936454849498,0.73374630032585,1.0,7/23,12.57%,YWHAQ;SFN;BCL2;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3941838162055479,1.0218842025496107,0.4280936454849498,0.73374630032585,1.0,7/23,12.57%,YWHAQ;SFN;BCL2;TFDP1;CASP8;YWHAE;PPP1R13B
prerank,negative regulation of endopeptidase activity (GO:0010951),0.34508425457046266,1.0210955994988185,0.4170403587443946,0.7350218196791702,1.0,2/47,1.51%,SERPINB8;SERPINB2
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.4257577551147173,-1.0210710178912188,0.4551422319474836,0.8518983839264923,1.0,3/12,4.86%,PTK2B;ANK2;UBASH3B
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3052053975903011,-1.0209828942658,0.4117647058823529,0.8508136540578078,1.0,9/39,10.98%,PIK3CB;GNAS;PLPP3;ITGB3;UBASH3B;TJP2;P2RY12;FERMT3;TLN1
prerank,positive regulation of cell development (GO:0010720),-0.3206235994962148,-1.0206694493740676,0.4371584699453552,0.850364622622951,1.0,5/31,11.23%,CX3CR1;NUMB;TGM2;NUMBL;PDE3A
prerank,positive regulation of intracellular transport (GO:0032388),-0.3069587788883168,-1.0206012130383153,0.3960674157303371,0.8492676414550234,1.0,11/38,13.18%,SORL1;PRR5L;DYNC1H1;STX18;STK11;ACTN2;PLK3;ZFAND1;NUMA1;TBC1D20;VAMP2
prerank,peptidyl-threonine modification (GO:0018210),-0.27846746960924107,-1.0204928704176763,0.3875432525951557,0.848243350091271,1.0,24/66,22.36%,TGFBR1;PRKCD;GALNT3;ACVR1;CDC42BPA;CIT;GALNT13;MAP3K12;DYRK2;WNK3;PDPK1;CDC42BPB;DYRK1B;TGFBR2;GALNTL6;CDK10;ACVR1B;ULK1;HIPK1;CAMK2D;MAPK8;TAF1;DYRK4;GALNT11
prerank,fatty acid catabolic process (GO:0009062),-0.26769544953578467,-1.0204231461357625,0.43174603174603177,0.8471281931633698,1.0,26/67,30.12%,LPIN2;ACAD10;PHYH;ECHS1;ACADL;PCCB;AIG1;MMUT;ABCD2;ACADM;MTLN;FAAH;SLC27A2;ECI2;ILVBL;HACL1;SLC27A4;HSD17B10;CPT2;ACADVL;PECR;ACOT8;ABHD2;PCCA;MCEE;ECI1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3081222107455209,1.0203439681160096,0.42090784044016505,0.7361749948178545,1.0,16/91,10.93%,APP;CP;HMOX1;FTL;NDFIP1;SMAD4;ATP7A;FBXL5;GLRX3;HFE;HMOX2;ATP6V1A;ACO1;NUBP1;SLC39A12;FTH1
prerank,glycerolipid metabolic process (GO:0046486),-0.41871821459983827,-1.0198650238588973,0.4326710816777042,0.8474624461058852,1.0,5/11,30.66%,DGKB;DGKZ;DGKG;DGKA;DGKQ
prerank,regulation of neurotransmitter secretion (GO:0046928),0.366965346402364,1.0198031083080261,0.4200680272108844,0.7368468070835902,1.0,4/32,7.81%,MCTP1;MEF2C;GSK3B;MCTP2
prerank,regulation of synapse assembly (GO:0051963),0.3419303372014765,1.019693234555098,0.4071207430340557,0.7366038788257938,1.0,5/46,4.90%,PDLIM5;APP;MEF2C;TLR2;GHRL
prerank,bicellular tight junction assembly (GO:0070830),-0.30304032499317346,-1.019459445814591,0.40350877192982454,0.8473902678458055,1.0,4/46,2.60%,F11R;TBCD;PARD3;CLDN11
prerank,regulation of autophagy (GO:0010506),0.28401017143338997,1.0192500141842282,0.43411764705882355,0.7370899120570944,1.0,55/216,18.23%,FBXW7;PRKAG2;NUPR1;DAPK1;PTPN22;EEF1A1;ATP6V1B1;PRKAG3;LAMP3;ERN1;SNX6;TRIM65;PRKN;MTMR3;MCL1;GSK3B;ROCK1;TBC1D14;ATP6V0A1;BCL2;HSPB1;DRAM1;EXOC4;DRAM2;ATF6;TRIM68;PIK3C2A;ATP6V1A;TRIM27;SMCR8;TPCN1;SREBF2;FOXK2;FOXO3;LAMTOR5;SNX5;ZC3H12A;FOXK1;FOXO1;RUBCN;MID2;STAT3;EP300;VPS26A;RB1CC1;NPRL2;EXOC8;ATP6V0D1;BNIP3;TAB3;HGF;PIP4K2A;WDR41;RHEB;RRAGC
prerank,regulation of DNA metabolic process (GO:0051052),-0.3041054721673999,-1.0186770242413856,0.4350282485875706,0.8485036955351516,1.0,8/44,8.76%,CDK9;XRCC5;THOC1;HDAC8;IL7R;SIRT7;TOM1L1;UPF1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.4219702357524356,1.0182109873723229,0.42758620689655175,0.7388190606429287,1.0,4/18,6.94%,ITGA4;ITGB1;ROCK1;TNF
prerank,regulation of response to cytokine stimulus (GO:0060759),0.41286996562835265,1.0174044507576074,0.4488734835355286,0.7400946560448748,1.0,5/19,10.75%,LIFR;CBFB;KLF4;SH2B3;ELF1
prerank,extracellular matrix disassembly (GO:0022617),-0.29813866564404234,-1.0173638849283486,0.4186851211072664,0.8510322831576264,1.0,24/53,36.07%,KLK2;TLL1;FLOT1;CTSS;BSG;ADAMTS4;MMP16;SCUBE1;ADAM8;ADAM10;FURIN;CTSK;A2M;HPN;MMP15;CAPNS1;MMP14;HTRA1;TLL2;KIF9;MMP8;ADAMTS15;TIMP1;CAPN1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.32923132903878044,-1.0172964339461972,0.43356643356643354,0.8499118261111369,1.0,9/26,22.86%,IL1A;SULF1;BRCA1;SARS1;HPSE;ATF4;CCBE1;TGFB1;HIF1A
prerank,positive regulation of protein deacetylation (GO:0090312),-0.4012893395071181,-1.0169459514280137,0.4369747899159664,0.8496526830228144,1.0,5/14,23.54%,AKAP8L;SAP30BP;AKAP8;FNTA;CTBP1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.4018491582501845,-1.016625109772856,0.4409282700421941,0.8492999282352972,1.0,9/14,37.49%,ENTPD6;ADPRM;NUDT1;ENTPD3;NUDT16;NUDT5;ENTPD2;ENTPD5;NUDT15
prerank,cell proliferation in forebrain (GO:0021846),-0.4452387611742649,-1.0163041739570142,0.4535637149028078,0.8489468926870604,1.0,5/10,27.92%,NUMB;NUMBL;AKNA;KIF14;WNT7A
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3970112847849365,1.0162370813184636,0.43865546218487395,0.7421744418545833,1.0,4/21,9.08%,RASSF2;RACK1;PDE4D;CNKSR3
prerank,phagosome maturation (GO:0090382),-0.31188664440206276,-1.016125912935892,0.425,0.8481693545424176,1.0,12/35,15.53%,TCIRG1;ATP6V1C1;ATP6V0A2;ATP6V1D;ATP6V1H;ATP6V1G1;ATP6V0B;RAB38;ATP6V0D2;ATP6V0C;CORO1A;RAB20
prerank,sulfate transport (GO:0008272),0.4302116589019518,1.0160945596485897,0.43189964157706096,0.7419905229343434,1.0,8/14,26.84%,SLC26A11;SLC26A7;SLC25A30;RACGAP1;SLC13A4;SLC26A8;SLC25A11;SLC26A2
prerank,SNARE complex assembly (GO:0035493),0.4697590616956959,1.0158616016921749,0.45136186770428016,0.7419775357993225,1.0,2/10,5.50%,UVRAG;STXBP6
prerank,negative regulation of cell differentiation (GO:0045596),0.2871892501900843,1.0158567908589433,0.42771804062126645,0.7414808188224774,1.0,24/181,10.04%,EGFR;SPRED1;ZBTB16;ZFP36L2;JAG1;CRIM1;TNN;OSR1;XDH;FGF23;IL17RD;CDK6;TRIO;RB1;GDF10;TNF;CDC73;VASN;LIMD1;ESRRB;ASXL1;USF3;PPP2CA;SFRP1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4335508965956368,-1.0158383471011192,0.44349680170575695,0.8464228795373857,1.0,3/10,6.29%,PRKCD;PLA2G6;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4335508965956368,-1.0158383471011192,0.44349680170575695,0.8464228795373857,1.0,3/10,6.29%,PRKCD;PLA2G6;NSMAF
prerank,positive regulation of glucose import (GO:0046326),0.39369523588439576,1.0153332156502923,0.44763513513513514,0.7421169166830796,1.0,6/21,14.84%,C1QTNF12;IRS2;INSR;IGF1;ARPP19;OSBPL8
prerank,regulation of osteoblast differentiation (GO:0045667),0.3129280081304419,1.0150813356263777,0.4326530612244898,0.7421537930790245,1.0,13/82,9.90%,NELL1;MEF2C;CRIM1;TNN;BMP2;FGF23;CDK6;GDF10;ACVR2A;IL6R;LIMD1;DDR2;IGF1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3531175678487275,1.0149317583921278,0.43119266055045874,0.7419624487168321,1.0,7/39,9.55%,CASK;JAG1;RASA1;RHOA;ITGB1BP1;RCC2;CORO1C
prerank,regulation of cell motility (GO:2000145),0.298115831975975,1.0148437789716038,0.4313222079589217,0.7416584595022152,1.0,16/121,8.80%,EGFR;SGK3;DIAPH1;FGF23;ARHGAP18;CCL19;CRK;PLXNC1;RHOA;CDK6;PKN2;ROCK1;TRIM32;PLXNA4;AMOT;RCC2
prerank,membrane repolarization during action potential (GO:0086011),-0.4054156370527361,-1.0144486608365657,0.437219730941704,0.8492292240782859,1.0,2/13,2.08%,KCNJ2;ATP1B1
prerank,fluid transport (GO:0042044),-0.4224495462097041,-1.0141879176496704,0.4605263157894737,0.8487420625355062,1.0,4/12,49.88%,PDPN;AQP4;AQP1;SLC4A11
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.4306609515154364,1.0139815371807475,0.4460431654676259,0.743033413359427,1.0,2/15,6.92%,FGFR1;HSPB1
prerank,dicarboxylic acid transport (GO:0006835),0.3800741289661122,1.0139002438434175,0.4097331240188383,0.7427159283743081,1.0,1/28,0.22%,FOLR2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3988077719609523,1.0135988567135144,0.4409722222222222,0.7429183554938847,1.0,9/22,17.88%,LYN;TNF;RANBP9;SP1;ROCK2;RELA;IFNGR1;PICALM;EFNA1
prerank,cytoskeleton organization (GO:0007010),0.29730431993043094,1.013477516233166,0.42912873862158646,0.7426825417941536,1.0,25/114,15.07%,FGD4;NEDD9;APOE;FGD6;DIAPH1;ARHGAP10;RHOA;DPYSL2;PPP2R3C;CNN2;RHOBTB1;CCL24;LIMD1;RANBP9;MAST1;PACSIN2;PHIP;DIAPH3;LARP4;RND3;RHOC;MDK;PDZD8;SIPA1L3;SYNE3
prerank,positive regulation of vascular permeability (GO:0043117),-0.42092289763140145,-1.0134738392167324,0.45295404814004375,0.8496195265936338,1.0,7/12,30.18%,TJP1;TJP2;PDE3A;TGFB1;ANGPT1;OCLN;TJP3
prerank,leukocyte tethering or rolling (GO:0050901),0.42208448113401925,1.0132692239159986,0.4518900343642612,0.7426224084818969,1.0,4/17,6.94%,ITGA4;ITGB1;ROCK1;TNF
prerank,peroxisomal membrane transport (GO:0015919),0.38993834123374616,1.0132070575772936,0.4444444444444444,0.7422454675712598,1.0,5/27,6.62%,RAB8B;SLC25A17;PXMP2;PEX7;PEX26
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.40850605173242194,-1.0129478369105422,0.4617067833698031,0.8498279785951076,1.0,10/13,53.13%,CAMK4;ADAM8;TESPA1;BMP4;SHH;SOD1;TOX;VNN1;ZC3H8;CLPTM1
prerank,ncRNA metabolic process (GO:0034660),0.3590813231880714,1.012923128058765,0.43042071197411,0.7423812639914,1.0,7/37,13.53%,PRKRA;MOV10L1;TUT7;DROSHA;TUT4;TRIM71;PIWIL2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3804999803346288,1.0127907081178738,0.44194107452339687,0.7421697926735935,1.0,5/26,12.32%,CHP2;GSK3B;TNF;IGF1;ATP2B4
prerank,stress fiber assembly (GO:0043149),0.4248047350913039,1.0121946053416553,0.43189964157706096,0.7424358366878218,1.0,6/15,10.21%,ITGB1;RHOA;PDLIM1;FHDC1;CUL3;ARRB1
prerank,contractile actin filament bundle assembly (GO:0030038),0.4248047350913039,1.0121946053416553,0.43189964157706096,0.7424358366878218,1.0,6/15,10.21%,ITGB1;RHOA;PDLIM1;FHDC1;CUL3;ARRB1
prerank,catecholamine metabolic process (GO:0006584),0.43645002687661827,1.0121698442291966,0.44655172413793104,0.7419897201357917,1.0,3/14,5.58%,DRD1;PRKN;ATP7A
prerank,ERAD pathway (GO:0036503),-0.2594468469922482,-1.0121687817575002,0.4,0.8507605054704203,1.0,38/83,27.85%,TMEM67;MAN1B1;UBE4A;AUP1;USP19;RNF103;BAG6;DNAJB2;EDEM1;UFD1;FBXO44;UBXN4;UBE2J1;NPLOC4;ECPAS;TRIM13;DNAJB14;ERLEC1;RNF5;BRSK2;GET4;STUB1;SYVN1;FAM8A1;SELENOS;RNF103-CHMP3;TMEM129;TOR1A;FOXRED2;FAF2;UBQLN1;YOD1;SEC61B;SGTA;DNAJC18;UBQLN2;UBE2G2;FBXO2
prerank,focal adhesion assembly (GO:0048041),0.4049930228099466,1.0119938394025652,0.41843971631205673,0.7418758052879382,1.0,5/21,10.22%,PEAK1;PTPRK;RCC2;PIP5K1A;THSD1
prerank,development of primary male sexual characteristics (GO:0046546),-0.3106896514690587,-1.0116019940973855,0.43041237113402064,0.8510070185316884,1.0,8/34,20.22%,LHFPL2;AR;NCOA4;WNT4;MSH2;TGFB2;COL9A3;WNT5A
prerank,regulation of erythrocyte differentiation (GO:0045646),0.36521424567302185,1.0113459308580643,0.44598765432098764,0.742780862280706,1.0,12/35,18.21%,LYN;ZFP36L1;CDK6;SPI1;ACVR2A;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;MAFB
prerank,sensory perception of taste (GO:0050909),0.45907096670795056,1.0112112527699746,0.44696969696969696,0.7425983026766435,1.0,2/10,14.58%,CD36;PKD2L1
prerank,neuron projection regeneration (GO:0031102),-0.4356828642512375,-1.0103676673855104,0.44565217391304346,0.853386685207766,1.0,1/10,0.26%,RTN4RL1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.31047250235274704,-1.0095044942426608,0.44352617079889806,0.8545393216202675,1.0,6/38,8.72%,KCNMA1;KCNJ2;NOS1AP;ANK2;AKAP6;ACTN2
prerank,protein homooligomerization (GO:0051260),0.2995362842665951,1.0094236267021448,0.43546284224250326,0.7460553880149777,1.0,22/114,15.92%,NLRC4;EHD4;ATL1;ALOX5AP;B2M;EHD1;BCL10;MPP2;CLYBL;NINJ1;BEND3;USP16;GNMT;TRPM2;DISP1;TRMT61B;SHMT1;PKD2L1;PKD2;PRMT1;SAMHD1;MLKL
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4687705902983264,1.009270699486029,0.46313799621928164,0.7458933374524112,1.0,3/11,12.19%,MAP3K5;STK24;DIABLO
prerank,cholesterol metabolic process (GO:0008203),0.31799305288205076,1.0089705003214937,0.4586255259467041,0.746049658113167,1.0,17/68,20.78%,APOE;HMGCR;SCARF1;CLN6;CYP27A1;PMVK;OSBPL1A;HSD17B7;LBR;CLN8;OSBPL5;CEL;FDPS;DHCR7;PIP4P1;NSDHL;ACLY
prerank,regulation of microtubule-based process (GO:0032886),-0.30533222358628154,-1.0088237202093062,0.41192411924119243,0.8552069146427483,1.0,10/36,13.33%,EFNA5;CYLD;CLASP2;MACF1;MAPT;BICD2;MAP6;PHLDB1;TPPP;EPHA3
prerank,positive regulation of autophagy (GO:0010508),0.31377519420723565,1.0083952533806335,0.4297297297297297,0.7467873224529818,1.0,21/81,16.79%,DAPK1;SESN1;GNAI3;WAC;TRIM65;PRKN;GSK3B;CAMKK2;ROCK1;ATF6;TRIM68;PIK3C2A;TRIM27;TPCN1;FOXO3;ZC3H12A;FOXO1;MID2;NPRL2;PAFAH1B2;BNIP3
prerank,negative regulation of defense response to virus (GO:0050687),-0.44131630462069016,-1.0083369027206344,0.46808510638297873,0.8553367447645218,1.0,8/10,31.84%,C1QBP;ITCH;PCBP2;MUL1;TARBP2;ILRUN;TRAF3IP1;TSPAN6
prerank,inositol phosphate metabolic process (GO:0043647),-0.2951752319560917,-1.0083128721481522,0.4221556886227545,0.8541047559468011,1.0,10/46,11.24%,INPP4B;INPP5D;PLCB2;PLD4;PLCB4;FGF2;PLCG1;MINPP1;PLCB1;PLCH1
prerank,regulation of postsynapse organization (GO:0099175),0.3720901236323949,1.0081991946084397,0.4330434782608696,0.7467199153172926,1.0,2/28,0.40%,PDLIM5;FCGR2B
prerank,cellular response to unfolded protein (GO:0034620),0.37887410449197634,1.0077990210115444,0.4219269102990033,0.7471096926926989,1.0,5/26,11.84%,ERN1;PRKN;RHBDD1;BAG3;HSPA13
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2711463677559203,-1.0075816566869524,0.43944636678200694,0.8549969993059492,1.0,7/70,4.22%,LPCAT2;LPIN2;SLC44A2;LPCAT1;ENPP2;PCYT1B;PLA2G6
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.31978864226195947,-1.0075598696949155,0.41909814323607425,0.8537892203737183,1.0,10/30,21.76%,CTC1;SRC;TP53;HNRNPU;STN1;TERF2;CERS1;HNRNPA1;GNL3L;ACD
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.42315727920438356,1.0069908288375078,0.4430604982206406,0.7484168489275804,1.0,3/17,9.86%,NRP1;NR4A1;EPHB4
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.27515147099952325,-1.006623829874192,0.4294478527607362,0.8551771827146741,1.0,18/57,28.77%,ADCY3;ADCY8;GRM7;GNAI1;P2RY12;CHRM3;ADCY7;PSAP;ADCY1;OPRL1;GNAL;FLNA;HTR1F;ADCY5;AKAP5;HTR1B;HTR4;GPR37L1
prerank,regulation of viral genome replication (GO:0045069),0.32578766140062226,1.0060684374116606,0.45982142857142855,0.7499837024938757,1.0,9/56,9.78%,IFITM3;OAS2;FAM111A;PKN2;RNASEL;TNF;BST2;IFITM2;ILF3
prerank,negative regulation of cellular catabolic process (GO:0031330),0.327462106399012,1.0057964904838363,0.42939481268011526,0.7500918795821144,1.0,13/63,13.90%,NELL1;NUPR1;PTPN22;RIC1;MCL1;ROCK1;TBC1D14;BCL2;FOXK2;FOXK1;RUBCN;MFSD2A;STAT3
prerank,regulation of peptide hormone secretion (GO:0090276),0.323485377965997,1.0057869100398749,0.4442793462109955,0.7496091675446226,1.0,18/67,18.37%,ALOX5;CLOCK;RAP1A;TNF;EIPR1;KCNG2;HFE;HADH;SLC8B1;SLC2A2;KCNB1;TFR2;FFAR1;ITPR3;CCL5;IL6;CACNA1A;RFX3
prerank,muscle cell development (GO:0055001),0.37157056856708737,1.0055086040418981,0.44285714285714284,0.7497051974169129,1.0,8/30,13.19%,NRAP;MYH6;ALPK3;MYOF;HEY2;IGF1;RAMP2;NEB
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4401840059781007,1.0053178422293,0.45768566493955093,0.7495900422132253,1.0,2/14,3.95%,BST1;ITGB1BP1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.36140585917804297,-1.005153986547332,0.43902439024390244,0.8581243019862624,1.0,4/19,4.10%,EXTL3;XYLT1;HS3ST5;HS6ST1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3255264268901066,-1.0051235530667013,0.41624365482233505,0.8569305381131413,1.0,5/29,13.88%,LPCAT2;LPCAT1;PLA2G6;LPCAT3;MBOAT7
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3639079108676509,1.0045175930892094,0.4438943894389439,0.7509125665206522,1.0,7/29,13.47%,RIPK1;BCL10;PAK2;TNF;TNFSF12;SFRP1;WWOX
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3787500562237211,-1.0045141442713137,0.4488888888888889,0.8574805605623423,1.0,3/15,7.64%,ACACA;DIP2A;ACSS1
prerank,positive regulation of macroautophagy (GO:0016239),0.3325979453976437,1.004494582226558,0.44970414201183434,0.7504529011569626,1.0,9/48,10.33%,SESN1;GNAI3;ADRB2;UVRAG;WAC;SPTLC2;BAG3;SMCR8;SLC25A5
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4000449527393074,1.004202154467676,0.45051194539249145,0.7506257443046809,1.0,7/20,18.57%,RB1;IGF1;NIBAN2;LAMTOR5;EP300;GTF2B;TRAF6
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3253712592574244,-1.004194580442133,0.4523809523809524,0.8571012374393999,1.0,5/27,5.60%,F11R;TJP1;TMEFF2;CLASP2;SHANK1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3598527781366429,-1.0041104489606025,0.4518348623853211,0.8560795046102035,1.0,5/18,11.84%,HPGDS;DAGLB;PTGS1;PTGES3;MIF
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.2772791890678223,-1.0040516684869845,0.43450479233226835,0.8524220497049653,1.0,21/61,20.89%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;SEC24B;TRAPPC2;SEC13;BET1;GOSR2;TRAPPC2L
prerank,vesicle coating (GO:0006901),-0.2772791890678223,-1.0040516684869845,0.43450479233226835,0.8524220497049653,1.0,21/61,20.89%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;SEC24B;TRAPPC2;SEC13;BET1;GOSR2;TRAPPC2L
prerank,COPII vesicle coating (GO:0048208),-0.2772791890678223,-1.0040516684869845,0.43450479233226835,0.8524220497049653,1.0,21/61,20.89%,TGFA;PREB;KLHL12;TRAPPC3;SEC31A;ANKRD28;CNIH1;NAPA;SEC24A;TBC1D20;F8;PPP6R1;TRAPPC9;TRAPPC6A;GOLGA2;SEC24B;TRAPPC2;SEC13;BET1;GOSR2;TRAPPC2L
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.35419495030070364,-1.0036803817155637,0.4075829383886256,0.8522631937023212,1.0,10/21,31.40%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF;FBXO5
prerank,carboxylic acid transmembrane transport (GO:1905039),0.34885733853641576,1.0035721409742475,0.43007518796992483,0.7515131550392937,1.0,11/40,17.60%,SLC16A7;SLC38A6;ABCC1;SLC38A1;SLC38A2;SLC23A1;SLC23A2;SLC25A30;SLC7A7;SLC5A6;SLC36A2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.38118504844742374,1.0035143312983452,0.4663382594417077,0.7511372896061449,1.0,5/26,4.77%,IRAK3;CD36;TLR2;NFKBIL1;BIRC3
prerank,response to ATP (GO:0033198),0.4059259910012499,1.003474366499038,0.4547038327526132,0.7507260569485797,1.0,1/18,0.51%,P2RX7
prerank,positive regulation of DNA recombination (GO:0045911),-0.3283282573355988,-1.003376481234211,0.4444444444444444,0.8518857572519016,1.0,5/27,9.13%,FUS;PARP1;ERCC6;ZCWPW1;ERCC2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.29414262085007425,-1.0031640279908556,0.45224719101123595,0.8512317692024042,1.0,21/42,29.05%,FARSA;AARS1;CARS1;TARS2;TARS1;NARS1;YARS1;IARS2;SARS1;DARS2;AARS2;SARS2;PARS2;HARS2;FARSB;WARS1;VARS2;VARS1;PPA2;NARS2;KARS1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4578878782432042,1.0030504350148934,0.46511627906976744,0.7511843155695819,1.0,3/10,16.01%,LILRB1;FN1;HSP90AB1
prerank,positive regulation of isotype switching (GO:0045830),0.41912534078131247,1.0025762310768747,0.45454545454545453,0.75171432348258,1.0,6/15,22.88%,CD40;KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,snRNA transcription (GO:0009301),-0.2648259271258689,-1.0025268053771257,0.4477124183006536,0.8517410441368747,1.0,26/70,30.13%,CDK9;RPAP2;INTS3;RPRD1A;CCNT2;POU2F2;ICE2;SRRT;POLR2C;NCBP1;INTS13;ELL2;ELL;TAF8;POLR2L;TAF9;INTS9;TBP;CCNK;INTS11;CCNT1;INTS7;POLR2I;TAF13;ICE1;SNAPC1
prerank,necroptotic process (GO:0070266),0.41783878292873966,1.0024898666508661,0.4641509433962264,0.751405200577033,1.0,3/16,5.47%,RIPK1;TLR4;LY96
prerank,regulation of synapse organization (GO:0050807),0.37572389990092764,1.0024031681160426,0.45805369127516776,0.7510986377394187,1.0,3/26,6.94%,PDLIM5;MEF2C;TNF
prerank,genitalia development (GO:0048806),-0.4096226665390616,-1.0023210157935698,0.4717391304347826,0.8510970277248342,1.0,3/12,20.22%,CHD7;PTPN11;WNT5A
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4329437605127745,-1.0022314121030618,0.47157894736842104,0.8500937028149462,1.0,2/10,1.21%,SIRPA;PTPRS
prerank,macrophage differentiation (GO:0030225),0.42918484528834466,1.0015387198182681,0.46577946768060835,0.7524813861884522,1.0,2/13,3.32%,IL15;CDC42
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.35470031066494884,-1.0014249829862545,0.4543147208121827,0.8511271359177985,1.0,2/21,0.88%,CX3CR1;CTNNB1
prerank,potassium ion transport (GO:0006813),-0.24516869255617835,-1.0013377570909414,0.4225941422594142,0.8501410065951693,1.0,16/120,9.84%,KCNMA1;SLC1A3;KCND2;KCNH7;KCNJ2;SLC24A3;SLC24A2;SLC9A8;KCNQ3;NALCN;SLC24A4;KCNQ5;KCNK2;KCNA1;KCNA2;KCNK12
prerank,cellular response to interferon-beta (GO:0035458),-0.3901243944872415,-1.0012084790619176,0.47874720357941836,0.8492992701077908,1.0,3/14,6.23%,STAT1;IRGM;HTRA2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.23562469752003054,-1.0009315959418694,0.4792626728110599,0.8488683434692589,1.0,55/146,31.86%,CSNK1E;SDCCAG8;CEP135;ODF2;DYNC1H1;SKP1;PSMD13;CEP192;PSMD12;RBX1;CEP250;FBXL7;HAUS8;CEP63;PSMD9;CDC7;CCP110;RAD51C;PSME3;HAUS7;CKAP5;MAPRE1;HAUS3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;CENPJ;PSME1;DCTN2;HMMR;DTL;CNTRL;HAUS2;DCTN1;KIF14;PLK4;PSMC2;CDK1;HAUS6;YWHAG;PSMB10;STOX1;PSMD3;TUBA4A;CEP152;PSMC5;TUBA1A;FHL1;CENPF;PSME2;FBXO5;TUBG1;AURKA
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4211018217858632,-1.0008783250335886,0.47380410022779046,0.8477797897104453,1.0,5/11,13.79%,GTF2H2;GRK2;GRK3;ARRB2;SAG
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3982671284762366,1.0008282344681432,0.44703770197486536,0.7535364512903667,1.0,3/20,6.29%,FBXW7;BMP2;ERLIN1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.44125022999811847,1.0003786254291755,0.44703770197486536,0.7540709747991313,1.0,3/13,9.07%,ESR1;NR3C1;ESR2
prerank,microtubule anchoring at centrosome (GO:0034454),0.45339859565697793,1.0003075596620388,0.4426229508196721,0.7537306260746953,1.0,3/10,13.96%,NIN;CEP19;PCM1
prerank,cellular defense response (GO:0006968),0.34672578338981314,1.0002807460753675,0.4597014925373134,0.7533001644641071,1.0,8/40,10.81%,C5AR1;ITGB1;LBP;KIR3DL2;LY96;ZNF148;RAB23;NCF2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.4475978722386896,0.9997187975824763,0.4725897920604915,0.7540739395687128,1.0,2/12,3.50%,PTPRJ;CBL
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3125952547367768,0.999686477219038,0.46082337317397076,0.7536409738760536,1.0,33/84,23.11%,APOE;RPS3;DAPK1;SAMD4A;MRPL13;RACK1;ROCK1;MALSU1;RBM4;ILF3;IGF1;RTN4;ORMDL1;DDX6;NANOS3;TRIM71;SHMT1;CNOT9;SYNCRIP;RNF139;EIF2AK2;EIF2AK3;CNOT1;CNOT8;GIGYF2;ENC1;DAPK3;IGF2BP3;PUS7;RTN3;EPRS1;CPEB3;PCIF1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.3590351711680334,-0.9992947117805716,0.4392523364485981,0.851096940285443,1.0,8/19,20.21%,TP53;BAG6;DYRK2;MSH2;HIPK1;PYCARD;PHLDA3;AEN
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3898184296974902,0.9988347110709886,0.45634266886326197,0.7550575811770076,1.0,9/23,23.91%,PDE6A;GUCY2D;PPEF1;CALM1;GRK4;METAP1;NMT1;NMT2;METAP2
prerank,double-strand break repair (GO:0006302),-0.22816081480389006,-0.9986454715768532,0.49404761904761907,0.851687517006858,1.0,39/158,18.38%,HERC2;DNA2;XRCC5;SETX;HELQ;ACTR8;ATM;AP5Z1;HPF1;PARP1;RMI1;BLM;RNF168;POLM;RECQL5;BRCA1;TNKS1BP1;HUS1;RAD51C;XRCC1;BRCA2;UBXN1;KDM4A;PRPF19;PPP5C;PARP3;PALB2;MORF4L1;XRCC6;APBB1;CHEK2;DDX1;PAXX;REV3L;TDP1;RAD51AP1;DCLRE1B;POLL;PARP9
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.29765601800018804,-0.9986147008250037,0.4441176470588235,0.8505235702860895,1.0,14/42,18.01%,JAK2;NPNT;PIK3CB;GCNT2;TBCD;NF1;MINK1;SPOCK1;TSC1;NDNF;THY1;PDPN;VIT;NOTCH1
prerank,neutrophil activation (GO:0042119),0.45331328987554714,0.9983688851320148,0.4700374531835206,0.7556166987374933,1.0,3/12,6.57%,IL15;FCER1G;SYK
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.33200019313578255,-0.9981580692929184,0.44686648501362397,0.8506203595700556,1.0,6/26,13.18%,ATP1B1;ATP1B2;ANK2;CACNA1D;ACTN2;VAMP2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.359818001019227,-0.9977793957755091,0.44755244755244755,0.8504469977287569,1.0,5/20,13.95%,BMPR1B;ACVR1;MDFI;DSCAML1;LMX1B
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.4230483880271949,-0.9977285216627988,0.4617117117117117,0.8468884319920886,1.0,4/10,25.85%,DNA2;BLM;SLX4;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.4230483880271949,-0.9977285216627988,0.4617117117117117,0.8468884319920886,1.0,4/10,25.85%,DNA2;BLM;SLX4;EXO1
prerank,t-circle formation (GO:0090656),-0.4230483880271949,-0.9977285216627988,0.4617117117117117,0.8468884319920886,1.0,4/10,25.85%,DNA2;BLM;SLX4;EXO1
prerank,tight junction assembly (GO:0120192),-0.2904689101490768,-0.9976688847802943,0.4289855072463768,0.8458053240734494,1.0,4/49,2.60%,F11R;TBCD;PARD3;CLDN11
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.3133307448256621,-0.9974041217554707,0.45931758530183725,0.8453109518897054,1.0,10/30,23.26%,GTF2H2;CCNH;UBTF;ERCC2;TAF1C;TAF1D;GTF2H4;POLR1C;POLR2L;TBP
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2948438800669622,0.9973483499476705,0.46332046332046334,0.7573691405397858,1.0,19/114,14.43%,TNFRSF25;PSMA7;TNFRSF1B;RIPK1;PLVAP;TNFRSF11A;BIRC3;CD40;EDARADD;TNF;EDA;PSMB2;TNFSF12;PSMA6;FOXO3;TNFRSF1A;PSMA3;PSMD1;PSMD5
prerank,regulation of cell cycle (GO:0051726),0.27158876639488655,0.9969988144847307,0.4730337078651685,0.7576603350738637,1.0,53/271,16.44%,LRP6;TCF7L2;NOTCH2;IQGAP1;KIF20B;NUPR1;RPL23;GRK5;FBXL17;BMP2;LILRB1;ERN1;ANKRD17;RGCC;DUSP1;CDK6;BIRC3;SND1;RB1;RACK1;PTPRK;NR4A1;TRIM32;NOP53;CHEK1;FOXM1;RPS15A;SDCBP;GMNN;MDM2;LIN54;MAP3K20;UHRF2;SFRP1;GAS2L1;MYBL2;RASSF1;NANOS3;CDKN2C;PPP1R13B;UHMK1;RARA;STAT3;EP300;JUND;CRLF3;PKD2;MYC;PRCC;RUNX3;HSP90AB1;HCFC1;LIN37
prerank,peptidyl-lysine acetylation (GO:0018394),0.46196553768104853,0.9968337546318927,0.47265625,0.757514609357466,1.0,4/10,14.00%,ESCO1;CREBBP;KAT7;EP300
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3419819657263383,0.996760147387726,0.44272445820433437,0.7571754269954044,1.0,2/43,3.09%,PID1;C1QTNF12
prerank,mitochondrial fusion (GO:0008053),-0.3581315291455241,-0.9955688851509861,0.4639423076923077,0.8493637635927814,1.0,7/18,25.82%,MFN1;GDAP1;AFG3L2;MIGA2;FIS1;THG1L;USP30
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4339513243933282,-0.9954381487380323,0.4860813704496788,0.8485476568734294,1.0,3/10,7.80%,GRB10;ITGB3;ITGA5
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3660855627786018,-0.9953437438620231,0.44713656387665196,0.8476030348422453,1.0,5/17,11.72%,NSA2;WDR12;MAK16;URB1;FTSJ3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.38778536641871164,0.9949824026707711,0.4724137931034483,0.7606653025504322,1.0,8/22,25.22%,PSMA7;PSMB2;PSMA6;PSMA3;ENC1;PSMB9;PSMB4;PSME4
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3040349246481935,0.9948772837404594,0.4479025710419486,0.7604094909840412,1.0,11/94,6.34%,MAP3K5;CRIP1;HINT1;CEBPB;TNFRSF1B;ERN1;MCL1;BCL2L2;STK24;SFN;BCL2
prerank,cytoplasmic translational initiation (GO:0002183),-0.37374850187830266,-0.9945715959318838,0.48735632183908045,0.8484916686365429,1.0,5/17,6.69%,EIF4G1;EIF4A1;EIF2B3;EIF4A2;EIF2D
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.37519126514192647,0.9945605647975523,0.46140939597315433,0.7606021389716021,1.0,7/26,13.02%,EGFR;ANKRD17;RGCC;CCND3;CCND2;TFDP1;KMT2E
prerank,proteasomal protein catabolic process (GO:0010498),0.27608221292807494,0.9944900817757417,0.4867149758454106,0.7602561521901215,1.0,39/201,15.31%,WWP1;FBXW7;SMURF2;PSMA7;RCN3;FBXL17;SIAH2;NR1D1;PELI1;RMND5A;PRKN;CLOCK;RHBDD1;SPOP;PSMB2;APPBP2;TBL1XR1;SPOPL;MDM2;TBL1X;UBE2K;UBE2D3;COP1;CUL3;ARMC8;ZFAND2B;ARRB1;PSMA6;RNF185;TRIM71;AGAP3;RNF187;BFAR;NEDD4L;PSMA3;PSMD1;PSMD5;RNF122;RNF41
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.33724491897508907,0.9942209311208653,0.4725609756097561,0.7603425974383594,1.0,10/47,14.00%,FBXW7;C1QTNF3;C1QTNF12;RAPGEF2;ERLIN1;FYN;ROCK2;ZC3H12A;ATP2B4;EP300
prerank,regulation of cellular pH (GO:0030641),0.3766266741601908,0.9940744696163247,0.45896147403685095,0.7601364253921721,1.0,7/29,14.19%,SLC9A9;SLC9A4;SLC4A4;SLC4A5;ATP1A4;SLC9A7;SLC9A6
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.3540648938702382,-0.9938914568657576,0.46352941176470586,0.8491560827802265,1.0,4/19,6.31%,EML3;CEP97;HNRNPU;CHMP4B
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.44606028637291295,0.9937927744446491,0.4689265536723164,0.7602411931835034,1.0,4/12,11.20%,KLF9;CTSB;THRB;GAS2L1
prerank,regulation of interferon-gamma production (GO:0032649),0.31121679473230673,0.9930957195619412,0.4558011049723757,0.7613583546406311,1.0,10/71,8.66%,TLR8;GAS6;NR1H4;PTPN22;LILRB1;TLR4;PDE4D;CCR2;CEBPG;TRIM27
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3821443825046411,0.9930846487445846,0.46238532110091746,0.7608748038574041,1.0,8/22,16.43%,DUSP1;PPM1B;DUSP2;PPP2CA;PPP2CB;PPP1CA;DUSP7;PPM1A
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.41959997263687554,0.9929447169972032,0.46785714285714286,0.7606730524918901,1.0,2/14,9.32%,GAS6;CARD16
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.32192615683700754,-0.9920609849051943,0.4562334217506631,0.8530012509743695,1.0,4/27,2.23%,FGF12;YWHAH;SCN1B;SNTA1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.40502270956553843,-0.9916700321114288,0.45617977528089887,0.8529259883735124,1.0,8/12,40.00%,UPP2;UMPS;UCKL1;CAD;DHODH;TK2;CDA;TK1
prerank,blood vessel endothelial cell migration (GO:0043534),0.3914819436689031,0.991661791802378,0.44880546075085326,0.763044726672224,1.0,3/22,9.86%,NRP1;NR4A1;EPHB4
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.35860995390300116,0.9915239460248455,0.4640625,0.7628298496032073,1.0,9/36,15.41%,TCF7L2;PPP3CA;GNG2;PDE6A;GNB1;CALM1;PLCB3;TNRC6C;NLK
prerank,regulation of intracellular pH (GO:0051453),0.358715238641628,0.9915229051422862,0.4746317512274959,0.7623311309256232,1.0,7/34,14.19%,SLC9A9;SLC9A4;SLC4A4;SLC4A5;TMEM165;SLC9A7;SLC9A6
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.3823319121033384,-0.9914646145140696,0.47306791569086654,0.8522290844830195,1.0,4/15,8.07%,PRKCD;PLA2G6;NSMAF;SAMD8
prerank,lung development (GO:0030324),-0.31423292450599283,-0.9914068942299584,0.47780678851174935,0.8511928113899443,1.0,14/33,29.16%,FGF2;FGFR2;LOXL3;BAG6;CCDC39;PROX1;PDPN;ERRFI1;SOX11;CCDC40;FGF1;WNT7B;FGF7;BMP4
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.45016264193754907,0.9913432645987035,0.49063670411985016,0.7621999373055666,1.0,3/11,3.51%,GAS6;LILRB1;CCL19
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4297462548871016,-0.9910352813013289,0.47489539748953974,0.851066344898926,1.0,6/10,34.65%,COMT;CHDH;SMOX;SARDH;ALDH7A1;LRTOMT
prerank,positive regulation of histone deacetylation (GO:0031065),-0.408809624533247,-0.9909094283502305,0.49581589958158995,0.850220538402889,1.0,3/12,11.96%,AKAP8L;SAP30BP;AKAP8
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.35102679808107606,-0.9907133133186078,0.4681818181818182,0.8472271473061247,1.0,9/20,30.17%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.35102679808107606,-0.9907133133186078,0.4681818181818182,0.8472271473061247,1.0,9/20,30.17%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.35102679808107606,-0.9907133133186078,0.4681818181818182,0.8472271473061247,1.0,9/20,30.17%,ATM;BUB1B;BUB1;ZW10;IK;ZWINT;MAD2L1;TTK;CENPF
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3757440492837852,0.9904341252050088,0.4355108877721943,0.763725066866989,1.0,4/26,7.30%,PRKAG2;ADIPOR2;ERLIN1;ELOVL5
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4300439891523698,0.9898982172360421,0.48014440433212996,0.7644529499410591,1.0,3/12,9.47%,PPHLN1;SETDB2;APOBEC1
prerank,protein targeting to peroxisome (GO:0006625),0.37249084232038493,0.9898352503942488,0.46557377049180326,0.7640975673718394,1.0,5/29,6.62%,RAB8B;SLC25A17;PXMP2;PEX7;PEX26
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.356238796422334,-0.9892868890488277,0.44028103044496486,0.8500534227750608,1.0,8/19,21.76%,CTC1;SRC;HNRNPU;STN1;TERF2;HNRNPA1;GNL3L;ACD
prerank,rRNA transcription (GO:0009303),0.4102594928033906,0.9888889630834139,0.4784172661870504,0.76570817969419,1.0,4/17,12.46%,ANG;GTF3C3;GTF3C6;POLR1G
prerank,regulation of gastrulation (GO:0010470),0.4311846541791746,0.9887036775520738,0.4835766423357664,0.7655948184947724,1.0,4/14,9.70%,OSR1;RACK1;CLASP1;POGLUT1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.45608632265364574,0.9884701369026497,0.45315487571701724,0.7651425708059639,1.0,1/10,3.32%,CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.45608632265364574,0.9884701369026497,0.45315487571701724,0.7651425708059639,1.0,1/10,3.32%,CDC42
prerank,response to gamma radiation (GO:0010332),0.37072846564512396,0.9884570588516778,0.4583333333333333,0.7646697441091808,1.0,10/24,16.18%,LIG4;RPL26;TSPYL5;MDM2;MAP3K20;CRYAB;TMEM109;MYC;KDM1A;ATR
prerank,regulation of protein localization (GO:0032880),-0.27218031228096007,-0.9880788836469968,0.46621621621621623,0.8521633515484155,1.0,9/58,10.36%,CSNK1E;PLEKHM2;CTSD;MAP2;ITGB3;DVL1;PARP1;ADCYAP1;AFDN
prerank,regulation of exosomal secretion (GO:1903541),0.39632513105563205,0.9880145792167709,0.4608540925266904,0.7650862611685485,1.0,5/19,9.08%,PRKN;SDCBP;VPS4B;RAB7A;SDC4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3663265093356766,0.9879910704827674,0.4830508474576271,0.7646371300176281,1.0,6/29,9.97%,RPS16;RPS21;RPS8;RPS14;MRPS11;HEATR1
prerank,phagolysosome assembly (GO:0001845),0.43547206735203026,0.9874148621699853,0.4690909090909091,0.765401313430184,1.0,4/12,8.92%,PIKFYVE;RAB7A;RAB7B;RAB14
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.396678903756189,0.9873528830455461,0.47017543859649125,0.7650494896193623,1.0,1/19,0.78%,PTPRJ
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3593527614356652,0.9873285179585866,0.47145187601957583,0.7646019570679544,1.0,9/30,16.01%,RYBP;WAC;NOP53;SDCBP;HFE;USP14;EIF3H;RPL11;HSP90AB1
prerank,positive regulation of cyclase activity (GO:0031281),-0.37895793475412864,-0.9870675439253063,0.4868995633187773,0.8537928463836815,1.0,4/14,11.72%,CACNA1D;NF1;MAPK3;CACNA1C
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3194252625075757,0.9866992939761672,0.4673157162726008,0.7654851497063325,1.0,7/75,4.87%,LRP6;APOE;PTPRJ;LYN;IRAK3;DUSP1;RB1
prerank,regulation of protein processing (GO:0070613),0.3960032939411429,0.9861681811546555,0.46572934973637964,0.7661243042592669,1.0,2/21,4.92%,NLRC4;RHBDD1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.4085929433174493,-0.9860443849292029,0.48660714285714285,0.8555446345280455,1.0,10/12,43.95%,TARDBP;CCL3;JUN;HDAC1;TFAP4;HMGA2;CCL4;PSMC3;POU2F3;REST
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.37191898342542895,0.9860338813127284,0.4772727272727273,0.7659210677452868,1.0,10/26,22.14%,CCL19;TRPM2;SLC8B1;ERO1A;IBTK;PKD2;ITPR3;F2R;PTPRC;PLCG2
prerank,nervous system development (GO:0007399),0.26092211447035685,0.9859486850737094,0.5010638297872341,0.7656159226811843,1.0,37/429,6.20%,WWP1;GDA;ZEB2;NELL1;EDNRB;NAV1;ST8SIA4;ADGRG6;NOTCH2;ITM2B;MBNL1;ZBTB16;OPHN1;JAG1;LIG4;MEF2C;CRIM1;FBXL17;DRD1;WNT2;NES;HMGCR;CLN5;RPS6KA3;PRKN;JARID2;BTBD1;INTU;GRHL2;PMP22;FEZ2;PCDHB13;MTR;CELSR1;GFRA3;DPYSL2;ATXN1
prerank,inorganic anion transport (GO:0015698),0.3275617158047444,0.9859384224634887,0.4740740740740741,0.7651430805130341,1.0,16/53,21.84%,ANO6;CLCNKB;CLIC4;ANO1;SLC26A11;TTYH3;BEST1;SLC26A7;CLCN1;XPR1;SLC25A30;CLIC5;ENPP1;RACGAP1;SLC13A4;SLC26A8
prerank,macromolecule catabolic process (GO:0009057),0.375884074991763,0.9857887934468376,0.4665523156089194,0.7649825254060975,1.0,7/26,10.29%,UVRAG;CLN5;CLN6;KIF16B;SNX25;TRIM24;CLPX
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.41367458256431483,-0.9853256667861564,0.48498845265588914,0.8563364524833053,1.0,2/11,2.08%,KCNJ2;ATP1B1
prerank,cilium organization (GO:0044782),-0.22077393752074528,-0.9852899460836402,0.5064935064935064,0.8552384299510409,1.0,75/210,27.76%,ASAP1;BBS9;TRAPPC14;PTPN23;TMEM67;RILPL1;SCLT1;ODF2;CCDC66;IFT81;ATP6V1D;IFT140;RAB3IP;DZIP1;CEP162;IFT88;TTC8;AHI1;CEP250;CCDC57;IFT20;BBS7;MKS1;DYNLT2B;WDR19;CCP110;SPAG16;DYNC2H1;KIF3A;SSX2IP;TCTN1;IFT52;KIF3B;WDR90;CDC14A;IQCG;ARMC2;CFAP298;CFAP410;NUDCD3;CENPJ;CPLANE2;NOTCH1;IFT43;DYNC2I1;EHD3;B9D2;RAB8A;TMEM138;DNAH5;PLA2G3;BBS4;ARL3;CEP89;IQCB1;HDAC6;TMEM231;MKKS;FLNA;GALNT11;TMEM17;PTPDC1;CFAP126;PLK4;CATIP;KIFAP3;CEP126;EXOC3;TTC39C;UNC119B;CFAP70;MNS1;IFT172;TTBK2;CFAP43
prerank,regulation of mRNA catabolic process (GO:0061013),0.2882696646506604,0.9851880641409732,0.4941329856584094,0.76577393480787,1.0,25/121,14.92%,ZFP36L2;PSMA7;RPS27A;SAMD4A;ZFP36L1;VIM;MAPKAPK2;RC3H1;PUM2;HSPB1;PSMB2;DCP1A;SERBP1;PCID2;DCP2;PSMA6;ZC3H14;ZC3H12A;EXOSC8;GTPBP1;EXOSC1;PSMA3;PSMD1;PSMD5;XPO1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.3268061946726399,-0.9850182270166284,0.456575682382134,0.8547342344389786,1.0,8/23,24.82%,FGF2;ITGAX;PAX8;WNT5B;SMO;EGF;AGT;SOX8
prerank,DNA recombination (GO:0006310),0.3467391467741931,0.9848292185865551,0.4750402576489533,0.7660658714208268,1.0,11/37,19.75%,ENDOG;LIG4;RPA1;RAD54L;RAD52;RHNO1;RAD51B;FBH1;DMC1;MRE11;RTEL1
prerank,in utero embryonic development (GO:0001701),0.37499179594527654,0.9846143744173683,0.48739495798319327,0.7660456692802419,1.0,5/25,6.93%,MBNL1;LIG4;BMP2;MYH6;ZNF568
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2624265379650477,0.9844951711280934,0.510314875135722,0.7658302497700402,1.0,76/327,18.59%,AHR;RREB1;FOXN2;NFXL1;ESR1;HINT1;MEF2C;NCOA2;CEBPB;MITF;RYBP;BMP2;NR3C1;CLOCK;SPI1;RB1;INSR;TGFBRAP1;TCF7;ATXN1;LYL1;IRF2;ATRX;ZNF628;LIMD1;ESRRB;BACH1;LIN54;HMG20A;ESR2;ATF7;NFATC2;PPP2CA;ZNF205;RPL6;GCFC2;TESMIN;RNF14;JMJD1C;SP1;ATXN1L;CREBBP;MYBL2;FOXK2;HINFP;NFIA;TERF2IP;SP3;PSPC1;KAT7;STAT3;EP300;MLF2;HMGN5;WWC1;NAB1;RALY;MYT1;NSD3;NLK;NR2C2;SFPQ;RUNX3;HCFC1;PPARGC1B;GPBP1;NR5A2;PRKCQ;RELA;ZNF22;GZF1;MAFB;ATF2;RFX3;PERM1;PLAG1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.2949086606547581,0.9843574226916363,0.4772413793103448,0.7656552394341509,1.0,18/98,12.57%,EGFR;ITGB1;SPTBN1;YWHAQ;ITGB1BP1;PRKN;SFN;BCL2;TNF;FYN;PLS1;MYO1C;TFDP1;CASP8;YWHAE;KCNB1;ATP2B4;PPP1R13B
prerank,cell junction maintenance (GO:0034331),0.4295416466573943,0.9838608903902655,0.4693140794223827,0.7661974971165743,1.0,1/14,1.21%,MYADM
prerank,negative regulation of transposition (GO:0010529),0.407844071598189,0.9831731194513557,0.45368620037807184,0.7672220709966627,1.0,4/16,13.53%,TUT7;SPOCD1;TUT4;PIWIL2
prerank,positive regulation of integrin activation (GO:0033625),-0.41599229848788943,-0.9830635051095122,0.47956989247311826,0.8590424959151542,1.0,4/11,6.59%,SRC;FERMT2;PIEZO1;P2RY12
prerank,mRNA metabolic process (GO:0016071),-0.24887618772065037,-0.9830115705928951,0.5238095238095238,0.8580255697486028,1.0,26/90,23.79%,DDX5;SON;CPSF6;AKAP8L;SRRM4;SRSF5;HNRNPA2B1;TP53;GEMIN2;SRSF2;RIDA;TCERG1;U2AF1;HSF1;RNH1;NCBP1;PCBP2;SRSF11;SRSF9;PRMT9;U2AF2;METTL3;ALKBH5;NUDT12;SLBP;HNRNPA0
prerank,positive regulation of phospholipase activity (GO:0010518),0.3841823765133263,0.9828765557558142,0.4682274247491639,0.7673607081741828,1.0,3/22,5.33%,FGFR1;ESR1;PDGFRA
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.30747724839820634,-0.9823769225545878,0.4465753424657534,0.8585790421803077,1.0,5/36,3.65%,SIRPA;CYLD;TREM2;DUSP10;GPS2
prerank,regulation of lamellipodium assembly (GO:0010591),0.3569625908134993,0.9821698299351623,0.4789391575663027,0.7684142649429206,1.0,5/34,7.30%,FER;ACTR3;WASF2;CDC42;ARPC2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.30677488472838854,-0.9818567168654886,0.5012987012987012,0.8588513996847154,1.0,11/32,20.21%,DDX5;TP53;STK11;BAG6;DYRK2;FHIT;MSH2;HIPK1;PYCARD;PHLDA3;AEN
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.45925666313404223,0.9817321969401511,0.49504950495049505,0.7688774810820328,1.0,1/10,1.73%,DPYD
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.433931866962317,0.9816135719167866,0.4805194805194805,0.7686612085594402,1.0,6/13,19.35%,GNAI3;RAB23;GTPBP1;EFL1;AK3;AK4
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2781306255428273,-0.9814597713782651,0.49859943977591037,0.8587552559096091,1.0,14/46,27.01%,LPCAT1;DGKB;LIPH;GNPAT;DGKZ;DDHD1;ACP6;AGPAT3;GPD1L;SLC27A1;ABHD8;DGKG;AGPAT2;DGKA
prerank,histone H4-K16 acetylation (GO:0043984),0.3913997715654996,0.9805071274463519,0.48986486486486486,0.7706672394236488,1.0,6/19,16.20%,KMT2A;PHF20;KANSL2;KANSL1;KAT7;HCFC1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3740368895674167,0.9803610937406366,0.44601769911504424,0.7704872640633297,1.0,5/27,8.32%,FCGR2B;GSK3B;DISC1;PSEN1;HOMER1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.36595268612613435,0.9800454681757379,0.48639455782312924,0.7706466551201737,1.0,3/28,3.26%,RASA1;FCHSD2;ARHGAP18
prerank,TOR signaling (GO:0031929),-0.31606480708818563,-0.9792821411736703,0.49122807017543857,0.8634359309588989,1.0,13/26,28.77%,RPTOR;PRR5L;CARD11;FLCN;MLST8;MTOR;RHEBL1;SYAP1;RPS6KB2;PRR5;RPS6KB1;LARP1;AKT1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.31909737363221835,-0.9791512229753134,0.48614609571788414,0.862616203470025,1.0,5/27,11.72%,PDE4B;FGF13;ANK2;CTNNA3;CACNA1C
prerank,response to interferon-beta (GO:0035456),0.3824352673135777,0.9789809404325324,0.4770797962648557,0.7725265496456595,1.0,5/22,9.46%,IFITM3;BST2;IFNAR2;UBE2K;IFITM2
prerank,central nervous system neuron differentiation (GO:0021953),0.3504944703249751,0.9784478102171347,0.47299509001636664,0.7732264825098917,1.0,5/33,7.86%,LRP6;OPHN1;WNT2;ATP7A;NR4A2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.3969127698933884,0.977720844127254,0.477112676056338,0.7743065664958854,1.0,10/19,24.76%,GNPDA1;GFPT2;PMM1;UAP1L1;GMPPB;NANS;RENBP;UGP2;UAP1;MPI
prerank,regulation of cellular biosynthetic process (GO:0031326),0.36478487855569314,0.9770976511884932,0.4717285945072698,0.775152664935036,1.0,5/28,5.81%,PRKAG2;NR1H4;MITF;TNFRSF1B;ADIPOR2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.4652955602190621,0.9767012833243577,0.4934823091247672,0.7754950637045012,1.0,3/10,12.28%,NFKBIZ;RC3H1;ZC3H12A
prerank,nucleic acid-templated transcription (GO:0097659),0.3345849115364346,0.9762182207600681,0.4953416149068323,0.7761042737806532,1.0,13/42,19.88%,MEF2A;THRB;EPC1;NR4A2;MED20;POLR2B;NFKBIB;MMS19;POLR2D;RRAGC;POLR2F;BCL3;DTX1
prerank,embryonic digestive tract development (GO:0048566),-0.3486644208545828,-0.9760723724617953,0.4830097087378641,0.8700149181523884,1.0,6/18,20.65%,SALL1;FGFR2;ID2;TGFB2;SOX11;GLI3
prerank,protein oxidation (GO:0018158),0.44669724933155563,0.975662338377659,0.4944029850746269,0.7767887185831395,1.0,4/11,19.44%,LOX;LOXL2;PRDX3;TMX3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.4633747362734824,0.9755787906205763,0.49320388349514566,0.776468987144252,1.0,1/10,0.63%,APP
prerank,glucose transmembrane transport (GO:1904659),-0.3577245052864797,-0.9749133127601824,0.5193236714975845,0.8720468792528138,1.0,3/18,7.13%,SORT1;SLC2A9;SLC2A5
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.30535403371115954,-0.9748276476754939,0.49865229110512127,0.8710818859886689,1.0,7/32,14.99%,LPIN2;SLC44A2;LPCAT1;PCYT1B;LPCAT3;CHPT1;STARD7
prerank,regulation of phospholipase activity (GO:0010517),0.44738859637466705,0.97468521461403,0.4830188679245283,0.7778909808383077,1.0,1/10,0.59%,FGFR1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3401179268595429,0.9746085873494666,0.4977578475336323,0.7775470310076582,1.0,4/41,7.30%,ALOX5;ALOX15;PNPLA8;ELOVL5
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.3829401004632729,0.9743558974526841,0.4947916666666667,0.7775696451574399,1.0,5/22,18.57%,B2M;STX7;FBXO38;ZBTB1;TRAF6
prerank,regulation of superoxide anion generation (GO:0032928),-0.38745567521743596,-0.9743118687282428,0.47767857142857145,0.8713454285068761,1.0,2/14,7.11%,PRKCD;MAPT
prerank,negative regulation of heart contraction (GO:0045822),0.44196924253235503,0.9742073379315568,0.49480968858131485,0.7774038238527596,1.0,4/11,19.49%,PDE4D;PLN;ZC3H12A;SPTBN4
prerank,protein ubiquitination (GO:0016567),0.2533487650861136,0.9738643479592914,0.5535524920466596,0.7776659517151719,1.0,94/471,16.08%,WWP1;SASH1;FBXW7;SMURF2;PSMA7;ARIH1;RPS27A;VCPIP1;SH3RF1;FBXL17;UBE2E3;SIAH2;WAC;CBL;PELI1;RMND5A;PRKN;BCL10;ZNRF3;RNF141;USP9X;RACK1;LNPEP;RC3H1;SPOP;TRIM33;KLHL13;UBE2Q2;CBFB;TRIM32;FBXL5;ANKIB1;MYCBP2;BCL2;CDC27;TRIM24;EIPR1;TRIM47;DTX2;PSMB2;BIRC6;CDC73;TRIM68;SHPRH;TRIM27;MDM2;RNF19B;TPP2;UBE2K;UBE2D3;UHRF2;CUL3;MKRN1;RNF38;ANAPC16;FBXO11;RNF14;ARRB1;ZNRF2;RNF111;AMFR;PSMA6;RNF185;UBE3B;TRIM71;MIB1;FBXO10;MKRN3;UBE2R2;RNF115;UBE2N;RBBP6;RNF187;RNF19A;ASB12;HIF3A;BFAR;NEDD4L;PSMA3;PSMD1;PSMD5;KLHL24;ELOC;MKRN2;RNF122;ASB4;RNF41;USP22;PEX14;FBXW2;FBH1;TRIM25;UBE2W;FANCL
prerank,regulation of sodium ion transport (GO:0002028),-0.2979377768377444,-0.9737565417337024,0.48501362397820164,0.8717458947175403,1.0,5/34,2.23%,FGF12;NKAIN2;YWHAH;SCN1B;SNTA1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.29823936805625395,0.9733506854959398,0.504054054054054,0.778313622978127,1.0,8/91,6.79%,HIP1;NRP1;OPHN1;RAB8B;RAB10;AP2S1;SYK;STXBP5
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.402233227661979,0.9730810568652788,0.5112262521588946,0.7784249452292498,1.0,4/18,11.90%,PRKN;SFRP1;CHGA;KCNB1
prerank,endomembrane system organization (GO:0010256),0.26999311006170534,0.9730659473173033,0.5139393939393939,0.7779641743842414,1.0,41/178,20.05%,TMCC1;REEP3;ATL1;USP6NL;SPTBN1;ARHGAP21;CDC42;ATP8B4;SRGN;MYOF;SERP1;TMED10;PI4K2B;WASHC4;GOLPH3L;RAB30;CLASP1;RAB1A;SNX10;SNX33;VAPA;BCAS3;SPTBN5;TMED2;REEP6;VPS51;COG7;EXOC8;SEC16A;MIA3;GOLPH3;CUL7;DNAJC13;TOR1B;RAB22A;TMED5;UBXN2B;EIF2AK3;TRIP11;LMAN2;ATP8B2
prerank,ether lipid biosynthetic process (GO:0008611),-0.42282300955323837,-0.9726671769103408,0.5062240663900415,0.8735879662190966,1.0,4/10,13.64%,LPCAT2;DHRS7B;GNPAT;CHPT1
prerank,cellular protein localization (GO:0034613),0.2641826129492206,0.9725342567367246,0.5566778900112234,0.7786124613083225,1.0,37/285,10.55%,ITSN1;EGFR;SNX9;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;USP6NL;CD74;SNX6;SNX27;EHD1;AP3B1;RIC1;HEY2;PTPRK;TBC1D14;CELSR1;TMED10;TBC1D2B;MYO7A;WIPI1;PIGU;RABGAP1L;SGSM1;TM9SF2;AMOT;STX7;VCL;RAB14;RAB1A;TM9SF3;RAB23;ARL4A;WLS
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.35296994071100957,0.9724558630506184,0.46991869918699186,0.778295643173575,1.0,8/33,13.02%,EGFR;ANKRD17;RGCC;CCND3;CDC73;CCND2;TFDP1;KMT2E
prerank,bone morphogenesis (GO:0060349),0.417659179029604,0.9724417220312618,0.507168458781362,0.7778276775328852,1.0,1/14,0.46%,LRP6
prerank,positive regulation of myoblast differentiation (GO:0045663),0.3988500762035681,0.9721886915428604,0.49829351535836175,0.7778975258373249,1.0,3/16,9.18%,RIPOR2;MEF2C;MAPK14
prerank,negative regulation of cation channel activity (GO:2001258),-0.3215041341987822,-0.9719483630546228,0.4900497512437811,0.8742928230682563,1.0,11/26,34.95%,CALM2;FMR1;CBARP;EPHB2;GPR35;CALM3;UBQLN1;CRHR1;KCNAB1;GSTO1;EPO
prerank,positive regulation of actin filament polymerization (GO:0030838),0.33489408978420643,0.9715214201306157,0.49922958397534667,0.7788910428777189,1.0,4/44,2.42%,SNX9;ALOX15;FER;FCHSD2
prerank,tRNA metabolic process (GO:0006399),-0.3597863945268858,-0.9712304021246501,0.4716981132075472,0.8750636888145458,1.0,12/17,34.28%,AARS1;SARS1;DARS2;POP1;RPP21;POP7;THG1L;KARS1;TRPT1;ADAT1;SSB;DTD2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.35926565470222394,-0.9710516710740646,0.5056179775280899,0.8743774814545496,1.0,3/17,19.53%,LPCAT1;LPGAT1;PLA2G3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4069450664134399,0.9708683826556687,0.5018115942028986,0.7797896939710601,1.0,3/17,11.27%,APOE;ERLIN1;SREBF2
prerank,regulation of cell division (GO:0051302),0.3071945602131597,0.970208207014973,0.48933143669985774,0.7807272006585267,1.0,11/72,10.99%,TXNIP;NCOA3;UVRAG;RACK1;KLHL13;SFN;EFHC1;BIRC6;ESRRB;CALM1;CETN2
prerank,modulation by host of viral genome replication (GO:0044827),0.4364154827454197,0.969436334755487,0.48426573426573427,0.7818911413108018,1.0,4/13,12.58%,CCL8;PRKN;ZC3H12A;VAPA
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.39937942594867715,-0.9692163914501463,0.492600422832981,0.8783569798162872,1.0,4/12,8.69%,IL33;TREM2;IL18;CCL3
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.325606267433668,-0.969109833589632,0.525,0.8774265252660275,1.0,16/23,42.64%,SLC12A2;SLC12A9;SLC12A6;SLC9A1;SLC12A4;SLC12A5;KCNH2;SLC12A1;PDK2;CLCN3;TFAP2B;ATP6V0A4;SCNN1A;PDK4;SLC26A4;SLC12A3
prerank,negative regulation of cellular component movement (GO:0051271),-0.36592395107198955,-0.9690227607806366,0.4846335697399527,0.8764792946891585,1.0,8/15,28.51%,CD9;SPOCK3;TGFBR3;PIN1;FRMD5;ACTN1;FBLN1;SPINT2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.32457941817702823,0.969002892030736,0.4927302100161551,0.7823292015211829,1.0,7/46,9.90%,TCF7L2;FOXP1;ANG;HMOX1;TNF;IL6R;IGF1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3273418952136044,0.9689230280727086,0.4933135215453195,0.782014341985969,1.0,6/51,7.23%,SNX2;KIF20B;GAS7;TRIO;ATP7A;NRK
prerank,positive regulation of protein depolymerization (GO:1901881),0.43553228500695473,0.9689104632756733,0.50293542074364,0.7815389544037932,1.0,1/11,3.43%,NES
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3464603816392756,0.9688900289292594,0.47775947281713343,0.7810857908918298,1.0,8/31,11.56%,OPHN1;CDC42;RHOA;SYNJ2BP;PARD3B;MSN;MARK2;MYO9A
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3865741705671757,0.968801936446909,0.49746192893401014,0.7807790657263945,1.0,11/21,23.07%,SAMD4A;TUT7;TUT4;CNOT9;CNOT11;CNOT6L;CNOT4;CNOT1;CNOT8;PAN3;CNOT2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.33525247305605055,-0.968698053009303,0.5035799522673031,0.8761804557379338,1.0,11/25,20.27%,RIN3;DLG4;ITGB3;APOC1;ANKRD13B;ANKRD13D;ARF6;ATXN2;ITGAV;ANKRD13A;ABCA2
prerank,neurotransmitter transport (GO:0006836),-0.25725155550796674,-0.9686481778916773,0.5165562913907285,0.8751424232793571,1.0,22/73,22.33%,SLC1A3;RIMS1;SNAP25;NRXN1;PPFIA2;PPFIA4;DVL1;APBA1;SYN3;CPLX1;SLC1A1;GABRA2;PTPRN2;LIN7A;VAMP2;LIN7C;SYT1;SLC17A6;SLC1A2;CHAT;BRSK1;GAD1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.32717985555741785,0.9683851634740717,0.4915254237288136,0.7812150959077745,1.0,7/43,9.90%,NELL1;MEF2C;BMP2;ACVR2A;IL6R;DDR2;IGF1
prerank,carnitine shuttle (GO:0006853),0.44934934022839895,0.9680438701064522,0.5113871635610766,0.781480613640719,1.0,1/11,1.30%,PRKAG2
prerank,connective tissue development (GO:0061448),0.3403874610496258,0.9674846832628401,0.4800637958532695,0.7822108773009728,1.0,6/35,8.81%,ZBTB16;CD44;GHRL;ATP7A;SPTLC2;SULF2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.299633129589386,0.96747257231731,0.49297752808988765,0.7817425509733144,1.0,15/88,11.66%,RPS3;RGCC;GSK3B;RACK1;SYK;SDCBP;TNF;VPS4B;RAB7A;FNIP1;SDC4;SPIDR;SYNPO;EMILIN1;CHGA
prerank,protein targeting (GO:0006605),-0.23776344276419314,-0.9674115445043354,0.55,0.8773564057012615,1.0,39/118,26.43%,SORL1;NLGN1;PARD3;FBXO7;HPS4;RAB3IP;MICALL1;PEX6;AKAP6;TIMM44;VPS37A;ZDHHC18;AP4B1;RTP4;EDEM1;GDAP1;TOMM40;SPCS1;AP1S3;SEC61A1;TIMM8B;AIP;ZDHHC1;TOMM20;ZFAND2A;ZDHHC15;HAP1;HACL1;KATNB1;BCAP31;PEX19;TOMM34;SRP14;ZDHHC22;PRKCI;FIS1;GOLGA7;TOMM5;GIPC1
prerank,respiratory tube development (GO:0030323),-0.31684549041936894,-0.966975221800492,0.49878345498783455,0.8774043945530282,1.0,12/28,29.16%,FGF2;FGFR2;LOXL3;BAG6;CCDC39;PROX1;PDPN;CCDC40;FGF1;WNT7B;FGF7;BMP4
prerank,regulation of double-strand break repair (GO:2000779),0.3367409750063164,0.9668435665368637,0.4992248062015504,0.782625216000602,1.0,13/39,20.83%,RNF169;CHEK1;FOXM1;DDX11;SPIDR;PPP4R2;DEK;TERF2IP;KDM1A;ACTR2;RTEL1;SHLD2;TRIP12
prerank,regulation of DNA binding (GO:0051101),-0.28240560827493555,-0.9664418160633066,0.4927536231884058,0.8777470568418093,1.0,16/44,23.99%,JAK2;DOT1L;SIRT2;HABP4;JUN;MDFI;EDF1;SMO;EGF;TXN;MAPK8;FOXC1;HMGB1;TGFB1;ILRUN;LEF1
prerank,protein localization to membrane (GO:0072657),0.2729198863109373,0.9662335347715584,0.5288461538461539,0.7834314218593419,1.0,42/187,16.51%,ITGA4;LRP6;MYO5A;EHD4;FCHO2;MYADM;GAS6;SPTBN1;RAB8B;RAB10;RAPGEF2;S100A10;ITGB1BP1;EHD1;RFTN1;RAP1A;SAV1;ROCK1;TNF;SYNJ2BP;TM9SF2;RABEP1;ZDHHC3;DENND4C;TM9SF3;PIP5K1A;JUP;KCNB1;ROCK2;RAMP2;TNFRSF1A;SCN3B;FYB1;RAB11A;ITGB2;TMED2;SYNE3;TSPAN14;ZDHHC2;RAB3B;SEC16A;RAB32
prerank,regulation of receptor recycling (GO:0001919),-0.37031700367340037,-0.9661875843642378,0.5145833333333333,0.8772761880394241,1.0,4/16,14.51%,TBC1D16;OPTN;INPP5F;AP1AR
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.32367013658734844,-0.9659835215201071,0.5025380710659898,0.8767061932585849,1.0,7/25,15.33%,SRRM1;GEMIN2;SRSF10;PRPF4;SF3B1;PRPF6;DDX23
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.42381137183687606,0.9657231033769605,0.5034602076124568,0.7840537390948501,1.0,2/13,5.11%,PDE8A;RACK1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3263752118564697,0.9656279424024578,0.5114854517611026,0.7837668483581856,1.0,12/43,17.66%,FOXP1;ERN1;P2RY6;HMOX1;TNF;IL6R;IGF1;RBPMS2;GJA1;BMPR1A;CCL5;IL6
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.30282648751657515,-0.9656033322525104,0.48984771573604063,0.8765530874514816,1.0,5/32,5.92%,CAPN3;CALM2;PLCG1;TRPC1;AKAP6
prerank,regulation of smoothened signaling pathway (GO:0008589),0.3195497127515542,0.9655926464629307,0.5156482861400894,0.7833507200372989,1.0,12/50,16.62%,HERC4;FBXL17;INTU;RACK1;TTC23;SFRP1;WDR11;CREBBP;STK36;GPC3;TXNDC15;GLIS2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.28937928467416163,-0.9655829408389167,0.5229885057471264,0.8754241841954561,1.0,6/45,4.08%,IRF8;PRKCD;NCAM1;JAK2;STAT1;IRF3
prerank,heart morphogenesis (GO:0003007),-0.2779545773876576,-0.965056295988159,0.5229357798165137,0.875700544436672,1.0,10/50,19.40%,TGFBR1;CHD7;ACVR1;OLFM1;TGFBR3;MDM4;NOTCH1;FLRT2;ENG;TGFB2
prerank,regulation of integrin activation (GO:0033623),-0.36868244148605445,-0.9648961824201212,0.5068493150684932,0.8749645296298105,1.0,4/15,5.03%,FBLIM1;SRC;FERMT2;PIEZO1
prerank,regulation of neuron differentiation (GO:0045664),0.3079676161592281,0.9641854487160653,0.5138121546961326,0.7858864787826785,1.0,8/76,5.88%,FGFR1;TCF4;MEF2C;BMP2;RHOA;GPRC5B;ROCK1;TRIM32
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.42973799861434325,0.9640695615318884,0.48576512455516013,0.7856465946825227,1.0,4/11,18.51%,GNPDA1;GFPT2;UAP1L1;RENBP
prerank,positive regulation of exosomal secretion (GO:1903543),0.4089110332387801,0.964041525234393,0.5008976660682226,0.7852220280255741,1.0,7/15,22.63%,SDCBP;VPS4B;RAB7A;SDC4;STAM;PDCD6IP;TSG101
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3315862690467163,-0.9635485408089911,0.5136476426799007,0.8776174821541668,1.0,5/24,12.43%,TTLL11;PARP1;TTLL7;GGCX;TTLL1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.2973120471217757,-0.9631243315913661,0.5053475935828877,0.877645576425421,1.0,11/35,24.30%,CALM2;MAGI2;NUAK1;PPP1R11;TSC1;PPP6R1;MTOR;PTPA;CALM3;MASTL;PDGFRB
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.39178392488718583,0.9630772500608016,0.4991181657848324,0.7868449299068644,1.0,7/18,13.90%,FER;CBL;SPI1;SMAD4;IL6R;JAK1;STAT3
prerank,regulation of stem cell population maintenance (GO:2000036),0.39347403855845114,0.9626403349225481,0.4965753424657534,0.7873104334500592,1.0,4/18,15.18%,NCOA3;ESRRB;LOXL2;MYC
prerank,artery morphogenesis (GO:0048844),0.3466239249622504,0.96263234804223,0.5128205128205128,0.7868334430356044,1.0,3/30,4.49%,NRP1;JAG1;HEY2
prerank,mRNA methylation (GO:0080009),0.40504856371621323,0.9626116896480206,0.4908759124087591,0.7863864652035271,1.0,7/15,23.11%,WTAP;NSUN2;VIRMA;TRMT61B;TRMT61A;METTL16;PCIF1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.38414596805258505,0.9624849732746283,0.4955595026642984,0.7861645393386403,1.0,3/19,5.02%,FBXW7;PRKN;CAMKK2
prerank,sphingolipid catabolic process (GO:0030149),-0.37519000218773585,-0.9619196228135389,0.4945054945054945,0.8798107255083147,1.0,6/15,13.09%,ENPP2;SMPD4;ASAH1;PPT1;ASAH2;ACER2
prerank,defense response to fungus (GO:0050832),0.4078657243800176,0.9619021791282744,0.5107913669064749,0.7869571551376808,1.0,4/17,12.01%,CLEC6A;BCL10;CLEC4D;FAM3A
prerank,cellular copper ion homeostasis (GO:0006878),0.4107127098122129,0.9617762758370842,0.5044883303411131,0.7867471615848872,1.0,2/14,5.58%,APP;ATP7A
prerank,global genome nucleotide-excision repair (GO:0070911),-0.32415045783295626,-0.9615955530992089,0.5105263157894737,0.8795343051819483,1.0,6/26,9.13%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,regulation of organelle assembly (GO:1902115),-0.2629584725545702,-0.9614911887907643,0.5470383275261324,0.8786292235335541,1.0,16/73,9.51%,TBC1D16;TBC1D8;SDCCAG8;CYLD;SGSM3;STX18;IFT140;ATXN2L;TBC1D10A;IFT88;RDX;TBC1D22A;IFT20;DYNLT2B;TBC1D22B;TBC1D9B
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.29868294122226907,0.9614001036937337,0.5172910662824207,0.7870809420130099,1.0,11/75,10.08%,APP;MEF2A;OPHN1;ATL1;MEF2C;RAB10;RB1;ACTB;MAPK8IP2;CCK;DOCK7
prerank,establishment of vesicle localization (GO:0051650),-0.3527556898637056,-0.9610212845642773,0.5254237288135594,0.8787489887223617,1.0,10/18,32.25%,RAB27A;KIF5A;SPG11;KIF5C;LIMK2;TOR1A;CCDC186;KIF5B;F8A1;SNAPIN
prerank,negative regulation of cell population proliferation (GO:0008285),0.25672095112489374,0.960653104184901,0.5460455037919827,0.7882120717761544,1.0,55/351,15.75%,MTSS1;NELL1;APP;PTPRJ;NUPR1;LYN;ANG;RARG;BNIPL;CBFA2T3;ABI1;TNN;BMP2;PRKRA;S100A11;HMOX1;RGCC;RAPGEF2;ITGB1BP1;B2M;MCC;FRK;GSDME;CDK6;PTPRK;TRIM32;KLF4;PDS5B;KLF10;CDC73;CGREF1;ADRA1A;CD33;THAP12;SH2B3;SFRP1;NUP62;TFDP1;FTH1;KANK2;STRN;NIBAN2;CDKN2C;DIS3L2;CTBP2;ZBTB7C;RBP4;PKD2;NOX4;MYC;RNF41;PINX1;PTPN14;VGLL4;RUNX3
prerank,carboxylic acid transport (GO:0046942),-0.2638368682615892,-0.960393910462469,0.5218855218855218,0.8792476634223194,1.0,14/55,17.34%,SLC16A6;SLC36A1;SLC16A3;CLN3;SLC36A4;SLC16A1;SLC1A1;SLC7A8;SLC17A5;SLC16A4;LLGL2;PSAP;SLC16A9;SLC25A10
prerank,positive regulation of transferase activity (GO:0051347),-0.2266695720012931,-0.9600686570295601,0.588,0.8789264067802962,1.0,27/142,14.01%,MERTK;SORL1;CTNNB1;XRCC5;TREM2;EPHA7;PABPN1;HNRNPA2B1;ARRDC4;FGFR2;FLT1;NTRK3;MAPK3;AXL;MAP2K7;EPHB1;EPHA10;PTGES3;ALK;FLT3;CSF1R;ERBB4;CD200;RFC2;MAP3K4;EPHA3;TYRO3
prerank,regulation of extracellular matrix organization (GO:1903053),0.397852041285389,0.9595236385787147,0.5017301038062284,0.7902156578205716,1.0,3/15,8.61%,RIC1;RB1;DDR2
prerank,programmed necrotic cell death (GO:0097300),0.39249261703408994,0.9593142394161859,0.5217391304347826,0.790168572623806,1.0,3/18,5.47%,RIPK1;TLR4;LY96
prerank,inositol phosphate catabolic process (GO:0071545),0.42322083093538065,0.9592186234872094,0.5009208103130756,0.7898567855869415,1.0,4/12,19.24%,SYNJ1;OCRL;PTEN;INPP5K
prerank,secretory granule organization (GO:0033363),-0.41549294256156855,-0.9588692446322976,0.5148305084745762,0.8810456619242523,1.0,1/10,0.34%,LYST
prerank,calcium ion transport (GO:0006816),0.2842786401182302,0.9582276699249898,0.5235531628532974,0.7915358383330869,1.0,19/113,12.83%,P2RX7;CCR1;TPT1;GAS6;ANO6;CALCRL;STIM2;CCL8;STIM1;CHRNA4;PSEN1;FYN;TRPV3;TMEM165;TRPM2;TRPC7;ATP2B4;MCOLN2;RAMP2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.4060145941165574,-0.9581911505654105,0.5175438596491229,0.8817000352458259,1.0,6/11,18.12%,ITGB3;CD34;MCAM;HPSE;NDNF;SRF
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4441175580298241,0.9581298832237389,0.527831094049904,0.7912720906326031,1.0,3/11,9.55%,RREB1;CD44;CORO1C
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.3900231689837635,-0.9578869241687995,0.5121412803532008,0.8813697856933088,1.0,2/13,7.11%,PRKCD;MAPT
prerank,negative regulation of cellular component organization (GO:0051129),0.2991817253053519,0.9578051900337825,0.5136239782016349,0.791461510427781,1.0,9/74,6.94%,MCTP1;IRAK3;NR1H4;LILRB1;CDC42;GSK3B;RIOK3;NOP53;TNF
prerank,potassium ion transmembrane transport (GO:0071805),-0.2312616220290314,-0.9577684933535212,0.5228426395939086,0.8805256214112377,1.0,19/135,9.84%,SLC1A3;KCND2;KCNH7;SLC12A2;KCNJ2;SLC24A3;SLC24A2;ATP1B1;SLC9A8;ATP1B2;SLC12A9;KCNQ3;NALCN;SLC24A4;KCNQ5;KCNK2;KCNA1;KCNA2;KCNK12
prerank,nuclear migration (GO:0007097),0.4167261011337906,0.9577290445717069,0.4991023339317774,0.7911410684914754,1.0,5/13,15.07%,SYNE2;DOCK7;PAFAH1B1;PCM1;SYNE3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.28484447852976097,0.9574751394480906,0.521108179419525,0.791214943927788,1.0,14/107,12.32%,ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;CD40;STIM1;CCR2;TMEM165;SLC39A12;SLC10A7;SLC8B1;ATP2B4
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2918694252801778,-0.9574710635790313,0.5076923076923077,0.8802047967760845,1.0,9/35,12.73%,EML3;DYNC1H1;GNAI1;CEP97;HNRNPU;CHMP4B;TACC3;NUMA1;PARP3
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.27993953440323016,0.9574026308297888,0.5353016688061617,0.7908778202280917,1.0,18/128,7.63%,NRROS;SMURF2;ITGB1;RPS27A;BMP2;GDF3;ADAM9;CBL;RHOA;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;ACVR2A;USP15;DUSP22;HFE
prerank,rRNA modification (GO:0000154),-0.33885093348080086,-0.9573579939743012,0.5263157894736842,0.8793702163806042,1.0,7/21,20.85%,TFB2M;FTSJ3;TSR3;GAR1;MRM2;MTERF4;THUMPD1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4020907326150052,0.957168951176196,0.5089285714285714,0.7908994420190085,1.0,3/15,10.61%,NCOA3;SFN;TRIM16
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3514083681345038,0.9569121883123849,0.49836065573770494,0.7909713440298356,1.0,7/32,11.97%,RB1;CDK14;ESRRB;BACH1;TFDP1;HINFP;CDK17
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4479000947103887,0.9565068497726052,0.49812734082397003,0.791397734284121,1.0,4/10,16.59%,RIPOR2;CD200R1;WASL;MIA3
prerank,negative regulation of lipid metabolic process (GO:0045833),0.3696521422739337,0.956209809933318,0.5068493150684932,0.7915406399480082,1.0,4/22,8.14%,UGT1A8;UGT1A1;TNF;NCOR1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.27995951435148086,-0.9560193604367253,0.5400516795865633,0.8818078256241209,1.0,7/41,10.87%,SLC24A2;SLC8A1;HTR2C;FGF2;CACNA2D1;ITPR2;GRIN2A
prerank,aorta development (GO:0035904),0.402836312153116,0.9558034860840838,0.4964912280701754,0.7919469913210951,1.0,5/14,16.56%,JAG1;PDE2A;ADAMTS9;PKD2;TBX2
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3558072466661174,-0.9555050099845468,0.5033860045146726,0.8820056511498927,1.0,8/16,26.87%,BLM;RECQL5;SSBP1;MCM6;RAD51;MCM2;MCM7;MCMDC2
prerank,mitotic cytokinesis (GO:0000281),0.32550692414883803,0.9553066685492878,0.5007541478129713,0.7925099923155512,1.0,17/47,21.82%,SNX9;RASA1;SPTBN1;INCENP;ROCK1;EFHC1;KIF4A;SNX33;ROCK2;RHOC;STMN1;CUL7;KIF23;PDCD6IP;EFHC2;RACGAP1;CEP55
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.37961709831910845,-0.9549416419445068,0.5167785234899329,0.8823435981915395,1.0,2/13,2.21%,CALM2;SLC8A1
prerank,protein O-linked mannosylation (GO:0035269),-0.34187872563885774,-0.9549410612468651,0.530952380952381,0.8811925294463029,1.0,3/18,10.09%,LARGE1;TMTC4;TMTC2
prerank,action potential (GO:0001508),-0.28165296557623826,-0.9547923340740293,0.532967032967033,0.8804432564298094,1.0,8/44,11.35%,KCND2;KCNJ2;YWHAH;CLN3;AKAP6;KCNA1;KCNA2;SCN8A
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3544311996334434,0.9544669934072852,0.4939550949913644,0.7938291950244462,1.0,7/30,12.68%,SH3BP5;PARP14;PIBF1;SH2B3;PPP2CA;SFRP1;SH3BP5L
prerank,regulation of ion transport (GO:0043269),0.2972225518844742,0.9542839237520394,0.5209176788124157,0.7937216232392393,1.0,9/76,7.63%,P2RX7;DRD1;KCNJ14;SNX6;B2M;PRKN;WNK1;CHRNA4;HFE
prerank,regulation of dendrite extension (GO:1903859),-0.3430809841708873,-0.9542403488646695,0.5023474178403756,0.8807691832747473,1.0,2/18,2.26%,RIMS1;RIMS2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3783493247066064,0.9538784586061827,0.5315315315315315,0.7941348564390105,1.0,4/19,7.08%,GAS6;PPP2R3C;SYK;ZAP70
prerank,negative regulation of cell motility (GO:2000146),0.2854767503525981,0.9535670408522172,0.5169270833333334,0.794324949194997,1.0,12/108,7.38%,MCTP1;PTPRJ;RAP2B;JAG1;MITF;CD74;CRK;CLIC4;PTPRK;STK24;BST2;DUSP22
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.41883495827388983,-0.9534016550436603,0.5414847161572053,0.8819024837814485,1.0,7/10,31.97%,IMPACT;SIRT2;JUN;DNAJB1;VHL;HIF1AN;HSPA1A
prerank,cellular response to light stimulus (GO:0071482),0.3062920595758689,0.9530249527408745,0.5021834061135371,0.7950216742319359,1.0,20/66,20.20%,RPL26;RHBDD1;PDE6A;PTPRK;RRH;GPR52;YY1;GNB1;RHNO1;CREBBP;EP300;USP28;MYC;USP47;KDM1A;ATR;ZBTB1;EIF2AK4;GPR88;PCNA
prerank,negative regulation of cell migration (GO:0030336),0.27650814447814676,0.9529902212045398,0.5527318932655655,0.7946064116696384,1.0,19/137,10.04%,MCTP1;PTPRJ;RAP2B;JAG1;MITF;TNN;CD74;HMOX1;ITGB1BP1;MCC;CLIC4;PTPRK;STK24;BST2;DUSP22;VCL;CLASP1;CORO1C;SFRP1
prerank,regulation of stem cell differentiation (GO:2000736),0.29095440810069784,0.9527660159332283,0.5292479108635098,0.7945959966509937,1.0,15/89,15.12%,KMT2A;ZFP36L2;PSMA7;JAG1;TCF12;PDGFRA;CBFB;PSMB2;ESRRB;NSUN2;PSMA6;PSMA3;PSMD1;PSMD5;BMPR1A
prerank,regulation of RNA export from nucleus (GO:0046831),-0.40003161511116714,-0.9527109046531919,0.5536842105263158,0.8826379117476367,1.0,5/11,22.38%,CPSF6;AKAP8L;DHX9;SETD2;NRDE2
prerank,cellular metal ion homeostasis (GO:0006875),0.28811552486121417,0.9524740513814183,0.543010752688172,0.7947130630625862,1.0,19/102,14.32%,ATP2B1;CCR1;TPT1;STIM2;CCL8;CCL19;CD40;STIM1;CCR2;TMEM165;TESMIN;SLC10A7;SLC8B1;ATP2B4;ATP1A3;ATP1A4;ATP1A1;ATP2A2;NEDD4L
prerank,mitotic spindle organization (GO:0007052),-0.22295202736881706,-0.9523599166405488,0.6059113300492611,0.8823750197801624,1.0,68/153,31.86%,CLASP2;DYNC1H1;CENPC;RANBP2;CEP192;CENPE;WDR62;KNL1;NEK6;NUP85;WRAP73;KIF11;TOGARAM1;CKAP5;EML1;MAPRE1;BUB1B;CHEK2;KIF3B;BUB1;SEH1L;DLGAP5;MAP4;KIFC2;SPDL1;NDC80;KIF2A;INTS13;GOLGA2;SKA2;BCCIP;NSL1;PTPA;CDCA8;AAAS;B9D2;RCC1;SEC13;KIFC1;DCTN2;ZW10;TOGARAM2;CENPP;CENPN;CENPH;FLNA;MAP9;ZWINT;STIL;BIRC5;MAD2L1;CEP126;CENPI;SPC25;AURKB;PMF1;DYNLL2;KIF2C;TTK;CENPF;SGO1;NUDC;PPP1CC;CLIP1;MZT1;NUF2;TUBG1;AURKA
prerank,response to organophosphorus (GO:0046683),0.39257846740843827,0.9520569912949265,0.5151515151515151,0.7951418951958825,1.0,1/16,0.51%,P2RX7
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.30647265756013947,-0.9514321916698685,0.5277777777777778,0.8837494553467582,1.0,8/29,19.16%,SIRT7;BAG6;ZCWPW1;FANCD2;SYCE2;IHO1;STAG3;P3H4
prerank,positive regulation of neuron projection development (GO:0010976),-0.2416091722973149,-0.9510448662150233,0.5661764705882353,0.8836077326394829,1.0,27/85,21.08%,PTK2B;SETX;ITGA6;SCN1B;MAGI2;TENM3;ATP1B2;NDRG4;SCARB2;NTRK3;TWF2;BDNF;SERPINI1;ALK;CAPRIN1;RAPGEF1;NDNF;EPHA3;GPC2;FUT9;ZDHHC15;DBN1;PLXNB2;PLA2G3;PLXNB3;WNT5A;TWF1
prerank,activation of protein kinase activity (GO:0032147),-0.23605952844570804,-0.9510212346438465,0.5671641791044776,0.8825243800878484,1.0,29/106,20.49%,MAP4K4;PRKCD;JAK2;PTK2B;ADCY3;ADCY8;PAK1;PRKAR1A;ITGB3;PRKAR1B;STK11;NTRK3;IL18;COPS8;TOM1L1;ADCY7;MINK1;PDPK1;TGFBR2;PARK7;MLST8;ADCY1;MTOR;PAK3;TXN;TGFB2;WNT5A;TLR3;PAK4
prerank,mitochondrial transport (GO:0006839),0.31500295433400816,0.9509205720107317,0.5174418604651163,0.7970795729791293,1.0,4/53,6.74%,SLC25A16;SLC25A24;BCL2;PITRM1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.4137288632616728,0.9502396687347097,0.5203703703703704,0.7980534040847371,1.0,3/12,10.31%,PARP8;PARP11;PARP16
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2848696967183,-0.9498306894101284,0.5634920634920635,0.8846390352420657,1.0,9/39,12.31%,TANC2;MYO1F;PPFIA2;KIF1A;CLN3;MYO1B;MYO6;MYO1D;MYO5B
prerank,spinal cord development (GO:0021510),-0.3836792661167002,-0.9496323902051077,0.5210643015521065,0.8840246388865178,1.0,4/12,20.57%,NF1;LOXL3;VIT;SOX11
prerank,regulation of fibroblast migration (GO:0010762),-0.33403804812229254,-0.9494690312017494,0.5282555282555282,0.8833111245373411,1.0,5/20,7.26%,PRKCE;PRR5L;FGF2;CLN3;APPL1
prerank,insulin receptor signaling pathway (GO:0008286),0.3065663446581426,0.9492535569104241,0.5290697674418605,0.7997077039386262,1.0,16/69,12.87%,FER;ATP6V1B1;GSK3B;IRS2;INSR;ATP6V0A1;GAB1;AP3S1;PIK3C2A;ATP6V1A;FOXC2;ZNF106;PHIP;SHC1;NAMPT;FOXO1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.434296594368744,0.9492041552324304,0.532803180914513,0.7993345846921227,1.0,1/10,1.22%,ZBTB16
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3563905141014673,-0.9489040884456775,0.531615925058548,0.8837171661502833,1.0,8/16,29.31%,NCL;CELF4;CIRBP;NCBP1;RBMXL1;TRA2A;TRA2B;PRDX6
prerank,negative regulation of coagulation (GO:0050819),0.4021790007192541,0.9488146700393107,0.5293040293040293,0.7997062502480018,1.0,1/14,0.49%,APOE
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.30737951884672843,-0.9487845140643585,0.5330073349633252,0.88286777263948,1.0,9/30,25.17%,PLD4;TP53;FLT1;FLT3;CSF1R;PLEK;TGFB1;PRRC2C;TNFRSF13B
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.29730174177659896,0.9481096623910598,0.5238784370477568,0.8006924484053188,1.0,12/67,14.48%,CYBB;PSMA7;CD36;B2M;PSMB2;NCF2;SNAP23;PSMA6;PSMA3;PSMD1;PSMD5;CYBA
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.3660721042341406,-0.9480523447755115,0.5444444444444444,0.8836928344788999,1.0,10/13,39.61%,ALG1;ALG12;ALG3;ALG8;SRD5A3;ALG6;DPAGT1;MPDU1;ALG14;ALG13
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.38524209017750066,0.947846869927447,0.541958041958042,0.8007502932130001,1.0,6/21,16.22%,RPL23;RPL5;RPS7;RAB1A;RPL11;PTEN
prerank,translational elongation (GO:0006414),0.28314188855732664,0.947661015614632,0.5472222222222223,0.8006708444397435,1.0,19/101,14.23%,MRPL23;MRPS12;EEF1A1;EEFSEC;ERAL1;MRPL13;RACK1;MRPL33;MRPS25;MRPS11;EEF1D;MRPL1;MRPL49;MRPL16;MRPS17;GTPBP1;MRPL44;MRPS34;MRPS14
prerank,eosinophil migration (GO:0072677),0.41004277587224874,0.9473135155418043,0.5106761565836299,0.8004489311662287,1.0,2/14,8.22%,CCL8;CCL24
prerank,eosinophil chemotaxis (GO:0048245),0.41004277587224874,0.9473135155418043,0.5106761565836299,0.8004489311662287,1.0,2/14,8.22%,CCL8;CCL24
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.27478773601895035,0.9470535838787663,0.5678704856787049,0.8005387434831968,1.0,28/151,15.27%,APOE;SGMS1;SGPP1;CEPT1;MOCS1;HACD4;MGST3;GCH1;ACER3;SGPL1;SLC25A2;TYW1;SPTLC2;LCMT2;PAM;ELOVL5;CHKB;CERS6;MGST1;B4GALT5;ACHE;ASS1;VAPA;MFSD2A;GSTT1;ARG2;PRKD2;ST3GAL4
prerank,ear morphogenesis (GO:0042471),-0.3383752541600562,-0.9469870656135542,0.5502392344497608,0.8854925852222326,1.0,6/20,15.61%,CHD7;FGFR2;MYO6;PAX8;ZIC1;EPHB2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.32498010874431305,0.9464037267849772,0.5350609756097561,0.8015006211500132,1.0,16/48,18.91%,ARID1B;ACTB;CHEK1;POLR1A;POLR1B;MYO1C;ELOF1;SERTAD2;DEK;POLR1G;EP300;SMARCD1;ARID1A;ASF1A;POLR2F;DDX21
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.42765548410641446,0.946288364054509,0.5225563909774437,0.8012835008349172,1.0,1/10,1.10%,FBXW7
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.361965315916984,0.946098944243068,0.5371329879101899,0.8011994602711988,1.0,1/22,0.13%,AHNAK
prerank,sodium ion transmembrane transport (GO:0035725),0.2917007876837657,0.9458432313271866,0.5427807486631016,0.8012437019917049,1.0,18/84,16.52%,SLC9A9;FXYD2;ANO6;SLC9A4;SLC4A4;HCN3;SCN3B;SLC6A2;SLC6A5;ATP1A3;ATP1A4;ATP1A1;SLC9A7;SLC9A6;PKD2L1;PKD2;SLC6A11;SLC6A6
prerank,protein modification by small protein conjugation (GO:0032446),0.24948312709239645,0.9451801360548983,0.5879180151024811,0.8021826539977871,1.0,70/361,16.02%,WWP1;FBXW7;SMURF2;ARIH1;RPS27A;VCPIP1;PIAS1;FBXL17;UBE2E3;WAC;CBL;PRKN;URM1;BCL10;ZNRF3;USP9X;RACK1;TRIM33;KLHL13;UBE2Q2;TRIM32;FBXL5;MYCBP2;PIAS2;CDC27;TRIM24;NSMCE2;EIPR1;TRIM47;DTX2;BIRC6;NUP133;CDC73;TRIM68;SHPRH;TRIM27;MDM2;UBE2K;UBE2D3;UHRF2;CUL3;MKRN1;RNF38;ANAPC16;FBXO11;RNF14;ARRB1;RNF111;NUP62;ATG7;AMFR;UFM1;MIB1;FBXO10;NUP98;MKRN3;UBE2R2;UBE2N;ATG10;RNF187;ASB12;HIF3A;NEDD4L;KLHL24;ELOC;MKRN2;RNF41;PEX14;FBH1;UBE2W
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.24945281641119066,0.9450738720713696,0.6100558659217877,0.8019058589594015,1.0,66/341,15.04%,WWP1;RNF150;FBXW7;SMURF2;PSMA7;ARIH1;FBXL17;SIAH2;CBL;PELI1;RMND5A;PRKN;CLOCK;ZNRF3;NDFIP1;USP9X;RC3H1;SPOP;TRIM32;ANKIB1;CDC27;VPS4B;PSMB2;APPBP2;TBL1XR1;BIRC6;SPOPL;MDM2;RNF19B;TBL1X;UBE2K;UBE2D3;COP1;CUL3;ANAPC16;ARMC8;ZFAND2B;UBQLN4;FBXO11;RNF14;VPS37C;ARRB1;RNF111;AMFR;PSMA6;RNF185;UBE3B;TRIM71;MIB1;FBXO10;UBE2R2;AGAP3;RNF115;RBBP6;RNF187;RNF19A;NDFIP2;BFAR;NEDD4L;PSMA3;PSMD1;PSMD5;ANAPC1;ELOC;WDR91;RNF122
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2533247760972162,-0.9450675665847088,0.579136690647482,0.8895264978846515,1.0,23/71,21.13%,LARGE1;ST3GAL5;SPNS2;SMPD4;PPM1L;PLPP3;ASAH1;ASAH2;CERS4;SAMD8;DEGS1;ST8SIA1;CERS5;ACER2;CERS1;ST8SIA3;SGMS2;SPTLC1;SMPD2;TLCD3B;CERS2;PLPP2;KDSR
prerank,organelle fusion (GO:0048284),-0.32270637315423634,-0.9449475037533085,0.5621890547263682,0.8887364758120367,1.0,9/22,25.82%,MFN1;VPS18;GDAP1;AFG3L2;MIGA2;VPS11;FIS1;THG1L;USP30
prerank,cardiolipin metabolic process (GO:0032048),0.4076784742916137,0.9447640905734873,0.5335689045936396,0.8020684451102632,1.0,6/13,21.69%,PNPLA8;HADHA;HADHB;PTPMT1;TAMM41;LCLAT1
prerank,anterior/posterior axis specification (GO:0009948),0.39790122073544576,0.9445277443353042,0.5313653136531366,0.8021367172238257,1.0,3/15,17.03%,HOXD8;WLS;LHX1
prerank,microtubule anchoring (GO:0034453),-0.3891681389689025,-0.9443980874634713,0.5446985446985447,0.8890701013032588,1.0,3/12,7.27%,CLASP2;GCC2;BICD2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.37790235733769995,-0.9443372561919383,0.5343035343035343,0.8881275025557226,1.0,5/13,10.87%,ASPH;LGMN;TBC1D10A;CYFIP2;GRIN2A
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.3784955628409643,-0.9442732253318609,0.527542372881356,0.8871511064427408,1.0,3/13,14.42%,CPSF6;CSTF2;NCBP1
prerank,organelle disassembly (GO:1903008),-0.2903210115079715,-0.9441462321140133,0.5343915343915344,0.8863794247265642,1.0,14/33,28.47%,RETREG1;GFM2;MTIF2;ATG2A;EIF2D;PLK3;ZFAND1;ULK1;GOLGA2;DENR;UBA5;CDK1;KIF5B;DYRK3
prerank,positive regulation of angiogenesis (GO:0045766),0.2786829505047591,0.9440169194056685,0.5551128818061088,0.8027069904525069,1.0,22/108,12.83%,SASH1;ITGB1;S100A1;GRN;HMOX1;CD40;PIK3R6;HSPB1;STIM1;KLF4;GAB1;PRKCB;ADAM12;TNFSF12;FOXC2;NINJ1;MYDGF;SP1;JUP;JAK1;ZC3H12A;RAMP2
prerank,lysosome localization (GO:0032418),-0.2901957540451636,-0.942548651606655,0.5546218487394958,0.8895634095026855,1.0,17/37,36.53%,PLEKHM2;FLCN;MAP6;FAM98A;S100A13;DEF8;HDAC6;KLC2;KXD1;MILR1;KIF5B;TMEM106B;RAB3A;SNAPIN;HPS6;SPAG9;BLOC1S2
prerank,response to thyroid hormone (GO:0097066),0.42052650148733955,0.942492738648598,0.5363984674329502,0.8053550032952553,1.0,4/13,11.20%,KLF9;CTSB;THRB;GAS2L1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3131633408356062,0.9422903336206405,0.5320417287630402,0.8053168485767865,1.0,12/56,15.28%,SNX9;RASA1;SPTBN1;RHOA;INCENP;ROCK1;EFHC1;KIF4A;SNX33;ROCK2;RHOC;STMN1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.39565831292209225,0.942263068172324,0.5185185185185185,0.8048837594196288,1.0,1/15,0.45%,EGFR
prerank,nucleoside catabolic process (GO:0009164),0.4278537294763779,0.9422547861079061,0.5547024952015355,0.8044091316279285,1.0,1/11,1.73%,DPYD
prerank,regulation of RNA splicing (GO:0043484),0.29931647108877624,0.94163462644363,0.5466284074605452,0.8052485788042893,1.0,11/69,9.25%,AHNAK;MBNL1;ERN1;RPS13;LARP7;PTBP3;MBNL2;HNRNPF;PTBP2;GRSF1;DYRK1A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.37783971556732077,0.9408011225220286,0.5369003690036901,0.8065168246492407,1.0,3/18,4.84%,RAP1B;GSK3B;RAP1A
prerank,heterochromatin organization (GO:0070828),0.3969237103247335,0.9406459568667119,0.5509433962264151,0.8063527701806809,1.0,4/14,17.46%,SETDB2;POLE3;LOXL2;MECOM
prerank,regulation of protein localization to cell surface (GO:2000008),0.3395939666708166,0.9400541033972187,0.5215231788079471,0.8071378801210513,1.0,5/33,7.63%,RAB11FIP5;KCNAB2;LEPROTL1;TNF;HFE
prerank,iron ion transport (GO:0006826),0.3145294191323954,0.939946538769253,0.5196232339089482,0.8068704224037319,1.0,12/47,16.26%,CP;CLTC;STEAP3;ATP6V1B1;ATP6V0A1;HFE;ATP6V1A;FTH1;TFR2;ABCB7;MELTF;ATP6V0D1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.41105397711948155,0.9397839072790201,0.5462794918330308,0.8067315977666242,1.0,4/14,8.79%,ALOX15;CEPT1;CHKB;ETNPPL
prerank,sodium ion import across plasma membrane (GO:0098719),0.3899108895278695,0.9397720252074092,0.5237226277372263,0.8062726792019913,1.0,4/17,14.19%,SLC9A9;SLC9A4;SLC9A7;SLC9A6
prerank,regulation of interferon-alpha production (GO:0032647),-0.32627700743604626,-0.9389331675341929,0.5532994923857868,0.8981135406120664,1.0,5/23,5.98%,PTPRS;HAVCR2;STAT1;IRF3;MAVS
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4066968365939005,-0.9388811397989341,0.5203619909502263,0.89712493604563,1.0,3/10,8.95%,PRKCE;HECW2;HECW1
prerank,Golgi ribbon formation (GO:0090161),-0.3778182836959198,-0.9388154307336671,0.5458515283842795,0.8961534470003195,1.0,4/13,18.06%,OPTN;GCC2;STX16;GOLGA2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.32412089251780984,0.9386911300770777,0.5292259083728278,0.8079858837548795,1.0,6/38,11.05%,RIPK1;HMOX1;GSK3B;SFRP1;SP100;CASP8
prerank,intracellular sterol transport (GO:0032366),-0.3798408467690696,-0.9386619580719134,0.5620915032679739,0.8954089412503978,1.0,5/13,23.91%,ABCG1;OSBPL2;ARV1;STAR;ABCA1
prerank,positive regulation of vacuole organization (GO:0044090),0.4176396999181481,0.9384736903305989,0.5096899224806202,0.8079657070020704,1.0,4/10,17.95%,GRN;ANXA2;RALB;PIP4K2A
prerank,negative regulation of cell growth (GO:0030308),-0.22706464551661107,-0.9382328174534872,0.6239316239316239,0.895447803971863,1.0,24/121,16.15%,APBB2;MAP2;PTPRS;DIP2B;TP53;FGF13;BTG1;OSGIN2;STK11;FLCN;DCBLD2;PPT1;ENO1;CCAR2;MAG;DNAJB2;HYAL1;GNG4;APBB1;BCL6;MINAR1;SMARCA2;ACVR1B;ULK1
prerank,arachidonic acid metabolic process (GO:0019369),0.33805743392920723,0.9381423003923873,0.5307692307692308,0.8081970559774829,1.0,3/35,4.93%,ALOX5;ALOX15;PNPLA8
prerank,hepaticobiliary system development (GO:0061008),-0.33324643384391006,-0.9381203591006169,0.5142857142857142,0.8946198408994089,1.0,7/20,21.10%,NF1;TGFBR3;PROX1;CDK5RAP3;WNT4;PHF2;ARID5B
prerank,positive regulation of blood coagulation (GO:0030194),0.3858600688855839,0.9378741183436348,0.5034602076124568,0.8082751310422492,1.0,5/17,18.04%,ANO6;ENPP4;USF1;ST3GAL4;F2R
prerank,positive regulation of cell cycle process (GO:0090068),0.2861000633190299,0.9378058445664639,0.5586510263929618,0.8079380872954479,1.0,16/91,11.15%,KIF20B;CDC42;RHOA;RGCC;INSR;PKN2;DDX11;ATRX;RCC2;MAP3K20;CUL3;IGF1;NUP62;PCID2;RHNO1;PHIP
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.33827407663145587,0.9376650593008896,0.5132890365448505,0.8077317879622887,1.0,4/30,8.59%,RAB31;SPTBN1;RAB10;GOLPH3L
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3438740837929197,-0.9375722292072634,0.5469483568075117,0.8949604472763198,1.0,11/18,42.29%,COX19;COX16;FASTKD3;TIMM21;COX17;COX14;COA3;OXA1L;SURF1;COX20;COX18
prerank,positive regulation of organelle assembly (GO:1902117),-0.26621663015827574,-0.9375375260816218,0.5674157303370787,0.8939307716793454,1.0,16/44,24.01%,ASAP1;DYNC1H1;STX18;CROCC;CCP110;ENTR1;NUMA1;PIP4K2B;PIP4K2C;LRSAM1;KCTD17;RAB3GAP2;BBS4;G3BP1;TAPT1;PLK4
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4236773933621103,0.9373172460013786,0.5177570093457944,0.8075059078321409,1.0,4/11,19.24%,SYNJ1;OCRL;PTEN;INPP5K
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4236773933621103,0.9373172460013786,0.5177570093457944,0.8075059078321409,1.0,4/11,19.24%,SYNJ1;OCRL;PTEN;INPP5K
prerank,negative regulation of protein polymerization (GO:0032272),-0.3137373219685574,-0.9365786581527988,0.59,0.895380277396733,1.0,8/27,16.02%,PRKCD;MAP2;TBCD;TWF2;ARFGEF1;MAPRE1;EML2;CLIP3
prerank,Golgi to lysosome transport (GO:0090160),0.42179665410289946,0.9360624000675567,0.51171875,0.8096652104449699,1.0,2/11,4.55%,ANKFY1;LAMP1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.33959343906560174,0.9360346206462556,0.536923076923077,0.8092405908060487,1.0,5/32,7.23%,BABAM2;NOP53;CHEK1;BRCC3;TOPBP1
prerank,sphingosine metabolic process (GO:0006670),0.3894402038861211,0.9358630120227177,0.5434412265758092,0.8091090264623197,1.0,3/17,6.07%,SGPP1;ACER3;SPTLC2
prerank,synaptic vesicle recycling (GO:0036465),0.3389940691536721,0.9355560873729577,0.5290215588723052,0.8092834266388745,1.0,4/31,7.72%,FCHO2;OPHN1;SYNJ1;CANX
prerank,sensory perception of chemical stimulus (GO:0007606),0.39957766368213754,0.9354933039830612,0.5365853658536586,0.8089390799310064,1.0,2/15,2.76%,C5AR1;CD36
prerank,DNA repair (GO:0006281),-0.19821029878113006,-0.9351904953297699,0.7227722772277227,0.8979536991491129,1.0,66/284,18.76%,HERC2;GTF2H2;CSNK1E;DNA2;XRCC5;SETX;TP53;UBE2B;ACTR8;INTS3;ASCC1;ATRIP;ATM;HPF1;PARP1;ENDOV;DDB2;PRIMPOL;FANCE;DOT1L;ERCC6;SLC30A9;BLM;RNF168;UPF1;RECQL5;BRCA1;ERCC2;ALKBH2;MLH3;TNKS1BP1;HUS1;LIG1;RAD51C;TRIM28;XRCC1;BRCA2;UBXN1;KDM4A;FANCD2;PPP5C;PARP3;RFC2;GADD45A;NEIL3;APBB1;CHEK2;RPAIN;POLI;FANCA;DDX1;PARP4;FAAP100;ASCC2;PARK7;TDP1;RAD51AP1;CENPX;MSH2;POLE;DCLRE1B;HUWE1;POLL;PARP9;NUDT1;UBB
prerank,regulation of smooth muscle cell migration (GO:0014910),0.37085794711842346,0.9349664335074065,0.5413005272407733,0.8095817599367185,1.0,2/20,3.77%,NRP1;S100A11
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.30116904653520915,-0.9348136553575633,0.531615925058548,0.8978288394189587,1.0,5/28,9.14%,IRAK2;CYLD;IRGM;OTULIN;AAMP
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3389478742993063,0.9347177096663191,0.5181347150259067,0.8096450846015391,1.0,3/33,3.80%,ANG;MEF2C;HMOX1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4046911560667625,-0.9343984895883791,0.5446224256292906,0.8978409937272602,1.0,3/10,8.95%,PRKCE;HECW2;HECW1
prerank,positive regulation of dendrite extension (GO:1903861),-0.3430823921335955,-0.9343548090299445,0.5311004784688995,0.8968208129500242,1.0,2/17,2.26%,RIMS1;RIMS2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.28572230852123975,0.9342694438877174,0.5681818181818182,0.8101410584010748,1.0,13/87,7.38%,NRROS;ITGB1;RPS27A;ADAM9;CBL;RHOA;USP9X;SMAD4;PTPRK;TGFBRAP1;GDF10;USP15;DUSP22
prerank,protein-DNA complex assembly (GO:0065004),0.2729068506234803,0.9340396013973774,0.5514993481095176,0.8101236041218152,1.0,25/116,17.65%,PADI4;TCF4;PSMA7;RPS27A;ORC5;ORC2;PSMB2;RPA1;GMNN;ATRX;H3-3A;CETN2;PSMA6;XPA;RPA3;XPC;PSMA3;PSMD1;PSMD5;GTF2H3;MCM8;ANP32B;GTF2H1;DMC1;ASF1A
prerank,sister chromatid segregation (GO:0000819),-0.2955974847107211,-0.9339499255508442,0.538860103626943,0.8968031540306773,1.0,15/31,32.52%,WRAP73;TOP2A;NDC80;NUSAP1;NSL1;CDCA8;KIFC1;ZW10;ESPL1;ZWINT;SPAG5;SGO1;LATS1;TUBG1;KIF18B
prerank,calcium ion import (GO:0070509),-0.31039867125318277,-0.9338954420626826,0.5497512437810945,0.8958432804946314,1.0,7/28,12.39%,CACNB2;SLC8A1;TRPC4;CACNA1D;CACNA1E;CACNA1C;AFG3L2
prerank,regulation of actin filament-based movement (GO:1903115),-0.4049107618628861,-0.9338663377787303,0.5548387096774193,0.8948072817531465,1.0,2/10,4.56%,PDE4B;ANK2
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2760248445345755,0.9337938237112432,0.5784695201037614,0.8101775679930292,1.0,13/117,9.99%,AOAH;CD36;UGT1A7;UGT1A8;UGT1A1;PNPLA8;GLO1;SGPL1;PDHB;ACOT12;IGF1;ACSL3;CYP26B1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.35616233173555223,0.933550663101451,0.533106960950764,0.8102129917808746,1.0,6/23,12.32%,GNG2;DRD1;PRKN;GNB1;KCNQ1;ATP2B4
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3095148138195886,-0.9334864419069895,0.5576923076923077,0.8946707000268914,1.0,4/26,4.22%,LRP5;ADCY8;EFNA5;PLA2G6
prerank,calcium ion transport into cytosol (GO:0060402),-0.32282142335326325,-0.9333802925018265,0.5412844036697247,0.8938626632712962,1.0,5/21,11.72%,SLC8A1;CACNA2D1;JPH1;GRIN2A;CACNA1C
prerank,positive regulation of type I interferon production (GO:0032481),0.2927633218127165,0.9331255598743108,0.5623229461756374,0.8106425014745656,1.0,13/73,12.63%,TLR8;OAS2;PTPN22;TLR4;TLR2;TRIM56;RIOK3;LRRFIP1;STAT6;RIPK2;CREBBP;DHX33;POLR3D
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2896592090023334,0.9327386498779082,0.5668604651162791,0.8109976848694339,1.0,13/76,12.28%,FBXW7;PIAS1;PRICKLE1;AXIN1;BCL10;BIRC3;NDFIP1;MYCBP2;TSPYL5;CUL3;RIPK2;WFS1;ZC3H12A
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.33013635338442626,-0.9326804930188358,0.5496688741721855,0.8945803407399161,1.0,3/21,6.96%,HK2;TALDO1;RPIA
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.311118625012446,-0.9325719910216601,0.5588235294117647,0.8937634147555354,1.0,4/25,6.32%,LYST;SORT1;CHMP4B;CHMP4A
prerank,metal ion transport (GO:0030001),-0.240778754944955,-0.9322982676801693,0.5985663082437276,0.8934100971250517,1.0,18/86,12.57%,CDH23;SLC8A1;NIPA1;TRPC4;RAMP1;CACNA2D1;GRIN3A;CACNA1D;TRPC1;SLC30A9;CACNA1E;TRPC3;CCL3;CACNG7;CACNA1C;TRPC5;ATP2C1;CACNG8
prerank,positive regulation of secretion (GO:0051047),0.4202233543904601,0.932140674461379,0.5067961165048543,0.8117645482136719,1.0,3/11,17.28%,ACSL3;TRH;XBP1
prerank,RNA catabolic process (GO:0006401),0.31833500853602886,0.932017644597418,0.547945205479452,0.8115466186328927,1.0,9/46,13.34%,ZFP36L2;ERN1;SND1;RNASE6;MTREX;DCP2;DIS3L2;ZC3H12D;LSM2
prerank,membrane lipid biosynthetic process (GO:0046467),0.3055518327399757,0.9318486159791701,0.5708029197080292,0.8114261342435173,1.0,8/58,8.85%,SGMS1;SGPP1;HACD4;ACER3;SGPL1;SPTLC2;ELOVL5;CERS6
prerank,release of cytochrome c from mitochondria (GO:0001836),0.38081958096202445,0.9318265010006084,0.5329861111111112,0.8109820305613054,1.0,2/17,6.34%,SFN;BCL2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.3944144798563314,-0.9317130503435,0.5488069414316703,0.8937897897934746,1.0,5/11,21.39%,AUP1;BAG6;UFD1;RNF5;TOR1A
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.35098715063854136,0.9315951857274949,0.5528455284552846,0.8110035066508583,1.0,7/29,13.29%,PRKRA;TUT7;PUM2;DROSHA;TUT4;TRIM71;MRPL44
prerank,transcription by RNA polymerase III (GO:0006383),-0.3048718129578158,-0.931593591441461,0.5251256281407035,0.8930097544883331,1.0,11/27,30.66%,IVNS1ABP;GTF3C2;ICE2;POLR3G;ELL;POLR2L;BRF1;TBP;ICE1;SNAPC1;POLR3GL
prerank,long-chain fatty acid metabolic process (GO:0001676),0.30600305990148635,0.9314348157524519,0.5708333333333333,0.8108543909892104,1.0,5/64,7.30%,ALOX5;LTC4S;ALOX15;PNPLA8;ELOVL5
prerank,negative regulation of viral release from host cell (GO:1902187),-0.3748164568222412,-0.9312164781152816,0.5701357466063348,0.8929006569646556,1.0,6/13,22.56%,TRIM28;TRIM13;TRIM11;TRIM21;CHMP3;TRIM8
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3600603780307254,0.9311866589178032,0.5306122448979592,0.8109133055367664,1.0,6/24,9.74%,PPHLN1;JARID2;SPI1;EPC1;TRIM27;H3-3A
prerank,stress granule assembly (GO:0034063),-0.330420666488227,-0.9307103725520111,0.5268065268065268,0.89307397722188,1.0,8/20,22.20%,DYNC1H1;ATXN2L;MAPT;OGFOD1;CIRBP;ATXN2;PRRC2C;G3BP1
prerank,stress-activated MAPK cascade (GO:0051403),0.2968595532960675,0.9305988039655327,0.5584795321637427,0.811613708141502,1.0,12/61,13.05%,MAP3K5;RPS27A;ZFP36L1;CCM2;MAP3K8;MAPK14;MAP3K20;RIPK2;PTGER4;MAP3K11;NOD2;UBE2N
prerank,phosphatidylserine metabolic process (GO:0006658),-0.29470168362274735,-0.9302459797093654,0.5721271393643031,0.8931988118476183,1.0,7/32,19.53%,ABHD12;PTDSS1;PTDSS2;LPCAT3;ABHD16A;SERINC1;PLA2G3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.2836617168936408,0.930179814226643,0.5742024965325936,0.8120233908353215,1.0,19/87,16.22%,ZFP36L2;PSMA7;ZFP36L1;RGCC;CDK6;RB1;KLF4;PSMB2;CDC73;KANK2;PSMA6;CDKN2C;PSMA3;PSMD1;PSMD5;PKD2;PINX1;USP47;PTEN
prerank,mitotic recombination (GO:0006312),0.39197261603097844,0.930092805966342,0.525,0.811726002098627,1.0,7/15,24.60%,NSMCE2;RAD52;DMC1;SMC6;XRCC3;RAD51D;ERCC1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2503695159815269,-0.9300258259534737,0.5777777777777777,0.8926687913198708,1.0,15/62,15.63%,GTF2H2;CDK9;CCNT2;MLLT1;CCNH;SSRP1;NELFB;CTR9;ERCC2;PAF1;NELFCD;EAF1;POLR2C;NCBP1;ELOB
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.40133148743117286,-0.929893102645476,0.5654008438818565,0.8919123501738513,1.0,6/10,35.78%,BRCA1;CTBP1;THAP7;TAF7;SIRT1;NOC2L
prerank,ceramide biosynthetic process (GO:0046513),-0.27818917698166584,-0.9297015038047202,0.5519287833827893,0.8913634404572227,1.0,17/40,20.07%,ST3GAL5;ST6GALNAC3;SMPD4;ASAH1;ST6GALNAC4;ASAH2;CERS4;SAMD8;DEGS1;CERS5;CERS1;ST8SIA3;SGMS2;SPTLC1;SMPD2;TLCD3B;CERS2
prerank,visual perception (GO:0007601),0.28537926971831673,0.9292330165995232,0.548431105047749,0.813087862104234,1.0,11/84,11.68%,ATXN7;RAX;DHRS3;PITPNA;CRYBG3;MYO7A;DRAM2;ATF6;BEST1;MYO9A;WFS1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.2881915284060553,0.9291789352536921,0.569583931133429,0.812709321917024,1.0,21/80,17.88%,EIF3E;SAMD4A;NIBAN1;RPL26;VIM;RACK1;RPS4X;TNF;RPL5;LARP4B;SP1;ROCK2;TNFRSF1A;LARP4;PIWIL2;RELA;IL6;PYM1;IFNGR1;PICALM;EFNA1
prerank,signal transduction in response to DNA damage (GO:0042770),-0.26904946405342495,-0.929178008524895,0.5782122905027933,0.891648446182731,1.0,13/49,13.93%,TP53;ATRIP;ATM;MYO6;DOT1L;ERCC6;CEP63;HUS1;MDM4;PRPF19;ACER2;GADD45A;CHEK2
prerank,negative regulation of cell division (GO:0051782),0.4171031732820203,0.9289408890609683,0.5358490566037736,0.8127391487613995,1.0,3/11,15.88%,TXNIP;MYC;E2F8
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.38246662717190577,-0.9287956405258083,0.5675675675675675,0.8915484599246135,1.0,5/12,23.71%,ADCY8;PLA2G6;CFTR;C2CD2L;BAIAP3
prerank,regulation of phospholipid metabolic process (GO:1903725),0.4230485657808154,0.9287856031416838,0.5452830188679245,0.8125998102367272,1.0,3/10,16.40%,MTMR3;MFSD2A;MTMR1
prerank,regulation of lymphocyte activation (GO:0051249),-0.37435277262418276,-0.9284247405755762,0.5610278372591007,0.8913934208781358,1.0,1/12,0.26%,PAG1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4107023770084679,0.9281776270730832,0.5495495495495496,0.813418054781443,1.0,1/10,1.56%,ESR1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.3394539801801907,-0.9275728596818675,0.5636792452830188,0.8924830485673674,1.0,8/17,24.74%,AUP1;UFD1;NPLOC4;SYVN1;SELENOS;TMEM129;FAF2;SEC61B
prerank,cellular response to ketone (GO:1901655),0.3309972913783619,0.9272286437289516,0.5439739413680782,0.8149331202348377,1.0,9/35,11.99%,AHR;GNG2;NR3C1;KLF9;GNB1;MSN;SFRP1;PTGER4;ROCK2
prerank,mitochondrial gene expression (GO:0140053),0.31925716382314023,0.9272031545703959,0.5314009661835749,0.8144991708255169,1.0,10/42,14.23%,MRPL23;MRPS12;NDUFA7;MRPS11;RARS2;FOXO3;MRPL16;MRPS17;MRPS34;MRPS14
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3961041614341109,-0.9270510818195733,0.55741127348643,0.8926928339495377,1.0,3/10,23.94%,NCKAP1L;TGFBR2;CD81
prerank,secondary alcohol metabolic process (GO:1902652),0.31442280989422455,0.926944768482202,0.5666178623718887,0.8145555586868696,1.0,11/42,20.23%,APOE;UGT1A4;CLN6;CYP27A1;OSBPL1A;CLN8;OSBPL5;IDH1;PIP4P1;IDH2;NSDHL
prerank,protein heterotetramerization (GO:0051290),-0.3716820559724985,-0.9267278051928942,0.5598086124401914,0.8924667492586948,1.0,2/13,2.84%,CPSF6;FARSA
prerank,polyol metabolic process (GO:0019751),-0.26824648311266164,-0.9265732678092247,0.5685714285714286,0.8917362493519914,1.0,9/46,11.24%,INPP4B;INPP5D;PLCB2;PLD4;PLCB4;PLCG1;MINPP1;PLCB1;PLCH1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.37981915225918605,-0.9262124618932044,0.5502283105022832,0.8915905445751102,1.0,3/12,8.88%,HNRNPU;PCGF5;BRCA1
prerank,regulation of peptidase activity (GO:0052547),-0.3387428816768388,-0.926100589864128,0.5542986425339367,0.8908004482684236,1.0,7/19,19.51%,NRDC;CST7;ATP13A2;CST3;PSMB8;FURIN;HDAC1
prerank,apoptotic cell clearance (GO:0043277),-0.2948314711405946,-0.9258762926954365,0.5849514563106796,0.890301457627753,1.0,13/30,21.43%,XKR6;TREM2;TGM2;ITGB3;RHOBTB2;XKR4;RHOH;TYRO3;ADGRB1;SCARB1;ITGAV;RHOG;HMGB1
prerank,negative regulation of hippo signaling (GO:0035331),0.4134715004229424,0.9258668353082583,0.5351043643263758,0.8162938029576342,1.0,7/12,20.00%,LIMD1;MAPK14;WWC1;VGLL4;MARK3;DLG5;WWC2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.380835902073151,0.9254737441122244,0.5260115606936416,0.8166069007216387,1.0,2/16,4.18%,RGCC;VIM
prerank,protein insertion into ER membrane (GO:0045048),0.32280685085687194,0.9253242240251173,0.535483870967742,0.8164576924610498,1.0,6/37,12.58%,APP;HMOX1;SERP1;TRAM2;EMC7;VAPA
prerank,postsynaptic membrane organization (GO:0001941),-0.34142967319291617,-0.9245879098157056,0.5669099756690997,0.8925471445090424,1.0,6/17,13.29%,NLGN1;NRXN1;DLG4;DNAJA3;LRRC4;SHISA7
prerank,negative regulation of secretion (GO:0051048),0.4320784605691893,0.9241030115954368,0.5549019607843138,0.8185365945916792,1.0,4/10,21.95%,CD74;VAMP8;TIFAB;ERBB3
prerank,positive regulation of cellular component movement (GO:0051272),-0.3122467988224381,-0.9235790199435795,0.576271186440678,0.8940559834060818,1.0,4/24,4.91%,TGFBR1;ETS1;CCDC25;STK11
prerank,regulation of cellular catabolic process (GO:0031329),0.3013428346841306,0.9234960288506878,0.5511363636363636,0.8193154983567976,1.0,10/62,8.90%,NUPR1;DAPK1;LAMP3;PRKN;MTMR3;ROCK1;HSPB1;DRAM1;DRAM2;SMCR8
prerank,gonad development (GO:0008406),-0.2713923014600223,-0.9234640364160802,0.5821727019498607,0.8932549424696303,1.0,10/41,21.46%,SALL1;BASP1;AR;NCOA4;WNT4;MSH2;TGFB2;COL9A3;WNT5A;MKKS
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.28154095171775306,0.9230509071935096,0.5761772853185596,0.8197873263393641,1.0,20/86,16.59%,KLF2;PSMA7;RPS27A;HMOX1;HIGD1A;CHEK1;BAG3;PSMB2;LIMD1;BACH1;CREBBP;PSMA6;HIF3A;EP300;PSMA3;PSMD1;PSMD5;ELOC;MAPK7;ARNT
prerank,glutamine family amino acid catabolic process (GO:0009065),0.4005414430220253,0.922571933093892,0.5408348457350273,0.8202955949864976,1.0,3/13,12.94%,DAO;GLS2;GLUD1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3920994584430581,0.9225468187587339,0.5495327102803739,0.8198564055497521,1.0,8/16,20.98%,IRAK3;INSR;TNF;ETF1;BNIP3;IGF1R;GSPT1;MTRF1
prerank,tRNA aminoacylation (GO:0043039),-0.2815775647322921,-0.9225078394612405,0.5815217391304348,0.8946223476398814,1.0,20/37,34.28%,FARSA;AARS1;CARS1;TARS1;NARS1;YARS1;IARS2;SARS1;DARS2;SARS2;HARS2;FARSB;WARS1;VARS1;PPA2;KARS1;QRSL1;HARS1;AIMP2;AIMP1
prerank,peptidyl-lysine modification (GO:0018205),0.2774393054972214,0.9223223531799913,0.5863453815261044,0.81985424714212,1.0,20/99,17.16%,HDAC9;PIAS1;LOX;ATP7A;PIAS2;NSMCE2;VCPKMT;ESCO1;NUP133;NUP62;PLOD1;LOXL2;NUP98;EEF1AKMT3;EP300;USPL1;HDAC4;SENP1;NUP153;SENP6
prerank,regulation of calcium-mediated signaling (GO:0050848),0.35108559612968204,0.921639601326941,0.5485436893203883,0.8208003493955175,1.0,2/25,1.79%,CMKLR1;BST1
prerank,regulation of leukocyte migration (GO:0002685),0.38703215616872527,0.9215649938089743,0.5471349353049908,0.8204560928748921,1.0,2/16,3.80%,BST1;HMOX1
prerank,positive regulation of axon extension (GO:0045773),0.3603353126917624,0.9212640811181265,0.5898305084745763,0.8206061320059848,1.0,1/22,0.34%,NRP1
prerank,regulation of cellular response to heat (GO:1900034),-0.2372400784060737,-0.9208578873714527,0.6462093862815884,0.8977101086593645,1.0,22/77,20.35%,RPTOR;DNAJC7;NUP210;RANBP2;ATM;MAPK3;MAPT;PTGES3;CCAR2;CD34;NUP85;HSF1;IER5;SEH1L;MLST8;DNAJB1;MTOR;AAAS;SEC13;FKBP4;CAMK2D;BAG5
prerank,negative regulation of chemokine production (GO:0032682),-0.35394700874786,-0.9206879042926319,0.5336225596529284,0.897021766557212,1.0,2/14,5.45%,SIRPA;APOD
prerank,DNA replication (GO:0006260),0.27271159885719076,0.9205153073689719,0.577023498694517,0.8217413309268479,1.0,20/105,13.86%,RBMS1;RBBP8;ORC5;FAM111A;MCMBP;ORC2;MCM9;POLE2;CHEK1;TOPBP1;TIPIN;RPA1;BRIP1;TOP1MT;POLG2;RHNO1;POLE3;RPA3;KAT7;KIN
prerank,protein deubiquitination (GO:0016579),0.2526808198652656,0.920032314247937,0.6463834672789897,0.8222638665336232,1.0,53/242,16.95%,ESR1;SMURF2;PSMA7;USP3;RPS27A;BABAM2;VCPIP1;ATXN7;ADRB2;RIPK1;SIAH2;RHOA;PRKN;BIRC3;USP9X;SNX3;SMAD4;ACTB;BRCC3;USP15;YY1;PSMB2;MDM2;ASXL1;USP21;USP16;MINDY2;USP24;PSMA6;FOXK2;USP14;ZC3H12A;FOXK1;TADA2B;WDR20;USP45;USP9Y;EP300;PSMA3;PSMD1;PSMD5;USP28;ENY2;MYC;USP22;USP25;ABRAXAS2;USP47;HCFC1;PTEN;STAM;UCHL3;USP32
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3193333003326815,0.9200027673372714,0.5595611285266457,0.8218434209281168,1.0,8/42,11.66%,TLR4;LBP;DROSHA;RPL30;RNASE6;IL6R;ROMO1;CHGA
prerank,neurotrophin signaling pathway (GO:0038179),-0.31758089466297396,-0.9198411449280338,0.5717948717948718,0.8981451982232416,1.0,4/21,6.81%,SORT1;MAGI2;ZFYVE27;BDNF
prerank,regulation of cellular localization (GO:0060341),0.3125911854856319,0.9195293400628538,0.5577211394302849,0.8223602978508046,1.0,16/46,19.43%,LYN;FER;NR1H4;NR1D1;PRKN;MAD1L1;TTL;TRIM67;UNC13D;WWC1;REEP6;KDM1A;HSP90AB1;FES;DVL3;STXBP2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.3916180993977291,-0.9195016151503387,0.5726872246696035,0.8978987928937076,1.0,3/11,6.17%,JAK2;STAT1;IL12RB2
prerank,cellular response to chemical stress (GO:0062197),0.2770084224066401,0.9189255828043544,0.5941644562334217,0.8231421235860862,1.0,21/96,17.04%,CYBB;LRRC8D;SLC25A24;VRK2;MSRA;RAD52;CYCS;TXNRD2;ATG7;NCF2;FOXO3;RBM11;ZC3H12A;ERO1A;FOXO1;CYBA;PKD2;PPIA;NOX4;PRDX3;PRDX2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.39691079207718044,0.9188860668379307,0.5664845173041895,0.822740590990042,1.0,6/13,24.52%,GNPDA1;GFPT2;UAP1L1;RENBP;SLC35A3;UAP1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.27752481819066305,-0.9188287517626788,0.5865921787709497,0.8985069505067309,1.0,20/38,36.28%,GEMIN2;SRSF10;DDX20;CD2BP2;PRPF19;SRSF12;TGS1;STRAP;PRPF6;SART1;SART3;PRPF31;AAR2;SNUPN;SNRPC;SNRPF;SNRPD3;GEMIN6;GEMIN5;PRMT7
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4284609682400726,0.9184506709944519,0.5449330783938815,0.8231707422549872,1.0,2/11,5.11%,PRKN;RACK1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2193982738275628,-0.9183238950579089,0.689795918367347,0.89874081896395,1.0,24/119,15.12%,INPP4B;INPP5D;PIK3CB;PGAP2;PITPNM1;PIP5K1C;EFR3B;PLEKHA1;FGF2;PI4KA;SOCS2;PIK3R4;PITPNM3;SYNJ2;TTC7B;INPP5F;SOCS7;PIK3C2B;PIK3R5;MTMR4;MBOAT7;CDS1;PIP4K2B;PIP4K2C
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4110842127804161,0.9179798050890928,0.5434782608695652,0.8236277730129196,1.0,3/12,9.90%,IRS2;INSR;IGF1
prerank,striated muscle contraction (GO:0006941),-0.2538057993401597,-0.9177945362362339,0.625,0.8990112613812454,1.0,7/53,7.31%,ATP1B1;SCN1B;SLC8A1;ALDOA;GRK2;DTNA;GAA
prerank,regulation of cholesterol transport (GO:0032374),-0.3277682581572805,-0.9177357721976299,0.5606796116504854,0.8981048238792644,1.0,9/20,32.69%,OSBPL6;APOC1;ABCB4;ABCA2;ARV1;ABCA5;ABCA13;LRP1;YJEFN3
prerank,positive regulation of positive chemotaxis (GO:0050927),0.39229149151591686,0.9175843320764145,0.5753899480069324,0.8239542931437317,1.0,1/15,0.66%,IL16
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3914641337296859,-0.9173636913074235,0.5872340425531914,0.8979096802791745,1.0,5/11,19.06%,NCL;SMARCB1;SIRT7;MTOR;NOL11
prerank,iron ion transmembrane transport (GO:0034755),-0.3791144489245678,-0.9170504203330754,0.5723404255319149,0.8976399438221331,1.0,3/10,15.85%,SLC40A1;SLC11A2;SLC39A14
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.33386139321266106,-0.9168617072346201,0.5804195804195804,0.8970213490235267,1.0,8/17,21.93%,BIN1;SERPINE2;TENM4;ID2;EGR2;NOTCH1;CLCF1;TGFB1
prerank,pancreas development (GO:0031016),0.4098195939455718,0.9167921223127659,0.5295202952029521,0.8251394140731778,1.0,1/12,0.84%,TCF7L2
prerank,response to ionizing radiation (GO:0010212),0.2877297029212564,0.9167125368687835,0.5988700564971752,0.8248205054670684,1.0,17/70,15.18%,LIG4;BABAM2;CLOCK;BRCC3;TOPBP1;MAPK14;COP1;NHEJ1;KDM4D;EEF1D;SPIDR;RHNO1;BRAT1;NET1;XRCC4;USP28;MYC
prerank,regulation of lipid storage (GO:0010883),0.35912470360439214,0.9163993522744671,0.552013422818792,0.8249911788654638,1.0,4/22,12.28%,FBXW7;TNF;VSTM2A;ZC3H12A
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.29191798654824275,0.9162191524909135,0.5641748942172073,0.8248923715532739,1.0,13/66,13.02%,EGFR;ANKRD17;RGCC;CDK6;RB1;KLF4;CCND3;CDC73;CCND2;TFDP1;KANK2;CDKN2C;KMT2E
prerank,negative regulation of RNA splicing (GO:0033119),0.37524713396902154,0.916201582410429,0.5663265306122449,0.824440217587432,1.0,4/19,7.92%,RPS13;PTBP3;SRSF4;PTBP2
prerank,L-serine metabolic process (GO:0006563),0.4259751755220836,0.9160884404919162,0.549165120593692,0.8241900056922716,1.0,5/10,23.92%,SERINC3;SHMT1;SERINC5;SRR;PSPH
prerank,kidney development (GO:0001822),-0.24326724077856776,-0.9159811868240094,0.6283783783783784,0.8982477284012019,1.0,10/65,12.70%,TGFBR1;SALL1;ROBO2;NF1;IFT88;SULF1;BAG6;VANGL2;PAX8;PROX1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4181506697331694,0.9159432907098155,0.5547309833024119,0.8240032612662668,1.0,1/11,2.01%,MEF2C
prerank,regulation of defense response to virus by host (GO:0050691),-0.2850824417636312,-0.9157301478253469,0.5674931129476584,0.8977857812934071,1.0,11/30,21.22%,STAT1;MAVS;RNF216;CGAS;PQBP1;ZDHHC1;MUL1;TARBP2;PARP9;DHX9;TRAF3IP2
prerank,hippo signaling (GO:0035329),-0.30274429258552255,-0.9156879307807034,0.5700712589073634,0.8968377891884495,1.0,7/26,12.01%,TJP1;FAT4;TJP2;WWTR1;YWHAB;TEAD1;DVL2
prerank,phagosome-lysosome fusion (GO:0090385),0.42850629103039384,0.9155486622156492,0.5638095238095238,0.8243460043270174,1.0,3/10,8.16%,PIKFYVE;RAB7A;RAB7B
prerank,regulation of coagulation (GO:0050818),-0.38477390676793455,-0.9154798300216668,0.5728744939271255,0.8963208049339962,1.0,3/11,26.61%,HS3ST5;EPHB2;PROCR
prerank,positive regulation of cellular senescence (GO:2000774),-0.3931703570202487,-0.9152840054669457,0.573170731707317,0.895766205808296,1.0,3/10,13.84%,ABI3;CGAS;YPEL3
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.41164939169531617,0.915227145599829,0.5531531531531532,0.824542962818805,1.0,2/11,6.31%,PPHLN1;SETDB2
prerank,glycine transport (GO:0015816),-0.3895983699444192,-0.9151035212850208,0.5491071428571429,0.8951583988762503,1.0,2/10,11.34%,SLC36A1;SLC7A8
prerank,positive regulation of hormone secretion (GO:0046887),0.3624579241142611,0.915071656960526,0.5571177504393673,0.8243934371159893,1.0,6/17,20.38%,C1QTNF3;HFE;TFR2;SNX4;VAMP8;NMB
prerank,sensory organ development (GO:0007423),-0.2667919714897789,-0.9146517123018562,0.625748502994012,0.89526724568843,1.0,16/51,22.78%,CHD7;PBX2;BMPR1B;AHI1;RAB18;MEIS3;SHROOM2;PAX8;MEIS1;SMG9;HIPK1;PBX1;TGFB2;FOXC1;PBX4;SALL2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.30484383906194273,0.9145131659964169,0.5838414634146342,0.8250492834128336,1.0,10/52,12.57%,FBXW7;YWHAQ;SFN;BCL2;UBE2D3;TFDP1;CASP8;SREBF2;YWHAE;PPP1R13B
prerank,response to hexose (GO:0009746),-0.29741110254576614,-0.9143000269309823,0.5766233766233766,0.8950505483887861,1.0,5/25,7.13%,PFKL;SELENOT;EIF2B3;LPL;SLC2A5
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.27684914937798016,0.9142457080325846,0.5941644562334217,0.82512876807858,1.0,14/100,9.99%,EGFR;FGFR1;LYN;CBL;IRS2;INSR;PDGFRA;NOP53;TNF;GAB1;PDGFC;MYDGF;IGF1;PIP5K1A
prerank,axonal fasciculation (GO:0007413),-0.3749350185788485,-0.9141647171044053,0.5685393258426966,0.8943046926713712,1.0,6/12,29.72%,CNTN4;EPHA3;EPHB2;NRCAM;EPHB3;AMIGO1
prerank,metanephric mesenchyme development (GO:0072075),-0.39311943213267575,-0.9138257005800494,0.572938689217759,0.8941365924687225,1.0,2/10,2.97%,BASP1;STAT1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3063493248053676,0.9136825015079834,0.5870253164556962,0.8257926918452366,1.0,8/46,8.50%,OPHN1;MEF2C;TSHZ3;DRD1;TNF;CCR2;HOMER1;MAPK8IP2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3631143935838234,-0.9133122863678113,0.5576923076923077,0.8944128888888933,1.0,5/13,20.27%,IL33;RAMP1;PLCB1;GOLGA2;ABCA2
prerank,positive regulation of vasculature development (GO:1904018),0.272175109166379,0.9128186042862482,0.6129032258064516,0.8270949466792951,1.0,18/94,12.83%,SASH1;ITGB1;GRN;HMOX1;CD40;PIK3R6;HSPB1;STIM1;GAB1;PRKCB;ADAM12;TNFSF12;NINJ1;MYDGF;SP1;JUP;ZC3H12A;RAMP2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.3364367055961028,0.9120258115199027,0.5858085808580858,0.8282995211625878,1.0,6/26,14.84%,C1QTNF12;IRS2;INSR;IGF1;ARPP19;OSBPL8
prerank,protein-containing complex subunit organization (GO:0043933),0.274815031632735,0.9119982142353609,0.6078947368421053,0.8278914020535861,1.0,15/109,8.74%,SNX9;KMT2A;REPS2;MITF;CD74;SKAP2;WIPF1;ST13;CD40;DARS1;HFE;NUP133;TUBGCP2;RANBP9;MDM2
prerank,negative regulation of DNA binding (GO:0043392),-0.2980617187978641,-0.9116530553960038,0.5833333333333334,0.8975305668378225,1.0,9/28,24.64%,JAK2;HABP4;JUN;MDFI;SMO;SOX11;ILRUN;LEF1;SIN3A
prerank,xenobiotic transport (GO:0042908),0.37271163664001383,0.91156682272045,0.5680580762250453,0.8282596903438351,1.0,3/17,13.10%,SLC22A18;ABCC1;GJA1
prerank,regulation of anoikis (GO:2000209),0.3716028308113149,0.9106316391762612,0.5702199661590525,0.8297710963653027,1.0,3/19,6.34%,ITGB1;MCL1;BCL2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.35075031491981745,0.9104127166701754,0.5689655172413793,0.8297638901745024,1.0,9/24,22.14%,CCL19;TRPM2;ERO1A;IBTK;PKD2;ITPR3;F2R;PTPRC;PLCG2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.37355788082152097,0.910268549017166,0.5642361111111112,0.8296005428107287,1.0,3/18,7.58%,ZFP36L2;ZFP36L1;CCR2
prerank,tRNA processing (GO:0008033),-0.2487771940694087,-0.9095799610490218,0.6548387096774193,0.9015767790755469,1.0,34/61,34.36%,AARS1;QTRT1;TRDMT1;PTCD1;CSTF2;TRNT1;SARS1;ANKRD16;POP1;DDX1;QTRT2;TRMT9B;FAM98B;CLP1;RPP21;METTL1;THUMPD1;CTU2;RTCB;AARS2;TSEN54;TRMT10B;TSEN15;POP7;THG1L;KARS1;ADAT2;PUS3;TRPT1;TRMT6;DTWD1;ADAT1;SSB;NSUN6
prerank,response to hydroxyurea (GO:0072710),0.40733984004761825,0.9093315477939403,0.5714285714285714,0.8310637224716336,1.0,4/11,13.82%,DDX11;ATRX;SPIDR;KAT7
prerank,fatty acid elongation (GO:0030497),0.39467056264925654,0.9091917014820662,0.564299424184261,0.8308863072473223,1.0,2/13,7.30%,HACD4;ELOVL5
prerank,mRNA 3'-end processing (GO:0031124),-0.23651060821799458,-0.908934594659809,0.7,0.9021788722559052,1.0,24/78,21.55%,CPSF6;THOC1;SRRM1;SRSF5;PABPN1;DDX39B;SRSF3;RPRD1A;SRSF2;CSTF2;RNPS1;PAF1;U2AF1;UPF3B;CASC3;NCBP1;CLP1;SRSF11;THOC3;SRSF9;AHCYL1;POLDIP3;ALYREF;U2AF2
prerank,cholesterol biosynthetic process (GO:0006695),0.3351117312645072,0.9086296459291783,0.5621019108280255,0.8315247075863723,1.0,12/31,24.87%,HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.33789715965863254,0.9085087806308825,0.5564516129032258,0.8313122704504304,1.0,12/30,24.87%,HMGCR;PMVK;HSD17B7;LBR;FDPS;DHCR7;NSDHL;ACLY;IDI1;CYP51A1;EBP;ACAA2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.4275238115417389,0.9085063447151398,0.573076923076923,0.8308377127342689,1.0,4/10,17.50%,TNFRSF1B;EMILIN1;TNFRSF1A;FAP
prerank,acidic amino acid transport (GO:0015800),-0.33191038646057025,-0.9084023630476776,0.5778301886792453,0.9023459305340962,1.0,7/17,26.43%,SLC1A3;SLC1A1;SLC25A22;SLC6A1;SLC1A2;SLC25A13;GIPC1
prerank,regulation of cellular response to stress (GO:0080135),0.2653267313477245,0.9082297547103874,0.620125786163522,0.8309187586558018,1.0,21/115,12.62%,ALOX5;NUPR1;CEBPB;PRKN;MCL1;GSK3B;MAPKAPK2;MANF;BAG3;RPA1;NUP133;NUP62;HSBP1;AMFR;CREBBP;CRYAB;YWHAE;ROCK2;SLC38A2;RPA3;NUP98
prerank,male meiosis I (GO:0007141),0.374633631243672,0.9081335838953642,0.5551330798479087,0.8306378434586994,1.0,2/16,9.22%,MOV10L1;FOXJ3
prerank,protein localization to chromosome (GO:0034502),0.3256973427541138,0.9079944374509883,0.5772230889235569,0.8304637286413425,1.0,13/34,20.98%,ESR1;RB1;MCM9;RPA1;ATRX;TERF2IP;XRCC4;PINX1;MCM8;ATR;CTCF;TINF2;TNKS2
prerank,cellular response to retinoic acid (GO:0071300),-0.26872096961348624,-0.9073642353215465,0.6695402298850575,0.9039124746294165,1.0,6/42,6.23%,PTK2B;SETX;BRINP3;ATM;TWF2;HTRA2
prerank,histone H2A ubiquitination (GO:0033522),-0.3262372383355646,-0.907288643564843,0.5860349127182045,0.9030483630504011,1.0,4/17,8.21%,UBE2B;SKP1;DDB2;RNF168
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.37038076206658294,-0.9072705660876189,0.5897435897435898,0.9020405025227499,1.0,2/12,2.26%,CTNNB1;HDAC8
prerank,positive regulation of RNA metabolic process (GO:0051254),0.309291402176261,0.9068994392957761,0.5964630225080386,0.8322157356536515,1.0,9/45,12.33%,EGFR;RIPK1;ERN1;NMD3;GRSF1;DYRK1A;HEATR1;ZC3H18;SLC38A2
prerank,membrane assembly (GO:0071709),-0.2775047042769374,-0.9067115751608056,0.6005291005291006,0.9024020990575822,1.0,9/34,15.04%,PTPRD;NLGN1;NRXN1;FLOT1;CHMP4B;TLCD2;NSFL1C;IL1RAPL1;STX2
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.33418152627552544,-0.9061083563376523,0.6100917431192661,0.9028463960969415,1.0,3/17,7.53%,NLGN1;RAB27A;SCAMP5
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.24366759072039534,-0.9058865940673382,0.6346153846153846,0.9023542705551523,1.0,17/65,18.14%,INTS3;SKP1;PSMD13;PSMD12;RBX1;FBXL7;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PABIR1;CDK5RAP3;PSMB8;ZFYVE19;PSME1
prerank,regulation of primary metabolic process (GO:0080090),0.26300896650358696,0.9056047229379627,0.6337285902503293,0.8344168419231338,1.0,21/126,14.43%,APOE;LDLR;PSMA7;NCOA2;NR1D1;HMGCR;IRS2;PSMB2;TBL1XR1;NCOR1;NCOA6;TBL1X;PMVK;SP1;SREBF2;CREBBP;PSMA6;ROCK2;PSMA3;PSMD1;PSMD5
prerank,regulation of calcium ion import (GO:0090279),-0.317377775434086,-0.9054547492724235,0.5925925925925926,0.9023407291697331,1.0,5/21,12.29%,CTNNB1;PRNP;CCL3;WNK3;PLPP4
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.309586001998324,-0.9051352174943387,0.6157635467980296,0.9020918569474706,1.0,9/22,19.29%,MAN1B1;MAN1C1;RNF103;EDEM1;TRIM13;MAN1A2;RNF5;UBB;SYVN1
prerank,myelination in peripheral nervous system (GO:0022011),0.3979866301354717,0.9050643431087455,0.5472727272727272,0.8349965500638186,1.0,1/13,0.88%,ADGRG6
prerank,mitotic nuclear division (GO:0140014),0.28152614595665226,0.9050046366873569,0.5684357541899442,0.834639011293028,1.0,16/71,20.13%,EPS8;PIBF1;RHOA;STAG2;CLASP1;NUP62;STAG1;SPICE1;RAB11A;ABRAXAS2;CENPK;CCDC61;SMC4;KPNB1;NDEL1;CTDP1
prerank,regulation of cell communication (GO:0010646),-0.2827741717307909,-0.9049912306937508,0.5983606557377049,0.9014010980223103,1.0,10/35,16.25%,MGLL;SLC8A1;ANK2;GRK2;SOCS2;GRK3;SCG5;NCLN;CXADR;MTCH1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.38915423053529247,0.904947284707137,0.5796064400715564,0.8342916436811263,1.0,2/13,5.69%,NKAP;CBFB
prerank,positive regulation of nuclear division (GO:0051785),-0.30105409259752225,-0.904835199276118,0.6238095238095238,0.9007375696039865,1.0,3/25,3.76%,TGFA;LRP5;IL1A
prerank,chordate embryonic development (GO:0043009),0.29645380357349294,0.9048338693197465,0.5976505139500734,0.8340391996432756,1.0,12/55,14.70%,FGFR1;MBNL1;LIG4;BMP2;MYH6;GRHL2;ZNF568;SULF2;HINFP;TRIM71;RBP4;PKD2
prerank,respiratory chain complex IV assembly (GO:0008535),-0.3148634916313222,-0.9045249931129035,0.6009501187648456,0.9004463416704772,1.0,13/21,42.29%,COX19;COX15;COX16;FASTKD3;TIMM21;COX17;COA6;COX14;COA3;OXA1L;SURF1;COX20;COX18
prerank,regulation of telomere capping (GO:1904353),-0.30714230295842615,-0.9042353720371497,0.6146341463414634,0.9000606414787715,1.0,5/23,13.29%,ATM;MAPK3;MAP2K7;TERF2;MAP3K4
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.3381815126811313,-0.9040839800270988,0.5926829268292683,0.8993753995284897,1.0,3/17,1.37%,BIN1;SORL1;RTN1
prerank,nucleosome assembly (GO:0006334),0.3299497009741082,0.9037955057740478,0.595,0.8356874869420595,1.0,11/31,22.30%,PADI4;ATRX;H3-3A;HAT1;ANP32B;ASF1A;IPO4;NAP1L2;CHAF1B;GRWD1;NPM1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.3481555574155313,0.9036415901835392,0.584717607973422,0.8355393110748902,1.0,3/23,5.38%,SMURF2;SMAD4;TRIM33
prerank,chromosome organization (GO:0051276),-0.22456413798293368,-0.90330149921049,0.7047244094488189,0.900216650134367,1.0,34/99,22.31%,LDB1;HDAC8;CUL4A;SAFB;BRWD1;COPS7A;FAM50A;PARP1;COPS8;GATAD1;DDB2;RBX1;DOT1L;COPS4;HDAC11;LRWD1;HMGN1;HDAC5;TOP2A;PADI2;COPS6;NDC80;GPS1;MSH2;PHF1;HDAC3;CDCA8;UBB;CENPV;HDAC1;MTF2;CENPH;BAHD1;HMGN2
prerank,chromatin assembly (GO:0031497),0.31587251214620904,0.9032420733844306,0.5892575039494471,0.8358807898988276,1.0,12/38,22.30%,PADI4;ATRX;LIN54;H3-3A;POLE3;ANP32B;ASF1A;CTCF;NAP1L2;CHAF1B;GRWD1;NPM1
prerank,muscle cell differentiation (GO:0042692),0.3347412364760255,0.9030929212825616,0.582905982905983,0.8357168525028145,1.0,8/32,17.51%,MEF2C;NRAP;HEY2;NINJ1;NEB;POPDC3;KDM1A;GLMN
prerank,chondrocyte differentiation (GO:0002062),0.3246030350041431,0.902994053643892,0.5703001579778831,0.8354278285311386,1.0,3/32,2.60%,MEF2C;OSR1;BMP2
prerank,neuromuscular process (GO:0050905),-0.3390016957238723,-0.9029191930758564,0.5724465558194775,0.9000986374825978,1.0,7/16,23.95%,NRXN1;CLN3;SHANK1;KCNA1;TPP1;UBA5;DCTN1
prerank,transition metal ion transport (GO:0000041),-0.28008885557399965,-0.9026580571853514,0.6434108527131783,0.8996682610511966,1.0,9/35,12.45%,ATOX1;TTYH1;TRPC4;TRPC1;SLC30A9;TRPC3;SLC11A2;TRPC5;ATP2C1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.36519864516108497,-0.9022319550714506,0.576837416481069,0.8996874499528332,1.0,5/12,25.31%,CHMP4B;CHMP4A;SEC61A1;SEC61B;SGTA
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.317495445723126,0.9019958299292831,0.5963455149501661,0.8369624601255021,1.0,5/36,8.59%,RAB31;SPTBN1;RAB10;RAB7A;GOLPH3L
prerank,amino sugar biosynthetic process (GO:0046349),0.3973977386287074,0.9018033879240231,0.5577617328519856,0.8368820131930792,1.0,4/12,18.51%,GNPDA1;GFPT2;UAP1L1;RENBP
prerank,supramolecular fiber organization (GO:0097435),0.24092953110547904,0.9017655984487352,0.6965669988925803,0.8364884012806105,1.0,62/334,16.01%,HIP1;TGFBI;APP;MYO5A;ITM2B;FLII;RPS27A;TMOD1;MTM1;RIPK1;FIGNL2;SIAH2;CD36;MYH6;DPT;CDC42;RHOA;B2M;PRKN;VIM;LOX;TMOD3;USP9X;ATP7A;KATNAL2;MYO7A;ARHGAP12;VPS4B;COL22A1;COL9A2;RHOBTB1;MFAP4;DDR2;TUBGCP2;MDM2;COL14A1;CORO1C;H3-3A;MYO1E;MYO1C;PXDN;EMILIN1;ARHGAP17;PLOD1;LOXL2;CORO7;RND3;COL24A1;KATNAL1;P4HA2;TPM3;PCM1;TNXB;RHOC;CGNL1;KLHL24;ELMO3;STMN1;TSPAN14;NCSTN;MARCKSL1;HSP90AB1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3971609554137446,0.9016670486344164,0.5786516853932584,0.836215370708591,1.0,3/13,14.16%,LAMP1;SYK;ITGB2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.3890036511692717,0.9016527669873791,0.5566218809980806,0.835769220000408,1.0,3/13,13.47%,HACD4;ELOVL5;TECRL
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.351077660354835,-0.9009275516075183,0.6168674698795181,0.9018382110558566,1.0,2/15,2.08%,KCNJ2;ATP1B1
prerank,chemical homeostasis (GO:0048878),0.2910458605904064,0.9008872739788321,0.6034236804564908,0.836871436673787,1.0,7/61,7.77%,FBXW7;ZBTB20;IRS2;PNPLA8;WNK1;SLC4A4;SLC4A5
prerank,detection of calcium ion (GO:0005513),0.3867894962973164,0.9008146418049165,0.5717017208413002,0.8365283905680129,1.0,3/13,10.64%,KCNMB1;STIM1;CALM1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2826952822489974,0.9005934334814049,0.6189069423929099,0.8365174744050221,1.0,11/73,14.43%,KMT2A;PSMA7;TCF12;KITLG;SPI1;CBFB;PSMB2;PSMA6;PSMA3;PSMD1;PSMD5
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3144510973504191,-0.9004836321054345,0.6213151927437641,0.9018802476983643,1.0,3/20,5.58%,SEMA4D;SEMA4C;SEMA4G
prerank,V(D)J recombination (GO:0033151),0.4143952330393953,0.9000503845703782,0.5899419729206963,0.8371491077710016,1.0,2/11,13.41%,LIG4;XRCC4
prerank,phospholipid biosynthetic process (GO:0008654),0.3200945802460644,0.899773263582877,0.5964912280701754,0.8372164619288412,1.0,7/36,10.36%,SGMS1;CPNE7;AGPAT5;DOLPP1;PIP5K1A;HDHD5;NUS1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.32863541950571146,-0.8997367014601174,0.616822429906542,0.9027017261623741,1.0,7/18,19.50%,PTK2B;NLGN1;NRXN1;CACNG7;CACNG8;CACNG4;CACNG2
prerank,regulation of blood circulation (GO:1903522),0.32029837847145504,0.8996513281727453,0.5935483870967742,0.8369954688706958,1.0,5/34,11.86%,S100A1;MYH6;KCNG2;PLN;KCNQ1
prerank,cation transport (GO:0006812),-0.20629669645966128,-0.8992301521926664,0.7790055248618785,0.9029330412218223,1.0,27/167,16.84%,KCNMA1;SLC12A2;KCNJ2;ATP1B1;SLC8A1;SLC36A1;SGK1;TRPM3;FGF13;CLN3;PIEZO1;SLC38A7;KCNA1;SLC36A4;KCNA2;SLC11A2;SLC1A1;SLC7A8;SCN8A;PIEZO2;TMEM63C;KCNS3;SCN1A;KCNK9;KCNN2;ABCC9;KCNK6
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.2934882296671679,0.8985956137920129,0.6017441860465116,0.8386918236204574,1.0,20/52,19.76%,DNAJC3;ERN1;SERP1;WIPI1;DDX11;CTDSP2;MYDGF;PARP16;SRPRB;SHC1;WFS1;EXTL2;ADD1;ATP6V0D1;CUL7;EXTL1;XBP1;LMNA;PPP2R5B;ERN2
prerank,arachidonate transport (GO:1903963),0.41452220651788885,0.8983417806583095,0.6065259117082533,0.8382543509853909,1.0,1/10,4.93%,PNPLA8
prerank,arachidonic acid secretion (GO:0050482),0.41452220651788885,0.8983417806583095,0.6065259117082533,0.8382543509853909,1.0,1/10,4.93%,PNPLA8
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.38694368247521915,0.8981841879507447,0.5719489981785064,0.83809839292731,1.0,3/14,7.58%,OXSR1;WNK1;CCR2
prerank,RNA interference (GO:0016246),0.36897631348575544,0.8981046271522529,0.5810344827586207,0.8377817058295216,1.0,3/17,13.29%,PRKRA;DROSHA;MRPL44
prerank,defense response to tumor cell (GO:0002357),0.4110371093282661,0.8977607114337456,0.5874524714828897,0.8380152754923883,1.0,3/10,7.22%,DAPK1;SPI1;KLF4
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3939977031658102,0.8976147128652695,0.5793226381461676,0.8378296172020034,1.0,3/13,9.90%,IRS2;INSR;IGF1
prerank,mitochondrion organization (GO:0007005),0.2553689248717364,0.8976113158283353,0.6469135802469136,0.837365616417859,1.0,36/165,21.09%,PID1;IMMP2L;MEF2A;MTM1;PRKN;ATP7A;HIGD1A;PITRM1;NIPSNAP2;FMC1;CYCS;COX7A2L;CHCHD3;POLG2;MTX1;VPS13C;RAB5IF;MGME1;PYROXD2;TRAK2;HCFC1;RAB32;PRDX3;BNIP3;TMEM11;MFF;LONP1;SLC25A4;GABPB1;SLC25A36;DNM1L;TRAK1;ADCK1;PISD;AIFM1;MTX2
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.35231252448116146,-0.8975899981010776,0.5853131749460043,0.9058733542318046,1.0,4/13,8.53%,STK11;ATM;SESN3;CASTOR2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3421657655612994,-0.8974739194623718,0.5907079646017699,0.9051145370910584,1.0,4/14,10.34%,CSF1;MAPK3;AKIRIN1;CSF1R
prerank,regulation of neuron migration (GO:2001222),0.33483864161002236,0.8971935941971888,0.5724020442930153,0.8377655819180023,1.0,3/26,3.92%,KIF20B;TNN;RAPGEF2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.31194430102655657,-0.8970637102759987,0.6014669926650367,0.9050264748533401,1.0,6/22,11.72%,KRI1;WDR12;EXOSC9;NOP14;URB1;FTSJ3
prerank,peptidyl-serine modification (GO:0018209),-0.20526284904013786,-0.8968820944945669,0.7616580310880829,0.9044285897765906,1.0,31/166,13.65%,TGFBR1;PRKCD;CSNK1E;MAST4;PRKCE;GALNT3;SGK1;CSNK1A1;GRK2;ATM;STK38L;RPS6KA1;HPF1;PARP1;PDK3;GALNT13;CAMK4;MAP3K12;DYRK2;DCLK3;CDC7;NEK6;SRPK2;RPS6KA2;PDPK1;IKBKE;AKT3;NDNF;DYRK1B;TGFBR2;MAP4K1
prerank,diol metabolic process (GO:0034311),0.3648540543927967,0.8966886271152192,0.584055459272097,0.8382660570759565,1.0,3/19,10.64%,SGPP1;GCH1;CALM1
prerank,histone H2A acetylation (GO:0043968),-0.3406380086627222,-0.8966136808821059,0.6036446469248291,0.9040434899823169,1.0,5/16,14.66%,MORF4L2;NAA40;BRD8;MORF4L1;RUVBL1
prerank,inorganic cation transmembrane transport (GO:0098662),-0.1936338697458261,-0.8964674519667285,0.782608695652174,0.9034249420086704,1.0,47/268,16.17%,SLC1A3;KCND2;KCNH7;SLC12A2;KCNJ2;SLC24A3;SLC24A2;ATP1B1;SCN1B;SLC8A1;SLC36A1;SLC9A8;MCOLN3;TRPM3;SLC40A1;KCNQ3;TRPC4;CACNA1D;TRPC1;ATP6V1H;NALCN;SLC24A4;KCNQ5;TRPC3;SLC39A11;KCNK2;KCNA1;KCNA2;SLC11A2;KCNK12;SLC25A14;SCN8A;CACNA1C;TRPC5;ATP6V0C;ATP2C1;KCNS3;HVCN1;SCN1A;KCNK9;COX15;SLC39A13;SLC9A1;SLC39A14;KCNN2;SLC6A1;ABCC9
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.267630990045227,-0.8963461318576776,0.6320224719101124,0.902696290694747,1.0,11/38,22.09%,NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;NDUFB10;NDUFA8;NDUFA10;NDUFAB1;NDUFS1
prerank,regulation of heart contraction (GO:0008016),0.27814208000108687,0.8962884044737047,0.6238030095759234,0.8386146166622254,1.0,18/90,14.90%,ATP2B1;FXYD2;S100A1;MYH6;PDE4D;TMEM65;STIM1;KCNG2;PLN;CALM1;KCNQ1;ATP2B4;ATP1A3;ATP1A4;ATP1A1;NPPC;ATP2A2;ITPR3
prerank,macrophage activation involved in immune response (GO:0002281),0.3848125183422514,0.896272292941651,0.581888246628131,0.8381794296886306,1.0,3/13,6.57%,GRN;LBP;SYK
prerank,protein import (GO:0017038),0.2741474364381759,0.8961714972425956,0.6110344827586207,0.8379067134897372,1.0,12/84,11.69%,APOE;PRICKLE1;RAB8B;SLC25A17;PXMP2;SYK;PEX26;IPO11;NUP133;LAMP2;NUP62;SNX33
prerank,regulation of trophoblast cell migration (GO:1901163),0.38941225850988404,0.8961154386721646,0.5745454545454546,0.8375419647258137,1.0,3/14,14.86%,SMURF2;GJA1;ARHGDIB
prerank,response to metal ion (GO:0010038),0.282180354513193,0.8958881783202132,0.6179941002949852,0.8375132121732111,1.0,17/67,15.24%,PPP3CA;CRIP1;ADAM9;PAM;BCL2;HFE;HOMER1;PPP2CA;PPP2CB;TESMIN;CALM1;PPP1CA;LOXL2;TFR2;NEDD4L;ITPR3;MTF1
prerank,metanephros development (GO:0001656),-0.29354054362995047,-0.8955253531920543,0.6035353535353535,0.9035777272715042,1.0,3/26,5.51%,BASP1;ROBO2;NF1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.320918000806664,-0.8952296054103569,0.5926829268292683,0.9033166001080005,1.0,3/19,1.37%,BIN1;SORL1;RTN1
prerank,cell junction organization (GO:0034330),0.28044198203044185,0.8945773293621085,0.613540197461213,0.8396436269382428,1.0,8/71,5.71%,APP;C1QA;OPHN1;CDC42;RAB8B;RHOA;GRHL2;ACTB
prerank,error-prone translesion synthesis (GO:0042276),0.35454458181002807,0.8945675879372728,0.5752961082910322,0.839198905703513,1.0,5/21,12.35%,RPS27A;POLE2;RPA1;POLH;RPA3
prerank,cellular response to starvation (GO:0009267),0.2590281428007492,0.8944622376704955,0.6531365313653137,0.838934757568642,1.0,41/147,19.12%,MAP3K5;PRKAG2;CEBPB;SESN1;ATP6V1B1;PRKAG3;MTMR3;AOC1;NPRL3;STK24;MIOS;WIPI1;KLF10;ATP6V1A;FNIP1;SFRP1;LAMP2;ATG7;GAS2L1;SREBF2;FOXO3;LAMTOR5;ZC3H12A;FOXO1;RALB;MFSD2A;SZT2;NPRL2;WIPI2;XPR1;GABARAP;ATG5;ATP6V0D1;XBP1;LARS1;TBL2;RHEB;RRAGC;ATF2;EIF2AK4;EIF2AK2
prerank,P-body assembly (GO:0033962),0.39188506990651367,0.8943675856276881,0.604355716878403,0.8386416064818691,1.0,4/12,12.89%,RC3H1;LIMD1;DDX6;LSM4
prerank,diol biosynthetic process (GO:0034312),0.3810186678274467,0.8943649686522029,0.5772058823529411,0.8381784699236361,1.0,3/15,6.07%,GCH1;ACER3;SPTLC2
prerank,regulation of blood coagulation (GO:0030193),0.3364398543895247,0.8939114144996723,0.587378640776699,0.838634430063749,1.0,6/27,18.04%,APOE;ENPP4;ST3GAL4;TFPI;FAP;F2R
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.29576488701850834,-0.8935494598838464,0.6311881188118812,0.9063417768033799,1.0,12/25,34.19%,DNAJC7;PTGES3;SDF2;DNAJB14;DNAJB1;DNAJB5;HSPA9;DNAJC18;DNAJB13;SDF2L1;HSPA1A;HSPA1B
prerank,cellular response to interleukin-1 (GO:0071347),0.2536887894034186,0.8935097577158859,0.6567741935483871,0.8389955675533656,1.0,48/143,25.22%,GBP3;PSMA7;IRAK3;RPS27A;CCL8;NR1D1;CCL19;PELI1;RC3H1;CD40;MAP3K8;PSMB2;CCL24;SFRP1;RIPK2;PSMA6;MAP3K3;ZC3H12A;NOD2;UBE2N;PSMA3;PSMD1;PSMD5;TAB3;CCL5;RELA;ACOD1;CCL25;TRAF6;IRAK4;TOLLIP;HAS2;PSMD2;CCL14;PSMD11;PSMB9;NFKB1;CD47;IL1R1;TANK;MAPK11;PSMB4;UBC;PSMD10;DAB2IP;MYD88;PSME4;FBXW11
prerank,sulfur compound transport (GO:0072348),0.338174847733574,0.8934114044670971,0.5903814262023217,0.8387251103587238,1.0,11/27,21.84%,LRRC8D;SLC26A11;MGST1;SLC26A7;SLC25A30;SLC6A6;SLC5A6;SLC35F3;RACGAP1;SLC13A4;SLC26A8
prerank,positive regulation of peptidase activity (GO:0010952),0.3516696840451686,0.893179551837242,0.6036036036036037,0.8387357917743777,1.0,2/20,3.26%,RCN3;GRN
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.2862970112734979,-0.8931142190684112,0.6327543424317618,0.9063741264433298,1.0,14/31,33.95%,SCAMP5;SYT6;CBARP;SYT8;SYT1;SYT13;SYT7;SYT5;STXBP1;SYT17;CACNA1H;ADRA2A;STX1A;CACNA1G
prerank,transferrin transport (GO:0033572),0.3188454856137376,0.8930156626183001,0.6045751633986928,0.8386153578041231,1.0,6/33,8.32%,CLTC;STEAP3;ATP6V1B1;ATP6V0A1;HFE;ATP6V1A
prerank,negative regulation of dephosphorylation (GO:0035305),0.36105459071829177,0.8929318250522389,0.5682967959527825,0.8383068505204616,1.0,3/18,11.42%,MFHAS1;PPP1R26;ARPP19
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.3158746140868744,0.892838117703801,0.5876288659793815,0.8380183302305665,1.0,9/44,13.73%,ZFP36L2;ZFP36L1;RC3H1;ROCK1;NANOS3;ROCK2;ZC3H12A;GTPBP1;TNRC6C
prerank,rRNA 3'-end processing (GO:0031125),0.4026683593251599,0.8923001543766641,0.5703839122486288,0.8386469189562163,1.0,2/10,12.43%,RPS21;EXOSC8
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.35545775984187356,0.892243662518817,0.5553602811950791,0.8382883676005687,1.0,4/18,12.04%,PHF8;RASL11A;HEATR1;DHX33
prerank,outflow tract septum morphogenesis (GO:0003148),0.3421737588161983,0.8922408711482634,0.5986159169550173,0.8378303773453699,1.0,2/24,5.19%,NRP1;SMAD4
prerank,peripheral nervous system development (GO:0007422),0.3425769784432816,0.8920264475512195,0.6058732612055642,0.8378070655453864,1.0,3/23,5.95%,ADGRG6;PMP22;GFRA3
prerank,negative regulation of transmembrane transport (GO:0034763),0.4101902632184896,0.8918502729730867,0.5928705440900562,0.837680491475813,1.0,2/10,7.67%,IRS2;PRKCB
prerank,alanine transport (GO:0032328),-0.38474537110635,-0.8916068192020092,0.5828092243186582,0.9090474412012883,1.0,2/10,9.30%,SLC36A1;SLC36A4
prerank,cellular response to cadmium ion (GO:0071276),0.3386071443569334,0.891374979347953,0.6173044925124792,0.8381704765422882,1.0,1/24,0.45%,EGFR
prerank,positive regulation of cell division (GO:0051781),0.3067036013911256,0.8913239354490679,0.6039603960396039,0.837807253538469,1.0,6/38,12.60%,KIF20B;CDC42;RHOA;PKN2;CUL3;SVIL
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.37067550900045926,0.8912488043692149,0.5854063018242123,0.8374936207405833,1.0,5/16,20.76%,LDLR;NR1H2;MFSD2A;CNEP1R1;ABHD5
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.393975943264752,0.8907776735345234,0.5901328273244781,0.8378987894228487,1.0,1/11,4.19%,LARP7
prerank,bile acid biosynthetic process (GO:0006699),0.34421329209880336,0.8905413330982773,0.5989761092150171,0.8379252424372947,1.0,4/24,9.75%,OSBPL9;HSD3B7;CYP27A1;OSBPL1A
prerank,selective autophagy (GO:0061912),0.28878488898243554,0.8904787726372515,0.6248153618906942,0.8376031901873922,1.0,14/56,16.21%,WDFY3;RPS27A;PRKN;VIM;ULK2;RAB7A;PCNT;DYNC1I2;UFM1;UBE2N;AMBRA1;RB1CC1;TEX264;ATG5
prerank,zinc ion transport (GO:0006829),-0.3156681656475208,-0.8903344029829263,0.5914786967418546,0.9110851636215739,1.0,8/21,31.64%,SLC30A9;SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.4073418038702874,0.8900576276885911,0.5911708253358925,0.8379910696145565,1.0,1/10,4.00%,PRKN
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3884469392401715,0.8898745028864922,0.5974025974025974,0.8378862288364014,1.0,2/12,8.21%,ERN1;ATF6
prerank,neural crest cell development (GO:0014032),-0.25843563622087895,-0.8895858734209253,0.654178674351585,0.911808730309993,1.0,7/44,11.32%,SEMA4D;CDH2;SEMA4C;KLHL12;SEMA4G;ERBB4;SOX10
prerank,androgen metabolic process (GO:0008209),-0.3222117974240811,-0.889305840450793,0.5967365967365967,0.9114604904071594,1.0,13/18,51.30%,SPP1;SRD5A3;HSD17B10;HSD17B11;DHRS9;SHH;SRD5A2;MED1;HSD3B2;HSD17B3;AKR1D1;CYP19A1;HSD17B4
prerank,central nervous system myelination (GO:0022010),-0.379919547456971,-0.8892521189877247,0.6053215077605322,0.9105850011572636,1.0,3/11,11.32%,PLP1;TENM4;SOX10
prerank,dicarboxylic acid metabolic process (GO:0043648),0.29399115553121596,0.8888780912374489,0.6309696092619392,0.8394182226842666,1.0,12/52,20.78%,FOLR2;MTHFD2L;SDHA;ASS1;GCLM;SHMT1;IDH1;OGDH;IDH2;MTHFD1L;ME1;ACLY
prerank,cellular response to hydrogen peroxide (GO:0070301),0.32534760685297515,0.8887247625556267,0.6144,0.8392660736245342,1.0,4/33,2.67%,MAP3K5;RPS3;OSER1;RIPK1
prerank,lamellipodium assembly (GO:0030032),0.3355188901785841,0.888656567025304,0.6091370558375635,0.8389595102033945,1.0,11/26,24.03%,ITGB1;VCL;S1PR1;PARVB;SPEF1;GOLPH3;ARFIP2;ARHGEF6;KIT;PTPRO;CCDC88A
prerank,Golgi organization (GO:0007030),-0.2202566260345379,-0.8884084798618751,0.7342995169082126,0.911561975565371,1.0,31/112,20.45%,PLEKHM2;CLASP2;OPTN;CSNK1A1;COG3;GCC2;ATP8B1;LYSMD3;PLK3;VTI1B;COG4;SURF4;STX16;ARFGEF1;DYNC2H1;NSFL1C;RAB2A;COG2;ARL1;TBC1D20;NPLOC4;TMED1;HUWE1;TMED7;TANGO2;GOLGA2;DNAJC28;BET1;GOSR2;BAG5;ZW10
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.36146922014916577,0.8883428022510844,0.5791245791245792,0.8391545154640944,1.0,4/19,13.73%,SULT1A1;PAPSS2;SLC35B3;SULT6B1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.37151945529780095,-0.8883387611225141,0.6016771488469602,0.9106913058746595,1.0,3/12,23.42%,GPAA1;ANKRD13C;TAPT1
prerank,response to cadmium ion (GO:0046686),0.3313022621822349,0.8881191684102161,0.6160130718954249,0.8391660154228142,1.0,1/26,0.45%,EGFR
prerank,mRNA stabilization (GO:0048255),-0.2678569322089322,-0.887790787301678,0.6384839650145773,0.9109742098860983,1.0,5/40,5.23%,TENT5C;FUS;TARDBP;HNRNPU;ELAVL4
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.286827814554405,0.8873661502150256,0.6366237482117311,0.8401788600534014,1.0,8/62,8.74%,TPT1;PRKN;MCL1;BCL2L2;TRIM32;BCL2;HSPB1;MDM2
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.28213610607919437,-0.8869380102027915,0.6204188481675392,0.911894024483431,1.0,9/31,20.57%,TGFBR1;HOXC4;FGFR2;TGFBR2;HOXA3;DSCAML1;HOXB9;DYNC2I1;SOX11
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3862438449338709,0.8868017495675924,0.6021314387211367,0.8408261786197854,1.0,2/13,3.58%,SPRED1;RPL26
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3970510080643296,0.8866296483719344,0.5840867992766727,0.8407072952353225,1.0,2/10,8.80%,CDC42;RCC2
prerank,replication fork processing (GO:0031297),-0.2654348107981833,-0.8865900291614479,0.655367231638418,0.911660747393653,1.0,7/38,11.07%,DNA2;CDK9;THOC1;ETAA1;PRIMPOL;BLM;BRCA2
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.32592342878250646,-0.8865549581604064,0.6519721577726219,0.910728649049003,1.0,4/18,8.75%,EHMT2;ASH1L;SETD4;SETD3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.26954582354938517,-0.8863417300934348,0.6584699453551912,0.9102189439476044,1.0,12/38,21.91%,CENPC;UBN1;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;ASF1B;CABIN1;CENPP;CENPN;CENPH
prerank,regulation of myoblast differentiation (GO:0045661),0.3241930532331437,0.8854728825891675,0.6283464566929133,0.842554434696164,1.0,3/32,3.70%,RIPOR2;MEF2C;ZFP36L1
prerank,nucleic acid metabolic process (GO:0090304),-0.2313096511652717,-0.8851932150609225,0.6824324324324325,0.9119032770320603,1.0,24/69,28.37%,DNA2;HNRNPA3;HNRNPA2B1;HNRNPU;RECQL5;POLG;DDX1;POLR2C;NCBP1;PCBP1;PCBP2;HNRNPA1;HNRNPH1;ATXN2;DDX24;METTL3;POLR2L;DNASE1L2;HNRNPA0;RAD50;DDX54;DUSP11;POLR2I;HNRNPK
prerank,positive regulation of protein transport (GO:0051222),0.2801271251381997,0.8851313477433087,0.6300417246175244,0.8427844371546146,1.0,16/67,14.92%,KIF20B;ANG;EXPH5;ADAM9;RACK1;TMED10;TNF;GOLPH3L;CD33;IGF1;ACSL3;PCNT;ACHE;BCAS3;PCM1;PPIA
prerank,response to UV-B (GO:0010224),0.39338936665533486,0.8850056512659011,0.6057866184448463,0.8425783240392087,1.0,2/12,8.43%,CRIP1;MFAP4
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2863220637847101,0.8848724181647128,0.636098981077147,0.8423753726430552,1.0,23/60,24.20%,TCF7L2;CEBPB;HEY2;CBFB;MED16;MED20;MED6;MED26;MED15;TNRC6C;MED27;PTEN;MED17;RELA;IL6;MECP2;MED14;NFKB1;MED7;MED24;AGO3;CCND1;SUB1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.28297004789275915,-0.8845669474065956,0.656,0.9124556574566169,1.0,10/29,23.50%,KYNU;ACADSB;FAH;IL4I1;ALDH4A1;SARDH;PRODH;HSD17B10;HOGA1;MTRR
prerank,negative regulation of catalytic activity (GO:0043086),-0.2991865395531135,-0.8838741510912753,0.6288416075650118,0.9130363162426746,1.0,14/24,35.98%,TP53;CLN3;NOSIP;CCAR2;NOTCH1;PARP9;HDAC6;TMBIM1;PHPT1;CAND1;SIRT1;TIMP1;OXA1L;HP
prerank,insulin secretion (GO:0030073),0.3627042694459489,0.8838160475097703,0.5946428571428571,0.8440215622911922,1.0,1/19,0.52%,RAB11FIP5
prerank,glutathione metabolic process (GO:0006749),-0.2688908720433647,-0.8835683183972662,0.6842105263157895,0.91272768634259,1.0,6/38,16.22%,HPGDS;GGT5;GSS;GGT7;CTNS;PARK7
prerank,cellular response to UV (GO:0034644),0.2774676990900113,0.8832138644332512,0.6540697674418605,0.844831428206197,1.0,18/76,16.18%,CRIP1;RPL26;RHBDD1;PTPRK;CHEK1;YY1;MFAP4;CARD16;RHNO1;CREBBP;XPA;XPC;EP300;USP28;MYC;USP47;KDM1A;ATR
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.3398507745291345,-0.88316541632374,0.6261061946902655,0.912665043481735,1.0,9/14,33.10%,FASTKD1;TFB2M;MTERF2;TFAM;SLC25A33;MRPL12;TFB1M;PNPT1;FASTKD5
prerank,regulation of viral life cycle (GO:1903900),0.3439311595470047,0.8831032204227638,0.5884413309982487,0.8445877190856931,1.0,6/21,15.82%,LAMP3;TRIM68;TRIM27;KPNA2;PPIA;TRIM25
prerank,regulation of endopeptidase activity (GO:0052548),0.2894438248900237,0.8830722026101238,0.6119186046511628,0.844182593913381,1.0,3/59,4.77%,SERPINB8;SERPINB2;BIRC3
prerank,anterograde axonal transport (GO:0008089),-0.26741413454267016,-0.8827886291664852,0.671957671957672,0.9125750950717885,1.0,9/37,14.09%,DLG2;KIF1A;KIF5A;KIF5C;AP3B2;AP3D1;KIF1C;KIF3A;KIF3B
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.2605451023541235,0.8824055627805705,0.67578125,0.8450449066885831,1.0,14/124,6.22%,APOE;APP;OPHN1;LYN;RAPGEF2;EHD1;LRP12;TTC29;GSK3B;RB1;ROCK1;FRY;MANF;BLOC1S5
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2953525672445411,0.8823770353824477,0.604135893648449,0.8446382191568583,1.0,6/48,6.34%,CRIP1;TNFRSF1B;MCL1;BCL2L2;SFN;BCL2
prerank,steroid metabolic process (GO:0008202),0.27754056005438427,0.8821915786190513,0.6329113924050633,0.8445518876702407,1.0,8/72,9.99%,UGT1A7;UGT1A8;UGT1A1;CYP27A1;SULT1A1;CYP26C1;HSD17B7;CYP26B1
prerank,protein processing (GO:0016485),-0.2175936136677739,-0.881734842098368,0.7125,0.9139637199820878,1.0,21/102,17.75%,KLK2;LGMN;CLN3;VSIR;CTSS;APH1A;ADAMTS3;HTRA2;F3;MMP16;FXN;SEC11C;AFG3L2;AEBP1;SPCS1;EEF1AKMT4-ECE2;TYSND1;ADAM10;CPM;CPE;FURIN
prerank,protein localization to microtubule organizing center (GO:1905508),0.37468508534148603,0.881427010508073,0.5925266903914591,0.8455832670360168,1.0,4/15,13.96%,PIBF1;CCDC14;SNX10;PCM1
prerank,recombinational repair (GO:0000725),0.2756547287880959,0.8813708259570875,0.6439499304589708,0.8452207674321757,1.0,20/77,15.90%,RBBP8;MCM9;NSMCE2;YY1;RPA1;RAD52;KDM4D;SPIDR;RHNO1;RPA3;AP5S1;UBE2N;SFR1;MMS22L;SEM1;RAD51B;SAMHD1;SFPQ;FBH1;MCM8
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.3328429008061413,-0.8813688260487561,0.6247139588100686,0.913790389282189,1.0,6/16,23.49%,NAA40;NAA60;NAA35;NAA25;NAA80;NAA30
prerank,actin filament network formation (GO:0051639),0.391866017678461,0.8811353769866471,0.610337972166998,0.8452568760921543,1.0,2/11,9.06%,LCP1;PLS1
prerank,multivesicular body organization (GO:0036257),-0.275796771038051,-0.8808561537677727,0.6421319796954315,0.9139808475430441,1.0,5/31,9.42%,SNF8;RAB27A;CHMP4B;CHMP4A;VPS37A
prerank,cellular response to pH (GO:0071467),0.3638372274011593,0.8808423908461817,0.6014760147601476,0.8453816481130677,1.0,1/17,0.52%,RAB11FIP5
prerank,regulation of lipid metabolic process (GO:0019216),0.26965996811922205,0.8802751386271005,0.6629055007052186,0.8460673730597763,1.0,14/88,11.67%,PRKAG2;NCOA2;NR1D1;HMGCR;IRS2;TBL1XR1;NCOR1;NCOA6;TBL1X;PMVK;SP1;SREBF2;CREBBP;NPC2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.32584749859224554,-0.8797178622970946,0.6181015452538632,0.9156404851137343,1.0,6/17,17.63%,TWSG1;SULF1;FSTL1;XIAP;TMEM204;DOK5
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.28599163608508593,0.8794878885952935,0.6370481927710844,0.847226859501385,1.0,4/53,2.20%,EGFR;SPRED1;RPS3;BABAM2
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.34136708716182734,0.8790033888307361,0.6275510204081632,0.8477319689617883,1.0,4/21,11.84%,MFHAS1;GSK3B;ARPP19;YWHAE
prerank,regulation of kinase activity (GO:0043549),0.2683027565641399,0.8789244835067999,0.6515775034293553,0.8474282959806415,1.0,9/89,5.33%,EGFR;FGFR1;EEF1A1;CD74;IRS2;RB1;INSR;CAMKK2;PDGFRA
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.33927046440397945,0.8788757905446563,0.6,0.8470685010608484,1.0,7/24,20.20%,LIG4;RPS27A;RPA1;RPA3;RFC3;POLD2;PCNA
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3223677310480209,0.8784800213710968,0.6225806451612903,0.8473692892557592,1.0,10/31,20.40%,CDK6;RB1;KLF4;CDC73;KANK2;CDKN2C;PKD2;PTEN;GPNMB;BRD7
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.35930279563303336,0.8783808844100436,0.6014625228519196,0.8471192114139316,1.0,3/18,10.33%,GSK3B;ZNF205;SLC25A5
prerank,RNA modification (GO:0009451),-0.24946522884143035,-0.8783550235648618,0.6707317073170732,0.9177565646526628,1.0,20/54,22.29%,ADAR;AARS1;QTRT1;TRDMT1;NSUN5;FTSJ3;ADARB1;TSR3;MEPCE;ANKRD16;BCDIN3D;QTRT2;TRMT9B;MRM2;PUS7L;METTL1;THUMPD1;CTU2;METTL3;AARS2
prerank,protein targeting to mitochondrion (GO:0006626),-0.2479808808323089,-0.8783429986420596,0.6875,0.9167775159120335,1.0,23/52,32.19%,FBXO7;HSPA4;SAMM50;TIMM44;GDAP1;TOMM40;TIMM8B;GRPEL1;AIP;TOMM20;TOMM40L;TIMM29;TIMM21;AGK;BCAP31;TOMM34;FIS1;TOMM5;IMMP1L;TIMM17B;TIMM13;DNLZ;CHCHD4
prerank,regulation of multicellular organismal development (GO:2000026),0.34313185883771885,0.8781581853407172,0.6311336717428088,0.8470919416145892,1.0,8/25,21.32%,OAS2;INSR;RAB14;CCSAP;EHMT1;TRIP12;RACGAP1;NIPBL
prerank,regulation of protein localization to membrane (GO:1905475),0.3247407049940557,0.8781001353206865,0.6009771986970684,0.8467470478783091,1.0,10/28,18.68%,SPTBN1;PRKN;ACTB;FYN;STX7;GPC3;NECAB2;ZDHHC2;SLC5A3;VAMP8
prerank,C-terminal protein amino acid modification (GO:0018410),0.3930562591788744,0.8780196565868609,0.5902777777777778,0.8464402547001874,1.0,4/11,16.21%,ATG7;TTL;ICMT;ATG5
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.31333558107175624,0.8779450337008795,0.598694942903752,0.8461233526564833,1.0,2/32,2.97%,P2RX7;DRD1
prerank,copper ion homeostasis (GO:0055070),0.36770756160206336,0.8774903418570125,0.6061151079136691,0.8465523850490138,1.0,2/17,5.58%,APP;ATP7A
prerank,cellular response to acid chemical (GO:0071229),-0.29157778949997093,-0.8773482210943556,0.6464646464646465,0.9180026284533351,1.0,12/27,27.36%,RPTOR;IPO5;NSMF;RRAGD;GLRA1;RRAGB;MTOR;SESN2;GLRA2;CPEB1;RRAGA;SH3BP4
prerank,striated muscle cell differentiation (GO:0051146),0.3680172857899716,0.8771683362688852,0.5861456483126111,0.846734681636673,1.0,2/16,2.60%,MEF2C;BMP2
prerank,positive regulation of chemotaxis (GO:0050921),0.30021507077514664,0.8766820859524815,0.6329113924050633,0.8472179374752947,1.0,8/43,14.69%,NRP1;CCL19;HSPB1;CCR2;IL6R;DSCAM;MDK;PRKD2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3715789371131397,0.8766355987789212,0.6003430531732419,0.8468549938219833,1.0,5/15,13.46%,NYNRIN;LACTB2;ZC3H12A;ZC3H12D;RPP30
prerank,positive regulation of telomere maintenance (GO:0032206),-0.27489817910127845,-0.8766087344864432,0.670076726342711,0.9187159638135481,1.0,4/31,6.66%,HNRNPA2B1;ATM;MAPK3;MAP2K7
prerank,T cell receptor signaling pathway (GO:0050852),0.2512368438382533,0.8761640035592005,0.6818181818181818,0.8473191491998996,1.0,25/138,14.69%,PTPRJ;PSMA7;PTPN22;DENND1B;NFKBIZ;RFTN1;BCL10;THEMIS2;PAK2;RC3H1;PDE4D;WNK1;ZAP70;PSMB2;FYN;RIPK2;EIF2B1;PSMA6;ZC3H12A;UBE2N;FYB1;PSMA3;PSMD1;PSMD5;PRKD2
prerank,cardiac ventricle development (GO:0003231),0.35602151959404854,0.8759634500719274,0.6306913996627319,0.8472242536255434,1.0,4/20,10.69%,PDE2A;HEY2;TMEM65;DAND5
prerank,macroautophagy (GO:0016236),-0.20800643894757664,-0.8759316319994347,0.7777777777777778,0.9192889590110921,1.0,35/118,23.41%,TCIRG1;TECPR1;MTERF3;SRC;SNF8;RUBCNL;PRKAG1;CLN3;MFN1;PGAM5;PIK3R4;CHMP4B;CHMP4A;ATG16L1;VTI1B;VPS37A;VDAC1;TOMM40;ATP13A2;MAP1LC3A;PIP4K2B;GABARAPL1;ULK1;TOMM20;VIPAS39;SQSTM1;ULK3;ATG14;VAMP7;CHMP6;CHMP3;SNX14;ILRUN;UBQLN1;YOD1
prerank,lytic vacuole organization (GO:0080171),-0.2747877109337814,-0.8758444314878314,0.681704260651629,0.9184676225493423,1.0,7/32,9.44%,GNPTAB;HPS4;CLVS1;CLN3;GAA;VPS18;ZKSCAN3
prerank,atrioventricular valve morphogenesis (GO:0003181),0.34876824259975936,0.8755077671031326,0.6263157894736842,0.8476923311598271,1.0,6/19,17.88%,BMP2;HEY2;SMAD4;SLIT3;BMPR1A;EFNA1
prerank,regulation of mRNA stability (GO:0043488),0.25131818213374246,0.8754855815826151,0.6828025477707006,0.8472698465318872,1.0,26/145,14.92%,ZFP36L2;PSMA7;RPS27A;SAMD4A;ZFP36L1;VIM;MAPKAPK2;TENT5A;RC3H1;PUM2;ROCK1;HSPB1;PSMB2;DCP1A;SERBP1;PCID2;DCP2;PSMA6;ROCK2;ZC3H14;EXOSC8;EXOSC1;PSMA3;PSMD1;PSMD5;XPO1
prerank,vacuolar acidification (GO:0007035),0.3410587067858475,0.8753442805814939,0.6096718480138169,0.8470729540337547,1.0,5/21,6.12%,GRN;CLN5;CLN6;ATP6V0A1;DMXL1
prerank,vesicle transport along actin filament (GO:0030050),0.3539245110307038,0.8752996843586595,0.6469534050179212,0.8467089553126782,1.0,5/19,14.11%,MYO5A;MYO7A;MYO1E;MYO1C;WASL
prerank,positive regulation of cell aging (GO:0090343),-0.36539743023501353,-0.8751722489790964,0.6255144032921811,0.9189950933901793,1.0,3/11,13.84%,ABI3;CGAS;YPEL3
prerank,oxoacid metabolic process (GO:0043436),0.32721599810156937,0.8748201143230537,0.6076794657762938,0.8471774546036598,1.0,5/27,13.73%,DAO;THAP4;SULT1A1;GNMT;SULT6B1
prerank,embryonic skeletal system development (GO:0048706),-0.27330990120987725,-0.8747919691479435,0.6270718232044199,0.9188771768299346,1.0,10/35,20.57%,KIAA1217;XYLT1;HOXC4;SULF1;HOXA3;DSCAML1;HOXB9;DYNC2I1;WNT5A;SOX11
prerank,negative regulation of neuron differentiation (GO:0045665),0.3464347410529327,0.8745898185801251,0.6,0.8471768854106071,1.0,2/22,4.76%,B2M;GSK3B
prerank,mitochondrial transcription (GO:0006390),-0.3707758654139631,-0.8745503834302542,0.6275720164609053,0.9184174565721553,1.0,6/10,31.15%,TFB2M;MTERF2;TFAM;SLC25A33;MRPL12;TFB1M
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.31173473763188436,-0.8745161300904882,0.6433915211970075,0.9174934988055513,1.0,7/19,23.03%,PIK3CB;ROBO1;ADAMTS3;CADM4;TSPAN12;CCBE1;DCN
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3715091429693609,0.8744460450544502,0.6113074204946997,0.8470029321994114,1.0,3/14,7.58%,PTPN22;SYK;CCR2
prerank,N-terminal protein amino acid modification (GO:0031365),-0.3426163125290276,-0.8742631361839397,0.6281179138321995,0.9170864162554441,1.0,3/14,14.39%,NAA40;NAA60;NAA35
prerank,aminoglycan biosynthetic process (GO:0006023),-0.25468157399971286,-0.874125339719723,0.6878787878787879,0.9163739420344983,1.0,21/49,26.32%,XYLT1;GCNT2;HS3ST5;HS6ST1;B3GALT1;SDC2;B3GALT5;B3GALT2;HS3ST3B1;B3GNT2;B4GALT7;GPC6;PXYLP1;GPC2;GPC5;UGDH;B3GALT6;GPC1;HSPG2;HS3ST1;HAS1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.40101261035651914,0.873707307097674,0.5988909426987061,0.8479984508116882,1.0,4/11,15.81%,TIPIN;GMNN;ZRANB3;FBH1
prerank,regulation of dephosphorylation (GO:0035303),0.35995038969487436,0.873046943549932,0.6333333333333333,0.8488421412515199,1.0,4/15,9.45%,MTMR3;SMG6;PPP1R17;IGBP1
prerank,modification-dependent protein catabolic process (GO:0019941),0.24398159373262063,0.8730077765881769,0.7314702308626975,0.8484582370580664,1.0,62/193,22.87%,RNF150;SMURF2;ARIH1;RPS27A;SIAH2;CBL;PRKN;ZNRF3;NDFIP1;RC3H1;TRIM32;ANKIB1;CDC27;BIRC6;MDM2;RNF19B;UBE2K;CUL3;ANAPC16;UBQLN4;FBXO11;RNF14;ARRB1;RNF111;AMFR;RNF185;UBE3B;MIB1;FBXO10;UBE2R2;RBBP6;RNF19A;NDFIP2;BFAR;NEDD4L;ANAPC1;ELOC;WDR91;TRIM25;RNF146;XBP1;UBE4B;UBE2A;CNOT4;LONP1;ANAPC10;ATXN3;TOLLIP;RNF6;TRPC4AP;SIAH1;TRIP12;RNF130;UBR3;CHFR;RNF149;PSMD11;NEDD4;ANAPC2;NUB1;FBXO8;RNF40
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.31335305201485736,0.8725618579923471,0.6288819875776398,0.8488765782871491,1.0,10/33,15.93%,ESR1;NCOA2;AXIN1;CBFB;TRIM68;H3-3A;RNF14;UFM1;EP300;KDM1A
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3192514037955884,0.8724390498199267,0.6333853354134166,0.8486585187355788,1.0,5/33,8.49%,LYN;ADAM9;ITGB1BP1;SYK;FOXC2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.29079968869104966,0.8724170817931777,0.6232091690544412,0.8482403067240262,1.0,10/54,15.07%,HGSNAT;EXT1;CLN6;SDC3;HS3ST2;SDC4;HS3ST3A1;XYLT2;GPC3;HEXA
prerank,peptidyl-serine phosphorylation (GO:0018105),0.24877237450420459,0.8722001958571063,0.7116104868913857,0.8481989991908256,1.0,43/153,19.60%,SGK3;GAS6;RIPK1;ERN1;CAMK1D;RPS6KA3;GSK3B;PKN2;PAK2;MAPKAPK2;ROCK1;WNK1;PIKFYVE;VRK2;PRKCB;ULK2;VRK1;MAPK14;DYRK1A;MAST1;RPS6KA6;MARK2;ROCK2;STK38;MKNK1;LATS2;UHMK1;PRKD2;NLK;PRKCG;ATR;MKNK2;PRKCQ;CAB39;MARK3;HIPK3;CAMK2A;CSNK1G3;PLK2;MORC3;CSNK2A2;CSNK2A1;EIF2AK3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.4052036149483737,0.8720729727030904,0.5902912621359223,0.8479822272762528,1.0,4/10,12.73%,TLR4;TLR2;NAMPT;NOD2
prerank,apoptotic mitochondrial changes (GO:0008637),-0.27218596729179056,-0.8719410941734019,0.660759493670886,0.9203069937757252,1.0,9/32,24.55%,HK2;CCAR2;ERBB4;AIFM2;THEM4;NDUFS1;NAIF1;BBC3;FIS1
prerank,regulation of pH (GO:0006885),0.3955670196985127,0.8717671901420199,0.6127272727272727,0.8481405934629427,1.0,3/11,14.18%,ATP6V1B1;ATP1A4;SLC9A7
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.2780256912855568,0.8717659359302675,0.6462196861626248,0.8476903241556493,1.0,11/72,9.90%,FGFR1;LYN;CBL;IRS2;INSR;PDGFRA;TNF;GAB1;PDGFC;MYDGF;IGF1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.21939961261728996,-0.8714195657419218,0.7376425855513308,0.920475775059394,1.0,34/87,31.25%,SAMM50;COX19;NUBPL;UQCC1;SDHAF4;TMEM126A;NDUFAF6;NDUFS7;NDUFV3;NDUFAF1;NDUFB8;NDUFB7;NDUFV1;COX16;NDUFB10;FASTKD3;SDHAF2;NDUFA8;NDUFA10;TTC19;TIMM21;ECSIT;NDUFAB1;COX17;NDUFS1;NDUFAF8;SLC25A33;ACAD9;NDUFA6;COX14;COA3;DMAC2;NDUFAF3;NDUFV2
prerank,microtubule bundle formation (GO:0001578),-0.26223672831634237,-0.8711486532822074,0.7285714285714285,0.9200806688450123,1.0,10/42,12.41%,CFAP74;LRGUK;CCDC66;NCKAP5L;MTCL1;NCKAP5;SPAG16;TPPP;TOGARAM1;NUMA1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4067719897531702,0.8710129336641133,0.5984848484848485,0.8487293922076324,1.0,2/10,10.61%,NCOA3;TRIM16
prerank,regulation of histone acetylation (GO:0035065),0.3142914367432688,0.870855173868969,0.6282894736842105,0.8485849140523265,1.0,6/33,12.41%,KMT2A;SPI1;CHEK1;IWS1;ARRB1;TADA2B
prerank,positive regulation of viral process (GO:0048524),-0.23905932517154485,-0.8708038793834366,0.6930091185410334,0.9198734146833051,1.0,16/60,18.99%,CDK9;ADAR;CNOT7;SRPK1;AXL;NELFB;PPIE;SRPK2;NELFCD;ADARB1;TBC1D20;TYRO3;POLR2C;TARBP2;DHX9;TMEM39A
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.29935365872976016,-0.8707396996106767,0.6462264150943396,0.9190343717838081,1.0,6/22,11.17%,THOC1;DDX39B;CCNT2;ERCC6;TCERG1;HMGN1
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.23252854771471734,-0.8706162055549986,0.7206349206349206,0.918306223869957,1.0,15/64,15.63%,GTF2H2;CDK9;CCNT2;MLLT1;CCNH;SSRP1;NELFB;CTR9;ERCC2;PAF1;NELFCD;EAF1;POLR2C;NCBP1;ELOB
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2433258903600653,-0.8703972517862875,0.7248322147651006,0.9178128760446669,1.0,20/59,22.18%,TGFBR1;PRKCD;ACVR1;CDC42BPA;CIT;MAP3K12;DYRK2;WNK3;PDPK1;CDC42BPB;DYRK1B;TGFBR2;CDK10;ACVR1B;ULK1;HIPK1;CAMK2D;MAPK8;TAF1;DYRK4
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2572404548896286,0.8695883697532986,0.6848249027237354,0.8505988377164883,1.0,16/104,12.43%,LRP6;ADRB2;UVRAG;RHOA;CDK12;RB1;INCENP;ACTB;CCND3;CCND2;PPP2CA;CCNJ;PARP16;CALM1;TRIB2;CDKN2C
prerank,RNA metabolic process (GO:0016070),0.2540282300232566,0.8695259081456482,0.7074122236671001,0.850285429602588,1.0,18/127,9.72%,DHX8;RBMS1;RNASE4;HNRNPC;SND1;DROSHA;RNASEL;TENT2;ATXN1;NOL9;HNRNPF;RNASE6;RNGTT;RBM4;WTAP;APOBEC1;MTREX;POLR2B
prerank,cellular response to oxygen levels (GO:0071453),-0.3740564582712009,-0.8694022929602201,0.6617954070981211,0.9190660422902449,1.0,3/10,14.69%,ATP6V0A2;ATP6V1G1;TMEM199
prerank,ESCRT III complex disassembly (GO:1904903),0.40391781186299514,0.8693224371805615,0.6447876447876448,0.8497766944878765,1.0,2/10,10.87%,VPS4B;CHMP5
prerank,ESCRT complex disassembly (GO:1904896),0.40391781186299514,0.8693224371805615,0.6447876447876448,0.8497766944878765,1.0,2/10,10.87%,VPS4B;CHMP5
prerank,stem cell development (GO:0048864),-0.32921986662757874,-0.8692366459977404,0.6539278131634819,0.9184432189841903,1.0,9/16,36.57%,CDH2;KLHL12;SOX11;TAPT1;SOX8;WNT7A;KBTBD8;SNAI2;SHH
prerank,histone H4 acetylation (GO:0043967),0.29736690848791736,0.8690353726172994,0.65284178187404,0.8498957540453413,1.0,13/47,16.46%,KMT2A;PHF20;EPC1;DMAP1;BEND3;TRIM16;KANSL2;HAT1;KANSL1;KAT7;EP300;HCFC1;PER1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.35700152869700924,0.8685888112114831,0.6303571428571428,0.8503244674541792,1.0,6/19,13.56%,GHRL;CD33;CARD16;IGF1;ZC3H12A;FFAR1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3345905211849472,0.8683671519273632,0.6279461279461279,0.8503113931178811,1.0,5/22,12.04%,PHF8;RASL11A;DDX11;HEATR1;DHX33
prerank,nerve growth factor signaling pathway (GO:0038180),0.4055503544683563,0.8683620112799775,0.6026615969581749,0.8498646457255667,1.0,2/10,4.84%,RAPGEF2;RAP1A
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3893239170098518,0.8681491954227367,0.6417910447761194,0.8498261987237611,1.0,2/13,7.76%,HEY2;PSEN1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.3778819053389908,0.8677600978722757,0.6127272727272727,0.8501060225832828,1.0,2/12,7.18%,LYN;BST2
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.36962331602460186,-0.8673421967391807,0.6279569892473118,0.9217624883473139,1.0,2/10,1.10%,MAP4K4;IQSEC1
prerank,regulation of protein polymerization (GO:0032271),-0.2685036348238271,-0.8672900267243258,0.6720430107526881,0.9208954079883531,1.0,11/35,20.19%,MAP2;CAMSAP1;MAPT;PLEKHG2;MAPRE3;GBA2;TPPP;HAX1;PAK3;DBN1;PRUNE1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3871069293042227,0.8671876625577284,0.6106870229007634,0.850744576094225,1.0,3/11,18.00%,CD46;BMPR1A;ATP6AP2
prerank,substantia nigra development (GO:0021762),0.3011457132812815,0.8670464033353219,0.6593059936908517,0.8505635528554603,1.0,11/37,14.12%,S100A1;CDC42;RHOA;YWHAQ;ACTB;ZNF148;CALM1;CCDC14;YWHAE;GLUD1;GNB4
prerank,protein homotrimerization (GO:0070207),0.3805403317747195,0.86688955089289,0.6467486818980668,0.8499737170360091,1.0,5/14,18.51%,ALOX5AP;CLYBL;DISP1;MLKL;SCARA5
prerank,protein trimerization (GO:0070206),0.3805403317747195,0.86688955089289,0.6467486818980668,0.8499737170360091,1.0,5/14,18.51%,ALOX5AP;CLYBL;DISP1;MLKL;SCARA5
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.3620914799066285,0.8668609186655684,0.62756052141527,0.8495901283033372,1.0,2/15,3.18%,CD36;TLR4
prerank,heterochromatin assembly (GO:0031507),-0.30598397059354365,-0.8665264197223409,0.682648401826484,0.9216093863829525,1.0,13/20,34.71%,SIRT2;CENPV;HDAC1;BAHD1;NRDE2;MBD2;SMCHD1;RRP8;HELLS;CDKN2A;SIRT1;HMGA1;HMGA2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.34641156395836153,0.8663242165495953,0.6026119402985075,0.8497327797361802,1.0,7/19,20.86%,ATRX;POLR2B;TERF2IP;TERF1;POLR2D;POLR2F;TINF2
prerank,regulation of DNA recombination at telomere (GO:0072695),0.34641156395836153,0.8663242165495953,0.6026119402985075,0.8497327797361802,1.0,7/19,20.86%,ATRX;POLR2B;TERF2IP;TERF1;POLR2D;POLR2F;TINF2
prerank,cellular response to dsRNA (GO:0071359),0.3645729765760862,0.8659538218176235,0.6196660482374768,0.85004944712502,1.0,2/15,5.78%,COLEC12;RIOK3
prerank,negative regulation of bone remodeling (GO:0046851),0.39317434144401725,0.8658067174693125,0.6308851224105462,0.8498722960885262,1.0,1/11,0.51%,P2RX7
prerank,triglyceride metabolic process (GO:0006641),0.2978956943586275,0.8656949401586368,0.653566229985444,0.8496477658784595,1.0,3/48,4.40%,APOE;AGMO;MOGAT2
prerank,regulation of axon regeneration (GO:0048679),-0.35795256224816324,-0.8654399969790308,0.6630901287553648,0.9230179947311248,1.0,3/12,8.45%,RTN4RL1;PTPRS;INPP5F
prerank,T cell mediated immunity (GO:0002456),0.37834748044471045,0.8650467410873194,0.6438848920863309,0.8504105267453365,1.0,2/13,3.41%,JAG1;CD46
prerank,cation transmembrane transport (GO:0098655),-0.25090320787752257,-0.8650053833114623,0.6931818181818182,0.9229682532733495,1.0,17/44,37.41%,ATP1B1;TRPM3;SLC36A4;SLC7A8;ATP13A2;ABCC9;ABCC8;MFSD12;TRPM7;SLC25A29;CACNA1H;SLC7A3;TRPM6;P2RX3;SLC3A2;TRPM1;SLC25A19
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.28601495091658,-0.8649639251997014,0.6535626535626535,0.9220751563031031,1.0,4/23,5.44%,OCIAD1;MGAT5;IL10RA;IL7R
prerank,NAD biosynthetic process (GO:0009435),-0.30812259972626166,-0.8647843121201908,0.6272965879265092,0.9214783871060491,1.0,8/20,24.57%,KYNU;PARP10;NAXD;PARP9;NMNAT1;NUDT12;PTGIS;NADSYN1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3236169800150671,-0.8646946497996003,0.6470588235294118,0.9207088818009198,1.0,6/18,20.48%,TIMM44;TOMM40;GRPEL1;TOMM20;TOMM40L;TIMM21
prerank,hexose metabolic process (GO:0019318),0.2983166979763821,0.8635913992705244,0.6603174603174603,0.8527891707011259,1.0,8/39,14.02%,SORD;IRS2;GHRL;FUOM;GALK2;PMM1;BRAT1;ADPGK
prerank,protein acetylation (GO:0006473),0.3166419061572735,0.8634611919551368,0.6396103896103896,0.8525838082421147,1.0,9/30,16.47%,CLOCK;ESCO2;ESCO1;CREBBP;HAT1;FOXO1;EP300;KAT6A;GTF2B
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.3732329070152683,0.8634356413910165,0.6256684491978609,0.8521831471188752,1.0,4/13,13.90%,OAS2;CANX;JAK1;STAT3
prerank,regulation of neuron apoptotic process (GO:0043523),0.2573191227884558,0.8632841576429996,0.6910344827586207,0.8520026068426655,1.0,10/96,6.94%,APOE;NUPR1;LIG4;MEF2C;RASA1;GRN;SNX6;PRKN;BCL2;TNF
prerank,regulation of mitotic cell cycle (GO:0007346),-0.19871346934565395,-0.8631273736078967,0.8638743455497382,0.9231331048694765,1.0,37/171,16.76%,TTC28;ANAPC15;CDK9;CYLD;LGMN;BRINP3;SKP1;BTG1;PSMD13;HNRNPU;SIK1;PSMD12;ASAH2;CCDC57;CUL9;ERCC2;PSMD9;NEK6;ANAPC11;UBE2S;PSME3;HSF1;BUB1B;GAS1;PSMA4;PSMD8;PSMF1;CDK11B;PSMD4;DLGAP5;UBE2E1;CDK5RAP3;CDK10;NEK11;UBE2D1;ANGEL2;PSMB8
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.29910096258581637,0.8631108970158935,0.6267716535433071,0.851866286371209,1.0,5/38,11.27%,FBXW7;PRKN;PARL;UBE2D3;SREBF2
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3713809478578366,0.862917081260312,0.6148409893992933,0.8518147366952997,1.0,1/13,2.61%,PRICKLE1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.2653474300748728,-0.8628868421337156,0.6657681940700808,0.9226843282225853,1.0,11/36,21.06%,CALM2;EPHA7;IMPACT;TOM1L1;TNKS1BP1;PPP2R5C;PPP2R5A;ERRFI1;PDGFA;ENG;CALM3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.40011883618459876,0.8626600573198718,0.6144814090019569,0.8518376738682447,1.0,1/10,3.88%,RGCC
prerank,positive regulation of protein ubiquitination (GO:0031398),0.26164487188748803,0.8622896304202307,0.6713286713286714,0.8521040558006242,1.0,14/80,13.83%,FBXW7;PRICKLE1;AXIN1;BCL10;BIRC3;NDFIP1;MYCBP2;ARRDC3;TSPYL5;CUL3;RIPK2;WFS1;UBE2N;NDFIP2
prerank,long-chain fatty acid import into cell (GO:0044539),0.4017713732115594,0.8619967770581216,0.6141304347826086,0.8521870883544209,1.0,2/10,9.97%,CD36;ACSL3
prerank,visual system development (GO:0150063),0.30387890504685205,0.8618261643707145,0.6752,0.8520425846419667,1.0,5/37,8.21%,C1QA;GDF3;PBX3;ADAMTS18;ATF6
prerank,cellular response to hydroxyurea (GO:0072711),0.39292314865542566,0.8617555676390336,0.6029143897996357,0.8517322376148591,1.0,3/10,10.34%,DDX11;ATRX;SPIDR
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3144095131630936,-0.8616391574755952,0.6404494382022472,0.9245724640718479,1.0,7/18,19.51%,TMEM119;BHLHE41;BDNF;HDAC5;NOTCH1;HDAC3;HDAC1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.36679930973563024,0.8616130111543037,0.62778730703259,0.8515571929820293,1.0,4/15,14.84%,RPL23;RPL5;RPS7;RPL11
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3140533607209338,-0.8612541283907885,0.6353711790393013,0.9244489340770284,1.0,4/16,12.35%,HNRNPA2B1;ATM;PARP1;TERF2
prerank,regulation of keratinocyte migration (GO:0051547),-0.3508844894946672,-0.860930986662284,0.6525612472160356,0.9241826820964912,1.0,2/12,1.10%,MAP4K4;IQSEC1
prerank,positive regulation of telomere capping (GO:1904355),-0.3199948204506192,-0.8604559406075241,0.6177777777777778,0.9243022652075025,1.0,3/17,13.29%,MAPK3;MAP2K7;MAP3K4
prerank,snRNA metabolic process (GO:0016073),-0.31899405677813,-0.860404163029623,0.6422018348623854,0.9234284577862567,1.0,6/17,25.27%,ZCCHC8;INTS3;MEPCE;INTS9;INTS11;INTS7
prerank,membrane lipid catabolic process (GO:0046466),-0.36997277931315664,-0.8599350868149676,0.6337448559670782,0.9234463752345667,1.0,3/10,18.58%,ENPP2;PPT1;SMPD2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.3955659994222108,0.8597146629114998,0.6054054054054054,0.8547088679474047,1.0,1/10,1.72%,LYN
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.2963601909425273,-0.8595612782688291,0.6777251184834123,0.9232890895279167,1.0,7/20,27.35%,ACACA;PPT1;ACSL4;SCD;SLC25A1;DGAT2;GCDH
prerank,positive regulation of DNA replication (GO:0045740),0.3603500343187577,0.8592743971853358,0.6352087114337568,0.8551004332127397,1.0,1/16,0.45%,EGFR
prerank,response to peptide hormone (GO:0043434),-0.2509991925169582,-0.8592288627065137,0.7369942196531792,0.9230151695389294,1.0,8/43,11.25%,SORT1;SRC;STAT1;GNAI1;EIF2B3;TGFBR3;STAT2;TSC1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3013987305765847,-0.8592013823261392,0.674074074074074,0.9220977896072916,1.0,4/21,10.15%,ADCY3;ADCY8;GUCY1B1;ADCY7
prerank,carnitine metabolic process (GO:0009437),-0.3491697579095548,-0.85911985216753,0.6746203904555315,0.9213027937780572,1.0,6/12,35.94%,ACADL;ACADM;CPT1C;CPT2;CPT1B;BBOX1
prerank,protein import into peroxisome matrix (GO:0016558),-0.3623063384696803,-0.8590873890460663,0.6666666666666666,0.920404997044268,1.0,3/12,11.84%,PEX5L;PEX6;PEX10
prerank,positive regulation of translation (GO:0045727),0.25645086615967433,0.8585565856330507,0.7099023709902371,0.8559576444762347,1.0,15/94,14.37%,EIF3E;SAMD4A;NIBAN1;RPL26;VIM;RPUSD3;RPS4X;RPL5;LARP4B;RPS9;USP16;LARP4;PIWIL2;UHMK1;POLR2D
prerank,chromatin organization (GO:0006325),0.2494784434304671,0.8585529915330831,0.7245430809399478,0.8555152932582479,1.0,28/132,18.20%,PADI4;ESR1;BAZ2B;JARID2;SPI1;RB1;SETDB2;KDM6A;DDX11;SATB2;ATRX;HMG20A;KDM4D;KDM5C;LOXL2;TADA2B;SMARCAD1;EHMT1;PWWP3A;MYC;SMARCD1;HDAC4;ARID1A;HCFC1;ZBTB7A;MECOM;NPM3;ZBTB1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.2717816318421393,-0.8583861766291022,0.7090909090909091,0.9210046211732045,1.0,14/30,34.19%,DNAJC7;PTGES3;SDF2;DNAJB14;DNAJB1;DNAJB5;CCT2;HSPA9;DNAJC18;DNAJB13;SDF2L1;HSPA1A;CHCHD4;HSPA1B
prerank,positive regulation of rRNA processing (GO:2000234),-0.3782578212285631,-0.8581726068820916,0.6549586776859504,0.9204748321489508,1.0,3/10,15.65%,SIRT7;WDR75;RIOK2
prerank,protein localization to lysosome (GO:0061462),-0.27379513990360915,-0.8579958068780477,0.7046632124352331,0.9198717648572872,1.0,8/28,16.92%,SORL1;SCARB2;GCC2;GLMP;ATP13A2;NCOA4;RNF128;GGA3
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.33433695864291757,-0.8577184879189116,0.6518847006651884,0.9195179687099894,1.0,5/13,22.45%,UBA3;UBA7;SAE1;UBA2;UBA5
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.25694642634187614,-0.8576937464804527,0.7100271002710027,0.9185998184667912,1.0,6/39,9.13%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.23316258448615224,-0.8574417484663883,0.7880597014925373,0.9181248062453714,1.0,21/60,27.95%,CTNNB1;XRCC5;FGF2;ATM;MAPK3;MAP2K7;PTGES3;RFC2;MAP3K4;CCT7;HNRNPA1;CCT2;WRAP53;ACD;CHTF18;NVL;CCT8;PDGFRB;FBXO4;AURKB;GREM1
prerank,glycoprotein metabolic process (GO:0009100),0.2841485904146469,0.8571216176747966,0.6793002915451894,0.8577439730706572,1.0,8/53,11.99%,MAN2A1;ST8SIA4;CNMD;MANBA;ADAMTS9;B4GALT5;NGLY1;ENGASE
prerank,organophosphate biosynthetic process (GO:0090407),0.30233604746068476,0.857050770452232,0.651017214397496,0.8574379434327026,1.0,6/37,9.99%,MOCS1;TPK1;IP6K3;AGPAT5;TKT;PIP5K1A
prerank,cellular response to gamma radiation (GO:0071480),0.3541726600964597,0.8569174618533262,0.625,0.8572308539011786,1.0,8/17,16.18%,RPL26;TSPYL5;MDM2;MAP3K20;CRYAB;TMEM109;KDM1A;ATR
prerank,muscle organ development (GO:0007517),0.2784219160506309,0.8567199977243932,0.6661721068249258,0.8571410305456721,1.0,5/54,3.79%,MEF2A;TCF12;MEF2C;MYH6;UTRN
prerank,apical protein localization (GO:0045176),-0.3596138129913012,-0.8556071026176919,0.6637931034482759,0.9210944624907434,1.0,5/10,14.94%,ATP8B1;MAL;SHROOM2;VANGL2;INSC
prerank,positive regulation of RNA splicing (GO:0033120),-0.2782219033632197,-0.8555266035909829,0.6816976127320955,0.9203042648629763,1.0,8/29,14.75%,SETX;NCL;HNRNPLL;CELF4;HABP4;CIRBP;NCBP1;RBMXL1
prerank,smooth muscle contraction (GO:0006939),0.3772104845421438,0.8553836366957899,0.6191304347826087,0.8592617601450083,1.0,5/14,17.25%,ROCK1;PIK3C2A;ADRA1A;ROCK2;CHRNB2
prerank,epithelium development (GO:0060429),-0.20884370467383598,-0.8553612276155265,0.8032128514056225,0.9196746469340841,1.0,30/107,24.94%,SALL1;JAK2;STAT1;NDRG4;FGFR2;DVL1;LOXL3;AHI1;PGK1;VDAC1;CASP6;CD34;SOX10;PAX8;PROX1;UPK1B;SMO;ALDH1A2;WNT4;TPP1;ERRFI1;TST;FN3K;SOX11;TGFB1;DACT1;STIL;ACADVL;SOX8;CDK1
prerank,DNA catabolic process (GO:0006308),0.39702678705698585,0.8553495122442183,0.635036496350365,0.8588710986340486,1.0,2/11,15.81%,DNASE1L1;FBH1
prerank,signal peptide processing (GO:0006465),0.3752692692441629,0.8552682125067187,0.6465201465201466,0.8585770221653909,1.0,2/11,5.82%,CLN5;PARL
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2802240024319362,0.8545100526877007,0.6944444444444444,0.8595569273249385,1.0,23/59,23.58%,TCF7L2;CEBPB;MITF;CBFB;MED16;MED20;MED6;MED26;MED15;TNRC6C;MED27;PTEN;MED17;RELA;IL6;THRA;MECP2;MED14;NFKB1;MED7;MED24;AGO3;CCND1
prerank,regulation of fatty acid oxidation (GO:0046320),0.3613030285082045,0.8543886494222593,0.6402877697841727,0.8593594346016579,1.0,1/16,1.30%,PRKAG2
prerank,protein O-linked glycosylation (GO:0006493),0.2572252190373331,0.8543742251146428,0.7033112582781457,0.8589377151117682,1.0,14/96,15.27%,POMK;ST6GAL1;LARGE2;ST3GAL1;C1GALT1;POGLUT3;TET3;POGLUT1;B4GALT5;PLOD1;TET2;FKRP;POMT2;ST3GAL4
prerank,regulation of synapse maturation (GO:0090128),-0.36131348380032735,-0.8542264073565781,0.6740576496674058,0.9211583475975068,1.0,1/10,2.75%,NRXN1
prerank,regulation of G0 to G1 transition (GO:0070316),0.3054359656413211,0.8541718450984489,0.6614173228346457,0.8588629533573373,1.0,7/38,11.22%,RBBP8;RYBP;EPC1;CHEK1;TFDP1;RHNO1;PHC3
prerank,tRNA methylation (GO:0030488),-0.25640499949769807,-0.853551155735893,0.7246753246753247,0.9216882584691707,1.0,16/34,35.50%,DALRD3;TRDMT1;METTL2B;METTL2A;TRMT12;ALKBH8;BCDIN3D;METTL1;HSD17B10;PRORP;WDR6;GTPBP3;TRMT44;THUMPD3;NSUN6;FTSJ1
prerank,positive regulation of mRNA processing (GO:0050685),-0.29988154601487504,-0.8531313627378192,0.6821515892420538,0.9216404200124709,1.0,6/21,14.75%,NCL;CELF4;PAF1;CIRBP;NCBP1;RBMXL1
prerank,regulation of vasculature development (GO:1901342),-0.2821043619776544,-0.8528024713910899,0.7052341597796143,0.9213387023444737,1.0,4/26,5.51%,CTNNB1;ETS1;FGF2;NF1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3742250596589969,0.8522624173966596,0.648014440433213,0.8620625772248585,1.0,2/14,4.15%,RPS3;BCL10
prerank,negative regulation of organelle assembly (GO:1902116),0.3092354893674401,0.8520801704871124,0.6772655007949125,0.86197678890042,1.0,5/35,8.90%,NUPR1;MTM1;FEZ2;SMAD4;SMCR8
prerank,protein modification by small protein removal (GO:0070646),0.23236718265540252,0.852036311799755,0.7819634703196348,0.8616097404331104,1.0,54/252,17.16%,ESR1;SMURF2;PSMA7;USP3;RPS27A;BABAM2;VCPIP1;ATXN7;ADRB2;RIPK1;SIAH2;RHOA;PRKN;BIRC3;USP9X;SNX3;SMAD4;ACTB;BRCC3;USP15;YY1;PSMB2;MDM2;ASXL1;USP21;USP16;USP24;PSMA6;FOXK2;USP14;ZC3H12A;FOXK1;TADA2B;WDR20;USP45;USP9Y;EP300;PSMA3;PSMD1;PSMD5;USP28;USPL1;MYC;USP22;SENP1;USP25;ABRAXAS2;USP47;HCFC1;PTEN;STAM;UCHL3;USP32;SENP6
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3276405674464269,0.8513945354490519,0.6468646864686468,0.8623818072349398,1.0,6/25,18.57%,HEY2;RB1;IGF1;NIBAN2;ZBTB7A;TRAF6
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.3637796428032518,-0.8513789432918453,0.6774193548387096,0.9234479060383642,1.0,3/10,11.23%,PDE3B;UBE2B;PDE3A
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.2910850637475441,-0.8512147298943731,0.6692913385826772,0.9228125156566264,1.0,11/22,27.13%,NFU1;NUBPL;ISCU;FXN;NFS1;ISCA1;CIAO1;GLRX5;HSPA9;CIAO2B;CIAPIN1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2735707194607985,0.8510232410535857,0.6833095577746077,0.8626288024246125,1.0,18/68,20.88%,HINT1;GNAI3;SULT1A1;ADSS2;ACOT12;RAB23;AMPD3;GTPBP1;SULT6B1;NT5C2;ADSS1;ACAT1;EFL1;ENPP1;AK3;AK4;ACLY;HPRT1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3192027275982751,0.8510190683439628,0.6295081967213115,0.8621868926069154,1.0,5/27,10.79%,EGFR;RIPK1;PUM2;LIMD1;DDX6
prerank,mitochondrion disassembly (GO:0061726),0.3066143189482504,0.8510052719083625,0.6539634146341463,0.8617660130251146,1.0,15/34,21.05%,PRKN;WIPI1;ULK2;MARK2;ATG7;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;BNIP3;ATG3;FUNDC1;FUNDC2;MAP1LC3B
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3125621463757188,0.8508312029235668,0.6584158415841584,0.8616528621197279,1.0,9/31,20.82%,ERN1;PRKN;RHBDD1;BAG3;HSPA13;UBE2W;ATXN3;TMBIM6;HSPA2
prerank,positive regulation of transporter activity (GO:0032411),0.3602378776168504,0.849941423741161,0.6326530612244898,0.8629244213018992,1.0,1/13,1.43%,KMT2A
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.36733674470397176,0.8498893167334678,0.6470588235294118,0.8625670960680409,1.0,2/14,3.92%,ADRB2;RAPGEF2
prerank,positive regulation of response to stimulus (GO:0048584),0.2984842588637532,0.8496178524832938,0.6752411575562701,0.8626146023680523,1.0,5/40,8.32%,FCGR2B;IL15;B2M;CD80;HOMER1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.19609857306449868,-0.8493680000965932,0.8983957219251337,0.9257827437304297,1.0,43/173,21.79%,TGFA;PREB;KLHL12;DYNC1H1;BCAP29;NRBP1;TRAPPC3;ANK2;SEC31A;COG3;HYOU1;ANK1;VTI1B;COG4;CNIH1;NAPA;ERGIC3;SEC24A;RAB2A;COG2;TBC1D20;SPTB;F8;USE1;TEX261;TMED1;TMED7;TRAPPC6A;SPTBN2;GOLGA2;SEC24B;TRAPPC2;COPA;SEC13;BET1;VAMP7;GOSR2;DCTN2;ZW10;TRAPPC2L;GOPC;CAPZB;TRAPPC12
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3503230997860107,-0.8493554925283823,0.6645021645021645,0.9248447554260778,1.0,8/12,31.91%,CENPC;CENPE;SEH1L;NDC80;CDT1;KIF2C;NUF2;BOD1
prerank,DNA methylation (GO:0006306),-0.291662205775578,-0.8492668143541303,0.6544117647058824,0.9240670770969989,1.0,2/23,1.41%,DNMT3A;EHMT2
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3272072851357097,-0.8490844530521797,0.6386946386946387,0.9234967687640995,1.0,2/15,5.90%,TREM2;LPL
prerank,negative regulation of epithelial cell migration (GO:0010633),0.30472291545835223,0.8490670078846487,0.635048231511254,0.86319662477374,1.0,6/33,10.54%,APOE;MCC;SYNJ2BP;ADAMTS9;CORO1C;SP100
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.27727831286573423,-0.8489358577924817,0.727735368956743,0.9228234852828313,1.0,6/29,13.88%,TENT5C;FUS;HNRNPU;FMR1;CIRBP;TAF15
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3247707757519095,-0.8481873055744145,0.6838709677419355,0.9234192502932648,1.0,4/16,12.05%,SNF8;CHMP4B;CHMP4A;TMEM50B
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.2581351891506666,-0.8480604977322798,0.7083333333333334,0.9227574577051221,1.0,9/36,18.32%,JAK2;OCIAD1;IL10RA;DOT1L;JAK3;ERBB4;CENPJ;NOTCH1;EGF
prerank,oogenesis (GO:0048477),0.3559124851690927,0.8480455810820874,0.6452173913043479,0.8646526364430479,1.0,7/15,26.18%,NANOS3;HORMAD1;PIWIL2;MDK;MARF1;FMN2;NANOS1
prerank,nuclear transport (GO:0051169),0.3560038866195835,0.8478490650239909,0.6548042704626335,0.8645854283280371,1.0,7/16,22.30%,RSRC1;NUP98;BANF1;XPO1;RGS14;RBM15B;NPM1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3530882718365198,0.8471057163814655,0.6544789762340036,0.8655043712717545,1.0,3/16,8.14%,UGT1A8;ERLIN1;NCOR1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2590770696014064,-0.8469130057850196,0.7295081967213115,0.9241808721273645,1.0,6/37,9.13%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;ERCC2
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.26034107426323055,-0.8466683252591403,0.7275280898876404,0.9237116316051801,1.0,11/35,23.22%,PARP1;LIG1;XRCC1;POLG;RFC2;POLE;POLL;RFC1;ADPRS;PARG;POLD4
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.32705626182841385,0.8463547623579833,0.6672297297297297,0.8664915360314527,1.0,1/25,0.47%,EXT1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.28856989514019965,-0.8463062398091797,0.6925064599483204,0.9234587630780725,1.0,4/23,11.87%,CADM1;ARRB2;NECTIN2;SLAMF6
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3355891423946792,0.8458579334745403,0.6643952299829642,0.8669704920511068,1.0,2/20,3.98%,DENND1B;B2M
prerank,embryonic digit morphogenesis (GO:0042733),0.3360323048722742,0.8450429431770374,0.631578947368421,0.8680680990099444,1.0,4/18,11.28%,OSR1;INTU;MAP3K20;CREBBP
prerank,sulfur amino acid catabolic process (GO:0000098),-0.3631323217348574,-0.8447967551069263,0.6402569593147751,0.9257088034252376,1.0,5/10,34.62%,TST;MTRR;CBS;GADL1;CTH
prerank,embryonic axis specification (GO:0000578),0.3594722771928873,0.8446520188617465,0.6545454545454545,0.8683573354298708,1.0,1/15,2.81%,HOXD8
prerank,non-motile cilium assembly (GO:1905515),0.3077298560357541,0.8444567516021375,0.6539735099337748,0.8682817960431566,1.0,3/30,5.55%,IFT57;PIBF1;DISC1
prerank,protein K63-linked ubiquitination (GO:0070534),0.2882726867753264,0.8443425779774837,0.6614906832298136,0.8680385408478494,1.0,8/41,13.97%,UBE2E3;PELI1;PRKN;TRIM56;TRIM27;RNF115;UBE2N;BFAR
prerank,protein acylation (GO:0043543),0.2939801047550332,0.8443298701956621,0.6645367412140575,0.867610727608103,1.0,10/38,16.47%,CLOCK;ZDHHC14;ZDHHC3;CREBBP;FOXO1;EP300;KAT6A;ZDHHC20;ZDHHC2;GTF2B
prerank,T cell migration (GO:0072678),0.36756508980730895,0.8439486386092805,0.6335174953959485,0.8678836132824048,1.0,6/13,20.25%,ZAP70;CXCL16;MSN;S1PR1;GPR183;PIK3CD
prerank,regulation of T cell differentiation (GO:0045580),0.3019421428104149,0.8438415078465452,0.6495327102803738,0.8676569211064589,1.0,11/33,23.39%,CBFB;TCF7;ZAP70;CCR2;NFATC2;MDK;XBP1;ZBTB1;ZMIZ1;IL7;TBX21
prerank,RNA methylation (GO:0001510),-0.22893019867464545,-0.8432334830724005,0.7701863354037267,0.9280104843954465,1.0,27/60,35.50%,TRDMT1;METTL2B;METTL2A;NSUN5;TFB2M;FTSJ3;TRMT12;MEPCE;ALKBH8;TGS1;BCDIN3D;MRM2;MTERF4;METTL1;METTL3;ZC3H13;CBLL1;WDR6;GTPBP3;TRMT44;TFB1M;NOP2;TRMT6;FBL;THUMPD3;NSUN6;FTSJ1
prerank,early endosome to late endosome transport (GO:0045022),0.3232876762013401,0.8431670679354778,0.660472972972973,0.8684852756025047,1.0,12/20,27.16%,RILP;KIF16B;RAB7A;SNX16;WDR91;EEA1;PIK3C3;RAB5A;STX8;BECN1;LMTK2;HOOK3
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3179347074091218,0.8424137679958124,0.657487091222031,0.8694283893334386,1.0,5/25,14.66%,ATP6V1B1;PRKN;FAM20A;WFS1;CNNM4
prerank,regulation of necroptotic process (GO:0060544),0.32352474414225063,0.8422047748806039,0.6672268907563025,0.8693773322296605,1.0,9/23,20.63%,RIPK1;PELI1;BIRC3;SDCBP;CASP8;MLKL;FLOT2;SLC25A4;PDCD6IP
prerank,mesoderm formation (GO:0001707),0.34054487241435943,0.8421962773842107,0.6312056737588653,0.8689430008304353,1.0,1/17,1.84%,ITGB1
prerank,regulation of rRNA processing (GO:2000232),-0.32081102546472606,-0.8420027138591658,0.6834061135371179,0.9295807545449675,1.0,6/16,29.77%,SIRT7;WDR75;RIOK2;RIOK1;NUDT16;METTL18
prerank,protein kinase A signaling (GO:0010737),0.38667226528016363,0.8419426725652894,0.6630824372759857,0.8689560089844395,1.0,5/12,25.64%,LCP1;PRKACB;EZR;RAB13;MYOM1
prerank,plasma membrane tubulation (GO:0097320),0.3688222454491626,0.8418565446411893,0.660377358490566,0.8686525483557116,1.0,3/13,11.69%,SNX9;PACSIN2;SNX33
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2568291872605515,-0.841165822817233,0.7108753315649867,0.9303385719375353,1.0,9/36,13.93%,DNA2;ATRIP;ATM;DOT1L;ERCC6;CEP63;HUS1;PRPF19;CHEK2
prerank,negative regulation of synaptic transmission (GO:0050805),0.3247151457194028,0.8410792731569289,0.6381578947368421,0.8696908988078932,1.0,7/23,21.08%,TMEM25;ACHE;PTEN;PRRT1;PLK2;SLC30A1;PICK1
prerank,RNA destabilization (GO:0050779),0.3476077451133134,0.8410235835253475,0.643581081081081,0.8693604794589047,1.0,10/18,27.72%,ROCK1;ZC3H18;ROCK2;DXO;GIGYF2;METTL16;FTO;YTHDF3;CELF1;YTHDF1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.330159931311812,0.8402432028076215,0.6715686274509803,0.8703430947973936,1.0,5/23,12.09%,MEF2C;MAPK14;IGF1;MAML1;NIBAN2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.3185441752999056,-0.8398902671414096,0.6884875846501128,0.9320398196661025,1.0,2/16,4.13%,PPP1R16B;FGF2
prerank,regulation of protein ubiquitination (GO:0031396),0.24727440789674793,0.8397084044561913,0.7456258411843876,0.8708745687619931,1.0,24/108,17.43%,SASH1;FBXW7;RPS3;PRICKLE1;AXIN1;PRKN;BCL10;BIRC3;NDFIP1;MYCBP2;SPOPL;TSPYL5;CUL3;RIPK2;ARRB1;WFS1;UBE2N;NDFIP2;PINX1;PRKCG;HSP90AB1;AMER1;FANCI;SPRY2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3802638648663111,0.8394991867307392,0.6507633587786259,0.8708476397901954,1.0,3/11,14.91%,ZFP36L1;CDC73;PAPOLA
prerank,regulation of cell growth (GO:0001558),0.2320574535417775,0.8388598950105947,0.7973621103117506,0.8715973967076109,1.0,34/204,14.33%,EGFR;PTPRJ;SGK3;CDC42;DCSTAMP;DNPH1;RPS6KA3;IL17RB;RB1;RACK1;SMAD4;TRIM32;BCL2;SDCBP;BST2;MTPN;CXCL16;ESR2;NUBP1;PPP2CA;H3-3A;RTN4;SFRP1;SERTAD2;SLIT3;ST7L;EBAG9;CDKN2C;BRAT1;GJA1;NET1;MFSD2A;DERL2;CRLF3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.3073114504115897,0.8387524578324506,0.6671974522292994,0.8713336340624482,1.0,14/33,23.29%,THPO;ACVR2A;RAB7B;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;FES;PITHD1;FAM210B;STAT5B;MAPK11
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.24883263927229315,-0.8387164874581317,0.7435158501440923,0.9334738245910503,1.0,9/42,11.42%,ACTR8;SMARCB1;SMARCC2;SMARCE1;ERCC6;CHD3;NASP;CECR2;SMARCA1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3118337280446815,0.8386770718434239,0.6722972972972973,0.8710334819613156,1.0,6/28,12.28%,CHP2;DMAP1;BAG3;PSEN1;JUP;ZC3H12A
prerank,respiratory electron transport chain (GO:0022904),0.360334685912977,0.8383576699385875,0.6542056074766355,0.8711738702129396,1.0,5/14,17.74%,ETFDH;ETFA;SDHA;UQCRFS1;ETFB
prerank,protein glycosylation (GO:0006486),0.24540435431770163,0.8383399619270611,0.7554980595084088,0.8707593216711692,1.0,21/125,14.52%,POMK;ST8SIA4;FUT4;LARGE2;ST3GAL1;MGAT2;SERP1;GFPT2;ALG9;TET3;TMEM165;ALG5;DOLPP1;POGLUT1;NUS1;B4GALT5;PLOD1;PMM1;TET2;RPN2;POMT2
prerank,proton transmembrane transport (GO:1902600),0.29698235307958676,0.8381290667199585,0.695852534562212,0.8706844583372528,1.0,10/36,18.90%,ATP6V1B1;ATP5PO;ATP6V1A;ATP1A3;ATP1A4;ATP1A1;ATP6V0D1;SLC36A2;ATP5MF;SLC25A27
prerank,phosphatidylinositol metabolic process (GO:0046488),0.24954081805327874,0.8374366933841165,0.7496723460026212,0.8715188219900474,1.0,36/109,22.14%,INPP4A;PGAP1;MTM1;SYNJ1;MTMR3;FIG4;IP6K3;OCRL;PI4K2B;PIKFYVE;PIK3R6;PLCD1;PLA2G2D;PIK3C2A;RAB14;PIP5K1A;PLCB3;PIP4P2;PLEKHA4;PLAAT3;PLBD1;PTPN13;PTEN;MTMR1;PIP4K2A;PIP4P1;INPP5K;PIK3C3;PIK3CD;MTMR6;PLA2G4C;LCLAT1;PI4K2A;MTMR12;RAB5A;PLCG2
prerank,DNA metabolic process (GO:0006259),0.22711186741679062,0.8373521474922974,0.8155784650630011,0.8712182495838532,1.0,69/270,20.20%,TCF7L2;ENDOG;RBBP8;USP3;LIG4;RPS27A;ORC5;UVRAG;DNASE1L1;ORC2;POLE2;NOP53;CHEK1;PRIM2;TOPBP1;CHRNA4;PDS5B;RPA1;GMNN;RAD54L;BACH1;TOP1MT;RAD52;UHRF2;PURA;ZRANB3;SP100;POLE3;KMT5B;XPA;HINFP;POLH;RPA3;TERF2IP;UBE2N;MUTYH;XPC;USP45;TERF1;KPNA2;MMS19;SMARCAD1;RAD51B;PWWP3A;SAMHD1;POLE4;GTF2H3;MCM8;FANCL;ATR;TOP2B;UBE2U;PRIM1;RFC3;GTF2H1;DMC1;ASF1A;MPG;UBE2A;ZBTB1;LONP1;SUMO1;DDX21;APEX1;POLD2;MRE11;RTEL1;USP7;PCNA
prerank,cognition (GO:0050890),0.2879681914279576,0.8371282088621995,0.6871165644171779,0.871203814972413,1.0,10/42,17.97%,APP;C5AR1;TNF;CHRNA4;MFSD2A;CBR3;GPR155;ST3GAL4;CHRNB2;JAKMIP1
prerank,regulation of secretion (GO:0051046),0.3677473036482407,0.8370248681129964,0.6584070796460177,0.8709538680477567,1.0,3/13,11.86%,OAS2;ACSL3;KCNQ1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.38211629323274715,0.8365569571083924,0.6332737030411449,0.8713913245838129,1.0,3/12,13.82%,TIPIN;GMNN;KAT7
prerank,protein localization to cell surface (GO:0034394),-0.27555493600404285,-0.8364820617097132,0.7419354838709677,0.9369886560657933,1.0,14/26,33.65%,CTNNB1;ANK2;ARF6;GGA3;PIGK;SMURF1;FLNA;ANGPT1;EMP2;GGA1;FGF7;MESD;JAM3;FBLN5
prerank,positive regulation of behavior (GO:0048520),0.38516085408553025,0.8360701901034436,0.6556776556776557,0.8718087283795167,1.0,1/10,2.01%,MEF2C
prerank,positive regulation of T cell activation (GO:0050870),0.2676949912747495,0.8359272721882928,0.7081545064377682,0.8716448655244668,1.0,20/62,23.00%,IL15;CD46;CCL19;CD80;ZAP70;CCR2;NOD2;MDK;CCL5;PRKCQ;XBP1;FLOT2;IL6;ZBTB1;PTPRC;ZMIZ1;IL7;CD47;TFRC;NCK1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3905580436199109,0.8356046366270626,0.6750972762645915,0.8717831405326635,1.0,3/10,14.89%,RARG;RARA;SNW1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.37763179820849796,0.8352561621162429,0.660952380952381,0.8719838137379461,1.0,7/12,20.78%,ACO1;ASS1;GLUD1;IDH1;IDH2;IREB2;ACLY
prerank,histone H2B ubiquitination (GO:0033523),0.3939094212466352,0.8352028645582397,0.6551724137931034,0.8716336777440001,1.0,2/10,8.11%,WAC;CDC73
prerank,lipid biosynthetic process (GO:0008610),0.25998478178714407,0.835155061184251,0.7427785419532325,0.8712724888713086,1.0,8/77,9.99%,ALOX5;HMGCR;PDSS1;PAM;AGPS;AGPAT5;DOLPP1;PIP5K1A
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3527631318052292,-0.8349059862675877,0.7,0.9392378192088487,1.0,5/11,27.95%,RIN3;MIF;PADI2;SLAMF8;GREM1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.36719323740547744,0.8348284021331118,0.6859205776173285,0.8714318486517633,1.0,2/14,5.93%,FXYD2;WNK1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.3568881061443441,0.8347154485136532,0.6568457538994801,0.8711910680220758,1.0,3/15,12.34%,HDC;MOXD1;SAT2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.24689482361404627,0.8345593135599072,0.7442176870748299,0.8710394912170161,1.0,19/113,14.27%,RAP1B;ESR1;RPS3;CD36;TLR4;LCP1;GSK3B;RACK1;SYK;TNF;RPA1;FNIP1;SPIDR;XPA;DHX33;RPA3;RHOC;IL5;TERF1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3306654140441666,0.834482313923828,0.6482142857142857,0.8707411422127749,1.0,2/19,3.88%,ADAM19;RGCC
prerank,apical junction assembly (GO:0043297),0.27940863096617174,0.834313779092834,0.7181409295352323,0.870600242762912,1.0,9/53,14.23%,CTNNA1;RHOA;GRHL2;PKN2;PAK2;VCL;STRN;RAMP2;RHOC
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.31158533491881923,0.8342311271642797,0.6644844517184942,0.870309459254724,1.0,3/26,6.07%,GCH1;ACER3;SPTLC2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.33532323754645277,-0.8338869851552655,0.6809954751131222,0.940337741515497,1.0,5/13,23.99%,PARP10;NAXD;PARP9;NUDT12;PTGIS
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.3588730255082397,0.8337637731881544,0.676416819012797,0.870299598176232,1.0,8/16,22.14%,ITGB1BP1;DUSP22;RCC2;CORO1C;BCAS3;PTEN;ACVRL1;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.3588730255082397,0.8337637731881544,0.676416819012797,0.870299598176232,1.0,8/16,22.14%,ITGB1BP1;DUSP22;RCC2;CORO1C;BCAS3;PTEN;ACVRL1;DLC1
prerank,mitochondrial fission (GO:0000266),-0.3150291020924098,-0.8337113676190144,0.6958637469586375,0.9397368011297049,1.0,8/16,31.71%,DNM3;GDAP1;MUL1;FIS1;SLC25A46;MTFR1;MTFP1;MTFR2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.30032129223119486,0.8335593005937406,0.6908783783783784,0.8702457334997487,1.0,3/30,4.76%,RIPK1;HMOX1;GSK3B
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.28613353618490533,-0.8335395573485813,0.7156398104265402,0.9391271905377393,1.0,4/20,8.95%,PRKCE;HECW2;ACTN2;HECW1
prerank,regulation of mitotic nuclear division (GO:0007088),0.27651362797475143,0.8327136163803003,0.7070707070707071,0.8713632259050564,1.0,9/55,11.62%,KIF20B;RGCC;DUSP1;INSR;CHEK1;IGF1;NUP62;PHIP;CDK13
prerank,protein targeting to membrane (GO:0006612),0.25640871057609704,0.8325045850818854,0.7507204610951008,0.8712932113444269,1.0,21/83,18.14%,RAB8B;SLC25A17;PXMP2;PIKFYVE;ZDHHC14;PEX26;SDCBP;ZDHHC3;VPS37C;SEC63;MYO1C;CHM;ZDHHC24;RABGEF1;ZDHHC20;PEX14;ICMT;ZDHHC2;GET3;PXMP4;ATG3
prerank,integrated stress response signaling (GO:0140467),-0.32573327650043904,-0.8317567847485151,0.6835164835164835,0.9417134723679192,1.0,2/14,9.17%,IMPACT;DDIT3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.29613327800630823,0.8315659062084704,0.7026143790849673,0.8725802180159705,1.0,7/34,17.66%,PTPN22;NOD2;RBP4;GPI;SCIMP;XBP1;IL6
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.34433327283900556,-0.8307923170690267,0.6825726141078838,0.9427364859293909,1.0,5/11,36.77%,CD34;ARIH2;WNT5A;YJEFN3;SFRP2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3062623171433825,0.8306790987702192,0.6991596638655462,0.8737380171105933,1.0,5/31,13.05%,FBXW7;AXIN1;ARRDC3;RAB1A;UBE2N
prerank,bile acid metabolic process (GO:0008206),0.31294769001740363,0.8303880337023755,0.6998313659359191,0.8738281997975964,1.0,4/27,9.75%,OSBPL9;HSD3B7;CYP27A1;OSBPL1A
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.27756725502710505,0.8301848411814166,0.7334384858044164,0.873753849033768,1.0,7/52,9.97%,EGFR;ITGB1;SPTBN1;RACK1;TNF;PLS1;ACSL3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.24446531085600842,0.8301698276465641,0.7572944297082228,0.873346542711945,1.0,12/110,8.33%,APOE;RPS3;CD36;CDC42;GSK3B;RB1;RACK1;RIOK3;NOP53;SYK;TNF;FNIP1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.31430538213312137,0.8301587308256597,0.7061769616026711,0.8729256426318937,1.0,11/27,19.85%,CD44;RHOA;TNF;CCR2;ITGB2;MDK;PRKCQ;RELA;IL6;TRAF6;HAS2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.3094063642725786,-0.8300550848775584,0.7262443438914027,0.9432762460114357,1.0,9/17,31.91%,KNL1;HASPIN;SPDL1;ZW10;IK;CDK1;AURKB;TTK;BOD1
prerank,cellular response to BMP stimulus (GO:0071773),0.26304863191949374,0.8295044440156258,0.717201166180758,0.8736626011761158,1.0,13/66,15.12%,BMP2;GDF3;USP9X;SMAD4;ACVR2A;USP15;HFE;VSTM2A;HIVEP1;SFRP1;USP9Y;SLC33A1;BMPR1A
prerank,negative regulation of nervous system development (GO:0051961),0.3447836010110112,0.8293791695807734,0.6873889875666075,0.8734415899135867,1.0,6/17,17.66%,B2M;TLR2;TNF;SLIT1;PCM1;IL6
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.34354683127013674,0.8291714213296295,0.6672443674176777,0.8733810654418341,1.0,7/17,21.39%,CYCS;COX7A2L;COX7C;COX10;NDUFA4;COX6C;COX5A
prerank,positive regulation of exocytosis (GO:0045921),0.2982999301499649,0.828503932212426,0.695,0.8741000206990339,1.0,8/35,12.63%,EXPH5;STXBP5;SDCBP;VPS4B;RAB7A;SDC4;CLASP1;UNC13D
prerank,sensory perception (GO:0007600),0.2774788305685436,0.8284346174264824,0.7001477104874446,0.8737904748047159,1.0,5/45,7.58%,P2RX7;C5AR1;MYO7A;CHRNA4;CCR2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3353106800367422,0.8283526059506068,0.6393728222996515,0.8735102371911501,1.0,2/19,3.18%,TLR8;TLR4
prerank,autophagosome maturation (GO:0097352),-0.25875445707376016,-0.8281345960368933,0.7387862796833773,0.9461369768262273,1.0,12/32,23.38%,TECPR1;RUBCNL;CLN3;VTI1B;MAP1LC3A;GABARAPL1;VIPAS39;ATG14;VAMP7;CHMP3;SNX14;UBQLN1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3067412962387736,-0.8280891156850481,0.7234513274336283,0.9452700195364827,1.0,2/17,4.56%,SNTA1;ANK2
prerank,melanosome transport (GO:0032402),0.3338531396342928,0.8280241981855924,0.6847635726795096,0.8732317060444506,1.0,2/18,6.22%,MYO5A;BLOC1S5
prerank,pigment granule transport (GO:0051904),0.3338531396342928,0.8280241981855924,0.6847635726795096,0.8732317060444506,1.0,2/18,6.22%,MYO5A;BLOC1S5
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.27320720441255225,-0.8278479857770644,0.746031746031746,0.9448086072587396,1.0,10/26,26.16%,ST3GAL6;CHST1;B4GALT4;CHST2;ST3GAL3;B3GNT2;ST3GAL2;FMOD;PRELP;B4GALT2
prerank,positive regulation of ATPase activity (GO:0032781),-0.24387532608618342,-0.827828897197698,0.7687861271676301,0.9439045666546437,1.0,14/41,29.06%,ATP1B1;ATP1B2;HNRNPU;SSBP1;DNAJB2;DNAJB11;MSH2;DNAJB1;DHX9;DNAJC9;TPM1;UHRF1;MSH6;DYNLL2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.31252931755324903,-0.8275645149781446,0.6988235294117647,0.9434802230868473,1.0,7/15,39.73%,PAX8;SMO;AGT;SOX8;BMP4;VEGFA;NOG
prerank,aminoglycan catabolic process (GO:0006026),0.3097463254106302,0.827449791871906,0.6920583468395461,0.873830437814426,1.0,3/28,9.08%,HGSNAT;SDC3;SDC4
prerank,motile cilium assembly (GO:0044458),0.3679132063576277,0.8266693153156506,0.6684303350970018,0.874788704165602,1.0,1/12,3.60%,SPATA6
prerank,cellular response to UV-A (GO:0071492),-0.34843775662114274,-0.826505933908156,0.7159090909090909,0.944680433237384,1.0,6/11,51.18%,CERS1;OPN3;TIMP1;PPID;OPN5;MME
prerank,melanocyte differentiation (GO:0030318),0.37145736148636077,0.8258767230455196,0.6711538461538461,0.8757760069921237,1.0,2/11,2.31%,MEF2C;MITF
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.28016109662404104,0.8254546496142616,0.7097744360902256,0.8760711485260201,1.0,8/48,15.22%,GAS6;IRAK3;PARP14;CARD16;SH2B3;SLIT3;NR1H2;SAMHD1
prerank,skeletal muscle tissue development (GO:0007519),0.30122501701412313,0.825074561600852,0.6923076923076923,0.8762942900066443,1.0,2/32,3.07%,MEF2C;MYORG
prerank,isotype switching (GO:0045190),0.38921844801877453,0.825049813454615,0.6728016359918201,0.8759005347994923,1.0,1/10,2.01%,LIG4
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.33022383283642526,-0.8246630219109448,0.7011494252873564,0.9473748541892288,1.0,3/13,8.76%,PRR5L;CNOT7;UPF1
prerank,telomere capping (GO:0016233),-0.3072188684476031,-0.8244848722519158,0.684085510688836,0.9467856437579035,1.0,7/16,24.66%,CTC1;STN1;TERF2;DCLRE1B;TFIP11;ACD;RAD50
prerank,inorganic cation import across plasma membrane (GO:0098659),0.2601419908001184,0.8242432830330553,0.726158038147139,0.8769275398212988,1.0,13/75,14.19%,SLC9A9;FXYD2;KCNJ14;SLC9A4;TRPV3;SLC39A12;TRPM2;ATP2B4;ATP1A3;ATP1A4;ATP1A1;SLC9A7;SLC9A6
prerank,DNA double-strand break processing (GO:0000729),-0.294071808049168,-0.8239154452111229,0.7272727272727273,0.9469382071191443,1.0,4/18,8.88%,DNA2;ATM;BLM;BRCA1
prerank,endochondral bone morphogenesis (GO:0060350),-0.3429147036261416,-0.8238634185222565,0.6941431670281996,0.9461057658707533,1.0,8/11,32.70%,BMPR1B;TMEM119;FOXC1;INPPL1;COL13A1;SCX;BMP4;BMPR2
prerank,nitrogen compound transport (GO:0071705),0.23879401791020605,0.8235664403744165,0.7892768079800498,0.8776901048640784,1.0,25/141,17.79%,TXNIP;SLC16A10;RCN3;CALCRL;RILP;TCN2;LRRC8D;SLC43A2;ABCC1;ARRDC3;RAB7A;CMTM6;SLC38A1;SLC38A2;RAMP2;SLC6A2;SLC23A1;SNX4;SLC7A7;HSP90B1;SLC6A6;MIA3;SLC35F3;SLC36A2;CERT1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.2931141582571591,-0.8235492543707377,0.71875,0.9457890004979376,1.0,1/18,0.35%,BIN1
prerank,histone H4-K5 acetylation (GO:0043981),0.34166891349233863,0.8234509413443275,0.6748251748251748,0.8770282104405717,1.0,6/15,19.67%,PHF20;KANSL2;KANSL1;KAT7;HCFC1;JADE3
prerank,histone H4-K8 acetylation (GO:0043982),0.34166891349233863,0.8234509413443275,0.6748251748251748,0.8770282104405717,1.0,6/15,19.67%,PHF20;KANSL2;KANSL1;KAT7;HCFC1;JADE3
prerank,neurogenesis (GO:0022008),0.2830476170706589,0.8229996120324662,0.7227414330218068,0.8774225301879127,1.0,8/43,13.59%,WNT2;CLN5;BTBD1;CDK6;CXCR4;DCHS1;VXN;TRAK2
prerank,regulation of amyloid-beta formation (GO:1902003),0.2946913958836387,0.8226768711995835,0.6896551724137931,0.8775514350756023,1.0,12/34,17.88%,APOE;ROCK1;TMED10;TNF;IGF1;RTN4;SP1;ROCK2;RELA;IFNGR1;PICALM;EFNA1
prerank,response to cholesterol (GO:0070723),-0.29900318799070297,-0.822231461895585,0.7158836689038032,0.9474277151423404,1.0,8/17,21.93%,TGFBR1;GRAMD1A;CCL3;TGFBR2;GRAMD1C;SMO;ABCA2;TGFB1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.37913740946233504,0.8216508566840356,0.681640625,0.8789364387790006,1.0,2/11,10.64%,GCH1;CALM1
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.2800893968838409,-0.8210989162574367,0.7142857142857143,0.9487058410789901,1.0,6/22,15.85%,LAG3;DUSP10;VSIR;FANCA;BCL6;IL4I1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.3749224652312726,0.8210897106280407,0.6691729323308271,0.8794778456762471,1.0,3/11,13.90%,PUM2;LIMD1;STAT3
prerank,positive regulation of DNA binding (GO:0043388),0.30205835744226256,0.8210495579025968,0.6845528455284553,0.8790997107346145,1.0,8/31,18.57%,PRKN;RB1;CEBPG;IGF1;NIBAN2;PINX1;PLAUR;TRAF6
prerank,serine family amino acid biosynthetic process (GO:0009070),0.36573285556941626,0.8200469480405822,0.675,0.8804063071782179,1.0,5/12,24.38%,SERINC3;SERINC5;SRR;PSPH;SEPHS2
prerank,regulation of store-operated calcium entry (GO:2001256),0.38007278609401896,0.8198076875133171,0.6787762906309751,0.8804036200707361,1.0,3/10,11.86%,STIM1;HOMER1;SLC8B1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.35331829941081305,-0.8197741594553896,0.70042194092827,0.950348995304133,1.0,1/10,2.38%,LAG3
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3104582780216842,-0.8196936281180911,0.7078651685393258,0.9495499611806335,1.0,6/16,14.85%,CTNNB1;WDR5;CTR9;BRCA1;AUTS2;DNMT1
prerank,positive regulation of protein import (GO:1904591),0.3003505141831131,0.8196526475275138,0.700164744645799,0.8802611109720097,1.0,6/30,12.28%,CHP2;DMAP1;BAG3;PSEN1;JUP;ZC3H12A
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3212219927570423,-0.8192816812133819,0.7270642201834863,0.9494438696964687,1.0,6/14,14.85%,CTNNB1;WDR5;CTR9;BRCA1;AUTS2;DNMT1
prerank,negative regulation of blood pressure (GO:0045776),0.3540957063673782,0.8185938412857217,0.6589285714285714,0.8816836828855855,1.0,2/13,15.66%,PRCP;SCPEP1
prerank,regulation of stem cell proliferation (GO:0072091),0.3413071732620189,0.8183832640002716,0.670863309352518,0.8816272530574841,1.0,8/17,26.05%,ZFP36L1;GJA1;KDM1A;EIF2AK2;PTPRC;AGO3;KDF1;TERT
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.37587420653352055,0.8182441012645112,0.6691729323308271,0.8814259541408282,1.0,1/11,2.63%,TPK1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2391177998622232,0.8180593194919566,0.7831021437578815,0.8813017916125654,1.0,27/136,19.30%,TCF7L2;CMKLR1;GAS6;ESR1;NUPR1;IRAK3;NFKBIL1;SPI1;RB1;KLF4;CEBPG;ARRB1;SP100;WFS1;ZC3H12A;PKD2;HDAC4;PEX14;KDM1A;GLIS2;ACOD1;PIM1;SUMO1;ID3;EIF2AK4;BRMS1;TRIB1
prerank,prostanoid biosynthetic process (GO:0046457),-0.3093075224275638,-0.8180377168324909,0.7178329571106095,0.9508770195275394,1.0,7/15,25.30%,DAGLB;PTGS1;PTGES3;MIF;PTGIS;PTGDS;PRXL2B
prerank,regulation of presynapse organization (GO:0099174),0.325789608486673,0.818002442132759,0.7132867132867133,0.8805433764073626,1.0,1/18,0.63%,APP
prerank,regulation of presynapse assembly (GO:1905606),0.325789608486673,0.818002442132759,0.7132867132867133,0.8805433764073626,1.0,1/18,0.63%,APP
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.31143685401074733,0.8176683949434186,0.7239583333333334,0.8806995748880232,1.0,4/26,9.32%,IRAK3;NFKBIL1;PPM1B;CARD16
prerank,regulation of lymphocyte migration (GO:2000401),0.3795188791316719,0.817613761637223,0.6629213483146067,0.8803525489211994,1.0,5/10,16.59%,MSN;STK10;SLC8B1;WASL;MIA3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.35567538551650624,0.8174602109517032,0.6689895470383276,0.8801995847323196,1.0,3/14,9.18%,HNRNPC;MAPKAPK2;MAPK14
prerank,tryptophan catabolic process (GO:0006569),-0.3415431651693933,-0.8172619667306388,0.7124183006535948,0.9514219648326149,1.0,5/11,35.78%,KYNU;IL4I1;AFMID;IDO2;HAAO
prerank,peptidyl-lysine methylation (GO:0018022),-0.26550635133694767,-0.8168478793344868,0.769620253164557,0.9512800457376888,1.0,13/26,37.27%,EHMT2;SETD4;SETD3;SMYD1;EEF2KMT;SETD2;SETD6;SMYD2;METTL18;EEF1AKMT2;METTL21A;SETD7;SUV39H2
prerank,cell differentiation in hindbrain (GO:0021533),0.371483547286512,0.8161842688367338,0.6848030018761726,0.8820089195140175,1.0,2/11,5.58%,OPHN1;ATP7A
prerank,urogenital system development (GO:0001655),0.37396981293869225,0.8160739952544391,0.6931818181818182,0.8817669845496212,1.0,1/11,2.38%,OSR1
prerank,regulation of cytokinesis (GO:0032465),0.2492989687661317,0.815919574866655,0.7562326869806094,0.881607734747695,1.0,12/78,13.78%,KIF20B;UVRAG;CDC42;RHOA;PKN2;KLHL13;BIRC6;CUL3;CALM1;CETN2;SVIL;RAB11A
prerank,positive regulation of cell adhesion (GO:0045785),0.25389618153744115,0.8159045066260139,0.7648686030428768,0.8811919177696611,1.0,7/74,8.49%,PTPRJ;PPP3CA;ALOX15;ADAM9;SYK;TNF;FOXC2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2074747049881816,-0.8158697496308657,0.8673835125448028,0.9522284301593965,1.0,36/88,31.26%,FBXL18;CUL4A;SKP1;PSMD13;FBXW5;PSMD12;RBX1;FBXL7;PSMD9;CUL2;PSME3;FBXO44;PSMA4;PSMD8;PSMF1;FBXL2;PSMD4;PSMB8;FBXL6;PSME1;FBXL3;FBXO31;FBXL16;KIF14;PSMC2;PSMB10;FBXL12;FBXO4;PSMD3;FBXO2;FBXL14;PSMC5;BTRC;DMAC2;FBXL22;PSME2
prerank,cell-cell junction maintenance (GO:0045217),-0.35091635348246153,-0.8158384025402493,0.7077244258872651,0.951350671128688,1.0,3/11,10.34%,TJP1;FERMT2;CSF1R
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2210495704576835,-0.8157856700668411,0.8266666666666667,0.9504948070743328,1.0,23/69,24.94%,GPR137B;FERMT2;WWTR1;CROCC;MAPT;CEP250;STX3;ENTR1;NUMA1;TMEM35A;CDK5RAP3;PARK7;LIMK2;NDC80;PARP9;ABCA7;GNL3L;SESN2;TRAPPC12;TGFB1;GPD1L;TM9SF4;CDK1
prerank,regulation of ATP metabolic process (GO:1903578),0.2712147551247511,0.8157013196455045,0.7412790697674418,0.8811360649025931,1.0,15/54,21.55%,PRKAG2;PGAM1;ATP7A;NUP133;BEND3;COX7A2L;NUP62;NUP98;EP300;NUP153;ZBTB7A;AK4;SLC2A6;NUP35;RAE1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3057058591661667,0.8156832539264027,0.7174959871589085,0.8807298621095819,1.0,7/29,16.77%,ESR1;AXIN1;CBFB;KANK2;UFM1;CNOT9;STRN3
prerank,regulation of spindle organization (GO:0090224),-0.294166494458919,-0.8156245350732862,0.7149321266968326,0.94985956702275,1.0,8/18,23.95%,DYNC1H1;GNAI1;TACC3;NUMA1;PARP3;FSD1;MAP9;DCTN1
prerank,sprouting angiogenesis (GO:0002040),0.2739425437899871,0.8152610347790903,0.7348703170028819,0.8810108105001715,1.0,10/51,16.59%,NRP1;ITGB1BP1;NRARP;NR4A1;EPHB4;LOXL2;RAMP2;PARVA;E2F8;MIA3
prerank,long-term synaptic potentiation (GO:0060291),-0.2867153901221315,-0.815017859880839,0.7469287469287469,0.9500812121277894,1.0,5/21,13.18%,PTK2B;SLC24A2;SHANK2;GRIN2A;VAMP2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2756918462509366,0.814676498869635,0.7226502311248074,0.8816236168554524,1.0,5/45,6.61%,ZFP36L2;HECA;ZFP36L1;RGCC;CHEK1
prerank,positive regulation of collagen metabolic process (GO:0010714),0.33012586329030924,0.814263907052526,0.6792452830188679,0.8818933094053939,1.0,2/17,4.18%,RGCC;VIM
prerank,DNA duplex unwinding (GO:0032508),-0.23021725540152843,-0.8142057631903321,0.794392523364486,0.9507070920572487,1.0,9/50,9.41%,GTF2H2;CUL4A;PARP1;DDB2;RBX1;BLM;RECQL5;ERCC2;SSBP1
prerank,translational termination (GO:0006415),0.24572841947016255,0.8141970122602762,0.7694483734087695,0.8815770692214778,1.0,30/95,22.80%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;MRPS11;MRPL1;MRPL49;MRPL16;MRPS17;ETF1;MRPL44;MRPS34;MRPS14;MRPS30;MRPS15;MRPL4;MRPS31;GSPT1;MTRF1;MRPL28;MRPL30;MRPL48;MRPS27;TRMT112;MRPL40;MRPL22;CHCHD1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.27541535381933274,-0.8137977649808456,0.7043010752688172,0.950569472193953,1.0,6/24,22.60%,CALM2;AKAP6;JPH1;CAMK2D;CALM3;JPH3
prerank,pre-replicative complex assembly (GO:0036388),0.25917830426444616,0.8135837672232432,0.7426470588235294,0.8821976413107417,1.0,11/64,15.90%,PSMA7;RPS27A;ORC5;ORC2;PSMB2;GMNN;PSMA6;PSMA3;PSMD1;PSMD5;MCM8
prerank,regulation of protein acetylation (GO:1901983),0.3621298802048987,0.8132719432006923,0.6934579439252336,0.8822851280007924,1.0,3/12,16.34%,GSK3B;TERF2IP;FAM161A
prerank,protein heterooligomerization (GO:0051291),-0.29981845062613227,-0.8126804039999074,0.7215189873417721,0.9517065567965434,1.0,8/17,32.48%,CPSF6;FARSA;TMEM120B;FARSB;KCNC2;CPSF7;CBR4;PKD1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2861710554231158,-0.8126605162596197,0.7379912663755459,0.9508100677063023,1.0,6/21,21.31%,BRCA1;SIRT2;ABCD2;SIRT5;PARK7;HDAC6
prerank,DNA geometric change (GO:0032392),-0.2683051541900874,-0.8125656574238066,0.7342995169082126,0.9500633371116083,1.0,9/24,24.66%,DNA2;HNRNPA2B1;BLM;RECQL5;DDX1;DHX9;HMGB1;HMGB3;RAD50
prerank,sensory perception of light stimulus (GO:0050953),0.2470860593650149,0.8120381939460062,0.7615803814713896,0.8840238618441496,1.0,11/87,11.68%,ATXN7;RAX;DHRS3;PITPNA;CRYBG3;MYO7A;DRAM2;ATF6;BEST1;MYO9A;WFS1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2681326596642427,0.8118827615177614,0.7630057803468208,0.8838475432179214,1.0,7/57,7.70%,BABAM2;WAC;NOP53;CHEK1;BRCC3;TOPBP1;TIPIN
prerank,determination of left/right symmetry (GO:0007368),-0.2434758549324315,-0.8113675549016641,0.7637362637362637,0.9513036845687505,1.0,11/37,23.61%,BBS7;CCDC39;KIF3B;SMO;NOTCH1;DNAH5;MKKS;ODAD2;CCDC40;GALNT11;STIL
prerank,histone exchange (GO:0043486),-0.24762431401285306,-0.8111951241401579,0.7994269340974212,0.9506839211272213,1.0,12/37,28.14%,CENPC;NASP;KNL1;MIS18BP1;RUVBL1;CENPX;CENPP;CENPN;CENPH;CENPI;ACTR6;MIS18A
prerank,ncRNA transcription (GO:0098781),0.35663740390497517,0.8105393182494891,0.690566037735849,0.8858049890490515,1.0,7/13,24.65%,ANG;POLR1G;USPL1;SNAPC2;NIFK;CAVIN1;SNAPC3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.3531945197459221,0.8101869969124352,0.6721311475409836,0.885963525790733,1.0,4/13,12.73%,TLR4;TLR2;NAMPT;NOD2
prerank,protein K11-linked ubiquitination (GO:0070979),0.30383907714070896,0.8097303572070143,0.734959349593496,0.8863213575870267,1.0,8/27,18.64%,UBE2E3;PRKN;CDC27;UBE2D3;ANAPC1;UBE2W;UBE2A;ANAPC10
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.25362060197806,0.8096410844866182,0.7751724137931034,0.8860319909644199,1.0,15/78,17.42%,EGFR;RGCC;ACTB;CCND3;CCNYL1;CCND2;CCNJ;CDKN2C;LATS2;CCNY;PKD2;HEXIM2;PTEN;NR2F2;GTF2H1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.333974497988486,-0.8090351724587211,0.7042553191489361,0.9537779727570326,1.0,5/11,34.54%,TIMM8B;TIMM29;AGK;TIMM13;TIMM10
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.2575376782475818,0.8088745231195795,0.7730496453900709,0.8869541692729038,1.0,10/75,11.99%,RASGRP4;GRK5;PDE6A;GUCY2D;ROCK1;ZDHHC3;PPEF1;CALM1;PDE6H;ROCK2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.32977847736509674,0.8088034054756083,0.6902654867256637,0.8866396194212851,1.0,5/17,21.69%,PLA2G2D;PLAAT3;PLBD1;PLA2G4C;LCLAT1
prerank,copper ion transport (GO:0006825),0.37211269659656,0.8086290001180234,0.655045871559633,0.8864971978074313,1.0,2/11,5.58%,STEAP3;ATP7A
prerank,regulation of nervous system process (GO:0031644),0.32494299035520147,0.8083115843815265,0.7056737588652482,0.8865983828916745,1.0,5/18,16.42%,APP;NPTX2;ROCK2;BEGAIN;DLGAP4
prerank,histone lysine methylation (GO:0034968),0.28874565349417913,0.8081645023626285,0.7291666666666666,0.8864388509385476,1.0,5/33,8.91%,KMT2A;SETDB2;KDM6A;ASH2L;WDR82
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.32622737018257025,-0.8075646898149712,0.7250554323725056,0.9554351154279611,1.0,4/12,21.06%,CALM2;GJD3;CAMK2D;CALM3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.2934070442822666,-0.8072725958827175,0.7622377622377622,0.9550236571980106,1.0,5/18,16.43%,ADCY8;CRTC2;CRTC1;CD200;ADCY1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3076557200135725,-0.8068890172477496,0.7146017699115044,0.9548008147514421,1.0,8/15,33.34%,HUS1;FANCD2;CHEK2;NEK11;RAD9A;EME1;MDC1;RAD17
prerank,regulation of cell cycle process (GO:0010564),0.2396502046474281,0.8066551477821767,0.7756160830090791,0.8886191826453722,1.0,16/104,12.38%,KIF20B;UVRAG;CDC42;SND1;MAD1L1;KLHL13;CEP85;CHEK1;TIPIN;BIRC6;SFRP1;CALM1;CETN2;TTL;CDK13;HORMAD1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3702305295602134,0.8066529452462289,0.6796875,0.8881895677795851,1.0,3/10,15.93%,JARID2;ATRX;KDM1A
prerank,mitochondrial translation (GO:0032543),0.23918617911084944,0.8063337897867681,0.7799442896935933,0.8883153339419486,1.0,31/104,22.80%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;NDUFA7;EARS2;MRPS11;RARS2;MRPL1;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14;MTIF3;MRPS30;MRPS15;MRPL4;MRPS31;MTRF1;MRPL28;MRPL30;MRPL48;MRPS27;MRPL40;MRPL22;CHCHD1
prerank,inner dynein arm assembly (GO:0036159),-0.341395424605843,-0.8059858791740407,0.7082405345211581,0.9554231774019702,1.0,6/11,41.67%,CCDC39;CCDC40;DNAI3;DNAAF1;DNAH1;CFAP100
prerank,cAMP metabolic process (GO:0046058),-0.31780694614777405,-0.8058468763657349,0.7065462753950339,0.9547650160129044,1.0,2/13,1.41%,ADCY3;ADCY8
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2851129061647549,-0.8056089867203722,0.7530266343825666,0.9542798664093559,1.0,3/21,5.08%,EPHA7;BIRC2;USP50
prerank,regulation of actin filament bundle assembly (GO:0032231),0.31135095539822416,0.8049589814804173,0.7158730158730159,0.8903040472490327,1.0,6/26,11.99%,CDC42;PRKN;ROCK1;SYNPO;PTGER4;ROCK2
prerank,glycine metabolic process (GO:0006544),-0.3247970596533128,-0.804814075719236,0.728110599078341,0.9547793604097427,1.0,9/12,47.58%,RIDA;GCSH;SHMT2;GLDC;SDS;GCAT;DLD;AMT;BAAT
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.30827055059479147,-0.8046471902653449,0.7466367713004485,0.9541280451131826,1.0,7/15,32.29%,LGMN;FGF2;NOTCH1;FGF1;PRKD1;SMOC2;MET
prerank,regulation of cellular protein localization (GO:1903827),0.26982732454297176,0.8033655801172458,0.741248097412481,0.8926139698010078,1.0,11/45,16.01%,RAB11FIP5;VCPIP1;KCNAB2;LCP1;HFE;SPIDR;TRIM67;RALB;GPC3;KDM1A;HSP90AB1
prerank,neuron projection fasciculation (GO:0106030),-0.34975419827123383,-0.8031487472139588,0.7037037037037037,0.955830514393789,1.0,5/10,29.72%,CNTN4;EPHB2;NRCAM;EPHB3;AMIGO1
prerank,presynapse organization (GO:0099172),0.36850919826358053,0.8030567148116516,0.6950092421441775,0.8927363500750751,1.0,1/10,1.45%,C5AR1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.3557667143880267,0.8028003966657624,0.6925996204933587,0.8927250959345147,1.0,1/12,0.80%,COLEC12
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2561581609814542,0.8027077881513832,0.7669064748201438,0.8924558146544873,1.0,23/72,20.20%,RPL26;RGCC;SFN;FOXM1;ATRX;ARID3A;MDM2;RPS6KA6;SP100;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;BATF;CNOT4;PLK2;BCL3;CNOT1;CNOT8;PCNA
prerank,"transcription, DNA-templated (GO:0006351)",0.22102340627225997,0.8025297430327917,0.8608799048751486,0.8923024655166581,1.0,55/207,20.31%,MAF;MEF2A;RREB1;TCEA2;NFIC;THRB;CBFB;EPC1;TRIM24;NELFA;MED16;NR4A2;RNGTT;IWS1;CDC73;GTF2A2;RO60;NCOA6;GTF3C3;GTF3C6;MED20;POLR2B;TFDP1;GTF2E2;EAF2;FOXO3;DEK;NFIX;GTF2A1;KLF13;NFKBIB;MBD1;MMS19;POLR2D;ELOC;GTF2H3;GTF2B;CRCP;LHX1;TAF12;XBP1;GTF2H1;RRAGC;HIPK3;TEFM;POLR2F;THRA;DDX21;BCL3;TRIP11;AFF4;DTX1;NELFE;CTDP1;SNAPC2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.3579419470367597,0.8024880467114451,0.6970802919708029,0.8919367868347732,1.0,1/11,2.21%,PLA2G7
prerank,protein kinase B signaling (GO:0043491),0.31363251249645085,0.8024869997476787,0.7272727272727273,0.8915048364475046,1.0,4/23,9.90%,GAS6;ZFP36L1;TNF;IGF1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.2346395786377792,0.8024340018683837,0.8254777070063695,0.8911544691340129,1.0,29/132,15.19%,RPL23A;RPS15;ERAL1;RPSA;RPS28;RSL24D1;RPL24;NOP53;RPL38;PRPF18;RPLP0;RPL5;CELF3;CDC73;RPS14;SNRPG;RPS5;MRPS11;RPL6;GCFC2;GEMIN7;EIF4B;RPL10;LSM4;RAMAC;POLR2D;TXNL4A;RPL11;EIF5
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.34769399836725906,0.8018419463338209,0.691743119266055,0.8917248814151324,1.0,1/13,0.63%,APP
prerank,response to retinoic acid (GO:0032526),0.2578536203962017,0.8016743963220399,0.7683453237410072,0.8915826553987404,1.0,11/59,14.89%,LYN;RARG;WNT2;OVCA2;WNT6;ASXL1;TRIM16;CREB1;RARA;RBP4;SNW1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.29582508434901506,0.8013135150698429,0.7154742096505824,0.891765785097829,1.0,3/29,7.74%,FBXW7;AXIN1;ARRDC3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.304299443770828,0.8013110599330573,0.7243150684931506,0.8913380817324874,1.0,7/23,24.80%,PNPLA8;PLA2G2D;PLAAT3;PLBD1;PLA2G4C;MBOAT1;MBOAT2
prerank,brain morphogenesis (GO:0048854),-0.32284020298938537,-0.8008259425338606,0.7467248908296943,0.9591586978298295,1.0,4/12,21.46%,CTNNA2;SPEF2;BBS4;MKKS
prerank,regulation of cell aging (GO:0090342),-0.33615938060978595,-0.8006185498636788,0.7294372294372294,0.958591776166532,1.0,3/11,11.84%,NUAK1;NEK6;MIF
prerank,pteridine-containing compound metabolic process (GO:0042558),0.3512845446661972,0.8004323887541306,0.7219152854511971,0.8924071071302867,1.0,2/13,10.64%,GCH1;CALM1
prerank,mesenchymal cell development (GO:0014031),-0.28482856395503303,-0.8002897910777366,0.7388535031847133,0.9582473075335451,1.0,7/18,24.82%,CDH2;KLHL12;NOTCH1;SOX11;FOXC1;TAPT1;SOX8
prerank,regulation of macroautophagy (GO:0016241),0.24245695449539553,0.7998251477971551,0.8080939947780679,0.8930066544335034,1.0,12/105,8.90%,PRKAG2;SESN1;GNAI3;ATP6V1B1;PRKAG3;ERN1;SNX6;WAC;ATP6V0A1;EXOC4;ATP6V1A;SMCR8
prerank,nuclear envelope organization (GO:0006998),0.3122767237581418,0.799761406574495,0.7120418848167539,0.8926868215347838,1.0,1/20,1.25%,REEP3
prerank,double-strand break repair via homologous recombination (GO:0000724),0.24225211197712598,0.7996738368722601,0.7870370370370371,0.8923921749528136,1.0,23/95,17.40%,RBBP8;MCM9;REC8;NSMCE2;YY1;RPA1;RAD54L;RAD52;KDM4D;SPIDR;RPA3;AP5S1;UBE2N;SFR1;MMS22L;SEM1;RAD51B;SAMHD1;SFPQ;FBH1;MCM8;GINS2;NSMCE1
prerank,lipoprotein catabolic process (GO:0042159),0.3672627377195392,0.7995737219977503,0.6961325966850829,0.8921356282819195,1.0,2/11,5.36%,APOE;NOTUM
prerank,external encapsulating structure organization (GO:0045229),0.2233775196696207,0.798992935293912,0.8657957244655582,0.8926487163515833,1.0,30/205,14.16%,TGFBI;ITGA4;APP;ADAM19;ADAMTSL5;ITGB1;ITGA9;CD44;ST7;LOX;ATP7A;ADAMTS19;ADAMTS18;COL22A1;COL9A2;ADAMTS10;ADAM12;DDR2;ADAMTS9;COL14A1;MIA;PXDN;COLQ;MMP24;MMP28;MMP25;NID2;ADAMTS17;COL24A1;ITGB2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.30649585639584903,-0.7989254901401039,0.7314814814814815,0.9596503689937175,1.0,7/15,23.30%,CSTF2;DDX1;FAM98B;CLP1;RTCB;TSEN54;TSEN15
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.31381400985152885,-0.798899074314552,0.740506329113924,0.9587831885751228,1.0,7/14,26.33%,WDR12;URB1;FTSJ3;BOP1;ZNHIT6;ZNHIT3;DDX18
prerank,neuron differentiation (GO:0030182),0.22617477279563766,0.7987450003042821,0.8353808353808354,0.8926324166606976,1.0,16/165,8.83%,LRP6;OPHN1;MEF2C;PHOX2A;WNT2;PBX3;MANF;IRX2;WNK1;MYO7A;MTPN;WNT6;NR4A2;LHX5;IRX5;OLIG2
prerank,endodermal cell differentiation (GO:0035987),-0.25337231731335874,-0.7986748040817127,0.8090452261306532,0.9582530331523073,1.0,11/31,22.23%,ITGB5;COL11A1;ITGA5;CTR9;PAF1;LAMA3;COL8A1;COL4A2;ITGAV;SETD2;COL6A1
prerank,post-translational protein modification (GO:0043687),0.21075867626136172,0.7983353386039178,0.9232480533926585,0.8929006234913632,1.0,54/332,16.88%,APOE;IGFBP4;APP;CP;FBXW7;ZBTB16;GAS6;PSMA7;DNAJC3;SHISA5;ASB14;FGF23;BTBD1;RHBDD1;NOTUM;KLHL13;FBXL5;KLHL5;ESCO2;PSMB2;UBXN7;ESCO1;COP1;RAB1A;CUL3;FBXO11;CHM;PSMA6;PTP4A2;WFS1;DCAF6;NUCB1;FBXO10;RAB11A;ASB12;HIF3A;SERPIND1;SUMF2;PSMA3;PSMD1;PSMD5;GPC3;ELOC;MELTF;ASB4;FN1;ICMT;FBXW2;ATG5;HSP90B1;MIA3;UCHL3;DCAF8;CUL7
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.29307318168344987,0.7980375831260773,0.7527910685805422,0.89294677551987,1.0,7/30,15.21%,ST6GAL1;MGAT2;ALG5;ASGR2;UGGT1;RPN2;MCFD2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.34288102484559563,0.7979691493615365,0.6886120996441281,0.8926394217441902,1.0,3/12,13.96%,NIN;CEP19;PCM1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.25245923364372913,-0.7979203929841965,0.783375314861461,0.9586042102366522,1.0,1/29,0.11%,CADM1
prerank,sulfur compound biosynthetic process (GO:0044272),0.24295389860229472,0.7966616893453334,0.8036649214659686,0.8944066554476301,1.0,13/104,11.83%,DSE;UST;TPK1;ST3GAL1;MGST3;B4GALT6;CHST12;PAPSS2;MGST1;SLC35B3;B4GALT5;SLC10A7;GCLM
prerank,autophagy of nucleus (GO:0044804),0.33670475374060543,0.7960229291901278,0.7140381282495667,0.8950281570177975,1.0,7/16,18.14%,WIPI1;ULK2;ATG7;RB1CC1;WIPI2;ATG5;ATG3
prerank,positive regulation of T cell differentiation (GO:0045582),-0.24006657916543225,-0.7956585580061558,0.8337662337662337,0.961704962963038,1.0,10/36,20.65%,DUSP10;VSIR;NCKAP1L;RHOH;ADAM8;BCL6;IL4I1;SART1;TESPA1;GLI3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.266624427366814,0.7955737655496027,0.7562111801242236,0.8953662864124572,1.0,13/47,19.12%,EGFR;FOXM1;MAPK8IP2;IGBP1;NOD2;FOXO1;PPIA;MYC;PER1;SCIMP;IGF1R;MID1;EIF2AK2
prerank,negative regulation of cell death (GO:0060548),0.24202604280433482,0.7955568806096771,0.7966573816155988,0.8949619117894135,1.0,25/88,20.39%,TNFRSF1B;PRKN;PDE8A;KIR3DL2;GSK3B;CD200R1;VPS4B;FYN;PARP16;NUP62;KANK2;CHGA;WFS1;SPEF1;CCN5;TMEM109;ATG5;BNIP3;MECOM;TXNDC12;CCN2;BTBD10;SNCA;GPNMB;DUS2
prerank,cellular response to heat (GO:0034605),0.2777511072010254,0.7955382742234764,0.7733118971061094,0.8945543183482975,1.0,9/35,18.84%,HMOX1;ANO1;BAG3;HSBP1;YWHAE;POLR2D;HSP90AB1;ATXN3;SUMO1
prerank,magnesium ion transport (GO:0015693),-0.32832157859447386,-0.7955327289180747,0.7370689655172413,0.9610054817913722,1.0,7/12,42.09%,NIPA1;TUSC3;MMGT1;NIPAL4;NIPAL3;NIPA2;NIPAL1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.3385001600618742,-0.7952152298008812,0.7239130434782609,0.9597305898766757,1.0,5/10,27.59%,ASCC1;ALKBH2;ASCC2;ALKBH5;ALKBH1
prerank,DNA dealkylation (GO:0035510),-0.3385001600618742,-0.7952152298008812,0.7239130434782609,0.9597305898766757,1.0,5/10,27.59%,ASCC1;ALKBH2;ASCC2;ALKBH5;ALKBH1
prerank,positive regulation of cation channel activity (GO:2001259),-0.23811064360031167,-0.7950709145152776,0.825065274151436,0.9590749870638352,1.0,11/40,23.17%,CALM2;ANK2;CTSS;AKAP6;ACTN2;STAC2;EPHB2;STAC;HAP1;CALM3;STAC3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.32788524658646334,-0.7950492067503401,0.7565217391304347,0.9581878034834307,1.0,5/12,23.12%,CCT7;GNL3L;CCT2;WRAP53;CCT8
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.32674098340622465,0.7943701126103647,0.71160409556314,0.8956999393306406,1.0,5/17,13.90%,TSLP;IRS2;JAK1;CRLF2;STAT3
prerank,cellular response to interleukin-7 (GO:0098761),0.32674098340622465,0.7943701126103647,0.71160409556314,0.8956999393306406,1.0,5/17,13.90%,TSLP;IRS2;JAK1;CRLF2;STAT3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3102678155561681,0.7942843097257654,0.71875,0.8954135493478489,1.0,5/21,15.12%,ERN1;P2RY6;IGF1;GJA1;BMPR1A
prerank,regulation of chromosome organization (GO:0033044),-0.2755702045526185,-0.7941789514116476,0.7511848341232228,0.9587854358016398,1.0,7/22,15.29%,XRCC5;HDAC8;MAPT;UPF1;TERF2;BUB1;SHCBP1L
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3015820286145198,0.7940851044344529,0.7295492487479132,0.8953563958806711,1.0,5/26,9.68%,DUSP1;RB1;CDC27;NSMCE2;CUL3
prerank,protein localization to vacuole (GO:0072665),0.34456614016020437,0.7936911064846996,0.7111111111111111,0.8955980892581337,1.0,5/13,16.93%,LMBRD1;RTN4;LAMTOR5;SZT2;MFSD1
prerank,organic anion transport (GO:0015711),0.24619463685382603,0.7935505463923872,0.7983193277310925,0.895395947096427,1.0,14/76,18.52%,LRRC8D;SLC25A17;SLC25A24;ABCC4;SLC4A4;SLC4A5;MGST1;SLCO5A1;SLC2A2;SLC23A1;SLC26A7;SLCO2A1;LRRC8C;SLC25A4
prerank,positive regulation of dendritic spine development (GO:0060999),0.31534587517317053,0.7932659427772579,0.723292469352014,0.8954519155396851,1.0,2/20,7.76%,APOE;PSEN1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3449570167081635,0.7931091881630085,0.6802973977695167,0.8952880389403879,1.0,2/13,6.39%,RPS21;NOL9
prerank,muscle tissue development (GO:0060537),-0.31502184703131897,-0.7927822503813318,0.7165178571428571,0.9602690824122488,1.0,5/13,29.16%,NF1;SMO;ENG;CSRP2;BMP4
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.21040821418063563,-0.7925775084826666,0.8896551724137931,0.9597052852742687,1.0,18/68,23.74%,GTF2H2;SETX;PABPN1;CCNH;UBTF;ERCC2;CSTF2;NCBP1;TAF1C;TAF1D;MAZ;CLP1;MTERF2;GTF2H4;POLR1C;POLR2L;TBP;SLBP
prerank,cellular amide metabolic process (GO:0043603),0.2368619549236067,0.7916533298979932,0.8125,0.8972554775564586,1.0,9/102,10.19%,FOLR2;ST6GAL1;ST3GAL1;SGPL1;MTHFD2L;ACOT12;PPP2CA;ORMDL1;PLAAT1
prerank,regulation of cardiac conduction (GO:1903779),0.2650293400529463,0.7915106622706704,0.7832369942196532,0.897063189056784,1.0,11/54,14.90%,ATP2B1;FXYD2;TMEM65;STIM1;ATP2B4;ATP1A3;ATP1A4;ATP1A1;NPPC;ATP2A2;ITPR3
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.25294371166196883,0.7913728339993391,0.7954220314735336,0.896854162764093,1.0,20/73,19.66%,PPHLN1;JARID2;SPI1;ACTB;EPC1;POLR1A;TRIM27;POLR1B;H3-3A;MYO1C;DEK;POLR1G;EP300;HDAC4;GLMN;POLR2F;DDX21;CTCF;MECP2;CREBZF
prerank,regulation of AMPA receptor activity (GO:2000311),-0.26169622580932705,-0.7913426247828483,0.7965686274509803,0.9609101059014583,1.0,9/25,19.50%,NLGN1;SHANK1;GSG1L;CACNG7;MINK1;CACNG8;SHISA7;CACNG4;CACNG2
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2773961054319194,-0.7909404774557381,0.7558139534883721,0.960661379310823,1.0,11/20,43.60%,STARD3;AKR1B1;FDX1;HSD17B10;STAR;CYP46A1;TSPOAP1;DHRS9;FDXR;HSD3B2;FDX2
prerank,nitric oxide metabolic process (GO:0046209),0.34608458285654287,0.7907980384397023,0.718978102189781,0.8974090315716582,1.0,2/14,14.55%,GCH1;ARG2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.29752466616995166,-0.7905960163999863,0.7242990654205608,0.9603184957272155,1.0,6/17,24.30%,CALM2;MAGI2;MTOR;PTPA;CALM3;PDGFRB
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.28338636045309784,0.7901609694948044,0.7526881720430108,0.8980304803744628,1.0,6/36,11.22%,RBBP8;RYBP;EPC1;CHEK1;TFDP1;PHC3
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.2175768683263925,-0.789564932602084,0.870253164556962,0.9611571743328273,1.0,23/62,29.33%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;AAAS;DHX9;SEC13;FXR1;AGO1;TGFB1;POLR2L;NDC1;NUP93;NUP50;POLR2I;WTIP;NUP54;NUP214
prerank,transport across blood-brain barrier (GO:0150104),0.2470721388643664,0.7891377896714324,0.8068965517241379,0.8992760426797551,1.0,14/83,13.91%,SLC16A7;SLC28A2;CD36;SLC2A4;INSR;ABCC4;SLC29A1;ABCC1;SLC4A4;SLC38A1;ATP2B4;SLC38A2;MFSD2A;ATP1A4
prerank,autophagy of mitochondrion (GO:0000422),0.2806657114844973,0.7889907293827972,0.7534456355283308,0.8990899009674573,1.0,15/38,21.05%,PRKN;WIPI1;ULK2;MARK2;ATG7;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;BNIP3;ATG3;FUNDC1;FUNDC2;MAP1LC3B
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2104902660918196,-0.7889234947754925,0.8993055555555556,0.9613643084206893,1.0,19/69,22.09%,COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFAF1;UQCRB;AFG1L;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;SDHAF2;NDUFA8;NDUFA10;UQCR10;NDUFAB1;COA6;NDUFS1
prerank,C4-dicarboxylate transport (GO:0015740),-0.2978984510593151,-0.7886204334270073,0.7554585152838428,0.9609787659333417,1.0,6/14,24.80%,SLC1A1;SLC25A14;SLC25A22;SLC25A10;SLC1A2;SLC25A13
prerank,cellular response to drug (GO:0035690),0.30434102883465025,0.7885871400115975,0.7403225806451613,0.8993055168851098,1.0,2/25,2.01%,GAS6;MEF2C
prerank,melanosome localization (GO:0032400),0.30349610095421287,0.7885642852873039,0.717607973421927,0.8989134763457087,1.0,2/21,6.22%,MYO5A;BLOC1S5
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.2301137319353958,-0.7884195151388311,0.8441176470588235,0.9604298208835549,1.0,4/43,4.13%,DDX5;TP53;ETS1;FGF2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2630526808596173,-0.7883614117234848,0.752,0.9596170279328349,1.0,12/24,27.13%,NFU1;NUBPL;ISCU;FXN;NFS1;ISCA1;CIAO1;BOLA2;GLRX5;HSPA9;CIAO2B;CIAPIN1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.34030089987680257,0.787712793051148,0.6990990990990991,0.899920118521795,1.0,7/13,25.70%,RACK1;WFS1;BFAR;PPP1R15B;NCK1;UFL1;HSPA5
prerank,organelle transport along microtubule (GO:0072384),0.2854669397377923,0.7876687917059304,0.746268656716418,0.8995695364277834,1.0,10/31,20.59%,ARHGAP21;CDC42;RAB1A;BORCS5;PAFAH1B1;TRAK2;PEX14;UXT;NDEL1;TRAK1
prerank,mitochondrial translational termination (GO:0070126),0.24004327447871282,0.7876126818778802,0.8197674418604651,0.8992187784287305,1.0,27/88,22.80%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRRF;MRPS11;MRPL1;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14;MRPS30;MRPS15;MRPL4;MRPS31;MTRF1;MRPL28;MRPL30;MRPL48;MRPS27;MRPL40;MRPL22;CHCHD1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.34178995429118597,-0.7875810208723883,0.7515657620041754,0.9599869779055701,1.0,2/10,3.53%,DUSP10;PDCD4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3655495201912053,0.7875495123518722,0.718336483931947,0.8984743972024622,1.0,3/11,16.82%,LARP7;CCT6A;CCT3
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3655495201912053,0.7875495123518722,0.718336483931947,0.8984743972024622,1.0,3/11,16.82%,LARP7;CCT6A;CCT3
prerank,epidermis development (GO:0008544),0.2625516946470158,0.7873237711851097,0.7660485021398002,0.8984270094446553,1.0,2/56,4.62%,EMP1;GRHL2
prerank,response to unfolded protein (GO:0006986),0.26390195255014726,0.7872649983155576,0.7596302003081664,0.8981029450241879,1.0,5/48,6.92%,ERN1;PRKN;RHBDD1;BAG3;HSPB1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.2938918662891992,-0.7869705415389414,0.7592137592137592,0.9601153427552127,1.0,2/16,7.13%,KLK2;SLC2A5
prerank,sphingoid metabolic process (GO:0046519),0.35262600947810085,0.7861124369373389,0.7287234042553191,0.8995441698980587,1.0,1/12,1.59%,SGPP1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3349789405296761,-0.7858256939832504,0.7640918580375783,0.9611255995060233,1.0,2/10,8.46%,GALNT3;GALNT13
prerank,epithelial cell development (GO:0002064),0.3183762402991142,0.7856488762519556,0.7396021699819169,0.8998710614044866,1.0,2/20,4.62%,EXPH5;GRHL2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.2677261799159121,-0.7855830075402629,0.7944862155388471,0.9605975355700271,1.0,6/23,16.40%,SMAD7;FGFR2;TGFBR3;PROX1;HOPX;ID2
prerank,vesicle organization (GO:0016050),0.268159721055156,0.7853941137723768,0.7769347496206374,0.8998495616199428,1.0,16/46,23.68%,EPS15;SRGN;PI4K2B;WASHC4;SNX10;SNX33;WASL;EXOC8;DNAJC13;RAB22A;SAR1B;PI4K2A;LAPTM4B;ARFGEF2;SAR1A;CAV1
prerank,cellular response to misfolded protein (GO:0071218),-0.27863244502177287,-0.7853167815172639,0.7775175644028103,0.9601273796479641,1.0,9/20,28.28%,AUP1;BAG6;UFD1;DNAJB14;RNF5;STUB1;TOR1A;DNAJC18;RNF126
prerank,histone methylation (GO:0016571),-0.2593549052344788,-0.7850059824363967,0.8320413436692506,0.9597408891798394,1.0,12/26,37.27%,EHMT2;SIRT7;PRMT2;CARM1;SMYD1;SETD6;EZH2;SMYD2;PRMT8;FBL;PRMT7;SUV39H2
prerank,protein autoprocessing (GO:0016540),-0.2916937316110524,-0.784732787631525,0.7788018433179723,0.9592657407139303,1.0,6/17,28.76%,HTRA2;FXN;AFG3L2;PIDD1;SPRTN;MYRFL
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.22659633637454393,-0.7847260032328096,0.8377581120943953,0.9574709731561037,1.0,19/50,29.33%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;AAAS;SEC13;AGO1;POLR2L;NDC1;NUP93;NUP50;POLR2I;NUP54;NUP214
prerank,regulation of gene silencing by RNA (GO:0060966),-0.22659633637454393,-0.7847260032328096,0.8377581120943953,0.9574709731561037,1.0,19/50,29.33%,EIF4G1;NUP210;RANBP2;FMR1;NUP85;IPO8;POLR2C;SEH1L;TNRC6A;AAAS;SEC13;AGO1;POLR2L;NDC1;NUP93;NUP50;POLR2I;NUP54;NUP214
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.29879825900337226,0.784600994378223,0.760797342192691,0.9007029556197956,1.0,5/24,14.16%,ITGB1BP1;FYN;MYO1C;KCNB1;ITGB2
prerank,UV protection (GO:0009650),0.35915744074976264,0.7845072335383663,0.7216699801192843,0.9004095923286733,1.0,2/10,11.59%,MFAP4;XPA
prerank,bicarbonate transport (GO:0015701),-0.25836223112917617,-0.7843905495245299,0.782716049382716,0.9571084174585153,1.0,6/25,19.18%,SLC4A10;SLC4A2;CYB5R1;CA2;CFTR;SLC4A3
prerank,positive regulation of histone acetylation (GO:0035066),-0.27243135583594547,-0.7839556136597117,0.7722772277227723,0.9569221447641396,1.0,4/23,9.20%,SMARCB1;MAPK3;BRCA1;WBP2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.31775962938972374,0.7839494204623954,0.729776247848537,0.9008767211324337,1.0,5/17,19.12%,LYN;NOD2;SCIMP;MID1;EIF2AK2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.24051306056376492,0.7838598006583487,0.8244473342002601,0.9005967599199223,1.0,17/95,15.27%,DSE;EXT1;UST;ST3GAL1;B4GALT6;SDC3;CHST12;HS3ST2;SDC4;B4GALT5;SLC10A7;HS3ST3A1;XYLT2;GPC3;CHST3;HEXA;ST3GAL4
prerank,entry into host (GO:0044409),0.33618466358999166,0.7830550367251987,0.7537878787878788,0.9014923474852242,1.0,3/13,7.44%,CBL;CTNND1;CXCR4
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.23485082023456738,0.7828531927626539,0.8356741573033708,0.9013914864573052,1.0,18/101,13.67%,EIF3E;SAMD4A;NIBAN1;RPL26;CLN6;VIM;TRIM32;RPS4X;KLF4;RPL5;LARP4B;MSN;ATG7;CASP8;ATG10;LARP4;PIWIL2;NR1H2
prerank,establishment of melanosome localization (GO:0032401),0.3101451413005725,0.7827511065515939,0.7345890410958904,0.901132981811313,1.0,2/19,6.22%,MYO5A;BLOC1S5
prerank,DNA damage checkpoint signaling (GO:0000077),-0.25335446928924,-0.78247266128404,0.8149100257069408,0.9585313526632243,1.0,8/28,13.93%,ATRIP;ATM;DOT1L;ERCC6;CEP63;HUS1;PRPF19;CHEK2
prerank,endocardial cushion development (GO:0003197),-0.2684326787022868,-0.7823355161452749,0.7704545454545455,0.9578780821598379,1.0,6/21,19.40%,ACVR1;CRELD1;MDM4;NOTCH1;ENG;TGFB2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.296269290578242,0.7822286822406628,0.7341337907375644,0.9016082930730057,1.0,9/25,18.78%,FBXL17;CUL3;NGLY1;RNF185;UGGT1;POMT2;UBE2W;LONP1;ATXN3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.29214600292893206,0.7818503843090331,0.7612456747404844,0.9018191530616166,1.0,6/26,13.05%,RPS27A;ALPK1;RIPK2;CASP8;NOD2;UBE2N
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.2785709593830983,-0.781788710405555,0.7607223476297968,0.9569673819889846,1.0,9/20,28.07%,BCKDHA;ECHS1;ACADSB;IVD;SLC25A44;HSD17B10;BCKDHB;BCAT1;MCCC2
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.2785709593830983,-0.781788710405555,0.7607223476297968,0.9569673819889846,1.0,9/20,28.07%,BCKDHA;ECHS1;ACADSB;IVD;SLC25A44;HSD17B10;BCKDHB;BCAT1;MCCC2
prerank,sphingosine biosynthetic process (GO:0046512),-0.3273990292053047,-0.781588944743278,0.7552301255230126,0.9555436606419617,1.0,5/11,20.27%,ASAH1;ASAH2;ACER2;SPTLC1;ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),-0.3273990292053047,-0.781588944743278,0.7552301255230126,0.9555436606419617,1.0,5/11,20.27%,ASAH1;ASAH2;ACER2;SPTLC1;ABCA2
prerank,cellular response to purine-containing compound (GO:0071415),0.3671684105885553,0.7814441720278147,0.7055449330783938,0.9021032529371545,1.0,2/10,10.88%,P2RY6;TRPM2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.25205107418319317,-0.7809840782190903,0.8091603053435115,0.9556535798478418,1.0,4/26,5.86%,MBP;VSIR;USP50;APH1A
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.21920895072628757,-0.7808142030892138,0.8795180722891566,0.9550446308159021,1.0,13/55,18.14%,SKP1;PSMD13;PSMD12;RBX1;FBXL7;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3032940087382219,0.7800406732598275,0.7669421487603306,0.903941747134152,1.0,4/26,8.07%,PRKN;PDE8A;HSPB1;FYN
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3234663753239373,0.7798432540457022,0.7386759581881533,0.9038288817027474,1.0,2/18,4.25%,PRKN;MCU
prerank,neuromuscular synaptic transmission (GO:0007274),0.31465570469942433,0.7796278511795592,0.7320819112627986,0.9037545608622739,1.0,4/18,17.25%,FCHSD2;ERC2;RIMBP2;CHRNB2
prerank,maturation of LSU-rRNA (GO:0000470),-0.258919475683179,-0.7795485792490698,0.8146341463414634,0.9561575278130725,1.0,7/26,15.80%,NSA2;WDR12;MAK16;URB1;FTSJ3;BOP1;ZNHIT6
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.24262104257021466,0.7794172462993911,0.8233657858136301,0.9036686832547606,1.0,22/83,20.20%,PHF8;CDK6;RB1;CDK14;BACH1;CACUL1;CUL3;TFDP1;HINFP;CDK17;EIF4EBP1;TRIM71;CDKN2C;LATS2;CRLF3;MYC;BRD4;CUL5;CAMK2A;PLK2;GSPT1;PCNA
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.32196335652133407,0.7791853866649255,0.734006734006734,0.9036061298214036,1.0,5/16,18.62%,ATP5PO;ATP5MC2;ATP5F1E;ATP5MC1;ATP5MF
prerank,muscle contraction (GO:0006936),0.2272770817596817,0.779062601279335,0.8518057285180572,0.9033724252111394,1.0,19/126,15.49%,TMOD1;MYH6;MYOM2;TNNT1;UTRN;MYOF;VIM;TMOD3;ROCK1;ADRA1A;VCL;CALM1;PXN;CRYAB;ROCK2;NEB;TPM3;MYBPC3;CLCN1
prerank,protein localization to centrosome (GO:0071539),0.3222197646343631,0.7790061205885679,0.743103448275862,0.9030314173687336,1.0,4/17,13.96%,PIBF1;CCDC14;SNX10;PCM1
prerank,glucan catabolic process (GO:0009251),-0.2996275215819125,-0.7788387464640363,0.7564402810304449,0.9564116857253091,1.0,9/15,33.17%,PHKB;GAA;PYGL;PHKA2;PGM2;PYGB;AGL;PHKG1;PYGM
prerank,purine-containing compound salvage (GO:0043101),0.3434581928037433,0.7787949271657868,0.7330754352030948,0.9029283830018778,1.0,2/12,10.48%,ADK;AMPD3
prerank,peptide catabolic process (GO:0043171),0.30349927458831205,0.7782764410144554,0.7349397590361446,0.9033464193240335,1.0,3/23,10.23%,CPQ;LNPEP;ENPEP
prerank,determination of bilateral symmetry (GO:0009855),-0.26445171434658477,-0.778036866118335,0.8222811671087533,0.9567947010762253,1.0,8/25,23.61%,BBS7;KIF3B;NOTCH1;DNAH5;MKKS;ODAD2;GALNT11;STIL
prerank,amide biosynthetic process (GO:0043604),-0.22335791265768962,-0.7779692123626374,0.8676923076923077,0.9560149474381244,1.0,17/47,22.63%,SMPD4;ASAH1;ASAH2;CERS4;SAMD8;DEGS1;CERS5;CERS1;FURIN;NMRAL1;SGMS2;SPTLC1;SMPD2;TLCD3B;CERS2;ASMT;AGK
prerank,DNA alkylation (GO:0006305),0.3199310206787813,0.7778785865408877,0.7495652173913043,0.9031176715352423,1.0,7/19,14.71%,DMAP1;GATAD2A;SPOCD1;ATRX;BEND3;KMT2E;EHMT1
prerank,DNA methylation or demethylation (GO:0044728),0.3199310206787813,0.7778785865408877,0.7495652173913043,0.9031176715352423,1.0,7/19,14.71%,DMAP1;GATAD2A;SPOCD1;ATRX;BEND3;KMT2E;EHMT1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.2787024889754981,-0.7774031815821645,0.7897091722595079,0.9560448859123922,1.0,6/18,19.40%,ACVR1;MDM4;TGFBR2;NOTCH1;ENG;TGFB2
prerank,negative regulation of autophagy (GO:0010507),0.2575338461738086,0.777319508356381,0.7889221556886228,0.9035899226854054,1.0,11/54,13.90%,NUPR1;PTPN22;MCL1;TBC1D14;BCL2;SMCR8;ATG7;FOXK2;FOXK1;RUBCN;STAT3
prerank,autophagy of peroxisome (GO:0030242),-0.31889293354268144,-0.776912800011162,0.7440860215053764,0.9559227979066711,1.0,2/12,5.66%,ATM;PIK3R4
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2833196229692723,0.7768889370110394,0.7748031496062993,0.9038533295082445,1.0,12/31,22.11%,DCP1A;DDX6;DCP2;EXOSC8;DIS3L2;LSM4;LSM2;EXOSC1;HBS1L;CNOT8;PATL1;EXOSC3
prerank,regulation of response to interferon-gamma (GO:0060330),-0.31175083908122736,-0.7762688862628355,0.765625,0.9560438645891967,1.0,2/14,2.97%,JAK2;STAT1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.33579737147843874,0.7759216535630549,0.7447619047619047,0.9049617713289171,1.0,1/14,1.73%,DPYD
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.35162767590046995,0.7753929905372768,0.707089552238806,0.905376666618276,1.0,3/10,11.84%,SESTD1;PLN;YWHAE
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.31422619125862683,-0.7752214932146407,0.7672209026128266,0.9568698632601356,1.0,3/13,14.90%,CNOT7;TNRC6B;TNRC6A
prerank,extracellular structure organization (GO:0043062),0.21681279723493732,0.7751539507359398,0.8986889153754469,0.9053146392539521,1.0,30/204,14.16%,TGFBI;ITGA4;APP;ADAM19;ADAMTSL5;ITGB1;ITGA9;CD44;ST7;LOX;ATP7A;ADAMTS19;ADAMTS18;COL22A1;COL9A2;ADAMTS10;ADAM12;DDR2;ADAMTS9;COL14A1;MIA;PXDN;COLQ;MMP24;MMP28;MMP25;NID2;ADAMTS17;COL24A1;ITGB2
prerank,regulation of isotype switching (GO:0045191),0.3305865557101696,0.774970279023328,0.751412429378531,0.905190870588101,1.0,5/14,22.88%,KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,camera-type eye development (GO:0043010),-0.260367711249639,-0.7748320982534735,0.8313253012048193,0.9565728642078745,1.0,4/25,11.72%,TENM3;NF1;SHROOM2;CACNA1C
prerank,gas transport (GO:0015669),-0.33779356865347804,-0.7747916425641644,0.7416666666666667,0.9557567051841113,1.0,1/10,0.98%,IPCEF1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3147346451156158,0.7747726412698136,0.7443082311733801,0.9050657115380168,1.0,5/18,17.09%,PRKN;HSPB1;PPIA;MAPK7;TRAP1
prerank,negative regulation of cell communication (GO:0010648),-0.26972840588723573,-0.7740406351452993,0.7911832946635731,0.9560434685947058,1.0,3/21,12.63%,ACVR1;UBASH3B;GLRA1
prerank,nitric oxide biosynthetic process (GO:0006809),0.3460937162213924,0.7738489650886564,0.7393715341959335,0.9061243010267656,1.0,2/13,14.55%,GCH1;ARG2
prerank,protein localization to organelle (GO:0033365),0.22364444762958413,0.7737053660037351,0.8646616541353384,0.9059180432724149,1.0,22/133,13.78%,APP;LAMP3;HMOX1;EHD1;LAMP1;SERP1;UBAC2;PIKFYVE;LMBRD1;RPA1;DCP1A;TRAM2;MDM2;LAMP2;PACSIN2;CD68;SNX10;XPA;YWHAE;VAPA;CNTLN;RAB11A
prerank,tryptophan metabolic process (GO:0006568),0.3641417276745287,0.7733982442077445,0.7467889908256881,0.9059872987470583,1.0,2/11,10.61%,ATP7A;KYAT1
prerank,regulation of nuclear division (GO:0051783),0.30931245834989607,0.7733606111168942,0.7549342105263158,0.9056198933204829,1.0,5/20,21.81%,KIF20B;CDK13;CUL7;DAPK3;BORA
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2536211816687541,0.7729028483176099,0.8084179970972424,0.9059287128177164,1.0,4/59,6.24%,ALOX5;OSBPL9;HSD3B7;CYP27A1
prerank,regulation of intracellular protein transport (GO:0033157),0.2810904606337187,0.7725995531930403,0.7924836601307189,0.9059938597165338,1.0,10/32,20.04%,KIF20B;LCP1;PCNT;BCAS3;UHMK1;PCM1;PTPN14;OAZ2;NDEL1;OAZ1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2812660260737654,0.7724476449652301,0.7672552166934189,0.905803662782405,1.0,8/33,16.22%,CDK6;RB1;KLF4;CDC73;KANK2;CDKN2C;PKD2;PTEN
prerank,negative regulation of actin filament polymerization (GO:0030837),0.30320287089974446,0.7723664220228418,0.7587354409317804,0.9054990703720128,1.0,2/22,4.79%,MYADM;SSH2
prerank,intracellular protein transport (GO:0006886),0.20652121975607846,0.772240871620626,0.9335585585585585,0.9052507724603381,1.0,35/304,10.55%,SNX9;TBC1D5;TBC1D4;RAB31;SNX8;CLTC;EVI5;USP6NL;PRICKLE1;CD74;SNX6;SNX27;EHD1;AP3B1;RIC1;TBC1D14;TMED10;SYK;IPO11;AP4S1;BAG3;TBC1D2B;RABGAP1L;SGSM1;NUP133;RAB7A;STX7;RAB14;RAB1A;RAB23;LAMP2;ARL4A;NUP62;MYO1C;WLS
prerank,positive regulation of sodium ion transport (GO:0010765),-0.3092011170598218,-0.7712489727734487,0.7577777777777778,0.9594013651001894,1.0,4/12,23.06%,SCN1B;WNK3;AHCYL1;GPD1L
prerank,cell cycle G1/S phase transition (GO:0044843),0.24959961227082447,0.7711102856766354,0.7997138769670958,0.9065852409484365,1.0,17/61,19.33%,PHF8;CDK6;RB1;CACUL1;CUL3;HINFP;EIF4EBP1;TRIM71;MAP3K11;CDKN2C;LATS2;CRLF3;MYC;CUL5;CAMK2A;PLK2;GSPT1
prerank,peptidyl-asparagine modification (GO:0018196),0.28261399867542086,0.7704628232068835,0.7907348242811502,0.9071660359556308,1.0,7/31,15.21%,ST6GAL1;MGAT2;ALG5;ASGR2;UGGT1;RPN2;MCFD2
prerank,striated muscle tissue development (GO:0014706),-0.24618905371074135,-0.7700002468950482,0.8239795918367347,0.9603780046593604,1.0,5/29,12.36%,SGCD;IGSF8;CFLAR;SGCZ;ZBTB18
prerank,endodermal cell fate commitment (GO:0001711),-0.3331721009098724,-0.7698213057765073,0.7505330490405118,0.9597643915513947,1.0,2/10,10.84%,CTR9;PAF1
prerank,tRNA wobble uridine modification (GO:0002098),0.32577313969931837,0.7694516631819167,0.7380073800738007,0.9083275742122745,1.0,4/14,13.88%,URM1;DPH3;ELP4;CTU1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2875881311509925,0.7688775971011338,0.7675585284280937,0.9088066843578667,1.0,8/25,16.91%,CDK12;LARP7;NELFA;CDC73;EAF2;CDK13;BRD4;EAPP
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3427599130801101,0.7687162172652613,0.7348754448398577,0.9086397446279684,1.0,2/12,6.94%,CD44;TNF
prerank,regulation of mitochondrial depolarization (GO:0051900),0.36776764580776566,0.7681451762843946,0.7495107632093934,0.9090963202552941,1.0,2/10,6.34%,RACK1;BCL2
prerank,positive regulation of immune system process (GO:0002684),0.322776245565602,0.7677336218147086,0.7348066298342542,0.9093097225984974,1.0,1/16,1.12%,IL15
prerank,glutathione derivative metabolic process (GO:1901685),0.3146986875033203,0.7674263532195253,0.7669039145907474,0.9089356592169848,1.0,5/20,20.72%,MGST3;MGST1;GSTT1;ESD;GSTA3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3146986875033203,0.7674263532195253,0.7669039145907474,0.9089356592169848,1.0,5/20,20.72%,MGST3;MGST1;GSTT1;ESD;GSTA3
prerank,lipid translocation (GO:0034204),0.3028111816343256,0.7666210689594197,0.7919463087248322,0.9097152887671952,1.0,4/21,10.78%,ATP11C;ATP8B4;ABCC1;ATP10B
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.3144325027423911,-0.7659685314742843,0.7417218543046358,0.9646901167087849,1.0,6/12,30.42%,STARD3;AKR1B1;FDX1;STAR;CACNA1H;TSPOAP1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.29958790237538835,-0.7655074797423165,0.7919621749408984,0.9645140153343906,1.0,3/15,15.85%,KYNU;FAH;IL4I1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2519782568569969,0.7649588471446246,0.8167155425219942,0.9118474693031479,1.0,18/63,20.20%,WAC;RPL26;RGCC;SFN;ARID3A;MDM2;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;CNOT4;PLK2;CNOT1;CNOT8;PCNA
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.2998815128430849,0.7649313295481537,0.7563025210084033,0.9114588594395525,1.0,4/22,11.99%,GSK3B;ROCK1;TNF;ROCK2
prerank,establishment of protein localization to organelle (GO:0072594),-0.204370161283287,-0.7648446517729953,0.9340277777777778,0.9646017102169737,1.0,29/72,30.04%,HK2;IPO5;IL10RA;APPL1;RANBP17;NUP85;IPO13;RPAIN;IPO8;NXT1;LRSAM1;ZDHHC15;LAMP5;SEC13;PPP1R10;PEX19;TNPO2;E2F3;CSE1L;TSC2;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;NUP214;EIF4ENIF1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.35003436058042214,0.7647628105897136,0.7449908925318761,0.9108794692608778,1.0,4/12,15.23%,ITGB1BP1;RCC2;CORO1C;MELTF
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.35003436058042214,0.7647628105897136,0.7449908925318761,0.9108794692608778,1.0,4/12,15.23%,ITGB1BP1;RCC2;CORO1C;MELTF
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.3181496603589973,0.7647176954691023,0.7649122807017544,0.9105241293001822,1.0,5/17,17.03%,ADAM9;SYK;FOXC2;CCL5;PODXL
prerank,hexose transmembrane transport (GO:0008645),-0.268493869205682,-0.7638641674423197,0.7965686274509803,0.9651466520220973,1.0,6/21,22.65%,SLC2A9;SLC2A5;SLC50A1;SLC45A3;SLC2A3;SLC45A1
prerank,endothelial cell differentiation (GO:0045446),0.3409814183138644,0.7638121592014183,0.768796992481203,0.911536628570158,1.0,1/12,1.94%,JAG1
prerank,nuclear pore complex assembly (GO:0051292),0.35647733993182484,0.7633855359256431,0.7306967984934086,0.911763785828127,1.0,3/10,16.84%,RTN4;NUP98;NUP153
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.30314647661861244,-0.7633561101943402,0.7682119205298014,0.9650420461911923,1.0,4/12,24.82%,PAX8;SMO;AGT;SOX8
prerank,cellular response to virus (GO:0098586),0.27883334108339636,0.762467779768364,0.7888513513513513,0.9128084936942518,1.0,8/30,18.60%,CCL19;GSDME;RIOK3;MAPK14;ZC3H12A;CCL5;IL6;RRP1B
prerank,positive regulation of histone methylation (GO:0031062),0.29468193710220886,0.7622192179627633,0.7906976744186046,0.9127508243407462,1.0,3/24,5.19%,KMT2A;JARID2;SMAD4
prerank,response to X-ray (GO:0010165),-0.3000889021099662,-0.76190775793415,0.7902542372881356,0.9662067878841771,1.0,5/14,17.16%,XRCC5;ATM;BLM;XRCC6;MSH2
prerank,cGMP biosynthetic process (GO:0006182),0.3537548811328834,0.7615753668054889,0.7421150278293135,0.9133090577680401,1.0,2/10,13.93%,GUCY2D;NPPC
prerank,growth hormone receptor signaling pathway (GO:0060396),0.32684983155814407,0.7594560050595777,0.75809199318569,0.916143817264787,1.0,4/14,13.90%,LYN;STAT6;PXN;STAT3
prerank,spermatid development (GO:0007286),-0.23848585234409772,-0.7589284060959323,0.8403141361256544,0.9697781961245051,1.0,7/32,24.15%,JAM2;NECTIN2;IQCG;NME5;BBS4;MKKS;SYCP3
prerank,replicative senescence (GO:0090399),-0.3135656262203619,-0.7588232140422667,0.7702127659574468,0.9690584938679562,1.0,4/12,18.67%,TP53;ATM;CHEK2;SERPINE1
prerank,cardiocyte differentiation (GO:0035051),-0.32455441037182947,-0.7583717470401121,0.7840172786177105,0.9688504218076971,1.0,4/10,19.40%,SIK1;AKAP13;EEF1AKMT4-ECE2;TGFB2
prerank,diterpenoid metabolic process (GO:0016101),0.2514260703559642,0.7578881083978256,0.8260869565217391,0.9180498166409072,1.0,9/55,18.29%,APOE;DHRS3;SDC3;SDC4;RBP4;GPC3;RDH5;RBP1;ABCA4
prerank,neural tube development (GO:0021915),-0.2859011470564371,-0.7578140433731188,0.8071748878923767,0.9687623140262883,1.0,7/15,23.61%,DVL1;PROX1;ALDH1A2;SOX11;TGFB1;DACT1;STIL
prerank,protein monoubiquitination (GO:0006513),0.27278402945085783,0.7575924023483919,0.7887323943661971,0.9180595917715072,1.0,9/36,16.08%,WAC;PRKN;CDC73;UBE2D3;CUL3;UBE2R2;TRIM25;UBE2W;FANCL
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.3433443426052787,0.7575512177014914,0.7699805068226121,0.9176979599799705,1.0,2/12,10.08%,MEF2C;DOCK7
prerank,peroxisome organization (GO:0007031),-0.2561877299393258,-0.7571401216705576,0.8128342245989305,0.9688697273302639,1.0,10/25,29.43%,PEX6;ABCD2;PEX10;PEX3;PEX11B;PEX19;FIS1;ACOT8;PEX11G;TMEM135
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.21492364582301818,-0.7571320767033021,0.8940809968847352,0.9680002217219317,1.0,19/50,32.58%,CCNG2;CCNT2;CCNH;BLM;GADD45A;CDK5RAP3;BCCIP;CDK5R2;CCNG1;CCNK;CDKN3;CCNT1;CCNA2;STOX1;CAMK2N1;CCNE1;CCNB2;CDK7;SERTAD1
prerank,regulation of translational initiation (GO:0006446),0.2404908840366402,0.7569364150618029,0.8492537313432836,0.9182101068849786,1.0,16/63,16.92%,DNAJC3;CEBPB;EIF3E;HSPB1;RBM4;EIF1;EIF4B;EIF4EBP2;EIF4EBP1;UHMK1;POLR2D;EIF3H;EIF5;PPP1R15B;CCL5;CSDE1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.30608191422643377,0.7566597250369326,0.7589928057553957,0.9181787857147297,1.0,4/16,15.06%,PDE6H;CHGA;ACP3;NECAB2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.33735078551239495,0.7565800241478184,0.7408829174664108,0.9178714297281878,1.0,2/12,6.29%,PIBF1;ERLIN1
prerank,blood circulation (GO:0008015),0.25562557302850925,0.755282084799296,0.8212121212121212,0.9194075529448483,1.0,7/49,11.99%,C3AR1;MYOF;ITGB1BP1;ROCK1;PLN;GCLM;ROCK2
prerank,nucleosome organization (GO:0034728),0.2520822889727454,0.7550489776378922,0.8330893118594437,0.9193170085148064,1.0,18/55,22.30%,PADI4;DMAP1;ATRX;LIN54;H3-3A;POLE3;SMARCD1;ARID1A;ANP32B;ASF1A;SRCAP;CTCF;SET;NAP1L2;ANP32E;CHAF1B;GRWD1;NPM1
prerank,phospholipid homeostasis (GO:0055091),-0.31423773152400913,-0.7550307515568885,0.7848101265822784,0.9701323296005308,1.0,2/11,6.49%,ABCG1;TLCD2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.2676794304536038,0.7543752962071408,0.778675282714055,0.9198967653032214,1.0,7/37,16.22%,MEF2C;ERN1;P2RY6;IGF1;GJA1;BMPR1A;PTEN
prerank,alpha-amino acid metabolic process (GO:1901605),0.26326513765926807,0.7541973722189831,0.8,0.9197104480335999,1.0,9/45,17.62%,ATP7A;THAP4;GNMT;KYAT1;ASS1;GLS2;GLUD1;NOX4;RIMKLA
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.2988570850002956,-0.7541045511108162,0.8018433179723502,0.9705642663694672,1.0,5/14,21.76%,XRCC5;BRCA2;TERF2;TPP1;ACD
prerank,homocysteine metabolic process (GO:0050667),-0.3189162085371148,-0.7540346329791938,0.8134831460674158,0.9697816542487858,1.0,5/11,34.62%,MMUT;TST;MTRR;CBS;CTH
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.31847778550292416,-0.7536582094249255,0.7949260042283298,0.9694328081002973,1.0,4/11,11.39%,TP53;ATF6B;DDIT3;ATF3
prerank,cellular response to hypoxia (GO:0071456),0.21896198140196935,0.7535019135103009,0.8974700399467377,0.920337775619504,1.0,23/126,15.18%,PSMA7;RPS27A;ZFP36L1;HMOX1;RGCC;NOP53;HIGD1A;PSMB2;LIMD1;BACH1;MDM2;CARD16;SFRP1;CREBBP;PSMA6;FAM162A;HIF3A;EP300;PSMA3;PSMD1;PSMD5;ELOC;MYC
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.24961134287235176,-0.7533808281469424,0.8429319371727748,0.9689753987894895,1.0,10/26,33.29%,CALM2;FMR1;CBARP;GPR35;CALM3;UBQLN1;CRHR1;TLR9;GSTO1;ADRA2A
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.30667097388350806,0.7531775142759957,0.7818499127399651,0.9204129383184227,1.0,5/18,14.11%,RPS27A;AMFR;RNF185;UGGT1;DERL2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.2905793175656066,0.7531025555754293,0.785472972972973,0.9201040675060889,1.0,6/23,19.31%,HERC4;RACK1;GPC3;GPR161;GLIS2;ENPP1
prerank,nuclear pore organization (GO:0006999),0.3257285017441329,0.7528824953802441,0.7680140597539543,0.9199893428436627,1.0,5/14,21.42%,NUP133;RTN4;NUP98;NUP153;NUP35
prerank,positive regulation of defense response to virus by host (GO:0002230),0.29264490273211974,0.7523256612102496,0.7964169381107492,0.9204137466790291,1.0,2/24,2.74%,PTPN22;LILRB1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.24645231087094466,-0.7523093577112452,0.8431372549019608,0.9695969346025823,1.0,11/28,24.99%,CLASP2;NSFL1C;NUMA1;INSC;SPDL1;NDC80;NUSAP1;ZW10;ESPL1;DCTN1;MAD2L1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2973748701199244,-0.7522868066344631,0.7880794701986755,0.9687506992333934,1.0,7/13,27.81%,EDEM1;UBE2J1;ERLEC1;BRSK2;BCAP31;YOD1;UBE2G2
prerank,aerobic electron transport chain (GO:0019646),-0.19996100301177233,-0.7518350842606275,0.9335548172757475,0.9685481714503829,1.0,18/68,22.09%,COX5B;NDUFS7;NDUFV3;UQCRC1;NDUFAF1;UQCRB;AFG1L;NDUFB8;NDUFB7;COX15;NDUFV1;NDUFB10;SDHAF2;NDUFA8;NDUFA10;UQCR10;NDUFAB1;NDUFS1
prerank,glycerophospholipid metabolic process (GO:0006650),0.23883019371552325,0.7513983544830883,0.8525280898876404,0.9213780104782977,1.0,15/75,16.55%,PLA2G7;SYNJ1;IP6K3;CPNE7;PLCD1;PLA2G2D;PIP5K1A;DGKH;HDHD5;PLAAT1;PLCB3;PAFAH1B1;FAR1;PIGQ;PIGX
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.2831545270588064,0.7511702246168684,0.8150572831423896,0.9213031500425451,1.0,5/29,9.33%,MYADM;PRKN;SSH2;SMAD4;CLASP1
prerank,potassium ion export across plasma membrane (GO:0097623),0.3258893968083073,0.7511679954965265,0.7765567765567766,0.9208845660284048,1.0,3/13,17.48%,KCNQ1;KCNK5;KCNE3
prerank,amyloid precursor protein catabolic process (GO:0042987),0.3199857684882072,0.7511176271669301,0.7761194029850746,0.9205350931216294,1.0,3/14,9.25%,ADAM19;PSEN1;DYRK1A
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.2561723307473825,0.7511040980619409,0.8148148148148148,0.9201334379323425,1.0,5/43,7.23%,BABAM2;NOP53;CHEK1;BRCC3;TOPBP1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.2971364821994425,-0.7509011492363308,0.7933194154488518,0.968987611503318,1.0,7/14,38.67%,COPS8;TLR3;TRAF2;MALT1;IRAK1;CARD10;MAP3K7
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23907487791517518,0.7507608185988763,0.847672778561354,0.9202147600909768,1.0,19/72,20.20%,RNASE4;RPS27A;DNASE1L1;RPA1;RNASE6;DCP1A;XPA;ZC3H12A;RPA3;HORMAD1;FBH1;GTF2H3;RFC3;GTF2H1;DXO;ENPP1;POLD2;MRE11;PCNA
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.30303777587398434,0.7502562190126596,0.7760416666666666,0.9205278872352491,1.0,5/18,18.59%,BCL2;SLC25A5;BNIP3;SLC25A4;CAMK2A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.29121209667065096,-0.7499660394675113,0.8314855875831486,0.9694062783958786,1.0,9/14,36.84%,FGF2;SULF1;GPC1;SPRY1;SPRY4;GATA3;SPRY3;APLN;FUZ
prerank,mitotic cell cycle phase transition (GO:0044772),0.20821191469003444,0.7499366895649632,0.9445100354191264,0.9205712236596525,1.0,34/204,15.54%,EPS8;FBXL17;PHF8;NES;CDK6;RB1;CDC27;FOXM1;CCND3;CDK14;CLASP1;CCND2;CCNJ;CACUL1;CUL3;PCNT;DYNC1I2;CETN2;ARPP19;HINFP;YWHAE;EIF4EBP1;TRIM71;CDKN2C;LATS2;PAFAH1B1;CCNY;PCM1;CRLF3;CEP78;HAUS5;ANAPC1;MYC;PPP2R2A
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3286615787896958,-0.7496935721008295,0.7901785714285714,0.9689058427857263,1.0,3/10,18.67%,PDE3B;ACER2;SERPINE1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.32328646900576363,-0.7495739263015889,0.7823275862068966,0.968221205857774,1.0,5/10,30.66%,SIRT7;ZNF692;SELENOS;PDK2;DGKQ
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.29131062230834687,-0.7495132422549282,0.8132387706855791,0.9674269968579233,1.0,3/15,14.90%,CNOT7;TNRC6B;TNRC6A
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.25276867343896203,-0.7481107193009892,0.8272727272727273,0.9684468556781939,1.0,2/24,1.70%,IRAK2;CYLD
prerank,cellular amino acid catabolic process (GO:0009063),0.2321305639439986,0.7472542808805523,0.8804347826086957,0.9240131220222135,1.0,14/87,17.52%,HAL;HDC;DAO;HIBADH;KYAT1;HIBCH;ACAD8;GLS2;GLUD1;SHMT1;ACAT1;HNMT;HYKK;PHYKPL
prerank,regulation of transmembrane transport (GO:0034762),0.27867898693266546,0.7465455842026117,0.8225039619651348,0.9246388669568835,1.0,4/31,7.67%,KCNJ14;ACTB;BCL2;PRKCB
prerank,protein secretion (GO:0009306),0.24580211631672202,0.7461537325770711,0.8393632416787264,0.924798682265718,1.0,10/56,16.72%,STEAP3;RCN3;RAB8B;RAB10;CANX;WLS;PDIA4;RAB3B;MIA3;GOLPH3
prerank,protein ADP-ribosylation (GO:0006471),0.28479476867409187,0.7458740324397402,0.8241379310344827,0.9247661308925029,1.0,3/28,3.97%,PARP14;PARP8;PARP11
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.34416604746124635,0.7455373920899512,0.7509025270758123,0.9248470311100618,1.0,3/10,10.54%,FOXM1;RPS6KA6;SP100
prerank,negative regulation of cell cycle process (GO:0010948),-0.20138725627042647,-0.74546629944821,0.9423076923076923,0.9711533675999002,1.0,25/61,31.72%,EHMT2;MGA;TOM1L1;PCGF6;BRCA1;CDC7;CCP110;PCGF2;CBX5;TERF2;RING1;ZFYVE19;RAD51;PPP1R10;BMI1;ESPL1;EZH2;AURKB;CHMP4C;YAF2;BMP4;PHC1;E2F7;FBXO5;CBX3
prerank,regulation of TOR signaling (GO:0032006),0.24036802590509707,0.7452674488115634,0.8376068376068376,0.924803736785003,1.0,14/67,18.23%,DEPTOR;GAS6;NPRL3;MIOS;FNIP1;SMCR8;LAMTOR5;HTR6;NPRL2;GOLPH3;GPAT3;LARS1;RHEB;RRAGC
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.34603779927169065,0.7450509638354236,0.7697841726618705,0.9246808661553753,1.0,3/10,13.90%,LYN;STAT6;STAT3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2510365578070544,0.7449705104269503,0.8296296296296296,0.9243886961006936,1.0,17/54,20.20%,RPL26;RGCC;SFN;ARID3A;MDM2;TFDP1;EP300;CNOT9;PRMT1;E2F8;CNOT11;CNOT6L;CNOT4;PLK2;CNOT1;CNOT8;PCNA
prerank,response to UV (GO:0009411),0.22355202488297665,0.7443836215087791,0.886685552407932,0.9248136574198805,1.0,25/95,19.40%,EGFR;RPL26;RHBDD1;PTPRK;TRIM32;YY1;MFAP4;ZRANB3;RHNO1;CREBBP;XPA;POLH;EP300;USF1;USP28;MYC;USP47;KDM1A;ATR;RELA;UBE4B;UBE2A;ZBTB1;EIF2AK4;BCL3
prerank,negative regulation of TOR signaling (GO:0032007),0.2699195958111695,0.7438841843903171,0.8278041074249605,0.9251148247168406,1.0,4/36,8.33%,DEPTOR;SESN1;NPRL3;FNIP1
prerank,positive regulation of receptor internalization (GO:0002092),0.2964259569711257,0.7437416684074941,0.788659793814433,0.9249047648141675,1.0,3/22,10.21%,TBC1D5;INSR;ARRB1
prerank,snRNA 3'-end processing (GO:0034472),-0.26903086616782274,-0.7437223945074198,0.8382352941176471,0.9726657281591292,1.0,2/19,8.16%,INTS6L;EXOSC9
prerank,cellular response to glucose starvation (GO:0042149),0.2620011159553462,0.7435343993042075,0.7981510015408321,0.9247714068267406,1.0,4/41,4.05%,PRKAG2;SESN1;PRKAG3;MTMR3
prerank,eye development (GO:0001654),-0.2107951861088164,-0.7435185249101652,0.887905604719764,0.9720959605383985,1.0,15/54,22.78%,PBX2;BMPR1B;RAB18;MEIS3;SHROOM2;CACNA1C;MEIS1;SMG9;HIPK1;PBX1;TGFB2;FOXC1;CRYBA4;PBX4;SALL2
prerank,diacylglycerol metabolic process (GO:0046339),-0.2500812744894909,-0.7433705481194227,0.85,0.9714438864929549,1.0,4/23,9.45%,DGKI;DGKB;DGKZ;DAGLA
prerank,vascular transport (GO:0010232),0.2321831111311402,0.7431719432762944,0.871900826446281,0.9248783136589601,1.0,13/81,13.91%,SLC16A7;SLC28A2;SLC2A4;INSR;ABCC4;SLC29A1;ABCC1;SLC4A4;SLC38A1;ATP2B4;SLC38A2;MFSD2A;ATP1A4
prerank,peptidyl-methionine modification (GO:0018206),-0.3032210543438424,-0.742555213674386,0.7805429864253394,0.9716992167055675,1.0,4/12,26.57%,NAA60;NAA25;NAA30;METAP1D
prerank,ubiquinone metabolic process (GO:0006743),-0.28407569953125156,-0.7424032358936233,0.8296460176991151,0.9710161816665187,1.0,4/15,15.43%,COQ8B;PDSS2;AIFM2;COQ7
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.28056860795661753,-0.7423587403736424,0.830316742081448,0.9702140641458041,1.0,3/16,7.48%,SCARB2;PDK1;PDK3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.24497299474151232,0.7422848083384205,0.8263988522238164,0.9256920794663757,1.0,12/58,17.18%,LIG4;BABAM2;UVRAG;DCLRE1C;BRCC3;NSMCE2;NHEJ1;UBE2N;XRCC4;KDM2A;CYREN;ZBTB7A
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2136168056675596,0.7417682223477912,0.9085365853658537,0.9260140618578275,1.0,35/148,20.40%,PRKAG2;RPL23;RBBP8;PRKAG3;RPS15;RPL37;RPS20;PHF20;NOP53;CHEK1;TOPBP1;RPL5;RPA1;BRIP1;MDM2;MAPK14;RHNO1;RPA3;PPP1R13B;EP300;KAT6A;EHMT1;RPL11;ATR;TAF12;RFC3;RRS1;PIP4K2A;PIP4P1;CSNK2A2;CSNK2A1;MRE11;USP7;JMY;BRD7
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.21060530605977923,-0.7417259229228254,0.9012345679012346,0.9702159789834989,1.0,9/57,11.21%,TREM2;FBXO7;TP53;BCL2L11;HTRA2;MLLT11;BMF;TNFSF10;DDHD1
prerank,DNA conformation change (GO:0071103),0.31105452019592145,0.7416740457599098,0.7978533094812165,0.9257262399826504,1.0,4/17,16.23%,TOP1MT;HAT1;KAT6A;TOP2B
prerank,establishment of spindle orientation (GO:0051294),-0.24601034937968436,-0.7412833997221112,0.8324873096446701,0.969932686268587,1.0,11/28,24.99%,LLGL1;NSFL1C;NUMA1;INSC;MAP4;LLGL2;SPDL1;NDC80;ZW10;DCTN1;MAD2L1
prerank,regulation of actomyosin structure organization (GO:0110020),0.32827308684139583,0.7411060350274806,0.775,0.9261018846183692,1.0,4/13,11.99%,CDC42;ROCK1;PTGER4;ROCK2
prerank,digestive tract development (GO:0048565),0.27150069600183047,0.7405264352319338,0.8012718600953895,0.9265102358909303,1.0,2/33,6.94%,EDNRB;TNF
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.1973362443368841,0.7404021030174218,0.9674157303370786,0.9262701871520094,1.0,49/314,15.04%,WWP1;FBXW7;SMURF2;PSMA7;RPS27A;FBXL17;SIAH2;SEL1L2;PELI1;RMND5A;PRKN;CLOCK;RB1;SPOP;FBXL5;ERLIN1;CDC27;PSMB2;APPBP2;TBL1XR1;SPOPL;RNF121;MDM2;TBL1X;UBE2K;UBE2D3;COP1;RHBDD2;CUL3;ANAPC16;ARMC8;ZFAND2B;ARRB1;AMFR;PSMA6;FBXO48;WFS1;RNF185;TRIM71;AGAP3;RNF187;BFAR;DERL2;NEDD4L;PSMA3;PSMD1;PSMD5;ANAPC1;RNF122
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2892357056230076,0.740223437862483,0.7986906710310966,0.9261070745759973,1.0,4/22,15.93%,NES;TRIM71;MDK;KDM1A
prerank,triglyceride biosynthetic process (GO:0019432),0.3073616601710919,0.738892321164549,0.7732656514382402,0.9275923183213152,1.0,2/18,4.40%,AGMO;MOGAT2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3231932994920288,0.7376430635231411,0.7817164179104478,0.9288986617089091,1.0,2/15,4.79%,ADM;IRS2
prerank,"wound healing, spreading of cells (GO:0044319)",0.28011407829321294,0.7366071849291078,0.7931034482758621,0.9298886369646336,1.0,3/24,4.01%,CD44;RHOA;LCP1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3079101839637305,-0.7364007878073543,0.832967032967033,0.9748076209485257,1.0,1/11,1.85%,CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3079101839637305,-0.7364007878073543,0.832967032967033,0.9748076209485257,1.0,1/11,1.85%,CALM2
prerank,positive regulation of macrophage activation (GO:0043032),0.30470505702464473,0.735930273618122,0.7931034482758621,0.9304327803175549,1.0,2/17,4.14%,TLR4;LBP
prerank,extracellular transport (GO:0006858),-0.288114232610378,-0.7356106885969234,0.8035320088300221,0.9749023692211024,1.0,6/13,36.06%,SPEF2;CCDC40;CABYR;ARRDC1;DNAAF2;SPA17
prerank,positive regulation of double-strand break repair (GO:2000781),-0.22100018359721704,-0.7352872096954387,0.8808864265927978,0.9744569044884375,1.0,5/39,8.00%,FUS;SLF2;PARP1;ERCC6;ZCWPW1
prerank,pentose-phosphate shunt (GO:0006098),-0.3070150732464576,-0.7347496501630193,0.8024691358024691,0.9742993161110345,1.0,4/11,20.95%,TALDO1;RPIA;PGM2;PGD
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.33226326197058714,0.7345178544779836,0.7855822550831792,0.9319986390643114,1.0,3/12,16.59%,DUSP1;WASL;MIA3
prerank,7-methylguanosine RNA capping (GO:0009452),-0.2306542025968323,-0.7337588807687675,0.8737113402061856,0.9738436484654759,1.0,15/31,38.32%,GTF2H2;CCNH;ERCC2;POLR2C;NCBP1;GTF2H4;POLR2L;POLR2I;CDK7;RNMT;POLR2H;ERCC3;GTF2F1;NCBP2;POLR2G
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.2306542025968323,-0.7337588807687675,0.8737113402061856,0.9738436484654759,1.0,15/31,38.32%,GTF2H2;CCNH;ERCC2;POLR2C;NCBP1;GTF2H4;POLR2L;POLR2I;CDK7;RNMT;POLR2H;ERCC3;GTF2F1;NCBP2;POLR2G
prerank,regulation of cell cycle phase transition (GO:1901987),-0.18664011919905818,-0.7336674483378207,0.966542750929368,0.9730994620254321,1.0,19/91,16.76%,ANAPC15;TP53;SKP1;PSMD13;PSMD12;ERCC2;PSMD9;ANAPC11;UBE2S;PSME3;BUB1B;PSMA4;PSMD8;PSMF1;PSMD4;UBE2E1;NEK11;UBE2D1;PSMB8
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.31994970416646856,0.7327586206844111,0.7734513274336283,0.9339964745339042,1.0,5/14,19.75%,PRKN;CREB3L1;XBP1;TXNDC12;TMBIM6
prerank,erythrocyte differentiation (GO:0030218),0.2528604746861621,0.7325733000045255,0.8456883509833586,0.9338148938912262,1.0,7/44,13.02%,LYN;MFHAS1;CEBPG;RPS14;SH2B3;SLC25A5;KMT2E
prerank,glucose import (GO:0046323),-0.29776318481788056,-0.7318541663010516,0.8181818181818182,0.9745738561767293,1.0,4/13,23.77%,SORT1;SLC27A4;SLC2A3;SLC27A1
prerank,BMP signaling pathway (GO:0030509),0.23423094301499858,0.7317431042623124,0.875,0.934535767410226,1.0,8/62,8.88%,BMP2;GDF3;USP9X;SMAD4;ACVR2A;USP15;HFE;HIVEP1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.3171429460075502,-0.7316530589403267,0.826879271070615,0.9739689421182959,1.0,2/10,8.69%,PIK3CB;CADM4
prerank,regulation of protein localization to nucleus (GO:1900180),0.25385001459830486,0.7313807892430609,0.8466353677621283,0.9346423225166747,1.0,3/43,4.76%,CTNNA1;MFHAS1;GSK3B
prerank,lysosome organization (GO:0007040),0.25916834042563275,0.7309263397078442,0.8322683706070287,0.9348425540027784,1.0,6/36,10.78%,GRN;CLN5;CLN6;MYO7A;TMEM165;ATP10B
prerank,serine family amino acid catabolic process (GO:0009071),0.34337994045371545,0.7305649712972828,0.776536312849162,0.93489137991253,1.0,2/10,13.56%,DAO;SHMT1
prerank,regulation of cell death (GO:0010941),0.2245221231279784,0.7304909903938496,0.8922651933701657,0.9345707219091293,1.0,18/94,16.81%,TNFRSF1B;CD36;PRKN;PDE8A;ACER3;SLC25A24;VPS4B;RIPK2;PARP16;CRYAB;ZC3H12A;SPEF1;CCN5;TMEM109;ATG5;SNCG;BNIP3;CCL5
prerank,chromosome condensation (GO:0030261),0.26062052541307523,0.7299011637827646,0.8403225806451613,0.9349039425806985,1.0,16/36,27.24%,PHF8;RB1;INCENP;BANF1;SMC4;CSNK2A2;CSNK2A1;SET;ERN2;AIFM1;CSNK2B;MCPH1;PLK1;ACIN1;NCAPD3;CHMP1A
prerank,monosaccharide transmembrane transport (GO:0015749),0.3007863208523501,0.7288594969358977,0.8112874779541446,0.9358805072673306,1.0,6/16,20.08%,SLC2A2;SLC23A1;SLC23A2;SLC2A12;SLC5A3;SLC2A6
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.32391681315353604,-0.7287916560241712,0.8268398268398268,0.9766769187570709,1.0,3/10,16.53%,LPGAT1;ABCD2;SLC45A3
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.3117134183062383,-0.7286703681700863,0.8290598290598291,0.9759688165260393,1.0,3/10,14.42%,PAF1;HSF1;NCBP1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.26285378637756546,0.7266905183636752,0.8140293637846656,0.9383989880872129,1.0,10/31,22.88%,KMT5B;RBP4;GPI;SHLD3;XBP1;IL6;HMCES;SHLD2;PTPRC;TFRC
prerank,positive regulation of viral transcription (GO:0050434),0.27448382680499295,0.7264072414616699,0.8318890814558059,0.9383511359628182,1.0,7/25,20.13%,MDFIC;NELFA;POLR2B;POLR2D;POLR2F;NELFE;CTDP1
prerank,embryonic organ morphogenesis (GO:0048562),0.24604488864858493,0.7263553908835885,0.8341013824884793,0.9380045860229294,1.0,3/42,5.33%,RARG;ALX1;PDGFRA
prerank,protein-DNA complex disassembly (GO:0032986),-0.2761380841844876,-0.7262091336234754,0.8471910112359551,0.978132157621119,1.0,3/16,4.52%,SMARCB1;SMARCC2;SMARCE1
prerank,endoderm formation (GO:0001706),0.25266867477362964,0.7260995624306447,0.8703403565640194,0.9379275755491868,1.0,3/35,7.52%,ITGA4;DUSP1;DUSP2
prerank,nucleotide metabolic process (GO:0009117),0.28029568061995835,0.7259755932622192,0.8131313131313131,0.9376758838312517,1.0,8/23,21.87%,REXO2;CMPK1;NMNAT3;NMNAT2;AK8;AK4;ME1;RNASEH2B
prerank,renal filtration (GO:0097205),0.3379966323962521,0.7255446170322236,0.7923387096774194,0.937818031932241,1.0,3/10,10.51%,XPNPEP3;SULF2;MYO1E
prerank,reticulophagy (GO:0061709),-0.29177109147972485,-0.7250560665414534,0.8165137614678899,0.9786342972494866,1.0,2/12,4.97%,RETREG1;ATG2A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.2902085395298267,-0.7249642899363944,0.8347639484978541,0.9779006136266973,1.0,5/12,29.42%,SKP1;UBE2S;GOLGA2;GORASP1;BTRC
prerank,mitochondrial translational elongation (GO:0070125),0.22022695896956646,0.7248098815008198,0.9181034482758621,0.9383736894839076,1.0,14/88,14.23%,MRPL23;MRPS12;ERAL1;MRPL13;MRPL33;MRPS25;MRPS11;MRPL1;MRPL49;MRPL16;MRPS17;MRPL44;MRPS34;MRPS14
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.33812948297458356,0.7247214040517613,0.7964774951076321,0.9376420720530448,1.0,3/11,13.73%,RBM4;TRIM71;TNRC6C
prerank,miRNA mediated inhibition of translation (GO:0035278),0.33812948297458356,0.7247214040517613,0.7964774951076321,0.9376420720530448,1.0,3/11,13.73%,RBM4;TRIM71;TNRC6C
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.32542600309417624,0.723614819269398,0.7835420393559929,0.9387138905008091,1.0,3/11,10.54%,FOXM1;RPS6KA6;SP100
prerank,platelet aggregation (GO:0070527),0.2631095579516494,0.7235502882430602,0.8401898734177216,0.9383713027496448,1.0,5/33,8.74%,RAP2B;PDGFRA;ACTB;HSPB1;VCL
prerank,retinol metabolic process (GO:0042572),0.3089408238685508,0.7232566003140066,0.7992700729927007,0.9383227179361889,1.0,2/14,14.37%,DHRS3;RBP4
prerank,DNA-dependent DNA replication (GO:0006261),0.20925857904745232,0.7229712782465493,0.9322250639386189,0.9382981606707592,1.0,25/128,17.34%,PSMA7;RPS27A;ORC5;MCMBP;ORC2;POLE2;PRIM2;TOPBP1;PSMB2;RPA1;GMNN;PURA;POLG2;POLE3;PSMA6;RPA3;MGME1;PSMA3;PSMD1;PSMD5;POLE4;MCM8;GINS2;PRIM1;RFC3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2683478641212272,0.7218713253027997,0.8368336025848142,0.9393178990520289,1.0,11/29,22.11%,DCP1A;DDX6;DCP2;EXOSC8;LSM4;LSM2;EXOSC1;HBS1L;CNOT8;PATL1;EXOSC3
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2514451606426345,0.7216951685386017,0.8657616892911011,0.9391314107849673,1.0,8/39,15.48%,FXYD2;RIPK1;UTRN;HOMER1;YWHAE;SCN3B;NEDD4L;FXYD5
prerank,carbohydrate transport (GO:0008643),0.32535800242040813,0.7214445704101029,0.8060836501901141,0.9390375433104154,1.0,3/11,14.45%,SLC2A2;SLC23A1;SLC23A2
prerank,cellular response to superoxide (GO:0071451),0.33571174220030997,0.7213038795294094,0.792910447761194,0.938797240763627,1.0,2/10,17.04%,ATP7A;PRDX2
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.19779891507063446,-0.7210960267204154,0.9662576687116564,0.9816144689895263,1.0,22/65,28.72%,KCND2;TP53;HYOU1;CPEB2;PGK1;SIRT2;MDM4;EGLN2;TSC1;ADAM8;NDNF;NPEPPS;MTOR;STUB1;EPAS1;HIF1A;UBQLN1;PTGIS;CPEB1;SLC8A3;PMAIP1;OPRD1
prerank,fatty acid oxidation (GO:0019395),0.2375130840324764,0.720500026147821,0.8777292576419214,0.9394382675901234,1.0,8/57,14.67%,ALOX15;SLC25A17;EHHADH;ADIPOR2;HADH;HADHA;HADHB;ACAT1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.28662259809122403,-0.7201880233328816,0.8494623655913979,0.9817900333295706,1.0,3/13,22.86%,MAPT;UBB;HIF1A
prerank,mRNA modification (GO:0016556),0.2797615302202134,0.7201458335671908,0.8144329896907216,0.9394668572575535,1.0,8/22,23.11%,WTAP;NSUN2;VIRMA;TRMT61B;PUS7;TRMT61A;METTL16;PCIF1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.28980732153422295,0.7190848644482537,0.8109965635738832,0.940431694819059,1.0,7/18,17.88%,TNF;SP1;ROCK2;RELA;IFNGR1;PICALM;EFNA1
prerank,regulation of exit from mitosis (GO:0007096),-0.21973612238366302,-0.7190384981465898,0.9060773480662984,0.9823027628411556,1.0,11/38,20.45%,ANAPC15;SIRT2;ANAPC11;UBE2S;BUB1B;CDC14A;UBE2E1;UBE2D1;UBB;ANAPC5;ZW10
prerank,JNK cascade (GO:0007254),0.24498402563615573,0.7182073117738608,0.8667711598746082,0.9411327895019636,1.0,7/40,13.05%,MAP3K5;RPS27A;RIPK2;PTGER4;MAP3K11;NOD2;UBE2N
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.22668502346548156,0.7181738921777528,0.8969072164948454,0.9407583174137292,1.0,9/70,14.43%,KMT2A;PSMA7;TCF12;CBFB;PSMB2;PSMA6;PSMA3;PSMD1;PSMD5
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.2865831276289356,0.7181514408810801,0.8186440677966101,0.9403669883054936,1.0,6/18,19.61%,VPS4B;RCC2;RAB11A;RAD51B;BRD4;MECP2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.27454348919458543,0.7180899455479794,0.8378839590443686,0.9400328101133213,1.0,6/25,22.28%,B2M;NOD2;SCIMP;TRAF6;PLCG2;KIT
prerank,purine-containing compound biosynthetic process (GO:0072522),0.26829330845964444,0.717738142956984,0.8235294117647058,0.9400715545510279,1.0,8/25,21.17%,ADK;AMPD3;SHMT1;GMPS;PRPS1L1;PRPS1;HPRT1;PAICS
prerank,ATP synthesis coupled proton transport (GO:0015986),0.2939992894645614,0.7174324595845094,0.8159203980099502,0.9400415909348812,1.0,5/17,18.62%,ATP5PO;ATP5MC2;ATP5F1E;ATP5MC1;ATP5MF
prerank,membrane fusion (GO:0061025),0.2545179968318317,0.717110454647178,0.8367670364500792,0.9400393018604897,1.0,12/33,22.33%,DCSTAMP;MYOF;RABEP1;SNAP23;VAPA;RABIF;UBXN2B;USO1;SNAP29;DNM1L;STX11;DYSF
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2495019406021486,-0.7166616252065011,0.8786407766990292,0.9841120289165808,1.0,6/21,25.17%,LPIN2;FAH;FAAH;HOGA1;AGXT;ACOT8
prerank,regulation of protein localization to cell periphery (GO:1904375),0.29218735948935165,0.7166458957863843,0.8431734317343174,0.9402094985938676,1.0,3/18,8.48%,SPTBN1;ACTB;STX7
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.30328492688532194,-0.7165439297999486,0.8114406779661016,0.9833915120448931,1.0,2/11,8.56%,MAVS;CAMK4
prerank,negative regulation of neurogenesis (GO:0050768),0.25828529847686016,0.7164493396453764,0.8517350157728707,0.9400213944808353,1.0,6/34,9.91%,RHOA;RAPGEF2;B2M;TNF;ARHGDIA;RTN4
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.2910602207633735,-0.7162811666412211,0.8546637744034707,0.9828126281561678,1.0,4/12,26.08%,APOC1;LPCAT3;APOC4;MTTP
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.3100542598019466,-0.7160699323004258,0.8482905982905983,0.9821867124324715,1.0,7/10,37.23%,PRKCE;SLC45A3;IRS1;PMAIP1;AKT1;GPLD1;PTH1R
prerank,steroid hormone biosynthetic process (GO:0120178),-0.23099149121824897,-0.7160354089709079,0.8854961832061069,0.9813714356250054,1.0,16/29,43.60%,STARD3;AKR1B1;FDX1;SRD5A3;STAR;HSD17B2;HSD17B1;HSD17B11;TSPOAP1;HSD17B8;SRD5A2;FDXR;MED1;HSD3B2;HSD17B14;FDX2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.3186743346103442,0.7158505581174992,0.7872340425531915,0.9403756792006136,1.0,5/11,20.95%,ATRX;H3-3A;HAT1;ASF1A;IPO4
prerank,histone acetylation (GO:0016573),0.22951119776334092,0.7154249035311312,0.8901569186875892,0.9405150454964898,1.0,18/69,19.67%,PHF20;SPI1;EPC1;DMAP1;BEND3;TRIM16;POLE3;CREBBP;HAT1;KAT7;EP300;KAT6A;PER1;TAF12;SGF29;ATF2;PHF20L1;JADE3
prerank,regulation of protein targeting to membrane (GO:0090313),0.26599410238091836,0.7149258561157642,0.8469055374592834,0.9407223025251701,1.0,7/28,19.24%,ITGB1BP1;FYN;MYO1C;KCNB1;ITGB2;MFF;INPP5K
prerank,peptidyl-proline modification (GO:0018208),-0.23441800658145115,-0.7145875139317515,0.8794871794871795,0.9821564505510787,1.0,13/25,38.62%,P3H2;PPIL3;PPIE;OGFOD1;FKBP7;FKBP4;PIN1;PPIL6;PPIC;FKBP10;PPIL1;PPIG;PPWD1
prerank,glycogen catabolic process (GO:0005980),-0.2729027581070362,-0.7125249976380684,0.8604118993135011,0.9836202065805641,1.0,9/15,33.17%,PHKB;GAA;PYGL;PHKA2;PGM2;PYGB;AGL;PHKG1;PYGM
prerank,activation of adenylate cyclase activity (GO:0007190),0.253163355291212,0.7122649965617034,0.8822605965463108,0.9436615891602544,1.0,5/35,10.30%,ADRB2;DRD1;ADCY9;ACR;TSHR
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.21571578140452458,-0.7119840342738584,0.9343283582089552,0.9833532838623387,1.0,6/40,11.25%,TP53;BCL2L11;MLLT11;BMF;TNFSF10;FXN
prerank,protein tetramerization (GO:0051262),-0.19118133700882772,-0.7116071124012822,0.9651567944250871,0.9829224940583773,1.0,5/67,4.43%,CPSF6;KCNJ2;FARSA;ACACA;ALDOA
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.31313853516109286,-0.7115179260006108,0.8524945770065075,0.9821663881689117,1.0,4/10,23.12%,CCT7;CCT2;WRAP53;CCT8
prerank,nucleocytoplasmic transport (GO:0006913),0.24759853372737675,0.7115079549613401,0.8810975609756098,0.9441618909676662,1.0,13/40,22.30%,ATXN1;HTATIP2;SNRPG;RSRC1;GEMIN7;NUP98;XPO1;RGS14;LSG1;SNRPE;SNRPD2;RBM15B;NPM1
prerank,aminoglycan metabolic process (GO:0006022),-0.2969724618903323,-0.7112775407610383,0.826530612244898,0.9815648573152641,1.0,4/10,22.91%,XYLT1;B4GALT7;B3GALT6;B3GAT1
prerank,regulation of lipase activity (GO:0060191),-0.2871027897587094,-0.710759306809053,0.8159645232815964,0.9812929458619519,1.0,4/13,18.04%,LPL;LMF1;FURIN;ANGPTL3
prerank,import into nucleus (GO:0051170),-0.1876895763452054,-0.7106758170821588,0.9736842105263158,0.980532526401436,1.0,36/73,36.58%,IPO5;GEMIN2;BACH2;APPL1;RANBP17;DDX20;NUP85;IPO13;RPAIN;IPO8;HNRNPA1;NXT1;SEC13;PPP1R10;TNPO2;E2F3;CSE1L;TSC2;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;NUP214;SNUPN;EIF4ENIF1;NUP88;SNRPF;SNRPD3;GEMIN6;RAN;GEMIN5;SPRN;FAM53C
prerank,telomere maintenance via recombination (GO:0000722),0.3244936157041307,0.709919772614603,0.819047619047619,0.945725733785338,1.0,5/11,24.60%,NSMCE2;SMC6;XRCC3;RAD51D;ERCC1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2662661295102871,-0.7094679590506657,0.8540772532188842,0.9810432068731741,1.0,10/16,39.46%,DNA2;HUS1;RAD9A;TICRR;CDT1;ORC1;RAD17;TIMELESS;CDC45;NAE1
prerank,glycoprotein catabolic process (GO:0006516),0.2893193638726609,0.7090386323390855,0.8241379310344827,0.9463884753010557,1.0,3/17,11.33%,MANBA;ADAMTS9;NGLY1
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.2341355857531236,-0.7089378114670792,0.9002433090024331,0.9808000815307896,1.0,6/27,14.66%,MORF4L2;BAG6;MRGBP;BRD8;MORF4L1;RUVBL1
prerank,protein N-linked glycosylation (GO:0006487),0.2248396474857368,0.7086745111916026,0.9041487839771102,0.9464080582938107,1.0,13/66,15.21%,ST6GAL1;ST3GAL1;MGAT2;GFPT2;ALG9;TMEM165;ALG5;DOLPP1;ASGR2;PMM1;UGGT1;RPN2;MCFD2
prerank,mitochondrial membrane organization (GO:0007006),0.25350349892245355,0.7078275346506322,0.8806451612903226,0.9470034988150894,1.0,8/32,18.52%,APOOL;BCL2;CHCHD3;SLC25A5;MTX1;BNIP3;TMEM11;SLC25A4
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.27192355731821805,-0.7078039851307675,0.852112676056338,0.9812337315048499,1.0,1/14,0.92%,ACOX3
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.22680403998664767,0.7072876930662741,0.9109792284866469,0.9472712470920647,1.0,3/61,2.03%,PRKAG2;PSMA7;NR1H4
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2271210761004056,0.707058556942664,0.8946608946608947,0.947133538397478,1.0,11/66,13.82%,CHP2;LARP7;NMD3;DMAP1;BAG3;PSEN1;CCT6A;JUP;LAMTOR5;ZC3H12A;KAT7
prerank,tRNA 5'-end processing (GO:0099116),-0.2666804200456946,-0.7069804684327166,0.8373205741626795,0.9812682189230783,1.0,6/15,24.67%,RPP14;POP1;RPP21;HSD17B10;PRORP;POP7
prerank,tRNA wobble base modification (GO:0002097),0.30168196876714964,0.7065356017778196,0.8309090909090909,0.9473488814868655,1.0,4/14,13.88%,URM1;DPH3;ELP4;CTU1
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.26536312991016536,-0.706514156755542,0.8590909090909091,0.9809459142216636,1.0,7/16,36.80%,RMI1;TOP2A;CENPX;SLX4;EME1;ERCC4;CENPS
prerank,negative regulation of ion transport (GO:0043271),0.27327791296685433,0.7062283513181412,0.841025641025641,0.9472983883163556,1.0,4/24,8.81%,LILRB1;WNK1;CD33;PLN
prerank,ion homeostasis (GO:0050801),-0.22474196438528035,-0.7056190757921403,0.9232736572890026,0.9810379547369267,1.0,12/30,29.97%,SLC4A10;AP3D1;WNK3;SLC4A2;SLC4A3;CAMK2D;UNC80;SLC12A5;KLHL3;HCN4;SLC30A3;FHL1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29214980056864776,0.7054503008790783,0.8223443223443223,0.9478168609229051,1.0,3/15,10.74%,RAB10;ZFAND2B;SRPRB
prerank,negative regulation of histone methylation (GO:0031061),-0.30477324440647297,-0.7054446900608721,0.8459958932238193,0.9803870313876101,1.0,5/10,20.61%,WDR5;BRCA1;DNMT1;PHF1;MTF2
prerank,peptidyl-amino acid modification (GO:0018193),0.3302830061052491,0.7053246170682923,0.7985739750445633,0.947542900954153,1.0,4/10,23.91%,ATP7A;METAP1;TTLL4;METAP2
prerank,protein localization to kinetochore (GO:0034501),-0.2794633157890034,-0.705216994716621,0.8409090909090909,0.9797899121016231,1.0,7/14,29.81%,KNL1;SPDL1;ZW10;IK;CDK1;AURKB;TTK
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.27166022816361246,0.7044505177289418,0.8388704318936877,0.9481932172441636,1.0,2/22,7.60%,ESR1;MED16
prerank,negative regulation of fat cell differentiation (GO:0045599),0.25669388867231896,0.7040982607804548,0.8659127625201939,0.9481911267327856,1.0,6/34,12.87%,ZFP36L2;TRIO;TNF;ASXL1;TRIB2;FOXO1
prerank,cellular component maintenance (GO:0043954),0.3160422166865795,0.7039737330007872,0.8067375886524822,0.9479362635061155,1.0,4/12,21.08%,INSR;FYN;IGF1R;PICK1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.29594419158135565,0.7032314894859266,0.8142076502732241,0.9484193067192075,1.0,5/15,14.85%,ZNRF3;SFRP1;SPEF1;NPHP3;GPC3
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.25109177809401184,0.7029632086607915,0.8486739469578783,0.9483151544991723,1.0,7/33,14.01%,NR3C1;SPI1;TNF;KLF4;FOXO3;STAT3;KLF5
prerank,modulation by symbiont of entry into host (GO:0052372),0.2927127205973603,0.7029139039560527,0.8153564899451554,0.9479515763493861,1.0,4/16,15.82%,TRIM68;TRIM27;EXOC2;TRIM25
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2777493776100449,-0.7025072220500729,0.8775055679287305,0.9817884079257468,1.0,5/13,31.57%,PHYH;GPT2;GOT1;ADHFE1;D2HGDH
prerank,protein destabilization (GO:0031648),0.24566299907018535,0.7023650010336008,0.8778501628664495,0.9481736271902701,1.0,7/32,14.00%,NR1D1;PRKN;CDC73;MDM2;CUL3;CREBBP;EP300
prerank,cellular response to nutrient levels (GO:0031669),0.2299271551114779,0.7019985982003608,0.9218523878437048,0.9481710794060288,1.0,17/62,18.23%,STK24;WIPI1;KLF10;FNIP1;SFRP1;LAMP2;CD68;ATG7;GAS2L1;SREBF2;KCNB1;FOXO1;RALB;MFSD2A;WIPI2;XBP1;RRAGC
prerank,digestive tract morphogenesis (GO:0048546),-0.2762564131062393,-0.7017343926978867,0.8321995464852607,0.9817818431420874,1.0,4/14,20.57%,FGFR2;BBS7;ID2;SOX11
prerank,GPI anchor metabolic process (GO:0006505),0.26355394319718217,0.7014424874632516,0.8597063621533442,0.9484182841670586,1.0,4/26,15.50%,PGAP1;PIGU;PGAP4;PIGQ
prerank,midbody abscission (GO:0061952),-0.25859518386430314,-0.701392451658672,0.8637413394919169,0.9812604605167708,1.0,9/17,34.65%,CHMP4B;CHMP4A;MITD1;CHMP6;CHMP3;CHMP4C;CHMP1B;KIF20A;CHMP2A
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.281904519884118,-0.7000454346238183,0.8915929203539823,0.9818098374882336,1.0,2/13,4.83%,IPO5;RANBP2
prerank,positive regulation of leukocyte migration (GO:0002687),0.2546979698010106,0.6997526607612689,0.8319870759289176,0.9500293436497191,1.0,6/27,17.66%,PLVAP;TNF;IL6R;MDK;MIA3;IL6
prerank,mitotic spindle assembly (GO:0090307),0.23878815474252674,0.6984876361534457,0.8816,0.9510358745569027,1.0,12/42,19.23%,PIBF1;RHOA;STAG2;CLASP1;KIF4A;STAG1;SPICE1;RAB11A;ABRAXAS2;CCDC61;KIF23;KPNB1
prerank,proteolysis (GO:0006508),0.19065671969577003,0.6984402603363498,0.9885321100917431,0.9506659412995927,1.0,38/252,17.67%,CTSC;CPQ;ADAM19;ENDOU;SRGN;XPNPEP3;FAM111A;LNPEP;CTSB;PRCP;PARL;CAPN5;HTRA3;ZMPSTE24;PITRM1;PSEN1;RNPEP;MDM2;TBL1X;ADAMTS9;ENPEP;CLPX;CASP8;PSMA6;MMP24;MMP25;ATG4C;SPPL2B;SENP1;USP25;NCSTN;FBXW2;ERAP1;SPPL2A;CUL7;SENP6;FAP;HGF
prerank,protein localization to nucleus (GO:0034504),-0.17237569616389395,-0.6977361147694165,0.9770992366412213,0.9833276274739428,1.0,37/102,30.04%,IPO5;SKP1;HNRNPU;DVL1;APPL1;RANBP17;SUPT7L;PAF1;NUP85;IPO13;RPAIN;IPO8;NOL8;ARL2BP;NXT1;INTS13;CTDNEP1;ABCA7;SEC13;BBS4;TOR1A;TAF8;PPP1R10;TNPO2;E2F3;CSE1L;TSC2;PTTG1IP;NUP93;NUP50;PHB2;NXT2;FAM53A;AKT1;BMP4;NUP214;EIF4ENIF1
prerank,transcription preinitiation complex assembly (GO:0070897),0.3091183013363652,0.697032556576431,0.8281535648994516,0.95190838764488,1.0,3/12,17.19%,GTF2A2;GTF2B;TAF12
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.31019422931419105,0.6961115218161886,0.8201160541586073,0.9521345482659996,1.0,2/12,12.32%,GSK3B;ATP2B4
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.31019422931419105,0.6961115218161886,0.8201160541586073,0.9521345482659996,1.0,2/12,12.32%,GSK3B;ATP2B4
prerank,error-free translesion synthesis (GO:0070987),0.2748757971409518,0.6955037497059038,0.855917667238422,0.9523924062043667,1.0,4/22,12.35%,RPS27A;RPA1;POLH;RPA3
prerank,tyrosine metabolic process (GO:0006570),0.31701806510718994,0.6953984876528049,0.8333333333333334,0.9520888990905195,1.0,1/11,5.75%,THAP4
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3245881743715947,0.6953687139687302,0.8454545454545455,0.9517072741958795,1.0,2/10,9.79%,ATP5PO;ATP5MC2
prerank,negative regulation of growth (GO:0045926),0.2050230430221386,0.6950246829109532,0.9457671957671958,0.9516567419988872,1.0,16/121,13.10%,PTPRJ;NOTCH2;DCSTAMP;RB1;RACK1;SMAD4;BST2;ESR2;PPP2CA;RTN4;SFRP1;SERTAD2;SLIT3;ST7L;CDKN2C;GJA1
prerank,positive regulation of wound healing (GO:0090303),0.24914172926016895,0.6943204790591426,0.8672699849170438,0.9520086170830888,1.0,4/36,10.53%,RREB1;ITGB1;FOXC2;ENPP4
prerank,regulation of oxidoreductase activity (GO:0051341),0.30594818990635064,0.6940170343715882,0.8467289719626169,0.951923778443633,1.0,3/13,14.70%,ATP7A;NOD2;SZT2
prerank,protein methylation (GO:0006479),-0.20277924462611913,-0.6933367161477515,0.9731343283582089,0.9869864883140902,1.0,18/40,37.85%,EHMT2;SETD3;PRMT2;METTL22;CARM1;FAM98B;FAM98A;EEF2KMT;LCMT1;PCMT1;EZH2;RAB6A;PRMT8;EEF1AKMT2;SNRPD3;METTL21A;PRMT7;CAMKMT
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2652303510053666,-0.6932754862809043,0.8723897911832946,0.98619679754377,1.0,6/16,32.80%,PIGL;PIGH;PIGB;DPM2;PIGV;PIGC
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2794467183418593,0.6926892140066557,0.8466898954703833,0.9529855405412033,1.0,5/18,15.18%,TRIM32;CDC73;SFRP1;FTH1;MYC
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.27695417103671277,0.6924854526649891,0.8361204013377926,0.9527870105372375,1.0,10/20,26.46%,MOV10L1;LIMD1;HELZ;TNRC6C;CNOT1;CNOT8;AGO3;AJUBA;CELF1;AGO2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.28440283619185575,0.6916434698440823,0.8471223021582733,0.9533404768442519,1.0,5/17,16.96%,NR3C1;ATP1A3;ATP1A1;TFPI;ACOD1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.3185315875957049,0.6913904740513033,0.829981718464351,0.9532018601542108,1.0,4/10,23.43%,MTHFD2L;SHMT1;MTHFD1L;MTHFS
prerank,translesion synthesis (GO:0019985),-0.2044455634451215,-0.6909840963730844,0.9215686274509803,0.9876174698462475,1.0,17/42,27.23%,PRIMPOL;PARP10;UFD1;RFC2;NPLOC4;POLI;RCHY1;REV3L;UBB;RFC1;POLN;PCLAF;DTL;POLD4;USP10;SPRTN;FAAP20
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.2907738202149361,0.6909274940641357,0.8450946643717728,0.953285533681423,1.0,2/15,9.90%,PRKN;IGF1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.300399270097488,0.6896299802701654,0.8380952380952381,0.9543079137793513,1.0,2/14,11.42%,IRS2;ARPP19
prerank,indolalkylamine catabolic process (GO:0046218),-0.2968849689728929,-0.6892748584963952,0.8518518518518519,0.9884394215631479,1.0,4/10,35.78%,KYNU;IL4I1;IDO2;HAAO
prerank,liver development (GO:0001889),-0.21876824025128452,-0.6891265539284153,0.9166666666666666,0.9877481695486542,1.0,10/32,22.14%,NF1;TGFBR3;CCDC39;PCK2;PROX1;CDK5RAP3;WNT4;PHF2;ARID5B;CCDC40
prerank,natural killer cell activation (GO:0030101),-0.2383195341505971,-0.6878912298051703,0.8849765258215962,0.9880633399165485,1.0,7/23,20.81%,IL21R;AXL;BAG6;RABL3;PBX1;RASGRP1;ULBP1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.25718321370496483,0.6868606180209378,0.8695652173913043,0.9569537893630016,1.0,8/27,20.17%,RGCC;SMG6;NIBAN2;PRKD2;MYC;PINX1;HGF;ACVRL1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3013949367788923,0.6866837902035163,0.8302919708029197,0.9567372306525828,1.0,3/12,12.26%,C1QTNF12;GKAP1;SNX5
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.28349336861972196,0.6866187974583856,0.8491228070175438,0.9563873254280146,1.0,1/17,2.01%,MEF2C
prerank,multivesicular body assembly (GO:0036258),-0.21670548527264955,-0.6862029362103171,0.9280205655526992,0.9887838105655092,1.0,4/30,9.42%,SNF8;CHMP4B;CHMP4A;VPS37A
prerank,protein import into nucleus (GO:0006606),0.21583703632929999,0.6860411551600606,0.9326647564469914,0.9565912363100222,1.0,10/66,14.28%,RPL23;PRICKLE1;KPNA4;SYK;IPO11;NUP133;NUP62;CBLB;STAT3;KPNA2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.27685568341736644,0.6855819234809912,0.8598290598290599,0.9566918727646911,1.0,4/20,14.25%,BCL2;PSEN1;WFS1;ATP2A2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.3079530467563911,0.6855399869765105,0.8355387523629489,0.9563121356013038,1.0,4/10,21.08%,DGKH;F2R;DGKD;PICK1
prerank,amino acid transport (GO:0006865),0.23392658117523774,0.6846203830468656,0.9165424739195231,0.9568448749117547,1.0,8/49,17.60%,SLC16A10;SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,adipose tissue development (GO:0060612),-0.29045013432748457,-0.6845240756524664,0.8617710583153347,0.9895234437721722,1.0,5/11,24.82%,LRP5;DYRK1B;ARID5B;DGAT2;SOX8
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.2874219851373375,0.6826211970497547,0.8625,0.9586098971888289,1.0,5/14,22.88%,KMT5B;SHLD3;HMCES;SHLD2;TFRC
prerank,mismatch repair (GO:0006298),0.26166095100364933,0.6825009510413836,0.8705501618122977,0.9583141104900531,1.0,10/27,24.60%,MCM9;RPA1;RPA3;MUTYH;XPC;POLD2;PCNA;MLH1;RNASEH2A;ERCC1
prerank,response to progesterone (GO:0032570),-0.25297752736346685,-0.6819340289593916,0.9051918735891648,0.9910909760244044,1.0,8/18,34.97%,SRC;WBP2;TGFB2;TGFB1;CATSPERD;ABHD2;UBE3A;TGFB3
prerank,cellular response to increased oxygen levels (GO:0036295),0.3071950346910672,0.6813087208238694,0.8277777777777777,0.9591250398101153,1.0,7/11,25.85%,ATP6V1A;ATG7;FOXO1;ATP6V0D1;CAV1;CCDC115;FAS
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.26429248751887024,0.6810453099690297,0.8827708703374778,0.9589930659162873,1.0,7/23,18.84%,PIAS1;PARP14;JAK1;NR1H2;HSP90AB1;IFNGR1;SUMO1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.28952548429575986,-0.6809878368063979,0.8650442477876106,0.9911097550030307,1.0,2/11,10.70%,SMAD7;JAK3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3009921277528971,0.6809850255281832,0.8415300546448088,0.9586458744908517,1.0,4/12,19.36%,ATP7A;TRH;HNMT;OAZ2
prerank,positive regulation of translational initiation (GO:0045948),-0.25317098996456033,-0.6807985468069147,0.9111111111111111,0.9904385854988994,1.0,7/18,27.94%,HABP4;MTOR;RPS6KB2;EIF2B5;BOLL;RPS6KB1;LARP1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.25702633559475396,-0.680520198586735,0.8992974238875878,0.9898618692492738,1.0,10/18,36.82%,TECR;ACSL4;ACSL6;ACSBG1;ELOVL1;ACSF3;ELOVL7;HACD2;ELOVL6;ELOVL2
prerank,regulation of defense response to virus (GO:0050688),-0.2654490249299115,-0.6804822382200367,0.8824786324786325,0.989053037994761,1.0,8/14,31.79%,RNF216;C1QBP;ITCH;PCBP2;DHX9;ILRUN;IFNLR1;TRAF3IP1
prerank,mitotic metaphase plate congression (GO:0007080),-0.18985270895222794,-0.6803865779837082,0.9532163742690059,0.9883034233001511,1.0,22/51,31.91%,EML3;CENPC;CHMP4B;CHMP4A;CENPE;SEH1L;SPDL1;NDC80;CDCA8;KIFC1;CHMP6;DCTN2;ZW10;CHMP3;KIF14;CHMP4C;CDT1;KIF2C;CHMP1B;NUDC;NUF2;BOD1
prerank,protein lipidation (GO:0006497),0.22068536518143245,0.6800347750659497,0.9175108538350217,0.9592473368210375,1.0,12/59,16.21%,ZDHHC14;WIPI1;PIGU;ZDHHC3;ATG7;ATG10;PGAP4;ZDHHC20;PIGQ;WIPI2;ZDHHC2;ATG5
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.2901552932582486,-0.6799262494575893,0.8655804480651731,0.9878823538228315,1.0,2/10,19.69%,DDIT3;ATF4
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.2751457701334704,0.6793857291612564,0.8669064748201439,0.9595248617670955,1.0,3/18,11.25%,PTPN22;WNK1;ASS1
prerank,regulation of glycogen metabolic process (GO:0070873),0.30102296913076,0.6790984483648083,0.8659420289855072,0.959400375080219,1.0,4/12,19.24%,PPP1R3C;PPP1R3D;PPP1R3B;INPP5K
prerank,DNA strand elongation (GO:0022616),-0.25365481024218706,-0.6789312311058667,0.8955223880597015,0.9879727479368197,1.0,6/18,26.87%,MCM3;GINS3;DCLRE1B;RAD50;MCM7;MCMDC2
prerank,peptide metabolic process (GO:0006518),0.21554924773129064,0.6788935401725158,0.9340659340659341,0.9591938201139263,1.0,7/75,11.34%,CPQ;CLN5;LNPEP;PARL;PSEN1;ENPEP;ETHE1
prerank,O-glycan processing (GO:0016266),0.22475204735834964,0.6782578238185917,0.9300595238095238,0.95943063283663,1.0,3/54,3.83%,ST6GAL1;ST3GAL1;C1GALT1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.23335300653649826,-0.677514601660702,0.9271356783919598,0.9884144442515249,1.0,5/24,23.77%,LPCAT1;LPGAT1;CDS2;PLA2G3;SLC27A1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.27719842890520424,0.6773260130815815,0.8613013698630136,0.9600016907628866,1.0,6/18,22.93%,ATP7A;TNF;NOD2;GDNF;SIRT3;POR
prerank,regulation of cilium movement (GO:0003352),-0.29602233887180107,-0.6768610894557789,0.8807947019867549,0.9881575712909112,1.0,5/10,27.76%,CCDC39;CFAP298;ODAD2;CCDC40;CFAP43
prerank,photoperiodism (GO:0009648),0.2563203792338701,0.6767722825660151,0.88379705400982,0.9601401137657272,1.0,4/28,11.02%,FBXL17;CLOCK;RBM4;PPP1CA
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.25456798404309805,0.6767196939605455,0.8630849220103987,0.9597778708606873,1.0,1/24,1.36%,GAS6
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.28848742141123057,-0.675958753016154,0.8789144050104384,0.9881517472774437,1.0,5/10,29.48%,GABRA2;GABRG2;GABRA4;GABRG3;GABRE
prerank,positive regulation of protein sumoylation (GO:0033235),0.31382135221281915,0.67556005972185,0.8326996197718631,0.9605435354406712,1.0,1/10,2.33%,PIAS1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.30538447475485053,0.6754316881636272,0.8512241054613936,0.9602490393367359,1.0,1/11,2.25%,RASA1
prerank,histone ubiquitination (GO:0016574),0.2714067553970194,0.6752143863823535,0.8477508650519031,0.9600367255267671,1.0,8/21,22.87%,WAC;CDC73;UBE2N;USP22;UBE2U;UBE2A;ATXN7L3;RNF40
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2699766465904309,0.6748239319661133,0.858603066439523,0.9599851407000043,1.0,12/20,27.78%,LATS2;HEXIM2;PTEN;NR2F2;CDKN1C;INCA1;CDKN1B;CEBPA;HEXIM1;PLK1;APC;HHEX
prerank,mammary gland development (GO:0030879),-0.23481334010114557,-0.6746363858484785,0.9021479713603818,0.988468096151584,1.0,4/21,18.94%,JAK2;ERBB4;WNT4;NOTCH4
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.23172300171690055,0.6743287745079638,0.8918083462132921,0.960082052256605,1.0,9/40,16.18%,FAM111A;MCM9;DDX11;TIPIN;ATRX;ZRANB3;MMS22L;FBH1;ATR
prerank,positive regulation of stem cell proliferation (GO:2000648),0.28196567389594046,0.6740149663905887,0.8444444444444444,0.9599643882821564,1.0,6/17,21.39%,THPO;GJA1;KAT7;KDM1A;N4BP2L2;PTPRC
prerank,RNA biosynthetic process (GO:0032774),0.24396013646034614,0.6734872519880328,0.9042386185243328,0.9600755491571316,1.0,6/31,17.19%,TCEA2;PRIM2;NCOA6;GTF2B;PRIM1;TAF12
prerank,mesenchyme morphogenesis (GO:0072132),-0.24279073780423582,-0.6734145970509937,0.891647855530474,0.9887017594559536,1.0,5/17,19.40%,ACVR1;MDM4;NOTCH1;ENG;TGFB2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.2615229941052122,0.6732139778010412,0.892436974789916,0.9599224257987635,1.0,8/21,23.58%,VPS4B;RCC2;RAB11A;RAD51B;BRD4;MECP2;NPM1;CCND1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.27370933299836714,0.6723725052322884,0.8705281090289608,0.9603442115393402,1.0,19/19,72.66%,HYKK;PHYKPL;OGDH;DDO;GOT2;AADAT;SDSL;MAT1A;DLST;ASPA;CRYM;DLD;SDS;AASS;PIPOX;SLC25A21;ALDH7A1;GOT1;GCDH
prerank,protein K48-linked deubiquitination (GO:0071108),-0.23296883588135792,-0.6721518355574229,0.9166666666666666,0.9889596553710828,1.0,15/23,40.53%,OTUD5;USP50;OTUB1;USP34;USP5;USP33;YOD1;USP8;OTUD3;OTUD7B;OTUD7A;BAP1;OTUB2;OTUD4;TNFAIP3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.30002981519045996,0.671959607147948,0.868421052631579,0.960379383766003,1.0,5/13,26.65%,SULT1A1;SULT6B1;ENPP1;SULT4A1;BPNT1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.30593413658238444,0.6702934790496349,0.86,0.9616073700118848,1.0,4/11,17.84%,LEPROTL1;SNX33;NEDD4L;PICALM
prerank,sensory perception of mechanical stimulus (GO:0050954),0.20548892393572338,0.6694614007814691,0.9537166900420757,0.9620329558543189,1.0,9/85,11.86%,RIPOR2;CCDC50;ATP6V1B1;GSDME;GRAP;MYO7A;TBL1X;WFS1;KCNQ1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.2753848659825957,0.6665952872925459,0.8546409807355516,0.9643505177684758,1.0,2/18,9.90%,RPS3;IGF1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.24554365039218778,0.6665120370301741,0.8855721393034826,0.964025038916568,1.0,3/30,5.38%,SMURF2;SMAD4;TRIM33
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.27158201497029905,-0.6664714486567681,0.8823529411764706,0.9928190892702463,1.0,2/12,8.69%,PIK3CB;CADM4
prerank,regulation of protein localization to centrosome (GO:1904779),0.3160474569845459,0.6657168579465198,0.8589211618257261,0.9643946982476528,1.0,2/10,10.44%,GSK3B;NUP62
prerank,autophagosome assembly (GO:0000045),0.22301502912846227,0.6654111725407595,0.920749279538905,0.9642789068164483,1.0,22/52,26.17%,WIPI1;ULK2;RAB7A;RAB1A;RAB23;ATG7;ATP2A2;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;ATG3;UBXN2B;PIK3C3;MAP1LC3B;RAB19;TP53INP2;ATG16L2;TMEM41B;BECN1;VMP1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.2867457776103472,0.6653990532943738,0.8616236162361623,0.9638779655909284,1.0,14/14,71.35%,ENPEP;CORIN;NOS3;EDN1;AGTR1;AVPR1A;EDN2;EDN3;OXTR;ACE2;ACE;AVPR2;RASL10B;ECE1
prerank,primary miRNA processing (GO:0031053),0.3103894937662168,0.665327402777804,0.8317399617590823,0.963530715410716,1.0,4/10,19.15%,DROSHA;MRPL44;DGCR8;SMAD1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3129942169076654,0.665123262833228,0.8468992248062015,0.963317072116062,1.0,4/10,19.75%,DCLRE1C;TERF2IP;APEX1;RTEL1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.18939290943759676,-0.6649389581525255,0.9744318181818182,0.9932593407970013,1.0,11/50,18.14%,AZIN1;PSMD13;PSMD12;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.27497209402795914,-0.6646280611892184,0.8849206349206349,0.9926679359093847,1.0,2/11,23.51%,RTP4;PKD1L3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2925590603797717,0.6641608893615487,0.8712522045855379,0.9638103030483025,1.0,1/13,2.82%,RTL10
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.2680181203665586,0.6639331521006333,0.8888888888888888,0.96361187972453,1.0,2/18,7.44%,TNFRSF1B;CXCR4
prerank,regulation of catabolic process (GO:0009894),0.2707244683987963,0.663921007705228,0.8881118881118881,0.9632093306113375,1.0,5/18,17.50%,ITGB1;MDM2;NEDD4L;ZDHHC2;FAP
prerank,cellular senescence (GO:0090398),-0.21881067946592303,-0.6634705906060789,0.9325,0.9927818263637416,1.0,6/27,18.15%,PRKCD;TERF2;HRAS;ID2;SRF;ULK3
prerank,regulation of mitochondrial translation (GO:0070129),-0.2313095467800011,-0.6621721594454968,0.9077669902912622,0.9929995601528974,1.0,10/21,34.50%,RMND1;MTG2;C1QBP;FASTKD3;MTG1;ALKBH1;COA3;SHMT2;UQCC2;TRUB2
prerank,glial cell differentiation (GO:0010001),0.24742924063384736,0.6611676368113123,0.8988391376451078,0.9653769412986714,1.0,4/28,13.90%,ADGRG6;METRN;MMP24;STAT3
prerank,histone monoubiquitination (GO:0010390),0.2548004953777278,0.6604887981712783,0.8733552631578947,0.9655817562472908,1.0,3/24,8.11%,RYBP;WAC;CDC73
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2302050811776751,0.6583304788247283,0.9279141104294478,0.9671678622489027,1.0,11/41,21.55%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;NUP153;ZBTB7A;SLC2A6;NUP35;RAE1
prerank,regulation of telomere maintenance (GO:0032204),-0.21527282659394603,-0.6581520765487217,0.9505208333333334,0.9953248257229556,1.0,4/26,12.35%,XRCC5;HDAC8;UPF1;TERF2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.25532715295348746,0.6568295416128731,0.9017857142857143,0.9677174457631567,1.0,5/22,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.25532715295348746,0.6568295416128731,0.9017857142857143,0.9677174457631567,1.0,5/22,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,eye morphogenesis (GO:0048592),0.2615003704971183,0.6561834845048965,0.8644939965694682,0.967851763178847,1.0,3/19,13.90%,RARG;NKD1;STAT3
prerank,protein alkylation (GO:0008213),-0.22504196302939536,-0.6552050197847146,0.9262899262899262,0.9967329789222206,1.0,13/22,39.85%,PRMT2;METTL22;FAM98B;FAM98A;EEF2KMT;LCMT1;PCMT1;PRMT8;EEF1AKMT2;SNRPD3;METTL21A;CAMKMT;SNRPB
prerank,neurotransmitter biosynthetic process (GO:0042136),0.2820596653726513,0.6535899277144733,0.8939929328621908,0.9697577891806333,1.0,2/14,10.91%,MOXD1;ACHE
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.19854602207921396,0.6535740902997317,0.9713467048710601,0.9693567339061688,1.0,30/94,25.22%,PSMA7;IRAK3;RPS27A;PELI1;MAP3K8;PSMB2;RIPK2;PSMA6;MAP3K3;NOD2;UBE2N;PSMA3;PSMD1;PSMD5;TAB3;RELA;TRAF6;IRAK4;TOLLIP;PSMD2;PSMD11;PSMB9;NFKB1;IL1R1;PSMB4;UBC;PSMD10;MYD88;PSME4;FBXW11
prerank,apoptotic nuclear changes (GO:0030262),0.24984403329896498,0.6530996297110938,0.9098360655737705,0.9693827066130067,1.0,1/24,1.51%,ENDOG
prerank,regulation of lipid kinase activity (GO:0043550),-0.2777216887501588,-0.6529853651817857,0.906054279749478,0.9976058306079808,1.0,5/11,25.54%,RBL2;PPP2R5A;EEF1A2;PIK3R2;PIK3R3
prerank,sensory perception of sound (GO:0007605),0.19992354454494476,0.6520525040810796,0.9631728045325779,0.9698927582658834,1.0,9/88,11.86%,RIPOR2;CCDC50;ATP6V1B1;GSDME;GRAP;MYO7A;TBL1X;WFS1;KCNQ1
prerank,regulation of protein neddylation (GO:2000434),-0.28323535784281145,-0.6515870197554204,0.882703777335984,0.9978091865889986,1.0,7/10,33.61%,EPAS1;COPS9;HIF1A;DCUN1D2;DCUN1D5;DCUN1D3;DCUN1D4
prerank,regulation of centrosome duplication (GO:0010824),-0.20954555820151236,-0.6501150331686968,0.9528795811518325,0.9980477238050939,1.0,4/30,8.09%,TMEM67;FBXW5;CHMP4B;CENATAC
prerank,ncRNA catabolic process (GO:0034661),0.24042331118197904,0.6500922680130187,0.9104477611940298,0.9711910442789516,1.0,5/28,12.67%,SND1;TUT4;MTREX;EXOSC8;DIS3L2
prerank,gene silencing by miRNA (GO:0035195),0.24528409525111222,0.6500764189303894,0.9176090468497576,0.9707891485243423,1.0,6/32,13.73%,PRKRA;PUM2;RBM4;LIMD1;TRIM71;TNRC6C
prerank,regulation of histone methylation (GO:0031060),0.286539725185947,0.6499545290453539,0.8714285714285714,0.9704766221317253,1.0,1/13,4.03%,JARID2
prerank,cristae formation (GO:0042407),0.2471406216687479,0.649689029401263,0.9036918138041734,0.9702757118882744,1.0,8/27,18.62%,ATP5PO;APOOL;ATP5MC2;CHCHD3;ATP5F1E;UQCC3;ATP5MC1;ATP5MF
prerank,protein sumoylation (GO:0016925),-0.18274551182392348,-0.6494057201646732,0.9875389408099688,0.9977350203165049,1.0,18/49,29.33%,NUP210;RANBP2;BCL11A;TRIM28;NUP85;SEH1L;EGR2;AAAS;SAE1;UBA2;EYA1;PIAS4;PIAS3;NDC1;NUP93;NUP50;NUP54;NUP214
prerank,response to zinc ion (GO:0010043),0.2486352185168763,0.6491647453969652,0.9248366013071896,0.9703108055230504,1.0,2/25,6.21%,CRIP1;PAM
prerank,autophagosome organization (GO:1905037),0.21593337487217426,0.6488994261152624,0.94,0.9701110491617797,1.0,22/50,26.17%,WIPI1;ULK2;RAB7A;RAB1A;RAB23;ATG7;ATP2A2;AMBRA1;RB1CC1;WIPI2;GABARAP;ATG5;ATG3;UBXN2B;PIK3C3;MAP1LC3B;RAB19;TP53INP2;ATG16L2;TMEM41B;BECN1;VMP1
prerank,negative regulation of cell aging (GO:0090344),0.2748424181083285,0.6488157030927896,0.8828996282527881,0.9697569579957225,1.0,3/16,11.96%,CDK6;FOXM1;MAP3K3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.282811086889405,0.6486039020112048,0.8971119133574007,0.9695202506846208,1.0,3/13,12.26%,C1QTNF12;GKAP1;SNX5
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2633723196363278,0.6474183381930826,0.8848167539267016,0.9701034270957813,1.0,4/18,16.82%,CCT6A;DCP2;NOP10;CCT3
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.2810142170056227,-0.64705644298372,0.8842105263157894,0.9986166928180641,1.0,1/10,3.72%,TP53
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.255197260196556,-0.6457503281679449,0.9051724137931034,0.9987454547123219,1.0,3/14,14.42%,CPSF6;CSTF2;NCBP1
prerank,establishment of skin barrier (GO:0061436),0.27558199143204554,0.6434377254974402,0.8737373737373737,0.9726300814464187,1.0,6/15,28.30%,SFN;STMN1;UGCG;LSR;KDF1;FA2H
prerank,regulation of water loss via skin (GO:0033561),0.27558199143204554,0.6434377254974402,0.8737373737373737,0.9726300814464187,1.0,6/15,28.30%,SFN;STMN1;UGCG;LSR;KDF1;FA2H
prerank,negative regulation of locomotion (GO:0040013),0.2821021500974036,0.6420418788064134,0.8939130434782608,0.9733458120556386,1.0,1/12,3.52%,CRK
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.2379907190580508,0.6420335690111538,0.912621359223301,0.9729416971292393,1.0,2/29,2.89%,BMP2;MYH6
prerank,negative regulation of telomere maintenance (GO:0032205),0.2698040924900925,0.6418739600028299,0.8896672504378283,0.9726669784818078,1.0,8/15,25.33%,SMG6;TERF2IP;TERF1;PINX1;RTEL1;TNKS2;ERCC1;NBN
prerank,regulation of DNA recombination (GO:0000018),0.23501973888109506,0.6411390845824881,0.9150943396226415,0.9728385359924375,1.0,11/32,20.29%,CHEK1;SPIDR;ZRANB3;PPP4R2;TERF2IP;KPNA2;SMARCAD1;KDM1A;MRE11;RTEL1;SHLD2
prerank,protein K63-linked deubiquitination (GO:0070536),-0.20688148212070148,-0.6410825911942835,0.9694444444444444,1.0,1.0,4/31,6.22%,CYLD;OTUD5;USP50;STAMBP
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.23246271362021467,-0.6407859255576434,0.9243902439024391,1.0,1.0,6/18,26.87%,LIG1;MCM3;GINS3;POLE;MCM7;MCMDC2
prerank,inner mitochondrial membrane organization (GO:0007007),0.21920582858332083,0.6405677854657357,0.9546827794561934,0.9729009816291775,1.0,11/47,18.62%,ATP5PO;APOOL;ATP5MC2;CHCHD3;MTX1;ROMO1;ATP5F1E;UQCC3;TMEM11;ATP5MC1;ATP5MF
prerank,rRNA pseudouridine synthesis (GO:0031118),0.2919216103208909,0.6399415297623321,0.8833034111310593,0.9730160189492691,1.0,2/10,16.18%,RPUSD3;NOP10
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2504947880973104,-0.6388354621536682,0.9235955056179775,1.0,1.0,3/14,16.04%,RMND1;C1QBP;FASTKD3
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.22883607990308674,-0.6386596559991532,0.9284009546539379,1.0,1.0,12/17,39.61%,ALG1;ALG12;ALG3;ALG8;DOLK;SRD5A3;MVD;ALG6;DPAGT1;MPDU1;ALG14;ALG13
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.27840074161577605,-0.6385880887931875,0.9202453987730062,0.9994434044638355,1.0,3/10,13.97%,UFD1;C1QBP;NPLOC4
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.27014072127629774,-0.6384482113921061,0.9126436781609195,0.9987012018670276,1.0,2/11,9.77%,TP53;SIRT2
prerank,negative regulation of DNA recombination (GO:0045910),0.21615772745930803,0.6379038807199333,0.940032414910859,0.9742532662916027,1.0,13/43,20.86%,ATRX;POLR2B;UBQLN4;ZRANB3;TERF2IP;TERF1;POLR2D;FBH1;SHLD3;POLR2F;RTEL1;SHLD2;TINF2
prerank,telomere maintenance via telomerase (GO:0007004),-0.20746540260185736,-0.6378272542595885,0.9674185463659147,0.9982868060505867,1.0,9/28,24.66%,ANKRD28;PTGES3;TNKS1BP1;TERF2;GAR1;RFC1;WRAP53;ACD;RAD50
prerank,regulation of centriole replication (GO:0046599),0.2574465335604455,0.6375384099811026,0.9013840830449827,0.9741350137039966,1.0,8/18,25.74%,CEP295NL;NUP62;SPICE1;CEP76;PLK2;NPM1;KAT2B;MDM1
prerank,polyamine metabolic process (GO:0006595),-0.2524673535437647,-0.6370947360093242,0.9049676025917927,0.9979478893456236,1.0,6/13,29.53%,SAT1;SMOX;SMS;HDAC6;ODC1;SRM
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.23328850025634668,-0.6367962628625737,0.9220183486238532,0.9973274514170037,1.0,5/17,23.38%,TREM2;HTRA2;NME5;BAG5;UBQLN1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.17941772956086904,-0.6363790401376118,0.9824046920821115,0.9967673343485032,1.0,11/53,18.14%,AZIN1;PSMD13;PSMD12;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.20496596068408346,-0.6362539255189349,0.9697732997481109,0.9960216153057199,1.0,8/29,21.65%,CNOT7;MAVS;NLRC5;STAT2;MUL1;PTPN11;WNT5A;METTL3
prerank,synaptonemal complex assembly (GO:0007130),-0.24272609016525643,-0.6361944549652395,0.9260089686098655,0.9944294286478955,1.0,4/15,19.16%,BAG6;SYCE2;STAG3;P3H4
prerank,synaptonemal complex organization (GO:0070193),-0.24272609016525643,-0.6361944549652395,0.9260089686098655,0.9944294286478955,1.0,4/15,19.16%,BAG6;SYCE2;STAG3;P3H4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.20308959374512092,-0.6359080535639202,0.9664082687338501,0.993834861519226,1.0,8/31,20.48%,PEX6;TIMM44;PEX10;TOMM40;GRPEL1;TOMM20;TOMM40L;TIMM21
prerank,nucleus organization (GO:0006997),0.21137943556516528,0.6335525344267009,0.9449275362318841,0.9768234253408128,1.0,6/47,12.62%,REEP3;ATXN7;VPS4B;NUP133;CHMP5;NUP98
prerank,membrane depolarization (GO:0051899),0.22880997644009335,0.6334455822677368,0.9184,0.9764858072538002,1.0,1/32,0.51%,P2RX7
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.24835939503445037,0.6333068020247008,0.9168110918544194,0.9761783646378445,1.0,5/21,19.40%,TTC23;SFRP1;STK36;TXNDC15;DLG5
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.2444004059272372,-0.6330457621722488,0.9238329238329238,0.9948204305900505,1.0,2/16,4.56%,BCAP29;ANK2
prerank,regulation of mitochondrial fission (GO:0090140),0.24530960261485862,0.6321641970182951,0.914572864321608,0.9766117683838426,1.0,2/24,4.25%,PRKN;MCU
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.2947084301048271,0.6319487794182794,0.8817005545286506,0.9763710485495145,1.0,10/10,70.55%,KCNE3;SUMO1;CAV1;KCNRG;KCNE5;KCNE1;KCNE2;KCNE4;ANK3;KCNAB1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2669699720633287,-0.6319262865049566,0.919908466819222,0.9938832395995733,1.0,3/11,14.92%,PTK2B;JAK3;IL2RG
prerank,cellular response to interleukin-2 (GO:0071352),-0.2669699720633287,-0.6319262865049566,0.919908466819222,0.9938832395995733,1.0,3/11,14.92%,PTK2B;JAK3;IL2RG
prerank,positive regulation of catalytic activity (GO:0043085),0.22201591051859454,0.6312126990190511,0.9317147192716236,0.9765095581776346,1.0,9/37,17.95%,ATP7A;PSEN1;MAPK14;NHEJ1;BCAS3;NOD2;XRCC4;NCSTN;SLC5A3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.22096452127544142,-0.6309296363827529,0.9312977099236641,0.9936765239043618,1.0,12/23,36.82%,TECR;ACSL4;ACSL6;ACOT7;ACSBG1;DGAT2;ELOVL1;ACSF3;ELOVL7;HACD2;ELOVL6;ELOVL2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.22685668232378073,-0.6301670722032106,0.9544419134396356,0.9933204502701745,1.0,5/19,18.02%,GMPR;TYMS;DGUOK;GMPR2;POLL
prerank,heart process (GO:0003015),-0.24551201579592302,-0.629621595616311,0.9304347826086956,0.992824824196908,1.0,10/14,46.71%,SGCD;SGCZ;GPX1;MYL2;PPCS;RAMP3;ACE;SOD1;TNNI3;SGCG
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.24427794134744996,0.6294336215912302,0.9123102866779089,0.9774649081381559,1.0,10/25,23.29%,ACVR2A;MAPK14;FOXO3;STAT3;PRMT1;ARNT;ABCB10;FAM210B;STAT5B;MAPK11
prerank,nuclear membrane disassembly (GO:0051081),-0.23836356278156756,-0.6272613345994529,0.945054945054945,0.9933892284787469,1.0,7/14,33.19%,AKAP8L;NEK6;CTDNEP1;DCTN1;CDK1;CCNB2;LPIN1
prerank,stabilization of membrane potential (GO:0030322),-0.23680491300127934,-0.6268847013446581,0.9348314606741573,0.9928160661094104,1.0,8/16,34.84%,KCNK2;KCNK12;KCNK9;KCNK6;KCNK10;KCNK3;CHCHD10;KCNK7
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.24140790795722727,-0.6263317173229789,0.9295154185022027,0.9923466907701048,1.0,5/14,34.22%,BCL2L11;TMEM33;FICD;DDRGK1;PTPN1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.28368841367498115,0.6259366433431585,0.898989898989899,0.9796409799107957,1.0,4/11,18.20%,CYCS;UQCRFS1;UQCC3;UQCRC2
prerank,renal absorption (GO:0070293),-0.26393345341898344,-0.6256070937270511,0.9180327868852459,0.991950452476406,1.0,1/10,2.96%,SGK1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.22574367677984045,0.6245812191365487,0.9400630914826499,0.9802043617581788,1.0,8/33,22.23%,FBXW7;CDC73;ATP2B4;PTEN;PTPN6;APPL2;PLCG2;CDKN1B
prerank,amino acid transmembrane transport (GO:0003333),0.21490642134888507,0.6245514765950168,0.9469026548672567,0.9798149816998044,1.0,7/45,17.60%,LRRC8D;SLC38A6;SLC38A1;SLC38A2;SLC7A7;SLC6A6;SLC36A2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.28600080669564887,0.623843407046633,0.8951310861423221,0.9798890091629617,1.0,3/11,16.82%,CCT6A;TERF1;CCT3
prerank,postreplication repair (GO:0006301),0.21419238289982626,0.6238310779762165,0.9476923076923077,0.9794901651810212,1.0,17/45,24.00%,RPS27A;RPA1;POLH;RPA3;UBE2N;WDR33;TRIM25;RFC3;NSMCE1;UBE2A;ZBTB1;POLD2;PCNA;REV1;UBE2V2;UBE2L6;UBC
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2624001925397905,0.6238271007858404,0.9090909090909091,0.9790803834068074,1.0,5/15,22.30%,CDC73;CUL3;KLHL18;PLCG2;NPM1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.21571325316120366,-0.6235345124013333,0.9440559440559441,0.9923980294844204,1.0,6/21,20.66%,BCL2L11;DDIT3;CREB3;PARK7;SYVN1;SELENOS
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.2598740492756075,-0.6222245518571906,0.9296703296703297,0.9923867865435678,1.0,6/11,30.32%,PLCB1;GIGYF1;TSC2;IRS1;AKT1;GHR
prerank,neutral amino acid transport (GO:0015804),0.2372135640636019,0.6222242274976112,0.944,0.9797537046804975,1.0,6/28,17.60%,SLC43A2;SLC38A6;SLC38A1;SLC38A2;SLC6A6;SLC36A2
prerank,negative regulation of biosynthetic process (GO:0009890),0.2575933435498954,0.6221453445785209,0.9131238447319778,0.9794049858939509,1.0,5/16,21.48%,EMILIN1;ABCB7;TRAP1;IL6;CIITA
prerank,regulation of feeding behavior (GO:0060259),0.2792748848788637,0.6220118074962828,0.9211009174311927,0.9790925922684686,1.0,3/11,21.73%,STAT3;EIF2AK4;AGRP
prerank,positive regulation of viral life cycle (GO:1903902),-0.21484673512617417,-0.6197418320897305,0.9515011547344111,0.9930079940314821,1.0,5/22,20.73%,AXL;FMR1;TYRO3;TRIM11;CHMP3
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.28608213818377914,0.6189055096769502,0.8866171003717472,0.9808473492184817,1.0,2/10,14.11%,UBAC2;DERL2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.2851809841891309,0.6186345853677202,0.900952380952381,0.9806201144576681,1.0,4/11,21.75%,FYN;ABCB7;TRAP1;MPV17L
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.16538373605494633,-0.6185544259683686,0.9932432432432432,0.992825309630994,1.0,24/72,31.26%,BIRC2;SKP1;PSMD13;PSMD12;COPS8;PSMD9;PSME3;PSMA4;PSMD8;PSMF1;PSMD4;PSMB8;PSME1;TLR3;MAP3K14;PSMC2;PSMB10;TRAF2;PSMD3;AKT1;PSMC5;BTRC;MALT1;PSME2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.25603599273027733,-0.6178353434105074,0.9076576576576577,0.9923985765278178,1.0,5/11,30.82%,WDR45;ATG9A;WDR45B;PACS2;ATG9B
prerank,tRNA 5'-leader removal (GO:0001682),-0.24426768518954073,-0.6160544963885399,0.9241379310344827,0.992586144244334,1.0,5/13,24.67%,RPP14;POP1;RPP21;PRORP;POP7
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2465195543622431,-0.6151250005265249,0.9232409381663113,0.9922883879249611,1.0,5/13,24.65%,STX3;TMEM35A;ABCA7;GPD1L;TM9SF4
prerank,regulation of chromosome segregation (GO:0051983),0.2586509772369497,0.614586921395115,0.9066427289048474,0.9829368345139446,1.0,5/16,19.57%,PUM2;HORMAD1;CSNK2A2;CSNK2A1;SMC6
prerank,peptide hormone secretion (GO:0030072),-0.20449647811452604,-0.614498809324681,0.9414758269720102,0.9918185462147902,1.0,3/26,9.79%,RIMS2;PTPRN;ADCYAP1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.22242316605098467,0.6141795907913904,0.9321486268174475,0.9827983901477769,1.0,3/30,11.27%,FBXW7;UBE2D3;SREBF2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.26724546797773113,0.612988702261596,0.894927536231884,0.9831540050160018,1.0,1/12,4.79%,IRS2
prerank,plasma membrane repair (GO:0001778),0.2671580185246939,0.6125058011763292,0.9193548387096774,0.9830641056835041,1.0,1/13,3.80%,MYOF
prerank,GPI anchor biosynthetic process (GO:0006506),0.22343077609090362,0.612270550940361,0.9526143790849673,0.9828004916604676,1.0,5/30,16.55%,PGAP1;PIGU;PGAP4;PIGQ;PIGX
prerank,regulation of dopamine secretion (GO:0014059),0.23174636170659516,0.6119041100816254,0.9331103678929766,0.982636750635089,1.0,10/25,25.62%,PRKN;CHRNA4;CHRNB2;SYT3;GDNF;SNCA;SYT11;SYT12;SYT10;DRD3
prerank,outer dynein arm assembly (GO:0036158),-0.23630200979640734,-0.6118092438961386,0.9423963133640553,0.9924163628274292,1.0,4/15,21.79%,DNAH8;DNAH5;ODAD1;ODAD2
prerank,nucleotide biosynthetic process (GO:0009165),0.24456492056410795,0.6117060129643169,0.9263502454991817,0.9823645631548821,1.0,6/18,20.88%,NMNAT3;NMNAT2;PRPS1L1;PRPS1;ME1;HPRT1
prerank,cilium movement (GO:0003341),0.20867130615837548,0.6115130478501096,0.961764705882353,0.9820876703653321,1.0,11/48,20.46%,TTC29;TEKT5;CFAP206;CFAP91;ODAD3;SPEF1;CFAP53;DNAH11;DNAAF5;SPAG17;ADCY10
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.19696596708104863,-0.6110077278971214,0.965,0.992044807502335,1.0,7/28,21.73%,SIRT7;ERCC6;HSF1;PARP3;PARP9;WRAP53;TFIP11
prerank,lysine metabolic process (GO:0006553),0.2735890514156569,0.6109896654175972,0.9139194139194139,0.9815941820191232,1.0,12/12,72.66%,HYKK;PHYKPL;OGDH;AADAT;DLST;CRYM;DLD;AASS;PIPOX;SLC25A21;ALDH7A1;GCDH
prerank,lysine catabolic process (GO:0006554),0.2735890514156569,0.6109896654175972,0.9139194139194139,0.9815941820191232,1.0,12/12,72.66%,HYKK;PHYKPL;OGDH;AADAT;DLST;CRYM;DLD;AASS;PIPOX;SLC25A21;ALDH7A1;GCDH
prerank,inositol phosphate biosynthetic process (GO:0032958),0.27684883414876854,0.6105137859094024,0.9064220183486239,0.9814895214364556,1.0,1/11,4.31%,IP6K3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2416304103970331,0.610277626440589,0.935042735042735,0.9812367417678127,1.0,13/22,28.34%,LATS2;HEXIM2;PTEN;NR2F2;CDKN1C;INCA1;CDKN1B;CEBPA;HEXIM1;PLK1;APC;HHEX;CDKN1A
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.21439819252195785,0.6097067366706381,0.9599383667180277,0.9812012436495086,1.0,11/41,21.55%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;NUP153;ZBTB7A;SLC2A6;NUP35;RAE1
prerank,negative regulation of double-strand break repair (GO:2000780),0.22240918058496578,0.6094476850868624,0.9420529801324503,0.9809492433712351,1.0,7/30,20.83%,RNF169;UBQLN4;FBH1;CYREN;SHLD3;SHLD2;TRIP12
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.24470388031299126,-0.6093291867184768,0.9365750528541226,0.9921106815574683,1.0,6/13,33.95%,SCAMP5;SYT1;CACNA1H;HYAL3;STX1A;CACNA1G
prerank,positive regulation of coagulation (GO:0050820),0.2899418722361278,0.6093189201552093,0.9121495327102803,0.9802035974308518,1.0,3/10,18.04%,ENPP4;ST3GAL4;F2R
prerank,positive regulation of hemostasis (GO:1900048),0.2899418722361278,0.6093189201552093,0.9121495327102803,0.9802035974308518,1.0,3/10,18.04%,ENPP4;ST3GAL4;F2R
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.18648866647577814,0.6090901349281975,0.9884726224783862,0.979936244177672,1.0,12/84,14.87%,PSMA7;RPS27A;RB1;CDC27;PSMB2;CUL3;ANAPC16;PSMA6;PSMA3;PSMD1;PSMD5;ANAPC1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2404190497125418,-0.6090523742496794,0.9361233480176211,0.9914411045262146,1.0,2/13,16.55%,NECTIN2;MR1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.18973307370462014,-0.6086423637098359,0.9811320754716981,0.9908306141736143,1.0,7/33,17.43%,FLCN;MAPT;IAPP;FXN;MUL1;TMEM14A;HUWE1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.2705237587619833,0.6076077932236452,0.9208103130755064,0.9804489348292974,1.0,2/12,8.51%,PRKCB;VRK1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.24186946096290596,-0.6070712295148896,0.9511111111111111,0.9908507962935185,1.0,5/13,34.72%,GAD1;ACOT8;GOT1;ACSF3;ACOT4
prerank,DNA modification (GO:0006304),-0.20877750202089923,-0.605262792457046,0.9736842105263158,0.9909424438240838,1.0,4/22,13.50%,PARP1;TERF2;PARP3;NEIL3
prerank,mitotic cytokinetic process (GO:1902410),0.23836956728018838,0.6023548509060275,0.907608695652174,0.9832206620694265,1.0,3/20,10.87%,RHOA;VPS4B;CHMP5
prerank,regulation of viral release from host cell (GO:1902186),-0.21210495504232935,-0.6011109704902025,0.9543269230769231,0.9920505406369157,1.0,6/21,22.56%,TRIM28;TRIM13;TRIM11;TRIM21;CHMP3;TRIM8
prerank,tRNA modification (GO:0006400),0.19581386857223412,0.6005168710284119,0.9837997054491899,0.9839176451490106,1.0,11/62,14.20%,DTWD2;URM1;TYW1;LCMT2;TRMO;NSUN2;ELP5;TRMT61B;CTU1;CDKAL1;TRIT1
prerank,primary alcohol metabolic process (GO:0034308),0.2284579365040589,0.5997991338567562,0.9510603588907015,0.9839226323558785,1.0,3/25,14.37%,DHRS3;IGF1;RBP4
prerank,anion transmembrane transport (GO:0098656),0.1934622129696175,0.5993732183951032,0.9789325842696629,0.9837617450787108,1.0,11/67,18.52%,SLC16A7;LRRC8D;ABCC1;SLC25A5;SLC6A5;SLC23A1;SLC23A2;SLC25A30;SLC5A6;LRRC8C;SLC25A4
prerank,negative regulation of phosphatase activity (GO:0010923),0.23043634440562605,0.5993689913502832,0.9454855195911414,0.9833545185647181,1.0,2/25,4.76%,PPP1R26;GSK3B
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.2458045660803998,0.5983823369428094,0.910873440285205,0.9835544248132204,1.0,4/18,17.80%,RIPOR2;CUL3;STMN1;ARHGAP35
prerank,cellular respiration (GO:0045333),-0.17757814279200582,-0.5981097332077568,0.9971988795518207,0.9926764486117761,1.0,17/41,35.36%,SDHAF4;SDHB;NDUFS7;SLC25A14;UQCRC1;UQCRB;COX15;MTLN;UQCR10;NDUFS1;SLC25A13;MTFR1;PPARGC1A;MTFR2;ATP5F1D;ETFRF1;OXA1L
prerank,rRNA catabolic process (GO:0016075),-0.2268832178417773,-0.5976661965714025,0.9476190476190476,0.9920688442959331,1.0,2/16,9.97%,EXOSC9;DIS3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.2381605482278674,-0.5972949345743752,0.9574468085106383,0.9914443981723547,1.0,5/14,32.49%,CCDC22;MDFI;SUFU;PKD1;NFKBIE
prerank,organic cation transport (GO:0015695),-0.21655443580914602,-0.5970096431115033,0.9585253456221198,0.9907768026033816,1.0,2/20,10.19%,SLC44A2;SLC25A26
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.25800194668903675,0.5949228829392603,0.9198542805100182,0.9851373629402521,1.0,1/14,2.01%,MEF2C
prerank,T cell homeostasis (GO:0043029),-0.26076436275247217,-0.5943325877644487,0.9512195121951219,0.991196801076483,1.0,7/10,42.17%,NCKAP1L;JAK3;PMAIP1;AKT1;FOXP3;FADD;RIPK3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.24218784355766876,0.5928042356264246,0.9474576271186441,0.9858656391865478,1.0,4/18,15.06%,IWS1;NUP133;PCID2;ENY2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.23280020956486397,0.592301098395067,0.940099833610649,0.9857412100230482,1.0,2/21,7.60%,MITF;MED16
prerank,meiosis I (GO:0007127),0.2249532195005702,0.5902370307946376,0.9575971731448764,0.986496205639776,1.0,2/23,9.22%,MOV10L1;FOXJ3
prerank,regulation of glucose metabolic process (GO:0010906),0.20758610122500837,0.5855431923519133,0.9732704402515723,0.9885438880392777,1.0,5/34,12.35%,PRKN;IRS2;GNMT;FOXK2;FOXK1
prerank,mitotic chromosome condensation (GO:0007076),0.22119133839984978,0.5840144064448891,0.9625850340136054,0.9889077922776304,1.0,2/26,4.87%,PHF8;RB1
prerank,DNA packaging (GO:0006323),0.24397840750266317,0.5835330081283086,0.9497307001795332,0.9887316652092836,1.0,5/16,21.94%,HAT1;BANF1;KAT6A;AIFM1;CHAF1B
prerank,quinone biosynthetic process (GO:1901663),0.2523295183905452,0.582896736804614,0.947935368043088,0.9886427156266256,1.0,6/14,23.51%,PDSS1;UBIAD1;COQ9;COQ5;COQ8A;COQ3
prerank,pseudouridine synthesis (GO:0001522),-0.23598824696252477,-0.5823284051240947,0.9485458612975392,0.9954681733742425,1.0,7/13,40.04%,GAR1;PUS1;PUS7L;PUS3;TRUB2;NHP2;DKC1
prerank,regulation of catecholamine secretion (GO:0050433),0.21371398838535083,0.5817561237929832,0.971947194719472,0.9887930765205681,1.0,11/29,25.62%,PRKN;CHRNA4;CHGA;KCNB1;CHRNB2;SYT3;SNCA;SYT11;SYT12;SYT10;DRD3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.2520632022311513,-0.5814676576280505,0.9375,0.9950106611782795,1.0,2/10,9.59%,SSBP1;CDC7
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.23678854369627136,-0.5807120216409607,0.9486081370449678,0.9944899952337464,1.0,5/12,33.34%,HUS1;CHEK2;TICRR;ORC1;RAD17
prerank,response to peptide (GO:1901652),0.20971819246980947,0.5803599959232325,0.9678456591639871,0.9890497931748075,1.0,7/33,13.90%,STAT4;FYN;STAT6;EIF2B1;NOD2;KAT7;STAT3
prerank,glutamate metabolic process (GO:0006536),-0.20955960858964817,-0.5799876108016985,0.9837209302325581,0.993977962976402,1.0,6/19,28.45%,ALDH18A1;ALDH5A1;PRODH;GAD1;GCLC;GOT1
prerank,positive regulation of cell killing (GO:0031343),0.25025396846214115,0.5797565947603496,0.9400749063670412,0.9889413090025174,1.0,2/13,14.48%,SYK;CYBA
prerank,mitotic sister chromatid segregation (GO:0000070),0.17580308612501144,0.579227730203853,0.9946164199192463,0.9887916877561072,1.0,24/98,21.82%,PHF8;PIBF1;RB1;REC8;VPS4B;PDS5B;CUL3;NUP62;CHMP5;DIS3L2;RAB11A;PINX1;CENPK;RRS1;KIF23;SMC4;KPNB1;CSNK2A2;CSNK2A1;SET;PDCD6IP;NIPBL;MIS12;CEP55
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.2604706989308333,0.578523554882525,0.9327102803738317,0.9887104305407263,1.0,1/12,3.41%,WAC
prerank,ethanol metabolic process (GO:0006067),0.2559954876978112,0.5782830742099069,0.9323583180987203,0.9884082166276088,1.0,1/12,6.32%,SULT1A1
prerank,positive regulation by host of viral transcription (GO:0043923),-0.22166592055792184,-0.5774262886759556,0.9576837416481069,0.9942002549399855,1.0,7/15,32.63%,SMARCB1;JUN;LEF1;CCNT1;HPN;TFAP4;SMARCA4
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.2230133915965679,-0.5765944038195432,0.9621380846325167,0.993683605276314,1.0,7/14,36.75%,ABCD2;TYSND1;MTLN;IRS1;AKT1;PPARA;TWIST1
prerank,negative regulation of nuclear division (GO:0051784),0.2630939131297183,0.5763043215387814,0.9206642066420664,0.9889217993441574,1.0,1/11,6.61%,CHEK1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.26450022373721543,0.5742677191919869,0.935969868173258,0.9894778861168755,1.0,3/10,17.03%,WNK1;CCL5;PODXL
prerank,interstrand cross-link repair (GO:0036297),0.18873090854701255,0.5737971248550302,0.9911764705882353,0.9892717271604531,1.0,11/53,18.67%,RPS27A;DCLRE1C;MCM9;RPA1;XPA;RPA3;MCM8;FANCL;ATR;FANCI;ERCC6L2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.25061379940571005,-0.5721145148160998,0.941908713692946,0.9944668828811097,1.0,5/10,27.35%,ACADL;ACADM;IVD;ACADVL;GCDH
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.25008123743976707,0.5719323803935762,0.9297297297297298,0.9897148903470957,1.0,1/12,7.58%,CCR2
prerank,establishment of mitotic spindle orientation (GO:0000132),0.22294289708513856,0.5712936123013986,0.9629005059021922,0.9896033958357396,1.0,5/23,19.46%,ITGB1;GJA1;PAFAH1B1;UBXN2B;NDEL1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.23330347263309792,-0.5712481519721626,0.975,0.9939861941040041,1.0,6/12,38.47%,LPCAT3;CLCN2;ABCA2;DGKQ;RAN;MBTPS1
prerank,regulation of activated T cell proliferation (GO:0046006),0.20938957230312233,0.5712113443902843,0.9559543230016313,0.9892321937912811,1.0,3/30,9.90%,RPS3;RC3H1;IGF1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.25141480106937414,0.5703581918842167,0.9446564885496184,0.9891951884655084,1.0,3/12,15.60%,RBM4;UHMK1;PTPN14
prerank,ubiquinone biosynthetic process (GO:0006744),0.24398539966272487,0.5696632011956527,0.9532374100719424,0.9890928759146986,1.0,6/15,23.51%,PDSS1;UBIAD1;COQ9;COQ5;COQ8A;COQ3
prerank,protein prenylation (GO:0018342),-0.24128622190128365,-0.5696309211369204,0.9469387755102041,0.9937372783575691,1.0,5/10,35.64%,RABGGTB;FNTA;PTAR1;RABGGTA;FNTB
prerank,axonal transport of mitochondrion (GO:0019896),-0.23764018490809102,-0.5696202626860392,0.9713114754098361,0.9929494617707416,1.0,3/11,22.86%,MAPT;HAP1;HIF1A
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.19351087190044378,0.5693422693781859,0.9846860643185299,0.988824281716227,1.0,11/48,21.55%,PRKAG2;PGAM1;NUP133;NUP62;NUP98;EP300;NUP153;ZBTB7A;SLC2A6;NUP35;RAE1
prerank,serine family amino acid metabolic process (GO:0009069),0.23510018700035296,0.5689978246669474,0.9538188277087034,0.9885739944388373,1.0,3/16,13.56%,DAO;SEPSECS;SHMT1
prerank,nucleoside salvage (GO:0043174),-0.24052260770702028,-0.565010456497405,0.9438444924406048,0.993706147549952,1.0,5/10,40.00%,UPP2;UCKL1;TK2;CDA;TK1
prerank,ncRNA export from nucleus (GO:0097064),-0.17404951615953812,-0.5649884185360916,0.9914285714285714,0.9929224252330867,1.0,17/36,37.39%,NUP210;RANBP2;TSC1;NUP85;SEH1L;AAAS;SEC13;NDC1;NUP93;NUP50;NUP54;NUP214;NUP88;SSB;RAN;NCBP2;NUP205
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.20878086363722131,0.5625072613077952,0.9769357495881383,0.9909196418844239,1.0,10/29,20.86%,RPA1;TERF2IP;TERF1;PPIA;PINX1;HSP90AB1;NOP10;MRE11;RTEL1;TINF2
prerank,tRNA transport (GO:0051031),-0.17328077852017884,-0.5623837732038501,0.9886039886039886,0.992993443871431,1.0,19/35,40.34%,NUP210;RANBP2;NUP85;SEH1L;TOMM20;AAAS;SEC13;NDC1;NUP93;NUP50;NUP54;NUP214;NUP88;SSB;RAN;TOMM20L;NUP205;NUP107;YBX1
prerank,zinc ion transmembrane transport (GO:0071577),-0.1928952436100237,-0.5619906938269729,0.9878345498783455,0.9923297412277071,1.0,7/22,31.64%,SLC39A11;SLC39A13;SLC39A14;SLC39A6;SLC39A1;SLC30A3;SLC39A7
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.21858536137801818,0.5611881854027715,0.9742268041237113,0.991059196529317,1.0,3/22,10.64%,RASSF2;PDGFC;CALM1
prerank,negative regulation of cellular senescence (GO:2000773),-0.225172446780725,-0.5609607609939012,0.9699570815450643,0.9918871570880899,1.0,10/13,41.94%,ZKSCAN3;AKT3;TERF2;FBXO5;RBL1;SIRT1;HMGA2;TWIST1;YBX1;SLC30A10
prerank,negative regulation of histone acetylation (GO:0035067),-0.23479658306070947,-0.5609090392598676,0.9664570230607966,0.9911207021419072,1.0,7/11,35.78%,BRCA1;CTBP1;SIN3A;THAP7;TAF7;SIRT1;NOC2L
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.24797559560342444,0.5602458467799815,0.9379562043795621,0.9910369498579703,1.0,1/12,7.30%,ELOVL5
prerank,UV-damage excision repair (GO:0070914),0.24620164114481882,0.5584970250356107,0.9661016949152542,0.9913097767191306,1.0,2/12,13.59%,XPA;XPC
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.20230125839576138,-0.5583049030409538,0.9735576923076923,0.9911472918361844,1.0,7/18,34.92%,NAALAD2;SMS;SLC25A13;GOT1;FOLH1;GADL1;NIT2
prerank,gastrulation (GO:0007369),0.23336034359832308,0.5572420741928538,0.9548736462093863,0.9913869303685756,1.0,4/15,17.03%,LMBRD1;NPHP3;GPC3;LHX1
prerank,negative regulation of histone modification (GO:0031057),0.2341785298154052,0.5571436172494109,0.9535315985130112,0.9910160815946486,1.0,1/14,4.03%,JARID2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.23542809284936123,0.5571246734967193,0.9580952380952381,0.9906169483455304,1.0,5/15,17.66%,DDR2;CLASP1;MELTF;FAP;IL6
prerank,response to ketone (GO:1901654),0.2148537880112653,0.5563251695552974,0.967741935483871,0.99051886851898,1.0,3/24,11.10%,CCL19;CATSPER3;SLIT3
prerank,atrioventricular valve development (GO:0003171),0.23824389139614477,0.5560388506955116,0.948051948051948,0.9902261812947944,1.0,3/14,15.12%,BMP2;SLIT3;BMPR1A
prerank,epithelial structure maintenance (GO:0010669),0.2468978761043903,0.554843054061117,0.9558011049723757,0.9902355306787427,1.0,2/11,14.37%,NOD2;RBP4
prerank,nucleotide-sugar metabolic process (GO:0009225),0.25193881050590133,0.5544885089903752,0.9436893203883495,0.9899677905343013,1.0,3/12,14.21%,GMDS;GFPT2;EXTL2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.19972128125531285,0.5539240955353558,0.9870340356564019,0.9897704997621198,1.0,11/33,23.23%,CPSF3;SNRPG;SCAF8;MED18;PAPOLA;WDR33;CPSF2;CSTF2T;SNRPE;LSM11;CSTF3
prerank,hydrogen peroxide catabolic process (GO:0042744),0.24889651372831204,0.5532237900611109,0.958029197080292,0.9896211951563584,1.0,3/11,17.04%,PXDN;PRDX3;PRDX2
prerank,mitotic nuclear membrane organization (GO:0101024),0.1850445612149166,0.5529165342959205,0.9896296296296296,0.9889305890306536,1.0,11/51,19.23%,REEP3;NUP133;VRK1;PPP2CA;LBR;NUP98;BANF1;PPP2R2A;LMNA;SUMO1;KPNB1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.1850445612149166,0.5529165342959205,0.9896296296296296,0.9889305890306536,1.0,11/51,19.23%,REEP3;NUP133;VRK1;PPP2CA;LBR;NUP98;BANF1;PPP2R2A;LMNA;SUMO1;KPNB1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.1873296825507267,0.5512076244227234,0.978494623655914,0.9891499134433553,1.0,12/42,20.29%,CHEK1;UBQLN4;SPIDR;PPP4R2;TERF2IP;MMS19;FBH1;KDM1A;ACTR2;SHLD3;RTEL1;SHLD2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.23246865274763662,0.550087646933798,0.96,0.9891399651147482,1.0,5/17,20.86%,TERF2IP;MUTYH;TERF1;MPG;TINF2
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.2236430880067699,-0.5490203598031268,0.9683257918552036,0.99309504258407,1.0,4/12,28.40%,PRPSAP1;GART;PRPSAP2;AMPD2
prerank,protein homotetramerization (GO:0051289),0.1806435703470352,0.546667592620206,0.9940564635958395,0.9899501315502985,1.0,8/49,15.22%,B2M;USP16;GNMT;TRPM2;SHMT1;PKD2L1;PKD2;SAMHD1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.2329253206752417,0.5464480827374188,0.9588785046728971,0.9896212342924632,1.0,2/14,17.66%,TNF;IL6
prerank,nuclear membrane reassembly (GO:0031468),0.18102914143647664,0.5455367634840503,0.9941002949852508,0.9895367305576122,1.0,12/54,19.33%,REEP3;NUP133;VRK1;PPP2CA;LBR;NUP98;BANF1;PPP2R2A;LMNA;SUMO1;KPNB1;UBXN2B
prerank,fatty acid beta-oxidation (GO:0006635),0.17973182106221391,0.5437271333970578,0.9926362297496318,0.9897474870643123,1.0,12/51,20.36%,SLC25A17;EHHADH;ETFDH;ETFA;HADH;HADHA;HADHB;ACAT1;ETFB;ECHDC1;ACOX1;MCAT
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.17154477192790696,-0.5436565239960358,0.9917127071823204,0.993731892743653,1.0,9/33,28.45%,ALDH18A1;ALDH5A1;SIRT4;ALDH4A1;PRODH;DDAH1;CAD;GCLC;GOT1
prerank,erythrocyte development (GO:0048821),0.260575050282267,0.5430703025767734,0.9452830188679245,0.9895593982663566,1.0,3/10,17.18%,SH2B3;ABCB10;ZBTB7A
prerank,nucleoside phosphate catabolic process (GO:1901292),0.2277571496695493,0.5410760606979033,0.9621928166351607,0.9897896366584744,1.0,1/13,3.78%,SMPDL3A
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.2372612562205276,0.5403996929540673,0.968978102189781,0.9896204659878063,1.0,2/13,10.72%,DUSP1;PCID2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.22200704703384128,0.5344351293157388,0.9648798521256932,0.991055961289788,1.0,4/15,19.35%,CMPK1;AK8;ENTPD1;AK4
prerank,methylguanosine-cap decapping (GO:0110156),0.24816495672019473,0.5331987708363567,0.9610136452241715,0.9910225775691534,1.0,2/10,11.37%,DCP1A;DCP2
prerank,cilium-dependent cell motility (GO:0060285),0.20646631338858762,0.5328686592025177,0.9741379310344828,0.9907161285146275,1.0,2/22,8.69%,EFHC1;TEKT5
prerank,hydrogen peroxide metabolic process (GO:0042743),0.20934208222062484,0.5307689662128915,0.9708904109589042,0.9909310356652287,1.0,5/19,19.21%,PXDN;CYBA;PRDX3;PRDX2;ACOX1
prerank,response to steroid hormone (GO:0048545),0.19133669817794774,0.5295347183299292,0.9803600654664485,0.9909034102922016,1.0,6/31,16.37%,NR3C1;CATSPER3;ATP1A3;ATP1A1;CATSPER2;TFPI
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.220612086759771,0.5271030574666797,0.9766187050359713,0.9912034666129899,1.0,4/16,20.29%,KDM4D;KMT5B;SHLD3;SHLD2
prerank,negative regulation of ATPase activity (GO:0032780),0.22401188893136434,0.5266558393997147,0.9618874773139746,0.9909340283353885,1.0,2/16,8.81%,VCPKMT;PLN
prerank,regulation of centrosome cycle (GO:0046605),-0.18912057773183333,-0.5237839091889729,0.9759036144578314,0.997618617561284,1.0,11/21,38.46%,FBXW5;CHMP4B;CHMP3;CHMP4C;CHMP1B;AURKA;SIRT1;CHMP2A;GEN1;CEP131;PKHD1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.1848883444530979,0.5237726487338099,0.9921507064364207,0.991321771139571,1.0,4/37,9.57%,SND1;DNASE1L1;RNASE6;MTREX
prerank,regulation of fibrinolysis (GO:0051917),-0.2114900939239655,-0.5237705985800502,0.9691629955947136,0.9968373704460266,1.0,9/13,47.51%,SERPINE1;APOH;SERPINF2;F11;KLKB1;PLG;F12;THBS1;HRG
prerank,negative regulation of cholesterol transport (GO:0032375),-0.22382825385358018,-0.5219596243363387,0.9758771929824561,0.9964216450634735,1.0,2/10,20.27%,APOC1;ABCA2
prerank,cochlea morphogenesis (GO:0090103),-0.2222865485380206,-0.5168401789979588,0.9749430523917996,0.9966444555911098,1.0,5/10,50.70%,MYO3B;HPN;POU3F4;TBX1;TBX18
prerank,basement membrane organization (GO:0071711),0.2259555919230144,0.5122427603067081,0.9664179104477612,0.9938403004290438,1.0,4/14,14.04%,PXDN;NID2;RAMP2;NTN4
prerank,intracellular protein transmembrane transport (GO:0065002),0.17516523341791435,0.5110530086691674,0.9969742813918305,0.993727591529771,1.0,14/42,25.70%,PEX7;PEX26;ZFAND2B;SEC63;ROMO1;PEX14;DNAJC15;AIFM1;PEX12;GRPEL2;SEC62;DNAJC19;TOMM70;HSPA5
prerank,motor neuron axon guidance (GO:0008045),0.21782395042832547,0.5102494355941815,0.9825783972125436,0.9934945259653383,1.0,3/15,17.03%,SLIT1;NTN1;LHX1
prerank,regulation of muscle contraction (GO:0006937),0.1945252732800234,0.5084596418217432,0.9891135303265941,0.9934898435325915,1.0,1/26,3.13%,TNNT1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.1841092494076283,-0.5075142298717962,0.9903381642512077,0.9975475792639383,1.0,9/19,38.97%,CCDC39;SPEF2;CCDC40;CABYR;NEK10;DNAAF2;SPA17;AQP4;DNAAF1
prerank,sulfur amino acid metabolic process (GO:0000096),0.1938919453316148,0.5065231270179092,0.9934102141680395,0.9935160128535306,1.0,4/24,16.62%,MTR;MSRA;NOX4;MPST
prerank,positive regulation of lipid localization (GO:1905954),0.23378869320322215,0.5050727148111882,0.9746376811594203,0.9934162134124007,1.0,2/11,12.28%,VSTM2A;ZC3H12A
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.21449968995550805,-0.5047345030554224,0.9707724425887265,0.9972264473716516,1.0,5/11,34.86%,PTPRT;VHL;ADIPOR1;SOCS3;SOCS1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.21094777967218498,0.5024053813496376,0.9731182795698925,0.9936021495609649,1.0,2/15,13.67%,ELOVL5;NR1H2
prerank,regulation of acute inflammatory response (GO:0002673),0.20579484456753336,0.5001638613426409,0.9840425531914894,0.9936703345635283,1.0,1/18,6.84%,PLA2G2D
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.1814398671175743,0.5000442792839862,0.9920508744038156,0.9928894798371766,1.0,4/32,12.62%,NOL6;NUP133;NUP62;NUP98
prerank,tRNA export from nucleus (GO:0006409),0.1814398671175743,0.5000442792839862,0.9920508744038156,0.9928894798371766,1.0,4/32,12.62%,NOL6;NUP133;NUP62;NUP98
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.18102266321803107,0.4988471626600765,0.9952380952380953,0.9927303242233566,1.0,4/30,13.87%,HACD4;ELOVL5;TECRL;SLC27A6
prerank,protein palmitoylation (GO:0018345),0.18095886748932968,0.49579231350526465,0.9933333333333333,0.9929516878319853,1.0,5/30,15.73%,ZDHHC14;ZDHHC3;ZDHHC24;ZDHHC20;ZDHHC2
prerank,regulation of transposition (GO:0010528),0.2138148247021269,0.4954311782147746,0.9765625,0.9926111791751379,1.0,2/13,13.53%,SPOCD1;PIWIL2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.17290370975559052,0.49524971990179306,1.0,0.9922393447368681,1.0,12/42,24.00%,RPS27A;RPA1;POLH;RPA3;TRIM25;RFC3;ZBTB1;POLD2;PCNA;REV1;UBE2L6;UBC
prerank,amyloid-beta metabolic process (GO:0050435),0.20940441147506117,0.4941565185350536,0.9855072463768116,0.9920460920104273,1.0,3/16,15.71%,PSEN1;DYRK1A;NCSTN
prerank,inorganic ion transmembrane transport (GO:0098660),-0.19850267466817162,-0.48714764099129393,0.9914346895074947,0.999000366038571,1.0,8/12,48.52%,ABCC9;ABCC8;CACNA1H;P2RX3;TRPM4;RHAG;KCNJ8;ATP1B4
prerank,male gonad development (GO:0008584),-0.15017611183291843,-0.48532767334215743,1.0,0.9984738351568129,1.0,7/34,20.22%,AR;NCOA4;WNT4;MSH2;TGFB2;COL9A3;WNT5A
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.19314726112445116,0.48433425021165216,0.9845094664371773,0.9933868022439245,1.0,5/20,17.43%,SULF2;PRKD2;DSTYK;CREB3L1;SPRY2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.1833438190648998,0.48186403620200013,0.9901960784313726,0.9934012122712916,1.0,3/27,11.02%,FBXL17;RBM4;PPP1CA
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.20087394808854528,0.47179259513644134,0.9820466786355476,0.9945341340584434,1.0,3/15,16.82%,CCT6A;NOP10;CCT3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.17228904545249937,-0.45006781639140325,0.9931662870159453,1.0,1.0,8/16,37.51%,CGAS;PARPBP;RADX;RMI2;SMCHD1;POLQ;RIF1;MAD2L2
prerank,positive regulation of dendrite development (GO:1900006),-0.19440618495093184,-0.4434644741138566,0.9957805907172996,1.0,1.0,2/10,18.29%,ALK;ZDHHC15
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.17775178114299173,-0.4372701071397018,0.9956989247311828,1.0,1.0,1/12,7.75%,GSS
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.16863719522146808,0.42545214945883847,0.998389694041868,0.9988872930734485,1.0,7/22,24.29%,ROCK1;CDKN2C;INPP5K;CDKN1C;DYNLL1;CDKN1B;STAP1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.16804782398713003,0.42404330108031185,0.994991652754591,0.998583352950031,1.0,5/20,21.37%,FKBP5;PPIA;NKTR;FKBP1A;CWC27
prerank,DNA biosynthetic process (GO:0071897),0.17955006365264747,0.42239319010785825,1.0,0.9982895866123214,1.0,4/16,19.50%,POLH;PPIA;RFC3;POLD2
prerank,microtubule-based transport (GO:0099111),-0.17180053579871857,-0.4189967192411735,1.0,1.0,1.0,6/13,37.73%,SPEF2;CCDC40;CABYR;DNAAF2;SPA17;DYNC1I1
prerank,glutathione biosynthetic process (GO:0006750),-0.17775664421691867,-0.4188337815976116,0.9957537154989384,0.9995345755742738,1.0,1/11,7.75%,GSS
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.1812531391260674,0.4175194790250497,0.9944954128440368,0.9981777182264814,1.0,13/13,81.89%,NFATC3;RELA;PPARG;NFIB;POU5F1;SOX9;PDGFB;NFATC4;REST;PPARD;PPARA;BMP4;SRF
prerank,regulation of actin nucleation (GO:0051125),-0.16906271580136858,-0.41577164038474085,0.9978354978354979,0.9988520416121052,1.0,12/12,83.11%,CORO1A;CORO1B;ARFIP1;WASHC5;ARF1;SCIN;WHAMM;VIL1;GSN;PICK1;ARFIP2;ARPIN
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.1519920469512385,0.3933639532566749,1.0,0.9988841630079549,1.0,3/22,17.49%,VKORC1;UBIAD1;RBP1
